# ID	Inflected form	Lemmatised form	Frequency	DDW	Head	Modifier	MainHead
111	COVID-19 pandemic	INFunknownSUP pandemic	166	0	113	40	113	
30047	% CI	% CI	118	0	30049	364	30049	
911	COVID-19 patients	INFunknownSUP patient	83	0	60	40	60	
338	coronavirus disease	coronavirus disease	79	0	209	339	209	
4714	respiratory syndrome	respiratory syndrome	40	0	1936	259	1936	
4712	acute respiratory syndrome	acute respiratory syndrome	40	0	4714	1461	1936	
1320	public health	public health	39	0	120	1321	120	
1272	SARS-CoV-2 infection	INFunknownSUP infection	37	0	41	28	41	
118	mental health	mental health	33	0	120	119	120	
20874	p &lt	p &lt	33	0	4863	13531	4863	
39	COVID-19 infection	INFunknownSUP infection	32	0	41	40	41	
4710	severe acute respiratory syndrome	severe acute respiratory syndrome	32	0	4712	262	1936	
4709	severe acute respiratory syndrome coronavirus	severe acute respiratory syndrome coronavirus	29	0	339	4710	339	
513	older adults	old adult	24	0	515	59	515	
6468	healthcare workers	INFunknownSUP worker	23	0	1136	494	1136	
7	intensive care	intensive care	22	0	9	8	9	
3644	novel coronavirus	novel coronavirus	22	0	339	3645	339	
308	COVID-19 outbreak	INFunknownSUP outbreak	20	0	310	40	310	
6303	mechanical ventilation	mechanical ventilation	19	0	6305	6304	6305	
1325	immune system	immune system	18	0	1327	970	1327	
1836	general population	general population	18	0	1838	1080	1838	
1869	in-hospital mortality	in-hospital mortality	17	0	1197	411	1197	
3561	risk factors	risk factor	17	0	583	1542	583	
36793	P &lt	P &lt	17	0	4863	13223	4863	
6	intensive care unit	intensive care unit	16	0	10	7	10	
382	social distancing	social distancing	16	0	384	383	384	
4962	protective equipment	protective equipment	16	0	3038	1455	3038	
3062	severe COVID-19	severe INFunknownSUP	16	0	40	262	40	
4960	personal protective equipment	personal protective equipment	15	0	4962	4961	3038	
22395	aim of this study	aim of this study	15	0	7070	2087	7070	
2445	chain reaction	chain reaction	15	0	2447	2362	2447	
1031	vaccine hesitancy	vaccine hesitancy	15	0	1033	577	1033	
11674	online version	online version	15	0	4435	541	4435	
4417	health professionals	health professional	15	0	121	120	121	
549	supplementary material	supplementary material	15	0	551	550	551	
2085	cohort study	cohort study	14	0	2087	601	2087	
18435	higher risk	high risk	14	0	1542	322	1542	
1134	care workers	care worker	13	0	1136	9	1136	
2388	online learning	online learning	13	0	2390	541	2390	
313	infectious diseases	infectious disease	13	0	315	64	315	
12349	global pandemic	global pandemic	13	0	113	1954	113	
2836	COVID-19 vaccination	INFunknownSUP vaccination	13	0	437	40	437	
3688	COVID-19 vaccine	INFunknownSUP vaccine	13	0	577	40	577	
4216	infectious disease	infectious disease	13	0	209	64	209	
1346	length of stay	length of stay	12	0	1347	1348	1347	
6281	Coronavirus disease	INFunknownSUP disease	12	0	209	3206	209	
6472	primary care	primary care	12	0	9	75	9	
1813	COVID-19 vaccines	INFunknownSUP vaccine	12	0	681	40	681	
18803	observational study	observational study	12	0	2087	3552	2087	
1795	spike protein	spike protein	12	0	1797	31	1797	
6115	immune response	immune response	12	0	409	970	409	
415	sick leave	sick leave	12	0	417	416	417	
11497	Coronavirus Disease	INFunknownSUP Disease	12	0	5148	3206	5148	
109	impact of the COVID-19 pandemic	impact of the INFunknownSUP pandemic	12	0	110	111	110	
38753	spread of COVID-19	spread of INFunknownSUP	11	0	570	40	570	
21692	clinical trials	clinical trial	11	0	8639	884	8639	
5132	logistic regression	logistic regression	11	0	5036	3803	5036	
6336	COVID-19 Pandemic	INFunknownSUP pandemic	11	0	6338	40	6338	
2443	polymerase chain reaction	polymerase chain reaction	11	0	2445	2444	2447	
31621	significant differences	significant difference	11	0	5663	908	5663	
969	immune responses	immune response	10	0	200	970	200	
5254	odds ratio	odd ratio	10	0	2635	5255	2635	
38214	ill patients	ill patient	10	0	60	4729	60	
20167	sleep quality	sleep quality	10	0	3713	15803	3713	
15224	COVID-19 pneumonia	INFunknownSUP pneumonia	10	0	2369	40	2369	
31981	gustatory dysfunction	gustatory dysfunction	10	0	3856	26634	3856	
14079	Alpha variant	Alpha variant	10	0	939	67	939	
6955	study period	study period	10	0	5677	2087	5677	
1081	adverse events	adverse event	10	0	1083	1082	1083	
14089	respiratory symptoms	respiratory symptom	10	0	86	259	86	
4004	patient care	patient care	10	0	9	2645	9	
1494	clinical characteristics	clinical characteristic	10	0	1496	884	1496	
788	T cells	T cell	10	0	133	789	133	
8957	T cell	T cell	9	0	197	789	197	
5448	clinical outcomes	clinical outcome	9	0	263	884	263	
7690	COVID-19 cases	INFunknownSUP case	9	0	229	40	229	
11427	face coverings	face covering	9	0	11429	731	11429	
149	impact of COVID-19	impact of INFunknownSUP	9	0	110	40	110	
1973	psychological distress	psychological distress	9	0	1975	1380	1975	
5421	PCR testing	PCR testing	9	0	1885	3981	1885	
1792	confidence interval	confidence interval	9	0	1794	1793	1794	
19216	mean age	mean age	9	0	906	194	906	
16141	antibody titers	antibody titer	9	0	8757	5924	8757	
3034	face masks	face mask	8	0	3036	731	3036	
311	neonatal infectious diseases	neonatal infectious disease	8	0	313	312	315	
4129	medical students	medical student	8	0	1177	947	1177	
24	chest CT	chest CT	8	0	26	25	26	
1379	psychological impact	psychological impact	8	0	110	1380	110	
8680	pulmonary rehabilitation	pulmonary rehabilitation	8	0	8682	590	8682	
37457	% confidence interval	% confidence interval	8	0	1792	364	1794	
5890	SARS-CoV-2 antibodies	INFunknownSUP antibody	8	0	929	28	929	
503	herd immunity	herd immunity	7	0	257	504	257	
4976	mortality rates	mortality rate	7	0	83	1197	83	
2755	convenience sample	convenience sample	7	0	2757	2756	2757	
5917	viral load	viral load	7	0	5919	1741	5919	
1196	mortality rate	mortality rate	7	0	1034	1197	1034	
1105	longitudinal strain	longitudinal strain	7	0	1107	1106	1107	
3305	health system	health system	7	0	1327	120	1327	
2969	autoregressive model	INFunknownSUP model	7	0	1078	2970	1078	
19183	adverse effects	adverse effect	7	0	156	1082	156	
10939	urgent need	urgent need	7	0	9579	8129	9579	
2492	cross-sectional study	cross-sectional study	7	0	2087	2493	2087	
4627	SARS-CoV-2 IgG	INFunknownSUP IgG	7	0	928	28	928	
21536	COVID-19 diagnosis	INFunknownSUP diagnosis	7	0	2168	40	2168	
15364	medical staff	medical staff	7	0	11	947	11	
1265	alcohol consumption	alcohol consumption	7	0	1267	1266	1267	
3742	RNA viruses	RNA virus	7	0	2217	1151	2217	
258	respiratory support	respiratory support	7	0	260	259	260	
25878	negative emotions	negative emotion	7	0	25880	1338	25880	
15548	present study	present study	7	0	2087	285	2087	
21919	disease severity	disease severity	7	0	5116	209	5116	
2878	travel restrictions	travel restriction	7	0	2880	2879	2880	
3109	treatment of COVID-19	treatment of INFunknownSUP	7	0	97	40	97	
29078	olfactory dysfunction	olfactory dysfunction	7	0	3856	1702	3856	
3137	pregnant women	pregnant woman	7	0	920	2739	920	
89	CDC guidelines	CDC guideline	7	0	91	90	91	
14223	disease burden	disease burden	7	0	1070	209	1070	
9924	Severe acute respiratory syndrome	severe acute respiratory syndrome	7	0	4712	9925	1936	
1350	early phase	early phase	7	0	1352	55	1352	
38135	seroprevalence of SARS-CoV-2 antibodies	seroprevalence of INFunknownSUP antibody	7	0	4090	5890	4090	
7746	SARS-CoV-2 spike	INFunknownSUP spike	7	0	31	28	31	
20368	online survey	online survey	7	0	967	541	967	
9304	SARS-CoV-2 pandemic	INFunknownSUP pandemic	7	0	113	28	113	
11476	social networks	social network	6	0	4171	383	4171	
9338	nurse managers	nurse manager	6	0	9340	9339	9340	
13316	emergency department	emergency department	6	0	13318	447	13318	
20850	Coronavirus Disease 2019	INFunknownSUP Disease 2019	6	0	20854	11497	20854	
13135	quality of life	quality of life	6	0	3713	1434	3713	
3367	case fatality	case fatality	6	0	3369	3368	3369	
2441	transcription polymerase chain reaction	transcription polymerase chain reaction	6	0	2443	2442	2447	
19633	novel coronavirus disease	novel coronavirus disease	6	0	209	3644	209	
6301	invasive mechanical ventilation	invasive mechanical ventilation	6	0	6303	6302	6305	
17092	college students	college student	6	0	1177	17093	1177	
883	clinical manifestations	clinical manifestation	6	0	885	884	885	
9587	primary outcome	primary outcome	6	0	295	75	295	
3360	respiratory failure	respiratory failure	6	0	1779	259	1779	
167	high levels	high level	6	0	169	13	169	
7812	blood groups	blood group	6	0	2486	3129	2486	
4940	infection control	infection control	6	0	510	41	510	
5150	clinical course	clinical course	6	0	5152	884	5152	
4749	receptor-binding domain	receptor-binding domain	6	0	697	4750	697	
13199	medical equipment	medical equipment	6	0	3038	947	3038	
36597	significant reduction	significant reduction	6	0	490	908	490	
6369	predictive value	predictive value	6	0	1037	4314	1037	
8964	LV LS	INFunknownSUP LS	6	0	8966	8965	8966	
6491	healthcare services	INFunknownSUP service	6	0	5980	494	5980	
9923	Severe acute respiratory syndrome coronavirus	severe acute respiratory syndrome coronavirus	6	0	339	9924	339	
975	palliative care	palliative care	6	0	9	976	9	
4234	vaccination rate	vaccination rate	6	0	1034	437	1034	
3068	viral infections	viral infection	6	0	779	1741	779	
21383	systematic review	systematic review	6	0	1723	343	1723	
12507	current pandemic	current pandemic	6	0	113	443	113	
16885	current study	current study	6	0	2087	443	2087	
5720	public health interventions	public health intervention	6	0	757	1320	757	
6873	infectious period	infectious period	6	0	5677	64	5677	
17723	respiratory distress	respiratory distress	6	0	1975	259	1975	
7219	Saudi Arabia	Saudi Arabia	6	0	7221	7220	7221	
2404	insurance companies	insurance company	6	0	2406	1711	2406	
2439	reverse transcription polymerase chain reaction	reverse transcription polymerase chain reaction	6	0	2441	2440	2447	
3807	risk stratification	risk stratification	6	0	3809	1542	3809	
12250	higher levels	high level	6	0	169	322	169	
2893	problem-focused coping	problem-focused coping	6	0	2895	2894	2895	
9785	Yinqiao powder	INFunknownSUP powder	6	0	9787	9786	9787	
666	South Africa	South Africa	6	0	668	667	668	
5986	health systems	health system	6	0	146	120	146	
1943	social support	social support	6	0	260	383	260	
982	rheumatic disease	rheumatic disease	6	0	209	983	209	
714	substance use	substance use	6	0	292	715	292	
3351	IHTCOVID-19 score	INFunknownSUP score	6	0	1843	3352	1843	
12688	COVID-19 crisis	INFunknownSUP crisis	6	0	408	40	408	
23321	United Kingdom	United Kingdom	6	0	23323	20503	23323	
1132	health care workers	health care worker	6	0	1134	120	1136	
13616	pregnant females	pregnant female	6	0	11037	2739	11037	
14137	healthcare systems	INFunknownSUP system	6	0	146	494	146	
2479	Covid-19 pandemic	INFunknownSUP pandemic	5	0	113	1884	113	
11285	position change	position change	5	0	9215	2825	9215	
84	PTSD symptoms	INFunknownSUP symptom	5	0	86	85	86	
5122	lung involvement	lung involvement	5	0	3599	772	3599	
24668	respiratory distress syndrome	respiratory distress syndrome	5	0	1936	17723	1936	
10253	undocumented infections	undocumented infection	5	0	779	958	779	
318	COVID-19 IU	INFunknownSUP IU	5	0	320	40	320	
30062	healthy subjects	healthy subject	5	0	4893	1021	4893	
33411	hospital setting	hospital setting	5	0	2854	185	2854	
21851	severe COVID-19 infection	severe INFunknownSUP infection	5	0	39	262	41	
2572	age groups	age group	5	0	2486	906	2486	
16567	public health measures	public health measure	5	0	317	1320	317	
9830	negative binomial	negative binomial	5	0	9832	1338	9832	
11694	mass vaccination	mass vaccination	5	0	437	11695	437	
11594	alveolar recruitment	alveolar recruitment	5	0	3518	11595	3518	
3912	COVID-19 symptoms	INFunknownSUP symptom	5	0	86	40	86	
5197	medical professionals	medical professional	5	0	121	947	121	
11904	healthcare personnel	INFunknownSUP personnel	5	0	7664	494	7664	
4874	New York	New York	5	0	4876	1162	4876	
4342	functional complaints	functional complaint	5	0	4344	4225	4344	
34976	GI symptoms	GI symptom	5	0	86	34977	86	
12566	blood tests	blood test	5	0	1365	3129	1365	
14549	ethnic minority	ethnic minority	5	0	14551	2122	14551	
23896	significant changes	significant change	5	0	1336	908	1336	
1877	University Hospital	University Hospital	5	0	1879	50	1879	
22488	non-invasive ventilation	non-invasive ventilation	5	0	6305	22489	6305	
16919	COVID-19 Patients	INFunknownSUP Patients	5	0	3207	40	3207	
7853	% of patients	% of patient	5	0	364	60	364	
7967	OTC supplements	OTC supplement	5	0	7969	7968	7969	
2271	occupational therapy	occupational therapy	5	0	2273	2272	2273	
20220	case series	case series	5	0	8050	3368	8050	
15656	acute stroke	acute stroke	5	0	15219	1461	15219	
24339	respiratory system	respiratory system	5	0	1327	259	1327	
11924	viral infection	viral infection	5	0	41	1741	41	
1246	vaccine acceptance	vaccine acceptance	5	0	1248	577	1248	
3829	Hubei Province	Hubei Province	5	0	3831	3830	3831	
21322	staff cases	staff case	5	0	229	11	229	
15296	odds of hospitalization	odd of hospitalization	5	0	5255	11637	5255	
1851	core outcome	core outcome	5	0	295	1852	295	
4261	RAAS blockade use	INFunknownSUP blockade use	5	0	4263	4143	292	
8824	Medicare beneficiaries	Medicare beneficiary	5	0	8826	2816	8826	
14172	asymptomatic cases	asymptomatic case	5	0	229	1131	229	
22330	human health	human health	5	0	120	2214	120	
32214	United States	United States	5	0	32216	20503	32216	
13103	second wave	second wave	5	0	10210	1279	10210	
3283	clinical practice	clinical practice	5	0	3285	884	3285	
3624	medical education	medical education	5	0	361	947	361	
1887	contact tracing	contact tracing	5	0	1889	1888	1889	
6272	shortness of breath	shortness of breath	5	0	6273	6274	6273	
15099	host cell	host cell	5	0	197	10133	197	
6847	RBC inventory	RBC inventory	5	0	6849	6848	6849	
27757	Secondary outcomes	secondary outcome	5	0	263	27758	263	
6741	eligibility criteria	eligibility criterion	5	0	3649	6742	3649	
20292	healthcare system	INFunknownSUP system	5	0	1327	494	1327	
3813	symptom onset	symptom onset	5	0	1647	3814	1647	
7324	prognostic value	prognostic value	5	0	1037	158	1037	
6661	kidney injury	kidney injury	5	0	713	5169	713	
2153	tract infections	tract infection	5	0	779	2154	779	
1041	gut microbiota	gut microbiota	5	0	429	1042	429	
34100	COVID cohort	INFunknownSUP cohort	5	0	601	1649	601	
14452	decompressive craniectomy	decompressive INFunknownSUP	5	0	14454	14453	14454	
28015	significant impact	significant impact	5	0	110	908	110	
2658	anti-S Abs	INFunknownSUP Abs	5	0	2660	2659	2660	
1161	New Zealand	New Zealand	5	0	1163	1162	1163	
4263	blockade use	blockade use	5	0	292	4145	292	
18198	cerebral microbleeds	cerebral INFunknownSUP	5	0	18200	4322	18200	
12615	World Health Organization	World Health Organization	5	0	12617	5804	1232	
7393	sample size	sample size	5	0	6366	2757	6366	
634	healthcare professionals	INFunknownSUP professional	5	0	121	494	121	
1509	higher rates	high rate	5	0	83	322	83	
25762	physical activity	physical activity	5	0	3990	1242	3990	
4249	large number	large number	5	0	916	4250	916	
7508	CT scan	CT scan	5	0	7510	26	7510	
2987	viral replication	viral replication	5	0	2989	1741	2989	
25806	median age	median age	5	0	906	2634	906	
37570	Omaha System	Omaha System	5	0	19651	11971	19651	
973	paediatric palliative care	paediatric palliative care	5	0	975	974	9	
7745	SARS-CoV-2 spike glycoprotein	INFunknownSUP spike glycoprotein	5	0	7749	7746	7749	
12617	Health Organization	Health Organization	5	0	1232	279	1232	
4404	life expectancy	life expectancy	5	0	4406	1434	4406	
21795	use of face coverings	use of face covering	5	0	292	11427	292	
2151	respiratory tract infections	respiratory tract infection	5	0	2153	259	779	
25601	food choices	food choice	4	0	25603	171	25603	
13768	non-intubated patients	INFunknownSUP patient	4	0	60	13769	60	
13502	suspension of patents	suspension of patent	4	0	13503	13504	13503	
14782	SARS-CoV-2 RNA	INFunknownSUP RNA	4	0	1151	28	1151	
11987	pandemic-focused time	pandemic-focused time	4	0	179	11988	179	
12785	Digital Content	Digital content	4	0	7950	8676	7950	
26959	malignant cerebral stroke	malignant cerebral stroke	4	0	26961	3530	15219	
31630	impact of the pandemic	impact of the pandemic	4	0	110	113	110	
6758	school identity	school identity	4	0	6760	355	6760	
17726	majority of patients	majority of patient	4	0	4481	60	4481	
21701	jail residents	jail resident	4	0	232	7721	232	
2013	effects of the COVID-19 pandemic	effect of the INFunknownSUP pandemic	4	0	156	111	156	
972	paediatric palliative care consultations	paediatric palliative care consultation	4	0	978	973	978	
22801	oral intake	oral intake	4	0	22803	427	22803	
24338	respiratory system compliance	respiratory system compliance	4	0	2726	24339	2726	
746	skin symptoms	skin symptom	4	0	86	161	86	
37545	North America	North America	4	0	37547	37546	37547	
2760	SARS-CoV-2 vaccines	INFunknownSUP vaccine	4	0	681	226	681	
16005	prevention practices	prevention practice	4	0	5378	1294	5378	
791	policy makers	policy maker	4	0	793	293	793	
4548	Western immunoblotting	Western INFunknownSUP	4	0	4550	4549	4550	
24666	acute respiratory distress syndrome	acute respiratory distress syndrome	4	0	24668	1461	1936	
19141	COVID-19 severity	INFunknownSUP severity	4	0	5116	40	5116	
19264	illness-associated cerebral microbleeds	illness-associated cerebral INFunknownSUP	4	0	18198	19265	18200	
30302	Disease Control	Disease Control	4	0	7255	5148	7255	
914	mean number	mean number	4	0	916	194	916	
7702	vaccine clinic	vaccine clinic	4	0	7704	577	7704	
9972	antibody response	antibody response	4	0	409	5924	409	
33580	South Australia	South Australia	4	0	33582	667	33582	
3920	long COVID	long INFunknownSUP	4	0	1649	3921	1649	
12760	ground-glass opacity	ground-glass opacity	4	0	12762	525	12762	
1987	follow-up CT	follow-up CT	4	0	26	175	26	
36868	residential care workers	residential care worker	4	0	1134	9936	1136	
29053	demographic characteristics	demographic characteristic	4	0	1496	1062	1496	
5130	binary logistic regression	binary logistic regression	4	0	5132	5131	5036	
2661	urinary incontinence	urinary incontinence	4	0	2663	2662	2663	
17901	paediatric urologists	paediatric urologist	4	0	17903	974	17903	
12810	recovery time	recovery time	4	0	179	3007	179	
919	women refugees	woman refugee	4	0	921	920	921	
12432	low level	low level	4	0	362	457	362	
1674	national lockdown	national INFunknownSUP	4	0	1676	517	1676	
5949	stress levels	stress level	4	0	169	199	169	
29018	emotional state	emotional state	4	0	1961	6765	1961	
6091	rheumatic disease patients	rheumatic disease patient	4	0	60	982	60	
18527	control cohort	control cohort	4	0	601	510	601	
16183	medical conditions	medical condition	4	0	2910	947	2910	
6576	quality of care	quality of care	4	0	3713	9	3713	
2749	new therapeutics	new therapeutics	4	0	2751	69	2751	
29329	family members	family member	4	0	16766	5380	16766	
5548	SARS-CoV-2 PCR	INFunknownSUP PCR	4	0	3981	28	3981	
14073	virus infection	virus infection	4	0	41	778	41	
1957	NO2 concentrations	INFunknownSUP concentration	4	0	1959	164	1959	
7928	viral epidemics	viral epidemic	4	0	7930	1741	7930	
3780	clinical symptoms	clinical symptom	4	0	86	884	86	
241	pericardial effusion	pericardial effusion	4	0	243	242	243	
5732	pro-inflammatory cytokines	pro-inflammatory cytokine	4	0	5734	5733	5734	
7974	Vero E6 cells	Vero INFunknownSUP cell	4	0	7976	7975	133	
7917	Primary Care	primary Care	4	0	5417	2464	5417	
3818	bowel disease	bowel disease	4	0	209	3819	209	
18483	treatment perceptions	treatment perception	4	0	2955	97	2955	
2812	Dessie City	Dessie City	4	0	2814	2813	2814	
32439	Google Scholar	INFunknownSUP scholar	4	0	6920	3542	6920	
2716	mental health status	mental health status	4	0	2720	118	2720	
3543	mobility data	mobility datum	4	0	22	2102	22	
8400	length of hospital	length of hospital	4	0	1347	185	1347	
12564	routine blood tests	routine blood test	4	0	12566	4898	1365	
6185	clinical data	clinical datum	4	0	22	884	22	
4980	high risk	high risk	4	0	1542	13	1542	
5553	social media	social medium	4	0	661	383	661	
7976	E6 cells	INFunknownSUP cell	4	0	133	7977	133	
14338	food choice	food choice	4	0	12775	171	12775	
6055	teaching strategies	teaching strategy	4	0	300	2074	300	
5978	health services	health service	4	0	5980	120	5980	
14204	health status	health status	4	0	2720	120	2720	
22456	positive attitude	positive attitude	4	0	12193	228	12193	
8103	infected patients	infected patient	4	0	60	1088	60	
5419	weekly PCR testing	weekly PCR testing	4	0	5421	5088	1885	
14118	SARS CoV2	INFunknownSUP INFunknownSUP	4	0	14120	2224	14120	
730	face mask	face mask	4	0	290	731	290	
4851	clinical care	clinical care	4	0	9	884	9	
5203	blood donations	blood donation	4	0	5205	3129	5205	
18801	prospective observational study	prospective observational study	4	0	18803	2084	2087	
26125	significant difference	significant difference	4	0	4260	908	4260	
1777	organ failure	organ failure	4	0	1779	1778	1779	
14757	COVID-19 disease	INFunknownSUP disease	4	0	209	40	209	
2377	seasonal influenza	seasonal influenza	4	0	2323	2378	2323	
8070	health equity	health equity	4	0	305	120	305	
6447	disease transmission	disease transmission	4	0	876	209	876	
7318	asymptomatic infection	asymptomatic infection	4	0	41	1131	41	
4198	surgical procedures	surgical procedure	4	0	4200	663	4200	
23330	remote areas	remote area	4	0	1579	2073	1579	
37070	spread of the virus	spread of the virus	4	0	570	778	570	
11095	ICU admission	ICU admission	4	0	2865	1658	2865	
2972	negative impacts	negative impact	4	0	1385	1338	1385	
8184	PPI use	PPI use	4	0	292	8185	292	
4794	residual disease	residual disease	4	0	209	4795	209	
5791	available evidence	available evidence	4	0	585	832	585	
10528	cancer care	cancer care	4	0	9	773	9	
23056	anti-spike titer	anti-spike titer	4	0	18030	8754	18030	
13869	course of the disease	course of the disease	4	0	5152	209	5152	
8977	exponential growth	exponential growth	4	0	1732	8978	1732	
8116	COVID-19 cohort	INFunknownSUP cohort	4	0	601	40	601	
21240	health workers	health worker	4	0	1136	120	1136	
15242	depression symptoms	depression symptom	4	0	86	1514	86	
10322	multivariable analysis	multivariable analysis	4	0	486	10323	486	
2092	digital pathology	digital pathology	4	0	2094	1094	2094	
10356	camostat mesylate	INFunknownSUP INFunknownSUP	4	0	7804	7866	7804	
3382	pandemic cohort	pandemic cohort	4	0	601	1354	601	
5526	severe cases	severe case	4	0	229	262	229	
1671	sense of coherence	sense of coherence	4	0	1672	1673	1672	
18723	findings of this study	finding of this study	4	0	3390	2087	3390	
29624	telehealth use	telehealth use	4	0	292	304	292	
9032	transmission of SARS-CoV-2	transmission of INFunknownSUP	4	0	876	28	876	
608	critical outcome	critical outcome	4	0	295	223	295	
3074	non COVID-19	non INFunknownSUP	4	0	3076	3075	3076	
7152	vaccination rates	vaccination rate	4	0	83	437	83	
33685	cohort of patients	cohort of patient	4	0	601	60	601	
11841	poor outcome	poor outcome	4	0	295	1372	295	
35377	future pandemics	future pandemic	4	0	103	1367	103	
940	% reduction	% reduction	4	0	490	364	490	
622	angiotensin-converting enzyme	INFunknownSUP enzyme	4	0	624	623	624	
4741	mortality risk	mortality risk	4	0	1542	1197	1542	
33631	side effects	side effect	4	0	156	18996	156	
2633	median ratio	median ratio	4	0	2635	2634	2635	
5878	reproduction number	reproduction number	4	0	916	4645	916	
3751	pair of gloves	pair of glove	4	0	3752	1821	3752	
14532	Quality Index	Quality Index	4	0	7907	14533	7907	
5812	myocardial injury	myocardial injury	4	0	713	5813	713	
14645	vaccine development	vaccine development	4	0	73	577	73	
5466	new variants	new variant	4	0	1002	69	1002	
4516	30-day mortality	30-day mortality	4	0	1197	4517	1197	
4817	blood pressure	blood pressure	4	0	1027	3129	1027	
12081	health care	health care	4	0	9	120	9	
2903	sensitivity analysis	sensitivity analysis	4	0	486	2904	486	
26672	financial education	financial education	4	0	361	547	361	
13180	viral spike	viral spike	4	0	31	1741	31	
6860	dental students	dental student	4	0	1177	5656	1177	
26961	cerebral stroke	cerebral stroke	4	0	15219	4322	15219	
22985	pharmaceutical companies	pharmaceutical company	4	0	2406	16420	2406	
22983	top pharmaceutical companies	top pharmaceutical company	4	0	22985	78	2406	
12783	Supplemental Digital Content	Supplemental Digital content	4	0	12785	12784	7950	
20051	Ct values	Ct value	4	0	825	20052	825	
19879	COVID-19 restrictions	INFunknownSUP restriction	4	0	2880	40	2880	
1725	higher rate	high rate	4	0	1034	322	1034	
34154	hospital length of stay	hospital length of stay	4	0	1346	185	1347	
3770	healthy controls	healthy control	4	0	3772	1021	3772	
9766	COVID-19 lockdowns	INFunknownSUP lockdown	4	0	1486	40	1486	
6266	inflammatory markers	inflammatory marker	4	0	5129	3817	5129	
671	healthcare providers	INFunknownSUP provider	4	0	673	494	673	
24070	S1 protein	INFunknownSUP protein	4	0	1797	23943	1797	
2908	health conditions	health condition	4	0	2910	120	2910	
13036	horse shows	horse show	4	0	13038	13037	13038	
3816	inflammatory bowel disease	inflammatory bowel disease	4	0	3818	3817	209	
17910	oxygen saturation	oxygen saturation	4	0	17912	3956	17912	
764	early stages	early stage	4	0	766	55	766	
36156	meeting people	meeting people	4	0	694	2543	694	
26750	ongoing COVID-19 pandemic	ongoing INFunknownSUP pandemic	4	0	111	1059	113	
9829	negative binomial autoregressive model	negative binomial INFunknownSUP model	4	0	2969	9830	1078	
15062	COVID-19 lockdown	INFunknownSUP INFunknownSUP	4	0	1676	40	1676	
13121	outpatient visits	outpatient visit	3	0	13123	327	13123	
22707	complication rates	complication rate	3	0	83	2206	83	
9213	policy change	policy change	3	0	9215	293	9215	
17744	moral principles	moral principle	3	0	17746	1315	17746	
37744	filtration masks	filtration mask	3	0	3036	145	3036	
11175	Organ Failure Assessment score	Organ failure Assessment score	3	0	11177	11176	1843	
442	current COVID-19 pandemic	current INFunknownSUP pandemic	3	0	111	443	113	
16797	kidney disease	kidney disease	3	0	209	5169	209	
18384	hazard ratio	hazard ratio	3	0	2635	17554	2635	
16572	reverse transcription-polymerase chain reaction	reverse transcription-polymerase chain reaction	3	0	16574	2440	2447	
22892	care providers	care provider	3	0	673	9	673	
4487	initial infection	initial infection	3	0	41	335	41	
6098	prioritization score	prioritization score	3	0	1843	3209	1843	
24067	high-need patients	INFunknownSUP patient	3	0	60	6507	60	
11177	Failure Assessment score	failure Assessment score	3	0	11179	11178	1843	
37411	COVID-19 patients	INFunknownSUP patient	3	0	60	3706	60	
17389	retrospective study	retrospective study	3	0	2087	10146	2087	
21707	skin problems	skin problem	3	0	6766	161	6766	
28236	mental health care	mental health care	3	0	12081	119	9	
16621	non-coding RNAs	INFunknownSUP INFunknownSUP	3	0	16623	16622	16623	
2587	Arabic health information	Arabic health information	3	0	2591	2588	2591	
3217	COVID-19-positive patients	COVID-19-positive patient	3	0	60	3218	60	
1626	elective spine surgery	elective spine surgery	3	0	1628	1627	1630	
14012	Acute Respiratory Syndrome Coronavirus	acute respiratory syndrome INFunknownSUP	3	0	14014	14013	3206	
4396	SARS-CoV-2 virus	INFunknownSUP virus	3	0	778	28	778	
14337	food choice determinants	food choice determinant	3	0	14341	14338	14341	
12671	nursing problems	nursing problem	3	0	6766	1209	6766	
37742	high filtration masks	high filtration mask	3	0	37744	13	3036	
4513	higher mortality	high mortality	3	0	1197	322	1197	
6659	acute kidney injury	acute kidney injury	3	0	6661	1461	713	
9702	onset of symptoms	onset of symptom	3	0	1647	86	1647	
31436	Charlson Comorbidity Index	Charlson INFunknownSUP Index	3	0	31438	31437	7907	
8464	Alert Level	Alert Level	3	0	8466	8465	8466	
36349	adjusted odds ratio	adjusted odd ratio	3	0	5254	36350	2635	
23338	social measures	social measure	3	0	317	383	317	
7177	Impact of COVID-19	impact of INFunknownSUP	3	0	802	40	802	
9495	mathematical model	mathematical model	3	0	1078	5598	1078	
9827	zero-inflated negative binomial autoregressive model	zero-inflated negative binomial INFunknownSUP model	3	0	9829	2966	1078	
9626	non-communicable diseases	non-communicable disease	3	0	315	9627	315	
20800	follow-up period	follow-up period	3	0	5677	175	5677	
7323	prognostic value of biventricular longitudinal strain	prognostic value of biventricular longitudinal strain	3	0	7324	7327	1037	
23227	medical schools	medical school	3	0	6421	947	6421	
35408	weeks PO	week po	3	0	35410	18278	35410	
3141	outpatient care	outpatient care	3	0	9	327	9	
3973	learning models	learning model	3	0	3975	2390	3975	
10516	infection patterns	infection pattern	3	0	548	41	548	
22442	female workers	female worker	3	0	1136	3041	1136	
26851	pre-pandemic period	pre-pandemic period	3	0	5677	16137	5677	
10630	infectious disease surveillance	infectious disease surveillance	3	0	2795	4216	2795	
3607	syndrome coronavirus-2	syndrome INFunknownSUP	3	0	3609	1936	3609	
13929	control measures	control measure	3	0	317	510	317	
5778	bad obstetric history	bad obstetric history	3	0	5780	5779	5381	
27986	mild symptoms	mild symptom	3	0	86	10809	86	
25732	further research	further research	3	0	36	7713	36	
9873	vaccination coverage	vaccination coverage	3	0	4933	437	4933	
4721	death rate	death rate	3	0	1034	4722	1034	
20390	innovative strategies	innovative strategy	3	0	300	18587	300	
7883	tissue damage	tissue damage	3	0	5946	4974	5946	
5400	food categories	food category	3	0	5402	171	5402	
23124	health care professionals	health care professional	3	0	23126	120	121	
3603	acute respiratory syndrome coronavirus-2	acute respiratory syndrome INFunknownSUP	3	0	3605	1461	3609	
17835	binding sites	binding site	3	0	9165	2921	9165	
29490	antibody levels	antibody level	3	0	169	5924	169	
38579	linear regression	linear regression	3	0	5036	8845	5036	
32448	household affordances	household affordance	3	0	32450	18468	32450	
3366	case fatality rates	case fatality rate	3	0	83	3367	83	
34258	physical distancing	physical distancing	3	0	384	1242	384	
4639	laboratory tests	laboratory test	3	0	1365	1392	1365	
24041	S1-ACE2 complex	INFunknownSUP complex	3	0	10445	24042	10445	
30931	older individuals	old individual	3	0	1113	59	1113	
12553	patient outcomes	patient outcome	3	0	263	2645	263	
2884	virus spread	virus spread	3	0	570	778	570	
1628	spine surgery	spine surgery	3	0	1630	1629	1630	
7563	thematic analysis	thematic analysis	3	0	486	7564	486	
3411	symptom-checking mobile application	INFunknownSUP mobile application	3	0	3413	3412	125	
927	IgG antibodies	IgG antibody	3	0	929	928	929	
12308	controlled trials	controlled trial	3	0	8639	1270	8639	
198	stress responses	stress response	3	0	200	199	200	
5998	early stage	early stage	3	0	1521	55	1521	
24092	literature review	literature review	3	0	1723	4698	1723	
821	high school	high school	3	0	355	13	355	
3605	respiratory syndrome coronavirus-2	respiratory syndrome INFunknownSUP	3	0	3607	259	3609	
16724	teaching hospital	teaching hospital	3	0	185	2074	185	
15837	Gabrin sign	INFunknownSUP sign	3	0	15839	15838	15839	
15118	primary endpoint	primary endpoint	3	0	10303	75	10303	
1500	Clinical characteristics	clinical characteristic	3	0	1496	1501	1496	
27529	severe disease	severe disease	3	0	209	262	209	
27637	low-SVI areas	INFunknownSUP area	3	0	1579	27638	1579	
21776	situations of emergencies	situation of emergency	3	0	17091	8094	17091	
16574	transcription-polymerase chain reaction	transcription-polymerase chain reaction	3	0	2445	16575	2447	
2752	serological assays	serological assay	3	0	2754	2753	2754	
12855	Chinese hospitals	Chinese hospital	3	0	76	1968	76	
14362	protective effect	protective effect	3	0	1809	1455	1809	
34523	COVID-19 epidemic	INFunknownSUP epidemic	3	0	6542	40	6542	
9133	unprecedented challenges	unprecedented challenge	3	0	2220	5915	2220	
24192	global COVID-19 pandemic	global INFunknownSUP pandemic	3	0	111	1954	113	
17783	evidence base	evidence base	3	0	3323	585	3323	
4675	aerosol-generating procedures	aerosol-generating procedure	3	0	4200	4676	4200	
19022	wildlife protection	wildlife protection	3	0	440	19023	440	
14657	viral diseases	viral disease	3	0	315	1741	315	
10337	public sphere	public sphere	3	0	10339	1321	10339	
22512	P-value &lt	P-value &lt	3	0	22514	22513	22514	
16225	inclusion criteria	inclusion criterion	3	0	3649	1787	3649	
3261	independent predictors	independent predictor	3	0	414	582	414	
7984	lung weight	lung weight	3	0	2711	772	2711	
28536	elderly patients	elderly patient	3	0	60	1329	60	
979	community-engaged research	community-engaged research	3	0	36	980	36	
8352	different patients	different patient	3	0	60	688	60	
28906	statistical significance	statistical significance	3	0	458	5263	458	
11728	therapeutic target	therapeutic target	3	0	11730	3349	11730	
22890	health care providers	health care provider	3	0	22892	120	673	
7360	literature search	literature search	3	0	344	4698	344	
9148	cutaneous manifestations	cutaneous manifestation	3	0	885	9149	885	
17254	standard drinks/day/1000 people	standard INFunknownSUP people	3	0	17256	2056	694	
6794	infection rates	infection rate	3	0	83	41	83	
9473	prevalence of COVID-19	prevalence of INFunknownSUP	3	0	9272	40	9272	
30464	virus-neutralizing antibody titers	INFunknownSUP antibody titer	3	0	16141	30465	8757	
14932	composite poor outcome	composite poor outcome	3	0	11841	10302	295	
36129	kynurenic acid	INFunknownSUP acid	3	0	7492	36130	7492	
7560	care of patients	care of patient	3	0	9	60	9	
33649	ethnic minority backgrounds	ethnic minority background	3	0	33653	14549	33653	
32970	percentage of healthcare personnel	percentage of INFunknownSUP personnel	3	0	3789	11904	3789	
25948	preventative measures	preventative measure	3	0	317	25949	317	
24138	different countries	different country	3	0	1599	688	1599	
27259	correlation analysis	correlation analysis	3	0	486	2889	486	
15506	IgY purification	IgY purification	3	0	15508	13004	15508	
4185	complete resolution	complete resolution	3	0	1448	4186	1448	
4097	purpose of this study	purpose of this study	3	0	4098	2087	4098	
1621	European countries	European country	3	0	1599	1622	1599	
2934	lung injury	lung injury	3	0	713	772	713	
10578	clinical presentation	clinical presentation	3	0	4163	884	4163	
3343	pediatric population	pediatric population	3	0	1838	3344	1838	
36696	S protein	S protein	3	0	1797	6831	1797	
2823	supine position	supine position	3	0	2825	2824	2825	
9019	scoping review	INFunknownSUP review	3	0	1723	9020	1723	
2169	obese patients	obese patient	3	0	60	2170	60	
29060	COVID-19 mortality	INFunknownSUP mortality	3	0	1197	40	1197	
3413	mobile application	mobile application	3	0	125	3414	125	
3620	levels of stress	level of stress	3	0	169	199	169	
3740	evolution of RNA viruses	evolution of RNA virus	3	0	3741	3742	3741	
21050	halo effect	halo effect	3	0	1809	21051	1809	
708	male patient	male patient	3	0	710	709	710	
6892	preventive measures	preventive measure	3	0	317	6893	317	
13579	transmission rate	transmission rate	3	0	1034	876	1034	
13536	times of acute crisis	time of acute crisis	3	0	12806	13538	12806	
16879	early detection	early detection	3	0	44	55	44	
3286	Respiratory failure	respiratory failure	3	0	1779	3287	1779	
20216	greater risk	great risk	3	0	1542	302	1542	
11221	symptomatic breast services	symptomatic breast service	3	0	11223	38	5980	
28854	terms of healthcare services	term of INFunknownSUP service	3	0	4908	6491	4908	
131	endothelial cells	endothelial cell	3	0	133	132	133	
18079	SARS-CoV-2 reinfection	INFunknownSUP reinfection	3	0	1451	226	1451	
9944	incidence rate	incidence rate	3	0	1034	2940	1034	
12916	primary schools	primary school	3	0	6421	75	6421	
17084	preferential option	preferential option	3	0	5022	13806	5022	
28540	Intensive Care Unit	intensive Care Unit	3	0	28542	28541	16875	
9478	seasonal coronaviruses	seasonal coronavirus	3	0	8796	2378	8796	
8144	food preferences	food preference	3	0	2599	171	2599	
39308	resource-limited settings	resource-limited setting	3	0	2729	18990	2729	
786	CD8 T cells	INFunknownSUP T cell	3	0	788	787	133	
12426	basic needs	basic need	3	0	3189	4643	3189	
24443	semen quality	semen quality	3	0	3713	9755	3713	
2890	coronavirus outbreaks	coronavirus outbreak	3	0	2892	339	2892	
28580	online questionnaire	online questionnaire	3	0	9620	541	9620	
15559	laboratory findings	laboratory finding	3	0	3390	1392	3390	
1850	core outcome measures	core outcome measure	3	0	317	1851	317	
21032	air purifier	air purifier	3	0	21034	868	21034	
11223	breast services	breast service	3	0	5980	11224	5980	
30850	influenza vaccination	influenza vaccination	3	0	437	2323	437	
1489	IBD patients	INFunknownSUP patient	3	0	60	1490	60	
18867	acute respiratory syndrome-coronavirus	acute respiratory syndrome-coronavirus	3	0	18869	1461	18871	
19480	sensory appeal	sensory appeal	3	0	19482	19481	19482	
2916	serine protease	serine protease	3	0	2918	2917	2918	
12261	active ingredients	active ingredient	3	0	12263	3597	12263	
11179	Assessment score	Assessment score	3	0	1843	2874	1843	
3682	work engagement	work engagement	3	0	3684	2162	3684	
24830	duration of hospitalization	duration of hospitalization	3	0	7404	11637	7404	
160	skin lesions	skin lesion	3	0	162	161	162	
38367	Sub-Saharan Africa	Sub-Saharan Africa	3	0	668	38368	668	
206	Rheumatic disease patients	rheumatic disease patient	3	0	60	207	60	
537	effects of COVID-19	effect of INFunknownSUP	3	0	156	40	156	
8786	potential mentors	potential mentor	3	0	8788	1276	8788	
1428	real-time RT-PCR	real-time INFunknownSUP	3	0	1430	1429	1430	
22822	confidence intervals	confidence interval	3	0	22087	1793	22087	
16073	arthroplasty procedures	INFunknownSUP procedure	3	0	4200	4243	4200	
28060	certainty of evidence	certainty of evidence	3	0	17649	585	17649	
22820	% confidence intervals	% confidence interval	3	0	22822	364	22087	
2588	Arabic health	Arabic health	3	0	120	2589	120	
8561	control group	control group	3	0	18	510	18	
17256	drinks/day/1000 people	INFunknownSUP people	3	0	694	17257	694	
12940	symptomatic cases	symptomatic case	3	0	229	38	229	
2627	pandemic response	pandemic response	3	0	409	1354	409	
21868	papillary necrosis	papillary necrosis	3	0	5738	21869	5738	
5646	exercise training	exercise training	3	0	235	4799	235	
9093	stress disorder	stress disorder	3	0	7358	199	7358	
5081	research approach	research approach	3	0	1538	36	1538	
11173	Sepsis-related Organ Failure Assessment score	Sepsis-related Organ failure Assessment score	3	0	11175	11174	1843	
22217	pneumonia models	pneumonia model	3	0	3975	2369	3975	
16071	knee arthroplasty procedures	knee INFunknownSUP procedure	3	0	16073	4241	4200	
12226	voice quality	voice quality	3	0	3713	12227	3713	
13538	acute crisis	acute crisis	3	0	408	1461	408	
7810	ABO blood groups	ABO blood group	3	0	7812	5208	2486	
7327	biventricular longitudinal strain	biventricular longitudinal strain	3	0	1105	7328	1107	
16461	reperfusion therapies	reperfusion therapy	3	0	5507	16462	5507	
2182	factor analysis	factor analysis	3	0	486	2183	486	
20693	rural areas	rural area	3	0	1579	8823	1579	
11519	viral RNA	viral RNA	3	0	1151	1741	1151	
2459	population immunity	population immunity	3	0	257	1838	257	
5297	new coronavirus	new coronavirus	3	0	339	69	339	
5209	blood group	blood group	3	0	18	3129	18	
2668	Syrian hamster	Syrian hamster	3	0	2670	2669	2670	
18446	100-mug dose	INFunknownSUP dose	3	0	2537	18447	2537	
14010	Severe Acute Respiratory Syndrome Coronavirus	Severe acute respiratory syndrome INFunknownSUP	3	0	14012	5189	3206	
17196	data analysis	datum analysis	3	0	486	22	486	
7526	mental health services	mental health service	3	0	5980	118	5980	
15860	SARS-CoV-2 transmission	INFunknownSUP transmission	3	0	876	28	876	
5688	CT features	CT feature	3	0	1469	26	1469	
6260	few months	few month	3	0	761	6261	761	
20973	pandemic waves	pandemic wave	3	0	1281	1354	1281	
20828	virtual horse shows	virtual horse show	3	0	13036	3148	13038	
1157	18F-FDG PET/CT	INFunknownSUP INFunknownSUP	3	0	1159	1158	1159	
7024	extracellular vesicles	extracellular vesicle	3	0	7026	7025	7026	
23593	CLEAR methodology	clear methodology	3	0	11687	422	11687	
29434	older age	old age	3	0	906	59	906	
5780	obstetric history	obstetric history	3	0	5381	5781	5381	
35690	residency programs	residency program	3	0	2246	35691	2246	
32355	lymphocyte count	lymphocyte count	3	0	1305	18645	1305	
8461	main protease	main protease	3	0	2918	4679	2918	
7108	objective of this study	objective of this study	3	0	3611	2087	3611	
13418	phthalate exposure	phthalate exposure	3	0	1054	13419	1054	
28601	AL amyloidosis	al INFunknownSUP	3	0	28603	7846	28603	
23126	care professionals	care professional	3	0	121	9	121	
18755	policy changes	policy change	3	0	1336	293	1336	
3428	low-income countries	low-income country	3	0	1599	953	1599	
13163	total number	total number	3	0	916	1485	916	
1775	multiple organ failure	multiple organ failure	3	0	1777	1776	1779	
798	spread of SARS-CoV-2	spread of INFunknownSUP	3	0	570	28	570	
107	economic impact of the COVID-19 pandemic	economic impact of the INFunknownSUP pandemic	3	0	109	108	110	
6471	primary care practices	primary care practice	3	0	5378	6472	5378	
24785	coronavirus outbreak	coronavirus outbreak	3	0	310	339	310	
2351	available data	available datum	3	0	22	832	22	
18942	screening strategy	screening strategy	3	0	3350	7961	3350	
25499	light of CST	light of CST	3	0	8068	25501	8068	
7006	prior year	prior year	3	0	3822	5165	3822	
23230	HepaRG cells	INFunknownSUP cell	3	0	133	23231	133	
21305	prevalence of vaccine hesitancy	prevalence of vaccine hesitancy	3	0	9272	1031	9272	
2967	Poisson autoregressive model	Poisson INFunknownSUP model	3	0	2969	2968	1078	
11185	BNT162b2 vaccine	INFunknownSUP vaccine	3	0	577	574	577	
9794	era of COVID-19	era of INFunknownSUP	3	0	9542	40	9542	
3601	severe acute respiratory syndrome coronavirus-2	severe acute respiratory syndrome INFunknownSUP	3	0	3603	262	3609	
10467	mainland China	mainland China	3	0	4295	10468	4295	
5064	pediatric patients	pediatric patient	3	0	60	3344	60	
2855	male patients	male patient	3	0	60	709	60	
18299	NLRP3 inflammasome	INFunknownSUP INFunknownSUP	3	0	18301	6317	18301	
2243	financial well-being	financial well-being	3	0	2245	547	2245	
7204	effects of the pandemic	effect of the pandemic	3	0	156	113	156	
34425	remote evaluations	remote evaluation	3	0	2456	2073	2456	
28167	comparative analysis	comparative analysis	3	0	486	5624	486	
10607	pandemic capacity	pandemic capacity	3	0	3026	113	3026	
4338	rapid response	rapid response	3	0	409	795	409	
10301	composite endpoint	composite endpoint	3	0	10303	10302	10303	
291	use policy	use policy	3	0	293	292	293	
2374	mitigation strategies	mitigation strategy	3	0	300	2375	300	
16056	COVID-19-related information	COVID-19-related information	3	0	2591	1384	2591	
14014	Respiratory Syndrome Coronavirus	respiratory syndrome INFunknownSUP	3	0	14016	3287	3206	
24223	response rate	response rate	3	0	1034	409	1034	
16472	preparatory school	preparatory school	3	0	355	16473	355	
8030	liver disease	liver disease	3	0	209	1138	209	
227	positive cases	positive case	3	0	229	228	229	
25468	non-pharmaceutical interventions	non-pharmaceutical intervention	3	0	757	25469	757	
7662	medical personnel	medical personnel	3	0	7664	947	7664	
5458	heart failure	heart failure	3	0	1779	2275	1779	
17315	triage pathway	triage pathway	3	0	5003	6258	5003	
34812	high-SVI areas	INFunknownSUP area	3	0	1579	34813	1579	
15	socioeconomic standard	socioeconomic standard	3	0	17	16	17	
3615	COVID-19 Outbreak	INFunknownSUP outbreak	3	0	3617	40	3617	
937	new variant	new variant	3	0	939	69	939	
11420	social isolation	social isolation	3	0	6569	383	6569	
2463	Primary outcome	primary outcome	3	0	295	2464	295	
22047	important determinants	important determinant	3	0	14341	273	14341	
33204	asymptomatic patients	asymptomatic patient	3	0	60	1131	60	
18070	treatment program	treatment program	3	0	1790	97	1790	
28065	SARS-CoV-2 infection	INFunknownSUP infection	3	0	41	226	41	
2914	transmembrane serine protease	INFunknownSUP serine protease	3	0	2916	2915	2918	
8768	personal hygiene	personal hygiene	3	0	8770	4961	8770	
15893	clinical trial	clinical trial	3	0	965	884	965	
14432	medical equipment management	medical equipment management	3	0	743	13199	743	
14229	replacement therapy	replacement therapy	3	0	2273	14230	2273	
5346	error rate	error rate	3	0	1034	373	1034	
15139	lower gestational age	low gestational age	3	0	15141	594	906	
15274	emotional difficulties	emotional difficulty	3	0	8240	6765	8240	
13374	high level	high level	3	0	362	13	362	
7676	COVID-19 information	INFunknownSUP information	3	0	2591	40	2591	
18865	severe acute respiratory syndrome-coronavirus	severe acute respiratory syndrome-coronavirus	3	0	18867	262	18871	
19466	COVID-19 COVID-19	INFunknownSUP INFunknownSUP	3	0	40	40	40	
28978	retrospective cohort study	retrospective cohort study	3	0	2085	10146	2087	
23492	chest CT scan	chest CT scan	3	0	7510	24	7510	
183	care hospital	care hospital	3	0	185	9	185	
4105	eye wear	eye wear	3	0	4107	4106	4107	
2965	zero-inflated Poisson autoregressive model	zero-inflated Poisson INFunknownSUP model	3	0	2967	2966	1078	
2295	heart rate	heart rate	3	0	1034	2275	1034	
8285	oxygen support	oxygen support	3	0	260	3956	260	
19262	Critical illness-associated cerebral microbleeds	critical illness-associated cerebral INFunknownSUP	3	0	19264	19263	18200	
31438	Comorbidity Index	INFunknownSUP Index	3	0	7907	31439	7907	
14016	Syndrome Coronavirus	syndrome INFunknownSUP	3	0	3206	14017	3206	
7750	nosocomial outbreak	INFunknownSUP outbreak	3	0	310	6858	310	
7450	observation period	observation period	3	0	5677	7451	5677	
10362	positive results	positive result	3	0	325	228	325	
23689	IgG levels	IgG level	3	0	169	928	169	
7828	care services	care service	3	0	5980	9	5980	
38418	epigenetic mechanism	epigenetic mechanism	3	0	10036	38419	10036	
18041	olfactory gyrus	olfactory gyrus	3	0	18043	1702	18043	
22237	pairs of gloves	pair of glove	3	0	22238	1821	22238	
13734	surgical mask	surgical mask	3	0	290	663	290	
16003	COVID-19 prevention practices	INFunknownSUP prevention practice	3	0	16005	40	5378	
11981	cardiac involvement	cardiac involvement	3	0	3599	3858	3599	
24001	room personnel	room personnel	3	0	7664	5742	7664	
1602	restrictive policy	restrictive policy	3	0	293	1603	293	
30477	protective measures	protective measure	3	0	317	1455	317	
35924	interquartile range	INFunknownSUP range	3	0	420	35925	420	
18729	prostate cancer	prostate cancer	3	0	773	18730	773	
207	Rheumatic disease	rheumatic disease	3	0	209	208	209	
22088	validation cohort	validation cohort	3	0	601	6319	601	
21577	mucosal vaccine	mucosal vaccine	3	0	577	21578	577	
18869	respiratory syndrome-coronavirus	respiratory syndrome-coronavirus	3	0	18871	259	18871	
5156	viral shedding	viral shedding	3	0	5158	1741	5158	
3240	significant increase	significant increase	3	0	392	908	392	
15141	gestational age	gestational age	3	0	906	15142	906	
1188	IoT MEMS	INFunknownSUP mem	3	0	1190	1189	1190	
1478	fewer resident	few resident	3	0	1480	1479	1480	
30023	detection of COVID-19	detection of INFunknownSUP	3	0	44	40	44	
16611	social position	social position	3	0	2825	383	2825	
6367	negative predictive value	negative predictive value	3	0	6369	1338	1037	
22130	incident AKI	incident Aki	3	0	13007	11330	13007	
37442	cases of COVID-19	case of INFunknownSUP	3	0	229	40	229	
37693	cell entry	cell entry	3	0	5629	197	5629	
3264	adverse outcomes	adverse outcome	3	0	263	1082	263	
3971	deep learning models	deep learning model	3	0	3973	2520	3975	
7933	management time	management time	3	0	179	743	179	
28542	Care Unit	Care Unit	3	0	16875	5417	16875	
22764	essential workers	essential worker	3	0	1136	4197	1136	
5678	Experimental results	experimental result	3	0	325	5679	325	
581	independent factors	independent factor	3	0	583	582	583	
16630	clinical study	clinical study	2	0	2087	884	2087	
21280	secondary cases	secondary case	2	0	229	712	229	
24404	ROC curve	roc curve	2	0	6817	24405	6817	
19304	Libyan hospitals	Libyan hospital	2	0	76	19305	76	
30244	rapid responses	rapid response	2	0	200	795	200	
13760	energy devices	energy device	2	0	6162	4543	6162	
20065	ease of use	ease of use	2	0	20066	292	20066	
23666	protective role	protective role	2	0	7288	1455	7288	
25837	structured method	structured method	2	0	6587	6409	6587	
3114	low-grade inflammation	low-grade inflammation	2	0	3116	3115	3116	
36882	empirical antimicrobial prescription	empirical antimicrobial prescription	2	0	36884	4924	36886	
25433	prominent role	prominent role	2	0	7288	23139	7288	
18282	fuzzy environment	fuzzy environment	2	0	3454	18283	3454	
13855	emergency department access	emergency department access	2	0	224	13316	224	
4287	long-term consequences	long-term consequence	2	0	4289	4288	4289	
34342	- January	INFunknownSUP January	2	0	34344	5345	34344	
11098	drug metabolism	drug metabolism	2	0	7776	352	7776	
9000	nasal oxygen	nasal oxygen	2	0	3956	1472	3956	
7589	discussion of the effects of the COVID-19 pandemic	discussion of the effect of the INFunknownSUP pandemic	2	0	3060	2013	3060	
29305	severity of illness	severity of illness	2	0	5116	1069	5116	
23277	post-traumatic stress disorder	post-traumatic stress disorder	2	0	9093	23278	7358	
19248	frontal cluster	frontal cluster	2	0	13441	19249	13441	
20698	phase of the pandemic	phase of the pandemic	2	0	1352	113	1352	
7897	inter-hospital transport	INFunknownSUP transport	2	0	7899	7898	7899	
32233	Abbott assay	Abbott assay	2	0	3119	265	3119	
20319	non COVID-19 patients	non INFunknownSUP patient	2	0	60	3074	60	
410	in-hospital outcomes	in-hospital outcome	2	0	263	411	263	
35090	COVID-19 therapy	INFunknownSUP therapy	2	0	2273	40	2273	
2223	SARS coronavirus	INFunknownSUP coronavirus	2	0	339	2224	339	
34019	web-based pulmonary rehabilitation	INFunknownSUP pulmonary rehabilitation	2	0	8680	2586	8682	
31077	kcal mol-1	INFunknownSUP INFunknownSUP	2	0	31079	31078	31079	
12217	great concern	great concern	2	0	79	4480	79	
31853	user reviews	user review	2	0	2554	12911	2554	
14604	nasal decongestant spray	nasal decongestant spray	2	0	14606	1472	14608	
3994	open book exam	open book exam	2	0	3996	3995	3998	
28075	convalescent plasma	convalescent plasma	2	0	28077	17510	28077	
21762	further studies	further study	2	0	136	7713	136	
33199	Effects of COVID-19	effect of INFunknownSUP	2	0	2994	40	2994	
19926	gaming disorder	gaming disorder	2	0	7358	9808	7358	
1477	fewer resident cases	few resident case	2	0	229	1478	229	
24065	High-cost high-need patients	high-cost INFunknownSUP patient	2	0	24067	24066	60	
14117	SARS CoV2 infection	INFunknownSUP INFunknownSUP infection	2	0	41	14118	41	
29649	outcomes of patients	outcome of patient	2	0	263	60	263	
19402	nursing interventions	nursing intervention	2	0	757	1209	757	
9279	pseudoparticle infection	pseudoparticle infection	2	0	41	9280	41	
6374	service provision	service provision	2	0	6376	6375	6376	
1933	respiratory syndrome coronavirus	respiratory syndrome coronavirus	2	0	1935	259	339	
36811	digital access	digital access	2	0	224	1094	224	
28606	female urinary incontinence	female urinary incontinence	2	0	2661	3041	2663	
1269	controlled trial	controlled trial	2	0	965	1270	965	
25361	contagious capacity	contagious capacity	2	0	3026	13053	3026	
3300	In-Hospital Mortality	in-hospital mortality	2	0	3302	3301	3302	
8841	viral entry	viral entry	2	0	5629	1741	5629	
24728	% of providers	% of provider	2	0	364	673	364	
23161	pediatric dialysis unit	pediatric dialysis unit	2	0	23163	3344	10	
8858	strict lockdowns	strict lockdown	2	0	1486	8859	1486	
8526	environmental surfaces	environmental surface	2	0	8528	6806	8528	
17089	borderline situations	borderline situation	2	0	17091	17090	17091	
25722	Homeless experts	homeless expert	2	0	6478	25723	6478	
6064	FACS acceptance	INFunknownSUP acceptance	2	0	1248	2472	1248	
19394	cellular therapies	cellular therapy	2	0	5507	4919	5507	
3525	COVID-19 test	INFunknownSUP test	2	0	754	40	754	
7455	respiratory infections	respiratory infection	2	0	779	259	779	
27022	social concerns	social concern	2	0	12106	383	12106	
38172	higher accuracy	high accuracy	2	0	4535	322	4535	
32145	potential therapeutics	potential therapeutics	2	0	2751	1276	2751	
4082	technical issues	technical issue	2	0	3758	4083	3758	
16882	secondary data	secondary datum	2	0	22	712	22	
16721	study protocol	study protocol	2	0	7962	2087	7962	
27523	Care Workers	Care Workers	2	0	18488	5417	18488	
21888	androgen receptors	androgen receptor	2	0	8960	8815	8960	
6857	nosocomial cases	INFunknownSUP case	2	0	229	6858	229	
11827	time period	time period	2	0	5677	179	5677	
19422	IoT technology	INFunknownSUP technology	2	0	1718	1189	1718	
9715	HIV prevention	HIV prevention	2	0	1294	5415	1294	
14648	Pittsburgh Sleep Quality Index	Pittsburgh sleep Quality Index	2	0	14650	14649	7907	
19205	diagnosis of COVID-19	diagnosis of INFunknownSUP	2	0	2168	40	2168	
35232	available materials	available material	2	0	2335	832	2335	
9387	in-hospital complications	in-hospital complication	2	0	705	411	705	
24784	coronavirus outbreak risks	coronavirus outbreak risk	2	0	8152	24785	8152	
36184	mechanisms of dexamethasone action	mechanism of INFunknownSUP action	2	0	1223	36185	1223	
7298	effective treatments	effective treatment	2	0	1295	2051	1295	
12386	potential etiologies	potential etiology	2	0	12388	1276	12388	
32346	high-cost high-need	high-cost INFunknownSUP	2	0	32348	6505	32348	
7495	peptide QAKTFLDKFNHEAEDLFYQ	peptide INFunknownSUP	2	0	7497	7496	7497	
31479	property rights	property right	2	0	31481	31480	31481	
14694	lockdown policies	INFunknownSUP policy	2	0	1760	1676	1760	
38190	shortage management	shortage management	2	0	743	8840	743	
462	probabilistic modeling	probabilistic modeling	2	0	464	463	464	
23210	COVID-19 Alert Level	INFunknownSUP Alert Level	2	0	8464	40	8466	
16332	quantitative reverse transcription polymerase chain reaction	quantitative reverse transcription polymerase chain reaction	2	0	2439	1426	2447	
8506	single-center cohort study	single-center cohort study	2	0	2085	8507	2087	
1263	weekend alcohol consumption	weekend alcohol consumption	2	0	1265	1264	1267	
7447	fractionation schemes	fractionation scheme	2	0	7449	7448	7449	
32298	pilot study	pilot study	2	0	2087	19913	2087	
30562	mental health difficulties	mental health difficulty	2	0	8240	118	8240	
12685	SARS-CoV-2 IgM	INFunknownSUP Igm	2	0	30	28	30	
5539	cytopathic effects	INFunknownSUP effect	2	0	156	5540	156	
19100	substantial impact	substantial impact	2	0	110	3239	110	
25026	public discourse	public discourse	2	0	25028	1321	25028	
13771	COVID-19 testing	INFunknownSUP testing	2	0	1885	40	1885	
20750	third dose	third dose	2	0	2537	7099	2537	
6225	Gulf Cooperation Council	Gulf Cooperation Council	2	0	6227	6226	6229	
12285	Esophageal manometry	esophageal manometry	2	0	12287	12286	12287	
39116	peptide-based therapeutics	INFunknownSUP therapeutics	2	0	2751	31700	2751	
21980	supply chains	supply chain	2	0	21982	271	21982	
19700	urinary tract	urinary tract	2	0	2154	2662	2154	
26964	anatomy laboratory	anatomy laboratory	2	0	1392	52	1392	
29603	outcomes of COVID-19 patients	outcome of INFunknownSUP patient	2	0	263	911	263	
35974	higher risk of mechanical ventilation	high risk of mechanical ventilation	2	0	18435	6303	1542	
25727	public health emergency	public health emergency	2	0	447	1320	447	
15875	positive case	positive case	2	0	3368	228	3368	
7954	vaccination activities	vaccination activity	2	0	192	437	192	
5379	family history	family history	2	0	5381	5380	5381	
32939	primer-probe sets	primer-probe set	2	0	32941	29723	32941	
2667	Syrian hamster lung lobes	Syrian hamster lung lobe	2	0	2671	2668	2673	
6824	possible mitigation	possible mitigation	2	0	2375	745	2375	
16453	terms of isolation	term of isolation	2	0	4908	6569	4908	
17386	Detection of SARS-CoV-2	detection of INFunknownSUP	2	0	10130	28	10130	
17509	convalescent individuals	convalescent individual	2	0	1113	17510	1113	
1965	traditional Chinese medicine	traditional Chinese medicine	2	0	1967	1966	1110	
3270	monitoring system	monitoring system	2	0	1327	3271	1327	
9115	aerosol exposure	aerosol exposure	2	0	1054	6808	1054	
5545	positive SARS-CoV-2 PCR results	positive INFunknownSUP PCR result	2	0	5547	228	325	
8537	Viral genome	viral genome	2	0	2173	8081	2173	
8431	liveoid lesions	INFunknownSUP lesion	2	0	162	8432	162	
2863	time of admission	time of admission	2	0	179	2865	179	
1249	music education	music education	2	0	361	1250	361	
21321	staff cases of COVID-19	staff case of INFunknownSUP	2	0	21322	40	229	
16944	regulatory authorities	regulatory authority	2	0	9210	5686	9210	
32483	prognostic biomarker of outcomes	prognostic biomarker of outcome	2	0	32485	158	6034	
7995	high blood pressure	high blood pressure	2	0	4817	13	1027	
819	senior high school	senior high school	2	0	821	820	355	
19671	COVID-19 pneumonia	INFunknownSUP pneumonia	2	0	2369	3706	2369	
19049	MAGLUMI 2019-nCoV	INFunknownSUP INFunknownSUP	2	0	4648	19050	4648	
4482	risk of adverse events	risk of adverse event	2	0	1542	1081	1542	
31204	SARS-CoV-2 antigens	INFunknownSUP antigen	2	0	21144	226	21144	
27369	Vaccine uptake	vaccine uptake	2	0	19195	685	19195	
3134	challenges of pregnant women protection	challenge of pregnant woman protection	2	0	2220	3136	2220	
15872	complex cases	complex case	2	0	229	13320	229	
7687	acute appendicitis	acute appendicitis	2	0	1983	1461	1983	
13721	secondary school	secondary school	2	0	355	712	355	
662	surgical treatment	surgical treatment	2	0	97	663	97	
1740	viral pathogens	viral pathogen	2	0	1057	1741	1057	
30074	vulnerable individuals	vulnerable individual	2	0	1113	6402	1113	
2502	hand washing	hand washing	2	0	2504	2503	2504	
12202	brain PET hypometabolism	brain pet hypometabolism	2	0	12204	10043	1260	
3340	urology consultations	urology consultation	2	0	978	3341	978	
16772	stroke care	stroke care	2	0	9	15219	9	
3027	diagnostic testing	diagnostic testing	2	0	1885	2219	1885	
10867	seasonality of neonatal infectious disease hospitalizations	seasonality of neonatal infectious disease hospitalization	2	0	1715	10869	1715	
7117	socioeconomic level	socioeconomic level	2	0	362	16	362	
4830	transmission of COVID-19	transmission of INFunknownSUP	2	0	876	40	876	
19780	Molecular dynamics	molecular dynamics	2	0	3694	19781	3694	
16031	main outcome	main outcome	2	0	295	4679	295	
31742	digital literacy	digital literacy	2	0	10288	1094	10288	
5310	university hospital	university hospital	2	0	185	1642	185	
12932	tract involvement	tract involvement	2	0	3599	2154	3599	
6998	predictors of in-hospital mortality	predictor of in-hospital mortality	2	0	414	1869	414	
24435	web-based Arabic health information	INFunknownSUP Arabic health information	2	0	2587	2586	2591	
6482	severity of COVID-19	severity of INFunknownSUP	2	0	5116	40	5116	
27504	sustainable development	sustainable development	2	0	73	8697	73	
13496	T cell epitopes	T cell epitope	2	0	13500	8957	13500	
6412	septic shock	septic shock	2	0	6414	6413	6414	
29938	marital status	marital status	2	0	2720	29939	2720	
17249	electronic health records	electronic health record	2	0	17251	10569	10747	
11084	cancer diagnosis rate	cancer diagnosis rate	2	0	11086	773	1034	
18983	pharmacy leadership	pharmacy leadership	2	0	18985	5222	18985	
37298	scientific literature	scientific literature	2	0	4698	2290	4698	
9356	Care Center	Care Center	2	0	2780	5417	2780	
7444	tomography angiography	tomography angiography	2	0	7446	7445	7446	
5547	SARS-CoV-2 PCR results	INFunknownSUP PCR result	2	0	325	5548	325	
22023	gas exchange	gas exchange	2	0	22025	3444	22025	
25160	CT images	CT image	2	0	4034	26	4034	
2997	home electro-stimulation device	home electro-stimulation device	2	0	2999	231	3001	
36258	public health guidelines	public health guideline	2	0	91	1320	91	
21866	renal papillary necrosis	renal papillary necrosis	2	0	21868	130	5738	
4888	PXS scores	PXS score	2	0	3726	4889	3726	
18747	predictors of PS	predictor of PS	2	0	414	18674	414	
12234	Discrete Choice Experiment	discrete choice experiment	2	0	12236	8044	12238	
28604	treatment of female urinary incontinence	treatment of female urinary incontinence	2	0	97	28606	97	
1662	Second edition	Second edition	2	0	1664	1663	1664	
17449	current evidence	current evidence	2	0	585	443	585	
17742	set of moral principles	set of moral principle	2	0	651	17744	651	
9692	relevant literature	relevant literature	2	0	4698	346	4698	
32830	pooled data	pooled datum	2	0	22	5372	22	
13797	COVID-19 neurological manifestations	INFunknownSUP neurological manifestation	2	0	13799	40	885	
8970	mask samples	mask sample	2	0	1765	290	1765	
4848	PEEP levels	peep level	2	0	169	3521	169	
16565	consequences of public health measures	consequence of public health measure	2	0	4289	16567	4289	
23475	flexible ureteroscopy	flexible INFunknownSUP	2	0	23477	23476	23477	
1331	work-related stress	work-related stress	2	0	199	1332	199	
2738	pregnant ladies	pregnant lady	2	0	2740	2739	2740	
25668	Risk factors	risk factor	2	0	583	1450	583	
32561	health authorities	health authority	2	0	9210	120	9210	
18356	Non-invasive respiratory support	non-invasive respiratory support	2	0	258	18357	260	
23830	specific online learning behavior	specific online learning behavior	2	0	23832	2515	16069	
15695	neurological disorder	neurological disorder	2	0	7358	2728	7358	
25975	substance use treatment program	substance use treatment program	2	0	18070	714	1790	
13383	wave of the COVID-19 pandemic	wave of the INFunknownSUP pandemic	2	0	10210	111	10210	
21145	Swiss Twitter-sphere	Swiss Twitter-sphere	2	0	21147	1817	21147	
28068	mild SARS-CoV-2 infection	mild INFunknownSUP infection	2	0	1272	10809	41	
8090	public health emergencies	public health emergency	2	0	8094	1320	8094	
289	mask use policy	mask use policy	2	0	291	290	293	
28557	Muscle Days	muscle day	2	0	28559	28558	28559	
11226	primary telehealth modality	primary telehealth modality	2	0	11228	75	11230	
34094	gastrointestinal symptoms	gastrointestinal symptom	2	0	86	4755	86	
11433	Congolese COVID-19 patients	Congolese INFunknownSUP patient	2	0	911	11434	60	
524	ground-glass opacities	ground-glass opacity	2	0	526	525	526	
2107	garment industry	garment industry	2	0	2109	2108	2109	
2747	development of new therapeutics	development of new therapeutics	2	0	73	2749	73	
8614	antibiotic dispensings	antibiotic dispensing	2	0	7193	8615	7193	
14477	white matter	white matter	2	0	2523	14478	2523	
19295	inflammatory cytokines	inflammatory cytokine	2	0	5734	3817	5734	
269	adequate supply	adequate supply	2	0	271	270	271	
22883	eukaryotic cell-free	INFunknownSUP INFunknownSUP	2	0	7824	22884	7824	
24035	new cases	new case	2	0	229	69	229	
599	pre-COVID-19 cohort	INFunknownSUP cohort	2	0	601	600	601	
23381	subgroup of patients	subgroup of patient	2	0	14031	60	14031	
17087	various borderline situations	various borderline situation	2	0	17089	1099	17091	
11602	occupational therapy students	occupational therapy student	2	0	1177	2271	1177	
14166	return to play/sport	return to play/sport	2	0	10040	14168	10040	
1020	healthy unexposed donors	healthy unexposed donor	2	0	1022	1021	1024	
10869	neonatal infectious disease hospitalizations	neonatal infectious disease hospitalization	2	0	5091	10870	5091	
36801	Roman Catholic Church	Roman Catholic Church	2	0	36803	36802	36805	
16925	high-risk patients	high-risk patient	2	0	60	1184	60	
27521	Health Care Workers	Health Care Workers	2	0	27523	279	18488	
15229	pump inhibitor	pump inhibitor	2	0	4569	15230	4569	
12334	COVID-19 Experience	INFunknownSUP experience	2	0	1582	40	1582	
28800	ongoing pandemic	ongoing pandemic	2	0	113	1059	113	
12127	psychiatric literature	psychiatric literature	2	0	4698	4594	4698	
31158	next step	next step	2	0	23817	2624	23817	
8033	characteristic analysis	characteristic analysis	2	0	486	8034	486	
27289	pandemic coronavirus disease	pandemic coronavirus disease	2	0	338	1354	209	
24418	risk communication	risk communication	2	0	11078	1542	11078	
37494	% female	% female	2	0	29764	364	29764	
32597	government support	government support	2	0	260	99	260	
19571	training cohort	training cohort	2	0	601	235	601	
37402	gardening activities	gardening activity	2	0	192	26171	192	
13527	nursing homes	nursing home	2	0	13529	1209	13529	
51	anatomy teachers	anatomy teacher	2	0	53	52	53	
25128	number of appendectomies	number of appendectomy	2	0	916	3513	916	
34919	household units	household unit	2	0	6042	18468	6042	
6346	COVID19 pandemic	INFunknownSUP pandemic	2	0	113	6347	113	
3923	long COVID	long INFunknownSUP	2	0	3925	3921	3925	
37556	higher risk of the critical outcome	high risk of the critical outcome	2	0	18435	608	1542	
15431	structural basis	structural basis	2	0	15433	3549	15433	
37007	government efforts	government effort	2	0	28282	99	28282	
23925	somatic responses	somatic response	2	0	200	23926	200	
24333	information quality	information quality	2	0	3713	2591	3713	
34987	terms of symptoms	term of symptom	2	0	4908	86	4908	
21494	hospital beds	hospital bed	2	0	17283	185	17283	
695	N-terminal domain	N-terminal domain	2	0	697	696	697	
32792	worldwide pandemic	worldwide pandemic	2	0	113	8376	113	
20965	serious concern	serious concern	2	0	79	3164	79	
34306	effect of SARS-CoV-2 infection	effect of INFunknownSUP infection	2	0	1809	1272	1809	
647	exit strategies	exit strategy	2	0	300	648	300	
14740	SARS-CoV-2 test	INFunknownSUP test	2	0	754	28	754	
7121	critical outcomes	critical outcome	2	0	263	223	263	
14859	gold immunochromatographic assay	gold immunochromatographic assay	2	0	14861	2054	3119	
23949	province of Santa Fe	province of Santa Fe	2	0	23950	23951	23950	
2815	Medicare patients	Medicare patient	2	0	60	2816	60	
14093	pervasive relevance	pervasive relevance	2	0	856	14094	856	
5586	nonhuman primate	nonhuman primate	2	0	4783	5587	4783	
2083	prospective cohort study	prospective cohort study	2	0	2085	2084	2087	
15098	host cell entry	host cell entry	2	0	5629	15099	5629	
7251	destination of earth	destination of earth	2	0	7252	7253	7252	
18830	IgG antibody	IgG antibody	2	0	5924	928	5924	
8555	bodies of evidence	body of evidence	2	0	8556	585	8556	
10913	COVID-19 prediction	INFunknownSUP prediction	2	0	3336	40	3336	
23194	school closures	school closure	2	0	23196	355	23196	
29232	nasal congestion	nasal congestion	2	0	29234	1472	29234	
35184	percentage of subjects	percentage of subject	2	0	3789	4893	3789	
7120	critical outcomes of COVID-19	critical outcome of INFunknownSUP	2	0	7121	40	263	
1061	demographic factors	demographic factor	2	0	583	1062	583	
1219	ELISA kit	Elisa kit	2	0	567	1220	567	
1967	Chinese medicine	Chinese medicine	2	0	1110	1968	1110	
1665	COVID-19 hospital	INFunknownSUP hospital	2	0	185	40	185	
19539	cases of patients	case of patient	2	0	229	60	229	
18431	larger project	large project	2	0	11012	9554	11012	
5735	tumor necrosis factor-alpha	tumor necrosis factor-alpha	2	0	5737	5736	5739	
29253	host cell adhesion	host cell adhesion	2	0	29257	15099	29257	
37536	p-value &lt	p-value &lt	2	0	4863	37537	4863	
16551	immunocompromised state	immunocompromised state	2	0	1961	16552	1961	
8399	length of hospital stay	length of hospital stay	2	0	1348	8400	1348	
13799	neurological manifestations	neurological manifestation	2	0	885	2728	885	
14530	Life Quality Index	Life Quality Index	2	0	14532	14531	7907	
12625	important criteria	important criterion	2	0	3649	273	3649	
28234	perinatal mental health care	perinatal mental health care	2	0	28236	8419	9	
27877	statistical analysis	statistical analysis	2	0	486	5263	486	
2999	electro-stimulation device	electro-stimulation device	2	0	3001	3000	3001	
11652	Nutritional status	nutritional status	2	0	2720	11653	2720	
2995	disposable home electro-stimulation device	disposable home electro-stimulation device	2	0	2997	2996	3001	
1377	severe psychological impact	severe psychological impact	2	0	1379	262	110	
8349	transition to telehealth	transition to telehealth	2	0	2091	304	2091	
26956	years of life	year of life	2	0	1313	1434	1313	
10759	activity of SARS-CoV-2 main protease	activity of INFunknownSUP main protease	2	0	3990	10761	3990	
22058	section delivery	section delivery	2	0	2840	22059	2840	
5631	heparin sodium	heparin sodium	2	0	5633	5632	5633	
30494	length of the hospital stay	length of the hospital stay	2	0	1348	30495	1348	
25367	long COVID patients	long INFunknownSUP patient	2	0	60	3920	60	
3400	moxibustion interventions	INFunknownSUP intervention	2	0	757	1964	757	
9632	treatment response	treatment response	2	0	409	97	409	
8919	COVID-19 response	INFunknownSUP response	2	0	409	40	409	
18280	intuitionistic fuzzy environment	INFunknownSUP fuzzy environment	2	0	18282	18281	3454	
7960	screening protocol	screening protocol	2	0	7962	7961	7962	
8339	high doses of methylprednisolone	high dose of INFunknownSUP	2	0	8341	13	678	
7207	team member	team member	2	0	7209	7208	7209	
36587	combination of hs-TNI levels	combination of INFunknownSUP level	2	0	367	36589	367	
37227	contact precautions	contact precaution	2	0	2126	1888	2126	
3397	sedentary lifestyle	sedentary lifestyle	2	0	3399	3398	3399	
11139	intervention studies	intervention study	2	0	136	5608	136	
31308	excellent performance	excellent performance	2	0	598	31309	598	
7992	lockdown measures	INFunknownSUP measure	2	0	317	1676	317	
4366	Dental Students	dental student	2	0	4368	4367	4368	
5746	Healthcare workers	Healthcare worker	2	0	1136	1355	1136	
36803	Catholic Church	Catholic Church	2	0	36805	36804	36805	
13820	pandemic capacity of SARS-CoV-2	pandemic capacity of INFunknownSUP	2	0	10607	28	3026	
6573	hand sanitizers	hand INFunknownSUP	2	0	6575	2503	6575	
3120	healthy adults	healthy adult	2	0	515	1021	515	
1935	syndrome coronavirus	syndrome coronavirus	2	0	339	1936	339	
36884	antimicrobial prescription	antimicrobial prescription	2	0	36886	35256	36886	
3640	community transmission of the novel coronavirus	community transmission of the novel coronavirus	2	0	3642	3641	876	
23875	key parameters	key parameter	2	0	6460	850	6460	
3274	High levels	high level	2	0	169	3275	169	
5929	bad dream	bad dream	2	0	5931	5779	5931	
15500	additional shield	additional shield	2	0	15502	7175	15502	
18037	global health	global health	2	0	120	1954	120	
26439	tough moment	tough moment	2	0	26441	26440	26441	
28703	spinal cord injury	spinal cord injury	2	0	28705	14047	713	
18712	prevalence of depression	prevalence of depression	2	0	9272	1514	9272	
36790	clinical decision-making	clinical decision-making	2	0	22388	884	22388	
1657	ICU length of stay	ICU length of stay	2	0	1346	1658	1347	
25049	safety concerns	safety concern	2	0	12106	6729	12106	
25491	Older Adults	old adult	2	0	25493	22390	25493	
1252	research outputs	research output	2	0	1254	36	1254	
1368	pandemic threats	pandemic threat	2	0	1370	1354	1370	
13348	capital area	capital area	2	0	1089	13349	1089	
34017	remote web-based pulmonary rehabilitation	remote INFunknownSUP pulmonary rehabilitation	2	0	34019	2073	8682	
16407	Significant associated factors	significant associated factor	2	0	16409	4575	583	
13222	P value	P value	2	0	1037	13223	1037	
5005	oxidative stress	oxidative stress	2	0	199	5006	199	
2793	Sewage surveillance	sewage surveillance	2	0	2795	2791	2795	
35575	Dominican Republic	Dominican Republic	2	0	35577	35576	35577	
17469	serious disease	serious disease	2	0	209	3164	209	
21009	composite outcome	composite outcome	2	0	295	10302	295	
24215	SARS-CoV-2 outbreak	INFunknownSUP outbreak	2	0	310	226	310	
6906	Infectious Diseases	infectious disease	2	0	6908	6907	6908	
17106	show participants	show participant	2	0	4950	17107	4950	
7865	camostat group	INFunknownSUP group	2	0	18	7866	18	
1750	parenchymal bands	INFunknownSUP band	2	0	1752	1751	1752	
19904	school belonging	school belonging	2	0	19906	355	19906	
32851	severe systemic inflammation	severe systemic inflammation	2	0	32853	262	3116	
14039	key role	key role	2	0	7288	850	7288	
7380	neuromuscular disorders	neuromuscular disorder	2	0	889	7381	889	
31686	History of intubation	history of intubation	2	0	31687	5500	31687	
181	tertiary care hospital	tertiary care hospital	2	0	183	182	185	
10097	X-ray images	X-ray image	2	0	4034	10098	4034	
16973	match outcomes	match outcome	2	0	263	16974	263	
23378	pre-COVID cohort	INFunknownSUP cohort	2	0	601	23379	601	
32729	breast clinic	breast clinic	2	0	7704	11224	7704	
36602	population of homeless people	population of homeless people	2	0	1838	36604	1838	
21848	PARP function	INFunknownSUP function	2	0	9243	21849	9243	
10375	structural proteins	structural protein	2	0	1126	3549	1126	
32481	significant prognostic biomarker of outcomes	significant prognostic biomarker of outcome	2	0	32483	908	6034	
15752	mass spectrometry	mass spectrometry	2	0	15754	15753	15754	
20976	spirituality of social transformation	spirituality of social transformation	2	0	20977	20978	20977	
27921	poor COVID-19 prognosis	poor INFunknownSUP prognosis	2	0	27923	1372	12920	
13850	medication shortages	medication shortage	2	0	13852	153	13852	
28750	big public health risk	big public health risk	2	0	28752	9540	1542	
26093	harsh conditions	harsh condition	2	0	2910	26094	2910	
21	data points	datum point	2	0	23	22	23	
32485	biomarker of outcomes	biomarker of outcome	2	0	6034	263	6034	
6113	humoral immune response	humoral immune response	2	0	6115	6114	409	
22417	models of care	model of care	2	0	3975	9	3975	
26505	health communication	health communication	2	0	11078	120	11078	
13646	blot analyses	blot analysis	2	0	4668	13647	4668	
33913	infected individuals	infected individual	2	0	1113	1088	1113	
18728	prostate cancer care	prostate cancer care	2	0	9	18729	9	
2809	years of age	year of age	2	0	1313	906	1313	
10046	modified teaching strategies	modified teaching strategy	2	0	6055	4210	300	
26898	hydroxychloroquine group	hydroxychloroquine group	2	0	18	633	18	
35908	child interviews	child interview	2	0	10034	12594	10034	
28382	possible role	possible role	2	0	7288	745	7288	
19525	future studies	future study	2	0	136	1367	136	
23222	health problem	health problem	2	0	4499	120	4499	
27798	underlying health conditions	underlying health condition	2	0	2908	27799	2910	
4091	revision hip	revision hip	2	0	4093	4092	4093	
16764	community members	community member	2	0	16766	3641	16766	
12656	main themes	main theme	2	0	12658	4679	12658	
5876	effective reproduction number	effective reproduction number	2	0	5878	2051	916	
23951	Santa Fe	Santa Fe	2	0	23953	23952	23953	
31528	safety measures	safety measure	2	0	317	6729	317	
19897	risk of COVID-19	risk of INFunknownSUP	2	0	1542	40	1542	
301	greater telehealth equity	great telehealth equity	2	0	303	302	305	
6431	B cell	B cell	2	0	197	1846	197	
29483	Adequate immune response	adequate immune response	2	0	6115	29484	409	
6227	Cooperation Council	Cooperation Council	2	0	6229	6228	6229	
29580	higher levels of stress	high level of stress	2	0	12250	199	169	
1587	independent predictor	independent predictor	2	0	1589	582	1589	
3628	COVID vaccines	INFunknownSUP vaccine	2	0	681	1649	681	
37222	convenience sample of children	convenience sample of child	2	0	2755	6153	2757	
9791	pre-intervention period	pre-intervention period	2	0	5677	9792	5677	
14278	patient populations	patient population	2	0	13188	710	13188	
34171	respiratory viral infections	respiratory viral infection	2	0	3068	259	779	
6755	relative of SARS-CoV-2	relative of INFunknownSUP	2	0	6756	28	6756	
11885	COVID-19 infection rate	INFunknownSUP infection rate	2	0	11887	40	1034	
10697	improvement of oxygenation	improvement of oxygenation	2	0	10698	7365	10698	
24871	mechanisms of Yinqiao powder	mechanism of INFunknownSUP powder	2	0	1456	9785	1456	
20746	influenza virus	influenza virus	2	0	778	2323	778	
10383	online MBI	online MBI	2	0	10385	541	10385	
3188	needs of school support	need of school support	2	0	3189	3190	3189	
74	primary hospitals	primary hospital	2	0	76	75	76	
5661	sex differences	sex difference	2	0	5663	5662	5663	
2118	proportion of bubbles	proportion of bubble	2	0	910	2120	910	
16842	great interest	great interest	2	0	7989	4480	7989	
7758	lung ultrasound	lung ultrasound	2	0	4246	772	4246	
25895	longer-term evolution	longer-term evolution	2	0	3741	25896	3741	
435	SARS-CoV-2 vaccination	INFunknownSUP vaccination	2	0	437	28	437	
26242	virtue of solidarity	virtue of solidarity	2	0	7461	26244	7461	
5405	Northern California	Northern California	2	0	5407	2528	5407	
28571	aerosol particles	aerosol particle	2	0	8275	6808	8275	
589	pulmonary immunopathology	pulmonary Immunopathology	2	0	94	590	94	
13325	risk factor	risk factor	2	0	2183	1542	2183	
2724	lower compliance	low compliance	2	0	2726	594	2726	
29816	% of respondents	% of respondent	2	0	364	861	364	
35488	intolerance of uncertainty	intolerance of uncertainty	2	0	35489	1287	35489	
18085	different families	different family	2	0	18087	688	18087	
13661	coagulase negative staphylococci	coagulase negative staphylococcus	2	0	13663	13662	13665	
18477	positive effect	positive effect	2	0	1809	228	1809	
18736	male sex	male sex	2	0	5662	709	5662	
36182	molecular mechanisms of dexamethasone action	molecular mechanism of INFunknownSUP action	2	0	36184	6935	1223	
32816	ventilatory ratio	ventilatory ratio	2	0	2635	32817	2635	
2402	health insurance companies	health insurance company	2	0	2404	120	2406	
22027	minority of patients	minority of patient	2	0	14551	60	14551	
12316	greater numbers	great number	2	0	12095	302	12095	
12355	experimental results	experimental result	2	0	325	12146	325	
22263	health reforms	health reform	2	0	22265	120	22265	
35737	standard of care	standard of care	2	0	17	9	17	
30629	prevalence of infection	prevalence of infection	2	0	9272	41	9272	
34780	prosocial values	prosocial value	2	0	825	34781	825	
21668	proportion of patients	proportion of patient	2	0	910	60	910	
22598	low level of misconceptions	low level of misconception	2	0	12432	1176	362	
15793	higher proportions	high proportion	2	0	15614	322	15614	
9665	Future research	future research	2	0	36	9666	36	
2407	multivariate analysis	multivariate analysis	2	0	486	2408	486	
6118	GRADE approach	grade approach	2	0	1538	6119	1538	
7090	COVID-19 Vaccines	INFunknownSUP vaccine	2	0	7092	40	7092	
19251	second immunization	second immunization	2	0	19253	1279	19253	
14486	support mechanisms	support mechanism	2	0	1456	260	1456	
28819	sarbecovirus RaTG13	sarbecovirus INFunknownSUP	2	0	6830	28820	6830	
1076	RF model	RF model	2	0	1078	1077	1078	
95	early treatment	early treatment	2	0	97	55	97	
32853	systemic inflammation	systemic inflammation	2	0	3116	1453	3116	
13663	negative staphylococci	negative staphylococcus	2	0	13665	1338	13665	
29813	2-fold increase	INFunknownSUP increase	2	0	392	29814	392	
28752	public health risk	public health risk	2	0	1542	1320	1542	
13720	secondary school students	secondary school student	2	0	1177	13721	1177	
4530	ZIP codes	zip code	2	0	4532	4531	4532	
22014	acral lesions	INFunknownSUP lesion	2	0	162	22015	162	
34526	demographic data	demographic datum	2	0	22	1062	22	
36113	% patients	% patient	2	0	60	364	60	
17132	respiratory disease	respiratory disease	2	0	209	259	209	
30859	medical specialties	medical specialty	2	0	22430	947	22430	
196	cell stress responses	cell stress response	2	0	198	197	200	
1619	selected European countries	selected European country	2	0	1621	1620	1599	
24027	total central management time	total central management time	2	0	24029	1485	179	
13578	transmission rate of undocumented infections	transmission rate of undocumented infection	2	0	13579	10253	1034	
5718	effective public health interventions	effective public health intervention	2	0	5720	2051	757	
5332	COVID-19 context	INFunknownSUP context	2	0	1567	40	1567	
42	limits of detection	limit of detection	2	0	43	44	43	
5707	brightness of the screen	brightness of the screen	2	0	5708	5709	5708	
14832	progression of the course of undiagnosed type	progression of the course of undiagnosed type	2	0	4414	14834	4414	
98	government of Ghana	government of Ghana	2	0	99	100	99	
2858	physical activity-supporting facilities	physical INFunknownSUP facility	2	0	2860	1242	2676	
21212	poor prognosis	poor prognosis	2	0	12920	1372	12920	
29852	higher risk of COVID-19	high risk of INFunknownSUP	2	0	18435	40	1542	
16459	percentage of reperfusion therapies	percentage of reperfusion therapy	2	0	3789	16461	3789	
19044	convalescent serum	convalescent serum	2	0	4556	17510	4556	
27923	COVID-19 prognosis	INFunknownSUP prognosis	2	0	12920	40	12920	
23163	dialysis unit	dialysis unit	2	0	10	23164	10	
20548	asymptomatic COVID-19 patients	asymptomatic INFunknownSUP patient	2	0	911	1131	60	
23282	six-month study period	six-month study period	2	0	6955	23283	5677	
24925	scientific knowledge	scientific knowledge	2	0	213	2290	213	
25677	Long COVID	Long INFunknownSUP	2	0	1649	3964	1649	
6842	policy advisory systems	policy advisory system	2	0	6844	293	146	
38677	strong evidence	strong evidence	2	0	585	3987	585	
18073	delivery mode	delivery mode	2	0	18075	2840	18075	
3458	human ACE2	human INFunknownSUP	2	0	3437	2214	3437	
25618	federal housing officials	federal housing official	2	0	25620	1598	25622	
467	task behaviour	task behaviour	2	0	469	468	469	
34165	staff retention	staff retention	2	0	8451	11	8451	
20404	positive impacts	positive impact	2	0	1385	228	1385	
38442	public policy	public policy	2	0	293	1321	293	
20566	lower birth weight	low birth weight	2	0	20568	594	2711	
15044	infectious cases	infectious case	2	0	229	64	229	
22611	ASD patients	INFunknownSUP patient	2	0	60	22612	60	
625	online MBIs	online INFunknownSUP	2	0	627	541	627	
4476	high-sensitivity troponin	high-sensitivity INFunknownSUP	2	0	4478	4477	4478	
38594	symptomatic individuals	symptomatic individual	2	0	1113	38	1113	
15154	disposable instruments	disposable instrument	2	0	15156	2996	15156	
13005	COVID-19-related AKI	COVID-19-related Aki	2	0	13007	1384	13007	
7249	universal destination of earth	universal destination of earth	2	0	7251	3738	7252	
12001	neighborhoods of Montreal	neighborhood of Montreal	2	0	12002	12003	12002	
38377	use of PPE	use of PPE	2	0	292	2192	292	
28555	Padua Muscle Days	Padua muscle day	2	0	28557	28556	28559	
32710	clinical specimens	clinical specimen	2	0	7245	884	7245	
2345	random forest	random forest	2	0	2347	2346	2347	
6603	global economy	global economy	2	0	6605	1954	6605	
476	exercised-induced myokines	INFunknownSUP myokine	2	0	478	477	478	
3748	healthcare workforce	INFunknownSUP workforce	2	0	3750	494	3750	
6938	online delivery	online delivery	2	0	2840	541	2840	
29758	COVID-19 patient	INFunknownSUP patient	2	0	710	40	710	
16788	ACE drugs	ace drug	2	0	4584	16789	4584	
34282	unique challenges	unique challenge	2	0	2220	3547	2220	
5597	mathematical models	mathematical model	2	0	3975	5598	3975	
36327	potential advantages	potential advantage	2	0	897	1276	897	
20343	resident cases	resident case	2	0	229	2241	229	
6419	secondary schools	secondary school	2	0	6421	712	6421	
8794	human coronaviruses	human coronavirus	2	0	8796	2214	8796	
6686	Experimental Biology	experimental biology	2	0	6688	5679	6688	
22258	indifferent consumers	indifferent consumer	2	0	22260	22259	22260	
32821	action of Arbidol	action of INFunknownSUP	2	0	1223	22943	1223	
15633	negative PCR	negative PCR	2	0	3981	1338	3981	
33526	low modes	low mode	2	0	15425	457	15425	
10615	overall increase	overall increase	2	0	392	2251	392	
14202	self-reported health status	self-reported health status	2	0	14204	3911	2720	
10389	primary language	primary language	2	0	10391	75	10391	
14836	undiagnosed type	undiagnosed type	2	0	775	14837	775	
8679	pulmonary rehabilitation service-users	pulmonary rehabilitation service-user	2	0	8683	8680	8683	
8388	patient specimens	patient specimen	2	0	7245	2645	7245	
17624	COVID-19 exposure	INFunknownSUP exposure	2	0	1054	40	1054	
14861	immunochromatographic assay	immunochromatographic assay	2	0	3119	14862	3119	
36860	medical history	medical history	2	0	5381	947	5381	
15077	examination scores	examination score	2	0	3726	1800	3726	
6609	prolonged sick leave	prolonged sick leave	2	0	415	5497	417	
15249	Food Choice	food choice	2	0	12237	15250	12237	
29811	8-fold to 2-fold increase	INFunknownSUP to INFunknownSUP increase	2	0	29812	29813	29812	
9079	laboratory data	laboratory datum	2	0	22	1392	22	
8666	sequence data	sequence datum	2	0	22	5716	22	
11115	age range	age range	2	0	420	906	420	
3898	age subgroups	age subgroup	2	0	3900	906	3900	
24881	Mental care	mental care	2	0	9	8856	9	
38188	drug shortage management	drug shortage management	2	0	38190	352	743	
3996	book exam	book exam	2	0	3998	616	3998	
9354	Health Care Center	Health Care Center	2	0	9356	279	2780	
4533	test accuracy	test accuracy	2	0	4535	754	4535	
6614	early phase of the COVID-19 pandemic	early phase of the INFunknownSUP pandemic	2	0	1350	111	1352	
15533	supplemental oxygen	supplemental oxygen	2	0	3956	15534	3956	
37800	university preprofessional program	university preprofessional program	2	0	37802	1642	1790	
30676	chronic kidney disease	chronic kidney disease	2	0	16797	8230	209	
9118	SARS-CoV-2 infections	INFunknownSUP infection	2	0	779	28	779	
4800	SC2 infection	INFunknownSUP infection	2	0	41	4801	41	
36301	congregate settings	congregate setting	2	0	2729	36302	2729	
27031	COVID-19 complications	INFunknownSUP complication	2	0	705	40	705	
19012	number of patients	number of patient	2	0	916	60	916	
34637	seasonal influenza vaccination	seasonal influenza vaccination	2	0	437	2377	437	
36252	interferon-gamma/JAK/STAT pathway	INFunknownSUP pathway	2	0	5003	36253	5003	
32058	risk of coronavirus disease	risk of coronavirus disease	2	0	1542	338	1542	
20435	relevant articles	relevant article	2	0	811	346	811	
10570	health record	health record	2	0	10572	120	10572	
4464	non-endemic provinces	non-endemic province	2	0	4466	4465	4466	
30691	cell cultures	cell culture	2	0	17850	197	17850	
15807	nasopharyngeal swab	nasopharyngeal swab	2	0	3979	7406	3979	
35425	glutamate release	glutamate release	2	0	3720	22994	3720	
25378	dynamic metapopulation model	dynamic metapopulation model	2	0	25380	1540	1078	
8739	vulnerable people	vulnerable people	2	0	694	6402	694	
11522	motor symptoms	motor symptom	2	0	86	11523	86	
16144	use of technology	use of technology	2	0	292	1718	292	
16941	Cochrane Library	Cochrane Library	2	0	218	16942	218	
13817	cell culture	cell culture	2	0	8988	197	8988	
36699	direct effect of COVID-19 IU	direct effect of INFunknownSUP IU	2	0	36701	2012	1809	
19939	diagnostic performance	diagnostic performance	2	0	598	2219	598	
5898	nonessential surgery	nonessential surgery	2	0	1630	5899	1630	
14200	poor self-reported health status	poor self-reported health status	2	0	14202	1372	2720	
15663	lasting impact	lasting impact	2	0	110	14413	110	
33094	COVID-19 global pandemic	INFunknownSUP global pandemic	2	0	12349	40	113	
30764	positive predictive value	positive predictive value	2	0	6369	228	1037	
6753	close relative of SARS-CoV-2	close relative of INFunknownSUP	2	0	6755	614	6756	
20203	RT-PCR-confirmed COVID-19	INFunknownSUP INFunknownSUP	2	0	40	20204	40	
4936	health policy	health policy	2	0	293	120	293	
14178	adult spinal deformity	adult spinal deformity	2	0	14180	14179	14182	
4694	scientific research literature	scientific research literature	2	0	4696	2290	4698	
22800	oral intake status	oral intake status	2	0	2720	22801	2720	
3642	transmission of the novel coronavirus	transmission of the novel coronavirus	2	0	876	3644	876	
37772	COVID-19 outbreaks	INFunknownSUP outbreak	2	0	2892	40	2892	
19874	emergence of COVID-19	emergence of INFunknownSUP	2	0	19875	40	19875	
25359	overwhelming contagious capacity	overwhelming contagious capacity	2	0	25361	25360	3026	
22415	new models of care	new model of care	2	0	22417	69	3975	
20971	second pandemic waves	second pandemic wave	2	0	20973	1279	1281	
26711	percentage of the population	percentage of the population	2	0	3789	1838	3789	
8192	informed consent	informed consent	2	0	8194	8193	8194	
7149	acute bronchiolitis	acute INFunknownSUP	2	0	5471	1461	5471	
10870	neonatal infectious disease	neonatal infectious disease	2	0	4216	312	209	
27760	present COVID-19 pandemic	present INFunknownSUP pandemic	2	0	111	285	113	
952	low-income patients	low-income patient	2	0	60	953	60	
7442	coherence tomography angiography	coherence tomography angiography	2	0	7444	1673	7446	
25406	IgM/IgG double positive	INFunknownSUP double positive	2	0	25408	25407	3365	
2920	binding affinity	binding affinity	2	0	2922	2921	2922	
14854	viral pneumonia	viral pneumonia	2	0	2369	1741	2369	
170	food insecurity	food insecurity	2	0	172	171	172	
19628	aspartate aminotransferase	INFunknownSUP aminotransferase	2	0	19630	19629	19630	
4918	cellular immunity	cellular immunity	2	0	257	4919	257	
33153	vesicular eruptions	vesicular eruption	2	0	33155	33154	33155	
8341	doses of methylprednisolone	dose of INFunknownSUP	2	0	678	2513	678	
1471	nasal prongs	nasal prong	2	0	1473	1472	1473	
2090	transition to digital pathology	transition to digital pathology	2	0	2091	2092	2091	
11196	binding site	binding site	2	0	11198	2921	11198	
10781	civil war	civil war	2	0	10783	10782	10783	
24619	antibiotic treatments	antibiotic treatment	2	0	1295	8615	1295	
26572	long-term follow-up	long-term follow-up	2	0	175	4288	175	
2741	COVID-19 outcomes	INFunknownSUP outcome	2	0	263	40	263	
568	disease spread	disease spread	2	0	570	209	570	
6636	important factors	important factor	2	0	583	273	583	
12460	Syncytial Virus	syncytial virus	2	0	12462	12461	12462	
12590	drug target	drug target	2	0	11730	352	11730	
25898	outpatient settings	outpatient setting	2	0	2729	327	2729	
874	vertical transmission	vertical transmission	2	0	876	875	876	
39094	demanding consumers	demanding consumer	2	0	22260	39095	22260	
32534	sequence diversification	sequence diversification	2	0	32536	5716	32536	
3440	quarantine measures	quarantine measure	2	0	317	2675	317	
17705	low problem-focused coping	low problem-focused coping	2	0	2893	457	2895	
37288	ANC levels	ANC level	2	0	169	24850	169	
30113	weeks of the outbreak	week of the outbreak	2	0	18278	310	18278	
37802	preprofessional program	preprofessional program	2	0	1790	37803	1790	
4042	program targets	program target	2	0	4044	1790	4044	
4411	viral disease	viral disease	2	0	209	1741	209	
14180	spinal deformity	spinal deformity	2	0	14182	14047	14182	
10352	Euganei Hills	INFunknownSUP Hills	2	0	10354	10353	10354	
4939	infection control policy	infection control policy	2	0	293	4940	293	
3535	impact of the COVID-19	impact of the INFunknownSUP	2	0	110	40	110	
4738	immature neutrophils	immature neutrophil	2	0	4740	4739	4740	
3988	antiviral activity	antiviral activity	2	0	3990	3989	3990	
36600	large population of homeless people	large population of homeless people	2	0	36602	4250	1838	
11014	Logistic regression	logistic regression	2	0	5036	11015	5036	
7160	part of the survey	part of the survey	2	0	734	967	734	
38848	patents of top pharmaceutical companies	patent of top pharmaceutical company	2	0	13504	22983	13504	
25973	residential substance use treatment program	residential substance use treatment program	2	0	25975	9936	1790	
18829	IgG antibody testing	IgG antibody testing	2	0	1885	18830	1885	
30614	Skin problems	skin problem	2	0	6766	14025	6766	
38810	2-person room	INFunknownSUP room	2	0	5742	38811	5742	
30044	HLA-A*02:01 epitopes	HLA-A*02:01 epitope	2	0	13500	988	13500	
1844	Group B	Group B	2	0	1846	1845	1846	
29569	global coronavirus disease	global coronavirus disease	2	0	338	1954	209	
21757	levels of anxiety	level of anxiety	2	0	169	2772	169	
30685	S proteins	S protein	2	0	1126	6831	1126	
9749	network construction	network construction	2	0	9751	719	9751	
5439	in-hospital release	in-hospital release	2	0	3720	411	3720	
5628	entry receptor	entry receptor	2	0	3502	5629	3502	
9428	right to health	right to health	2	0	9429	120	9429	
23115	nasopharyngeal polymerase chain reaction test	nasopharyngeal polymerase chain reaction test	2	0	23117	7406	754	
2796	research study	research study	2	0	2087	36	2087	
38458	Laparoendoscopic procedures	Laparoendoscopic procedure	2	0	4200	38459	4200	
23135	study design	study design	2	0	4183	2087	4183	
11887	infection rate	infection rate	2	0	1034	41	1034	
3850	Health care workers	Health care worker	2	0	1134	3851	1136	
6895	younger people	young people	2	0	694	2571	694	
2215	respiratory viruses	respiratory virus	2	0	2217	259	2217	
9484	lower life expectancy	low life expectancy	2	0	4404	594	4406	
22398	Hong Kong	Hong Kong	2	0	22400	22399	22400	
26943	survival group	survival group	2	0	18	1498	18	
10126	coronavirus disease-2019	coronavirus INFunknownSUP	2	0	10128	339	10128	
1468	features of COVID-19	feature of INFunknownSUP	2	0	1469	40	1469	
20717	blood parameters	blood parameter	2	0	6460	3129	6460	
23837	exact mechanism	exact mechanism	2	0	10036	23838	10036	
32880	psychiatry/addiction medicine	psychiatry/addiction medicine	2	0	1110	32881	1110	
11743	T cell immunity	T cell immunity	2	0	257	8957	257	
19240	Care Organization	Care Organization	2	0	1232	5417	1232	
2231	continuous positive airway pressure	continuous positive airway pressure	2	0	2233	2232	1027	
4546	Automated Western immunoblotting	automated Western INFunknownSUP	2	0	4548	4547	4550	
2400	private health insurance companies	private health insurance company	2	0	2402	2401	2406	
14	socioeconomic standard group	socioeconomic standard group	2	0	18	15	18	
24127	LSS humans	LSS human	2	0	13718	24128	13718	
8844	linear model	linear model	2	0	1078	8845	1078	
1463	CD/FND patients	INFunknownSUP patient	2	0	60	1464	60	
22044	unfavorable attitude	unfavorable attitude	2	0	12193	22045	12193	
3379	biological processes	biological process	2	0	3381	855	3381	
13414	potential source of phthalate exposure	potential source of phthalate exposure	2	0	13415	13418	1971	
31337	safe strategy	safe strategy	2	0	3350	4136	3350	
21997	single-cell RNA sequencing	single-cell RNA sequencing	2	0	21999	11466	8097	
34687	SD levels	SD level	2	0	169	34688	169	
5710	NICE guidelines	nice guideline	2	0	91	5711	91	
28949	greater number	great number	2	0	916	302	916	
12994	clear heterogeneity	clear heterogeneity	2	0	1972	9482	1972	
12709	end users	end user	2	0	1818	7132	1818	
22858	research articles	research article	2	0	811	36	811	
12892	SARS-CoV-2 antibody	INFunknownSUP antibody	2	0	5924	28	5924	
2088	abrupt transition to digital pathology	abrupt transition to digital pathology	2	0	2090	2089	2091	
10150	COVID-2019 pandemic	COVID-2019 pandemic	2	0	113	10151	113	
13530	p &gt	p &gt	2	0	2385	13531	2385	
38740	significant role	significant role	2	0	7288	908	7288	
25101	test kits	test kit	2	0	25103	754	25103	
31965	causes of hospitalizations	cause of hospitalization	2	0	19560	5091	19560	
19048	MAGLUMI 2019-nCoV IgG	INFunknownSUP INFunknownSUP IgG	2	0	928	19049	928	
9818	Levels of anxiety	level of anxiety	2	0	9819	2772	9819	
4436	high preference	high preference	2	0	4438	13	4438	
20316	PPE use	PPE use	2	0	292	2192	292	
9677	psychiatric conditions	psychiatric condition	2	0	2910	4594	2910	
23275	prevalence of post-traumatic stress disorder	prevalence of post-traumatic stress disorder	2	0	9272	23277	9272	
5923	antibody responses	antibody response	2	0	200	5924	200	
23348	vulnerable populations	vulnerable population	2	0	13188	6402	13188	
15693	disorder/functional neurological disorder	disorder/functional neurological disorder	2	0	15695	15694	7358	
30241	non-woven media	non-woven medium	2	0	661	656	661	
9508	COVID-19-hospitalized patients	INFunknownSUP patient	2	0	60	9509	60	
36571	snake venoms	snake venom	2	0	36573	32421	36573	
3078	global emergency	global emergency	2	0	447	1954	447	
29242	stroke guidelines	stroke guideline	2	0	91	15219	91	
15191	ECG machine	ECG machine	2	0	934	6161	934	
22544	new treatments	new treatment	2	0	1295	69	1295	
16817	ED attendances	editor attendance	2	0	16819	6256	16819	
25416	important findings	important finding	2	0	3390	273	3390	
30444	number of articles	number of article	2	0	916	811	916	
21338	prone position	prone position	2	0	2825	21339	2825	
25620	housing officials	housing official	2	0	25622	3497	25622	
23353	outbreak of COVID-19	outbreak of INFunknownSUP	2	0	310	40	310	
32026	number of people	number of people	2	0	916	694	916	
4604	zoonotic diseases	INFunknownSUP disease	2	0	315	4605	315	
33272	Gates Foundation	Gates Foundation	2	0	11348	33273	11348	
32856	personal care	personal care	2	0	9	4961	9	
21097	management times	management time	2	0	12806	743	12806	
30197	Acute kidney injury	acute kidney injury	2	0	6661	14013	713	
5944	cell damage	cell damage	2	0	5946	197	5946	
5822	Cox regression	Cox regression	2	0	5036	5823	5036	
20814	recent research	recent research	2	0	36	2128	36	
10286	financial literacy	financial literacy	2	0	10288	547	10288	
12497	COVID-19 data	INFunknownSUP datum	2	0	22	40	22	
12485	University Hospitals	University Hospitals	2	0	12487	50	12487	
25408	double positive	double positive	2	0	3365	1820	3365	
20074	disease progression	disease progression	2	0	4414	209	4414	
15569	monoclonal antibodies	monoclonal antibody	2	0	929	15570	929	
2437	real-time reverse transcription polymerase chain reaction	real-time reverse transcription polymerase chain reaction	2	0	2439	1429	2447	
2218	diagnostic challenges	diagnostic challenge	2	0	2220	2219	2220	
23956	score &gt	score &gt	2	0	2385	1843	2385	
1466	clinical features of COVID-19	clinical feature of INFunknownSUP	2	0	1468	884	1469	
22624	recent observations	recent observation	2	0	8522	2128	8522	
15282	Elecsys Anti-SARS-CoV-2	INFunknownSUP INFunknownSUP	2	0	15284	15283	15284	
32987	application of the IHTCOVID-19 score	application of the INFunknownSUP score	2	0	125	3351	125	
24869	potential mechanisms of Yinqiao powder	potential mechanism of INFunknownSUP powder	2	0	24871	1276	1456	
26182	aim of the study	aim of the study	2	0	7070	2087	7070	
5933	addiction treatment	addiction treatment	2	0	97	5934	97	
22779	combined model	combined model	2	0	1078	9071	1078	
21999	RNA sequencing	RNA sequencing	2	0	8097	1151	8097	
5737	necrosis factor-alpha	necrosis factor-alpha	2	0	5739	5738	5739	
10029	CT data	CT datum	2	0	22	26	22	
19825	genome sequences	genome sequence	2	0	19827	2173	19827	
17876	difficile infection	INFunknownSUP infection	2	0	41	498	41	
34572	small primary care practices	small primary care practice	2	0	6471	9600	5378	
26882	Recent research	Recent research	2	0	36	2477	36	
15050	Lung ultrasound	lung ultrasound	2	0	4246	8737	4246	
22716	sense of school identity	sense of school identity	2	0	1672	6758	1672	
24202	dependent variable	dependent variable	2	0	9235	24203	9235	
11847	small improvements	small improvement	2	0	11849	9600	11849	
18644	lymphocyte ratio	lymphocyte ratio	2	0	2635	18645	2635	
1990	senior pathologists	senior pathologist	2	0	1992	820	1992	
36269	Polish Adolescents	Polish adolescent	2	0	1165	27908	1165	
23263	death rates	death rate	2	0	83	4722	83	
12930	respiratory tract involvement	respiratory tract involvement	2	0	12932	259	3599	
18495	Exclusion criteria	exclusion criterion	2	0	3649	18496	3649	
17026	health-related stressors	health-related INFunknownSUP	2	0	14923	17027	14923	
14528	Dermatology Life Quality Index	dermatology Life Quality Index	2	0	14530	10860	7907	
13415	potential source	potential source	2	0	1971	1276	1971	
4142	RAAS blockade exposure	INFunknownSUP blockade exposure	2	0	4144	4143	1054	
7016	all-cause in-hospital mortality	INFunknownSUP in-hospital mortality	2	0	1869	7017	1197	
15152	use of disposable instruments	use of disposable instrument	2	0	292	15154	292	
9953	progression to surgery	progression to surgery	2	0	4414	1630	4414	
12204	PET hypometabolism	pet hypometabolism	2	0	1260	12205	1260	
35825	SARS-CoV-2 genomes	INFunknownSUP genome	2	0	865	226	865	
5644	supervised exercise training	supervised exercise training	2	0	5646	5645	235	
6038	intensive care units	intensive care unit	2	0	6042	7	6042	
22733	invasive ventilation	invasive ventilation	2	0	6305	6302	6305	
5283	rapid evolution of RNA viruses	rapid evolution of RNA virus	2	0	3740	795	3741	
2552	topic reviews	topic review	2	0	2554	2553	2554	
14606	decongestant spray	decongestant spray	2	0	14608	14607	14608	
1819	double gloves	double glove	2	0	1821	1820	1821	
17748	narrative review	narrative review	2	0	1723	17749	1723	
33862	neurocognitive symptoms	neurocognitive symptom	2	0	86	33863	86	
2671	lung lobes	lung lobe	2	0	2673	772	2673	
2025	Clinical Characteristics	clinical characteristic	2	0	2027	1501	2027	
33977	automated Western immunoblotting	automated Western INFunknownSUP	2	0	4548	33978	4550	
22701	chi-square test	chi-square test	2	0	754	7267	754	
4931	atypical coverage	atypical coverage	2	0	4933	4932	4933	
6511	moral distress	moral distress	2	0	1975	1315	1975	
303	telehealth equity	telehealth equity	2	0	305	304	305	
14464	cardiovascular readings	cardiovascular reading	2	0	14466	13290	14466	
16021	cancer care line	cancer care line	2	0	6031	10528	6031	
29192	structured questionnaire	structured questionnaire	2	0	9620	6409	9620	
6844	advisory systems	advisory system	2	0	146	6845	146	
9689	number of infections	number of infection	2	0	916	779	916	
26202	potent driver	potent driver	2	0	26204	1408	26204	
39185	zinc supplementation	zinc supplementation	2	0	19658	22807	19658	
24109	COVID-19 transmission	INFunknownSUP transmission	2	0	876	40	876	
10189	public mental health	public mental health	2	0	118	1321	120	
21717	health center	health center	2	0	8718	120	8718	
8391	procurement strategies	procurement strategy	2	0	300	1086	300	
9558	inpatient consultations	inpatient consultation	2	0	978	3339	978	
5991	serology study	serology study	2	0	2087	5992	2087	
11079	Semi-structured interviews	semi-structured interview	2	0	10034	11080	10034	
29182	low-resource countries	low-resource country	2	0	1599	29183	1599	
20715	routine blood parameters	routine blood parameter	2	0	20717	4898	6460	
6585	theological method	theological method	2	0	6587	6586	6587	
5850	Mann-Whitney U-test	Mann-Whitney INFunknownSUP	2	0	5852	5851	5852	
1654	Measure of Gobbledygook	measure of gobbledygook	2	0	1655	1656	1655	
1022	unexposed donors	unexposed donor	2	0	1024	1023	1024	
5909	release of COVID-19 patients	release of INFunknownSUP patient	2	0	3720	911	3720	
5704	outcome of the disease	outcome of the disease	2	0	295	209	295	
2235	airway pressure	airway pressure	2	0	1027	2236	1027	
7174	additional time	additional time	2	0	179	7175	179	
24029	central management time	central management time	2	0	7933	3393	179	
22882	eukaryotic cell-free systems	INFunknownSUP INFunknownSUP system	2	0	146	22883	146	
22993	glutamate abundance	glutamate abundance	2	0	10779	22994	10779	
8742	tailored approach	tailored approach	2	0	1538	756	1538	
16660	WBC count	WBC count	2	0	1305	16661	1305	
12580	home confinement	home confinement	2	0	12582	231	12582	
21944	traditional mentoring	traditional mentoring	2	0	4041	1966	4041	
12606	Review Background	Review background	2	0	4013	9991	4013	
14990	light chain	light chain	2	0	2362	13478	2362	
1303	neutrophil count	neutrophil count	2	0	1305	1304	1305	
2803	neutrophil states	neutrophil state	2	0	2805	1304	2805	
12145	experimental study	experimental study	2	0	2087	12146	2087	
8150	higher risks	high risk	2	0	8152	322	8152	
14373	morality of India	morality of India	2	0	14374	14375	14374	
16534	research questions	research question	2	0	4066	36	4066	
1505	pandemic control	pandemic control	2	0	510	1354	510	
12236	Choice Experiment	choice experiment	2	0	12238	12237	12238	
177	average time	average time	2	0	179	178	179	
6942	common understanding	common understanding	2	0	2715	699	2715	
6929	surgical care	surgical care	2	0	9	663	9	
28551	dietary management	dietary management	2	0	743	3126	743	
15961	millions of people	million of people	2	0	15962	694	15962	
1000	SARS-CoV-2 variants	INFunknownSUP variant	2	0	1002	226	1002	
917	integration of women refugees	integration of woman refugee	2	0	918	919	918	
29430	COVID-19 detection	INFunknownSUP detection	2	0	44	40	44	
20656	early detection of COVID-19	early detection of INFunknownSUP	2	0	16879	40	44	
13575	purposive sampling	purposive sampling	2	0	11863	13576	11863	
17368	logit model	INFunknownSUP model	2	0	1078	17369	1078	
8553	qualitative bodies of evidence	qualitative body of evidence	2	0	8555	8554	8556	
3947	diagnostic tests	diagnostic test	2	0	1365	2219	1365	
4923	empirical evidence	empirical evidence	2	0	585	4924	585	
8439	disease detection	disease detection	2	0	44	209	44	
2061	thermal cameras	thermal camera	2	0	2063	2062	2063	
20178	persistent functional complaints	persistent functional complaint	2	0	4342	8660	4344	
8816	deprivation therapy	deprivation therapy	2	0	2273	8817	2273	
4891	COVID-19 subjects	INFunknownSUP subject	2	0	4893	40	4893	
37116	excessive inflammation	excessive inflammation	2	0	3116	35471	3116	
2233	positive airway pressure	positive airway pressure	2	0	2235	228	1027	
21139	mental disorders	mental disorder	2	0	889	119	889	
33270	Melinda Gates Foundation	Melinda Gates Foundation	2	0	33272	33271	11348	
3425	medical centers	medical center	2	0	3427	947	3427	
23117	polymerase chain reaction test	polymerase chain reaction test	2	0	754	2443	754	
2630	de los	de los	2	0	2632	1421	2632	
20037	Chest CT	chest CT	2	0	26	1401	26	
15209	majority of respondents	majority of respondent	2	0	4481	861	4481	
3861	nervous system	nervous system	2	0	1327	3862	1327	
1847	Western Norway	Western Norway	2	0	1849	1848	1849	
32195	sewage surveillance	sewage surveillance	2	0	2795	6963	2795	
14323	major cities	major city	2	0	11802	1318	11802	
17874	Clostridium difficile infection	clostridium INFunknownSUP infection	2	0	17876	17875	41	
37301	HAI episodes	hai episode	2	0	1595	6959	1595	
28024	negative cases	negative case	2	0	229	1338	229	
19322	laboratory-confirmed cases	laboratory-confirmed case	2	0	229	6439	229	
11638	medical co-morbidities	medical co-morbidity	2	0	11640	947	11640	
14084	COVID-19 deaths	INFunknownSUP death	2	0	553	40	553	
33027	National Stroke	National stroke	2	0	5248	46	5248	
3775	COVID-19 infections	INFunknownSUP infection	2	0	779	40	779	
342	systematic search	systematic search	2	0	344	343	344	
24433	readability of web-based Arabic health information	readability of INFunknownSUP Arabic health information	2	0	996	24435	996	
722	doses of vancomycin	dose of vancomycin	2	0	678	724	678	
8170	window of tolerance	window of tolerance	2	0	8171	1289	8171	
35341	next outbreak	next outbreak	2	0	310	2624	310	
6543	first-positive swab	first-positive swab	2	0	3979	6544	3979	
7459	companion virtue	companion virtue	2	0	7461	7460	7461	
32883	25-mug dose	INFunknownSUP dose	2	0	2537	32884	2537	
3128	blood transfusion	blood transfusion	2	0	3130	3129	3130	
16313	humoral response	humoral response	2	0	409	6114	409	
10985	JAK/STAT pathway	INFunknownSUP pathway	2	0	5003	10986	5003	
13134	quality of life of older adults	quality of life of old adult	2	0	13135	513	3713	
16409	associated factors	associated factor	2	0	583	240	583	
29240	current stroke guidelines	current stroke guideline	2	0	29242	443	91	
19238	Accountable Care Organization	accountable Care Organization	2	0	19240	19239	1232	
10761	SARS-CoV-2 main protease	INFunknownSUP main protease	2	0	8461	28	2918	
11670	hospital admissions	hospital admission	2	0	3085	185	3085	
3054	current situation	current situation	2	0	3056	443	3056	
13945	Health workers	health worker	2	0	1136	5250	1136	
21986	progression of COVID-19	progression of INFunknownSUP	2	0	4414	40	4414	
6014	sectors of life	sector of life	2	0	6015	1434	6015	
14169	HSS humans	HSS human	2	0	13718	14170	13718	
12609	profound impact	profound impact	2	0	110	12610	110	
7146	international trade	international trade	2	0	5888	4086	5888	
17655	final exam	final exam	2	0	3998	4256	3998	
12886	antiviral therapies	antiviral therapy	2	0	5507	3989	5507	
18539	Emergency Department	Emergency Department	2	0	18541	18540	18541	
7674	sources of COVID-19 information	source of INFunknownSUP information	2	0	4158	7676	4158	
19162	non-hospitalized healthcare	INFunknownSUP INFunknownSUP	2	0	494	11059	494	
33065	time of COVID-19	time of INFunknownSUP	2	0	179	40	179	
11201	% of cases	% of case	2	0	364	229	364	
11813	depression levels	depression level	2	0	169	1514	169	
28817	bat sarbecovirus RaTG13	bat sarbecovirus INFunknownSUP	2	0	28819	8902	6830	
38763	oral health policies	oral health policy	2	0	38765	427	1760	
1554	digital health	digital health	2	0	120	1094	120	
6802	Alveolar recruitment	alveolar recruitment	2	0	3518	6803	3518	
24300	bubble sizes	bubble size	2	0	9557	11062	9557	
9301	consecutive patients	consecutive patient	2	0	60	6607	60	
29024	seasonal coronavirus	seasonal coronavirus	2	0	339	2378	339	
20202	RT-PCR-confirmed COVID-19 patients	INFunknownSUP INFunknownSUP patient	2	0	60	20203	60	
25380	metapopulation model	metapopulation model	2	0	1078	25381	1078	
26697	protein synthesis	protein synthesis	2	0	14638	1797	14638	
23418	wave of COVID-19	wave of INFunknownSUP	2	0	10210	40	10210	
11397	Environment Scale	Environment Scale	2	0	1203	11398	1203	
13388	high transmissibility	high INFunknownSUP	2	0	3451	13	3451	
14109	vaccination status	vaccination status	2	0	2720	437	2720	
16291	neurological patients	neurological patient	2	0	60	2728	60	
37486	restrictive government policy	restrictive government policy	2	0	37488	1603	293	
35684	onset of the pandemic	onset of the pandemic	2	0	1647	113	1647	
36589	hs-TNI levels	INFunknownSUP level	2	0	169	8174	169	
3464	clinical manifestation	clinical manifestation	2	0	3466	884	3466	
8226	DBS sample	DBS sample	2	0	2757	8227	2757	
20244	heart transplantation	heart transplantation	2	0	10540	2275	10540	
19859	outcome measures	outcome measure	2	0	317	295	317	
36701	effect of COVID-19 IU	effect of INFunknownSUP IU	2	0	1809	318	1809	
6670	measurement method	measurement method	2	0	6587	6671	6587	
14320	open surgery	open surgery	2	0	1630	3995	1630	
22639	filtration efficiency	filtration efficiency	2	0	14461	145	14461	
28705	cord injury	cord injury	2	0	713	28694	713	
30422	vascular inflammation	vascular inflammation	2	0	3116	30423	3116	
3579	immunodeficiency virus	immunodeficiency virus	2	0	778	3580	778	
30225	Better adherence	good adherence	2	0	3636	30226	3636	
35773	areas of high exposure	area of high exposure	2	0	1579	35775	1579	
8877	mental health condition	mental health condition	2	0	8881	118	8881	
2860	activity-supporting facilities	INFunknownSUP facility	2	0	2676	2861	2676	
18742	unprecedented challenge	unprecedented challenge	2	0	62	5915	62	
19542	prevention measures	prevention measure	2	0	317	1294	317	
24097	autoimmune disease	autoimmune disease	2	0	209	12247	209	
30962	positive attitudes	positive attitude	2	0	30964	228	30964	
29537	different regions	different region	2	0	5240	688	5240	
17104	horse show participants	horse show participant	2	0	17106	13037	4950	
17472	mechanical ventilators	mechanical ventilator	2	0	17474	6304	17474	
25364	rhesus macaques	rhesus macaque	2	0	25366	25365	25366	
36095	logistic regression analysis	logistic regression analysis	2	0	486	5132	486	
13833	receptor expression	receptor expression	2	0	5729	3502	5729	
17552	proportional hazard	proportional hazard	2	0	17554	17553	17554	
30495	length of the hospital	length of the hospital	2	0	1347	185	1347	
32848	COVID-19 pneumonia-induced	INFunknownSUP INFunknownSUP	2	0	32850	40	32850	
4290	long-lasting immunity	long-lasting immunity	2	0	257	4291	257	
37005	patchwork of government efforts	patchwork of government effort	2	0	37006	37007	37006	
21516	spike protein S1	spike protein INFunknownSUP	2	0	8763	1795	8763	
33730	male COVID-19 patients	male INFunknownSUP patient	2	0	911	709	60	
13237	pandemic potential	pandemic potential	2	0	6265	1354	6265	
7172	little additional time	little additional time	2	0	7174	7173	179	
37985	median follow-up	median follow-up	2	0	175	2634	175	
6524	clinical decision	clinical decision	2	0	5486	884	5486	
27624	seasonal HCoVs	seasonal INFunknownSUP	2	0	27626	2378	27626	
20920	potential vaccines	potential vaccine	2	0	681	1276	681	
20568	birth weight	birth weight	2	0	2711	12345	2711	
37057	challenging topic	challenging topic	2	0	2553	37058	2553	
24676	whole world	whole world	2	0	4336	2359	4336	
12277	food security	food security	2	0	12279	171	12279	
4026	physical inactivity	physical inactivity	2	0	4028	1242	4028	
720	higher doses of vancomycin	high dose of vancomycin	2	0	722	322	678	
3190	school support	school support	2	0	260	355	260	
12352	educational debt	educational debt	2	0	3627	834	3627	
21922	binary logistic regression model	binary logistic regression model	2	0	1078	5130	1078	
7712	further investigation	further investigation	2	0	7714	7713	7714	
13847	air samples	air sample	2	0	1765	868	1765	
10794	standardized masks	standardized mask	2	0	3036	10795	3036	
36604	homeless people	homeless people	2	0	694	36605	694	
33419	redox balance	redox balance	2	0	33421	16740	33421	
20164	olfactory function	olfactory function	2	0	9243	1702	9243	
12588	potential drug target	potential drug target	2	0	12590	1276	11730	
32847	COVID-19 pneumonia-induced severe systemic inflammation	INFunknownSUP INFunknownSUP severe systemic inflammation	2	0	32851	32848	3116	
24616	COVID-19 Era	INFunknownSUP Era	2	0	24618	40	24618	
552	deaths of COVID-19	death of INFunknownSUP	2	0	553	40	553	
5552	social media platforms	social medium platform	2	0	3919	5553	3919	
10568	electronic health record	electronic health record	2	0	10570	10569	10572	
32819	mechanism of action of Arbidol	mechanism of action of INFunknownSUP	2	0	10036	32821	10036	
8814	androgen deprivation therapy	androgen deprivation therapy	2	0	8816	8815	2273	
14568	cohort of CD/FND	cohort of INFunknownSUP	2	0	601	1464	601	
11816	food safety	food safety	2	0	6729	171	6729	
25482	COVID pandemic	INFunknownSUP pandemic	2	0	113	1649	113	
4696	research literature	research literature	2	0	4698	36	4698	
15370	New York City	New York City	2	0	2814	4874	2814	
11228	telehealth modality	telehealth modality	2	0	11230	304	11230	
14834	course of undiagnosed type	course of undiagnosed type	2	0	5152	14836	5152	
9886	overall analysis	overall analysis	2	0	486	2251	486	
18266	presence of the Gabrin sign	presence of the INFunknownSUP sign	2	0	675	15837	675	
4582	antiviral drugs	antiviral drug	2	0	4584	3989	4584	
32332	prognostic factors	prognostic factor	2	0	583	158	583	
34790	Social distancing	social distancing	2	0	384	24387	384	
23454	Inclusion criteria	inclusion criterion	2	0	3649	23455	3649	
4069	sporadic outbreaks	sporadic outbreak	2	0	2892	4070	2892	
21704	cardiac manifestations	cardiac manifestation	2	0	885	3858	885	
9883	levels of IL-10	level of INFunknownSUP	2	0	169	9885	169	
29510	natural compounds	natural compound	2	0	14102	3229	14102	
17251	health records	health record	2	0	10747	120	10747	
6527	Egyptian cohort	Egyptian cohort	2	0	601	6528	601	
453	effects of stress	effect of stress	2	0	156	199	156	
10757	biological activity of SARS-CoV-2 main protease	biological activity of INFunknownSUP main protease	2	0	10759	855	3990	
12266	epidemic period	epidemic period	2	0	5677	12267	5677	
20928	Additional file	additional file	2	0	20930	853	20930	
1103	ventricular longitudinal strain	ventricular longitudinal strain	2	0	1105	1104	1107	
20902	scientific community	scientific community	2	0	3641	2290	3641	
15843	2-drug regimen	INFunknownSUP regimen	2	0	15845	15844	15845	
2505	Australian healthcare	Australian INFunknownSUP	2	0	494	2506	494	
14639	employment status	employment status	2	0	2720	13090	2720	
6903	medical supplies	medical supply	2	0	6905	947	6905	
13397	point clouds	point cloud	2	0	13399	10333	13399	
35876	all-cause mortality	all-cause mortality	2	0	1197	35877	1197	
15418	home care	home care	2	0	9	231	9	
1328	elderly individuals	elderly individual	2	0	1113	1329	1113	
117	mental health professionals	mental health professional	2	0	121	118	121	
17340	pandemic restrictions	pandemic restriction	2	0	2880	1354	2880	
10010	negative effects	negative effect	2	0	156	1338	156	
26994	online learning environment	online learning environment	2	0	3454	2388	3454	
14650	Sleep Quality Index	sleep Quality Index	2	0	14532	14651	7907	
12956	mean time	mean time	2	0	179	194	179	
6582	viral epidemic	viral epidemic	2	0	6542	1741	6542	
1373	clinical outcome	clinical outcome	2	0	295	884	295	
38169	vaccination programme	vaccination programme	2	0	2839	437	2839	
24717	surgical mask use	surgical mask use	2	0	292	13734	292	
18509	Covid-19 infection	INFunknownSUP infection	2	0	41	1884	41	
354	school staff	school staff	2	0	11	355	11	
9753	human semen	human semen	2	0	9755	2214	9755	
16643	cohort studies	cohort study	2	0	136	601	136	
5207	ABO blood group	ABO blood group	2	0	5209	5208	18	
31186	respiratory illness	respiratory illness	2	0	1069	259	1069	
7600	clinical presentations	clinical presentation	2	0	2848	884	2848	
37307	COVID-19 vaccine acceptance	INFunknownSUP vaccine acceptance	2	0	1246	40	1248	
36185	mechanisms of dexamethasone	mechanism of INFunknownSUP	2	0	1456	12123	1456	
12169	Bayesian inference	INFunknownSUP inference	2	0	579	12170	579	
23750	clozapine treatment	clozapine treatment	2	0	97	23751	97	
13644	Western blot analyses	Western blot analysis	2	0	13646	4549	4668	
22409	evidence map	evidence map	2	0	22411	585	22411	
11915	care center	care center	2	0	8718	9	8718	
3136	pregnant women protection	pregnant woman protection	2	0	440	3137	440	
7257	COVID-19 Vaccine	INFunknownSUP vaccine	2	0	685	40	685	
413	predictors of sick leave	predictor of sick leave	2	0	414	415	414	
4144	blockade exposure	blockade exposure	2	0	1054	4145	1054	
11086	diagnosis rate	diagnosis rate	2	0	1034	2168	1034	
28948	greater number of hospitals	great number of hospital	2	0	28949	76	916	
14076	month of March	month of March	2	0	2167	8900	2167	
15606	heavy personal protective equipment	heavy personal protective equipment	2	0	4960	8258	3038	
3895	Chi-square test	Chi-square test	2	0	754	3896	754	
33073	Preventive measures	preventive measure	2	0	317	32270	317	
1130	asymptomatic health care workers	asymptomatic health care worker	2	0	1132	1131	1136	
35874	28-day all-cause mortality	INFunknownSUP all-cause mortality	2	0	35876	35870	1197	
35741	absence of symptoms	absence of symptom	2	0	4917	86	4917	
19980	data collection	datum collection	2	0	16824	22	16824	
828	test results	test result	2	0	325	754	325	
9840	Bayesian inference	INFunknownSUP inference	2	0	579	3700	579	
25348	clinical setting	clinical setting	2	0	2854	884	2854	
35775	high exposure	high exposure	2	0	1054	13	1054	
2773	probable depression	probable depression	2	0	1514	2774	1514	
12488	big data	big datum	2	0	22	9540	22	
39081	critical juncture	critical juncture	2	0	39083	223	39083	
5901	intervention effects	intervention effect	2	0	156	5608	156	
16107	healthcare access	INFunknownSUP access	2	0	224	494	224	
25179	predictive models	predictive model	2	0	3975	4314	3975	
18925	cytokines levels	cytokine level	2	0	169	5734	169	
21463	COVID-19 Infection	INFunknownSUP infection	2	0	9866	40	9866	
8762	S1 subunit	INFunknownSUP subunit	2	0	8764	8763	8764	
13701	kappa coefficient	kappa coefficient	2	0	4664	13702	4664	
711	secondary injury	secondary injury	2	0	713	712	713	
1534	average age	average age	2	0	906	178	906	
33306	innate immune system	innate immune system	2	0	1325	12377	1327	
20704	Remote Delivery	remote delivery	2	0	20706	20705	20706	
12621	high rates	high rate	2	0	83	13	83	
38765	health policies	health policy	2	0	1760	120	1760	
3696	general public	general public	2	0	3698	1080	3698	
15623	infected people	infected people	2	0	694	1088	694	
27117	normal range	normal range	2	0	420	2708	420	
19674	severe COVID-19 pneumonia	severe INFunknownSUP pneumonia	2	0	2369	3062	2369	
3577	human immunodeficiency virus	human immunodeficiency virus	2	0	3579	2214	778	
38588	severity criteria	severity criterion	2	0	3649	5116	3649	
34070	findings of coronavirus disease	finding of coronavirus disease	2	0	3390	338	3390	
9367	SLT evaluation	INFunknownSUP evaluation	2	0	2399	9368	2399	
12985	Era of COVID-19	era of INFunknownSUP	2	0	12986	40	12986	
33993	specialty care	specialty care	2	0	9	33994	9	
5981	B.1.1.7 lineage	B.1.1.7 lineage	2	0	485	5982	485	
24178	in-person outpatient visits	in-person outpatient visit	2	0	13121	9275	13123	
28841	antibody positivity	antibody INFunknownSUP	2	0	1238	5924	1238	
22727	anti-SARS-CoV-2-antibodies prevalence	anti-SARS-CoV-2-antibody prevalence	2	0	9272	22728	9272	
37488	government policy	government policy	2	0	293	99	293	
12458	Respiratory Syncytial Virus	respiratory syncytial virus	2	0	12460	3287	12462	
16658	initial WBC count	initial WBC count	2	0	16660	335	1305	
18827	SARS-CoV-2 IgG antibody testing	INFunknownSUP IgG antibody testing	2	0	18829	28	1885	
9642	symptomatic patients	symptomatic patient	2	0	60	38	60	
5989	cross-sectional serology study	cross-sectional serology study	2	0	5991	2493	2087	
7788	severity of disease	severity of disease	2	0	5116	209	5116	
6145	second waves	second wave	2	0	1281	1279	1281	
6450	screen brightness	screen brightness	2	0	5708	5709	5708	
9373	hand hygiene	hand hygiene	2	0	8770	2503	8770	
1682	consensus statement	consensus statement	2	0	1684	1683	1684	
37652	cytokine storm	INFunknownSUP storm	2	0	37654	3718	37654	
21659	time points	time point	2	0	23	179	23	
10511	full protocol	full protocol	2	0	7962	6703	7962	
30290	IFNactive neutrophils	IFNactive neutrophil	2	0	4740	30291	4740	
34485	social care	social care	2	0	9	383	9	
22324	nonsurvival group	INFunknownSUP group	2	0	18	22325	18	
8961	Work engagement	work engagement	2	0	3684	8962	3684	
26030	semi-structured interviews	semi-structured interview	2	0	10034	26031	10034	
12256	African countries	African country	2	0	1599	5365	1599	
10496	sectional study	sectional study	2	0	2087	10497	2087	
7753	health economics	health economics	2	0	7755	120	7755	
3910	self-reported COVID-19 symptoms	self-reported INFunknownSUP symptom	2	0	3912	3911	86	
6250	TMPRSS2 expression	INFunknownSUP expression	2	0	5729	6251	5729	
4271	large number of people	large number of people	2	0	4249	694	916	
32600	OS group	os group	2	0	18	32601	18	
30050	% CI	% INFunknownSUP	2	0	30052	364	30052	
5340	hospital capacity	hospital capacity	2	0	3026	185	3026	
23832	online learning behavior	online learning behavior	2	0	16069	2388	16069	
20978	social transformation	social transformation	2	0	1708	383	1708	
10095	chest X-ray images	chest X-ray image	2	0	10097	25	4034	
26758	recognition speed	recognition speed	2	0	4300	13787	4300	
5952	hospital admission	hospital admission	2	0	2865	185	2865	
15784	time series	time series	2	0	8050	179	8050	
11711	aim of this paper	aim of this paper	2	0	7070	11713	7070	
29792	proof of concept	proof of concept	2	0	29793	29276	29793	
17246	civil liberties	civil liberty	2	0	17248	10782	17248	
31990	case studies	case study	2	0	136	3368	136	
6453	rapid increase	rapid increase	2	0	392	795	392	
10331	measurement point	measurement point	2	0	10333	6671	10333	
10026	e-learning methods	e-learning method	2	0	205	3918	205	
9399	Covid-19 mortality	INFunknownSUP mortality	2	0	1197	1884	1197	
21878	UK Cultural Sector	UK cultural sector	1	0	21880	5052	21882	
10953	Inflammatory Bowel Disease Patients	inflammatory bowel disease patient	1	0	10959	10954	10959	
26321	(EDL)-gated field-effect transistor-based	INFunknownSUP INFunknownSUP INFunknownSUP	1	0	9960	26322	9960	
38829	positive SARS-CoV-2	positive INFunknownSUP	1	0	28	228	28	
8060	antibody profile to SARS-CoV-2 infection	antibody profile to INFunknownSUP infection	1	0	8062	5924	3088	
39131	de la magnitud de la epidemia	de la INFunknownSUP de la INFunknownSUP	1	0	39133	1914	39141	
36417	air conditioners	air conditioner	1	0	36419	868	36419	
33387	priority ranking	priority ranking	1	0	4270	19575	4270	
11450	Forty-two patients	Forty-two patient	1	0	60	11451	60	
8925	sound benefit-risk assessment	sound INFunknownSUP assessment	1	0	8927	4922	238	
34898	Coronavirus-caused diseases	INFunknownSUP disease	1	0	315	34899	315	
32392	stratification of high-risk patients	stratification of high-risk patient	1	0	3809	16925	3809	
21825	information security	information security	1	0	12279	2591	12279	
27282	portable device	portable device	1	0	3001	564	3001	
38205	plasma glucose	plasma glucose	1	0	29011	28077	29011	
25154	alternatives -	alternative INFunknownSUP	1	0	5345	4141	5345	
16076	Clinical presentations	clinical presentation	1	0	2848	1501	2848	
15314	throat swabs	throat swab	1	0	15316	15315	15316	
39158	low-grade fever	low-grade fever	1	0	6465	3115	6465	
24491	Activity Redesign	activity redesign	1	0	24493	24492	24493	
11883	postoperative COVID-19 infection rate	postoperative INFunknownSUP infection rate	1	0	11885	8142	1034	
8501	county rate of COVID-19	county rate of INFunknownSUP	1	0	8503	8502	1034	
27592	residential substance use treatment facilities	residential substance use treatment facility	1	0	27594	9936	2676	
23777	maternal infection	maternal infection	1	0	41	23778	41	
22354	column densities	column density	1	0	22356	12795	22356	
19775	adaption of the existing framework	adaption of the existing framework	1	0	2609	19777	2609	
19146	local reactions	local reaction	1	0	19148	3173	19148	
34401	Prolonged viral carriage	prolonged viral carriage	1	0	34403	12299	34405	
38157	isolation centers	isolation center	1	0	3427	6569	3427	
15124	University Hospital Center Zagreb	University Hospital Center Zagreb	1	0	15126	50	15130	
27671	complex mechanisms	complex mechanism	1	0	1456	13320	1456	
25450	medical offices	medical office	1	0	10495	947	10495	
6479	Threshold cycle	threshold cycle	1	0	6481	6480	6481	
26879	game-changer quest	game-changer quest	1	0	387	26880	387	
6731	HoloLens2 MR device	INFunknownSUP Mr device	1	0	6733	3482	3001	
1940	management decisions	management decision	1	0	1942	743	1942	
28565	belief model	belief model	1	0	1078	28566	1078	
36982	rhesus macaque	rhesus macaque	1	0	36984	25365	36984	
1178	key domains	key domain	1	0	1180	850	1180	
28721	psychiatric comorbidity	psychiatric comorbidity	1	0	28723	4594	28723	
19343	corona virus	corona virus	1	0	778	19344	778	
12084	Global fine-scale changes	global fine-scale change	1	0	12086	12085	1336	
10470	resumption of elective spine surgery services	resumption of elective spine surgery service	1	0	187	10472	187	
9065	Major COVID-19 Surge	Major INFunknownSUP surge	1	0	9067	9066	9069	
31801	Likert-type scale	INFunknownSUP scale	1	0	2422	31802	2422	
4658	DASS subscales B coefficient	Dass subscales B coefficient	1	0	4660	4659	4664	
8112	different quarters of the COVID-19 cohort	different quarter of the INFunknownSUP cohort	1	0	8114	688	8115	
448	proper threshold orderings	proper threshold ordering	1	0	450	449	452	
39135	magnitud de la epidemia	INFunknownSUP de la INFunknownSUP	1	0	39137	39136	39141	
35453	natural question	natural question	1	0	7833	3229	7833	
20247	medical practitioners	medical practitioner	1	0	13543	947	13543	
27059	causative agent of COVID-19 related lung injury	causative agent of INFunknownSUP related lung injury	1	0	27061	27060	12122	
37602	National Stroke Registry	National stroke registry	1	0	17610	33027	17610	
34548	public children	public child	1	0	6153	1321	6153	
32114	learning-based multi-class convolutional neural network model	INFunknownSUP INFunknownSUP convolutional neural network model	1	0	32118	32115	1078	
38110	series analysis	series analysis	1	0	486	8050	486	
16026	subject of particular interest	subject of particular interest	1	0	16027	16028	16027	
10392	London School of Hygiene	London School of hygiene	1	0	10394	10393	3669	
13394	similar effect	similar effect	1	0	1809	102	1809	
18720	target dose	target dose	1	0	2537	11730	2537	
18116	lockdown conditions	INFunknownSUP condition	1	0	2910	1676	2910	
252	melt spinning	melt spinning	1	0	254	253	254	
24904	fungi compounds	fungus compound	1	0	14102	24905	14102	
26803	de organismos	de INFunknownSUP	1	0	26805	1421	26805	
32808	different measures of entropy	different measure of entropy	1	0	32810	688	317	
25172	Web-mediated Counseling Relationship	INFunknownSUP counseling relationship	1	0	25174	25173	25176	
26253	primary care clinic	primary care clinic	1	0	7704	6472	7704	
31886	experiences of perinatal mental health services	experience of perinatal mental health service	1	0	1339	31888	1339	
767	non-small cell lung cancer	non-small cell lung cancer	1	0	769	768	773	
2299	U upstream context	U upstream context	1	0	2301	2300	1567	
30753	complicated appendicitis	complicated appendicitis	1	0	1983	30754	1983	
21832	SARS-CoV-2 rT-PCR testing	INFunknownSUP INFunknownSUP testing	1	0	1885	21833	1885	
30729	functional importance of these molecular vehicles	functional importance of these molecular vehicle	1	0	30731	4225	2765	
1562	Local pharmacies	local pharmacy	1	0	1564	1563	1564	
31748	technical issues of these apps	technical issue of these INFunknownSUP	1	0	4082	17206	3758	
22685	min travel time	min travel time	1	0	22687	22686	179	
7657	Neuropathologic features	Neuropathologic feature	1	0	1469	7658	1469	
36119	identification of a suitable combination of antibody	identification of a suitable combination of antibody	1	0	57	36121	57	
30484	non-intubated COVID-19	INFunknownSUP INFunknownSUP	1	0	40	13769	40	
14873	non-urgent surgery	non-urgent surgery	1	0	1630	1045	1630	
9253	quicker response	quick response	1	0	409	9254	409	
11529	composite influent wastewater samples	composite influent wastewater sample	1	0	11531	10302	1765	
29846	high problem-focused	high INFunknownSUP	1	0	29848	13	29848	
137	allogeneic Mesenchymal Stem Cell-	INFunknownSUP mesenchymal Stem INFunknownSUP	1	0	139	138	143	
35757	non-urgent surgical procedures	non-urgent surgical procedure	1	0	4198	1045	4200	
9049	Extensive lung involvement	extensive lung involvement	1	0	5122	9050	3599	
27874	adverse consequences	adverse consequence	1	0	4289	1082	4289	
27025	Additional analysis	additional analysis	1	0	486	853	486	
15111	profile of brain PET hypometabolism	profile of brain pet hypometabolism	1	0	3088	12202	3088	
1030	vaccine hesitancy rate	vaccine hesitancy rate	1	0	1034	1031	1034	
10038	potential return	potential return	1	0	10040	1276	10040	
16415	acquisition of active pharmaceutical ingredients	acquisition of active pharmaceutical ingredient	1	0	3710	16417	3710	
35023	COVID-19 patients Clostridioides difficile infection	INFunknownSUP patient INFunknownSUP INFunknownSUP infection	1	0	41	35024	41	
35199	short time help	short time help	1	0	1207	35200	1207	
8455	administrative duties	administrative duty	1	0	8457	8456	8457	
21636	life years	life year	1	0	1313	1434	1313	
3280	spondylitis surgery	spondylitis surgery	1	0	1630	3281	1630	
37304	staff well-being	staff well-being	1	0	2245	11	2245	
33598	meta-analysis of regional risk factors	meta-analysis of regional risk factor	1	0	286	33600	286	
9854	invasive complete excision of endometriosis	invasive complete excision of endometriosis	1	0	9856	6302	9859	
38634	SARS-CoV-2 outbreaks	INFunknownSUP outbreak	1	0	2892	226	2892	
32303	betacoronaviruses spike protein	betacoronavirus spike protein	1	0	1795	32304	1797	
21583	global pandemic of coronavirus disease	global pandemic of coronavirus disease	1	0	12349	338	113	
29932	office visits	office visit	1	0	13123	29933	13123	
10847	acute lung injury	acute lung injury	1	0	2934	1461	713	
261	severe outcomes	severe outcome	1	0	263	262	263	
2704	related challenges	related challenge	1	0	2220	2647	2220	
13490	risk severity	risk severity	1	0	5116	1542	5116	
33618	Context of the COVID-19 Pandemic	context of the INFunknownSUP pandemic	1	0	33619	6336	33619	
20207	acute bronchiolitis hospitalizations	acute INFunknownSUP hospitalization	1	0	5091	7149	5091	
16440	tertiary hospital	tertiary hospital	1	0	185	182	185	
25745	Recipients 32327321/ Development of a telehealth geriatric assessment model	recipient 32327321/ Development of a INFunknownSUP geriatric assessment model	1	0	25747	12782	9277	
18822	public health experts	public health expert	1	0	6478	1320	6478	
32760	moderate preterm infant	moderate INFunknownSUP infant	1	0	32762	4684	32764	
20152	vaccine protocol	vaccine protocol	1	0	7962	577	7962	
14019	likely increase	likely increase	1	0	392	14020	392	
1719	single-institution retrospective review	single-institution retrospective review	1	0	1721	1720	1723	
32594	self-isolation policies	self-isolation policy	1	0	1760	32595	1760	
23287	extent PA	extent pa	1	0	23289	17456	23289	
38397	Digital technologies	Digital technology	1	0	70	8676	70	
4321	cerebral SARS-CoV2 associated strokes	cerebral INFunknownSUP associated stroke	1	0	4323	4322	3531	
39153	Improving staff confidence	improving staff confidence	1	0	39155	39154	1793	
21182	sex-disaggregated data	INFunknownSUP datum	1	0	22	21183	22	
34858	Less evidence of cross-reactive memory CD8 T cells	less evidence of cross-reactive memory INFunknownSUP T cell	1	0	34860	34859	585	
9154	consequence of international trade	consequence of international trade	1	0	9155	7146	9155	
24046	Sequences of SARS-CoV-2	sequence of INFunknownSUP	1	0	24047	28	24047	
31036	mg of IgY	mg of IgY	1	0	22112	13004	22112	
25632	Non-carcinogenic risks	Non-carcinogenic risk	1	0	8152	25633	8152	
2584	accessible web-based	accessible INFunknownSUP	1	0	2586	2585	2586	
10708	analysis of whole Syrian hamster lung lobes	analysis of whole Syrian hamster lung lobe	1	0	486	10710	486	
25594	d-optimal design	d-optimal design	1	0	4183	25595	4183	
14942	traumatic events	traumatic event	1	0	1083	14943	1083	
14257	Universitario Marques de Valdecilla	INFunknownSUP Marques de Valdecilla	1	0	14259	14258	14263	
20077	RT-qPCR determination of SARS-CoV-2	INFunknownSUP determination of INFunknownSUP	1	0	20079	7851	15931	
26208	better understanding of the extent of the impact	good understanding of the extent of the impact	1	0	26210	1635	2715	
33245	virtual horse showing	virtual horse showing	1	0	33247	3148	33249	
14100	marine compounds	marine compound	1	0	14102	9837	14102	
30276	extensive computational validation of the methodology	extensive computational validation of the methodology	1	0	30278	15213	6319	
32295	ClinicalTrials.gov number	INFunknownSUP number	1	0	916	32296	916	
28884	virtual shows	virtual show	1	0	13038	3148	13038	
4644	reproduction number of 2019-nCoV	reproduction number of INFunknownSUP	1	0	4646	4645	916	
3955	oxygen species	oxygen specie	1	0	3957	3956	3957	
11615	variables respuesta	variable INFunknownSUP	1	0	11617	817	11617	
26462	Philadelphia story Supplemental	Philadelphia story Supplemental	1	0	26464	26463	26466	
16562	acceptance model	acceptance model	1	0	1078	1248	1078	
38644	indirect costs	indirect cost	1	0	22726	643	22726	
9456	sex difference	sex difference	1	0	4260	5662	4260	
5614	length of ICU stay	length of ICU stay	1	0	1347	5616	1347	
377	report writing	report writing	1	0	379	378	379	
31301	classification model	classification model	1	0	1078	1121	1078	
13462	South African government	South African government	1	0	13464	5363	99	
21653	prioritization of expertise	prioritization of expertise	1	0	3209	19017	3209	
20264	% required tube feeding	% required tube feeding	1	0	20266	364	20270	
17194	Bayesian data analysis	INFunknownSUP datum analysis	1	0	17196	3700	486	
32412	Non-Coding RNAs	INFunknownSUP INFunknownSUP	1	0	16623	32413	16623	
14697	trainee education	trainee education	1	0	361	8828	361	
33283	immunosuppressed patients	INFunknownSUP patient	1	0	60	33284	60	
14310	sialic acid layer	sialic acid layer	1	0	14312	14311	14314	
18313	mRNA BNT 162b2 vaccination	INFunknownSUP BNT INFunknownSUP vaccination	1	0	18315	575	437	
35817	main ENT subspecialties	main Ent subspecialty	1	0	35819	4679	35821	
36844	key cause of age-associated diseases	key cause of age-associated disease	1	0	36846	850	14198	
36974	CT images of COVID-19 patients	CT image of INFunknownSUP patient	1	0	25160	911	4034	
11555	current semi-quantitative data	current semi-quantitative datum	1	0	11557	443	22	
37578	CAD framework	cad framework	1	0	4860	33188	4860	
35021	treatment of COVID-19 patients Clostridioides difficile infection	treatment of INFunknownSUP patient INFunknownSUP INFunknownSUP infection	1	0	97	35023	97	
31815	Sense of Coherence Scale	sense of coherence Scale	1	0	1203	31816	1203	
29267	higher viral load	high viral load	1	0	5917	322	5919	
18834	delayed response to vaccination	delayed response to vaccination	1	0	18836	4161	409	
26636	adaptive changes	adaptive change	1	0	1336	6264	1336	
2140	benefit-risk analysis	INFunknownSUP analysis	1	0	486	2141	486	
7551	School Identity	School identity	1	0	7553	3669	7553	
38471	implementation of online learning	implementation of online learning	1	0	396	2388	396	
9718	stronger support	strong support	1	0	260	9719	260	
25953	estimate of the kit	estimate of the kit	1	0	19137	567	19137	
7180	Common clinical features of COVID-19	common clinical feature of INFunknownSUP	1	0	1466	7181	1469	
32586	item response theory	item response theory	1	0	32588	32587	21053	
37019	existing paradigms	existing paradigm	1	0	37021	6308	37021	
29027	Smoke Evacuation	Smoke evacuation	1	0	29029	29028	29029	
1978	types of technologies	type of technology	1	0	1979	70	1979	
22698	model design	model design	1	0	4183	1078	4183	
1882	Covid-19 testing programmes	INFunknownSUP testing programme	1	0	1886	1883	1886	
28914	vaccine recipients	vaccine recipient	1	0	11385	577	11385	
28680	communicable/infectious condition	communicable/infectious condition	1	0	8881	28681	8881	
6549	enforcement of the Health Insurance Portability	enforcement of the Health Insurance portability	1	0	6550	6551	6550	
13459	mild-to-moderate disease	mild-to-moderate disease	1	0	209	13460	209	
1698	effector subsets	effector subset	1	0	1700	1699	1700	
26839	sex-related differences	sex-related difference	1	0	5663	26840	5663	
6182	Blood Regulation	Blood Regulation	1	0	6184	1229	6184	
9522	Government of Catalonia	government of Catalonia	1	0	9523	9524	9523	
26177	false negative rate	false negative rate	1	0	26179	3364	1034	
23527	reactivity of antibodies	reactivity of antibody	1	0	8022	929	8022	
13371	social stability	social stability	1	0	11137	383	11137	
11253	corresponding decrease	corresponding decrease	1	0	3084	20	3084	
33801	global assault of the novel Corona virus	global assault of the novel Corona virus	1	0	33803	1954	11449	
35297	antibody validation	antibody validation	1	0	6319	5924	6319	
12291	various facial skin lesions	various facial skin lesion	1	0	12293	1099	162	
12586	knowledge of the potential drug target	knowledge of the potential drug target	1	0	213	12588	213	
33052	structured innovation methods	structured innovation method	1	0	33054	6409	205	
5135	% women	% woman	1	0	920	364	920	
4585	Distinct Metagenomic Signatures	distinct INFunknownSUP signature	1	0	4587	4586	4589	
29213	unknown SI	unknown SI	1	0	29215	1475	29215	
15220	Fifty-two cases of COVID-19 pneumonia	INFunknownSUP case of INFunknownSUP pneumonia	1	0	15221	15224	229	
24510	S1-ACE2 complex dissociation	INFunknownSUP complex dissociation	1	0	24514	24041	24514	
20451	consecutive infections	consecutive infection	1	0	779	6607	779	
30842	number R01 GM124280	number R01 GM124280	1	0	30844	916	30846	
13313	elective surgeries	elective surgery	1	0	13315	1627	13315	
19080	repeated-measures MANOVA	repeated-measures INFunknownSUP	1	0	19082	19081	19082	
13704	Descriptive comparison of admission characteristics	descriptive comparison of admission characteristic	1	0	13706	13705	13707	
16727	KASID Coronavirus disease	INFunknownSUP INFunknownSUP disease	1	0	209	16728	209	
4307	future zoonoses	future zoonosis	1	0	4309	1367	4309	
34693	Global case fatality	global case fatality	1	0	3367	12085	3369	
16962	extracellular volume	extracellular volume	1	0	3445	7025	3445	
12076	further disruption	further disruption	1	0	12078	7713	12078	
37386	boost to human coronaviruses	boost to human coronavirus	1	0	37387	8794	37387	
17844	intensive production of vegetal cultures	intensive production of vegetal culture	1	0	17846	8	654	
9110	p-cluster &lt	INFunknownSUP &lt	1	0	4863	9111	4863	
20096	proven protease inhibitor	proven protease inhibitor	1	0	20098	20097	4569	
23401	COVID-19 Delta wave	INFunknownSUP Delta wave	1	0	23403	40	10210	
38058	drivers of acute respiratory distress syndrome	driver of acute respiratory distress syndrome	1	0	33848	24666	33848	
32842	online anatomy teaching	online anatomy teaching	1	0	32844	541	2074	
3857	cardiac autonomic nervous system	cardiac autonomic nervous system	1	0	3859	3858	1327	
896	advantages of peptidomimetics	advantage of peptidomimetic	1	0	897	898	897	
36176	greater reduction	great reduction	1	0	490	302	490	
39191	two-week period	two-week period	1	0	5677	39192	5677	
19887	impact ratios	impact ratio	1	0	19889	110	19889	
186	resumption of usual daily activities	resumption of usual daily activity	1	0	187	188	187	
21326	prospective safety	prospective safety	1	0	6729	2084	6729	
34067	education programs	education program	1	0	2246	361	2246	
31533	governance of all people	governance of all people	1	0	2616	694	2616	
26949	Immunological imprinting of the antibody response	immunological imprinting of the antibody response	1	0	26951	13826	26952	
33657	% of the participants	% of the participant	1	0	364	4950	364	
25627	dental care services	dental care service	1	0	7828	5656	5980	
27734	decision making	decision making	1	0	27736	5486	27736	
5763	su relacion con las busquedas	Su INFunknownSUP con la INFunknownSUP	1	0	5765	5764	5771	
24422	delivery of this face-to-face intervention	delivery of this face-to-face intervention	1	0	2840	24424	2840	
28524	information providers	information provider	1	0	673	2591	673	
3125	dietary guidelines	dietary guideline	1	0	91	3126	91	
33798	ready-made garment	ready-made garment	1	0	2108	33799	2108	
11456	Takotsubo cardiomyopathy	INFunknownSUP INFunknownSUP	1	0	11458	11457	11458	
15776	epidemic curve of 2019-nCoV cases time series	epidemic curve of INFunknownSUP case time series	1	0	15778	12267	6817	
29378	mental health support	mental health support	1	0	260	118	260	
32681	feasible way	feasible way	1	0	701	27423	701	
37465	Elecsys Anti-SARS-CoV-2 assay	INFunknownSUP INFunknownSUP assay	1	0	3119	15282	3119	
36607	association index metric	association index metric	1	0	36609	11619	36611	
38021	geometric mean titer	geometric mean titer	1	0	38023	38022	18030	
13483	COVID-19 Therapy	INFunknownSUP therapy	1	0	13485	40	13485	
18017	microglial activation-induced neuroinflammation	INFunknownSUP INFunknownSUP neuroinflammation	1	0	18019	220	18021	
24845	borderline moderate-severe ANC level	borderline INFunknownSUP ANC level	1	0	24847	17090	362	
1724	higher rate of venous thromboembolism	high rate of venous thromboembolism	1	0	1725	1728	1034	
25777	workings of symptomatic breast services	working of symptomatic breast service	1	0	25778	11221	25778	
7190	community dispensings of antibiotics	community dispensing of antibiotic	1	0	7192	3641	7193	
9318	pairwise comparisons	INFunknownSUP comparison	1	0	9320	9319	9320	
28091	equivalent materials	equivalent material	1	0	2335	28092	2335	
25473	placebo tablet	placebo tablet	1	0	22119	18443	22119	
34732	antiviral assays	antiviral assay	1	0	2754	3989	2754	
16258	range of psychopathologies	range of psychopathology	1	0	420	16260	420	
37860	major mechanism	major mechanism	1	0	10036	1318	10036	
9407	younger cohorts	young cohort	1	0	3894	2571	3894	
11467	RNAseq levels	INFunknownSUP level	1	0	169	11468	169	
33450	control of vaccine hesitancy	control of vaccine hesitancy	1	0	510	1031	510	
28113	neural network of the Epitope Database	neural network of the Epitope Database	1	0	28115	28114	719	
16513	early termination	early termination	1	0	16515	55	16515	
14497	cluster outbreaks	cluster outbreak	1	0	2892	13441	2892	
13225	significance level	significance level	1	0	362	458	362	
23712	insufficient knowledge	insufficient knowledge	1	0	213	3024	213	
38782	un indice de letalidad relativa	un INFunknownSUP de letalidad INFunknownSUP	1	0	38784	38783	38790	
10488	hairiness estimation	hairiness estimation	1	0	10490	10489	10490	
15750	resolution mass spectrometry	resolution mass spectrometry	1	0	15752	1448	15754	
33161	containment strategies	containment strategy	1	0	300	12039	300	
34554	Toll-like receptor	INFunknownSUP receptor	1	0	3502	34555	3502	
13126	Front Line -	Front Line INFunknownSUP	1	0	5345	13127	5345	
11067	function of time	function of time	1	0	9243	179	9243	
11662	limits of agreement	limit of agreement	1	0	43	11664	43	
2309	allogeneic cells	INFunknownSUP cell	1	0	133	138	133	
25518	strong support	strong support	1	0	260	3987	260	
24159	delivery preferences of service-users	delivery preference of service-user	1	0	24161	2840	2599	
1946	European Mobility Medicine Association	European mobility Medicine Association	1	0	1948	1622	1952	
34115	Observational study	observational study	1	0	2087	13408	2087	
14092	pervasive relevance of COVID-19	pervasive relevance of INFunknownSUP	1	0	14093	40	856	
2911	help of transmembrane serine protease type	help of INFunknownSUP serine protease type	1	0	1207	2913	1207	
2993	Effects of a disposable home electro-stimulation device	effect of a disposable home electro-stimulation device	1	0	2994	2995	2994	
3321	training base	training base	1	0	3323	235	3323	
19134	mean estimate of R0	mean estimate of INFunknownSUP	1	0	19136	194	19137	
32071	findings of this study call	finding of this study call	1	0	32075	18723	32075	
24878	prophylactic measure	prophylactic measure	1	0	2466	16476	2466	
15221	Fifty-two cases	INFunknownSUP case	1	0	229	15222	229	
323	accurate results	accurate result	1	0	325	324	325	
14481	2019-nCoV ranges	INFunknownSUP range	1	0	5086	14482	5086	
35096	temperature screening	temperature screening	1	0	7961	195	7961	
4394	novel SARS-CoV-2 virus	novel INFunknownSUP virus	1	0	4396	810	778	
25055	Effect of ABO blood groups	effect of ABO blood group	1	0	6097	7810	6097	
35888	immune cell types	immune cell type	1	0	35890	970	1979	
1923	funding support	funding support	1	0	260	1924	260	
30488	SARS-CoV-2 variant	INFunknownSUP variant	1	0	939	28	939	
16321	Outcome Association	outcome association	1	0	16323	10594	16323	
14186	structured genomes	structured genome	1	0	865	6409	865	
28268	study periods	study period	1	0	873	2087	873	
6292	sudden changes	sudden change	1	0	1336	3583	1336	
21871	Online informational bariatric seminars	online informational bariatric seminar	1	0	21873	217	21877	
3086	incidence profile	incidence profile	1	0	3088	2940	3088	
11656	independent variables	independent variable	1	0	817	582	817	
15034	paediatric urological practice	paediatric urological practice	1	0	15036	974	3285	
26245	educational initiatives	educational initiative	1	0	6532	834	6532	
3958	user-friendly interfaces	user-friendly interface	1	0	3960	3959	3960	
23467	literate females	literate female	1	0	11037	23468	11037	
15953	dissemination of novel coronavirus	dissemination of novel INFunknownSUP	1	0	6877	15955	6877	
10342	cut-off point of SAVE-9	cut-off point of INFunknownSUP	1	0	10344	5277	10333	
30459	Various procurement strategies	various procurement strategy	1	0	8391	7431	300	
14115	Diagnosis of SARS CoV2 infection	diagnosis of INFunknownSUP INFunknownSUP infection	1	0	10673	14117	10673	
2133	geriatric population impacts	geriatric population impact	1	0	2135	2134	1385	
13554	study area	study area	1	0	1089	2087	1089	
30510	Effects of social position	effect of social position	1	0	2994	16611	2994	
1822	Open label	open label	1	0	1824	1823	1824	
33007	Pediatric Intensive Care Unit	pediatric intensive Care Unit	1	0	28540	401	16875	
16745	local manufacturing of personal protective equipment	local manufacturing of personal protective equipment	1	0	16747	3173	718	
36761	medical consultant	medical consultant	1	0	36763	947	36763	
12519	memory T cells	memory T cell	1	0	788	7635	133	
12494	Camostat Mesylate	INFunknownSUP INFunknownSUP	1	0	12496	12495	12496	
12413	exposure to the index case	exposure to the index case	1	0	1054	12415	1054	
28149	Training sessions	training session	1	0	15478	28150	15478	
34538	marker of hospitalization risk	marker of hospitalization risk	1	0	10814	34540	10814	
1206	help to nursing administrators	help to nursing administrator	1	0	1207	1208	1207	
37384	memory boost to human coronaviruses	memory boost to human coronavirus	1	0	37386	7635	37387	
7169	Negative Emotions	negative emotion	1	0	7171	7170	7171	
2411	Severity of COVID-19	severity of INFunknownSUP	1	0	1202	40	1202	
23568	useful tools	useful tool	1	0	274	10503	274	
34820	New Haven Health	New Haven Health	1	0	34822	1162	279	
30924	emergence of SARS-CoV-2 new variants	emergence of INFunknownSUP new variant	1	0	19875	30926	19875	
7111	VIDAS assays	Vidas assay	1	0	2754	7112	2754	
15306	export of the virus	export of the virus	1	0	15307	778	15307	
3613	Light of COVID-19 Outbreak	Light of INFunknownSUP outbreak	1	0	3614	3615	3614	
32266	SARS-CoV2 infection	INFunknownSUP infection	1	0	41	4324	41	
12651	absence of reliable data	absence of reliable datum	1	0	4917	12653	4917	
19574	priority categories	priority category	1	0	5402	19575	5402	
22772	whole of Poland	whole of Poland	1	0	22773	22774	22773	
13878	diverse US metropolitan area Sex	diverse US metropolitan area sex	1	0	13880	10278	10683	
37141	single image	single image	1	0	22960	1652	22960	
27183	T clones	T clone	1	0	27185	789	27185	
23706	competency-based assessments	INFunknownSUP assessment	1	0	1393	23707	1393	
11204	public shared repertoire	public shared repertoire	1	0	11206	1321	10422	
24297	communication network	communication network	1	0	719	11078	719	
3023	insufficient capacity of diagnostic testing	insufficient capacity of diagnostic testing	1	0	3025	3024	3026	
13932	availability of virtual horse	availability of virtual horse	1	0	5099	13934	5099	
6253	Paediatric ED triage staff	paediatric editor triage staff	1	0	6255	6254	11	
8882	significant systemic disease	significant systemic disease	1	0	8884	908	209	
1291	secondary prevention treatments	secondary prevention treatment	1	0	1293	712	1295	
17681	main reference	main reference	1	0	17683	4679	17683	
22938	Geographic heatmap	geographic INFunknownSUP	1	0	22940	22939	22940	
17174	face masks:a	face INFunknownSUP	1	0	17176	731	17176	
28554	Padua Muscle Days meeting	Padua muscle day meeting	1	0	2543	28555	2543	
23954	PXS score &gt	PXS score &gt	1	0	23956	4889	2385	
32999	post-COVID-19 hyperinflammation	INFunknownSUP hyperinflammation	1	0	33001	23168	33001	
14151	University Stroke	University stroke	1	0	5248	50	5248	
29529	new generation biological therapies	new generation biological therapy	1	0	29531	69	5507	
18739	anatomy courses	anatomy course	1	0	4358	52	4358	
6324	single T403R	single INFunknownSUP	1	0	6326	1652	6326	
24688	sialic acid-binding domain	sialic acid-binding domain	1	0	24690	14311	697	
15630	SARS Cov2	INFunknownSUP INFunknownSUP	1	0	15632	2224	15632	
6538	reconstruction of the SARS-CoV-2 epidemic	reconstruction of the INFunknownSUP epidemic	1	0	6539	6540	6539	
16663	Eastern regions of Spain	Eastern region of Spain	1	0	16665	15472	5240	
38287	history of alcohol consumption	history of alcohol consumption	1	0	5381	1265	5381	
14975	current guidelines	current guideline	1	0	91	443	91	
37408	COVID-19 patients	INFunknownSUP patient	1	0	60	3076	60	
28931	tumor necrosis factor	tumor necrosis factor	1	0	28933	5736	2183	
29684	postvaccination polyclonal antibodies	postvaccination polyclonal antibody	1	0	29686	29685	929	
18373	Urology Consultations	urology consultation	1	0	18375	18374	18375	
37259	prevailing concerns	prevailing concern	1	0	12106	37260	12106	
7274	field barrier system	field barrier system	1	0	7276	6748	1327	
23250	major cancer surgeries	major cancer surgery	1	0	23252	1318	13315	
864	genomes L-1 air	genome L-1 air	1	0	866	865	868	
26497	understanding of immune changes	understanding of immune change	1	0	2715	26499	2715	
12249	higher levels of vaccine hesitancy	high level of vaccine hesitancy	1	0	12250	1031	169	
33291	immunocompromised state of COVID-19	immunocompromised state of INFunknownSUP	1	0	16551	40	1961	
21378	SD measures	INFunknownSUP measure	1	0	317	21379	317	
30880	later presentation	late presentation	1	0	4163	30881	4163	
12867	levels of infection	level of infection	1	0	169	41	169	
31375	suggested model	suggested model	1	0	1078	31376	1078	
844	impact of Sars-Cov-2 infection	impact of INFunknownSUP infection	1	0	110	846	110	
18583	structural parameter	structural parameter	1	0	16173	3549	16173	
33461	extracellular vehicles	extracellular vehicle	1	0	30735	7025	30735	
12172	CINAHL y CUIDEN	INFunknownSUP y INFunknownSUP	1	0	12174	12173	12176	
12340	present season	present season	1	0	12342	285	12342	
36990	possible future scenarios	possible future scenario	1	0	36992	745	7142	
2763	paramount importance	paramount importance	1	0	2765	2764	2765	
3452	pandemic environment	pandemic environment	1	0	3454	1354	3454	
1079	general adverse events	general adverse event	1	0	1081	1080	1083	
30623	minimal risk	minimal risk	1	0	1542	5336	1542	
2213	human respiratory viruses	human respiratory virus	1	0	2215	2214	2217	
17815	contagious disease	contagious disease	1	0	209	13053	209	
3976	pharyngeal swab PCR tests	pharyngeal swab PCR test	1	0	3978	3977	1365	
27989	Structural proteins	structural protein	1	0	1126	27990	1126	
27611	COVID19 outbreak	INFunknownSUP outbreak	1	0	310	27612	310	
15562	data of the past year	datum of the past year	1	0	22	15564	22	
38902	unusual presentation of severe acute papillary necrosis	unusual presentation of severe acute papillary necrosis	1	0	38904	3462	4163	
34629	treatment escalation	treatment escalation	1	0	34631	97	34631	
4313	predictive abilities	predictive ability	1	0	4315	4314	4315	
36618	11.99 QALM	11.99 INFunknownSUP	1	0	36620	36619	36620	
23884	grant number R01 AI112970	grant number R01 AI112970	1	0	23886	23885	23890	
12194	end of the pandemic	end of the pandemic	1	0	7132	113	7132	
140	Mesenchymal Stem	mesenchymal Stem	1	0	142	141	142	
21076	private ownership	private ownership	1	0	20403	2401	20403	
31396	ventricular assist device	ventricular assist device	1	0	31398	1104	3001	
37522	intraoperative endoscopic images	intraoperative endoscopic image	1	0	37524	37523	4034	
14462	atypical cardiovascular readings	atypical cardiovascular reading	1	0	14464	4932	14466	
862	virus genomes L-1 air	virus genome L-1 air	1	0	864	778	868	
27120	collective summary	collective summary	1	0	10506	8087	10506	
23565	suspected cases	suspected case	1	0	229	1112	229	
30215	S1-ACE2 complex formation	INFunknownSUP complex formation	1	0	10441	24041	10441	
31831	este momento de excepcionalidad	INFunknownSUP momento de INFunknownSUP	1	0	31833	31832	31837	
36283	positive impact	positive impact	1	0	110	228	110	
1976	various types of technologies	various type of technology	1	0	1978	1099	1979	
6683	leaders of the Experimental Biology Host Societies	leader of the experimental biology Host society	1	0	6684	6685	6684	
15202	exponential growth model method	exponential growth model method	1	0	15206	8977	6587	
15537	health education	health education	1	0	361	120	361	
4726	critical ill coronavirus disease	critical ill coronavirus disease	1	0	4728	223	209	
22912	start of the treatment	start of the treatment	1	0	18935	97	18935	
34241	efforts of engineers	effort of engineer	1	0	28282	34243	28282	
17307	fabrication techniques	fabrication technique	1	0	691	17308	691	
8308	RNA vaccine	RNA vaccine	1	0	577	1151	577	
36711	optical clearing	optical clearing	1	0	36713	7441	36713	
11549	products integration	product integration	1	0	918	1874	918	
36937	adherence to infection control practices	adherence to infection control practice	1	0	3636	36939	3636	
31711	urinary retention	urinary retention	1	0	8451	2662	8451	
19797	type of simulation	type of simulation	1	0	775	9152	775	
13999	stem cell	stem cell	1	0	197	8748	197	
37500	Nutritional status of individual	nutritional status of individual	1	0	11652	25337	2720	
28593	Minority Ethnic Women	Minority ethnic woman	1	0	28595	28594	28597	
28260	website survey	website survey	1	0	967	545	967	
8791	school mentoring	school mentoring	1	0	4041	355	4041	
24861	online teaching strategy	online teaching strategy	1	0	24863	541	3350	
23946	review studies	review study	1	0	136	1723	136	
17597	review/perspective of potential applications of bacteriophages	review/perspective of potential application of bacteriophage	1	0	17598	17599	17598	
21277	range of the SELES	range of the INFunknownSUP	1	0	420	21279	420	
5498	endotracheal intubation	endotracheal intubation	1	0	5500	5499	5500	
38323	severe manifestations	severe manifestation	1	0	885	262	885	
35790	acute renal injury	acute renal injury	1	0	35792	1461	713	
34264	endothelial function	endothelial function	1	0	9243	132	9243	
23520	phenomenological research approach	phenomenological research approach	1	0	5081	23521	1538	
36672	treatment groups	treatment group	1	0	2486	97	2486	
36742	Anti-SARS-CoV-2 antibody titers	INFunknownSUP antibody titer	1	0	16141	1218	8757	
37508	significant recognition	significant recognition	1	0	13787	908	13787	
10394	School of Hygiene	School of hygiene	1	0	3669	8857	3669	
39150	testing step	testing step	1	0	23817	1885	23817	
28162	Levels of social support	level of social support	1	0	9819	1943	9819	
1358	pad test	pad test	1	0	754	1359	754	
28945	public figures	public figure	1	0	10372	1321	10372	
16152	practical challenges	practical challenge	1	0	2220	6164	2220	
19956	pandemic Bronchiolitis	pandemic INFunknownSUP	1	0	19958	113	19958	
7880	Treatment of pericarditis	treatment of pericarditis	1	0	7881	1596	7881	
38696	higher number of complications	high number of complication	1	0	38698	322	916	
24149	risks of the phthalates	risk of the INFunknownSUP	1	0	8152	21792	8152	
10584	urology patient care strategy	urology patient care strategy	1	0	10586	3341	3350	
25439	striking lack of evidence of germinal centre mutation	striking lack of evidence of germinal centre mutation	1	0	25441	25440	11210	
21833	SARS-CoV-2 rT-PCR	INFunknownSUP INFunknownSUP	1	0	21835	28	21835	
12376	innate immune responses	innate immune response	1	0	969	12377	200	
26134	T cell response	T cell response	1	0	409	8957	409	
3329	systemic treatments	systemic treatment	1	0	1295	1453	1295	
26378	low fatality rate	low fatality rate	1	0	26380	457	1034	
13423	recent operative guidelines	recent operative guideline	1	0	13425	2128	91	
36500	spread of the pandemic	spread of the pandemic	1	0	570	113	570	
22178	Use of Certolizumab Pegol	use of INFunknownSUP INFunknownSUP	1	0	3481	22180	3481	
34833	substantial advantages	substantial advantage	1	0	897	3239	897	
9989	Literature Review	literature Review	1	0	9991	4865	9991	
35636	German Department of Radiation Oncology	German department of radiation oncology	1	0	35638	35637	35639	
33925	Global Fund	Global Fund	1	0	33927	14037	33927	
36123	combination of antibody	combination of antibody	1	0	367	5924	367	
30286	higher proportions of IFNactive neutrophils	high proportion of IFNactive neutrophil	1	0	15793	30290	15614	
37084	Serum samples	serum sample	1	0	1765	17905	1765	
27614	% acute non-ischemic	% acute INFunknownSUP	1	0	27616	364	27618	
18109	early stage of the outbreak	early stage of the outbreak	1	0	5998	310	1521	
29827	syncytial virus	syncytial virus	1	0	778	29828	778	
16482	glass opacities	glass opacity	1	0	526	16483	526	
6073	median LOS	median los	1	0	6075	2634	6075	
6546	structural analysis	structural analysis	1	0	486	3549	486	
37517	high transmission	high transmission	1	0	876	13	876	
30840	grant number R01 GM124280	grant number R01 GM124280	1	0	30842	23885	30846	
36734	Analysis of Variance	analysis of variance	1	0	204	36736	204	
6689	Host Societies	Host society	1	0	6691	6690	6691	
21531	dental curricula	dental curriculum	1	0	13382	5656	13382	
4137	social interaction alternatives	social interaction alternative	1	0	4141	4138	4141	
29752	spinal surgical services	spinal surgical service	1	0	29754	14047	5980	
7889	Tropical Medicine	tropical medicine	1	0	3022	7890	3022	
4108	Maternity Hospital of GMC Anantnag	maternity hospital of GMC INFunknownSUP	1	0	4110	4109	4111	
5216	introduction of multidisciplinary teams	introduction of multidisciplinary team	1	0	381	5218	381	
29280	Taiwan Healthcare workers	Taiwan Healthcare worker	1	0	5746	48	1136	
19123	Cytidine deamination-induced perpetual immunity to SAR-CoV-2 infection	cytidine INFunknownSUP perpetual immunity to INFunknownSUP infection	1	0	19125	19124	257	
4580	development of antiviral drugs	development of antiviral drug	1	0	73	4582	73	
16747	manufacturing of personal protective equipment	manufacturing of personal protective equipment	1	0	718	4960	718	
35496	contact-rate reduction	INFunknownSUP reduction	1	0	490	35497	490	
33311	TCM anti-COVID-19	TCM INFunknownSUP	1	0	33313	33312	33313	
25967	Marine Recruits	Marine recruit	1	0	25969	3319	25969	
31724	simulation research	simulation research	1	0	36	9152	36	
22061	SARS-CoV-2 nucleoprotein	INFunknownSUP nucleoprotein	1	0	22063	28	22063	
30123	acute respiratory syndrome-coronavirus-2	acute respiratory INFunknownSUP	1	0	30125	1461	30127	
33002	significant elevation of particles	significant elevation of particle	1	0	33004	908	33005	
33425	alterations of redox balance	alteration of redox balance	1	0	33426	33419	33426	
16859	effects of social support	effect of social support	1	0	156	1943	156	
6536	Genomic reconstruction of the SARS-CoV-2 epidemic	INFunknownSUP reconstruction of the INFunknownSUP epidemic	1	0	6538	6537	6539	
33298	elective spinal surgery	elective spinal surgery	1	0	33300	1627	1630	
27640	low-SVI areas	INFunknownSUP area	1	0	1579	27641	1579	
6832	average accuracy	average accuracy	1	0	4535	178	4535	
25528	COVID-19-positive patients Tracheostomy	COVID-19-positive patient tracheostomy	1	0	15043	3217	15043	
31161	PLACE-19 Study	INFunknownSUP Study	1	0	2596	31162	2596	
19703	Smart investments	smart investment	1	0	19705	19704	19705	
32768	community closures	community closure	1	0	23196	3641	23196	
23627	cross-sectional survey	cross-sectional survey	1	0	967	2493	967	
30986	vertical transmission of COVID-19	vertical transmission of INFunknownSUP	1	0	4830	875	876	
26218	dietary supplementation	dietary supplementation	1	0	19658	3126	19658	
10784	SABR radiobiology study	INFunknownSUP radiobiology study	1	0	10786	10785	2087	
37763	proactive efforts	proactive effort	1	0	28282	18311	28282	
15669	postoperative interventions	postoperative intervention	1	0	757	8142	757	
23682	functions of multicellular organisms	function of multicellular organism	1	0	23683	23684	23683	
32327	different particles sizes	different particle size	1	0	32329	688	9557	
30150	Identification of SARS-CoV-2 Receptor	identification of INFunknownSUP receptor	1	0	30151	30152	30151	
14895	Exposure to trauma	exposure to trauma	1	0	14896	2783	14896	
38035	important determinants of food choices	important determinant of food choice	1	0	22047	25601	14341	
12477	severity of the situation	severity of the situation	1	0	5116	3056	5116	
22064	number of ENT articles	number of Ent article	1	0	916	22066	916	
16524	Einfluss einer Mund-Nase-Maske auf	INFunknownSUP einer Mund-Nase-Maske auf	1	0	16526	16525	16530	
4672	face-to-face classroom	face-to-face classroom	1	0	4674	4673	4674	
58	older patients	old patient	1	0	60	59	60	
5002	pathway analysis	pathway analysis	1	0	486	5003	486	
17264	related editorial	related editorial	1	0	17266	2647	17266	
15911	possible immunological mechanisms	possible immunological mechanism	1	0	15913	745	1456	
3018	Translational Mobility Medicine	translational mobility medicine	1	0	3020	3019	3022	
36935	strict adherence to infection control practices	strict adherence to infection control practice	1	0	36937	8859	3636	
5144	De-isolating Coronavirus Disease	INFunknownSUP INFunknownSUP Disease	1	0	5148	5145	5148	
17460	L. Spallanzani	L. INFunknownSUP	1	0	17462	17461	17462	
33303	vaccine responses	vaccine response	1	0	200	577	200	
14387	SARS-CoV-2-positive mothers	SARS-CoV-2-positive mother	1	0	14389	14388	14389	
10656	entry pathway of severe acute respiratory syndrome coronavirus	entry pathway of severe acute respiratory syndrome coronavirus	1	0	10658	5629	5003	
3864	common individuals	common individual	1	0	1113	699	1113	
11833	positive correlation	positive correlation	1	0	2889	228	2889	
33844	COVID-19 case-fatality	INFunknownSUP case-fatality	1	0	33846	3706	33846	
19822	cause of BSI	cause of BSI	1	0	14198	19824	14198	
5227	Nightingale Notes software	Nightingale Notes software	1	0	5229	5228	5231	
10155	clozapine monitoring system	clozapine monitoring system	1	0	3270	10156	1327	
28438	space of cardiovascular data	space of cardiovascular datum	1	0	11832	28440	11832	
33859	infected HCWs	infected INFunknownSUP	1	0	33861	1088	33861	
31494	understanding of the matrix of factors	understanding of the matrix of factor	1	0	2715	31496	2715	
10315	test sample	test sample	1	0	2757	754	2757	
12298	Prolonged sick leave	prolonged sick leave	1	0	415	12299	417	
20622	resource settings	resource setting	1	0	2729	2703	2729	
11076	Bluetooth communication	INFunknownSUP communication	1	0	11078	11077	11078	
13779	metabolomes of COVID-19 patients	INFunknownSUP of INFunknownSUP patient	1	0	13780	911	13780	
22474	universal destination	universal destination	1	0	7252	3738	7252	
29424	lower NO2 concentrations	low INFunknownSUP concentration	1	0	1957	594	1959	
8397	mean length of hospital stay	mean length of hospital stay	1	0	8399	194	1348	
5658	trust building	trust building	1	0	4653	5659	4653	
5537	SARS-CoV-2 cytopathic effects	INFunknownSUP INFunknownSUP effect	1	0	5539	226	156	
3037	equipment procurement	equipment procurement	1	0	1086	3038	1086	
3670	Mentoring Programs Research	mentoring Programs Research	1	0	3672	3671	3674	
13357	periventricular leukomalacia	periventricular INFunknownSUP	1	0	13359	13358	13359	
5179	das subjektive Belastungsempfinden bei gut-trainierten	das INFunknownSUP INFunknownSUP bei INFunknownSUP	1	0	5181	5180	5187	
37649	need of the day	need of the day	1	0	9579	6271	9579	
17156	unexposed subjects	unexposed subject	1	0	4893	1023	4893	
33854	viral RBD	viral RBD	1	0	33856	1741	33856	
28011	duration of sleep	duration of sleep	1	0	7404	15803	7404	
38439	% of women	% of woman	1	0	364	920	364	
9567	correlation of these changes	correlation of these change	1	0	2889	1336	2889	
35467	Essential Role	essential role	1	0	33596	35468	33596	
3574	y el	y el	1	0	1910	1439	1910	
17378	metabolic inflammation	metabolic inflammation	1	0	3116	6357	3116	
21964	multisystemic disease	multisystemic disease	1	0	209	21965	209	
15417	home care services	home care service	1	0	5980	15418	5980	
25917	ventricular free wall longitudinal strain	ventricular free wall longitudinal strain	1	0	25919	1104	1107	
23747	18-week period	INFunknownSUP period	1	0	5677	23748	5677	
20642	variable regions of OC43	variable region of INFunknownSUP	1	0	20644	6800	5240	
19026	perceptual voice quality	perceptual voice quality	1	0	12226	19027	3713	
22796	care service	care service	1	0	6375	9	6375	
33812	New Sexuality	New sexuality	1	0	33814	1162	33814	
37655	liver dysfunction	live dysfunction	1	0	3856	23362	3856	
8218	pathophysiological pathways	pathophysiological pathway	1	0	8220	8219	8220	
18614	personal isolation	personal isolation	1	0	6569	4961	6569	
4282	shifts of COVID-19 patients	shift of INFunknownSUP patient	1	0	4283	911	4283	
3969	(ConvLSTM)-based deep learning models	INFunknownSUP deep learning model	1	0	3971	3970	3975	
19431	development of zero-inflated time series models	development of zero-inflated time series model	1	0	73	19433	73	
11237	knee arthroplasty procedure	knee INFunknownSUP procedure	1	0	11239	4241	4693	
34642	telehealth revolution	telehealth revolution	1	0	1095	304	1095	
27629	Corona Virus Disease	Corona virus Disease	1	0	27631	10431	5148	
26666	potential associations	potential association	1	0	5750	1276	5750	
21049	halo effect theory	halo effect theory	1	0	21053	21050	21053	
16294	higher asthma prevalence	high asthma prevalence	1	0	16296	322	9272	
21030	portable air purifier	portable air purifier	1	0	21032	564	21034	
3196	registered data of COVID-19 patients	registered datum of INFunknownSUP patient	1	0	3198	3197	22	
23183	use of green font	use of green font	1	0	292	23185	292	
15194	alpha coefficients	alpha coefficient	1	0	15196	15195	15196	
23024	Acute Stroke Admissions	acute stroke admission	1	0	23028	23025	23028	
15424	modes of occupational therapy instruction	mode of occupational therapy instruction	1	0	15425	15426	15425	
17287	high-flow nasal cannula patients	INFunknownSUP nasal cannula patient	1	0	17289	14899	60	
6289	% Cl	% Cl	1	0	6291	364	6291	
25185	Residential Substance Use Treatment Program	residential substance Use Treatment Program	1	0	25187	25186	25193	
15584	Impact of the COVID-19 pandemic	impact of the INFunknownSUP pandemic	1	0	802	111	802	
9262	vaccination samples	vaccination sample	1	0	1765	437	1765	
25301	outbreak of a novel coronavirus	outbreak of a novel coronavirus	1	0	310	3644	310	
12796	NO2 data	INFunknownSUP datum	1	0	22	164	22	
5145	De-isolating Coronavirus	INFunknownSUP INFunknownSUP	1	0	3206	5146	3206	
18895	PCT levels	PCT level	1	0	169	16014	169	
23732	adequate evidence	adequate evidence	1	0	585	270	585	
32716	uncertainty-time-efficacy-emotion model	uncertainty-time-efficacy-emotion model	1	0	1078	32717	1078	
34445	trend of referrals	trend of referral	1	0	6677	4124	6677	
35196	Goods Administration	Goods Administration	1	0	7614	35197	7614	
20938	elective pediatric general surgery	elective pediatric general surgery	1	0	20940	1627	1630	
4502	liver injury	liver injury	1	0	713	1138	713	
15826	care systems	care system	1	0	146	9	146	
11430	patient preferences	patient preference	1	0	2599	710	2599	
35102	inpatient care departments	inpatient care department	1	0	35104	3339	328	
366	combination of high copying error frequencies	combination of high copying error frequency	1	0	367	368	367	
21748	Endoscopic Gastrostomy	endoscopic gastrostomy	1	0	21750	17125	21750	
3705	COVID-19 infection	INFunknownSUP infection	1	0	41	3706	41	
16304	expert clinical care	expert clinical care	1	0	4851	1686	9	
26876	material resources	material resource	1	0	835	551	835	
36527	prefusion SARS-CoV-2 spike protein	prefusion INFunknownSUP spike protein	1	0	36529	36528	1797	
19191	COVID-19 vaccine uptake	INFunknownSUP vaccine uptake	1	0	19195	3688	19195	
11957	context of the COVID-19 pandemic	context of the INFunknownSUP pandemic	1	0	1567	111	1567	
4839	respiratory sample PCR	respiratory sample PCR	1	0	4841	259	3981	
19106	urgent outbreak	urgent outbreak	1	0	310	8129	310	
19309	test cases	test case	1	0	229	754	229	
24607	site infection	site infection	1	0	41	11198	41	
12913	severe infection	severe infection	1	0	41	262	41	
5040	higher proportion of males	high proportion of male	1	0	5041	5044	910	
7619	sensitivity of NO2	sensitivity of INFunknownSUP	1	0	2904	7621	2904	
20173	potential therapeutic targets	potential therapeutic target	1	0	20175	1276	4044	
9442	sex-specific differences	sex-specific difference	1	0	5663	9443	5663	
28811	cluster information	cluster information	1	0	2591	13441	2591	
27056	high-resolution manometry	high-resolution manometry	1	0	12287	27057	12287	
35778	regular PCR testing	regular PCR testing	1	0	5421	870	1885	
19877	timing of COVID-19 restrictions	timing of INFunknownSUP restriction	1	0	9056	19879	9056	
7815	immunological profile	immunological profile	1	0	3088	148	3088	
31237	software engineering teams	software engineering team	1	0	31239	5231	5220	
18187	emergency department of the public company	emergency department of the public company	1	0	13316	18191	13318	
16900	synthetic phages	synthetic phage	1	0	16902	16901	16902	
39258	infection-associated death	infection-associated death	1	0	4722	39259	4722	
25088	frequent regimes	frequent regime	1	0	14068	1168	14068	
31207	economic activity:leading	economic activity:leading	1	0	31209	108	31209	
36050	long period	long period	1	0	5677	3921	5677	
7430	Various vaccines	various vaccine	1	0	681	7431	681	
5856	use of advanced technological tools	use of advanced technological tool	1	0	292	5858	292	
22724	operational costs	operational cost	1	0	22726	16220	22726	
3532	effective measure	effective measure	1	0	2466	2051	2466	
18688	Medicaid coverage	Medicaid coverage	1	0	4933	18689	4933	
19493	Occupational therapy students	occupational therapy student	1	0	1177	19494	1177	
6588	Empirical research of healthcare workers experiences	empirical research of INFunknownSUP worker experience	1	0	6590	6589	36	
32389	surgery cases	surgery case	1	0	229	1630	229	
39127	una subestimacion	Una INFunknownSUP	1	0	39129	39128	39129	
17329	second-line defense	second-line defense	1	0	13742	17330	13742	
28795	IgG type antibodies	IgG type antibody	1	0	28797	928	929	
32800	burden of COVID-19	burden of INFunknownSUP	1	0	1070	40	1070	
368	high copying error frequencies	high copying error frequency	1	0	370	13	374	
25024	intensified public discourse	intensified public discourse	1	0	25026	25025	25028	
31488	support options	support option	1	0	23261	260	23261	
14616	sanitario ni de los servicios sanitarios	INFunknownSUP Ni de los INFunknownSUP INFunknownSUP	1	0	14626	14617	14626	
8569	population movement	population movement	1	0	8571	1838	8571	
27432	convergent mutation	convergent mutation	1	0	333	2259	333	
21864	acute renal papillary necrosis	acute renal papillary necrosis	1	0	21866	1461	5738	
31095	online video teaching	online video teaching	1	0	31097	541	2074	
20584	individual cities	individual city	1	0	11802	753	11802	
28546	access to medical supplies	access to medical supply	1	0	224	6903	224	
24090	narrative literature review	narrative literature review	1	0	24092	17749	1723	
37430	standard paediatric palliative care consultations	standard paediatric palliative care consultation	1	0	972	2056	978	
20170	age of the children	age of the child	1	0	906	6153	906	
34703	area south of Milan	area south of Milan	1	0	34705	1089	34706	
24208	transplant patients	transplant patient	1	0	60	21249	60	
17630	unknown subject	unknown subject	1	0	16027	1475	16027	
24199	rise of nucleocapsid	rise of nucleocapsid	1	0	13903	24201	13903	
8013	understanding of the effects of the COVID-19 pandemic	understanding of the effect of the INFunknownSUP pandemic	1	0	2715	2013	2715	
679	Oxford-AstraZeneca vaccines	INFunknownSUP vaccine	1	0	681	680	681	
34666	international taxonomy	international taxonomy	1	0	34668	4086	34668	
2003	transmissible Alpha	transmissible Alpha	1	0	67	2004	67	
5958	distinction of a malignant process	distinction of a malignant process	1	0	5959	5960	5959	
19386	Surgery Practices	surgery Practices	1	0	19388	2338	19388	
4421	Narrative review	narrative review	1	0	1723	4422	1723	
3318	Marine recruit	Marine recruit	1	0	3320	3319	3320	
7596	predominant set of clinical presentations	predominant set of clinical presentation	1	0	7598	7597	651	
16163	basic reproductive number	basic reproductive number	1	0	16165	4643	916	
2325	telehealth GP consultations	INFunknownSUP GP consultation	1	0	2327	2326	978	
7839	Social Networks	Social Networks	1	0	7841	2019	7841	
21634	disability-adjusted life years	disability-adjusted life year	1	0	21636	21635	1313	
20285	polymeric matrix	polymeric matrix	1	0	8449	20286	8449	
4958	number of personal protective equipment	number of personal protective equipment	1	0	916	4960	916	
12700	psoriatic arthritis	psoriatic arthritis	1	0	11903	12701	11903	
30336	developmental period	developmental period	1	0	5677	30337	5677	
30213	kinetics of S1-ACE2 complex formation	kinetics of INFunknownSUP complex formation	1	0	24077	30215	24077	
16800	average increases	average increase	1	0	6329	178	6329	
28824	related immune hemolysis	related immune hemolysi	1	0	28826	2647	28828	
35001	Italian Chemical Society	Italian Chemical Society	1	0	35003	115	17123	
1427	real-time RT-PCR results	real-time INFunknownSUP result	1	0	325	1428	325	
6724	recommended upper safety limits	recommended upper safety limit	1	0	6726	2125	43	
8026	metabolic-associated fatty liver disease	metabolic-associated fatty liver disease	1	0	8028	8027	209	
18656	Japanese encephalitis	Japanese encephalitis	1	0	18658	18657	18658	
16820	positive proteinuria	positive proteinuria	1	0	7378	228	7378	
32228	situation of insufficient data	situation of insufficient datum	1	0	3056	32230	3056	
6855	number of nosocomial cases	number of INFunknownSUP case	1	0	916	6857	916	
21310	individual units	individual unit	1	0	6042	753	6042	
39011	prognostic implications	prognostic implication	1	0	9549	158	9549	
2721	relationship to mortality	relationship to mortality	1	0	2722	1197	2722	
6631	blood parameters of the patients	blood parameter of the patient	1	0	6633	3129	6460	
33950	rapid heart transplantation Adequate immune response	rapid heart transplantation adequate immune response	1	0	33952	795	409	
4490	test positivity rates of RDT	test INFunknownSUP rate of INFunknownSUP	1	0	4492	754	83	
492	healthcare facility-onset Clostridioides difficile	INFunknownSUP facility-onset INFunknownSUP INFunknownSUP	1	0	498	493	498	
24371	deleterious health challenges	deleterious health challenge	1	0	24373	24372	2220	
16039	deployment of new telemedicine technology	deployment of new telemedicine technology	1	0	10837	16041	10837	
9265	test set metrics	test set metric	1	0	9267	754	9269	
38949	pressure ulcers	pressure ulcer	1	0	38951	1027	38951	
16214	Respiratory Syndrome virus	respiratory syndrome virus	1	0	16216	3287	778	
11557	semi-quantitative data	semi-quantitative datum	1	0	22	11558	22	
32403	mild elevations	mild elevation	1	0	32405	10809	32405	
28563	health belief model	health belief model	1	0	28565	120	1078	
25005	blood product	blood product	1	0	1735	3129	1735	
10706	volumetric analysis of whole Syrian hamster lung lobes	volumetric analysis of whole Syrian hamster lung lobe	1	0	10708	10707	486	
2247	usage of steroid	usage of steroid	1	0	2248	1173	2248	
29564	high levels of class	high level of class	1	0	167	353	169	
22279	Low cost centrifugal melt	Low cost centrifugal melt	1	0	22281	20790	253	
4883	special attention	special attention	1	0	4885	4884	4885	
35567	Rapid Scoring Systems	Rapid Scoring Systems	1	0	35569	9843	20278	
30552	y la muerte	y la INFunknownSUP	1	0	30554	1908	30556	
12948	acute respiratory coronavirus virus	acute respiratory coronavirus virus	1	0	12950	1461	778	
5715	sequence of SARS-CoV-2	sequence of INFunknownSUP	1	0	5716	28	5716	
23536	Coronavirus infection	INFunknownSUP infection	1	0	41	3206	41	
26394	measures of lockdowns	measure of lockdown	1	0	317	1486	317	
15551	higher percentage of Caucasians	high percentage of Caucasians	1	0	15553	322	3789	
36632	rehabilitation programme	rehabilitation programme	1	0	2839	8682	2839	
17954	NO2 changes	INFunknownSUP change	1	0	1336	164	1336	
11262	body radiation therapy	body radiation therapy	1	0	11264	2710	2273	
15691	Conversion disorder/functional neurological disorder	conversion disorder/functional neurological disorder	1	0	15693	15692	7358	
22659	mean baseline seroprevalence of SARS-CoV-2	mean baseline seroprevalence of INFunknownSUP	1	0	22660	28	4090	
28360	total force	total force	1	0	28362	1485	28362	
17533	Stroke Practice	stroke practice	1	0	17535	5248	17535	
7501	centralized setting	centralized setting	1	0	2854	7502	2854	
10800	various needs	various need	1	0	3189	1099	3189	
32513	Health Organizations	Health Organizations	1	0	32515	279	32515	
38813	pilot data	pilot datum	1	0	22	19913	22	
12634	degree of confidence	degree of confidence	1	0	12635	1793	12635	
2990	benefits of vaccination	benefit of vaccination	1	0	2306	437	2306	
26164	sample entropy	sample entropy	1	0	26166	2757	26166	
9861	Antibody response	antibody response	1	0	409	9862	409	
3072	intra-hospital non COVID-19	INFunknownSUP non INFunknownSUP	1	0	3074	3073	3076	
12383	US $6	US INFunknownSUP	1	0	12385	3316	12385	
32609	Pakistani adult	Pakistani adult	1	0	32611	14424	32611	
8785	potential mentors of ongoing school mentoring	potential mentor of ongoing school mentoring	1	0	8786	8789	8788	
18361	cycle threshold	cycle threshold	1	0	451	6481	451	
26450	quality standards	quality standard	1	0	14383	3713	14383	
34933	manufacturing strategy	manufacturing strategy	1	0	3350	718	3350	
5018	valid treatment option	valid treatment option	1	0	5020	5019	5022	
17943	phone data	phone datum	1	0	22	17944	22	
10833	terms of the interaction	term of the interaction	1	0	4908	2525	4908	
17411	preceding sampling period	preceding sampling period	1	0	17413	17412	5677	
33169	brain areas	brain area	1	0	1579	10043	1579	
5371	pooled odds ratio	pooled odd ratio	1	0	5254	5372	2635	
15212	extensive homoplasy of this transition	extensive homoplasy of this transition	1	0	15214	15213	15215	
1816	Swiss users	Swiss user	1	0	1818	1817	1818	
9140	hospitalizations of neonates	hospitalization of neonate	1	0	5091	9142	5091	
35253	post-pandemic antimicrobial stewardship	post-pandemic antimicrobial stewardship	1	0	35255	14377	15345	
35501	new pandemic threats	new pandemic threat	1	0	1368	69	1370	
1025	systolic pressure	systolic pressure	1	0	1027	1026	1027	
27101	tissue repair factors BDNF	tissue repair factor INFunknownSUP	1	0	27103	4974	27107	
9932	different illnesses	different illness	1	0	1459	688	1459	
32186	SARS-CoV-2-specific T cells	SARS-CoV-2-specific T cell	1	0	788	32187	133	
8098	Higher rates of Covid-19	high rate of INFunknownSUP	1	0	8099	1884	83	
12640	snowballing sample technique	snowballing sample technique	1	0	12642	12641	562	
19091	cases of MSD lung tumor data	case of MSD lung tumor datum	1	0	229	19093	229	
8711	tertiary referral COVID-19 center COVID-19	tertiary referral INFunknownSUP center INFunknownSUP	1	0	8713	182	40	
1866	et Metiers	et INFunknownSUP	1	0	1868	1867	1868	
23104	topic agenda	topic agenda	1	0	4377	2553	4377	
12645	structural snapshot	structural snapshot	1	0	12647	3549	12647	
17588	admission to an intensive care unit	admission to an intensive care unit	1	0	2865	6	2865	
21733	psychological safety	psychological safety	1	0	6729	1380	6729	
22976	SARS-CoV infection dynamics	INFunknownSUP infection dynamics	1	0	3694	22977	3694	
21682	end of September	end of September	1	0	7132	21684	7132	
2606	rapid adaption of drug use policy governance	rapid adaption of drug use policy governance	1	0	2608	795	2609	
14733	selective increase	selective increase	1	0	392	7387	392	
17095	dataset of Ayatollah Talleghani hospital	INFunknownSUP of Ayatollah Talleghani hospital	1	0	17096	17097	17096	
28986	2x2 factorial design	INFunknownSUP factorial design	1	0	28988	28987	4183	
34211	Spanish health professionals	Spanish health professional	1	0	4417	26052	121	
33832	nonessential hip	nonessential hip	1	0	4093	5899	4093	
39194	adverse outcomes of patients	adverse outcome of patient	1	0	3264	60	263	
29068	renin-angiotensin-aldosterone system	renin-angiotensin-aldosterone system	1	0	1327	29069	1327	
33725	process of digital transition	process of digital transition	1	0	180	33727	180	
30104	possibility of the appearance of new variants of the virus	possibility of the appearance of new variant of the virus	1	0	30103	30106	30103	
22852	healthcare provision	INFunknownSUP provision	1	0	6376	494	6376	
12004	Innate immune dynamics	innate immune dynamics	1	0	12006	12005	3694	
25802	metabolic pathway	metabolic pathway	1	0	5003	6357	5003	
31017	final responsibility	final responsibility	1	0	31019	4256	31019	
8357	respiratory interference viruses	respiratory interference virus	1	0	2217	8358	2217	
27006	online-only learning	INFunknownSUP learning	1	0	2390	27007	2390	
5818	poor readability	poor readability	1	0	996	1372	996	
21609	essential materials	essential material	1	0	2335	4197	2335	
22266	effects model to pool data	effect model to pool datum	1	0	22268	156	1078	
18404	radiologic pattern	INFunknownSUP pattern	1	0	4682	18405	4682	
36147	genitourinary organs	genitourinary organ	1	0	10453	36148	10453	
20877	systematic approach	systematic approach	1	0	1538	343	1538	
28271	response time	response time	1	0	179	409	179	
12694	healthy age-	healthy INFunknownSUP	1	0	12696	1021	12696	
6553	Insurance Portability	Insurance portability	1	0	6555	6554	6555	
19872	sudden emergence of COVID-19	sudden emergence of INFunknownSUP	1	0	19874	3583	19875	
3485	Reality Headset	reality headset	1	0	3487	3486	3487	
25741	Liver Transplantation Recipients 32327321/ Development of a telehealth geriatric assessment model	live transplantation recipient 32327321/ Development of a INFunknownSUP geriatric assessment model	1	0	25745	25742	9277	
28691	spinal cord injury Excessive inflammation post-traumatic spinal cord injury	spinal cord injury excessive inflammation post-traumatic spinal cord injury	1	0	28693	14047	713	
30450	3-month interval	INFunknownSUP interval	1	0	1794	30451	1794	
351	drug class	drug class	1	0	353	352	353	
23703	COVID-19 period	INFunknownSUP period	1	0	5677	40	5677	
31833	momento de excepcionalidad	momento de INFunknownSUP	1	0	31835	31834	31837	
30586	further genomic studies of gene flow	further INFunknownSUP study of gene flow	1	0	30587	30592	136	
2258	convergent IGHV3-53/3-66 antibodies	convergent IGHV3-53/3-66 antibody	1	0	2260	2259	929	
28900	Common comorbidities	common comorbidity	1	0	676	7181	676	
33225	COVID-19 severity	INFunknownSUP severity	1	0	5116	3706	5116	
1834	national general population	national general population	1	0	1836	517	1838	
122	Force application of laparoscopic surgeons	Force application of INFunknownSUP surgeon	1	0	124	123	125	
29870	stimulator of the SC2 receptor angiotensin	stimulator of the INFunknownSUP receptor angiotensin	1	0	29871	29872	29871	
36230	uptake of health economics methods	uptake of health economics method	1	0	19195	36232	19195	
294	outcome benefit of NIRS strategies	outcome benefit of INFunknownSUP strategy	1	0	296	295	297	
3338	inpatient urology consultations	inpatient urology consultation	1	0	3340	3339	978	
10514	SARS-CoV-2 infection patterns	INFunknownSUP infection pattern	1	0	10516	226	548	
8758	C-terminal domain of the S1 subunit	C-terminal domain of the INFunknownSUP subunit	1	0	8760	8759	697	
28695	injury Excessive inflammation post-traumatic spinal cord injury	injury excessive inflammation post-traumatic spinal cord injury	1	0	28697	713	713	
24791	hemisphere countries	hemisphere country	1	0	1599	24792	1599	
23665	protective role of COVID-19 vaccination	protective role of INFunknownSUP vaccination	1	0	23666	2836	7288	
24706	recurrent disease	recurrent disease	1	0	209	13079	209	
26073	nano-sized pores	nano-sized pore	1	0	26075	26074	26075	
25066	Global Pandemic	Global pandemic	1	0	6338	14037	6338	
23525	diverse reactivity of antibodies	diverse reactivity of antibody	1	0	23527	10278	8022	
38872	further elaboration	further elaboration	1	0	38874	7713	38874	
33942	weekend to mid-week consumption ratios	weekend to mid-week consumption ratio	1	0	1264	33944	1264	
37781	health systems analysis	health system analysis	1	0	486	5986	486	
28263	personal protection equipment	personal protection equipment	1	0	28265	4961	3038	
25640	SARS-CoV-2 differential gene expression signatures	INFunknownSUP differential gene expression signature	1	0	25648	25641	25648	
37539	SF SABR	SF INFunknownSUP	1	0	10785	37540	10785	
36592	impact of UpToDate searches	impact of INFunknownSUP search	1	0	36596	36593	36596	
28561	factors of the health belief model	factor of the health belief model	1	0	583	28563	583	
9741	daily management	daily management	1	0	743	191	743	
7848	Evaluation of RT-qPCR Primer-Probe	evaluation of INFunknownSUP INFunknownSUP	1	0	7849	7850	7849	
6364	group size	group size	1	0	6366	18	6366	
5843	knowledge scores of dentists	knowledge score of dentist	1	0	5845	213	3726	
9431	European Medical Agency	European Medical Agency	1	0	9433	9209	9435	
16848	delicate technical act	delicate technical act	1	0	16850	16849	16852	
6380	respiratory tract infection	respiratory tract infection	1	0	6382	259	41	
18138	registered nurses	registered nurse	1	0	2735	3197	2735	
35365	potential infection	potential infection	1	0	41	1276	41	
20882	coordinators of IADS member organizations	coordinator of INFunknownSUP member organization	1	0	20883	20884	20883	
13275	Confirmation of efficacy	confirmation of efficacy	1	0	13276	6704	13276	
22981	patents of the top pharmaceutical companies	patent of the top pharmaceutical company	1	0	13504	22983	13504	
14965	Entry Molecules	entry molecule	1	0	14967	14966	14967	
12104	injury concerns	injury concern	1	0	12106	713	12106	
12033	key delivery characteristics	key delivery characteristic	1	0	12035	850	1496	
18851	severe acute respiratory syndrome coronavirus:SARS-CoV	severe acute respiratory syndrome INFunknownSUP	1	0	18853	262	18859	
38615	Social Teaching	Social teaching	1	0	31147	2019	31147	
22462	risk of pneumonia	risk of pneumonia	1	0	1542	2369	1542	
10531	physician safety-conscious manner	physician safety-conscious manner	1	0	10533	10532	10535	
23180	human ACE-2	human INFunknownSUP	1	0	23182	2214	23182	
35581	severe adverse effects	severe adverse effect	1	0	19183	262	156	
16701	limited ground-based monitoring data	limited ground-based monitoring datum	1	0	16703	5322	22	
14589	adaptive immunity:post-vaccination	adaptive immunity:post-vaccination	1	0	14591	6264	14591	
35938	integration process	integration process	1	0	180	918	180	
13084	prevalence of Hospital-Acquired Infections	prevalence of INFunknownSUP infection	1	0	9272	13086	9272	
5072	daily COVID-19 patients	daily INFunknownSUP patient	1	0	911	191	60	
39261	communication networks	communication network	1	0	4171	11078	4171	
3203	Suspected Coronavirus Patients	suspected INFunknownSUP Patients	1	0	3205	3204	3207	
17145	lens of science Inequalities	lens of science inequality	1	0	17146	17147	17146	
24057	Wales Cancer Network	Wales Cancer Network	1	0	24059	24058	7089	
329	spike E484K mutation	spike INFunknownSUP mutation	1	0	331	31	333	
32559	regional health authorities	regional health authority	1	0	32561	4068	9210	
29559	assigned arm	assigned arm	1	0	8215	29560	8215	
16081	various concentrations of the peptide	various concentration of the peptide	1	0	16083	1099	1959	
30910	information needs	information need	1	0	3189	2591	3189	
37135	Council measure	Council measure	1	0	2466	6229	2466	
2194	deeper impact	deep impact	1	0	110	2195	110	
28869	review of the patients	review of the patient	1	0	1723	60	1723	
10224	rare cardiac complication of COVID-19 infection	rare cardiac complication of INFunknownSUP infection	1	0	10226	10225	2206	
6736	technological teams	technological team	1	0	5220	3876	5220	
8745	spermatogonial stem cells	spermatogonial stem cell	1	0	8747	8746	133	
25047	great safety concerns	great safety concern	1	0	25049	4480	12106	
10163	Mortality Prediction	mortality prediction	1	0	10165	3302	10165	
24085	Mann-Whitney U test	Mann-Whitney U test	1	0	24087	5851	754	
22011	Physical therapists	physical therapist	1	0	22013	22012	22013	
16266	young people	young people	1	0	694	2882	694	
23934	urgent suspected cancers	urgent suspected cancer	1	0	23936	8129	8602	
17512	Global Perspective Clinical characteristics	Global Perspective clinical characteristic	1	0	17514	14037	1496	
27231	lower-income regions	lower-income region	1	0	5240	27232	5240	
15540	health access	health access	1	0	224	120	224	
31968	gateway PCR testing	gateway PCR testing	1	0	5421	17337	1885	
37957	fast motion	fast motion	1	0	37959	4297	37959	
35836	Civil Rights	Civil Rights	1	0	14328	35837	14328	
31714	Adult Nephrology Training Program	adult Nephrology Training Program	1	0	31716	20618	25193	
1366	future pandemic threats	future pandemic threat	1	0	1368	1367	1370	
25557	high probability of postoperative intensive care unit	high probability of postoperative intensive care unit	1	0	25559	13	7627	
31502	effects of potential SARS-CoV-2 variants	effect of potential INFunknownSUP variant	1	0	156	31504	156	
3963	Long Short-Term Memory (ConvLSTM)-based deep learning models	Long short-term Memory INFunknownSUP deep learning model	1	0	3965	3964	3975	
28305	Validation experiments	validation experiment	1	0	16356	12666	16356	
11525	Twenty-four hour composite influent wastewater samples	Twenty-four hour composite influent wastewater sample	1	0	11527	11526	1765	
36565	three-quarters of the nurses	three-quarter of the nurse	1	0	36566	2735	36566	
20398	suppression therapy	suppression therapy	1	0	2273	20399	2273	
31117	features of obese patient metabolism	feature of obese patient metabolism	1	0	1469	31119	1469	
2534	intravenous dose of vitamin C	intravenous dose of vitamin C	1	0	2536	2535	2537	
39069	Remote management of hidradenitis suppurativa	remote management of hidradenitis INFunknownSUP	1	0	39071	20705	743	
35238	stress mitigation	stress mitigation	1	0	2375	199	2375	
5469	severe bronchiolitis	severe INFunknownSUP	1	0	5471	262	5471	
37344	higher odds	high odd	1	0	5255	322	5255	
15126	Hospital Center Zagreb	Hospital Center Zagreb	1	0	15128	1879	15130	
16271	risk of exposure to severe acute respiratory syndrome coronavirus	risk of exposure to severe acute respiratory syndrome coronavirus	1	0	1542	16273	1542	
13335	Hamilton-Norwood scale	Hamilton-Norwood scale	1	0	2422	13336	2422	
6222	SARS-CoV-2 Antibodies	INFunknownSUP antibody	1	0	6224	226	6224	
38244	effectiveness of the BNT162b2 vaccine	effectiveness of the INFunknownSUP vaccine	1	0	16379	11185	16379	
11142	religious gatherings	religious gathering	1	0	11144	11143	11144	
36463	tryptophan metabolite kynurenic acid	tryptophan metabolite INFunknownSUP acid	1	0	36465	36464	7492	
20968	none of the hospitals	none of the hospital	1	0	20969	76	20969	
602	pre-COVID-19 cohort	INFunknownSUP cohort	1	0	601	603	601	
7034	Paediatric palliative care	paediatric palliative care	1	0	975	6254	9	
998	impact of SARS-CoV-2 variants	impact of INFunknownSUP variant	1	0	110	1000	110	
10451	whole organs	whole organ	1	0	10453	2359	10453	
24226	macular optical coherence tomography	macular optical coherence tomography	1	0	24228	19275	7445	
4211	oral diets	oral diet	1	0	4213	427	4213	
12392	two-day history	two-day history	1	0	5381	12393	5381	
21433	sharing of basic needs	sharing of basic need	1	0	2986	12426	2986	
2538	vitamin C	vitamin C	1	0	2540	2539	2540	
37131	Medical Research Council measure	Medical Research Council measure	1	0	37133	2779	2466	
2160	published work	published work	1	0	2162	2161	2162	
32156	severe complication of coronavirus disease	severe complication of coronavirus disease	1	0	32158	262	2206	
35387	associated containment measures	associated containment measure	1	0	35389	240	317	
22958	CT image	CT image	1	0	22960	26	22960	
5589	average training false-positive	average training false-positive	1	0	5591	178	5593	
4786	SARS-CoV-2 vaccine candidates	INFunknownSUP vaccine candidate	1	0	4790	4787	4790	
3647	exclusion criteria	exclusion criterion	1	0	3649	3648	3649	
7286	pivotal role	pivotal role	1	0	7288	7073	7288	
24633	point-of-care clinical resource	INFunknownSUP clinical resource	1	0	24635	24634	2703	
30091	downregulated interferon-stimulated genes	downregulated interferon-stimulated gene	1	0	30093	30092	12362	
4064	clinical questions	clinical question	1	0	4066	884	4066	
32516	targeted therapies	targeted therapy	1	0	5507	2239	5507	
32835	hospital-acquired infections	hospital-acquired infection	1	0	779	32836	779	
32666	clinical benefits	clinical benefit	1	0	2306	884	2306	
25462	Grade Level	Grade Level	1	0	8466	25463	8466	
14329	resident interviews	resident interview	1	0	10034	1480	10034	
8415	Regulatory Network	Regulatory Network	1	0	7089	8416	7089	
3455	human ACE2	human INFunknownSUP	1	0	3457	2214	3457	
24382	The Effects of Social Support	The effect of social support	1	0	24384	2618	2994	
23533	satisfaction levels	satisfaction level	1	0	169	106	169	
27744	random effects model	random effect model	1	0	27746	2346	1078	
38073	better interpretation of the sewage data	good interpretation of the sewage datum	1	0	38075	1635	11044	
33408	Limit Efficacy	Limit efficacy	1	0	2112	33409	2112	
11118	severe form of COVID-19 infection Individual susceptibility	severe form of INFunknownSUP infection individual susceptibility	1	0	11120	262	11121	
26993	online learning environment support	online learning environment support	1	0	260	26994	260	
24361	long-lasting immune responses	long-lasting immune response	1	0	969	4291	200	
1391	laboratory assessments	laboratory assessment	1	0	1393	1392	1393	
28363	protection of global human health	protection of global human health	1	0	440	28365	440	
20507	high level of IES-R	high level of INFunknownSUP	1	0	13374	20511	362	
22317	direction of research	direction of research	1	0	22318	36	22318	
30736	urticarial rash	urticarial rash	1	0	6675	30737	6675	
35200	short time	short time	1	0	179	16760	179	
20223	Probable depression	probable depression	1	0	1514	20224	1514	
14715	industrial areas of the country	industrial area of the country	1	0	14717	4428	1579	
22522	treatment program setting	treatment program setting	1	0	22524	97	2854	
27279	provider-related barriers	provider-related barrier	1	0	10121	10311	10121	
27075	acute cardiac involvement	acute cardiac involvement	1	0	11981	1461	3599	
29227	systemic therapy	systemic therapy	1	0	2273	1453	2273	
29073	situation of the patients	situation of the patient	1	0	3056	60	3056	
29614	symbolic dynamics	symbolic dynamics	1	0	3694	29615	3694	
3881	inappropriate decisions	inappropriate decision	1	0	1942	3882	1942	
13837	fundamental reproduction number	fundamental reproduction number	1	0	5878	3003	916	
15863	SARS-CoV-2 transmission	INFunknownSUP transmission	1	0	876	226	876	
27470	centralized manufacturing facilities	centralized manufacturing facility	1	0	27472	7502	2676	
5267	Streptococcus pneumoniae	streptococcus INFunknownSUP	1	0	5269	5268	5269	
2226	inhibitory impacts	inhibitory impact	1	0	1385	2227	1385	
10491	staff of government offices	staff of government office	1	0	11	10493	11	
8254	CDR1 region	INFunknownSUP region	1	0	8256	8255	8256	
596	higher performance	high performance	1	0	598	322	598	
10751	mid-regional proadrenomedullin	mid-regional INFunknownSUP	1	0	10753	10752	10753	
68	new technologies	new technology	1	0	70	69	70	
23399	control of COVID-19 Delta wave	control of INFunknownSUP Delta wave	1	0	510	23401	510	
19233	Medical Sciences Pearson	Medical Sciences Pearson	1	0	19235	2779	4230	
20558	Influenza B virus	influenza B virus	1	0	20560	18625	778	
15367	consecutive websites	consecutive website	1	0	15369	6607	15369	
5926	pandemic peak	pandemic peak	1	0	5928	1354	5928	
8283	necessary oxygen support	necessary oxygen support	1	0	8285	8284	260	
35104	care departments	care department	1	0	328	9	328	
32926	heavy contamination	heavy contamination	1	0	12549	8258	12549	
24407	COVID-19 pandemic cohort	INFunknownSUP pandemic cohort	1	0	3382	40	601	
31295	data-driven random forest classification model	data-driven random forest classification model	1	0	31297	11515	1078	
15277	effective active ingredients	effective active ingredient	1	0	12261	2051	12263	
31898	aurintricarboxylic acid	INFunknownSUP acid	1	0	7492	31899	7492	
3172	local database	local database	1	0	879	3173	879	
9621	better team processes	good team process	1	0	9623	1635	3381	
37903	COVID-19 Malignant Cerebral Artery Infarction	INFunknownSUP malignant cerebral artery infarction	1	0	37905	40	37911	
27396	overall case fatality rate	overall case fatality rate	1	0	27398	2251	1034	
12937	economic security	economic security	1	0	12279	108	12279	
30491	Non-invasive Ventilation	non-invasive ventilation	1	0	30493	18357	30493	
19371	viral-host membrane fusion	INFunknownSUP membrane fusion	1	0	19373	19372	13230	
5141	spite of the fact	spite of the fact	1	0	5142	5143	5142	
3438	population-based quarantine measures	INFunknownSUP quarantine measure	1	0	3440	3439	317	
6937	online delivery methods	online delivery method	1	0	205	6938	205	
39271	landmark year	landmark year	1	0	3822	39272	3822	
2694	General Self-Efficacy Scale	General INFunknownSUP Scale	1	0	2696	2695	1203	
8179	conflicting information	conflicting information	1	0	2591	8180	2591	
28711	diabetic nephropathy	diabetic INFunknownSUP	1	0	28713	15617	28713	
15353	S subunit	S subunit	1	0	8764	6831	8764	
14087	upper respiratory symptoms	upper respiratory symptom	1	0	14089	2150	86	
618	high levels of angiotensin-converting enzyme	high level of INFunknownSUP enzyme	1	0	620	13	169	
33670	mean R	mean R	1	0	33672	194	33672	
19419	disease understanding	disease understanding	1	0	2715	209	2715	
23387	course of the pandemic	course of the pandemic	1	0	5152	113	5152	
12439	% of individuals	% of individual	1	0	364	1113	364	
18168	effect of the ABO blood group	effect of the ABO blood group	1	0	1809	5207	1809	
34339	mitigation measures	mitigation measure	1	0	317	2375	317	
23604	COVID-19 wave	INFunknownSUP wave	1	0	10210	40	10210	
29475	essential role	essential role	1	0	7288	4197	7288	
13953	Chimeric Antigen Receptor	chimeric antigen receptor	1	0	13955	13954	13957	
13218	second theme	second theme	1	0	13220	1279	13220	
14354	characteristics of the communities	characteristic of the community	1	0	1496	948	1496	
20954	Japanese University	Japanese University	1	0	50	18657	50	
32566	ambient ground-level concentrations	ambient ground-level concentration	1	0	32568	11598	1959	
34825	nursing care targets	nursing care target	1	0	34827	1209	4044	
3503	System alignment	system alignment	1	0	3505	3504	3505	
14289	time of coronavirus disease	time of coronavirus disease	1	0	179	338	179	
29750	planned spinal surgical services	planned spinal surgical service	1	0	29752	29751	5980	
15346	Public health responses	public health response	1	0	200	15347	200	
30745	Metropolitan France	Metropolitan France	1	0	30747	30746	30747	
29536	different regions of the UK	different region of the UK	1	0	29537	5052	5240	
25612	continuous increase	continuous increase	1	0	392	2232	392	
18659	stable interactions	stable interaction	1	0	13158	18660	13158	
8838	staff shortage	staff shortage	1	0	8840	11	8840	
15452	admission to hospital	admission to hospital	1	0	2865	185	2865	
12653	reliable data	reliable datum	1	0	22	12654	22	
28000	timely care	timely care	1	0	9	2713	9	
14442	risk of tissue rejection	risk of tissue rejection	1	0	1542	14444	1542	
13400	bilateral lung involvement	bilateral lung involvement	1	0	3599	13401	3599	
28115	network of the Epitope Database	network of the Epitope Database	1	0	719	28117	719	
24955	higher rates of marriage	high rate of marriage	1	0	1509	24959	83	
25354	detection of SARS-CoV-2 nucleocapsid	detection of INFunknownSUP INFunknownSUP	1	0	44	25356	44	
22603	plastic waste crisis	plastic waste crisis	1	0	22605	13621	408	
19037	inflammation post-SCI	inflammation INFunknownSUP	1	0	19039	3116	19039	
38088	Ontario children	Ontario child	1	0	6153	32909	6153	
5327	Experiences of Nurse Managers	experience of nurse manager	1	0	433	5329	433	
18011	multiple sclerosis	multiple sclerosis	1	0	18013	18012	18013	
33674	saliva-based COVID-19	INFunknownSUP INFunknownSUP	1	0	40	33675	40	
20059	Behavior Tracker	behavior tracker	1	0	20061	20060	20061	
8593	metabolomics analysis	INFunknownSUP analysis	1	0	486	8594	486	
3061	severe COVID-19 patients	severe INFunknownSUP patient	1	0	60	3062	60	
9836	marine metabolites	marine metabolite	1	0	8323	9837	8323	
16516	health-care systems	health-care system	1	0	146	16517	146	
18456	pulmonary tropism	pulmonary tropism	1	0	18458	590	18458	
15293	work life	work life	1	0	1434	2162	1434	
6445	risk of disease transmission	risk of disease transmission	1	0	1542	6447	1542	
31683	epidemiological observation	epidemiological observation	1	0	7451	18107	7451	
34396	factors of lockdown resilience	factor of INFunknownSUP resilience	1	0	583	34398	583	
10166	COVID-19 era	INFunknownSUP era	1	0	9542	40	9542	
2242	financial well-being programs	financial well-being program	1	0	2246	2243	2246	
12018	satellite instrument TROPOMI	satellite instrument INFunknownSUP	1	0	12020	7264	7262	
34255	virological studies	virological study	1	0	136	31086	136	
20951	medical universities	medical university	1	0	10501	947	10501	
32107	pooled-sample screening protocol	pooled-sample screening protocol	1	0	7960	32108	7962	
23510	new perspective	new perspective	1	0	21724	69	21724	
31234	aspects of care	aspect of care	1	0	2429	9	2429	
36887	poor information quality	poor information quality	1	0	24333	1372	3713	
8755	IgG titers	IgG titer	1	0	8757	928	8757	
36831	self-isolating household units	self-isolating household unit	1	0	34919	33545	6042	
22139	single center	single center	1	0	8718	1652	8718	
9083	health care provider	health care provider	1	0	9085	120	9087	
38415	possible priority	possible priority	1	0	19575	745	19575	
30926	SARS-CoV-2 new variants	INFunknownSUP new variant	1	0	5466	226	1002	
37868	start of the pandemic	start of the pandemic	1	0	18935	113	18935	
34370	random sample of non-hospitalized patients	random sample of INFunknownSUP patient	1	0	34372	2346	2757	
3324	effective public health	effective public health	1	0	1320	2051	120	
5775	advent of a vaccine	advent of a vaccine	1	0	5776	577	5776	
29748	effective planned spinal surgical services	effective planned spinal surgical service	1	0	29750	2051	5980	
25933	outbreak of the COVID-19 pandemic	outbreak of the INFunknownSUP pandemic	1	0	310	111	310	
33470	response of medical personnel	response of medical personnel	1	0	409	7662	409	
20592	prolonged neurological dysfunction	prolonged neurological dysfunction	1	0	20594	5497	3856	
23846	university student	university student	1	0	23848	1642	23848	
25182	predictive factor	predictive factor	1	0	2183	4314	2183	
29203	introduction of training	introduction of training	1	0	381	235	381	
20143	surrogate virus	surrogate virus	1	0	778	20144	778	
15347	Public health	public health	1	0	120	15348	120	
10694	baseline periods	baseline period	1	0	873	5344	873	
38787	de letalidad	de letalidad	1	0	11613	1421	11613	
23911	mass COVID-19 vaccination	mass INFunknownSUP vaccination	1	0	2836	11695	437	
17408	sixth month	sixth month	1	0	2167	760	2167	
19498	system knowledge base	system knowledge base	1	0	19500	1327	3323	
15390	risk of further transmission	risk of further transmission	1	0	1542	15392	1542	
11688	New Insights	New insight	1	0	11690	1162	11690	
21103	security dimension of integration	security dimension of integration	1	0	21105	12279	10927	
10070	Inhibition of the terminal complement pathway	inhibition of the terminal complement pathway	1	0	4076	10072	4076	
16557	Sex differences	sex difference	1	0	5663	10683	5663	
19977	rural setting	rural setting	1	0	2854	8823	2854	
15935	trends of the articles	trend of the article	1	0	11700	811	11700	
1503	progress of pandemic control	progress of pandemic control	1	0	1504	1505	1504	
17670	Adjusted Odds Ratio	adjusted odd ratio	1	0	17672	9902	9907	
1539	dynamic risk modeling of mortality	dynamic risk modeling of mortality	1	0	1541	1540	464	
32426	oncologic cases	INFunknownSUP case	1	0	229	32427	229	
1460	acute hospitals	acute hospital	1	0	76	1461	76	
37709	retrovirus genome sequences	retrovirus genome sequence	1	0	19825	37710	19827	
32707	public sites	public site	1	0	9165	1321	9165	
7696	daily average temperature	daily average temperature	1	0	7698	191	195	
26985	command structure	command structure	1	0	2427	11332	2427	
35932	urgent development	urgent development	1	0	73	8129	73	
23784	remote delivery	remote delivery	1	0	2840	2073	2840	
1096	consideration of various factors	consideration of various factor	1	0	1097	1098	1097	
33123	home therapy	home therapy	1	0	2273	231	2273	
71	CDI development	CDI development	1	0	73	72	73	
15317	detection of IL-10	detection of INFunknownSUP	1	0	44	9885	44	
23302	oral cavity mucosa	oral cavity mucosa	1	0	23304	427	23306	
8447	correlation matrix	correlation matrix	1	0	8449	2889	8449	
36294	Health Information Quality Authority	Health Information Quality Authority	1	0	36296	279	36300	
14685	% of the respondents	% of the respondent	1	0	364	861	364	
4473	levels of education	level of education	1	0	169	361	169	
20606	Protection Measures	Protection Measures	1	0	20608	11483	20608	
34386	severe COVID-19	severe INFunknownSUP	1	0	3076	262	3076	
19202	SARS-CoV-2 Variants	INFunknownSUP variant	1	0	19204	226	19204	
2031	sobre salud mental durante	INFunknownSUP INFunknownSUP mental INFunknownSUP	1	0	2035	2032	2037	
6657	risk of acute kidney injury	risk of acute kidney injury	1	0	1542	6659	1542	
31784	II receptor blockers	II receptor blocker	1	0	31786	10856	31788	
33673	saliva-based COVID-19 antigen test	INFunknownSUP INFunknownSUP antigen test	1	0	33677	33674	754	
5941	tree of the value	tree of the value	1	0	5942	1037	5942	
6105	statement AISF	statement INFunknownSUP	1	0	6107	1684	6107	
25705	general decrease	general decrease	1	0	3084	1080	3084	
19368	mutation frequencies	mutation frequency	1	0	374	333	374	
14156	COVID-19 personal protective equipment	INFunknownSUP personal protective equipment	1	0	4960	40	3038	
9192	anti-inflammatory drugs	anti-inflammatory drug	1	0	4584	9193	4584	
39051	service delivery model	service delivery model	1	0	39053	6375	1078	
887	Chemosensory disorders	INFunknownSUP disorder	1	0	889	888	889	
10745	case records	case record	1	0	10747	3368	10747	
39241	circulatory support	circulatory support	1	0	260	23843	260	
27942	MD -	Md INFunknownSUP	1	0	27944	27940	27944	
4894	electron cryo-microscopy	electron cryo-microscopy	1	0	4896	4895	4896	
16394	potential of 2019-nCoV	potential of INFunknownSUP	1	0	6265	4648	6265	
32824	ligand simulations	ligand simulation	1	0	7353	32825	7353	
27061	agent of COVID-19 related lung injury	agent of INFunknownSUP related lung injury	1	0	12122	27063	12122	
34143	loss of taste	loss of taste	1	0	3586	17031	3586	
10299	primary composite endpoint	primary composite endpoint	1	0	10301	75	10303	
15149	exercise trainers	exercise trainer	1	0	15151	4799	15151	
5767	con las busquedas	con la INFunknownSUP	1	0	5769	816	5771	
21809	y la	y la	1	0	3572	1908	3572	
31388	satellite-derived surface concentration	INFunknownSUP surface concentration	1	0	31390	12791	11518	
24455	delayed access cohort	delayed access cohort	1	0	24457	4161	601	
6898	health care institutions	health care institution	1	0	6900	120	2602	
12824	Dermatology undergraduate exposure	dermatology undergraduate exposure	1	0	12826	10860	1054	
18317	162b2 vaccination	INFunknownSUP vaccination	1	0	437	18318	437	
2260	IGHV3-53/3-66 antibodies	IGHV3-53/3-66 antibody	1	0	929	2261	929	
23602	large COVID-19 wave	large INFunknownSUP wave	1	0	23604	4250	10210	
23971	post-marketing cases	post-marketing case	1	0	229	23972	229	
20175	therapeutic targets	therapeutic target	1	0	4044	3349	4044	
16124	input-process relationship	input-process relationship	1	0	2722	16125	2722	
14565	disease process	disease process	1	0	180	209	180	
36072	month period	month period	1	0	5677	2167	5677	
8147	breathing difficulty	breathing difficulty	1	0	8149	8148	8149	
9687	evolution of the number of infections	evolution of the number of infection	1	0	3741	9689	3741	
7490	ellagic acid	INFunknownSUP acid	1	0	7492	7491	7492	
27888	confirmatory factor analysis	confirmatory factor analysis	1	0	2182	21130	486	
9611	cross-entropies of heart rate signals	cross-entropy of heart rate signal	1	0	9612	9613	9612	
36046	external consultancy	external consultancy	1	0	36048	14485	36048	
24755	yellow fever	yellow fever	1	0	6465	24756	6465	
19638	history of SARS-CoV-2 infection	history of INFunknownSUP infection	1	0	5381	1272	5381	
9760	specific precautionary measures	specific precautionary measure	1	0	9762	2515	317	
20776	signal sources	signal source	1	0	4158	11501	4158	
12748	Spontaneous ilio-psoas hematoma	spontaneous INFunknownSUP hematoma	1	0	12750	12749	12752	
34557	protein analyses	protein analysis	1	0	4668	1797	4668	
22973	efficiency improvement	efficiency improvement	1	0	10698	14461	10698	
11042	data interpretation	datum interpretation	1	0	11044	22	11044	
18029	titer of anti-S1 antibodies	titer of INFunknownSUP antibody	1	0	18030	18031	18030	
522	peripheral ground-glass opacities	peripheral ground-glass opacity	1	0	524	523	526	
23012	range of secondary attack rate	range of secondary attack rate	1	0	420	23014	420	
13557	differential responses	differential response	1	0	200	3104	200	
1101	combination of ventricular longitudinal strain	combination of ventricular longitudinal strain	1	0	367	1103	367	
16728	KASID Coronavirus	INFunknownSUP INFunknownSUP	1	0	3206	16729	3206	
30871	temporary reduction	temporary reduction	1	0	490	21319	490	
8304	trial of a messenger RNA vaccine	trial of a messenger RNA vaccine	1	0	965	8306	965	
21209	hospital-based analyses	hospital-based analysis	1	0	4668	21210	4668	
4993	genome annotations	genome annotation	1	0	4995	2173	4995	
15015	gram-negative bacilli	Gram-negative bacillus	1	0	15017	15016	15017	
2508	SARS-CoV-2 challenge	INFunknownSUP challenge	1	0	62	28	62	
7069	aim of this research	aim of this research	1	0	7070	36	7070	
15450	hour of admission to hospital	hour of admission to hospital	1	0	11528	15452	11528	
19695	cohort of laboratory-confirmed cases	cohort of laboratory-confirmed case	1	0	601	19322	601	
27582	contract tracing	contract tracing	1	0	1889	27583	1889	
16244	history of any mental disorder	history of any mental disorder	1	0	5381	16246	5381	
31616	entry of pseudotyped viruses	entry of INFunknownSUP virus	1	0	5629	31618	5629	
29235	~86 % of cases	~86 % of case	1	0	11201	29236	364	
19015	use expertise	use expertise	1	0	19017	292	19017	
32319	pattern recognition receptors	pattern recognition receptor	1	0	32321	4682	8960	
29516	mixed results	mixed result	1	0	325	9227	325	
23563	SARS-CoV-2 suspected cases	INFunknownSUP suspected case	1	0	23565	28	229	
6356	metabolic profile	metabolic profile	1	0	3088	6357	3088	
27958	current guidance	current guidance	1	0	18482	443	18482	
37755	COVID-19 prevention measures	INFunknownSUP prevention measure	1	0	19542	40	317	
34105	Health Questionnaire-9	Health INFunknownSUP	1	0	34107	279	34107	
3870	Korea Vaccination	Korea vaccination	1	0	3872	3871	3872	
2072	remote teaching	remote teaching	1	0	2074	2073	2074	
4787	SARS-CoV-2 vaccine	INFunknownSUP vaccine	1	0	577	28	577	
12583	model parameters	model parameter	1	0	6460	1078	6460	
33793	Helsinki University Hospital	Helsinki University Hospital	1	0	1877	33794	1879	
943	JAK phosphorylation	Jak INFunknownSUP	1	0	945	944	945	
18227	human testis	human testis	1	0	18229	2214	18229	
8938	unvaccinated patient	unvaccinated patient	1	0	710	8939	710	
34460	analysis of subgroup of patients	analysis of subgroup of patient	1	0	486	23381	486	
17034	multicohort population-based serological survey	multicohort INFunknownSUP serological survey	1	0	17036	17035	967	
16061	British Association of Spine Surgeons	British Association of Spine surgeon	1	0	16063	16062	1952	
35303	genetic counseling programs	genetic counseling program	1	0	2246	35304	2246	
37425	medium length of hospital	medium length of hospital	1	0	8400	8873	1347	
24731	ongoing research	ongoing research	1	0	36	1059	36	
38832	in-person rotations	in-person rotation	1	0	9364	9275	9364	
39047	deployment of an integrated service delivery model	deployment of an integrated service delivery model	1	0	10837	39049	10837	
17831	viral complementary binding sites	viral complementary binding site	1	0	17833	1741	9165	
17531	Clinical Stroke Practice	clinical stroke practice	1	0	17533	1501	17535	
7582	Iranian New Year	Iranian New Year	1	0	7584	7583	7586	
38637	Hospital Supplemental Digital Content	Hospital Supplemental Digital content	1	0	12783	1879	7950	
12011	average of the laboratory tests results	average of the laboratory test result	1	0	12012	12013	12012	
31441	evaluation of COVID-19	evaluation of INFunknownSUP	1	0	2399	40	2399	
16469	urinary volume	urinary volume	1	0	3445	2662	3445	
14973	implementation of current guidelines	implementation of current guideline	1	0	396	14975	396	
28125	Gulf Cooperation Council countries Electronic health	Gulf Cooperation Council country electronic health	1	0	28131	6225	120	
682	Altered Vaccine Efficiency	altered vaccine efficiency	1	0	684	683	686	
25541	number of measures	number of measure	1	0	916	317	916	
9073	cumulative analysis	cumulative analysis	1	0	486	9074	486	
1695	methodological approach	methodological approach	1	0	1538	1696	1538	
1610	public awareness	public awareness	1	0	1612	1321	1612	
8637	large-scale trials	large-scale trial	1	0	8639	8638	8639	
16759	short generation times	short generation time	1	0	16761	16760	12806	
6352	individual relevance of this metabolic profile	individual relevance of this metabolic profile	1	0	6354	753	856	
2781	experience of trauma	experience of trauma	1	0	2782	2783	2782	
20743	patient-level characteristics	patient-level characteristic	1	0	1496	20744	1496	
28698	Excessive inflammation	excessive inflammation	1	0	3116	28699	3116	
22547	main reason of these differences	main reason of these difference	1	0	22549	4679	5140	
24294	stay-at-home guidelines	stay-at-home guideline	1	0	91	1759	91	
23700	control sera	control sera	1	0	17161	510	17161	
1713	overlapping seasonality	overlapping seasonality	1	0	1715	1714	1715	
28928	employment changes	employment change	1	0	1336	13090	1336	
13270	diagnostic biomarkers of COVID-19	diagnostic biomarker of INFunknownSUP	1	0	13272	2219	2577	
9102	terms of reinfection resistance	term of reinfection resistance	1	0	4908	9104	4908	
35669	non-viral parameters	non-viral parameter	1	0	6460	35670	6460	
6330	ill COVID-19 patients	ill INFunknownSUP patient	1	0	911	4729	60	
2771	anxiety to probable depression	anxiety to probable depression	1	0	2772	2773	2772	
6797	instrumental variable Dimitris	instrumental variable INFunknownSUP	1	0	6799	6798	6801	
33660	laparoscoendoscopic procedures	laparoscoendoscopic procedure	1	0	4200	33661	4200	
25085	assessment of the evidence	assessment of the evidence	1	0	238	585	238	
38778	ha creado un indice de letalidad relativa	ha creado un INFunknownSUP de letalidad INFunknownSUP	1	0	38780	38779	38790	
24336	poor respiratory system compliance	poor respiratory system compliance	1	0	24338	1372	2726	
21100	Dysarthria Outcomes	INFunknownSUP outcome	1	0	9631	1201	9631	
16649	autonomous regions of mainland China	autonomous region of mainland China	1	0	16651	16650	5240	
30595	Potential inhibitors	potential inhibitor	1	0	8870	30596	8870	
38093	stimulator of ACE2	stimulator of INFunknownSUP	1	0	29871	3437	29871	
28378	symptoms of pneumonia	symptom of pneumonia	1	0	86	2369	86	
24011	system of equations	system of equation	1	0	1327	3105	1327	
19669	severe COVID-19 pneumonia	severe INFunknownSUP pneumonia	1	0	19671	262	2369	
37073	COVID-19-Positive Patient	INFunknownSUP Patient	1	0	34104	37074	34104	
21423	Public Health Interventions	Public Health intervention	1	0	21425	840	12708	
16903	segmentation of MSD lung tumors	segmentation of MSD lung tumor	1	0	16498	16905	16498	
124	application of laparoscopic surgeons	application of INFunknownSUP surgeon	1	0	125	126	125	
17539	exclusive groups Patients	exclusive group patient	1	0	17541	17540	10959	
6213	expert physical therapy services	expert physical therapy service	1	0	6215	1686	5980	
6335	COVID-19 Pandemic Influenced Public Discourse	INFunknownSUP pandemic Influenced Public Discourse	1	0	6339	6336	6343	
3298	Predictors of In-Hospital Mortality	predictor of in-hospital mortality	1	0	3299	3300	3299	
32552	assessment of Reunion Island inpatients	assessment of Reunion Island inpatient	1	0	238	32554	238	
24166	diagnostic devices	diagnostic device	1	0	6162	2219	6162	
12133	Time-dependent bias	time-dependent bias	1	0	4930	12134	4930	
13067	effective life-saving treatment	effective life-saving treatment	1	0	13069	2051	97	
29734	manifestations of the disease	manifestation of the disease	1	0	885	209	885	
24326	units of a selected district hospital	unit of a selected district hospital	1	0	6042	24328	6042	
7053	higher binding-	high INFunknownSUP	1	0	7055	322	7055	
33344	available healthcare	available INFunknownSUP	1	0	494	832	494	
39236	outcome scores	outcome score	1	0	3726	295	3726	
37095	pandemic period	pandemic period	1	0	5677	1354	5677	
16910	desirable human antibody	desirable human antibody	1	0	16912	16911	5924	
4965	behavioural explanation	INFunknownSUP explanation	1	0	4967	4966	4967	
14409	Nurse managers	nurse manager	1	0	9340	5330	9340	
17506	transmissibility of these variants	INFunknownSUP of these variant	1	0	3451	1002	3451	
31876	binding mode of Arbidol	binding mode of INFunknownSUP	1	0	31877	22943	18075	
22977	SARS-CoV infection	INFunknownSUP infection	1	0	41	22978	41	
11388	coordinates of the pedestrian	coordinate of the pedestrian	1	0	11389	11390	11389	
23539	degree of anxiety	degree of anxiety	1	0	12635	2772	12635	
23635	risk framing of COVID-19	risk framing of INFunknownSUP	1	0	23637	1542	9534	
1911	numero de profesionales de medicina	numero de INFunknownSUP de INFunknownSUP	1	0	1913	1902	1919	
13714	mental health of humans	mental health of human	1	0	118	13718	120	
28232	appropriate perinatal mental health care	appropriate perinatal mental health care	1	0	28234	1256	9	
11870	prolonged home isolation	prolonged home isolation	1	0	11872	5497	6569	
12110	field-effect transistors	field-effect transistor	1	0	12112	12111	12112	
17863	characteristic curves	characteristic curve	1	0	1499	8034	1499	
10586	patient care strategy	patient care strategy	1	0	3350	4004	3350	
23774	Research Institute	Research Institute	1	0	20525	3674	20525	
32724	infectious stage	infectious stage	1	0	1521	64	1521	
23816	step of viral infection	step of viral infection	1	0	23817	11924	23817	
17755	new data pipelines	new datum pipeline	1	0	17757	69	17759	
32178	higher level of viremia	high level of INFunknownSUP	1	0	32179	32182	362	
23530	Antibody positivity	antibody INFunknownSUP	1	0	1238	9862	1238	
1230	Transfusion Organization	transfusion Organization	1	0	1232	1231	1232	
11082	% cancer diagnosis rate	% cancer diagnosis rate	1	0	11084	364	1034	
28280	future efforts	future effort	1	0	28282	1367	28282	
18908	simultaneous increase	simultaneous increase	1	0	392	18909	392	
2516	bacterial consortium	bacterial consortium	1	0	2518	2517	2518	
21768	activation-induced cytidine deaminase	INFunknownSUP cytidine INFunknownSUP	1	0	21770	18020	21772	
23197	online assessments	online assessment	1	0	1393	541	1393	
21179	successive days	successive day	1	0	1645	21180	1645	
22491	policy formulation	policy formulation	1	0	22493	293	22493	
31394	left ventricular assist device	left ventricular assist device	1	0	31396	28863	3001	
32503	lipid bilayer measurements	lipid bilayer measurement	1	0	32505	4348	8077	
26068	direct COVID-19 infection	direct INFunknownSUP infection	1	0	39	2012	41	
1519	earlier stage	early stage	1	0	1521	1520	1521	
36134	Reading Ease scales	Reading ease scale	1	0	36136	36135	7864	
25814	Engagement Scale	engagement Scale	1	0	1203	25815	1203	
26486	scientific information	scientific information	1	0	2591	2290	2591	
14491	dysarthria rating	INFunknownSUP rating	1	0	14493	14492	14493	
18962	Se realizo busqueda bibliografica	Se INFunknownSUP INFunknownSUP INFunknownSUP	1	0	18964	18963	18968	
30592	gene flow	gene flow	1	0	6423	6495	6423	
34008	adequate keywords	adequate keyword	1	0	30642	270	30642	
19761	cross-sectional analysis of neurosurgery match data	cross-sectional analysis of neurosurgery match datum	1	0	19763	2493	486	
21564	90th percentile score	INFunknownSUP percentile score	1	0	21566	21565	1843	
769	cell lung cancer	cell lung cancer	1	0	771	197	773	
35942	Knowledge of the dermatologic	knowledge of the INFunknownSUP	1	0	23429	17491	23429	
36010	predictors of COVID-19 mortality	predictor of INFunknownSUP mortality	1	0	414	29060	414	
21559	Spearman Correlation test	Spearman correlation test	1	0	754	21560	754	
7634	memory consumption	memory consumption	1	0	1267	7635	1267	
5502	Allogeneic donor-derived	INFunknownSUP INFunknownSUP	1	0	5504	5503	5504	
22627	social nature of COVID-19 disease	social nature of INFunknownSUP disease	1	0	22629	383	1476	
32942	sero-prevalence rate	sero-prevalence rate	1	0	1034	32943	1034	
8182	pre-admission/in-hospital PPI use	pre-admission/in-hospital PPI use	1	0	8184	8183	292	
25821	ML models	ML model	1	0	3975	690	3975	
35368	period March-May	period March-May	1	0	35370	5677	35370	
35211	arrival to brain imaging	arrival to brain imaging	1	0	4700	35213	4700	
4669	participant behaviour	participant behaviour	1	0	469	4670	469	
31042	setting of severe COVID-19	setting of severe INFunknownSUP	1	0	2854	3062	2854	
13872	diagnostic accuracy	diagnostic accuracy	1	0	4535	2219	4535	
30681	psychosocial stressors	psychosocial INFunknownSUP	1	0	14923	9177	14923	
11536	Results of the main characteristics	result of the main characteristic	1	0	10882	11538	10882	
4125	mental health of medical students	mental health of medical student	1	0	118	4129	120	
23084	close correlation	close correlation	1	0	2889	614	2889	
7799	respiratory complications	respiratory complication	1	0	705	259	705	
24373	health challenges	health challenge	1	0	2220	120	2220	
21415	clinical diagnosis	clinical diagnosis	1	0	2168	884	2168	
39323	Use of in-Person	use of in-person	1	0	3481	39325	3481	
28881	recent findings	recent finding	1	0	3390	2128	3390	
35783	essential different receptor molecules	essential different receptor molecule	1	0	35785	4197	7076	
29806	major risk factors	major risk factor	1	0	3561	1318	583	
31594	life quality of the health care workers	life quality of the health care worker	1	0	31596	1434	3713	
24130	worldwide mortality	worldwide mortality	1	0	1197	8376	1197	
147	immunological impact of COVID-19	immunological impact of INFunknownSUP	1	0	149	148	110	
13588	% of students	% of student	1	0	364	1177	364	
29308	novel severe acute respiratory syndrome coronavirus	novel severe acute respiratory syndrome coronavirus	1	0	4709	3645	339	
19944	COVID-19 treatments	INFunknownSUP treatment	1	0	1295	40	1295	
2876	COVID-19 travel restrictions	INFunknownSUP travel restriction	1	0	2878	40	2880	
4678	main transmission pattern	main transmission pattern	1	0	4680	4679	4682	
14242	educational yield	educational yield	1	0	14244	834	14244	
5127	metagenomic markers	INFunknownSUP marker	1	0	5129	5128	5129	
7546	coagulation factors	coagulation factor	1	0	583	7547	583	
14819	Preliminary estimation of the basic reproduction number of novel coronavirus	preliminary estimation of the basic reproduction number of novel coronavirus	1	0	14821	7031	10490	
8575	vivo/in vitro approach	INFunknownSUP INFunknownSUP approach	1	0	1538	8576	1538	
33339	judicious use of the available healthcare resources	judicious use of the available INFunknownSUP resource	1	0	33341	33340	292	
28933	necrosis factor	necrosis factor	1	0	2183	5738	2183	
19690	laboratory midterm score	laboratory midterm score	1	0	19692	1392	1843	
23449	isolation of infected people	isolation of infected people	1	0	6569	15623	6569	
4777	ACE2 receptor	INFunknownSUP receptor	1	0	3502	4778	3502	
15065	standardized structure coefficient	standardized structure coefficient	1	0	15067	10795	4664	
15144	% of the mask samples	% of the mask sample	1	0	364	8970	364	
36939	infection control practices	infection control practice	1	0	5378	4940	5378	
12116	Higher-risk adolescents	higher-risk adolescent	1	0	12118	12117	12118	
29153	low cytotoxicity to Vero E6 cells	low cytotoxicity to Vero INFunknownSUP cell	1	0	29155	457	25851	
30358	ferritin &gt	ferritin &gt	1	0	2385	30359	2385	
1293	prevention treatments	prevention treatment	1	0	1295	1294	1295	
26586	Blood supply sufficiency	Blood supply sufficiency	1	0	26588	1229	26590	
36405	type of surgical technique	type of surgical technique	1	0	775	36407	775	
39019	laboratory analysis	laboratory analysis	1	0	486	1392	486	
28577	treatment personalization	treatment personalization	1	0	28579	97	28579	
10245	paucity of data	paucity of datum	1	0	10246	22	10246	
12781	Recipients Supplemental Digital Content	recipient Supplemental Digital content	1	0	12783	12782	7950	
4323	SARS-CoV2 associated strokes	INFunknownSUP associated stroke	1	0	4325	4324	3531	
8276	emergency surgery outcomes	emergency surgery outcome	1	0	8278	447	263	
7623	low-cost method	low-cost method	1	0	6587	7624	6587	
7334	expression patterns of ACE2	expression pattern of INFunknownSUP	1	0	7335	3437	548	
27037	ELISA tests	Elisa test	1	0	1365	1220	1365	
22515	multidisciplinary needs of care	multidisciplinary need of care	1	0	22517	5219	3189	
11701	regular management	regular management	1	0	743	870	743	
24560	Function Assessment	function Assessment	1	0	2874	24561	2874	
30996	smaller computing resources	small computing resource	1	0	30998	30997	835	
8355	influenza respiratory interference viruses	influenza respiratory interference virus	1	0	8357	2323	2217	
16309	Heterogeneous SARS-CoV-2 humoral response	heterogeneous INFunknownSUP humoral response	1	0	16311	16310	409	
24902	marine fungi compounds	marine fungus compound	1	0	24904	9837	14102	
20442	organic framework	organic framework	1	0	4860	20443	4860	
36336	myocardial oedema	myocardial oedema	1	0	36338	5813	36338	
26533	continuing HIV/AIDS epidemic	continuing INFunknownSUP epidemic	1	0	26535	9996	6542	
11597	ambient NO2	ambient INFunknownSUP	1	0	7621	11598	7621	
14513	number of procedures	number of procedure	1	0	916	4200	916	
21047	application of halo effect theory	application of halo effect theory	1	0	125	21049	125	
34809	Prevotella salivae	INFunknownSUP INFunknownSUP	1	0	34811	34810	34811	
17957	effectiveness of remdesivir	effectiveness of INFunknownSUP	1	0	16379	9405	16379	
7920	post-market evaluation	post-market evaluation	1	0	2399	7921	2399	
22338	resource scarcity	resource scarcity	1	0	22340	2703	22340	
190	daily activities	daily activity	1	0	192	191	192	
3160	oronasal symptoms	oronasal symptom	1	0	86	3161	86	
31864	sharp injuries	sharp injury	1	0	31866	25373	31866	
6058	half of the participants	half of the participant	1	0	6059	4950	6059	
35440	Leuven University Hospital	Leuven University Hospital	1	0	1877	35441	1879	
11010	aim of this project	aim of this project	1	0	7070	11012	7070	
36456	respiratory syndrome coronavirus:MERS-CoV	respiratory syndrome INFunknownSUP	1	0	36458	259	36460	
11050	Western hospitals	Western hospital	1	0	76	4549	76	
33722	body of evidence	body of evidence	1	0	2710	585	2710	
6979	Mixed Methods Appraisal Tool	mixed method appraisal Tool	1	0	6981	3484	6985	
24311	different clinical features	different clinical feature	1	0	24313	688	1469	
4061	implementation success	implementation success	1	0	4063	396	4063	
31559	Western system	Western system	1	0	1327	4549	1327	
32916	impact of this benefit	impact of this benefit	1	0	110	297	110	
36389	medical/non-medical resources	medical/non-medical resource	1	0	835	36390	835	
22541	telehealth utilization	telehealth utilization	1	0	4011	304	4011	
20098	protease inhibitor	protease inhibitor	1	0	4569	2918	4569	
33341	use of the available healthcare resources	use of the available INFunknownSUP resource	1	0	292	33343	292	
24100	Risk of Depression	risk of Depression	1	0	1450	24102	1450	
32387	general surgery cases	general surgery case	1	0	32389	1080	229	
12767	simulation training	simulation training	1	0	235	9152	235	
3030	new generation of face masks	new generation of face mask	1	0	3032	69	3033	
8288	Simple Measure of Gobbledygook	simple measure of gobbledygook	1	0	1654	8289	1655	
14046	spinal units	spinal unit	1	0	6042	14047	6042	
32795	traveller registration	traveller registration	1	0	17572	32796	17572	
18753	healthcare policy changes	INFunknownSUP policy change	1	0	18755	494	1336	
30071	clinical worsening	clinical worsening	1	0	30073	884	30073	
26187	health of medical undergraduates	health of medical undergraduate	1	0	120	26189	120	
31090	vein thrombosis	vein thrombosis	1	0	31092	31091	31092	
9618	SAVE-9 questionnaire	INFunknownSUP questionnaire	1	0	9620	9619	9620	
21742	Healthcare Providers	Healthcare provider	1	0	21744	1355	21744	
25544	acceptable method	acceptable method	1	0	6587	4379	6587	
8319	numerous active metabolites	numerous active metabolite	1	0	8321	531	8323	
3554	natural killer cells	natural killer cell	1	0	3556	3229	133	
846	Sars-Cov-2 infection	INFunknownSUP infection	1	0	41	847	41	
9877	dental council/associations	dental council/association	1	0	9879	5656	9879	
3754	COVID-19 vaccination issues	INFunknownSUP vaccination issue	1	0	3758	2836	3758	
4525	key trade-offs	key trade-off	1	0	4527	850	4527	
36784	version of record	version of record	1	0	4435	10572	4435	
28337	adult horse show participants	adult horse show participant	1	0	17104	14179	4950	
31315	non-critical patients	non-critical patient	1	0	60	31316	60	
11242	volume projections	volume projection	1	0	11244	3445	11244	
37679	negative hs-TnI manifestation	negative INFunknownSUP manifestation	1	0	37681	1338	3466	
4301	Public Sphere	public sphere	1	0	4303	4302	4303	
9067	COVID-19 Surge	INFunknownSUP surge	1	0	9069	40	9069	
28099	% of health care providers	% of health care provider	1	0	364	22890	364	
31085	virological sampling	virological sampling	1	0	11863	31086	11863	
9892	company brochures	company brochure	1	0	9894	9893	9894	
18560	Kaplan-Meier method	Kaplan-Meier method	1	0	6587	1829	6587	
11641	ENT departments of the Italian Universities	Ent department of the Italian university	1	0	11643	11642	328	
9937	substance use programs	substance use program	1	0	2246	714	2246	
22990	expression of TMPRSS2	expression of INFunknownSUP	1	0	5729	6251	5729	
31450	dramatic decrease of bronchiolitis cases	dramatic decrease of INFunknownSUP case	1	0	31452	31451	3084	
23358	HRM catheter	HRM catheter	1	0	23360	15401	23360	
33414	response to the Coronavirus disease	response to the INFunknownSUP disease	1	0	409	6281	409	
9804	psychopathological presentations	psychopathological presentation	1	0	2848	9805	2848	
2699	expectant mother	expectant mother	1	0	2701	2700	2701	
28726	Resource-Limited Africa	Resource-Limited Africa	1	0	668	28727	668	
27179	reactive CD8 T clones	reactive INFunknownSUP T clone	1	0	27181	785	27185	
28410	superiority of non-invasive ventilation	superiority of non-invasive ventilation	1	0	28411	22488	28411	
1397	Learning-Derived Chest Radiograph Scores COVID-19	INFunknownSUP chest radiograph score INFunknownSUP	1	0	1399	1398	40	
1363	penetration tests	penetration test	1	0	1365	1364	1365	
25441	lack of evidence of germinal centre mutation	lack of evidence of germinal centre mutation	1	0	11210	25443	11210	
9393	cortisol levels	cortisol level	1	0	169	9394	169	
7665	Psychosocial Adversities	psychosocial adversity	1	0	7667	432	7667	
28407	population health	population health	1	0	120	1838	120	
10876	health reform implementation	health reform implementation	1	0	396	10877	396	
37972	average item scores	average item score	1	0	37974	178	3726	
32833	frequent hospital-acquired infections	frequent hospital-acquired infection	1	0	32835	1168	779	
9605	affected people	affected people	1	0	694	9606	694	
3354	management of COVID-19-associated acute respiratory failure	management of COVID-19-associated acute respiratory failure	1	0	743	3356	743	
20684	consecutive exposures	consecutive exposure	1	0	20686	6607	20686	
22895	p-voxel &lt	INFunknownSUP &lt	1	0	4863	22896	4863	
4683	moderate gaps	moderate gap	1	0	4685	4684	4685	
13842	part of the Pharmacy Partnership	part of the Pharmacy Partnership	1	0	734	13844	734	
28170	wave of the COVID-19 outbreak	wave of the INFunknownSUP outbreak	1	0	10210	308	10210	
2614	policy governance	policy governance	1	0	2616	293	2616	
13221	P value significance level	P value significance level	1	0	13225	13222	362	
33928	pervasiveness of COVID-19	pervasiveness of INFunknownSUP	1	0	33929	40	33929	
9163	dependence of sites	dependence of site	1	0	9164	9165	9164	
38154	drug use	drug use	1	0	292	352	292	
1893	Breakthrough COVID-19	breakthrough INFunknownSUP	1	0	40	1894	40	
1998	medication abortion care	medication abortion care	1	0	2000	153	9	
34179	Specific demands of the local street population	specific demand of the local street population	1	0	34181	17360	10237	
7606	predictive power	predictive power	1	0	7608	4314	7608	
38211	accepted chemoprophylaxis	accepted chemoprophylaxis	1	0	8584	38212	8584	
34448	Confirmatory Factor	confirmatory Factor	1	0	34450	34449	34450	
8223	endoscopic removal	endoscopic removal	1	0	8225	8224	8225	
33348	Performance evaluation of selected machine	performance evaluation of selected machine	1	0	33350	10141	2399	
30249	Immunoglobulin G Antibody Levels	immunoglobulin G antibody Levels	1	0	30253	30250	30255	
16582	complex epidemiology of the COVID-19	complex epidemiology of the INFunknownSUP	1	0	16584	13320	16585	
10635	associated morbidities	associated morbidity	1	0	10637	240	10637	
10419	selection of the repertoire risk off-target effects	selection of the repertoire risk off-target effect	1	0	5520	10421	5520	
31513	diabetic patients	diabetic patient	1	0	60	15617	60	
5337	clinical impact	clinical impact	1	0	110	884	110	
39199	low misconceptions	low misconception	1	0	1176	457	1176	
28250	abnormal CT findings	abnormal CT finding	1	0	28252	13888	3390	
31292	Clinical Trials	clinical trial	1	0	544	1501	544	
24528	Iran The COVID-19 pandemic	Iran The INFunknownSUP pandemic	1	0	24530	24529	113	
36751	care delivery system	care delivery system	1	0	1327	36752	1327	
24034	new cases of COVID-19	new case of INFunknownSUP	1	0	24035	40	229	
30250	Immunoglobulin G	immunoglobulin G	1	0	30252	12464	30252	
30207	hospital-at-home settings	hospital-at-home setting	1	0	2729	30208	2729	
8643	betacoronavirus severe acute respiratory syndrome coronavirus	betacoronavirus severe acute respiratory syndrome coronavirus	1	0	4709	8644	339	
28936	viral spike protein priming proteases	viral spike protein priming protease	1	0	28942	28937	28944	
27203	high prevalence	high prevalence	1	0	9272	13	9272	
24144	organizers of international events	organizer of international event	1	0	24145	24146	24145	
30278	computational validation of the methodology	computational validation of the methodology	1	0	30280	13184	6319	
21714	volume of testing	volume of testing	1	0	3445	1885	3445	
31127	uninformative sites	uninformative site	1	0	9165	31128	9165	
13563	Family Medicine	Family Medicine	1	0	1951	13564	1951	
1349	early phase of the pandemic Healthcare	early phase of the pandemic Healthcare	1	0	1350	1353	1352	
1055	aerosolized pathogens	INFunknownSUP pathogen	1	0	1057	1056	1057	
16425	cumulative block grades	cumulative block grade	1	0	16427	9074	13725	
24742	undiagnosed coronavirus disease	undiagnosed coronavirus disease	1	0	338	14837	209	
16053	overall effects	overall effect	1	0	156	2251	156	
29008	blood glucose control	blood glucose control	1	0	29010	3129	510	
21598	unidimensionality of the FCV-19S	unidimensionality of the INFunknownSUP	1	0	21599	21600	21599	
22621	doses of lipopolysaccharides	dose of lipopolysaccharide	1	0	678	22623	678	
166	high levels of food insecurity	high level of food insecurity	1	0	167	170	169	
28426	generation of tetramers	generation of INFunknownSUP	1	0	3033	28428	3033	
7557	Health policies	health policy	1	0	1760	5250	1760	
35485	Management Systems	Management Systems	1	0	20278	307	20278	
10822	pandemic of coronavirus disease	pandemic of coronavirus disease	1	0	113	338	113	
5731	pro-inflammatory cytokines tumor necrosis factor-alpha	pro-inflammatory cytokine tumor necrosis factor-alpha	1	0	5735	5732	5739	
29872	SC2 receptor angiotensin	INFunknownSUP receptor angiotensin	1	0	29876	29873	29876	
11800	big cities	big city	1	0	11802	9540	11802	
39033	psychological counseling	psychological counseling	1	0	35306	1380	35306	
12804	pandemic times	pandemic time	1	0	12806	1354	12806	
3500	protein receptor	protein receptor	1	0	3502	1797	3502	
15941	important voice	important voice	1	0	12227	273	12227	
22365	internet health resources	Internet health resource	1	0	22367	1528	835	
1482	massive total lockdowns	massive total lockdown	1	0	1484	1483	1486	
28664	Ministries of Health	ministry of Health	1	0	28665	279	28665	
15591	chronic lung sequela of COVID-19	chronic lung sequela of INFunknownSUP	1	0	15593	8230	15596	
516	national coordination	national coordination	1	0	518	517	518	
5364	African model	African model	1	0	1078	5365	1078	
20401	absolute ownership	absolute ownership	1	0	20403	1302	20403	
16996	subgenomic RNA	INFunknownSUP RNA	1	0	1151	16997	1151	
7949	Content Accessibility Guidelines	content accessibility guideline	1	0	7951	7950	2501	
7715	role of gut microbiota	role of gut microbiota	1	0	7288	1041	7288	
11921	common viral infection of the lower respiratory tract	common viral infection of the low respiratory tract	1	0	11923	699	41	
34586	COVID-19 impact	INFunknownSUP impact	1	0	110	40	110	
25177	high-quality predictive models	high-quality predictive model	1	0	25179	21045	3975	
8803	financial support	financial support	1	0	260	547	260	
1938	hospital management decisions	hospital management decision	1	0	1940	185	1942	
17422	diagnosis of SARS-CoV-2 infection	diagnosis of INFunknownSUP infection	1	0	2168	1272	2168	
10918	su ecuacion booleana correspondiente	su INFunknownSUP INFunknownSUP INFunknownSUP	1	0	10920	10919	10924	
24799	vertical transmission of COVID-19 infection	vertical transmission of INFunknownSUP infection	1	0	24801	875	876	
11021	ambitious targets	ambitious target	1	0	4044	11022	4044	
10857	Undergraduate Dermatology Education Covid-19	undergraduate dermatology Education INFunknownSUP	1	0	10859	10858	1884	
13937	Group C	Group C	1	0	2540	1845	2540	
39076	public health subsector	public health subsector	1	0	39080	1320	39080	
18060	population-based sample	INFunknownSUP sample	1	0	2757	3439	2757	
18965	realizo busqueda	INFunknownSUP INFunknownSUP	1	0	18967	18966	18967	
2431	tertiary academic hospital	tertiary academic hospital	1	0	2433	182	185	
10843	COVID-19 related acute lung injury	INFunknownSUP related acute lung injury	1	0	10845	40	713	
15013	non-fermenter gram-negative bacilli	INFunknownSUP Gram-negative bacillus	1	0	15015	15014	15017	
24273	association of RAAS blockade use	association of INFunknownSUP blockade use	1	0	11619	4261	11619	
7911	public health context	public health context	1	0	1567	1320	1567	
34954	overview of the history of the concept	overview of the history of the concept	1	0	19301	34956	19301	
21967	outpatient department of the child	outpatient department of the child	1	0	21968	12594	13318	
21022	survey items	survey item	1	0	21024	967	21024	
12242	alternative damaging autoimmune mechanisms	alternative damaging autoimmune mechanism	1	0	12244	10647	1456	
20690	evidence of neurotropism	evidence of neurotropism	1	0	585	20692	585	
31565	case fatality rates of COVID-19 infection	case fatality rate of INFunknownSUP infection	1	0	3366	39	83	
36767	unique challenges of Covid-19 transmission	unique challenge of INFunknownSUP transmission	1	0	34282	36771	2220	
34315	questionnaire survey	questionnaire survey	1	0	967	9620	967	
38466	SARS-CoV-2 IgG seroprevalence	INFunknownSUP IgG seroprevalence	1	0	4090	4627	4090	
30902	sample of Turkish patients	sample of Turkish patient	1	0	2757	30904	2757	
22788	additional goal	additional goal	1	0	22790	7175	22790	
23045	entire community	entire community	1	0	3641	2269	3641	
31627	community characteristics	community characteristic	1	0	1496	3641	1496	
2317	training recall	training recall	1	0	2319	235	2319	
6818	drug profiles	drug profile	1	0	6820	352	6820	
2030	sobre salud mental durante el primer ano de pandemia	INFunknownSUP INFunknownSUP mental INFunknownSUP el primer Ano de INFunknownSUP	1	0	2038	2031	2046	
31539	COVID-19 pandemic performance of insurance companies	INFunknownSUP pandemic performance of insurance company	1	0	31543	111	598	
25104	public opinion	public opinion	1	0	25106	1321	25106	
14879	risk of school	risk of school	1	0	1542	355	1542	
33532	cause of the COVID-19 pandemic	cause of the INFunknownSUP pandemic	1	0	14198	111	14198	
23652	infection control interventions	infection control intervention	1	0	757	4940	757	
20438	Incorporation of metal organic framework	incorporation of metal organic framework	1	0	20439	20440	20439	
39317	casos notificados	INFunknownSUP INFunknownSUP	1	0	39319	39318	39319	
8725	reinfection swab	reinfection swab	1	0	3979	1451	3979	
18978	% of nurses	% of nurse	1	0	364	2735	364	
17949	primary care patient	primary care patient	1	0	710	6472	710	
25338	Border control measures	border control measure	1	0	13929	25339	317	
36627	web-based pulmonary rehabilitation programme models	INFunknownSUP pulmonary rehabilitation programme model	1	0	36629	2586	3975	
16624	pathogenic mechanism	pathogenic mechanism	1	0	10036	6190	10036	
32285	immunological imprinting	immunological imprinting	1	0	26952	148	26952	
28737	few scales	few scale	1	0	7864	6261	7864	
23687	Blood IgG levels	Blood IgG level	1	0	23689	1229	169	
35392	better perception	good perception	1	0	2387	1635	2387	
38891	functional deficit	functional deficit	1	0	38893	4225	38893	
28483	Distress Syndrome	distress syndrome	1	0	14017	28484	14017	
36288	bacterial counts	bacterial count	1	0	5090	2517	5090	
6406	variability of structured viruses	variability of structured virus	1	0	6407	6408	6407	
24175	methodological quality	methodological quality	1	0	3713	1696	3713	
26286	large societal crises	large societal crisis	1	0	26288	4250	26290	
24233	effective adolescent treatment options	effective adolescent treatment option	1	0	23261	24234	23261	
114	Italian hospitals	Italian hospital	1	0	76	115	76	
35921	parent-child exemption	parent-child exemption	1	0	35923	35922	35923	
11199	~65 % of cases	~65 % of case	1	0	11201	11200	364	
14691	further analysis	further analysis	1	0	486	7713	486	
28661	adoption of these apps	adoption of these INFunknownSUP	1	0	88	17206	88	
30417	safety of booster immunization	safety of booster immunization	1	0	6729	30419	6729	
30776	undocumented novel coronavirus	undocumented novel coronavirus	1	0	3644	958	339	
25591	member states	member state	1	0	2805	7209	2805	
31637	solange die Belastungen	INFunknownSUP die INFunknownSUP	1	0	31639	31638	31641	
12524	hemorrhagic phenotypes	hemorrhagic phenotype	1	0	12526	12525	12526	
13544	Customs Enforcement agency	Customs Enforcement agency	1	0	13546	13545	13507	
8930	clinical trial HARMONICOV	clinical trial INFunknownSUP	1	0	8932	884	8934	
1035	R value	R value	1	0	1037	1036	1037	
2846	injury presentations	injury presentation	1	0	2848	713	2848	
18498	great value	great value	1	0	1037	4480	1037	
6359	Neutrophil Gelatinase-Associated Lipocalin	neutrophil Gelatinase-Associated Lipocalin	1	0	6361	6360	6363	
39145	hospital mortality	hospital mortality	1	0	1197	185	1197	
4996	mutational process	mutational process	1	0	180	4997	180	
11839	risk of poor outcome	risk of poor outcome	1	0	1542	11841	1542	
31792	introduction to humans	introduction to human	1	0	381	13718	381	
38935	web-based orientation	INFunknownSUP orientation	1	0	28020	2586	28020	
18449	vitro RBD-ACE2 binding assay	Vitro INFunknownSUP binding assay	1	0	18451	18450	3119	
16475	prophylactic treatment	prophylactic treatment	1	0	97	16476	97	
5600	surgical oncology	surgical oncology	1	0	5602	663	5602	
31256	oral Hydroxychloroquine	oral Hydroxychloroquine	1	0	31258	427	31258	
16845	information bias	information bias	1	0	4930	2591	4930	
30774	contagiousness of undocumented novel coronavirus	contagiousness of undocumented novel coronavirus	1	0	23066	30776	23066	
34035	ongoing process	ongoing process	1	0	180	1059	180	
26008	respiratory pathogens	respiratory pathogen	1	0	1057	259	1057	
17544	free energies	free energy	1	0	17546	4542	17546	
24155	pulmonary rehabilitation delivery preferences of service-users	pulmonary rehabilitation delivery preference of service-user	1	0	24159	8680	2599	
12181	MR-proADM values	INFunknownSUP value	1	0	825	12182	825	
29686	polyclonal antibodies	polyclonal antibody	1	0	929	29687	929	
30390	high filtration efficiency	high filtration efficiency	1	0	22639	13	14461	
6744	NK cell	INFunknownSUP cell	1	0	197	6745	197	
901	font colors	font color	1	0	903	902	903	
20889	development of antibody	development of antibody	1	0	73	5924	73	
10340	appropriate cut-off point of SAVE-9	appropriate cut-off point of INFunknownSUP	1	0	10342	1256	10333	
2322	influenza infection	influenza infection	1	0	41	2323	41	
20905	core outcome set initiative	core outcome set initiative	1	0	20909	1851	1986	
31138	diagnostic data	diagnostic datum	1	0	22	2219	22	
32921	consequences of the COVID-19 pandemic	consequence of the INFunknownSUP pandemic	1	0	4289	111	4289	
4492	positivity rates of RDT	INFunknownSUP rate of INFunknownSUP	1	0	4493	4496	83	
34589	set of dashboards	set of dashboard	1	0	651	34591	651	
4607	Transcriptomics-based drug	INFunknownSUP drug	1	0	352	4608	352	
3637	cultural industry	cultural industry	1	0	2109	3638	2109	
38011	pandemic-related matters	pandemic-related matter	1	0	16589	18400	16589	
18989	resource-limited setting	resource-limited setting	1	0	2854	18990	2854	
658	polypropylene filtration	polypropylene filtration	1	0	145	659	145	
16803	National Committee	National Committee	1	0	11030	46	11030	
39231	global models	global model	1	0	3975	1954	3975	
4587	Metagenomic Signatures	INFunknownSUP signature	1	0	4589	4588	4589	
29003	regulatory philosophy	regulatory philosophy	1	0	19989	5686	19989	
17689	cotton candy machines	cotton candy machine	1	0	17691	17690	4511	
11462	changed priors	changed prior	1	0	11464	11463	11464	
9295	pandemic context	pandemic context	1	0	1567	1354	1567	
4035	Telehealth Outpatient Visits	Telehealth outpatient visit	1	0	4037	4036	4039	
15253	pooled analyses	pooled analysis	1	0	4668	5372	4668	
25134	detailed patient history	detailed patient history	1	0	25136	21498	5381	
24376	expression of the gene	expression of the gene	1	0	5729	6495	5729	
32875	maintenance of personal hygiene	maintenance of personal hygiene	1	0	32876	8768	32876	
26380	fatality rate	fatality rate	1	0	1034	3369	1034	
16540	new network structure	new network structure	1	0	16542	69	2427	
20136	hold great promise	hold great promise	1	0	20138	20137	20140	
16531	PCR +ve	PCR +ve	1	0	16533	3981	16533	
37341	psychopathological sequelae	psychopathological sequela	1	0	35431	9805	35431	
21523	Educational Script	Educational script	1	0	21525	21524	21525	
15532	supplemental oxygen requirement	supplemental oxygen requirement	1	0	15536	15533	15536	
29409	10th-60th percentiles	INFunknownSUP percentile	1	0	24576	29410	24576	
34428	gateway testing	gateway testing	1	0	1885	17337	1885	
20194	compounding of essential medications	compounding of essential medication	1	0	20195	20196	20195	
33358	potential role of the pharmacy profession	potential role of the pharmacy profession	1	0	33360	1276	7288	
35024	COVID-19 patients Clostridioides difficile	INFunknownSUP patient INFunknownSUP INFunknownSUP	1	0	498	35025	498	
18005	development of vaccines	development of vaccine	1	0	73	681	73	
32469	Neisseria meningitidis	INFunknownSUP INFunknownSUP	1	0	32471	13803	32471	
10601	COVID-19-Related Changes	COVID-19-related Changes	1	0	10603	10602	10603	
25191	Treatment Program	Treatment Program	1	0	25193	5596	25193	
18055	count of COVID-19 deaths	count of INFunknownSUP death	1	0	1305	14084	1305	
7074	entry molecules	entry molecule	1	0	7076	5629	7076	
34569	JAK/STAT inhibitors	INFunknownSUP inhibitor	1	0	8870	10986	8870	
22753	virtual video format	virtual video format	1	0	22755	3148	22757	
24197	sufficient rise of nucleocapsid	sufficient rise of nucleocapsid	1	0	24199	4719	13903	
8869	inhibitors of phosphorylation	inhibitor of INFunknownSUP	1	0	8870	945	8870	
31145	Ways of Teaching	Ways of teaching	1	0	31146	31147	31146	
8544	Interim Estimates of Vaccine Effectiveness of BNT162b2	interim estimate of vaccine effectiveness of INFunknownSUP	1	0	8546	8545	8547	
25403	intra-pandemic periods	intra-pandemic period	1	0	873	25404	873	
7367	Cycle threshold values	cycle threshold value	1	0	825	7368	825	
25019	game download volume	game INFunknownSUP volume	1	0	25021	21721	3445	
9839	Bayesian inference Rapid	INFunknownSUP inference Rapid	1	0	9843	9840	9843	
13401	bilateral lung	bilateral lung	1	0	772	10335	772	
4559	worrisome level of vaccine hesitancy	worrisome level of vaccine hesitancy	1	0	4561	4560	362	
18836	response to vaccination	response to vaccination	1	0	409	437	409	
35099	preferences of 18-29-year-olds	preference of INFunknownSUP	1	0	2599	35101	2599	
29640	left lateral	left lateral	1	0	29642	28863	29642	
2536	dose of vitamin C	dose of vitamin C	1	0	2537	2538	2537	
24303	representative data	representative datum	1	0	22	24304	22	
26484	substantial scientific information	substantial scientific information	1	0	26486	3239	2591	
33944	mid-week consumption ratios	mid-week consumption ratio	1	0	33946	33945	19889	
27606	weaker T cell	weak T cell	1	0	8957	27607	197	
25758	different facets of physical activity	different facet of physical activity	1	0	25760	688	18783	
18771	panel dataset of prefectures	panel INFunknownSUP of prefecture	1	0	18773	7588	17096	
7098	third quarter	third quarter	1	0	7100	7099	7100	
30557	stringent national lockdown	stringent national INFunknownSUP	1	0	1674	24123	1676	
14982	Obsessive-compulsive disorder	obsessive-compulsive disorder	1	0	7358	14983	7358	
22535	numeric sequence	numeric sequence	1	0	5716	22536	5716	
24554	Remote Delivery of Motor Function Assessment	remote delivery of Motor function Assessment	1	0	20704	24558	20706	
26014	travel restriction	travel restriction	1	0	14512	2879	14512	
10041	CT of the brain	CT of the brain	1	0	26	10043	26	
21508	complete virus particles	complete virus particle	1	0	21510	4186	8275	
28611	response to a viral epidemic	response to a viral epidemic	1	0	409	6582	409	
15741	I allele	I allele	1	0	15743	15742	15743	
38672	cost-effectiveness of common strategies	cost-effectiveness of common strategy	1	0	16689	38674	16689	
278	Health Products	Health Products	1	0	280	279	280	
18002	study protocols	study protocol	1	0	18004	2087	18004	
11113	frequent age range	frequent age range	1	0	11115	1168	420	
9054	appointment timing	appointment timing	1	0	9056	1569	9056	
15270	higher levels of emotional difficulties	high level of emotional difficulty	1	0	12250	15274	169	
7246	CRAC study	INFunknownSUP study	1	0	2087	7247	2087	
36897	abdominal radiographs	abdominal radiograph	1	0	36899	36898	36899	
890	time passes	time pass	1	0	892	179	892	
18387	rapid development of mitigation strategies	rapid development of mitigation strategy	1	0	18389	795	73	
22075	high negative predictive value	high negative predictive value	1	0	6367	13	1037	
26951	imprinting of the antibody response	imprinting of the antibody response	1	0	26952	9972	26952	
13934	virtual horse	virtual horse	1	0	13037	3148	13037	
32743	prime position	prime position	1	0	2825	5139	2825	
36497	use pattern	use pattern	1	0	4682	292	4682	
21754	international perspectives	international perspective	1	0	3304	4086	3304	
34961	medical indications	medical indication	1	0	34963	947	34963	
2263	national committee	national committee	1	0	2265	517	2265	
26940	ischemic stroke	ischemic stroke	1	0	15219	5059	15219	
15403	rationale of the decision to post-pone 2020PMD	rationale of the decision to INFunknownSUP INFunknownSUP	1	0	15404	15405	15404	
14379	different socioeconomic standards	different socioeconomic standard	1	0	14381	688	14383	
8619	analysis of the COVID-19 pandemic response	analysis of the INFunknownSUP pandemic response	1	0	486	8621	486	
6323	single T403R mutation increases	single INFunknownSUP mutation increase	1	0	6327	6324	6329	
16703	ground-based monitoring data	ground-based monitoring datum	1	0	22	16704	22	
4387	existential philosopher Albert Camus	existential philosopher Albert Camus	1	0	4389	4388	4393	
25940	rRNA V2	INFunknownSUP INFunknownSUP	1	0	25942	25941	25942	
2473	species richness	species richness	1	0	2475	2474	2475	
20884	IADS member organizations	INFunknownSUP member organization	1	0	20886	20885	5251	
24384	Effects of Social Support	effect of social support	1	0	2994	24386	2994	
17503	pressure environment	pressure environment	1	0	3454	1027	3454	
34312	Google Form-based	INFunknownSUP INFunknownSUP	1	0	34314	3542	34314	
32259	risk of evolution to a serious disease	risk of evolution to a serious disease	1	0	1542	32261	1542	
20393	teamwork components	teamwork component	1	0	19056	3839	19056	
27931	Romanian teachers	Romanian teacher	1	0	53	27932	53	
36680	follow-up of women	follow-up of woman	1	0	175	920	175	
31425	reduction assay	reduction assay	1	0	3119	490	3119	
3488	rapid implementation of medication policy	rapid implementation of medication policy	1	0	3490	795	396	
2363	outcomes of SARS-CoV-2 infected pneumonia	outcome of INFunknownSUP infected pneumonia	1	0	263	2365	263	
18903	care teaching hospital	care teaching hospital	1	0	16724	9	185	
593	lower levels	low level	1	0	169	594	169	
1890	video analysis	video analysis	1	0	486	1891	486	
8410	amino acid	amino acid	1	0	7492	8411	7492	
157	prognostic nomogram	prognostic nomogram	1	0	159	158	159	
15781	2019-nCoV cases	INFunknownSUP case	1	0	229	14482	229	
24928	severe COVID-19 course	severe INFunknownSUP course	1	0	5152	3062	5152	
17848	vegetal cultures	vegetal culture	1	0	17850	17849	17850	
28136	risk stratification guidelines	risk stratification guideline	1	0	91	3807	91	
19949	performance of the sensor chips	performance of the sensor chip	1	0	598	19951	598	
4443	air filters	air filter	1	0	4445	868	4445	
32529	purposive sampling strategy	purposive sampling strategy	1	0	3350	13575	3350	
3112	Systemic low-grade inflammation	systemic low-grade inflammation	1	0	3114	3113	3116	
18812	IgA antibodies	IgA antibody	1	0	929	18813	929	
13231	erratic work schedules	erratic work schedule	1	0	13233	466	13235	
22041	health-related behaviors	health-related behavior	1	0	22043	17027	22043	
13213	device-based measurement methods	INFunknownSUP measurement method	1	0	13215	13214	205	
12472	Disability Insurance Scheme	disability insurance scheme	1	0	12474	12473	12476	
30815	aeroben und aerob-anaeroben	INFunknownSUP und INFunknownSUP	1	0	30817	30816	30819	
5655	dental healthcare	dental INFunknownSUP	1	0	494	5656	494	
35613	pandemic stress levels	pandemic stress level	1	0	5949	1354	169	
14655	similar viral diseases	similar viral disease	1	0	14657	102	315	
25165	specific personal protective equipment	specific personal protective equipment	1	0	4960	2515	3038	
17069	diagnostic capability of computer-aided diagnosis	diagnostic capability of computer-aided diagnosis	1	0	17071	2219	16406	
11424	lipid peroxidation	lipid peroxidation	1	0	11426	4348	11426	
25848	higher cytotoxicity of HCQ	high cytotoxicity of HCQ	1	0	25850	322	25851	
14765	investigational agents	investigational agent	1	0	14767	14766	14767	
37414	clinical management of patients	clinical management of patient	1	0	37416	884	743	
21604	globalization of trade	globalization of trade	1	0	21605	5888	21605	
19561	quantum dots	quantum dot	1	0	19563	19562	19563	
2301	upstream context	upstream context	1	0	1567	2302	1567	
29705	multi- country research programs	INFunknownSUP country research program	1	0	29707	29706	2246	
3220	COVID-19 Fear	INFunknownSUP fear	1	0	3222	40	3222	
17259	readability of the ECG machine	readability of the ECG machine	1	0	996	15191	996	
25253	rest of the aetiological investigations	rest of the aetiological investigation	1	0	25254	25255	25254	
13149	public sphere theories	public sphere theory	1	0	13153	10337	13153	
15899	COVID-19 Airway Management Isolation Chamber	INFunknownSUP airway Management isolation Chamber	1	0	15901	40	15907	
16046	important rate reduction	important rate reduction	1	0	16048	273	490	
8611	supply chain	supply chain	1	0	2362	271	2362	
35546	physical therapists	physical therapist	1	0	22013	1242	22013	
26196	individual interviews	individual interview	1	0	10034	753	10034	
14008	spread of Severe Acute Respiratory Syndrome Coronavirus	spread of Severe acute respiratory syndrome INFunknownSUP	1	0	570	14010	570	
38125	characteristic curve	characteristic curve	1	0	6817	8034	6817	
15901	Airway Management Isolation Chamber	airway Management isolation Chamber	1	0	15903	15902	15907	
29084	new connection method	new connection method	1	0	29086	69	6587	
584	evidence of vaccine-related pulmonary immunopathology enhancement	evidence of vaccine-related pulmonary Immunopathology enhancement	1	0	585	586	585	
30904	Turkish patients	Turkish patient	1	0	60	8006	60	
24814	repertoire of COVID	repertoire of INFunknownSUP	1	0	10422	1649	10422	
30874	microglial activation	INFunknownSUP activation	1	0	1013	220	1013	
11659	venous admixture	venous admixture	1	0	11661	1729	11661	
38070	national basis	national basis	1	0	15433	517	15433	
17073	computer-aided diagnosis	computer-aided diagnosis	1	0	2168	17074	2168	
34995	ventricular strain	ventricular strain	1	0	1107	1104	1107	
6017	lot of people	lot of people	1	0	4650	694	4650	
16794	vaccination policies	vaccination policy	1	0	1760	437	1760	
25290	year experience	year experience	1	0	2782	3822	2782	
38281	safety profile	safety profile	1	0	3088	6729	3088	
22320	NLR value of nonsurvival group	NLR value of INFunknownSUP group	1	0	22321	22324	1037	
21067	application of trauma-informed principles of care	application of trauma-informed principle of care	1	0	125	21069	125	
18715	psychological motivation	psychological motivation	1	0	13526	1380	13526	
19276	vessel density	vessel density	1	0	19278	19277	19278	
34318	online survey study	online survey study	1	0	2087	20368	2087	
22571	phosphorylation of STATs	INFunknownSUP of stat	1	0	945	22573	945	
5446	disease-specific clinical outcomes	disease-specific clinical outcome	1	0	5448	5447	263	
27971	app stores	App store	1	0	27973	502	27973	
8043	Discrete count time series data	discrete count time series datum	1	0	8045	8044	22	
14209	training precision	training precision	1	0	14211	235	14211	
25654	Collection of a positive sample	collection of a positive sample	1	0	15383	25656	15383	
37542	language barriers	language barrier	1	0	10121	10391	10121	
4375	research agenda	research agenda	1	0	4377	36	4377	
33187	CAD solution	cad solution	1	0	33189	33188	33189	
36997	outpatient cohort of patients	outpatient cohort of patient	1	0	33685	327	601	
4595	sequalae of COVID-19	INFunknownSUP of INFunknownSUP	1	0	4596	40	4596	
7982	% of lung weight	% of lung weight	1	0	364	7984	364	
15057	node involvement	node involvement	1	0	3599	13683	3599	
2595	Study Food preferences	Study Food preference	1	0	2597	2596	2599	
19093	MSD lung tumor data	MSD lung tumor datum	1	0	19095	16906	22	
24686	flat sialic acid-binding domain	flat sialic acid-binding domain	1	0	24688	24687	697	
9539	big data	big data	1	0	9541	9540	9541	
27167	corticosteroid treatment	corticosteroid treatment	1	0	97	8001	97	
14281	underrepresentation of older adults	underrepresentation of old adult	1	0	14282	513	14282	
28333	target audience of adult horse show participants	target audience of adult horse show participant	1	0	28335	11730	23080	
38737	nucleocapsid antibodies	nucleocapsid antibody	1	0	929	24201	929	
6404	sequence variability of structured viruses	sequence variability of structured virus	1	0	6406	5716	6407	
28622	neurological involvement	neurological involvement	1	0	3599	2728	3599	
36116	conclusive evidence	conclusive evidence	1	0	585	36117	585	
22268	model to pool data	model to pool datum	1	0	1078	22270	1078	
14248	SARS-CoV-2 infection patterns SARS-CoV-2	INFunknownSUP infection pattern INFunknownSUP	1	0	14250	226	28	
4149	altered home-lives	altered home-life	1	0	4151	4150	4151	
29247	inducible SH2	inducible INFunknownSUP	1	0	29249	29248	29249	
24944	course of disease	course of disease	1	0	5152	209	5152	
32537	adoption of these coefficients	adoption of these coefficient	1	0	88	15196	88	
27414	immune response differences	immune response difference	1	0	5663	6115	5663	
26318	layer (EDL)-gated field-effect transistor-based biosensor	layer INFunknownSUP INFunknownSUP INFunknownSUP biosensor	1	0	26320	14314	26326	
16699	representativeness of limited ground-based monitoring data	representativeness of limited ground-based monitoring datum	1	0	16700	16701	16700	
32634	immunosorbent assay	immunosorbent assay	1	0	3119	32635	3119	
3722	last pre-confinement scores	last pre-confinement score	1	0	3724	3723	3726	
23827	frequent HAI	frequent hai	1	0	6959	1168	6959	
38476	single-center study	single-center study	1	0	2087	8507	2087	
35578	Italian association	Italian association	1	0	11619	115	11619	
12612	personal resilience	personal resilience	1	0	4654	4961	4654	
17778	low blood pressure	low blood pressure	1	0	4817	457	1027	
27262	protein tyrosine phosphatases	protein tyrosine phosphatase	1	0	27264	1797	27266	
11881	30-day postoperative COVID-19 infection rate	30-day postoperative INFunknownSUP infection rate	1	0	11883	4517	1034	
13095	higher occurrence rate of leukocytosis	high occurrence rate of INFunknownSUP	1	0	13096	13101	1034	
28829	cardiac structure	cardiac structure	1	0	2427	3858	2427	
34437	% of consultations	% of consultation	1	0	364	978	364	
15851	urological productivity	urological productivity	1	0	7145	15037	7145	
30504	IoT-based paradigm	INFunknownSUP paradigm	1	0	30506	30505	30506	
29552	closures of physical activity venues	closure of physical activity venue	1	0	23196	29554	23196	
31184	outbreak of respiratory illness	outbreak of respiratory illness	1	0	310	31186	310	
27220	further sensor collection	further sensor collection	1	0	27222	7713	16824	
10416	articulos seleccionados	INFunknownSUP INFunknownSUP	1	0	10418	10417	10418	
22585	gaming disorder risk	gaming disorder risk	1	0	1542	19926	1542	
10910	long experience	long experience	1	0	2782	3921	2782	
3238	substantial significant increase	substantial significant increase	1	0	3240	3239	392	
3727	Online Music Education	online Music Education	1	0	3729	217	3731	
16256	broad range of psychopathologies	broad range of psychopathology	1	0	16258	7135	420	
5815	pragmatic effects	pragmatic effect	1	0	156	5816	156	
1337	negative experiences	negative experience	1	0	1339	1338	1339	
16210	Middle East Respiratory Syndrome virus	middle East respiratory syndrome virus	1	0	16212	16211	778	
15412	patches of ground-glass opacity	patch of ground-glass opacity	1	0	15413	12760	15413	
9647	motility testing Aerosol spread	motility testing aerosol spread	1	0	9649	9648	570	
5868	drastic lifestyle changes	drastic lifestyle change	1	0	5870	5869	1336	
37273	neoplastic process	neoplastic process	1	0	180	37274	180	
10454	higher likelihood of SARS-CoV-2 susceptibility	high likelihood of INFunknownSUP susceptibility	1	0	10456	322	2204	
2852	particular setting	particular setting	1	0	2854	2853	2854	
491	healthcare facility-onset Clostridioides difficile infection	INFunknownSUP facility-onset INFunknownSUP INFunknownSUP infection	1	0	41	492	41	
15675	final decision	final decision	1	0	5486	4256	5486	
28443	subpleural parenchymal bands	subpleural INFunknownSUP band	1	0	1750	16300	1752	
12753	sex-specific link to immune responses	sex-specific link to immune response	1	0	12755	9443	3478	
34391	Interventional Trials	interventional trial	1	0	544	34392	544	
32341	further implementation of epidemiology	further implementation of epidemiology	1	0	32343	7713	396	
37236	urgent next step	urgent next step	1	0	31158	8129	23817	
28479	Acute Respiratory Distress Syndrome	acute respiratory distress syndrome	1	0	28481	14013	14017	
2644	patient related outcome	patient related outcome	1	0	2646	2645	295	
10119	report barriers	report barrier	1	0	10121	378	10121	
26428	few cases of patients	few case of patient	1	0	19539	6261	229	
1389	performance of laboratory assessments	performance of laboratory assessment	1	0	598	1391	598	
13541	senior practitioners	senior practitioner	1	0	13543	820	13543	
6654	genetic changes	genetic change	1	0	1336	6655	1336	
35716	one-month cross-sectional observational study	one-month cross-sectional observational study	1	0	35718	35717	2087	
3714	examination performance	examination performance	1	0	598	1800	598	
4598	rapid response to novel zoonotic diseases	rapid response to novel INFunknownSUP disease	1	0	4338	4602	409	
8424	obesity-related metabolic derangements	obesity-related metabolic derangement	1	0	8426	8425	8428	
32662	anti-SARS-CoV-2 IgG-infused	INFunknownSUP INFunknownSUP	1	0	32664	4554	32664	
1474	unknown nature	unknown nature	1	0	1476	1475	1476	
24842	protective immunity	protective immunity	1	0	257	1455	257	
25765	Adverse Outcome Prediction	adverse outcome prediction	1	0	10165	25766	10165	
15264	Protease Serine	protease serine	1	0	15266	15265	15266	
19456	prospective cross-sectional cohort study	prospective cross-sectional cohort study	1	0	19458	2084	2087	
4660	subscales B coefficient	subscales B coefficient	1	0	4662	4661	4664	
27171	Mental health	mental health	1	0	120	8856	120	
26470	model possible causes	model possible cause	1	0	26472	6457	19560	
31670	Olfactory dysfunction	olfactory dysfunction	1	0	3856	31671	3856	
10754	cytokine receptors	INFunknownSUP receptor	1	0	8960	8807	8960	
34501	elevated levels of IL6	elevated level of INFunknownSUP	1	0	34503	1705	169	
37175	Similar types of training	similar type of training	1	0	37177	37176	1979	
10003	maximum Pulmonary X-Ray Severity	maximum pulmonary x-ray severity	1	0	10005	2651	1202	
21842	IgG titer	IgG titer	1	0	18030	928	18030	
14771	spread of respiratory viruses	spread of respiratory virus	1	0	570	2215	570	
32827	emergency cystoscopy	emergency cystoscopy	1	0	32829	447	32829	
12852	detention facilities	detention facility	1	0	2676	12853	2676	
36956	predominant respiratory symptoms	predominant respiratory symptom	1	0	14089	7597	86	
9671	Greater awareness of the various psychiatric conditions	great awareness of the various psychiatric condition	1	0	9673	9672	1612	
11018	mere freedom	mere freedom	1	0	11020	11019	11020	
16110	non-essential service shutdowns	non-essential service shutdown	1	0	16112	16111	16114	
30376	ADC arena	ADC arena	1	0	18621	30377	18621	
8631	% of all outpatient	% of all outpatient	1	0	364	327	364	
4276	heterogeneous gut microbiota shifts of COVID-19 patients	heterogeneous gut microbiota shift of INFunknownSUP patient	1	0	4278	4277	4283	
3043	mental health burden	mental health burden	1	0	1070	118	1070	
5558	social media	social media	1	0	5560	383	5560	
23403	Delta wave	Delta wave	1	0	10210	19992	10210	
9350	University Student Health Care Center	University Student Health Care Center	1	0	9352	50	2780	
16691	re-open universities	INFunknownSUP university	1	0	10501	16692	10501	
28212	healthcare burden	INFunknownSUP burden	1	0	1070	494	1070	
632	hydroxychloroquine to healthcare professionals	hydroxychloroquine to INFunknownSUP professional	1	0	633	634	633	
23384	dietary supplements	dietary supplement	1	0	7969	3126	7969	
35344	features of SARS-CoV-2	feature of INFunknownSUP	1	0	1469	28	1469	
28583	deep learning algorithm	deep learning algorithm	1	0	28585	2520	1525	
17043	chronic healthcare model	chronic INFunknownSUP model	1	0	17045	8230	1078	
22142	% Credible Interval	% credible interval	1	0	22144	364	13250	
26845	nucleocapsid protein	nucleocapsid protein	1	0	1797	24201	1797	
9470	transient benefits	transient benefit	1	0	2306	9471	2306	
36846	cause of age-associated diseases	cause of age-associated disease	1	0	14198	36848	14198	
25716	concern of social psychiatry Homeless experts	concern of social psychiatry homeless expert	1	0	79	25718	79	
15000	outbreak sites	outbreak site	1	0	9165	310	9165	
12089	English-language articles	English-language article	1	0	811	12090	811	
15025	vaccine delivery	vaccine delivery	1	0	2840	577	2840	
5252	crude odds ratio	crude odd ratio	1	0	5254	5253	2635	
5670	Home parenteral nutrition	Home parenteral nutrition	1	0	5672	5671	5674	
12997	Stroke Epidemiology	stroke epidemiology	1	0	399	5248	399	
9341	rank-based pattern	INFunknownSUP pattern	1	0	4682	9342	4682	
3470	identifier CRD42020175069	identifier CRD42020175069	1	0	3472	3471	3472	
16770	urgent stroke care	urgent stroke care	1	0	16772	8129	9	
4214	new infectious disease	new infectious disease	1	0	4216	69	209	
37631	detection techniques	detection technique	1	0	691	44	691	
32084	level of satisfaction	level of satisfaction	1	0	362	106	362	
33549	disease infectivity	disease infectivity	1	0	26717	209	26717	
37358	primary NSCLC	primary INFunknownSUP	1	0	37360	75	37360	
23886	number R01 AI112970	number R01 AI112970	1	0	23888	916	23890	
30280	validation of the methodology	validation of the methodology	1	0	6319	11687	6319	
385	capitalist quest	capitalist quest	1	0	387	386	387	
27983	Institute methodology	Institute methodology	1	0	11687	20525	11687	
6341	Public Discourse	Public Discourse	1	0	6343	840	6343	
32436	bed size	bed size	1	0	6366	32437	6366	
26293	production technique	production technique	1	0	562	654	562	
687	different ML techniques	different ML technique	1	0	689	688	691	
2685	Middle East respiratory syndrome coronavirus	Middle East respiratory syndrome coronavirus	1	0	2687	2686	339	
15755	intestinal organoids	intestinal organoid	1	0	15757	15756	15757	
25580	use of NIRS modalities:alone	use of INFunknownSUP INFunknownSUP	1	0	292	25582	292	
32684	recent investigations of sequence diversity of SARS coronavirus	recent investigation of sequence diversity of INFunknownSUP coronavirus	1	0	32686	2128	12639	
22306	didactic time	didactic time	1	0	179	22307	179	
34247	Moral distress levels	moral distress level	1	0	169	34248	169	
1583	higher paranoia	high paranoia	1	0	1585	322	1585	
38958	Effect of vaccination	effect of vaccination	1	0	6097	437	6097	
6790	Clostridioides difficile infection rates	INFunknownSUP INFunknownSUP infection rate	1	0	6792	497	83	
11302	strong CD4 cytokine response	strong INFunknownSUP INFunknownSUP response	1	0	11304	3987	409	
25194	Allograft rejection	Allograft rejection	1	0	14446	25195	14446	
345	relevant studies	relevant study	1	0	136	346	136	
34908	local community hospitals	local community hospital	1	0	34910	3173	76	
27793	activities of older adults	activity of old adult	1	0	192	513	192	
36107	local governments	local government	1	0	7556	3173	7556	
9104	reinfection resistance	reinfection resistance	1	0	9106	1451	9106	
36394	primer-probe set	primer-probe set	1	0	651	29723	651	
19598	health system capacity	health system capacity	1	0	3026	3305	3026	
32933	surface receptor	surface receptor	1	0	3502	7645	3502	
27717	pandemic of Coronavirus disease	pandemic of INFunknownSUP disease	1	0	113	6281	113	
3308	different systems of policy advice	different system of policy advice	1	0	3310	688	146	
11489	15-year-old male adolescent	15-year-old male adolescent	1	0	11491	11490	11493	
21513	critical need	critical need	1	0	9579	223	9579	
29718	human society	human society	1	0	8007	2214	8007	
17041	integrated chronic healthcare model	integrated chronic INFunknownSUP model	1	0	17043	507	1078	
25615	experience reinfection	experience reinfection	1	0	1451	2782	1451	
3524	COVID-19 test result	INFunknownSUP test result	1	0	2267	3525	2267	
9459	instrumental variable analysis	instrumental variable analysis	1	0	9461	6798	486	
24876	useful prophylactic measure	useful prophylactic measure	1	0	24878	10503	2466	
9060	multivisceral resections	multivisceral resection	1	0	9062	9061	9062	
4986	salaries of the Consortium secretariat	salary of the Consortium secretariat	1	0	4987	4988	4987	
16497	segmentation of COVID-19	segmentation of INFunknownSUP	1	0	16498	40	16498	
34291	filtration membranes	filtration membrane	1	0	34293	145	34293	
1586	independent predictor of mortality	independent predictor of mortality	1	0	1587	1197	1589	
25112	systolic dysfunction	systolic dysfunction	1	0	3856	1026	3856	
2758	development of SARS-CoV-2 vaccines	development of INFunknownSUP vaccine	1	0	73	2760	73	
35032	study findings	study finding	1	0	3390	2087	3390	
36033	trust-wide technology-enhanced training	INFunknownSUP technology-enhanced training	1	0	36035	36034	235	
22669	experiences of interpersonal trauma	experience of interpersonal trauma	1	0	1339	22671	1339	
17071	capability of computer-aided diagnosis	capability of computer-aided diagnosis	1	0	16406	17073	16406	
38680	years of reductions	year of reduction	1	0	1313	15138	1313	
30273	upgrade procedures	upgrade procedure	1	0	4200	30274	4200	
5362	South African model	South African model	1	0	5364	5363	1078	
13008	COVID-19-related AKI	COVID-19-related Aki	1	0	13007	13009	13007	
26264	estimated concentration	estimated concentration	1	0	11518	18816	11518	
9731	quantitative descriptive methods	quantitative descriptive method	1	0	9733	1426	205	
28771	oral health guidelines	oral health guideline	1	0	28773	427	91	
21725	Immune memory	Immune memory	1	0	7635	20682	7635	
17124	Endoscopic Surgery	endoscopic surgery	1	0	2338	17125	2338	
14052	evaluation of D - Dimer	evaluation of D INFunknownSUP dimer	1	0	2399	14054	2399	
38735	IgG nucleocapsid antibodies	IgG nucleocapsid antibody	1	0	38737	928	929	
22467	evolution of the SARS-CoV-2 virus	evolution of the INFunknownSUP virus	1	0	3741	4396	3741	
31275	ethical demand	ethical demand	1	0	20530	19315	20530	
5463	tertiary referral	tertiary referral	1	0	2964	182	2964	
12303	perception of health professionals	perception of health professional	1	0	2387	4417	2387	
3058	current discussion	current discussion	1	0	3060	443	3060	
15384	SARS-CoV-2 Virus	INFunknownSUP virus	1	0	12462	28	12462	
26727	services workers	service worker	1	0	1136	5980	1136	
19853	External factors	external factor	1	0	583	19854	583	
9130	physiology practicals	physiology practical	1	0	9132	9131	9132	
27272	Catholic social teaching	Catholic social teaching	1	0	27274	27273	2074	
37681	hs-TnI manifestation	INFunknownSUP manifestation	1	0	3466	10112	3466	
3571	la prevencion	la INFunknownSUP	1	0	3573	3572	3573	
7356	compulsive disorder	compulsive disorder	1	0	7358	7357	7358	
29206	strong back-boosting effect	strong back-boosting effect	1	0	29208	3987	1809	
14945	su vez la prevencion del duelo complicado	su vez la INFunknownSUP del INFunknownSUP INFunknownSUP	1	0	14947	10919	14957	
11441	peripheral distribution	peripheral distribution	1	0	2621	523	2621	
29703	Cooperative multi- country research programs	cooperative INFunknownSUP country research program	1	0	29705	29704	2246	
8567	restricted population movement	restricted population movement	1	0	8569	8568	8571	
23584	CoV-mediated disease.1 Paroxysmal nocturnal haemoglobinuria	INFunknownSUP INFunknownSUP paroxysmal nocturnal haemoglobinuria	1	0	23588	23585	23592	
25394	pediatric dialysis unit Coronavirus disease	pediatric dialysis unit INFunknownSUP disease	1	0	6281	23161	209	
28640	COVID-19 IgG1 repertoires	INFunknownSUP INFunknownSUP repertoire	1	0	8234	28641	8234	
5937	probabilistic decision tree of the value	probabilistic decision tree of the value	1	0	5939	463	5942	
6710	Tongji Hospital	INFunknownSUP Hospital	1	0	1879	6711	1879	
6852	lines of this epidemic	line of this epidemic	1	0	6853	6542	6853	
18379	satisfactory internal consistency	satisfactory internal consistency	1	0	18381	17494	18383	
24758	pre-morbid conditions	INFunknownSUP condition	1	0	2910	24759	2910	
4704	important factor	important factor	1	0	2183	273	2183	
8773	core outcomes	core outcome	1	0	263	1852	263	
13431	majority form antibody	majority form antibody	1	0	13433	4481	5924	
7243	viral specimens	viral specimen	1	0	7245	1741	7245	
11217	substantial overhaul of the symptomatic breast services	substantial overhaul of the symptomatic breast service	1	0	11219	3239	11220	
2330	telehealth usage	telehealth usage	1	0	2248	304	2248	
12269	human Face masks	human Face mask	1	0	12271	2214	3036	
19609	Mean country-level population-weighted NO2 concentrations	mean country-level population-weighted INFunknownSUP concentration	1	0	19611	19610	1959	
16386	Participatory Action Research	participatory Action Research	1	0	16388	16387	3674	
19856	cleavage site	cleavage site	1	0	11198	19857	11198	
30012	expectations of community members	expectation of community member	1	0	30013	16764	30013	
6676	trend of blood donations	trend of blood donation	1	0	6677	5203	6677	
19735	sociocultural dimensions of integration	sociocultural dimension of integration	1	0	19737	19736	15311	
36375	diagnostics strategy	diagnostic strategy	1	0	3350	36376	3350	
7990	result of lockdown measures	result of INFunknownSUP measure	1	0	2267	7992	2267	
7435	effect of the COVID-19 pandemic	effect of the INFunknownSUP pandemic	1	0	1809	111	1809	
17633	classification models	classification model	1	0	3975	1121	3975	
6300	invasive mechanical ventilation n=	invasive mechanical ventilation INFunknownSUP	1	0	6306	6301	6306	
4298	execution speed	execution speed	1	0	4300	4299	4300	
34065	university education programs	university education program	1	0	34067	1642	2246	
20242	successful heart transplantation	successful heart transplantation	1	0	20244	9403	10540	
23444	National Government	National Government	1	0	23446	46	23446	
11153	socio-emotional well-being of older people	socio-emotional well-being of old people	1	0	11155	11154	2245	
9675	various psychiatric conditions	various psychiatric condition	1	0	9677	1099	2910	
38208	vulnerable population	vulnerable population	1	0	1838	6402	1838	
17946	daily needs	daily need	1	0	3189	191	3189	
9844	value of additional interventions	value of additional intervention	1	0	1037	9846	1037	
36026	evaluation of different primer-probe	evaluation of different primer-probe	1	0	2399	36028	2399	
37965	level of infection transmissibility of children	level of infection INFunknownSUP of child	1	0	362	37967	362	
3790	uninsured people	uninsured people	1	0	694	3791	694	
16618	Failure Assessment	failure Assessment	1	0	2874	11178	2874	
29216	optimal levels of positive-end expiratory pressure	optimal level of INFunknownSUP expiratory pressure	1	0	29218	7633	1027	
4088	cross-sectional seroprevalence	cross-sectional seroprevalence	1	0	4090	2493	4090	
28909	UpToDate learning activity	INFunknownSUP learning activity	1	0	3990	28910	3990	
38518	SARS-CoV-2 RT-PCR	INFunknownSUP INFunknownSUP	1	0	7046	28	7046	
9447	cohort of service-users	cohort of service-user	1	0	601	8683	601	
17599	potential applications of bacteriophages	potential application of bacteriophage	1	0	17601	1276	17602	
16756	therapeutic agent	therapeutic agent	1	0	12122	3349	12122	
33546	household unit	household unit	1	0	10	18468	10	
13495	T cell epitopes of SARS-CoV-2	T cell epitope of INFunknownSUP	1	0	13496	28	13500	
15719	et al	et al	1	0	15721	15720	15721	
20491	detention centers	detention center	1	0	3427	12853	3427	
24249	lesser need	lesser need	1	0	9579	6648	9579	
37945	COVID-19 Vaccine Global Access Facility	INFunknownSUP vaccine Global Access Facility	1	0	37949	7257	37953	
36407	surgical technique	surgical technique	1	0	562	663	562	
16136	pre-pandemic year	pre-pandemic year	1	0	3822	16137	3822	
36645	sites of mutations	site of mutation	1	0	9165	3785	9165	
30823	fand sich keine Verminderung	INFunknownSUP INFunknownSUP INFunknownSUP INFunknownSUP	1	0	30829	30824	30829	
23881	positive experiences	positive experience	1	0	1339	228	1339	
4911	garment factory workers	garment factory worker	1	0	4913	2108	1136	
25142	perspectives of people	perspective of people	1	0	3304	694	3304	
33988	Food Preference Questionnaire	food preference questionnaire	1	0	19258	33989	19258	
18219	higher percentage of people	high percentage of people	1	0	18221	322	3789	
33752	clinical decision support to healthcare workers	clinical decision support to INFunknownSUP worker	1	0	33756	6524	260	
24078	SARS-CoV-2 spike protein S1	INFunknownSUP spike protein INFunknownSUP	1	0	21516	28	8763	
35819	ENT subspecialties	Ent subspecialty	1	0	35821	21127	35821	
3511	surgical appendectomies	surgical appendectomy	1	0	3513	663	3513	
14968	unnecessary exposure to the coronavirus	unnecessary exposure to the coronavirus	1	0	14970	14969	1054	
20984	group learning	group learning	1	0	2390	18	2390	
24009	algebraic system of equations	algebraic system of equation	1	0	24011	24010	1327	
6726	upper safety limits	upper safety limit	1	0	6728	2150	43	
18136	level of registered nurses	level of registered nurse	1	0	362	18138	362	
27737	undergraduate dermatology teaching	undergraduate dermatology teaching	1	0	27739	11601	2074	
35795	intervention score	intervention score	1	0	1843	5608	1843	
15088	follow-up chest CT scans	follow-up chest CT scan	1	0	15090	175	15094	
18572	overall rates of hospitalizations	overall rate of hospitalization	1	0	18574	2251	83	
21662	Certain countries	certain country	1	0	1599	21663	1599	
12860	rapid diagnostic testing	rapid diagnostic testing	1	0	3027	795	1885	
12884	novel antiviral therapies	novel antiviral therapy	1	0	12886	810	5507	
4536	combination of Vina	combination of Vina	1	0	367	4538	367	
10646	alternative treatment algorithms	alternative treatment algorithm	1	0	10648	10647	10650	
25306	Regression analyses	regression analysis	1	0	4668	25307	4668	
28486	common household reagents	common household reagent	1	0	28488	699	28490	
18901	tertiary care teaching hospital	tertiary care teaching hospital	1	0	18903	182	185	
26000	determinants of the antibody response	determinant of the antibody response	1	0	14341	9972	14341	
29015	disease wave	disease wave	1	0	10210	209	10210	
8327	complicate healthcare delivery	complicate INFunknownSUP delivery	1	0	8329	8328	2840	
32158	complication of coronavirus disease	complication of coronavirus disease	1	0	2206	338	2206	
13086	Hospital-Acquired Infections	INFunknownSUP infection	1	0	13088	13087	13088	
20082	P group	P group	1	0	18	13223	18	
11932	healthcare givers	INFunknownSUP giver	1	0	11934	494	11934	
38231	terms of knowledge acquisition	term of knowledge acquisition	1	0	4908	38233	4908	
29185	main effects logit model	main effect INFunknownSUP model	1	0	29187	4679	1078	
22838	Odd ratio	odd ratio	1	0	2635	22839	2635	
23720	convalescent patients	convalescent patient	1	0	60	17510	60	
29533	biological therapies	biological therapy	1	0	5507	855	5507	
37353	long Covid	long INFunknownSUP	1	0	26923	3921	26923	
21521	COVID-19 Educational Script	INFunknownSUP Educational script	1	0	21523	40	21525	
33043	panel discussion of a number of practical implications	panel discussion of a number of practical implication	1	0	33045	7588	3060	
33054	innovation methods	innovation method	1	0	205	19710	205	
8782	encephalomyelitis-like changes	INFunknownSUP change	1	0	1336	8783	1336	
613	close book exams	close book exam	1	0	615	614	617	
35839	Living arrangements	living arrangement	1	0	13728	35840	13728	
3904	best-fit model	INFunknownSUP model	1	0	1078	3905	1078	
20597	mere bogy of the mind	mere bogy of the mind	1	0	20599	11019	20600	
2315	average training recall	average training recall	1	0	2317	178	2319	
2646	related outcome	related outcome	1	0	295	2647	295	
34222	blood supply	blood supply	1	0	271	3129	271	
801	Impact of booster vaccination	impact of booster vaccination	1	0	802	803	802	
1963	moxibustion of traditional Chinese medicine	INFunknownSUP of traditional Chinese medicine	1	0	1964	1965	1964	
33113	interaction mechanism of the SARS-CoV2 virus	interaction mechanism of the INFunknownSUP virus	1	0	33115	2525	10036	
12533	real-time effective reproduction numbers (R(t))	real-time effective reproduction number INFunknownSUP	1	0	12535	1429	12541	
22113	hydroxychloroquine sulfate coated tablet	hydroxychloroquine sulfate coated tablet	1	0	22115	633	22119	
11803	activity redesign	activity redesign	1	0	11805	3990	11805	
6476	medical experts	medical expert	1	0	6478	947	6478	
18533	Model Prediction	Model prediction	1	0	10165	7734	10165	
31465	adverse effects of androgen deprivation therapy	adverse effect of androgen deprivation therapy	1	0	19183	8814	156	
30007	3D printed adapter	3D printed adapter	1	0	30009	10448	30011	
12144	experimental study reveal	experimental study reveal	1	0	12148	12145	12148	
22386	quick decision-making	quick decision-making	1	0	22388	22387	22388	
34967	huge discrepancy	huge discrepancy	1	0	34969	5836	34969	
4973	tissue characteristics	tissue characteristic	1	0	1496	4974	1496	
3260	independent predictors of adverse outcomes	independent predictor of adverse outcome	1	0	3261	3264	414	
7870	COVID-19 Pfizer-BioNTech BNT16B2b2	INFunknownSUP INFunknownSUP INFunknownSUP	1	0	7874	7871	7874	
14154	use of COVID-19 personal protective equipment	use of INFunknownSUP personal protective equipment	1	0	292	14156	292	
32547	Endometriosis Surgery	endometriosis surgery	1	0	2338	32548	2338	
28133	Electronic health	electronic health	1	0	120	1754	120	
23029	negative binomial regressions	negative binomial regression	1	0	23031	1338	9229	
434	SARS-CoV-2 vaccination offer protection	INFunknownSUP vaccination offer protection	1	0	438	435	440	
33770	whole procedure	whole procedure	1	0	4693	2359	4693	
28230	access to appropriate perinatal mental health care	access to appropriate perinatal mental health care	1	0	224	28232	224	
25119	21st century	21st century	1	0	808	25120	808	
30053	physiological characteristics	physiological characteristic	1	0	1496	1335	1496	
27094	indicator of exposure to the disease	indicator of exposure to the disease	1	0	20310	27096	20310	
19410	TD method	TD method	1	0	6587	19411	6587	
35241	free time	free time	1	0	179	4542	179	
5386	Early treatment	early treatment	1	0	97	5387	97	
11678	CT severity involvement index	CT severity involvement index	1	0	11680	26	4017	
1780	up-to-date review	up-to-date review	1	0	1723	1781	1723	
16139	anti-SARS-CoV-2 antibody titers	INFunknownSUP antibody titer	1	0	16141	4554	8757	
26535	HIV/AIDS epidemic	INFunknownSUP epidemic	1	0	6542	26536	6542	
38128	Rapid Emergency Medicine Score	Rapid Emergency Medicine Score	1	0	38130	9843	38134	
15905	Isolation Chamber	isolation Chamber	1	0	15907	15906	15907	
36568	COVID-19 susceptibility	INFunknownSUP susceptibility	1	0	10460	40	10460	
28628	chemiluminescence serological assays	chemiluminescence serological assay	1	0	2752	10465	2754	
17788	SARS-CoV-2 mRNA-1273 Vaccine	INFunknownSUP mRNA-1273 vaccine	1	0	17790	28	685	
30447	various elements	various element	1	0	10510	1099	10510	
38221	logic model	logic model	1	0	1078	38222	1078	
19181	multiple adverse effects	multiple adverse effect	1	0	19183	1776	156	
29488	Measurement of antibody levels	measurement of antibody level	1	0	15388	29490	15388	
15018	ABO blood types	ABO blood type	1	0	15020	5208	1979	
1288	tolerance model	tolerance model	1	0	1078	1289	1078	
23547	Crisis Mode	crisis Mode	1	0	23549	23413	23549	
27634	awareness of the link	awareness of the link	1	0	1612	3478	1612	
12415	index case	index case	1	0	3368	4017	3368	
9063	Event of a Major COVID-19 Surge	event of a Major INFunknownSUP surge	1	0	9064	9065	9064	
25115	third pandemic of 21st century	third pandemic of 21st century	1	0	25117	7099	113	
18354	research Non-invasive respiratory support	research non-invasive respiratory support	1	0	18356	36	260	
3479	Use of the HoloLens2 Mixed Reality Headset	use of the INFunknownSUP mixed reality headset	1	0	3483	3480	3487	
12329	body temperature monitoring	body temperature monitoring	1	0	12331	2710	3271	
10072	terminal complement pathway	terminal complement pathway	1	0	10074	10073	5003	
21302	U.S. Locations	U.S. location	1	0	21304	21303	21304	
33507	person-to-person transmission	person-to-person transmission	1	0	876	33508	876	
10067	status of children	status of child	1	0	2720	6153	2720	
6318	validation of available antibodies	validation of available antibody	1	0	6319	6320	6319	
25790	important restrictions	important restriction	1	0	2880	273	2880	
32982	seasonal coronavirus infections	seasonal coronavirus infection	1	0	779	29024	779	
17015	VSV pseudoparticle infection of human lung cells	INFunknownSUP pseudoparticle infection of human lung cell	1	0	17016	17021	41	
26280	observational studies	observational study	1	0	136	3552	136	
17621	urgent treatment	urgent treatment	1	0	97	8129	97	
16670	infected region	infected region	1	0	8256	1088	8256	
37158	related factors	related factor	1	0	583	2647	583	
20733	independent-samples t test	independent-sample t test	1	0	20735	20734	754	
23891	shorter hospital stays	short hospital stays	1	0	23893	8635	23895	
7768	care resources	care resource	1	0	835	9	835	
23324	naive CFR	naive CFR	1	0	23326	3656	23326	
36932	efficacy of vaccines	efficacy of vaccine	1	0	6704	681	6704	
14022	Treatment of Skin Lesions	Treatment of skin lesion	1	0	5596	14024	5596	
26543	cases of public COVID-19 data	case of public INFunknownSUP datum	1	0	229	26545	229	
31840	la COVID-19	la INFunknownSUP	1	0	40	14950	40	
13719	secondary school students of all grades	secondary school student of all grade	1	0	13720	13725	1177	
35653	pandemic-adapted implementations	INFunknownSUP implementation	1	0	8155	35654	8155	
1114	science communities	science community	1	0	948	1115	948	
13025	surgical societies	surgical society	1	0	350	663	350	
35166	radiographic lung disease severity	radiographic lung disease severity	1	0	35168	5121	5116	
29370	ORF1ab set	INFunknownSUP set	1	0	651	29371	651	
25002	relation to severity	relation to severity	1	0	14883	5116	14883	
1299	various absolute neutrophil count	various absolute neutrophil count	1	0	1301	1099	1305	
14599	basic reproduction number	basic reproduction number	1	0	5878	4643	916	
31210	Gender inequality	gender inequality	1	0	31212	31211	31212	
24346	adverse well-being outcomes	adverse well-being outcome	1	0	24348	1082	263	
18034	major global health crisis	major global health crisis	1	0	18036	1318	408	
22434	Prompt SLT evaluation	prompt INFunknownSUP evaluation	1	0	9367	22435	2399	
508	pest control	pest control	1	0	510	509	510	
29969	IGH repertoire	INFunknownSUP repertoire	1	0	10422	29970	10422	
28960	impact of this type of variants	impact of this type of variant	1	0	110	28962	110	
21025	high exposure areas	high exposure area	1	0	21027	13	1579	
29865	affordable prophylaxis	affordable prophylaxis	1	0	4121	29866	4121	
26420	publication of articles	publication of article	1	0	26421	811	26421	
35147	work-related psychological distress	work-related psychological distress	1	0	1973	1332	1975	
9849	early stages of the outbreak	early stage of the outbreak	1	0	764	310	766	
20346	COVID-19 Genomics UK Consortium	INFunknownSUP INFunknownSUP UK Consortium	1	0	20350	20347	4989	
5293	global spread of the new coronavirus	global spread of the new coronavirus	1	0	5295	1954	570	
34698	detectable SARS-CoV-2 nAbs	detectable INFunknownSUP INFunknownSUP	1	0	34700	9660	1240	
24146	international events	international event	1	0	1083	4086	1083	
7140	clinical scenarios	clinical scenario	1	0	7142	884	7142	
9461	variable analysis	variable analysis	1	0	486	6800	486	
11414	amount of aerosol production	amount of aerosol production	1	0	8629	11416	8629	
10437	yolks of hens	yolk of hen	1	0	10438	10439	10438	
37076	antibody positivity rates	antibody INFunknownSUP rate	1	0	83	28841	83	
20674	psychological impact of COVID-19 pandemic	psychological impact of INFunknownSUP pandemic	1	0	1379	111	110	
24073	qualitative techniques	qualitative technique	1	0	691	8554	691	
25046	great safety concerns of antibody-dependent enhancement	great safety concern of antibody-dependent enhancement	1	0	25047	25052	12106	
36415	use of air conditioners	use of air conditioner	1	0	292	36417	292	
6050	pandemic COVID-19	pandemic INFunknownSUP	1	0	40	1354	40	
36560	optimal lockdown strategies	optimal INFunknownSUP strategy	1	0	300	36561	300	
692	business people	business people	1	0	694	693	694	
33483	bubble members	bubble member	1	0	16766	11062	16766	
26725	environmental services workers	environmental service worker	1	0	26727	6806	1136	
21171	second stage of COVID-19	second stage of INFunknownSUP	1	0	21173	1279	1521	
37597	impact of disease	impact of disease	1	0	110	209	110	
37690	dental undergraduates	dental undergraduate	1	0	26191	5656	26191	
18209	crucial pillar of medical systems	crucial pillar of medical system	1	0	18211	10865	18212	
23478	academic production	academic production	1	0	654	606	654	
32755	current COVID-2019 pandemic	current COVID-2019 pandemic	1	0	10150	443	113	
3417	major SARS-CoV-2 variants	major INFunknownSUP variant	1	0	1002	3418	1002	
25285	high levels of stress	high level of stress	1	0	167	199	169	
25032	higher risks of anxiety	high risk of anxiety	1	0	8150	2772	8152	
22380	probiotics-assisted therapy	INFunknownSUP therapy	1	0	2273	22381	2273	
25445	germinal centre mutation	germinal centre mutation	1	0	25447	25446	333	
1400	Chest Radiograph Scores	chest radiograph score	1	0	1402	1401	1404	
23078	broad audience	broad audience	1	0	23080	7135	23080	
17988	higher rate of intensive care unit	high rate of intensive care unit	1	0	1725	6	1034	
6594	workers experiences	worker experience	1	0	1339	1136	1339	
8481	analysis of influent wastewater data	analysis of influent wastewater datum	1	0	486	8483	486	
7396	facial skin damage	facial skin damage	1	0	7398	7397	5946	
31417	susceptibility patterns	susceptibility pattern	1	0	548	10460	548	
23916	professional experiences	professional experience	1	0	1339	234	1339	
31895	PaO2/FiO2 ratio	INFunknownSUP ratio	1	0	2635	31896	2635	
14044	individual spinal units	individual spinal unit	1	0	14046	753	6042	
1574	Twenty-five patients	INFunknownSUP patient	1	0	60	1575	60	
815	con variables	con variable	1	0	817	816	817	
7643	epithelial surface	epithelial surface	1	0	7645	7644	7645	
21190	health infrastructure	health infrastructure	1	0	21192	120	21192	
1568	appointment invitations	appointment invitation	1	0	1570	1569	1570	
9870	routine vaccination coverage of children	routine vaccination coverage of child	1	0	9872	4898	4933	
5756	Mortalidad por COVID-19	INFunknownSUP por INFunknownSUP	1	0	5758	5757	40	
15199	diagnostic tasks	diagnostic task	1	0	15201	2219	15201	
10564	retrospective review of electronic health record	retrospective review of electronic health record	1	0	10566	10146	1723	
1772	fetal development	fetal development	1	0	73	1773	73	
1286	uncertainty tolerance model	uncertainty tolerance model	1	0	1288	1287	1078	
29646	COVID-19 Responses	INFunknownSUP response	1	0	29648	40	29648	
33382	number of emergent appendectomies	number of emergent appendectomy	1	0	916	33384	916	
13144	control of disease spread	control of disease spread	1	0	510	568	510	
1808	effect of this model	effect of this model	1	0	1809	1078	1809	
2172	genome of SARS-CoV-2	genome of INFunknownSUP	1	0	2173	28	2173	
26706	preclinical studies	preclinical study	1	0	136	26707	136	
13131	Special attention	special attention	1	0	4885	13132	4885	
14135	fragile healthcare systems	fragile INFunknownSUP system	1	0	14137	14136	146	
32798	low burden of COVID-19	low burden of INFunknownSUP	1	0	32800	457	1070	
37356	peripheral primary NSCLC	peripheral primary INFunknownSUP	1	0	37358	523	37360	
15526	aspects of life	aspect of life	1	0	2429	1434	2429	
5960	malignant process	malignant process	1	0	180	3530	180	
35879	dental treatment rooms	dental treatment room	1	0	35881	5656	35883	
20555	care organizations	care organization	1	0	5251	9	5251	
29981	deep macular vessel densities	deep macular vessel density	1	0	29983	2520	22356	
27327	golden year	golden year	1	0	3822	27328	3822	
30262	post hoc analysis of data	post hoc analysis of datum	1	0	30264	2282	486	
16922	context of COVID-19	context of INFunknownSUP	1	0	1567	40	1567	
12703	intense connections	intense connection	1	0	12705	12704	12705	
38816	A Rare Presentation of Renal Papillary Necrosis	A rare Presentation of renal papillary necrosis	1	0	38818	3475	4657	
25246	han analizado variables demograficas	han INFunknownSUP variable INFunknownSUP	1	0	25248	25247	818	
9091	Post-Traumatic stress disorder	post-traumatic stress disorder	1	0	9093	9092	7358	
3516	quartile of recruitment	quartile of recruitment	1	0	475	3518	475	
8583	chemoprophylaxis of infection	chemoprophylaxis of infection	1	0	8584	41	8584	
1707	transformation platform	transformation platform	1	0	1709	1708	1709	
4999	daily intakes	daily intake	1	0	5001	191	5001	
653	production of the non-woven polypropylene filtration media	production of the non-woven polypropylene filtration medium	1	0	654	655	654	
32429	Restoration of elective spine surgery	restoration of elective spine surgery	1	0	32430	1626	32430	
19988	philosophy COVID-19	philosophy INFunknownSUP	1	0	40	19989	40	
34162	nine-item scale	INFunknownSUP scale	1	0	2422	34163	2422	
31033	urban students	urban student	1	0	1177	11894	1177	
18290	real-time monitoring of transmission	real-time monitoring of transmission	1	0	18292	1429	3271	
35855	Sociological Abstracts	sociological abstract	1	0	18276	19454	18276	
27782	cross-reactivity of SARS-CoV-2	cross-reactivity of INFunknownSUP	1	0	27783	28	27783	
9433	Medical Agency	Medical Agency	1	0	9435	2779	9435	
37993	severe PXS score	severe PXS score	1	0	37995	262	1843	
20266	required tube feeding	required tube feeding	1	0	20268	20267	20270	
22198	wound infections	wound infection	1	0	779	22199	779	
152	medication action/side effects	medication INFunknownSUP effect	1	0	154	153	156	
35157	long duration of hospitalization	long duration of hospitalization	1	0	24830	3921	7404	
9321	secondary bronchi	secondary bronchus	1	0	2314	712	2314	
20364	cross-sectional national online survey	cross-sectional national online survey	1	0	20366	2493	967	
32997	consequence of post-COVID-19 hyperinflammation	consequence of INFunknownSUP hyperinflammation	1	0	9155	32999	9155	
18758	years - range	year INFunknownSUP range	1	0	18760	1313	420	
32454	7th May	7th May	1	0	32456	32455	32456	
12637	further investigations	further investigation	1	0	12639	7713	12639	
25131	mask compression	mask compression	1	0	25133	290	25133	
3745	ligand-binding affinity	ligand-binding affinity	1	0	2922	3746	2922	
6776	Covid-19 vaccine transmission	INFunknownSUP vaccine transmission	1	0	6778	1884	876	
27694	positive COVID-19 prediction	positive INFunknownSUP prediction	1	0	10913	228	3336	
9802	range of psychopathological presentations	range of psychopathological presentation	1	0	420	9804	420	
21132	Cochrane Library Plus	Cochrane Library Plus	1	0	21136	16941	21136	
18664	SARS-COV-2 IgG	INFunknownSUP IgG	1	0	928	4985	928	
12770	Effective Method	effective method	1	0	12772	12771	12772	
28837	important role	important role	1	0	7288	273	7288	
4103	protective eye wear	protective eye wear	1	0	4105	1455	4107	
803	booster vaccination	booster vaccination	1	0	437	804	437	
38123	operator characteristic curve	operator characteristic curve	1	0	38125	38124	6817	
6461	patient experienced fever	patient experienced fever	1	0	6463	2645	6465	
29906	neurological COVID-19 patients	neurological INFunknownSUP patient	1	0	911	2728	60	
9190	nonsteroidal anti-inflammatory drugs	nonsteroidal anti-inflammatory drug	1	0	9192	9191	4584	
17079	length of inpatient stay	length of inpatient stay	1	0	1347	17081	1347	
32995	potential consequence of post-COVID-19 hyperinflammation	potential consequence of INFunknownSUP hyperinflammation	1	0	32997	1276	9155	
31733	brain PET of long COVID patients	brain pet of long INFunknownSUP patient	1	0	31735	10043	12205	
4754	gastrointestinal inflammatory process	gastrointestinal inflammatory process	1	0	4756	4755	180	
25335	vulnerable individual	vulnerable individual	1	0	25337	6402	25337	
20196	essential medications	essential medication	1	0	4355	4197	4355	
2869	general population Assessment of the intensity	general population Assessment of the intensity	1	0	2873	1836	2874	
9958	field-effect transistor-based	INFunknownSUP INFunknownSUP	1	0	9960	9959	9960	
28396	structural bases	structural base	1	0	6498	3549	6498	
15796	academic medical centers	academic medical center	1	0	3425	606	3427	
36433	long-term mental health care	long-term mental health care	1	0	28236	4288	9	
25174	Counseling Relationship	counseling relationship	1	0	25176	15638	25176	
19831	Pandemic Cybersecurity threats	pandemic Cybersecurity threat	1	0	19833	2450	1370	
10888	poor outcome of patients	poor outcome of patient	1	0	10890	1372	295	
1436	apoyo emocional	INFunknownSUP INFunknownSUP	1	0	1438	1437	1438	
6295	potential COVID-19 treatment	potential INFunknownSUP treatment	1	0	97	6296	97	
38108	time series analysis	time series analysis	1	0	38110	179	486	
5316	territory pandemic plans	territory pandemic plan	1	0	5318	5317	5320	
12421	TMPRSS2 expression profiles	INFunknownSUP expression profile	1	0	6820	6250	6820	
10852	World War II	World War II	1	0	10854	5804	10856	
29132	fogged eye wear	fogged eye wear	1	0	4105	1	4107	
38756	multiple linear regression methods	multiple linear regression method	1	0	38758	1776	205	
36454	East respiratory syndrome coronavirus:MERS-CoV	East respiratory syndrome INFunknownSUP	1	0	36456	2688	36460	
38301	medical experience	medical experience	1	0	2782	947	2782	
3252	features of COVID-19 patients	feature of INFunknownSUP patient	1	0	1469	911	1469	
3312	policy advice	policy advice	1	0	3314	293	3314	
3317	Marine recruit training base	Marine recruit training base	1	0	3321	3318	3323	
19139	pulmonary COVID-19 severity	pulmonary INFunknownSUP severity	1	0	19141	590	5116	
19549	health threats	health threat	1	0	1370	120	1370	
7213	respondents of the general public of Saudi Arabia	respondent of the general public of Saudi Arabia	1	0	861	7215	861	
10640	socio-economic complications	socio-economic complication	1	0	705	8670	705	
8418	perinatal period	perinatal period	1	0	5677	8419	5677	
8008	asymptomatic staff	asymptomatic staff	1	0	11	1131	11	
10982	% of the subjects	% of the subject	1	0	364	4893	364	
31485	SRS-22 questionnaire	INFunknownSUP questionnaire	1	0	9620	14517	9620	
17159	subset of sera	subset of sera	1	0	13968	17161	13968	
8067	light of these findings	light of these finding	1	0	8068	3390	8068	
8684	safe integration of OTC supplements	safe integration of OTC supplement	1	0	8686	4136	918	
34287	capacity adsorption filtration membranes	capacity adsorption filtration membrane	1	0	34289	3026	34293	
7348	overall morbidity	overall morbidity	1	0	1216	2251	1216	
1324	immune system of elderly individuals	immune system of elderly individual	1	0	1325	1328	1327	
5092	wastewater treatment plants	wastewater treatment plant	1	0	5094	5093	5096	
21206	outbreak COVID-19	outbreak INFunknownSUP	1	0	40	310	40	
5385	Early treatment of COVID-19 patients	early treatment of INFunknownSUP patient	1	0	5386	911	97	
6973	Positive results	positive result	1	0	325	6974	325	
29338	somatic hypermutation	somatic hypermutation	1	0	29340	23926	29340	
17290	nasal cannula	nasal cannula	1	0	17292	1472	17292	
24769	care service workers	care service worker	1	0	24771	9	1136	
2620	distribution of comorbidities	distribution of comorbidity	1	0	2621	676	2621	
25494	Testing of vaccine candidates	Testing of vaccine candidate	1	0	25495	25496	25495	
11305	CD4 cytokine	INFunknownSUP INFunknownSUP	1	0	3718	11306	3718	
12240	occurrence of alternative damaging autoimmune mechanisms	occurrence of alternative damaging autoimmune mechanism	1	0	2207	12242	2207	
16780	Viral Culture Methods	viral Culture method	1	0	16782	8081	6982	
38527	health-related stressor stimulation	health-related INFunknownSUP stimulation	1	0	15642	38528	15642	
34289	adsorption filtration membranes	adsorption filtration membrane	1	0	34291	34290	34293	
12792	atmospheric column NO2 data	atmospheric column INFunknownSUP datum	1	0	12794	12793	22	
3099	nonlinear system of differential equations	nonlinear system of differential equation	1	0	3101	3100	1327	
13752	insufficient information	insufficient information	1	0	2591	3024	2591	
14682	local level	local level	1	0	362	3173	362	
2156	mainstream of the up-to-date published work	mainstream of the up-to-date published work	1	0	2157	2158	2157	
9815	new insights	new insight	1	0	9664	69	9664	
28078	UK Medical Research Council	UK Medical Research Council	1	0	28080	5052	6229	
1728	venous thromboembolism	venous thromboembolism	1	0	1730	1729	1730	
34267	country of residence	country of residence	1	0	2270	12684	2270	
26475	olfactory dysfunctions	olfactory dysfunction	1	0	26477	1702	26477	
987	HLA-A*02:01 monomers	HLA-A*02:01 monomer	1	0	989	988	989	
87	adoption of CDC guidelines	adoption of CDC guideline	1	0	88	89	88	
13981	selectivity of SARS-CoV-2-induced humoral immunity	selectivity of INFunknownSUP humoral immunity	1	0	13051	13983	13051	
32423	historical institutionalism	historical institutionalism	1	0	32425	32424	32425	
5100	total outpatient care	total outpatient care	1	0	3141	1485	9	
7572	additional duty of patient care	additional duty of patient care	1	0	7574	7175	7575	
32844	anatomy teaching	anatomy teaching	1	0	2074	52	2074	
4242	arthroplasty surgery	INFunknownSUP surgery	1	0	1630	4243	1630	
36383	pre-test depression	pre-test depression	1	0	1514	36384	1514	
24379	total gastrectomies	total gastrectomy	1	0	24381	1485	24381	
10285	financial literacy levels	financial literacy level	1	0	169	10286	169	
11258	stereotactic ablative body radiation therapy	stereotactic ablative body radiation therapy	1	0	11260	11259	2273	
3837	Characteristics of teamwork	characteristic of teamwork	1	0	2027	3839	2027	
16656	high initial WBC count	high initial WBC count	1	0	16658	13	1305	
19580	epidemic peak	epidemic peak	1	0	5928	12267	5928	
10766	endolaparoscopic practice	INFunknownSUP practice	1	0	3285	10767	3285	
18536	independent reviewers	independent reviewer	1	0	18538	582	18538	
11629	insurance sector	insurance sector	1	0	11631	1711	11631	
9315	technical report	technical report	1	0	378	4083	378	
10840	digital technologies	digital technology	1	0	70	1094	70	
10507	key elements of the full protocol	key element of the full protocol	1	0	10509	850	10510	
26189	medical undergraduates	medical undergraduate	1	0	26191	947	26191	
6647	lesser reduction	lesser reduction	1	0	490	6648	490	
12982	return to workplaces	return to workplace	1	0	10040	12984	10040	
15351	viral S subunit	viral S subunit	1	0	15353	1741	8764	
7963	integration of different OTC supplements	integration of different OTC supplement	1	0	918	7965	918	
23984	ground monitoring	ground monitoring	1	0	3271	16481	3271	
32369	kynurenine aminotransferase	INFunknownSUP aminotransferase	1	0	19630	32370	19630	
35289	human angiotensin-converting enzyme	human INFunknownSUP enzyme	1	0	624	35290	624	
21765	statistical power	statistical power	1	0	7608	5263	7608	
30697	peripapillary retinal nerve fiber	peripapillary retinal nerve fiber	1	0	30699	30698	26292	
21671	role of pandemic-focused time	role of pandemic-focused time	1	0	7288	11987	7288	
7388	inhibitor of JAK1/2	inhibitor of INFunknownSUP	1	0	4569	7390	4569	
5472	group of health professionals	group of health professional	1	0	18	4417	18	
56	identification of older patients	identification of old patient	1	0	57	58	57	
5416	Care Infrastructures	Care infrastructure	1	0	5418	5417	5418	
22742	low-cost interventions	low-cost intervention	1	0	757	7624	757	
16791	high compliance	high compliance	1	0	2726	13	2726	
6085	comparative cohort study of rheumatic disease patients	comparative cohort study of rheumatic disease patient	1	0	6087	5624	2087	
6986	proper PPE training	proper PPE training	1	0	6988	449	235	
38132	Medicine Score	Medicine Score	1	0	38134	1951	38134	
17416	study of this drug	study of this drug	1	0	2087	352	2087	
642	indirect effects of stress	indirect effect of stress	1	0	453	643	156	
12229	wider body of Discrete Choice Experiment evidence	wide body of discrete choice experiment evidence	1	0	12231	11790	2710	
14420	ordinary wards	ordinary ward	1	0	14422	14421	14422	
20010	measured variables	measured variable	1	0	817	20011	817	
1591	radiological attributes	radiological attribute	1	0	1593	1592	1593	
15704	binary distribution	binary distribution	1	0	2621	5131	2621	
39137	de la epidemia	de la INFunknownSUP	1	0	39139	1914	39141	
23802	domestic staff	domestic staff	1	0	11	23803	11	
19325	influenza vaccine	influenza vaccine	1	0	577	2323	577	
20981	quality assessments	quality assessment	1	0	1393	3713	1393	
16694	severity of viral infections	severity of viral infection	1	0	5116	3068	5116	
6698	lecture content	lecture content	1	0	6700	6699	6700	
8951	prime/boost vaccination	prime/boost vaccination	1	0	437	8952	437	
26967	micromolar concentrations	micromolar concentration	1	0	1959	26968	1959	
438	offer protection	offer protection	1	0	440	439	440	
13072	non-woven materials	non-woven material	1	0	2335	656	2335	
1841	ASA score	ASA score	1	0	1843	1842	1843	
33744	warrant long-term investigation	warrant long-term investigation	1	0	33746	33745	7714	
637	Fourty-seven patients	INFunknownSUP patient	1	0	60	638	60	
6315	contribution of NLRP3	contribution of INFunknownSUP	1	0	6316	6317	6316	
31039	EDIs of the phthalates	INFunknownSUP of the INFunknownSUP	1	0	31040	21792	31040	
8606	naive controls	naive control	1	0	3772	3656	3772	
19298	alarming overview of the unpreparedness of Libyan hospitals	alarming overview of the unpreparedness of Libyan hospital	1	0	19300	19299	19301	
19279	nosocomial outbreak of SARS-CoV-2 infections	INFunknownSUP outbreak of INFunknownSUP infection	1	0	7750	9118	310	
17653	successful final exam	successful final exam	1	0	17655	9403	3998	
27040	novel disposable home electro-stimulation device	novel disposable home electro-stimulation device	1	0	2995	810	3001	
6196	aggregation-based lightweight network	INFunknownSUP lightweight network	1	0	6198	6197	719	
37714	accuracy of the biosensors	accuracy of the biosensor	1	0	4535	37716	4535	
31727	retrospective analysis of 18F-FDG brain PET of long COVID patients	retrospective analysis of INFunknownSUP brain pet of long INFunknownSUP patient	1	0	31729	10146	486	
34328	respiratory condition	respiratory condition	1	0	8881	259	8881	
9298	vaccination campaigns	vaccination campaign	1	0	3886	437	3886	
13096	higher occurrence rate	high occurrence rate	1	0	13098	322	1034	
14367	post-operative complications	post-operative complication	1	0	705	14368	705	
1984	COVAX initiative	INFunknownSUP initiative	1	0	1986	1985	1986	
20843	Clinical engagement-	clinical INFunknownSUP	1	0	20845	1501	20845	
18798	time to death	time to death	1	0	179	4722	179	
27507	diagnosis of CDI	diagnosis of CDI	1	0	2168	72	2168	
9701	onset of symptoms to maximum hs-TnI	onset of symptom to maximum INFunknownSUP	1	0	9702	9705	1647	
38236	surgical tasks	surgical task	1	0	15201	663	15201	
13360	quality of diagnoses	quality of diagnosis	1	0	3713	13045	3713	
7886	levels of Fibrobacteres	level of Fibrobacteres	1	0	169	7888	169	
12620	high rates of dysphonia	high rate of dysphonia	1	0	12621	12624	83	
18019	activation-induced neuroinflammation	INFunknownSUP neuroinflammation	1	0	18021	18020	18021	
7013	genomic surveillance	INFunknownSUP surveillance	1	0	2795	5714	2795	
36716	contribution to improvements	contribution to improvement	1	0	6316	11849	6316	
10786	radiobiology study	radiobiology study	1	0	2087	10787	2087	
35403	large US cohort	large US cohort	1	0	35405	4250	601	
27254	place of strict lockdowns	place of strict lockdown	1	0	27255	8858	27255	
38006	self-report demographic questionnaire	self-report demographic questionnaire	1	0	38008	38007	9620	
24764	re-align priorities	INFunknownSUP priority	1	0	16371	24765	16371	
38481	enhancement methods	enhancement method	1	0	205	592	205	
15320	above serum cytokines	above serum cytokine	1	0	15322	15321	5734	
26320	(EDL)-gated field-effect transistor-based biosensor	INFunknownSUP INFunknownSUP INFunknownSUP biosensor	1	0	26326	26321	26326	
29275	concept of a public sphere	concept of a public sphere	1	0	29276	10337	29276	
25766	Adverse Outcome	adverse outcome	1	0	10594	25767	10594	
23788	t-SNE visualization	INFunknownSUP visualization	1	0	23790	23789	23790	
2959	self care	self care	1	0	9	2960	9	
34913	resident physicians	resident physician	1	0	21128	2241	21128	
30210	right lessons	right lesson	1	0	30212	15176	30212	
25217	different items	different item	1	0	21024	688	21024	
25883	coronavirus pandemic	coronavirus pandemic	1	0	113	339	113	
9329	effective strategies	effective strategy	1	0	300	2051	300	
10074	complement pathway	complement pathway	1	0	5003	10075	5003	
2950	Brain MRI	Brain MRI	1	0	2952	2951	2952	
23064	unprecedented contagiousness	unprecedented contagiousness	1	0	23066	5915	23066	
34244	Multivariable regressions	Multivariable regression	1	0	9229	9562	9229	
36651	mild patients	mild patient	1	0	60	10809	60	
20553	health care organizations	health care organization	1	0	20555	120	5251	
21126	ENT physicians	Ent physician	1	0	21128	21127	21128	
10776	relative abundance of Candidatus_Saccharibacteria	relative abundance of INFunknownSUP	1	0	10778	10777	10779	
13292	detection of antibodies	detection of antibody	1	0	44	929	44	
12374	toxic innate immune responses	toxic innate immune response	1	0	12376	3619	200	
18082	usage diaries	usage diary	1	0	18084	2248	18084	
9752	human semen quality	human semen quality	1	0	3713	9753	3713	
38605	Bacterial viruses	bacterial virus	1	0	2217	38606	2217	
25875	development processes	development process	1	0	3381	73	3381	
29707	country research programs	country research program	1	0	29709	2270	2246	
29064	potential effect of renin-angiotensin-aldosterone system	potential effect of renin-angiotensin-aldosterone system	1	0	29066	1276	1809	
27788	etiology of acute diarrhea	etiology of acute diarrhea	1	0	27789	27790	27789	
19152	sensitivity analysis findings	sensitivity analysis finding	1	0	3390	2903	3390	
37624	cheaper screening strategy	cheap screening strategy	1	0	18942	37625	3350	
21160	Environmental sampling	environmental sampling	1	0	11863	21161	11863	
1920	chest CTs	chest CTs	1	0	1922	25	1922	
31552	Medical Association	Medical Association	1	0	1952	2779	1952	
8511	ANOVA test	INFunknownSUP test	1	0	754	8512	754	
9623	team processes	team process	1	0	3381	7208	3381	
9379	neutrophils-lymphocyte ratio	neutrophils-lymphocyte ratio	1	0	2635	9380	2635	
26277	watery stools	watery stool	1	0	26279	26278	26279	
33288	SARS-CoV-2 receptor	INFunknownSUP receptor	1	0	3502	28	3502	
25465	age &gt	age &gt	1	0	2385	906	2385	
21315	statistical tests	statistical test	1	0	1365	5263	1365	
16665	regions of Spain	region of Spain	1	0	5240	13610	5240	
14619	ni de los servicios	Ni de los INFunknownSUP	1	0	14625	14620	14625	
11182	Combined effects	combined effect	1	0	156	11183	156	
1150	RNA test	RNA test	1	0	754	1151	754	
21230	Risk Factors	risk factor	1	0	21232	1450	21232	
38528	health-related stressor	health-related INFunknownSUP	1	0	38530	17027	38530	
24260	de Valdecilla University Hospital	de Valdecilla University Hospital	1	0	24262	1421	1879	
33775	QoL of ASD patients	QoL of INFunknownSUP patient	1	0	33776	22611	33776	
11296	lockdown of areas	INFunknownSUP of area	1	0	1676	1579	1676	
22761	empirical data	empirical datum	1	0	22	4924	22	
32016	delivery approach	delivery approach	1	0	1538	2840	1538	
6900	care institutions	care institution	1	0	2602	9	2602	
717	manufacturing network	manufacturing network	1	0	719	718	719	
24330	district hospital	district hospital	1	0	185	24331	185	
6133	global longitudinal strain	global longitudinal strain	1	0	1105	1954	1107	
22769	information of COVID-19	information of INFunknownSUP	1	0	2591	40	2591	
10350	Village of the Euganei Hills	Village of the INFunknownSUP Hills	1	0	10351	10352	10351	
10543	suites de la pandemie COVID-19 une occasion de reformer la sante	suite de la INFunknownSUP INFunknownSUP une occasion de reformer la INFunknownSUP	1	0	10545	10544	10563	
5264	evidence of a difference	evidence of a difference	1	0	585	4260	585	
38202	hepatitis B	hepatitis B	1	0	1846	36837	1846	
824	values of all positive test results	value of all positive test result	1	0	825	826	825	
5726	mRNA expression levels	INFunknownSUP expression level	1	0	5728	5727	169	
26288	societal crises	societal crisis	1	0	26290	26058	26290	
17997	contagious coronavirus variant	contagious coronavirus variant	1	0	17999	13053	939	
19196	Human studies	human study	1	0	136	19197	136	
17275	untreatable diseases	untreatable disease	1	0	315	17276	315	
17381	HLA-A*02:01 stabilization assay	HLA-A*02:01 stabilization assay	1	0	17383	17382	3119	
13692	SARS-Cov2 virus	INFunknownSUP virus	1	0	778	13693	778	
37752	unique stages	unique stage	1	0	766	3547	766	
25799	platelet count	platelet count	1	0	1305	25800	1305	
20767	whole tissues	whole tissue	1	0	20769	2359	20769	
12504	contextual practices	contextual practice	1	0	5378	12505	5378	
9359	An Insight	An Insight	1	0	9361	9360	9361	
1314	moral stress	moral stress	1	0	199	1315	199	
17595	comprehensive review/perspective of potential applications of bacteriophages	comprehensive review/perspective of potential application of bacteriophage	1	0	17597	2902	17598	
29499	heterogenicity of troponin sampling	INFunknownSUP of INFunknownSUP sampling	1	0	11863	29500	11863	
31020	Premature termination	premature termination	1	0	16515	31021	16515	
34844	Nisreen Alwan	INFunknownSUP Alwan	1	0	34846	34845	34846	
11160	SARS-CoV-2 Infection Severe acute respiratory syndrome coronavirus	INFunknownSUP infection severe acute respiratory syndrome coronavirus	1	0	11162	28	339	
38448	albumin Creatinine ratio &gt	albumin creatinine ratio &gt	1	0	38450	16399	2385	
34465	Point-of-care rapid antigen-based tests	INFunknownSUP rapid INFunknownSUP test	1	0	34467	34466	1365	
16999	potent virucidal effects	potent INFunknownSUP effect	1	0	17001	1408	156	
26514	detection of viruses	detection of virus	1	0	44	2217	44	
36024	Diagnostic evaluation of different primer-probe	diagnostic evaluation of different primer-probe	1	0	36026	12099	2399	
18339	naive severe coronavirus disease	naive severe coronavirus disease	1	0	18341	3656	209	
38121	receiver operator characteristic curve	receiver operator characteristic curve	1	0	38123	38122	6817	
26893	screening of individual samples	screening of individual sample	1	0	7961	26895	7961	
31141	Learning New Ways of Teaching	Learning New Ways of teaching	1	0	31143	11396	31146	
24480	I2=0 %	INFunknownSUP %	1	0	364	24481	364	
30415	term safety of booster immunization	term safety of booster immunization	1	0	30417	30416	6729	
27499	initial infection symptoms	initial infection symptom	1	0	86	4487	86	
9532	risk framing	risk framing	1	0	9534	1542	9534	
36838	C infections	C infection	1	0	779	2540	779	
34398	lockdown resilience	INFunknownSUP resilience	1	0	4654	16099	4654	
22159	Severe Acute Respiratory Disease Coronavirus	Severe acute respiratory disease INFunknownSUP	1	0	22161	5189	3206	
29531	generation biological therapies	generation biological therapy	1	0	29533	3033	5507	
9965	course of antibody concentrations	course of antibody concentration	1	0	5152	9967	5152	
2984	material sharing	material sharing	1	0	2986	551	2986	
12246	autoimmune mechanisms	autoimmune mechanism	1	0	1456	12247	1456	
37031	novel research	novel research	1	0	36	3645	36	
18049	characteristics of the trend of daily count of COVID-19 deaths	characteristic of the trend of daily count of INFunknownSUP death	1	0	1496	18051	1496	
11998	daily scheduling	daily scheduling	1	0	12000	191	12000	
3729	Music Education	Music Education	1	0	3731	3730	3731	
10065	serological status of children	serological status of child	1	0	10067	2753	2720	
4666	Computational analyses	computational analysis	1	0	4668	4667	4668	
20773	Meta-regression analysis	Meta-regression analysis	1	0	486	20774	486	
1677	early-stage COVID-19	early-stage INFunknownSUP	1	0	40	1678	40	
37897	Angiotensin-converting enzyme	INFunknownSUP enzyme	1	0	624	37898	624	
15256	numerous domains	numerous domain	1	0	1180	531	1180	
34148	Beiwe platform	INFunknownSUP platform	1	0	1709	34149	1709	
11941	viral load of SARS-CoV-2	viral load of INFunknownSUP	1	0	5917	28	5919	
31639	die Belastungen	die INFunknownSUP	1	0	31641	1008	31641	
23367	official websites	official website	1	0	15369	20518	15369	
8529	age of health care workers	age of health care worker	1	0	906	1132	906	
12946	severe acute respiratory coronavirus virus	severe acute respiratory coronavirus virus	1	0	12948	262	778	
26415	e-Learning Environment Scale	e-Learning Environment Scale	1	0	11397	25346	1203	
28925	estimates of DALYs	estimate of INFunknownSUP	1	0	5370	7683	5370	
9498	respiratory control	respiratory control	1	0	510	259	510	
24897	Baseline characteristics	baseline characteristic	1	0	1496	24898	1496	
9143	exceptional cases	exceptional case	1	0	229	9144	229	
9986	Covid-19 patients	INFunknownSUP patient	1	0	60	1884	60	
1651	single cells	single cell	1	0	133	1652	133	
30847	randomization rate	randomization rate	1	0	1034	25524	1034	
39104	healthy eyes	healthy eye	1	0	18974	1021	18974	
30319	wailupemycins H	INFunknownSUP H	1	0	30321	30320	30321	
24543	crucial protein	crucial protein	1	0	1797	10865	1797	
30806	preventive methods	preventive method	1	0	205	6893	205	
14768	non-COVID-19 pneumonia	INFunknownSUP pneumonia	1	0	2369	8107	2369	
30068	data source	data source	1	0	1971	14273	1971	
31368	trial reports:that	trial INFunknownSUP	1	0	31370	965	31370	
33586	Iranian woman	Iranian woman	1	0	33588	1227	33588	
27157	established high-risk comorbidities	established high-risk comorbidity	1	0	27159	10154	676	
10262	personal characteristics	personal characteristic	1	0	1496	4961	1496	
578	inference time	inference time	1	0	179	579	179	
8080	Viral Load	viral load	1	0	8082	8081	8082	
25718	social psychiatry Homeless experts	social psychiatry homeless expert	1	0	25720	383	6478	
32024	accurate number of people	accurate number of people	1	0	32026	324	916	
9200	important differences	important difference	1	0	5663	273	5663	
129	renal endothelial cells	renal endothelial cell	1	0	131	130	133	
14970	exposure to the coronavirus	exposure to the coronavirus	1	0	1054	339	1054	
33529	CDC recommendations	CDC recommendation	1	0	652	90	652	
15067	structure coefficient	structure coefficient	1	0	4664	2427	4664	
9807	gaming data usage	gaming datum usage	1	0	9809	9808	2248	
9778	acute diseases	acute disease	1	0	315	1461	315	
2643	patient related outcome measures	patient related outcome measure	1	0	317	2644	317	
1090	way of treatment	way of treatment	1	0	701	97	701	
37013	induction of IgG	induction of IgG	1	0	11782	928	11782	
37634	innovative pedestrian 3D localization method	innovative pedestrian 3D localization method	1	0	37636	18587	6587	
20514	morbidity rates	morbidity rate	1	0	83	1216	83	
25041	framework to every patient encounter	framework to every patient encounter	1	0	4860	25043	4860	
20001	modes of presentation	mode of presentation	1	0	15425	4163	15425	
19820	frequent cause of BSI	frequent cause of BSI	1	0	19822	1168	14198	
36506	human endemic betacoronaviruses	human endemic betacoronavirus	1	0	36508	2214	32304	
12124	vaccine availability	vaccine availability	1	0	5099	577	5099	
4165	virtual local area networks	virtual local area network	1	0	4167	3148	4171	
20411	air flow	air flow	1	0	6423	868	6423	
407	crisis response	crisis response	1	0	409	408	409	
32166	sperm count	sperm count	1	0	1305	32167	1305	
935	dangerous new variant	dangerous new variant	1	0	937	936	939	
21019	clinical telemedicine	clinical telemedicine	1	0	16044	884	16044	
30865	patient demographics	patient demographic	1	0	26768	2645	26768	
26248	Conference Papers Index	Conference Papers Index	1	0	26250	26249	7907	
5728	expression levels	expression level	1	0	169	5729	169	
9412	novel strategies	novel strategy	1	0	300	810	300	
6372	essential service provision	essential service provision	1	0	6374	4197	6376	
6917	Google Scholar databases	INFunknownSUP scholar database	1	0	6919	3542	1755	
20305	long periods	long period	1	0	873	3921	873	
38385	non-woven media Centralized manufacturing	non-woven medium centralized manufacturing	1	0	38389	30241	718	
13533	Optimal nutrition	optimal nutrition	1	0	5674	13534	5674	
29544	Trauma-Informed Care	INFunknownSUP Care	1	0	5417	29545	5417	
28283	primary mode of telehealth	primary mode of telehealth	1	0	28285	75	18075	
34001	estimated herd immunity threshold	estimated herd immunity threshold	1	0	34003	18816	451	
36944	King Saud bin Abdulaziz University	King Saud bin Abdulaziz University	1	0	36946	36945	50	
27440	Ill Patients	Ill Patients	1	0	3207	27441	3207	
4401	disease virus	disease virus	1	0	778	209	778	
28619	extensive research	extensive research	1	0	36	15213	36	
8669	socio-economic policies	socio-economic policy	1	0	1760	8670	1760	
1066	clinical illness burden	clinical illness burden	1	0	1068	884	1070	
20494	deep space infections	deep space infection	1	0	20496	2520	779	
29464	Healthcare Workers	Healthcare Workers	1	0	18488	1355	18488	
16560	technology acceptance model	technology acceptance model	1	0	16562	1718	1078	
29727	utility of e-learning methods	utility of e-learning method	1	0	3934	10026	3934	
31177	situational analysis of the public health	situational analysis of the public health	1	0	31179	8618	486	
9867	different characteristics	different characteristic	1	0	1496	688	1496	
32308	safe approach	safe approach	1	0	1538	4136	1538	
17289	nasal cannula patients	nasal cannula patient	1	0	60	17290	60	
35380	Stanford Acute Stress Reaction	Stanford acute stress reaction	1	0	35382	35381	17014	
7766	health care resources	health care resource	1	0	7768	120	835	
20335	IgY production	IgY production	1	0	654	13004	654	
12293	facial skin lesions	facial skin lesion	1	0	160	7397	162	
3223	geriatric patients	geriatric patient	1	0	60	2134	60	
29896	Skin Problems	skin Problems	1	0	29898	14025	29898	
39161	last vaccine injection	last vaccine injection	1	0	39163	3723	26275	
11781	induction of specific antibodies	induction of specific antibody	1	0	11782	11783	11782	
33946	consumption ratios	consumption ratio	1	0	19889	1267	19889	
6664	emergency setting	emergency setting	1	0	2854	447	2854	
36629	pulmonary rehabilitation programme models	pulmonary rehabilitation programme model	1	0	3975	36630	3975	
14827	number of novel coronavirus	number of novel coronavirus	1	0	916	3644	916	
5218	multidisciplinary teams	multidisciplinary team	1	0	5220	5219	5220	
33360	role of the pharmacy profession	role of the pharmacy profession	1	0	7288	33362	7288	
22431	SARS-CoV-2 Coronavirus	INFunknownSUP INFunknownSUP	1	0	3206	28	3206	
15028	on-premises operation	on-premises operation	1	0	15030	15029	15030	
33694	gastric intestinal infections	gastric intestinal infection	1	0	33696	33695	779	
12474	Insurance Scheme	insurance scheme	1	0	12476	12475	12476	
19055	components of vertebrate antiretroviral defence mechanisms	component of vertebrate antiretroviral defence mechanism	1	0	19056	19057	19056	
37863	variety of cardiac manifestations	variety of cardiac manifestation	1	0	881	21704	881	
22582	protein validation	protein validation	1	0	6319	1797	6319	
25685	digital behavior	digital behavior	1	0	16069	1094	16069	
4968	Drug Toxicities Studies	Drug toxicity study	1	0	4970	4969	1533	
19378	situation of the school	situation of the school	1	0	3056	355	3056	
32697	survey of female workers	survey of female worker	1	0	967	22442	967	
9744	premium price	premium price	1	0	9746	9745	9746	
22855	objective evaluations	objective evaluation	1	0	2456	8297	2456	
38894	Educational documents	educational document	1	0	38896	38895	38896	
15267	Mikrogen Diagnostik	INFunknownSUP INFunknownSUP	1	0	15269	15268	15269	
21344	StopCOVID NI	INFunknownSUP NI	1	0	21346	21345	21346	
29261	relation to the phthalates	relation to the INFunknownSUP	1	0	14883	21792	14883	
15744	Liquid chromatography high resolution mass spectrometry	liquid chromatography high resolution mass spectrometry	1	0	15746	15745	15754	
8514	lifesaving procedures	lifesaving procedure	1	0	4200	8515	4200	
6082	neurosurgery residents	neurosurgery resident	1	0	232	6083	232	
17054	Selected District Hospital	selected District Hospital	1	0	17056	17055	1879	
23574	PCR positive swab	PCR positive swab	1	0	23576	3981	3979	
2799	expansion of distinct neutrophil states	expansion of distinct neutrophil state	1	0	781	2801	781	
1492	comparable clinical characteristics	comparable clinical characteristic	1	0	1494	1493	1496	
33583	future threats	future threat	1	0	1370	1367	1370	
31343	fewer outings	few outing	1	0	31345	1479	31345	
23553	impact of modified teaching strategies	impact of modified teaching strategy	1	0	110	10046	110	
1153	Sulfated polysaccharides	Sulfated polysaccharide	1	0	1155	1154	1155	
24503	selected variables	selected variable	1	0	817	1620	817	
20282	binding capacity	binding capacity	1	0	3026	2921	3026	
7056	effective diagnostic decisions	effective diagnostic decision	1	0	7058	2051	1942	
23959	los ritos funebres alternativos	los INFunknownSUP INFunknownSUP INFunknownSUP	1	0	23961	2632	23965	
27853	Anti-viral immunity	anti-viral immunity	1	0	257	27854	257	
22950	phage cocktails	phage cocktail	1	0	22952	22951	22952	
16633	light of the COVID-19 outbreak	light of the INFunknownSUP outbreak	1	0	8068	308	8068	
29652	HIV-focused infrastructure	HIV-focused infrastructure	1	0	21192	29653	21192	
588	pulmonary immunopathology enhancement	pulmonary Immunopathology enhancement	1	0	592	589	592	
24135	Medical Students	Medical student	1	0	4368	2779	4368	
36752	care delivery	care delivery	1	0	2840	9	2840	
35204	severe skin lesions	severe skin lesion	1	0	160	262	162	
3719	release syndrome	release syndrome	1	0	1936	3720	1936	
17361	Concerns Cancer patients	concern Cancer patient	1	0	17363	17362	60	
37942	viral genome	viral genome	1	0	2173	1741	2173	
1801	current coronavirus disease	current coronavirus disease	1	0	338	443	209	
19649	Control System	Control System	1	0	19651	7255	19651	
15908	business of medicine	business of medicine	1	0	693	1110	693	
34183	local street population	local street population	1	0	34185	3173	1838	
24858	school settings	school setting	1	0	2729	355	2729	
6887	genetic/environmental factors	genetic/environmental factor	1	0	583	6888	583	
909	proportion of COVID-19 patients	proportion of INFunknownSUP patient	1	0	910	911	910	
1148	SARS-CoV-2 RNA test	INFunknownSUP RNA test	1	0	1150	28	754	
29585	negative impact of SARS-CoV-2 infection	negative impact of INFunknownSUP infection	1	0	29587	1338	110	
17270	correct management of diabetes	correct management of diabetes	1	0	17272	1120	743	
17636	data entry	datum entry	1	0	5629	22	5629	
39056	activation of the complement system	activation of the complement system	1	0	1013	39058	1013	
14269	significant loss	significant loss	1	0	3586	908	3586	
1733	national product	national product	1	0	1735	517	1735	
2417	presence of genome scale RNA secondary structure	presence of genome scale RNA secondary structure	1	0	675	2419	675	
18233	serial nasopharyngeal swabs	serial nasopharyngeal swab	1	0	18235	12026	15316	
27677	Initial Pandemic Surge	initial pandemic surge	1	0	27679	27678	9069	
21648	in-hospital care	in-hospital care	1	0	9	411	9	
10797	basic supplies	basic supply	1	0	6905	4643	6905	
1117	% correct classification	% correct classification	1	0	1119	364	1121	
35736	standard of care therapy	standard of care therapy	1	0	2273	35737	2273	
33190	Native myocardial T1 relaxation times	native myocardial INFunknownSUP relaxation time	1	0	33192	33191	12806	
39300	severity of coronavirus disease	severity of coronavirus disease	1	0	5116	338	5116	
37974	item scores	item score	1	0	3726	32587	3726	
26694	person-bound expertise	person-bound expertise	1	0	19017	26695	19017	
32202	COVID-19 closures of physical activity-supporting facilities	INFunknownSUP closure of physical INFunknownSUP facility	1	0	32204	40	23196	
38946	potential targets	potential target	1	0	4044	1276	4044	
21402	wider range of data collection	wide range of data collection	1	0	21404	11790	420	
16412	resource availability	resource availability	1	0	5099	2703	5099	
31721	short review	short review	1	0	1723	16760	1723	
20823	global psychiatric literature	global psychiatric literature	1	0	12127	1954	4698	
26508	modulation of responses	modulation of response	1	0	19294	200	19294	
8706	family history of autoimmunity	family history of autoimmunity	1	0	5379	8710	5381	
30402	Post-COVID Era Telehealth	INFunknownSUP Era Telehealth	1	0	2114	30403	2114	
26155	World Health Organization)-China Joint Mission	World Health Organization)-China Joint Mission	1	0	26157	5804	26163	
23621	univariate model	INFunknownSUP model	1	0	1078	23622	1078	
14806	risk of surgical site infection	risk of surgical site infection	1	0	1542	14808	1542	
1278	second waves of COVID-19	second wave of INFunknownSUP	1	0	1280	1279	1281	
10942	public health orders	public health order	1	0	7838	1320	7838	
31264	functional abnormalities	functional abnormality	1	0	22738	4225	22738	
17267	Cutaneous manifestations	cutaneous manifestation	1	0	885	17268	885	
21086	Model Perspective	Model Perspective	1	0	10704	7734	10704	
12790	satellite-derived atmospheric column NO2 data	INFunknownSUP atmospheric column INFunknownSUP datum	1	0	12792	12791	22	
14395	radiographic patterns	radiographic pattern	1	0	548	5121	548	
23899	Covid-19 patients Coronavirus Disease 2019	INFunknownSUP patient INFunknownSUP Disease 2019	1	0	20854	23900	20854	
12712	in-person introductory seminar	in-person introductory seminar	1	0	12714	9275	12716	
13486	main effects-factors of risk severity	main effects-factor of risk severity	1	0	13488	4679	13489	
6828	T403R RaTG13	INFunknownSUP INFunknownSUP	1	0	6830	6326	6830	
15356	public-health experts	public-health expert	1	0	6478	15357	6478	
23067	implementation of e-health	implementation of e-health	1	0	396	23069	396	
12023	role of serial hs-TnI assessment	role of serial INFunknownSUP assessment	1	0	7288	12025	7288	
2532	high intravenous dose of vitamin C	high intravenous dose of vitamin C	1	0	2534	13	2537	
28291	worldwide task	worldwide task	1	0	468	8376	468	
23869	new innovative strategies	new innovative strategy	1	0	20390	69	300	
21431	effective sharing of basic needs	effective sharing of basic need	1	0	21433	2051	2986	
32956	immunoglobulin G	immunoglobulin G	1	0	30252	23490	30252	
28785	localization techniques	localization technique	1	0	691	16351	691	
17790	mRNA-1273 Vaccine	mRNA-1273 vaccine	1	0	685	17791	685	
34188	collaborative study	collaborative study	1	0	2087	34189	2087	
31511	challenge to diabetic patients	challenge to diabetic patient	1	0	62	31513	62	
24806	significant challenges	significant challenge	1	0	2220	908	2220	
27170	Mental health professionals	mental health professional	1	0	121	27171	121	
20472	number of teachers	number of teacher	1	0	916	53	916	
26594	psychological status	psychological status	1	0	2720	1380	2720	
1432	social life	social life	1	0	1434	383	1434	
35401	analysis of a large US cohort	analysis of a large US cohort	1	0	486	35403	486	
28993	standard of viral detection	standard of viral detection	1	0	17	28995	17	
32311	median of a panel of controls	median of a panel of control	1	0	32312	32313	32312	
380	introduction of social distancing	introduction of social distancing	1	0	381	382	381	
16233	precariousness of income	precariousness of income	1	0	16234	5356	16234	
19302	unpreparedness of Libyan hospitals	unpreparedness of Libyan hospital	1	0	19303	19304	19303	
26854	complete blood cell count	complete blood cell count	1	0	26856	4186	1305	
27228	economic reform	economic reform	1	0	10879	108	10879	
2035	mental durante	mental INFunknownSUP	1	0	2037	119	2037	
33521	predictors of treatment success	predictor of treatment success	1	0	414	33523	414	
37514	decoder section	decoder section	1	0	22059	37515	22059	
3123	authentic dietary guidelines	authentic dietary guideline	1	0	3125	3124	91	
20542	similar research	similar research	1	0	36	102	36	
4204	understanding of the biological processes	understanding of the biological process	1	0	2715	3379	2715	
13681	lymph node	lymph node	1	0	13683	13682	13683	
29493	feature selection	feature selection	1	0	5520	29494	5520	
13593	referral COVID-19 center	referral INFunknownSUP center	1	0	13595	2964	8718	
36493	weekday alcohol use pattern	weekday alcohol use pattern	1	0	36495	36494	4682	
5329	Nurse Managers	nurse manager	1	0	5331	5330	5331	
14450	cases of decompressive craniectomy	case of decompressive INFunknownSUP	1	0	229	14452	229	
29116	spread of coronavirus disease	spread of coronavirus disease	1	0	570	338	570	
34545	federal government	federal government	1	0	99	1598	99	
28874	team member in-person contact	team member in-person contact	1	0	28878	7207	1888	
29825	Respiratory syncytial virus	respiratory syncytial virus	1	0	29827	3287	778	
33343	available healthcare resources	available INFunknownSUP resource	1	0	835	33344	835	
36136	Ease scales	ease scale	1	0	7864	36137	7864	
30644	off-the shelf	INFunknownSUP shelf	1	0	30646	30645	30646	
16467	low urinary volume	low urinary volume	1	0	16469	457	3445	
34517	cognitive presence	cognitive presence	1	0	675	4498	675	
5079	action research approach	action research approach	1	0	5081	1223	1538	
31259	final psychologic survey	final INFunknownSUP survey	1	0	31261	4256	967	
20817	in-depth review of the current global psychiatric literature	in-depth review of the current global psychiatric literature	1	0	20819	20818	1723	
9044	response to social distancing	response to social distancing	1	0	409	382	409	
10735	fatality cases	fatality case	1	0	229	3369	229	
16369	global priorities	global priority	1	0	16371	1954	16371	
38703	damage to patients	damage to patient	1	0	5946	60	5946	
1710	insurance customers	insurance customer	1	0	1712	1711	1712	
29680	transfer of diluted postvaccination polyclonal antibodies	transfer of diluted postvaccination polyclonal antibody	1	0	10218	29682	10218	
2410	Severity of COVID-19 Lung Injury	severity of INFunknownSUP Lung Injury	1	0	2414	2411	2416	
24394	rapid chromatographic test	rapid chromatographic test	1	0	24396	795	754	
21142	types of antigens	type of antigen	1	0	1979	21144	1979	
37699	PXS scores &gt	PXS score &gt	1	0	37701	4889	2385	
20942	general surgery	general surgery	1	0	1630	1080	1630	
7498	common problems	common problem	1	0	6766	699	6766	
12321	anti-viral immunity	anti-viral immunity	1	0	257	1410	257	
24725	strength of mRNA-vaccination	strength of mRNA-vaccination	1	0	11503	23131	11503	
9311	cross-sectional analysis	cross-sectional analysis	1	0	486	2493	486	
4446	rtRT-PCR tests	INFunknownSUP test	1	0	1365	4447	1365	
33135	used multiple sources	used multiple source	1	0	33137	33136	4158	
10188	public mental health strategies	public mental health strategy	1	0	300	10189	300	
22378	course of a probiotics-assisted therapy	course of a INFunknownSUP therapy	1	0	5152	22380	5152	
25189	Use Treatment Program	Use Treatment Program	1	0	25191	20603	25193	
29689	socioeconomic context	socioeconomic context	1	0	1567	16	1567	
34199	reproductive numbers (R(t))	reproductive number INFunknownSUP	1	0	12541	34200	12541	
34916	Ongoing evaluation	ongoing evaluation	1	0	2399	34917	2399	
27128	18F-FDG uptake	INFunknownSUP uptake	1	0	19195	12201	19195	
13028	font color	font color	1	0	13030	902	13030	
25843	COVID-19 convalescent individuals	INFunknownSUP convalescent individual	1	0	17509	40	1113	
30324	extracorporeal membrane oxygenation	extracorporeal membrane oxygenation	1	0	30326	30325	7365	
38546	COVID-19-related disruptions	COVID-19-related disruption	1	0	38548	1384	38548	
34928	outbreak trend	outbreak trend	1	0	6677	310	6677	
25231	list of internet-based resources	list of INFunknownSUP resource	1	0	15703	25233	15703	
32411	Non-Coding RNAs Reveal Extracellular Vesicles	INFunknownSUP INFunknownSUP Reveal extracellular vesicle	1	0	32415	32412	32419	
836	use of UpToDate	use of INFunknownSUP	1	0	292	838	292	
19347	Monocular Pedestrian 3D Localization	monocular pedestrian 3D localization	1	0	19349	19348	19353	
14710	applicability of the methodology	applicability of the methodology	1	0	7137	11687	7137	
30538	permitieron identificar	INFunknownSUP INFunknownSUP	1	0	30540	30539	30540	
26742	COVID-19 contact-tracing apps	INFunknownSUP contact-tracing INFunknownSUP	1	0	26744	40	17206	
3519	levels of PEEP	level of peep	1	0	169	3521	169	
3103	differential equations	differential equation	1	0	3105	3104	3105	
13124	COVID-19 Front Line -	INFunknownSUP Front Line INFunknownSUP	1	0	13126	40	5345	
30483	non-intubated COVID-19 inpatients	INFunknownSUP INFunknownSUP inpatient	1	0	30487	30484	30487	
38337	forced widespread use of face coverings	forced widespread use of face covering	1	0	38339	38338	292	
4770	junior high school	junior high school	1	0	821	282	355	
32737	Intolerance of Uncertainty	intolerance of uncertainty	1	0	32738	32739	32738	
23560	Hospital admissions	hospital admission	1	0	3085	4111	3085	
18667	Coronavirus COVID-19 outbreak	INFunknownSUP INFunknownSUP outbreak	1	0	310	18668	310	
22227	Colloidal gold immunochromatographic assay	colloidal gold immunochromatographic assay	1	0	14859	22228	3119	
30537	permitieron identificar estrategias	INFunknownSUP INFunknownSUP INFunknownSUP	1	0	30541	30538	30541	
26433	transcriptome analysis	INFunknownSUP analysis	1	0	486	26434	486	
31454	bronchiolitis cases	INFunknownSUP case	1	0	229	5471	229	
11383	SOT recipients	sot recipient	1	0	11385	11384	11385	
15880	Disorder-7 scale	INFunknownSUP scale	1	0	2422	15881	2422	
33241	current popularity of virtual horse showing	current popularity of virtual horse showing	1	0	33243	443	17205	
12832	Ocular coherence tomography angiography	ocular coherence tomography angiography	1	0	7442	12833	7446	
21113	care situation	care situation	1	0	3056	9	3056	
13511	large international study	large international study	1	0	13513	4250	2087	
15512	fresh topics	fresh topic	1	0	8732	15513	8732	
35762	-SVEIHQRD mathematical model	INFunknownSUP mathematical model	1	0	9495	35763	1078	
812	asocian con variables demograficas	INFunknownSUP con variable INFunknownSUP	1	0	814	813	818	
11206	shared repertoire	shared repertoire	1	0	10422	3496	10422	
10197	assessment of lung CT	assessment of lung CT	1	0	238	10199	238	
21529	undergraduate dental curricula	undergraduate dental curriculum	1	0	21531	11601	13382	
12569	Viral laboratory-confirmation	viral laboratory-confirmation	1	0	12571	8081	12571	
10838	new digital technologies	new digital technology	1	0	10840	69	70	
32003	potential association	potential association	1	0	11619	1276	11619	
36851	self-isolation measures	self-isolation measure	1	0	317	32595	317	
21916	Cybersecurity Risks	Cybersecurity risk	1	0	21918	19834	21918	
35508	malignant cerebral strokes	malignant cerebral stroke	1	0	35510	3530	3531	
5343	baseline -	baseline INFunknownSUP	1	0	5345	5344	5345	
8609	FFR supply chain	FFR supply chain	1	0	8611	8610	2362	
674	presence of comorbidities	presence of comorbidity	1	0	675	676	675	
13546	Enforcement agency	Enforcement agency	1	0	13507	13547	13507	
4221	height values	height value	1	0	825	4222	825	
27619	negative effects of COVID-19	negative effect of INFunknownSUP	1	0	10010	40	156	
18399	pandemic-related impacts	pandemic-related impact	1	0	1385	18400	1385	
18969	evidence of Covid-19	evidence of INFunknownSUP	1	0	585	1884	585	
24469	pandemic talk	pandemic talk	1	0	20663	1354	20663	
5828	impact of an extended lockdown	impact of an extended INFunknownSUP	1	0	110	5830	110	
33600	regional risk factors	regional risk factor	1	0	3561	4068	583	
19564	Likelihood of survival of coronavirus disease	likelihood of survival of coronavirus disease	1	0	19565	19566	19565	
9161	structure dependence of sites	structure dependence of site	1	0	9163	2427	9164	
4864	Literature review	literature review	1	0	1723	4865	1723	
225	SARS-CoV-2 positive cases	INFunknownSUP positive case	1	0	227	226	229	
33083	mechanisms of immune regulation	mechanism of immune regulation	1	0	1456	33085	1456	
9230	allogeneic MSCs	INFunknownSUP INFunknownSUP	1	0	9232	138	9232	
32236	early experiences	early experience	1	0	1339	55	1339	
14993	inhibitory effect of the non-structural protein	inhibitory effect of the non-structural protein	1	0	14995	2227	1809	
27181	CD8 T clones	INFunknownSUP T clone	1	0	27183	787	27185	
22367	health resources	health resource	1	0	835	120	835	
11352	diagnostic importance	diagnostic importance	1	0	2765	2219	2765	
22815	future psychiatric conditions	future psychiatric condition	1	0	9677	1367	2910	
4002	appropriate patient care	appropriate patient care	1	0	4004	1256	9	
13268	potential diagnostic biomarkers of COVID-19	potential diagnostic biomarker of INFunknownSUP	1	0	13270	1276	2577	
29326	adherence levels	adherence level	1	0	169	3636	169	
7531	effective COVID-19 vaccine	effective INFunknownSUP vaccine	1	0	3688	2051	577	
19783	Wakayama prefecture	Wakayama prefecture	1	0	19785	19784	19785	
11124	infection Individual susceptibility	infection individual susceptibility	1	0	11126	41	10460	
29836	COVID-19 negative participants	INFunknownSUP negative participant	1	0	29838	3706	4950	
34026	neurosurgery program	neurosurgery program	1	0	1790	6083	1790	
465	erratic task behaviour	erratic task behaviour	1	0	467	466	469	
37010	low preference	low preference	1	0	4438	457	4438	
31877	binding mode	binding mode	1	0	18075	2921	18075	
4854	IRGC risk governance framework	INFunknownSUP risk governance framework	1	0	4856	4855	4860	
101	similar pandemics	similar pandemic	1	0	103	102	103	
12928	complaint of respiratory tract involvement	complaint of respiratory tract involvement	1	0	12929	12930	12929	
16192	infection control COVID-19	infection control INFunknownSUP	1	0	40	4940	40	
495	facility-onset Clostridioides	facility-onset INFunknownSUP	1	0	497	496	497	
10742	SCI mice	SCI mouse	1	0	10744	10743	10744	
10408	conservation of biodiversity	conservation of biodiversity	1	0	10409	10410	10409	
23025	Acute Stroke	acute stroke	1	0	5248	14013	5248	
25858	combination of AutoDock Vina	combination of INFunknownSUP Vina	1	0	367	25860	367	
11773	COVID-19 Cardiovascular	INFunknownSUP Cardiovascular	1	0	11775	40	11775	
9705	maximum hs-TnI	maximum INFunknownSUP	1	0	9707	2651	9707	
5313	technology adoption	technology adoption	1	0	88	1718	88	
26703	data analysis	data analysis	1	0	486	14273	486	
6006	adherence to national guidelines	adherence to national guideline	1	0	3636	6008	3636	
21264	COVID-19 infection Neurologic complications	INFunknownSUP infection neurologic complication	1	0	21266	40	705	
2146	trimerization of the spike	INFunknownSUP of the spike	1	0	2147	31	2147	
29044	Internal Medicine	Internal Medicine	1	0	1951	29045	1951	
38050	data repositories	datum repository	1	0	38052	22	38052	
3661	unexposed individuals Recent studies	unexposed individual Recent study	1	0	3663	1023	136	
11951	world points	world point	1	0	23	4336	23	
17310	independent hospital	independent hospital	1	0	185	582	185	
29198	incidence rate of reinfection	incidence rate of reinfection	1	0	9944	1451	1034	
3389	findings of patients	finding of patient	1	0	3390	60	3390	
1058	ongoing relevance	ongoing relevance	1	0	856	1059	856	
1308	spring semester	spring semester	1	0	1310	1309	1310	
26517	emergency surgery morbidity	emergency surgery morbidity	1	0	26519	447	1216	
27443	Three SSIs	Three INFunknownSUP	1	0	27445	27444	27445	
1007	die sportlichen	die sportlichen	1	0	1009	1008	1009	
25749	Development of a telehealth geriatric assessment model	Development of a INFunknownSUP geriatric assessment model	1	0	9277	25751	9277	
21580	dental setting	dental setting	1	0	2854	5656	2854	
17606	Joint Replacement Registry	Joint replacement registry	1	0	17608	17607	17610	
26301	high schools	high school	1	0	6421	13	6421	
25323	workforce data	workforce datum	1	0	22	3750	22	
10669	real-time information	real-time information	1	0	2591	1429	2591	
33885	undergraduate occupational therapy	undergraduate occupational therapy	1	0	2271	11601	2273	
5514	medication use policy	medication use policy	1	0	291	153	293	
9821	surgical associations	surgical association	1	0	5750	663	5750	
5154	high viral shedding	high viral shedding	1	0	5156	13	5158	
15162	related sick leave	related sick leave	1	0	415	2647	417	
9957	field-effect transistor-based biosensing	INFunknownSUP INFunknownSUP INFunknownSUP	1	0	9961	9958	9961	
26827	extent of the risks	extent of the risk	1	0	17456	8152	17456	
2200	worried well	worried well	1	0	2202	2201	2202	
23327	telehealth outpatient	telehealth outpatient	1	0	327	304	327	
25064	COVID-19 Global Pandemic	INFunknownSUP Global pandemic	1	0	25066	40	6338	
24475	healthcare system preparedness	INFunknownSUP system preparedness	1	0	6467	20292	6467	
20792	person living	person living	1	0	8905	6403	8905	
13102	second wave of COVID-19	second wave of INFunknownSUP	1	0	13103	40	10210	
36779	% level	% level	1	0	362	364	362	
25915	right ventricular free wall longitudinal strain	right ventricular free wall longitudinal strain	1	0	25917	15176	1107	
10077	medical school ranking	medical school ranking	1	0	4270	10078	4270	
39166	master regulator of metaflammation	master regulator of INFunknownSUP	1	0	39168	39167	39169	
10228	complication of COVID-19 infection	complication of INFunknownSUP infection	1	0	2206	39	2206	
21150	beta coronavirus	beta coronavirus	1	0	339	21151	339	
12491	national lockdowns	national lockdown	1	0	1486	517	1486	
35178	viral circulation	viral circulation	1	0	4087	1741	4087	
16917	Testis of COVID-19 Patients	testis of INFunknownSUP Patients	1	0	16918	16919	16918	
849	key mutations:K417N	key INFunknownSUP	1	0	851	850	851	
23202	population quarantine	population quarantine	1	0	2675	1838	2675	
12331	temperature monitoring	temperature monitoring	1	0	3271	195	3271	
36380	value &lt	value &lt	1	0	4863	1037	4863	
38326	therapeutic data	therapeutic datum	1	0	22	3349	22	
20062	use of masks	use of mask	1	0	292	3036	292	
9151	simulation results	simulation result	1	0	325	9152	325	
18429	sub-study of a larger project	sub-study of a large project	1	0	18430	18431	18430	
14705	concentrations of viral RNA	concentration of viral RNA	1	0	1959	11519	1959	
5570	Household Sample Survey	household Sample Survey	1	0	5572	5571	5574	
1905	pruebas y el numero de profesionales de medicina	INFunknownSUP y el numero de INFunknownSUP de INFunknownSUP	1	0	1907	1906	1919	
14890	Symptoms of dyspnea	symptom of dyspnea	1	0	14891	14892	14891	
17200	Mental Health	mental health	1	0	5250	8856	5250	
1613	3p21.31 locus	3p21.31 locus	1	0	1615	1614	1615	
19595	complementary strategy	complementary strategy	1	0	3350	16434	3350	
10536	solid organ transplantation	solid organ transplantation	1	0	10538	10537	10540	
3245	oxide treatment	oxide treatment	1	0	97	3246	97	
20122	reverse transcription-polymerase chain reaction machine	reverse transcription-polymerase chain reaction machine	1	0	934	16572	934	
1950	Medicine Association	Medicine Association	1	0	1952	1951	1952	
2391	prospective bariatric patients	prospective bariatric patient	1	0	2393	2084	60	
25810	Utrecht Work Engagement Scale	Utrecht Work engagement Scale	1	0	25812	25811	1203	
16812	copula parameters	copula parameter	1	0	6460	16813	6460	
26772	impact of COVID-19 restrictions	impact of INFunknownSUP restriction	1	0	110	19879	110	
9698	efficacy studies	efficacy study	1	0	136	6704	136	
30269	well-defined software upgrade procedures	well-defined software upgrade procedure	1	0	30271	30270	4200	
34794	vaccination campaign	vaccination campaign	1	0	34796	437	34796	
29611	common symbolic dynamics entropy	common symbolic dynamics entropy	1	0	26166	29612	26166	
26864	registered 503B outsourcing facilities	registered INFunknownSUP outsourcing facility	1	0	26866	3197	2676	
34603	physical fitness	physical fitness	1	0	34605	1242	34605	
11505	effective adjunct risk stratification tool	effective adjunct risk stratification tool	1	0	11507	2051	5487	
24852	Padova University	Padova University	1	0	50	24853	50	
4691	points of the procedure	point of the procedure	1	0	23	4693	23	
34108	non-invasive cardiac magnetic resonance	non-invasive cardiac magnetic resonance	1	0	34110	22489	9917	
3678	High levels of work engagement	high level of work engagement	1	0	3274	3682	169	
4456	Repertoire Analysis	repertoire analysis	1	0	204	4457	204	
23185	green font	green font	1	0	902	900	902	
14195	frequent cause of VAP	frequent cause of VAP	1	0	14197	1168	14198	
12465	gene heterogeneity	gene heterogeneity	1	0	1972	6495	1972	
29108	European cohort	European cohort	1	0	601	1622	601	
14163	present article	present article	1	0	3869	285	3869	
16826	medical field	medical field	1	0	6748	947	6748	
32637	neonatal SARS-CoV-2 test	neonatal INFunknownSUP test	1	0	14740	312	754	
33319	T-cell receptor	T-cell receptor	1	0	3502	33320	3502	
30116	tremendous impact	tremendous impact	1	0	110	1205	110	
1402	Radiograph Scores	radiograph score	1	0	1404	1403	1404	
8106	non-COVID-19 cases	INFunknownSUP case	1	0	229	8107	229	
34467	rapid antigen-based tests	rapid INFunknownSUP test	1	0	34469	795	1365	
4646	number of 2019-nCoV	number of INFunknownSUP	1	0	916	4648	916	
29918	non-white resident census	non-white resident census	1	0	29920	2483	2123	
34673	lung ultrasound score involvement	lung ultrasound score involvement	1	0	34675	772	3599	
31398	assist device	assist device	1	0	3001	31399	3001	
22605	waste crisis	waste crisis	1	0	408	13620	408	
30883	clinical procedures	clinical procedure	1	0	4200	884	4200	
7743	residues of SARS-CoV-2 spike glycoprotein	residue of INFunknownSUP spike glycoprotein	1	0	7744	7745	7744	
22868	one-way ANOVA	one-way INFunknownSUP	1	0	8512	22869	8512	
34705	south of Milan	south of Milan	1	0	34706	34707	34706	
4167	local area networks	local area network	1	0	4169	3173	4171	
10274	neuronal support	INFunknownSUP support	1	0	260	10275	260	
27493	B-cell malignancies	B-cell malignancy	1	0	27495	27494	27495	
22191	target virus	target virus	1	0	778	11730	778	
11533	wastewater samples	wastewater sample	1	0	1765	5093	1765	
16537	multiple myeloma	multiple myeloma	1	0	16539	1776	16539	
29162	Reduction of immunosuppression	reduction of immunosuppression	1	0	29163	2144	29163	
11726	new therapeutic target	new therapeutic target	1	0	11728	69	11730	
9226	mixed effects	mixed effect	1	0	156	9227	156	
16548	high-throughput screening	high-throughput screening	1	0	7961	16549	7961	
12397	access to emergency surgical care	access to emergency surgical care	1	0	224	12399	224	
16228	Integrated Chronic Disease	Integrated chronic disease	1	0	16230	16229	10958	
9548	implications COVID-19 infection	implication INFunknownSUP infection	1	0	39	9549	41	
35640	Radiation Oncology	radiation oncology	1	0	35642	35641	35642	
14571	viral loads	viral load	1	0	14573	1741	14573	
23849	health care center	health care center	1	0	11915	120	8718	
17419	category of teaching	category of teaching	1	0	17420	2074	17420	
38549	Implementation of these strategies	implementation of these strategy	1	0	17800	300	17800	
2707	normal body weight	normal body weight	1	0	2709	2708	2711	
34621	peak months	peak month	1	0	761	5928	761	
7383	imaging findings	imaging finding	1	0	3390	3936	3390	
9270	IgG prevalence	IgG prevalence	1	0	9272	928	9272	
11447	ongoing assault	ongoing assault	1	0	11449	1059	11449	
20106	management of inter-hospital transport	management of INFunknownSUP transport	1	0	743	7897	743	
904	recipient age	recipient age	1	0	906	905	906	
10658	pathway of severe acute respiratory syndrome coronavirus	pathway of severe acute respiratory syndrome coronavirus	1	0	5003	4709	5003	
22108	eligible articles	eligible article	1	0	811	5236	811	
30897	two-phase screening process	two-phase screening process	1	0	30899	30898	180	
9981	chest CT studies	chest CT study	1	0	136	24	136	
27546	Coronavirus disease-19	INFunknownSUP INFunknownSUP	1	0	27548	3206	27548	
33552	commercial centrifuge	commercial centrifuge	1	0	33554	1770	33554	
22690	integration of wearable devices	integration of wearable device	1	0	918	22692	918	
25296	in-person instruction	in-person instruction	1	0	15430	9275	15430	
20602	Use Personal Protection Measures	Use Personal Protection Measures	1	0	20604	20603	20608	
2018	Social Support Rate Scale	Social support Rate Scale	1	0	2020	2019	1203	
14103	recent discoveries	recent discovery	1	0	2684	2128	2684	
24460	hygiene measures	hygiene measure	1	0	317	8770	317	
3418	major SARS-CoV-2	major INFunknownSUP	1	0	226	1318	226	
10021	false-negative rates	false-negative rate	1	0	83	10022	83	
15197	different diagnostic tasks	different diagnostic task	1	0	15199	688	15201	
6815	epidemic curve	epidemic curve	1	0	6817	6542	6817	
19114	times of coronavirus	time of coronavirus	1	0	12806	339	12806	
37361	initial peak of COVID-19 cases	initial peak of INFunknownSUP case	1	0	37363	335	5928	
21153	Assessment of the risk of SARS-CoV-2 reinfection	Assessment of the risk of INFunknownSUP reinfection	1	0	2874	21155	2874	
32576	Consequences of COVID-19 pandemic	consequence of INFunknownSUP pandemic	1	0	32577	111	32577	
31321	small scales	small scale	1	0	7864	9600	7864	
9649	testing Aerosol spread	testing aerosol spread	1	0	9651	1885	570	
29891	positive samples	positive sample	1	0	1765	228	1765	
7979	herpes zoster	herpes zoster	1	0	7981	7980	7981	
17441	malarial patients	malarial patient	1	0	60	17442	60	
13666	innate immune cells	innate immune cell	1	0	13668	12377	133	
17223	metabolite ethyl sulfate	metabolite ethyl sulfate	1	0	17225	17224	17227	
37043	modified curriculum	modified curriculum	1	0	37045	4210	37045	
1413	Pesquisa Nacional por Amostra	INFunknownSUP Nacional por INFunknownSUP	1	0	1415	1414	1419	
16526	einer Mund-Nase-Maske auf	einer Mund-Nase-Maske auf	1	0	16528	16527	16530	
26716	infectivity of the virus	infectivity of the virus	1	0	26717	778	26717	
38786	de letalidad relativa	de letalidad INFunknownSUP	1	0	38790	38787	38790	
27979	Joanna Briggs Institute methodology	Joanna Briggs Institute methodology	1	0	27981	27980	11687	
26199	pathogenic species	pathogenic specie	1	0	3957	6190	3957	
7668	neurological status	neurological status	1	0	2720	2728	2720	
33540	mean size of a self-isolating household unit	mean size of a self-isolating household unit	1	0	33542	194	6366	
26159	Organization)-China Joint Mission	Organization)-China Joint Mission	1	0	26161	26160	26163	
31327	novel coronavirus infectious disease	novel coronavirus infectious disease	1	0	4216	3644	209	
16427	block grades	block grade	1	0	13725	16428	13725	
2578	COVID-19 Clinical similarities	INFunknownSUP clinical similarity	1	0	2580	40	2582	
35540	false negatives	false negative	1	0	35542	3364	35542	
13210	lung disease	lung disease	1	0	209	772	209	
33194	T1 relaxation times	INFunknownSUP relaxation time	1	0	33196	33195	12806	
26117	tertially care hospital	INFunknownSUP care hospital	1	0	183	26118	185	
4316	technology companies	technology company	1	0	2406	1718	2406	
10928	IPS group	IPS group	1	0	18	8559	18	
36167	diverse range of mammalian RNA viruses	diverse range of mammalian RNA virus	1	0	36169	10278	420	
27907	Polish study	Polish study	1	0	2087	27908	2087	
14261	de Valdecilla	de Valdecilla	1	0	14263	1421	14263	
29513	Spearman correlations	Spearman correlation	1	0	4576	13756	4576	
33738	prostate cancer care warrant long-term investigation	prostate cancer care warrant long-term investigation	1	0	33744	18728	7714	
31110	Structural equation modeling	structural equation modeling	1	0	31112	27990	464	
32702	critical tool	critical tool	1	0	5487	223	5487	
25559	probability of postoperative intensive care unit	probability of postoperative intensive care unit	1	0	7627	25561	7627	
31642	primar im aeroben Intensitatsbereich durchgefuhrt werden	primar im INFunknownSUP Intensitatsbereich INFunknownSUP INFunknownSUP	1	0	31644	31643	31652	
30814	aeroben und aerob-anaeroben Ubergangsbereich fand sich keine Verminderung der objektiven Leistungsparameter	INFunknownSUP und INFunknownSUP Ubergangsbereich INFunknownSUP INFunknownSUP INFunknownSUP INFunknownSUP der INFunknownSUP Leistungsparameter	1	0	30820	30815	30834	
27552	biological threats	biological threat	1	0	1370	855	1370	
38494	onset of the COVID-19 pandemic	onset of the INFunknownSUP pandemic	1	0	1647	111	1647	
27557	surgical mask use policy	surgical mask use policy	1	0	289	663	293	
28689	traumatic spinal cord injury Excessive inflammation post-traumatic spinal cord injury	traumatic spinal cord injury excessive inflammation post-traumatic spinal cord injury	1	0	28691	14943	713	
37550	resource-poor settings	INFunknownSUP setting	1	0	2729	37551	2729	
28205	medical equipment management systems	medical equipment management system	1	0	146	14432	146	
32508	similar framework	similar framework	1	0	4860	102	4860	
4637	early laboratory tests	early laboratory test	1	0	4639	55	1365	
16352	web survey experiments	web survey experiment	1	0	16354	16353	16356	
20806	mechanisms of COVID-19	mechanism of INFunknownSUP	1	0	1456	40	1456	
33091	inverse correlation	inverse correlation	1	0	2889	33092	2889	
17775	disease pathogenesis	disease pathogenesis	1	0	14794	209	14794	
13802	Neisseria perflava	INFunknownSUP INFunknownSUP	1	0	13804	13803	13804	
3663	individuals Recent studies	individual Recent study	1	0	3665	1113	136	
14574	significance levels	significance level	1	0	169	458	169	
3953	Reactive oxygen species	reactive oxygen specie	1	0	3955	3954	3957	
18235	nasopharyngeal swabs	nasopharyngeal swab	1	0	15316	7406	15316	
32136	hospital-discharge protocol	INFunknownSUP protocol	1	0	7962	32137	7962	
25383	long-term impact	long-term impact	1	0	110	4288	110	
11731	theoretical subjects	theoretical subject	1	0	4893	11732	4893	
35710	response to vaccines	response to vaccine	1	0	409	681	409	
23596	pulmonary metastasis	pulmonary metastasis	1	0	23598	590	23598	
15448	1st hour of admission to hospital	1st hour of admission to hospital	1	0	15450	15449	11528	
27771	Libraries Severe acute respiratory syndrome coronavirus	library severe acute respiratory syndrome coronavirus	1	0	9923	27772	339	
33145	immunity to the SARS-CoV-2 virus	immunity to the INFunknownSUP virus	1	0	257	4396	257	
32461	phase 3b ALITHIOS study	phase INFunknownSUP INFunknownSUP study	1	0	32463	1352	2087	
12763	Percutaneous tracheostomy simulation training	percutaneous tracheostomy simulation training	1	0	12765	12764	235	
22212	clinical settings	clinical setting	1	0	2729	884	2729	
15121	music faculties	music faculty	1	0	15123	1250	15123	
31756	COVID hospital areas	INFunknownSUP hospital area	1	0	31758	1649	1579	
10304	Wuhan City	Wuhan City	1	0	2814	6709	2814	
21862	severe acute renal papillary necrosis	severe acute renal papillary necrosis	1	0	21864	262	5738	
11272	less social support	less social support	1	0	1943	5525	260	
32066	distinct national publics	distinct national public	1	0	32068	2802	32070	
20650	behavioral responses	behavioral response	1	0	200	20651	200	
37822	RBD-ACE2 binding inhibitors	INFunknownSUP binding inhibitor	1	0	37824	37823	8870	
29442	low level of transmissibility	low level of INFunknownSUP	1	0	12432	3451	362	
28274	interferon programming	interferon programming	1	0	5936	28275	5936	
38445	COVID infection	INFunknownSUP infection	1	0	41	1649	41	
20236	chest images	chest image	1	0	4034	25	4034	
17135	young healthy adults	young healthy adult	1	0	3120	2882	515	
15653	protocol of acute stroke patients	protocol of acute stroke patient	1	0	7962	15655	7962	
17004	avoidance strategies	avoidance strategy	1	0	300	17005	300	
32581	centre of public discourse	centre of public discourse	1	0	25448	25026	25448	
27538	points post-confinement	point post-confinement	1	0	27540	23	27540	
6606	consecutive days	consecutive day	1	0	1645	6607	1645	
3476	intricate link	intricate link	1	0	3478	3477	3478	
15903	Management Isolation Chamber	Management isolation Chamber	1	0	15905	307	15907	
20798	30-day follow-up period	30-day follow-up period	1	0	20800	4517	5677	
14250	infection patterns SARS-CoV-2	infection pattern INFunknownSUP	1	0	28	10516	28	
17932	Personalized Diagnosis of Trivial Lesions	personalized diagnosis of trivial lesion	1	0	17934	17933	10673	
17487	small lesions	small lesion	1	0	162	9600	162	
484	lineage analysis	lineage analysis	1	0	486	485	486	
19800	clinical impact of this policy change	clinical impact of this policy change	1	0	19802	884	110	
16251	Notebaert Premier Fellowship	INFunknownSUP Premier fellowship	1	0	16253	16252	16255	
14525	central laboratories	central laboratory	1	0	9126	3393	9126	
9418	effective binding inhibition	effective binding inhibition	1	0	9420	2051	9422	
36609	index metric	index metric	1	0	36611	4017	36611	
34735	development of undesirable effects	development of undesirable effect	1	0	73	34737	73	
37322	sectors of the global economy	sector of the global economy	1	0	6015	6603	6015	
26554	phospholipase A2s exhibit strong virucidal activity	phospholipase A2s exhibit strong INFunknownSUP activity	1	0	26556	26555	3990	
34723	impact of the coronavirus disease	impact of the coronavirus disease	1	0	110	338	110	
12470	National Disability Insurance Scheme	National disability insurance scheme	1	0	12472	46	12476	
17747	narrative review study	narrative review study	1	0	2087	17748	2087	
650	set of recommendations	set of recommendation	1	0	651	652	651	
27549	eight-dimensional model	eight-dimensional model	1	0	1078	27550	1078	
17127	positive moderation effect	positive moderation effect	1	0	17129	228	1809	
22363	utilization of internet health resources	utilization of Internet health resource	1	0	4011	22365	4011	
22810	retinal thickness overall	retinal thickness overall	1	0	22812	22811	22814	
4079	regional injury	regional injury	1	0	713	4068	713	
8238	understanding of the difficulties	understanding of the difficulty	1	0	2715	8240	2715	
12407	COVID-19 mitigation	INFunknownSUP mitigation	1	0	2375	40	2375	
9233	final variable	final variable	1	0	9235	4256	9235	
16330	number of the quantitative reverse transcription polymerase chain reaction	number of the quantitative reverse transcription polymerase chain reaction	1	0	916	16332	916	
17909	oxygen saturation &lt	oxygen saturation &lt	1	0	4863	17910	4863	
21574	neutralisation rates	neutralisation rate	1	0	83	21575	83	
12051	average training accuracy	average training accuracy	1	0	12053	178	4535	
1435	apoyo emocional y	INFunknownSUP INFunknownSUP y	1	0	1439	1436	1439	
35330	Time Series	Time Series	1	0	35332	35331	35332	
32014	education delivery approach	education delivery approach	1	0	32016	361	1538	
441	current COVID-19 pandemic emergency	current INFunknownSUP pandemic emergency	1	0	447	442	447	
37786	immune system changes	immune system change	1	0	1336	1325	1336	
23107	Emotional difficulties	emotional difficulty	1	0	8240	23108	8240	
15301	findings of COVID-19 patients	finding of INFunknownSUP patient	1	0	3390	911	3390	
30403	Post-COVID Era	INFunknownSUP Era	1	0	24618	30404	24618	
28080	Medical Research Council	Medical Research Council	1	0	28082	2779	6229	
38304	dedication dimension	dedication dimension	1	0	10927	38305	10927	
39027	adult inpatients	adult inpatient	1	0	30487	14179	30487	
31124	immunologic assessment	immunologic assessment	1	0	238	29733	238	
26502	use of peptides	use of peptide	1	0	292	26504	292	
14679	Community Gardening	Community gardening	1	0	14681	1192	14681	
10114	fundamental shifts	fundamental shift	1	0	4283	3003	4283	
4784	studies of SARS-CoV-2 vaccine candidates	study of INFunknownSUP vaccine candidate	1	0	136	4786	136	
7058	diagnostic decisions	diagnostic decision	1	0	1942	2219	1942	
27961	Standard in-person encounters	Standard in-person encounter	1	0	27963	27962	13168	
36402	nasogastric catheter	nasogastric catheter	1	0	23360	36403	23360	
8731	topics of general interest	topic of general interest	1	0	8732	8733	8732	
11103	heterogeneity of the antibody response	heterogeneity of the antibody response	1	0	1972	9972	1972	
35164	measure of radiographic lung disease severity	measure of radiographic lung disease severity	1	0	2466	35166	2466	
8358	respiratory interference	respiratory interference	1	0	8360	259	8360	
31920	original diagnoses	original diagnosis	1	0	13045	13288	13045	
28197	envelope proteins	envelope protein	1	0	1126	10177	1126	
31644	im aeroben Intensitatsbereich durchgefuhrt werden	im INFunknownSUP Intensitatsbereich INFunknownSUP INFunknownSUP	1	0	31646	31645	31652	
36666	neutralization activity	neutralization activity	1	0	3990	36667	3990	
34051	multiple cases of undetectable adaptive immunity	multiple case of undetectable adaptive immunity	1	0	34053	1776	229	
31083	serial virological sampling	serial virological sampling	1	0	31085	12026	11863	
493	healthcare facility-onset Clostridioides	INFunknownSUP facility-onset INFunknownSUP	1	0	495	494	497	
14677	Impact of Community Gardening	impact of Community gardening	1	0	802	14679	802	
28429	Preoperative Risk	INFunknownSUP Risk	1	0	7906	28430	7906	
38150	non-steroidal anti-inflammatory drug use	non-steroidal anti-inflammatory drug use	1	0	38152	38151	292	
17324	RBC inventory levels	RBC inventory level	1	0	169	6847	169	
20756	protein expression levels of tumor necrosis factor-alpha	protein expression level of tumor necrosis factor-alpha	1	0	20758	1797	169	
30824	fand sich keine	INFunknownSUP INFunknownSUP INFunknownSUP	1	0	30828	30825	30828	
20957	rate of complete resolution	rate of complete resolution	1	0	1034	4185	1034	
21296	dimensionalization of the problem	INFunknownSUP of the problem	1	0	21297	4499	21297	
18397	COVID-19 pandemic-related impacts	INFunknownSUP pandemic-related impact	1	0	18399	3706	1385	
20309	indicator of subjective health assessment	indicator of subjective health assessment	1	0	20310	20311	20310	
33907	serious limitations	serious limitation	1	0	33909	3164	33909	
77	top concern	top concern	1	0	79	78	79	
35244	PCR testing of asymptomatic cancer patients	PCR testing of asymptomatic cancer patient	1	0	5421	35248	1885	
6879	online music education	online music education	1	0	1249	541	361	
23791	present cross sectional study of proteinuria status	present cross sectional study of proteinuria status	1	0	23792	23799	2087	
16931	Severity of Coronavirus Disease	severity of INFunknownSUP Disease	1	0	1202	11497	1202	
13904	adequate immune response	adequate immune response	1	0	6115	270	409	
31835	de excepcionalidad	de INFunknownSUP	1	0	31837	1914	31837	
22748	public health perspective	public health perspective	1	0	21724	1320	21724	
13246	% Confidence Interval	% confidence interval	1	0	13248	364	13250	
36529	SARS-CoV-2 spike protein	INFunknownSUP spike protein	1	0	1795	28	1797	
25956	sense of social identity	sense of social identity	1	0	1672	25958	1672	
13737	vaccine strategies	vaccine strategy	1	0	300	577	300	
5318	pandemic plans	pandemic plan	1	0	5320	113	5320	
2709	body weight	body weight	1	0	2711	2710	2711	
5797	aspects of COVID-19	aspect of INFunknownSUP	1	0	2429	40	2429	
5772	retirement planning	retirement planning	1	0	5774	5773	5774	
1053	exposure to aerosolized pathogens	exposure to INFunknownSUP pathogen	1	0	1054	1055	1054	
12113	research centers	research center	1	0	3427	36	3427	
27995	larger sample size	large sample size	1	0	7393	9554	6366	
6257	triage staff	triage staff	1	0	11	6258	11	
21091	international graduates	international graduate	1	0	21093	4086	21093	
14489	global dysarthria rating	global INFunknownSUP rating	1	0	14491	1954	14493	
38355	correct diagnosis of diseases	correct diagnosis of disease	1	0	38357	1120	2168	
5171	objektive korperliche Leistungsfahigkeit sowie das subjektive Belastungsempfinden bei gut-trainierten	INFunknownSUP INFunknownSUP INFunknownSUP INFunknownSUP das INFunknownSUP INFunknownSUP bei INFunknownSUP	1	0	5179	5172	5187	
19291	clinical modulation of inflammatory cytokines	clinical modulation of inflammatory cytokine	1	0	19293	884	19294	
25228	package of interventions	package of intervention	1	0	5607	757	5607	
21027	exposure areas	exposure area	1	0	1579	1054	1579	
2103	reduction strategies	reduction strategy	1	0	300	490	300	
7732	Intelligence-Based Model	INFunknownSUP Model	1	0	7734	7733	7734	
32813	vaccine injections	vaccine injection	1	0	32815	577	32815	
18853	acute respiratory syndrome coronavirus:SARS-CoV	acute respiratory syndrome INFunknownSUP	1	0	18855	1461	18859	
34728	live SARS-CoV-2 antiviral assays	live INFunknownSUP antiviral assay	1	0	34730	7346	2754	
17466	Kolmogorov-Smirnov Statistic	Kolmogorov-Smirnov statistic	1	0	17468	17467	17468	
14097	unexpected complication	unexpected complication	1	0	2206	4591	2206	
4115	Affordable IgY-based antiviral prophylaxis	affordable INFunknownSUP antiviral prophylaxis	1	0	4117	4116	4121	
11758	pharmacological strategies	pharmacological strategy	1	0	300	11759	300	
3668	School Mentoring Programs Research	School mentoring Programs Research	1	0	3670	3669	3674	
20749	third dose of BNT162b2 vaccine	third dose of INFunknownSUP vaccine	1	0	20750	11185	2537	
24922	Verwendung chirurgischer	INFunknownSUP chirurgischer	1	0	24924	24923	24924	
20726	high rate of asymptomatic infection	high rate of asymptomatic infection	1	0	20727	7318	1034	
29745	Manifestations of COVID-19	manifestation of INFunknownSUP	1	0	1693	40	1693	
21084	Belief Model Perspective	belief Model Perspective	1	0	21086	21085	10704	
30756	college graduates	college graduate	1	0	21093	17093	21093	
23922	depression subscale	depression subscale	1	0	23924	1514	23924	
14876	eligible responses	eligible response	1	0	200	5236	200	
24519	marker Ki67	marker INFunknownSUP	1	0	24521	10814	24521	
1217	Anti-SARS-CoV-2 ELISA kit	INFunknownSUP Elisa kit	1	0	1219	1218	567	
17498	epidemic of COVID-19	epidemic of INFunknownSUP	1	0	6542	40	6542	
28521	Warning Score	Warning score	1	0	28523	28522	28523	
20917	Medical Records	Medical Records	1	0	20919	2779	20919	
23129	BNT162b2 mRNA-vaccination	INFunknownSUP mRNA-vaccination	1	0	23131	23130	23131	
27896	symptom onset times	symptom onset time	1	0	12806	3813	12806	
28995	viral detection	viral detection	1	0	44	1741	44	
8477	Longitudinal quantitative analysis of influent wastewater data	longitudinal quantitative analysis of influent wastewater datum	1	0	8479	8478	486	
21035	Distinct spatial arrangements of ACE2	distinct spatial arrangement of INFunknownSUP	1	0	21037	4586	13728	
16614	Sequential Organ Failure Assessment	sequential Organ failure Assessment	1	0	16616	16615	2874	
4191	Investigacion cientifica prioritaria	INFunknownSUP INFunknownSUP INFunknownSUP	1	0	4195	4192	4195	
31496	matrix of factors	matrix of factor	1	0	8449	583	8449	
9290	topics of discussion	topic of discussion	1	0	8732	3060	8732	
13519	diseases patients	disease patient	1	0	60	315	60	
15395	online period of schooling	online period of schooling	1	0	15397	541	5677	
23220	global health problem	global health problem	1	0	23222	1954	4499	
4988	Consortium secretariat	Consortium secretariat	1	0	4990	4989	4990	
6713	Connectivity Map	connectivity map	1	0	6715	6714	6715	
14882	relation to simple parameters	relation to simple parameter	1	0	14883	14884	14883	
18381	internal consistency	internal consistency	1	0	18383	18382	18383	
13156	understanding of the interactions	understanding of the interaction	1	0	2715	13158	2715	
34822	Haven Health	Haven Health	1	0	279	34823	279	
39008	planned operations	planned operation	1	0	7285	29751	7285	
32992	systemic immunization	systemic immunization	1	0	19253	1453	19253	
7728	Domain-Adaptive Artificial Intelligence-Based Model	Domain-adaptive artificial INFunknownSUP Model	1	0	7730	7729	7734	
38608	efficient communication	efficient communication	1	0	11078	4329	11078	
37335	DHS-associated facilities	DHS-associated facility	1	0	2676	37336	2676	
9918	bacterial pathogen	bacterial pathogen	1	0	9920	2517	9920	
20482	health care system	health care system	1	0	20484	120	1327	
21631	reactive cells	reactive cell	1	0	133	785	133	
17562	CT scans of pediatric patients	CT scan of pediatric patient	1	0	17563	5064	15094	
36948	bin Abdulaziz University	bin Abdulaziz University	1	0	36950	36949	50	
8564	Rheumatic Diseases	rheumatic disease	1	0	6908	208	6908	
7646	recent COVID-19 pandemic	recent INFunknownSUP pandemic	1	0	111	2128	113	
13777	serum metabolomes of COVID-19 patients	serum INFunknownSUP of INFunknownSUP patient	1	0	13779	4556	13780	
9573	COVID-19 prognostic stratification	INFunknownSUP prognostic stratification	1	0	9575	40	3809	
4836	telehealth encounter	telehealth encounter	1	0	4838	304	4838	
21880	Cultural Sector	cultural sector	1	0	21882	21881	21882	
25163	use of specific personal protective equipment	use of specific personal protective equipment	1	0	292	25165	292	
3490	implementation of medication policy	implementation of medication policy	1	0	396	3492	396	
11748	disease deterioration	disease deterioration	1	0	11750	209	11750	
10551	COVID-19 une occasion de reformer la sante	INFunknownSUP une occasion de reformer la INFunknownSUP	1	0	10553	40	10563	
23645	estimated intrinsic growth rate	estimated intrinsic growth rate	1	0	23647	18816	1034	
7158	second part of the survey	second part of the survey	1	0	7160	1279	734	
10016	mAbs of human origin	INFunknownSUP of human origin	1	0	4228	10018	4228	
38913	Current discussions	current discussion	1	0	28764	7710	28764	
22017	Socioeconomic standard	socioeconomic standard	1	0	17	22018	17	
21406	data collection	data collection	1	0	16824	9541	16824	
15666	bronchiolitis admissions	INFunknownSUP admission	1	0	3085	5471	3085	
7405	nasopharyngeal positivity	nasopharyngeal INFunknownSUP	1	0	1238	7406	1238	
11685	unique methodology	unique methodology	1	0	11687	3547	11687	
24152	postoperative infections	postoperative infection	1	0	779	8142	779	
22901	novel viral disease	novel viral disease	1	0	4411	810	209	
30222	testing campaigns/surveys	testing campaigns/survey	1	0	30224	1885	30224	
22970	OptoVue Inc	INFunknownSUP Inc	1	0	22972	22971	22972	
30238	efficacy of hydroxychloroquine	efficacy of hydroxychloroquine	1	0	6704	633	6704	
9553	larger particle sizes	large particle size	1	0	9555	9554	9557	
26089	healthcare provider	INFunknownSUP provider	1	0	9087	494	9087	
25250	variables demograficas	variable INFunknownSUP	1	0	818	817	818	
38163	new dates	new date	1	0	38165	69	38165	
12527	sample units	sample unit	1	0	6042	2757	6042	
1864	Arts et Metiers	Arts et INFunknownSUP	1	0	1866	1865	1868	
26453	early phase of the COVID-19 pandemic:the Philadelphia story Supplemental digital content	early phase of the INFunknownSUP INFunknownSUP Philadelphia story Supplemental digital content	1	0	1350	26457	1352	
30984	risks of vertical transmission of COVID-19	risk of vertical transmission of INFunknownSUP	1	0	8152	30986	8152	
18726	standard prostate cancer care	standard prostate cancer care	1	0	18728	2056	9	
13346	residents of the capital area	resident of the capital area	1	0	232	13348	232	
3117	multiplex assay	multiplex assay	1	0	3119	3118	3119	
32540	stressors of the COVID-19 pandemic -	INFunknownSUP of the INFunknownSUP pandemic INFunknownSUP	1	0	14923	32542	14923	
20419	Pandemic:(COVID-19):A Narrative Review Background Coronavirus disease	INFunknownSUP narrative Review background INFunknownSUP disease	1	0	209	20420	209	
9846	additional interventions	additional intervention	1	0	757	7175	757	
29757	COVID-19 patient hospitalization	INFunknownSUP patient hospitalization	1	0	11637	29758	11637	
287	extended mask use policy	extended mask use policy	1	0	289	288	293	
1222	action plan of the Iranian Blood Transfusion Organization	action plan of the Iranian Blood transfusion Organization	1	0	1224	1223	1225	
38309	infectious period of COVID-19	infectious period of INFunknownSUP	1	0	6873	40	5677	
4331	Scientific Sessions	Scientific Sessions	1	0	4333	4332	4333	
29429	COVID-19 detection accuracy	INFunknownSUP detection accuracy	1	0	4535	29430	4535	
19530	signature of HCQ	signature of HCQ	1	0	19531	7775	19531	
8088	response to public health emergencies	response to public health emergency	1	0	409	8090	409	
2115	Medication Abortions	medication abortion	1	0	2117	2116	2117	
16456	travel routes	travel route	1	0	16458	2879	16458	
14978	treatment considerations Obsessive-compulsive disorder	treatment consideration obsessive-compulsive disorder	1	0	14980	97	7358	
34684	individual courses	individual course	1	0	4358	753	4358	
22327	short periods	short period	1	0	873	16760	873	
9901	Adjusted Incidence Rate Ratio	adjusted incidence rate ratio	1	0	9903	9902	9907	
35852	Fragment Interaction	fragment Interaction	1	0	35854	35853	35854	
28186	early prediction of the disease	early prediction of the disease	1	0	28188	55	3336	
38489	part of a multistep project	part of a multistep project	1	0	734	38491	734	
16095	angiotensin-converting enzyme-2	INFunknownSUP INFunknownSUP	1	0	16097	11587	16097	
36017	model of spinal cord injury	model of spinal cord injury	1	0	1078	28703	1078	
17221	alcohol metabolite ethyl sulfate	alcohol metabolite ethyl sulfate	1	0	17223	1266	17227	
39121	diferencias sugieren una subestimacion generalizada de la magnitud de la epidemia	INFunknownSUP INFunknownSUP Una INFunknownSUP INFunknownSUP de la INFunknownSUP de la INFunknownSUP	1	0	39131	39122	39141	
8165	cross-validated AUC	cross-validated AUC	1	0	8167	8166	8167	
255	virus-specific immunity	virus-specific immunity	1	0	257	256	257	
26358	pilot mindfulness-based intervention	pilot INFunknownSUP intervention	1	0	26360	26359	5608	
39264	potential source of phthalate exposure	potential source of phthalate exposure	1	0	39266	1276	1971	
20861	knowledge of COVID-19	knowledge of INFunknownSUP	1	0	213	40	213	
24463	mid-term chest	mid-term chest	1	0	25	19223	25	
7166	key strategies	key strategy	1	0	300	850	300	
17099	Talleghani hospital	Talleghani hospital	1	0	185	17100	185	
7398	skin damage	skin damage	1	0	5946	161	5946	
27209	Categorical variables	categorical variable	1	0	817	27210	817	
18008	cytokine surge	INFunknownSUP surge	1	0	1128	3718	1128	
29467	combination:and validation of tools	INFunknownSUP validation of tool	1	0	29469	29468	6319	
20361	option cost-effectiveness	option cost-effectiveness	1	0	16689	5022	16689	
37838	disease outbreak/pandemic situation	disease outbreak/pandemic situation	1	0	37840	209	3056	
17739	renal outcomes	renal outcome	1	0	263	130	263	
34478	technique of traditional Chinese medicine	technique of traditional Chinese medicine	1	0	562	1965	562	
30786	modeling of SARS-CoV-2 behavior	modeling of INFunknownSUP behavior	1	0	464	30788	464	
38085	lower lobe	low lobe	1	0	38087	594	38087	
12025	serial hs-TnI assessment	serial INFunknownSUP assessment	1	0	12027	12026	238	
5182	subjektive Belastungsempfinden	INFunknownSUP INFunknownSUP	1	0	5184	5183	5184	
16043	telemedicine technology	telemedicine technology	1	0	1718	16044	1718	
30502	novel IoT-based paradigm	novel INFunknownSUP paradigm	1	0	30504	810	30506	
12030	information receivers	information receiver	1	0	12032	2591	12032	
2580	Clinical similarities	clinical similarity	1	0	2582	1501	2582	
2519	deep gray matter	deep gray matter	1	0	2521	2520	2523	
14508	form of border restriction	form of border restriction	1	0	11121	14510	11121	
400	Pediatric Foreign Body Ingestions	pediatric foreign body ingestion	1	0	402	401	406	
38768	demonstration of the kit	demonstration of the kit	1	0	19715	567	19715	
18247	high battery drainage	high battery drainage	1	0	18249	13	18251	
36615	percent of people	percent of people	1	0	4123	694	4123	
9594	allogeneic cell therapies	INFunknownSUP cell therapy	1	0	9596	138	5507	
11651	Nutritional status of individuals	nutritional status of individual	1	0	11652	1113	2720	
21939	total number of referrals	total number of referral	1	0	13163	4124	916	
32329	particles sizes	particle size	1	0	9557	8275	9557	
5491	chemiluminescent microparticle immunoassay	chemiluminescent microparticle immunoassay	1	0	5493	5492	5495	
27305	accurate detection of COVID-19-related findings	accurate detection of COVID-19-related finding	1	0	27307	324	44	
30499	psychological interventions	psychological intervention	1	0	757	1380	757	
29010	glucose control	glucose control	1	0	510	29011	510	
12369	cardiac dysfunction	cardiac dysfunction	1	0	3856	3858	3856	
35333	mandatory step	mandatory step	1	0	23817	35334	23817	
31491	ischemic events	ischemic event	1	0	1083	5059	1083	
37607	target selection	target selection	1	0	5520	11730	5520	
25674	post-infection period	post-infection period	1	0	5677	25675	5677	
7416	death of children	death of child	1	0	4722	6153	4722	
32786	immunofluorescence assay	immunofluorescence assay	1	0	3119	10450	3119	
37098	Odds Ratios	Odds ratio	1	0	37100	37099	37100	
36675	assistive devices	INFunknownSUP device	1	0	6162	36676	6162	
36144	postgraduate training	postgraduate training	1	0	235	36145	235	
11704	efficient utilization of human ACE2	efficient utilization of human INFunknownSUP	1	0	11706	4329	4011	
8691	early disease detection	early disease detection	1	0	8439	55	44	
16510	myocardial damage	myocardial damage	1	0	5946	5813	5946	
11574	current General Medical Practitioner treatment	current General Medical practitioner treatment	1	0	11576	443	97	
7263	satellite instrument	satellite instrument	1	0	7265	7264	7265	
12559	antibody titre	antibody titre	1	0	12561	5924	12561	
17550	Cox proportional hazard	Cox proportional hazard	1	0	17552	5823	17554	
32139	different FBs	different FB	1	0	14247	688	14247	
29985	vessel densities	vessel density	1	0	22356	19277	22356	
17999	coronavirus variant	coronavirus variant	1	0	939	339	939	
20998	vivo experiments	vivo experiment	1	0	16356	20999	16356	
23262	death rates evolution	death rate evolution	1	0	3741	23263	3741	
21845	partial-likelihood framework	partial-likelihood framework	1	0	4860	21846	4860	
12682	urban residence	urban residence	1	0	12684	11894	12684	
19389	confirmed COVID-19 cases	confirmed INFunknownSUP case	1	0	7690	4370	229	
26461	Philadelphia story Supplemental digital content	Philadelphia story Supplemental digital content	1	0	26467	26462	6700	
139	Mesenchymal Stem Cell-	mesenchymal Stem INFunknownSUP	1	0	143	140	143	
32247	frontline health workers	frontline health worker	1	0	21240	2256	1136	
32499	electrophysiological planar lipid bilayer measurements	electrophysiological planar lipid bilayer measurement	1	0	32501	32500	8077	
10440	formation of the ternary complex of S1	formation of the ternary complex of INFunknownSUP	1	0	10441	10442	10441	
20576	special contexts	special context	1	0	20578	4884	20578	
2623	next stages of the pandemic response	next stage of the pandemic response	1	0	2625	2624	766	
14122	Impact of the COVID-19 Pandemic	impact of the INFunknownSUP pandemic	1	0	802	6336	802	
17112	transcriptional promoters of genes	transcriptional promoter of gene	1	0	17114	5787	17115	
34311	Google Form-based questionnaire survey	INFunknownSUP INFunknownSUP questionnaire survey	1	0	34315	34312	967	
30654	geographical distribution	geographical distribution	1	0	2621	13448	2621	
24133	Chinese Medical Students	Chinese Medical student	1	0	24135	1968	4368	
39266	source of phthalate exposure	source of phthalate exposure	1	0	1971	13418	1971	
21016	application of these techniques	application of these technique	1	0	125	691	125	
13892	nursing care management plan	nursing care management plan	1	0	13894	1209	1225	
9775	SF-36 questionnaires	INFunknownSUP questionnaire	1	0	4509	9776	4509	
22509	population groups	population group	1	0	2486	1838	2486	
4686	early summer	early summer	1	0	4688	55	4688	
16871	Clinical Research Unit	clinical Research Unit	1	0	16873	1501	16875	
2419	genome scale RNA secondary structure	genome scale RNA secondary structure	1	0	2421	2173	2427	
18201	fourth quarters	fourth quarter	1	0	8115	17211	8115	
18014	multiple sclerosis	multiple sclerosis	1	0	18013	1776	18013	
17392	various activities	various activity	1	0	192	1099	192	
3181	high levels of clonal expansion	high level of clonal expansion	1	0	167	3185	169	
11898	autopsy series	autopsy series	1	0	8050	11899	8050	
21712	large volume of testing	large volume of testing	1	0	21714	4250	3445	
26022	cell counts	cell count	1	0	5090	197	5090	
16438	referral tertiary hospital	referral tertiary hospital	1	0	16440	2964	185	
14255	Hospital Universitario Marques de Valdecilla	Hospital INFunknownSUP Marques de Valdecilla	1	0	14257	1879	14263	
3348	therapeutic strategy	therapeutic strategy	1	0	3350	3349	3350	
33996	laboratory task behaviour	laboratory task behaviour	1	0	467	1392	469	
20409	pressure air flow	pressure air flow	1	0	20411	1027	6423	
8474	subjective factors	subjective factor	1	0	583	8475	583	
20858	de novo	de Novo	1	0	20860	1421	20860	
18114	strict lockdown conditions	strict INFunknownSUP condition	1	0	18116	8859	2910	
30750	learning-based models	INFunknownSUP model	1	0	3975	30751	3975	
38613	Catholic Social Teaching	Catholic Social teaching	1	0	38615	36804	31147	
32321	recognition receptors	recognition receptor	1	0	8960	13787	8960	
26687	different types of alopecia	different type of alopecia	1	0	26689	688	1979	
9724	SARS-CoV-2 polymerase chain reaction	INFunknownSUP polymerase chain reaction	1	0	2443	28	2447	
20233	% chronic	% chronic	1	0	20235	364	20235	
5643	supervised exercise training intervention	supervised exercise training intervention	1	0	5608	5644	5608	
20111	spinal centres	spinal centre	1	0	2851	14047	2851	
10956	Bowel Disease	bowel disease	1	0	10958	10957	10958	
33515	future responses	future response	1	0	200	1367	200	
14326	Patent Rights	Patent Rights	1	0	14328	14327	14328	
4184	complete resolution of pulmonary findings	complete resolution of pulmonary finding	1	0	4185	4188	1448	
25853	chromatography-tandem mass spectrometry	chromatography-tandem mass spectrometry	1	0	15752	25854	15754	
11129	recent RAAS blockade use	recent INFunknownSUP blockade use	1	0	4261	2128	292	
21199	well-known coronavirus diseases	well-known coronavirus disease	1	0	21201	21200	315	
17582	variation of the parameter	variation of the parameter	1	0	9427	16173	9427	
777	virus infections	virus infection	1	0	779	778	779	
37087	passive infusion	passive infusion	1	0	37089	29679	37089	
11070	great importance	great importance	1	0	2765	4480	2765	
3929	potential clinical utility of this imaging technique	potential clinical utility of this imaging technique	1	0	3931	1276	3934	
35250	cancer patients	cancer patient	1	0	60	773	60	
13829	organ-level architecture of receptor expression	organ-level architecture of receptor expression	1	0	13830	13833	13832	
15887	nature of pandemics	nature of pandemic	1	0	1476	103	1476	
9273	outpatient in-person	outpatient in-person	1	0	9275	327	9275	
39004	complete disruption to planned operations	complete disruption to planned operation	1	0	39006	4186	12078	
28732	continuous negative pressure	continuous negative pressure	1	0	28734	2232	1027	
21978	numerous supply chains	numerous supply chain	1	0	21980	531	21982	
30601	existing nursing problems	existing nursing problem	1	0	12671	6308	6766	
17857	economic gain	economic gain	1	0	3213	108	3213	
38683	emission controls	emission control	1	0	3772	38684	3772	
26179	negative rate	negative rate	1	0	1034	1338	1034	
3708	COVID-19 acquisition	INFunknownSUP acquisition	1	0	3710	40	3710	
2544	evidence-based guidelines	INFunknownSUP guideline	1	0	91	2545	91	
28872	urology team member in-person contact	urology team member in-person contact	1	0	28874	3341	1888	
5783	Health Sciences	Health Sciences	1	0	5785	279	5785	
20735	t test	t test	1	0	754	20736	754	
7549	Sense of School Identity	sense of School identity	1	0	7550	7551	7550	
5077	participatory action research approach	participatory action research approach	1	0	5079	5078	1538	
16186	Inherited Thrombophilias	inherited INFunknownSUP	1	0	16188	16187	16188	
14027	additional subgroup analyses of the characteristics age	additional subgroup analysis of the characteristic age	1	0	14028	14033	4668	
36028	different primer-probe	different primer-probe	1	0	29723	688	29723	
34956	history of the concept	history of the concept	1	0	5381	29276	5381	
31366	clinical trial reports:that	clinical trial INFunknownSUP	1	0	31368	884	31370	
31215	NO2 levels	INFunknownSUP level	1	0	169	164	169	
29406	SARS-CoV2 vaccines	INFunknownSUP vaccine	1	0	681	4324	681	
11045	viral load evaluation	viral load evaluation	1	0	2399	5917	2399	
38932	effective treatment	effective treatment	1	0	97	2051	97	
23640	current available evidence	current available evidence	1	0	5791	443	585	
27355	ceiling of treatment	ceiling of treatment	1	0	27356	97	27356	
2008	Staff Shifts	staff shift	1	0	2010	2009	2010	
23406	acceptability study	acceptability study	1	0	2087	23407	2087	
10088	global public health emergencies	global public health emergency	1	0	8090	1954	8094	
2901	comprehensive sensitivity analysis	comprehensive sensitivity analysis	1	0	2903	2902	486	
25077	school FACS	school INFunknownSUP	1	0	2472	355	2472	
20087	significant capabilities	significant capability	1	0	6868	908	6868	
29302	detection tests	detection test	1	0	1365	44	1365	
28788	admission to intensive care unit	admission to intensive care unit	1	0	2865	6	2865	
20311	subjective health assessment	subjective health assessment	1	0	20313	8475	238	
7584	New Year	New Year	1	0	7586	1162	7586	
14343	autopsied COVID-19	INFunknownSUP INFunknownSUP	1	0	40	14344	40	
10836	deployment of new digital technologies	deployment of new digital technology	1	0	10837	10838	10837	
31987	additional file	additional file	1	0	20930	7175	20930	
16130	virus outbreak	virus outbreak	1	0	310	778	310	
24172	market-reach of pandemics	market-reach of pandemic	1	0	24173	103	24173	
28514	similar circumstances	similar circumstance	1	0	7568	102	7568	
36946	Saud bin Abdulaziz University	Saud bin Abdulaziz University	1	0	36948	36947	50	
19885	vaccine-activity-stratified impact ratios	INFunknownSUP impact ratio	1	0	19887	19886	19889	
30407	younger Brazilians	young Brazilian	1	0	30409	2571	30409	
11544	Healthcare Professionals	Healthcare professional	1	0	11546	1355	11546	
38392	potential risk of AKI	potential risk of Aki	1	0	38394	1276	1542	
29527	wave of new generation biological therapies	wave of new generation biological therapy	1	0	10210	29529	10210	
1996	asynchronous medication abortion care	asynchronous medication abortion care	1	0	1998	1997	9	
23486	annual booster	annual booster	1	0	804	23487	804	
7637	CT Features	CT feature	1	0	7639	26	7639	
3149	application process	application process	1	0	180	125	180	
11836	viral pathogen	viral pathogen	1	0	9920	1741	9920	
19959	cost-effective delivery of complex change programmes	cost-effective delivery of complex change programme	1	0	19961	19960	2840	
27868	Future studies	future study	1	0	136	9666	136	
29993	costs of all Consortium members	cost of all Consortium member	1	0	22726	29995	22726	
7869	COVID-19 Pfizer-BioNTech BNT16B2b2 mRNA	INFunknownSUP INFunknownSUP INFunknownSUP INFunknownSUP	1	0	575	7870	575	
18916	COVID-19 control	INFunknownSUP control	1	0	510	40	510	
12510	impact of adjunctive MBIs	impact of adjunctive INFunknownSUP	1	0	110	12512	110	
31174	residual connection	residual connection	1	0	8937	4795	8937	
9856	complete excision of endometriosis	complete excision of endometriosis	1	0	9858	4186	9859	
6188	pathogenic mechanisms of SARS-CoV-2	pathogenic mechanism of INFunknownSUP	1	0	6189	28	1456	
33807	Corona virus	Corona virus	1	0	778	10431	778	
37589	system success	system success	1	0	4063	1327	4063	
21534	weeks of COVID-19 diagnosis	week of INFunknownSUP diagnosis	1	0	18278	21536	18278	
21607	distribution of essential materials	distribution of essential material	1	0	2621	21609	2621	
26719	drug libraries	drug library	1	0	26721	352	26721	
3198	data of COVID-19 patients	datum of INFunknownSUP patient	1	0	22	911	22	
36756	Oral Health Policies	Oral Health policy	1	0	36758	11717	25314	
16991	psychological effects	psychological effect	1	0	156	1380	156	
20329	Transmission of this virus	transmission of this virus	1	0	20330	778	20330	
22998	well-being High educational debt	well-being High educational debt	1	0	23000	2245	3627	
23072	evidence synthesis	evidence synthesis	1	0	14638	585	14638	
38224	Knee Arthroplasty Surgical Volume	Knee INFunknownSUP surgical volume	1	0	38226	38225	38230	
37312	regulatory pathway	regulatory pathway	1	0	5003	5686	5003	
13472	high levels of depression	high level of depression	1	0	167	1514	169	
24417	risk communication strategies	risk communication strategy	1	0	300	24418	300	
39314	structural relationship	structural relationship	1	0	2722	3549	2722	
13205	voluntary compliance	voluntary compliance	1	0	2726	1881	2726	
15556	ideal criteria	ideal criterion	1	0	3649	15557	3649	
28388	healthy control eyes	healthy control eye	1	0	28390	1021	18974	
6563	(OMI)-derived year-to-year decreases	INFunknownSUP year-to-year decrease	1	0	6565	6564	165	
5808	non-guideline definition of myocardial injury	INFunknownSUP definition of myocardial injury	1	0	5810	5809	5811	
32902	remote care	remote care	1	0	9	2073	9	
34850	available alternative	available alternative	1	0	20073	832	20073	
216	Online Library	online Library	1	0	218	217	218	
37241	second dose	second dose	1	0	2537	1279	2537	
13241	System pharmacy services	system pharmacy service	1	0	13243	3504	5980	
11236	knee arthroplasty procedure volume projections	knee INFunknownSUP procedure volume projection	1	0	11242	11237	11244	
30348	average grade levels	average grade level	1	0	30350	178	169	
34089	early period of the pandemic	early period of the pandemic	1	0	34091	55	5677	
37119	adequate invitation sources	adequate invitation source	1	0	37121	270	4158	
33185	robust CAD solution	robust cad solution	1	0	33187	6640	33189	
35478	taste loss	taste loss	1	0	3586	17031	3586	
2098	potential SARS-CoV-2	potential INFunknownSUP	1	0	28	1276	28	
3875	technological vulnerabilities	technological vulnerability	1	0	3877	3876	3877	
11162	Infection Severe acute respiratory syndrome coronavirus	infection severe acute respiratory syndrome coronavirus	1	0	339	11163	339	
20022	manejo competencial de	INFunknownSUP INFunknownSUP de	1	0	1421	20023	1421	
37520	paucity of intraoperative endoscopic images	paucity of intraoperative endoscopic image	1	0	10246	37522	10246	
10976	emergency clinicians	emergency clinician	1	0	10978	447	10978	
17021	human lung cells	human lung cell	1	0	17023	2214	133	
35046	large number of cases	large number of case	1	0	4249	229	916	
26970	cancer screening	cancer screening	1	0	7961	773	7961	
14215	Siriraj Hospital	INFunknownSUP Hospital	1	0	1879	14216	1879	
10373	non- structural proteins	non- structural protein	1	0	10375	10374	1126	
2906	current health conditions	current health condition	1	0	2908	443	2910	
27177	proportion of the reactive CD8 T clones	proportion of the reactive INFunknownSUP T clone	1	0	910	27179	910	
34532	Pulmonary hemorrhage	pulmonary hemorrhage	1	0	25795	10006	25795	
16086	core domains of respiratory failure	core domain of respiratory failure	1	0	16088	16087	1180	
17729	severe consequences	severe consequence	1	0	4289	262	4289	
30769	COVID-19 pandemic spread	INFunknownSUP pandemic spread	1	0	570	111	570	
22533	computer-generated numeric sequence	computer-generated numeric sequence	1	0	22535	22534	5716	
1228	Blood Transfusion Organization	Blood transfusion Organization	1	0	1230	1229	1232	
10307	vaccination policy	vaccination policy	1	0	293	437	293	
395	implementation of telehealth	implementation of telehealth	1	0	396	304	396	
4815	systolic blood pressure	systolic blood pressure	1	0	4817	1026	1027	
31830	este momento de excepcionalidad de la COVID-19	INFunknownSUP momento de INFunknownSUP de la INFunknownSUP	1	0	31838	31831	40	
6422	flow cytometry	flow INFunknownSUP	1	0	6424	6423	6424	
24605	surgical site infection	surgical site infection	1	0	24607	663	41	
13178	notable viral spike	notable viral spike	1	0	13180	13179	31	
4921	sound empirical evidence	sound empirical evidence	1	0	4923	4922	585	
16299	subpleural distribution	subpleural distribution	1	0	2621	16300	2621	
30305	efficacy of antibiotics	efficacy of antibiotic	1	0	6704	7194	6704	
6540	SARS-CoV-2 epidemic	INFunknownSUP epidemic	1	0	6542	28	6542	
32047	assessment of pericardial effusion	assessment of pericardial effusion	1	0	238	241	238	
18766	worldwide attention	worldwide attention	1	0	4885	8376	4885	
9538	big data era	big data era	1	0	9542	9539	9542	
34038	in-person shows	in-person show	1	0	13038	9275	13038	
19381	situation report	situation report	1	0	378	3056	378	
23637	framing of COVID-19	framing of INFunknownSUP	1	0	9534	40	9534	
16401	Australian healthcare workforce	Australian INFunknownSUP workforce	1	0	3750	2505	3750	
2289	scientific transparency	scientific transparency	1	0	2291	2290	2291	
37216	Outcomes Registry	outcome registry	1	0	17610	9631	17610	
31704	status of intensive care units	status of intensive care unit	1	0	2720	6038	2720	
34757	Current evidence	current evidence	1	0	585	7710	585	
13251	y las tasas de incidencia	y la INFunknownSUP de INFunknownSUP	1	0	13253	1908	13259	
19057	vertebrate antiretroviral defence mechanisms	vertebrate antiretroviral defence mechanism	1	0	19059	19058	1456	
15466	survivors of coronavirus infection	survivor of coronavirus infection	1	0	2732	15468	2732	
7143	national productivity	national productivity	1	0	7145	517	7145	
16079	presence of various concentrations of the peptide	presence of various concentration of the peptide	1	0	675	16081	675	
26901	positive SARS-CoV-2 quantitative reverse transcription polymerase chain reaction	positive INFunknownSUP quantitative reverse transcription polymerase chain reaction	1	0	26903	228	2447	
21805	La mortalidad y la	La INFunknownSUP y la	1	0	21809	21806	3572	
12468	The National Disability Insurance Scheme	The National disability insurance scheme	1	0	12470	2618	12476	
27425	lower rates of medical co-morbidities	low rate of medical co-morbidity	1	0	27427	594	83	
18389	development of mitigation strategies	development of mitigation strategy	1	0	73	2374	73	
31412	local clinical evaluators	local clinical evaluator	1	0	31414	3173	31416	
25711	Maternal mental health	maternal mental health	1	0	118	25712	120	
36902	Emerging evidence	Emerging evidence	1	0	585	36903	585	
37332	negative case	negative case	1	0	3368	1338	3368	
37439	EJTM Communications	INFunknownSUP Communications	1	0	37441	37440	37441	
2541	goals of the meeting	goal of the meeting	1	0	2542	2543	2542	
15636	Genetic Counseling	genetic counseling	1	0	15638	15637	15638	
12200	18F-FDG brain PET hypometabolism	INFunknownSUP brain pet hypometabolism	1	0	12202	12201	1260	
33196	relaxation times	relaxation time	1	0	12806	33197	12806	
35187	COVID-19 Pandemic Objective	INFunknownSUP pandemic objective	1	0	11461	6336	11461	
8187	categorical variables	categorical variable	1	0	817	8188	817	
23188	monthly data	monthly datum	1	0	22	18770	22	
8484	influent wastewater	influent wastewater	1	0	5093	8485	5093	
628	oral administration of hydroxychloroquine to healthcare professionals	oral administration of hydroxychloroquine to INFunknownSUP professional	1	0	630	427	631	
12734	usability of information	usability of information	1	0	8888	2591	8888	
20499	prospective model	prospective model	1	0	1078	2084	1078	
3935	imaging technique	imaging technique	1	0	562	3936	562	
5089	counts of hospitalizations	count of hospitalization	1	0	5090	5091	5090	
19077	local control	local control	1	0	510	3173	510	
21779	end of the follow-up	end of the follow-up	1	0	7132	175	7132	
28759	care plan	care plan	1	0	1225	9	1225	
1701	olfactory bulbs	olfactory bulb	1	0	1703	1702	1703	
2047	life style	life style	1	0	2049	1434	2049	
12151	Allogeneic Mesenchymal Stem/Stromal Cells	INFunknownSUP mesenchymal INFunknownSUP cell	1	0	12153	5503	12157	
25747	32327321/ Development of a telehealth geriatric assessment model	32327321/ Development of a INFunknownSUP geriatric assessment model	1	0	25749	25748	9277	
36422	low detection limit	low detection limit	1	0	36424	457	1141	
15978	glomerular filtration rate	glomerular filtration rate	1	0	15980	15979	1034	
3480	Use of the HoloLens2	use of the INFunknownSUP	1	0	3481	3482	3481	
28417	adverse event	adverse event	1	0	14930	1082	14930	
3278	infectious spondylitis surgery	infectious spondylitis surgery	1	0	3280	64	1630	
7965	different OTC supplements	different OTC supplement	1	0	7967	688	7969	
12107	key skills	key skill	1	0	12109	850	12109	
33982	oral steroid	oral steroid	1	0	1173	427	1173	
25277	negative consequences	negative consequence	1	0	4289	1338	4289	
15479	Year of the COVID-19 Pandemic	year of the INFunknownSUP pandemic	1	0	15480	6336	15480	
14475	perivascular white matter	perivascular white matter	1	0	14477	11563	2523	
17549	Cox proportional hazard analyses	Cox proportional hazard analysis	1	0	4668	17550	4668	
13055	bilevel positive airway pressure:on patients	bilevel positive airway INFunknownSUP patient	1	0	13057	13056	60	
13711	level of readability	level of readability	1	0	362	996	362	
10596	transmission of infected aerosols	transmission of infected aerosol	1	0	876	10598	876	
13059	airway pressure:on patients	airway INFunknownSUP patient	1	0	13061	2236	60	
4728	ill coronavirus disease	ill coronavirus disease	1	0	338	4729	209	
11093	postoperative ICU admission	postoperative ICU admission	1	0	11095	8142	2865	
10199	lung CT	lung CT	1	0	26	772	26	
21358	committee of the International Association of Dental Students	committee of the International Association of dental student	1	0	2265	21360	2265	
14030	subgroup analyses	subgroup analysis	1	0	4668	14031	4668	
16806	Impact of Covid-19	impact of INFunknownSUP	1	0	802	1884	802	
1415	Nacional por Amostra	Nacional por INFunknownSUP	1	0	1419	1416	1419	
12512	adjunctive MBIs	adjunctive INFunknownSUP	1	0	627	12513	627	
28832	Pandemic-adapted hygiene regulations	INFunknownSUP hygiene regulation	1	0	28834	28833	11423	
23244	cell lines	cell line	1	0	6853	197	6853	
13330	humoral responses	humoral response	1	0	200	6114	200	
13305	Journal of Translational Myology	journal of translational myology	1	0	13306	13307	13306	
23857	current hip	current hip	1	0	4093	443	4093	
27360	ventilator management	ventilator management	1	0	743	27361	743	
22682	total levels	total level	1	0	169	1485	169	
19740	Saudi Arabia Health care workers	Saudi Arabia Health care worker	1	0	3850	7219	1136	
1237	positivity rate	INFunknownSUP rate	1	0	1034	1238	1034	
7693	COVID-19 cases	INFunknownSUP case	1	0	229	3076	229	
5431	long-term impact of COVID-19	long-term impact of INFunknownSUP	1	0	149	4288	110	
9410	development of novel strategies	development of novel strategy	1	0	73	9412	73	
38145	Self-Rating Anxiety Scale	INFunknownSUP anxiety Scale	1	0	38147	38146	1203	
20366	national online survey	national online survey	1	0	20368	517	967	
10329	second measurement point	second measurement point	1	0	10331	1279	10333	
5860	technological tools	technological tool	1	0	274	3876	274	
2835	COVID-19 vaccination programme	INFunknownSUP vaccination programme	1	0	2839	2836	2839	
13619	waste plastic	waste plastic	1	0	13621	13620	13621	
23753	lung pathology	lung pathology	1	0	2094	772	2094	
20448	perception score	perception score	1	0	1843	2387	1843	
22240	collection of data	collection of datum	1	0	16824	22	16824	
26392	population-level measures of lockdowns	population-level measure of lockdown	1	0	26394	19519	317	
36452	Middle East respiratory syndrome coronavirus:MERS-CoV	Middle East respiratory syndrome INFunknownSUP	1	0	36454	2686	36460	
33070	urologic issues	urologic issue	1	0	3758	33071	3758	
37327	anti-viral mechanisms of action	anti-viral mechanism of action	1	0	37329	1410	1456	
4983	transmission of SARS-COV-2	transmission of INFunknownSUP	1	0	876	4985	876	
33182	inflammatory index	inflammatory index	1	0	4017	3817	4017	
9439	significant factors	significant factor	1	0	583	908	583	
16593	test use case	test use case	1	0	16595	754	3368	
2075	critical steps	critical step	1	0	2077	223	2077	
20838	limited alveolar recruitment	limited alveolar recruitment	1	0	11594	5322	3518	
8078	COVID-19 Viral Load	INFunknownSUP viral load	1	0	8080	40	8082	
5429	medium to long-term impact of COVID-19	medium to long-term impact of INFunknownSUP	1	0	5430	5431	5430	
2032	sobre salud	INFunknownSUP INFunknownSUP	1	0	2034	2033	2034	
10732	school outbreaks	school outbreak	1	0	2892	355	2892	
22286	aim of this retrospective comparative study	aim of this retrospective comparative study	1	0	7070	22288	7070	
26175	large false negative rate	large false negative rate	1	0	26177	4250	1034	
10251	fraction of undocumented infections	fraction of undocumented infection	1	0	7068	10253	7068	
18696	rate of mass vaccination	rate of mass vaccination	1	0	1034	11694	1034	
11438	Ethiopia Governments	Ethiopia government	1	0	11440	11439	11440	
7826	community care services	community care service	1	0	7828	3641	5980	
10100	representation to the ED	representation to the editor	1	0	10101	6256	10101	
25110	ventricular systolic dysfunction	ventricular systolic dysfunction	1	0	25112	1104	3856	
1691	Clinical Manifestations	clinical manifestation	1	0	1693	1501	1693	
13513	international study	international study	1	0	2087	4086	2087	
32118	convolutional neural network model	convolutional neural network model	1	0	1078	32119	1078	
35798	critical attention to the conservation of personal protective equipment	critical attention to the conservation of personal protective equipment	1	0	35800	223	4885	
9014	hepatic disease	hepatic disease	1	0	209	9015	209	
16893	negative binomial regression	negative binomial regression	1	0	16895	1338	5036	
4630	level of understanding	level of understanding	1	0	362	2715	362	
12070	COVID-19 setting	INFunknownSUP setting	1	0	2854	40	2854	
36495	alcohol use pattern	alcohol use pattern	1	0	36497	1266	4682	
1156	18F-FDG PET/CT results	INFunknownSUP INFunknownSUP result	1	0	325	1157	325	
11938	degenerative diseases	degenerative disease	1	0	315	11939	315	
19136	estimate of R0	estimate of INFunknownSUP	1	0	19137	5384	19137	
10485	daily fluctuations	daily fluctuation	1	0	10487	191	10487	
32052	Alternate methods	alternate method	1	0	205	32053	205	
22314	small increases	small increase	1	0	6329	9600	6329	
4160	delayed presentation of pericarditis	delayed presentation of pericarditis	1	0	4162	4161	4163	
5149	clinical course of COVID-19	clinical course of INFunknownSUP	1	0	5150	40	5152	
27705	tomography assessment of PEEP-induced alveolar recruitment	tomography assessment of INFunknownSUP alveolar recruitment	1	0	27707	7445	238	
35543	new rules	new rule	1	0	18679	69	18679	
17691	candy machines	candy machine	1	0	4511	17692	4511	
6048	days of pandemic COVID-19	day of pandemic INFunknownSUP	1	0	1645	6050	1645	
17371	available datasets	available INFunknownSUP	1	0	4432	832	4432	
26157	Health Organization)-China Joint Mission	Health Organization)-China Joint Mission	1	0	26159	279	26163	
36412	epidemiological characteristics	epidemiological characteristic	1	0	1496	18107	1496	
36814	uninfected health care workers	uninfected health care worker	1	0	1132	14643	1136	
24833	laparoscopic instruments	INFunknownSUP instrument	1	0	15156	127	15156	
18606	access control system	access control system	1	0	1327	18607	1327	
27299	Care Children	Care Children	1	0	27301	5417	27301	
38075	interpretation of the sewage data	interpretation of the sewage datum	1	0	11044	38077	11044	
6398	surveillance data	surveillance datum	1	0	22	2795	22	
21111	health care situation	health care situation	1	0	21113	120	3056	
37939	asymptomatic people	asymptomatic people	1	0	694	1131	694	
1416	Nacional por	Nacional por	1	0	1418	1417	1418	
26258	standard deviation	standard deviation	1	0	26260	2056	26260	
25386	past COVID-19 patients	past INFunknownSUP patient	1	0	911	1234	60	
28420	Surgical practice	surgical practice	1	0	3285	28421	3285	
12904	relatives of the children	relative of the child	1	0	12905	6153	12905	
14552	low resource setup	low resource setup	1	0	14554	457	14556	
14823	basic reproduction number of novel coronavirus	basic reproduction number of novel coronavirus	1	0	14825	4643	916	
29612	common symbolic dynamics	common symbolic dynamics	1	0	29614	699	3694	
22920	isolation assays	isolation assay	1	0	2754	6569	2754	
38455	early parts	early part	1	0	4335	55	4335	
470	health finance	health finance	1	0	472	120	472	
14226	renal replacement therapy n=	renal replacement therapy INFunknownSUP	1	0	14232	14227	14232	
38611	Light of Catholic Social Teaching	Light of Catholic Social teaching	1	0	3614	38613	3614	
7877	functional analysis	functional analysis	1	0	486	4225	486	
38199	region of Indonesia	region of Indonesia	1	0	8256	38201	8256	
25206	area representative	area representative	1	0	25208	1089	25208	
28672	COVID-19 pandemic:Data	INFunknownSUP INFunknownSUP	1	0	28674	40	28674	
36841	quasi-experimental design	quasi-experimental design	1	0	4183	36842	4183	
3431	Multiple Expression Assessments of ACE2	multiple expression assessment of INFunknownSUP	1	0	3433	2198	3436	
38329	institution-based cross-sectional study	INFunknownSUP cross-sectional study	1	0	2492	38330	2087	
370	copying error frequencies	copying error frequency	1	0	374	371	374	
21485	research papers	research paper	1	0	21487	36	21487	
6497	bases de datos MEDLINE	base de dato INFunknownSUP	1	0	6499	6498	6503	
336	outbreak of coronavirus disease	outbreak of coronavirus disease	1	0	310	338	310	
15885	ongoing nature of pandemics	ongoing nature of pandemic	1	0	15887	1059	1476	
31058	long-term distress	long-term distress	1	0	1975	4288	1975	
20226	Haemophilus influenzae type b	INFunknownSUP influenzae type b	1	0	20228	20227	20232	
11893	urban location	urban location	1	0	11895	11894	11895	
19317	individual goals	individual goal	1	0	2542	753	2542	
22022	gas exchange data	gas exchange datum	1	0	22	22023	22	
30548	del duelo y la muerte	del INFunknownSUP y la INFunknownSUP	1	0	30550	14955	30556	
7523	effective tool	effective tool	1	0	5487	2051	5487	
36458	syndrome coronavirus:MERS-CoV	syndrome INFunknownSUP	1	0	36460	1936	36460	
23416	fourth wave of COVID-19	fourth wave of INFunknownSUP	1	0	23418	17211	10210	
20101	Item Response Theory	item Response theory	1	0	20103	20102	20105	
21225	spectrum of COVID-19 illness	spectrum of INFunknownSUP illness	1	0	5866	21227	5866	
11716	Oral Intake Scale	Oral intake Scale	1	0	11718	11717	1203	
35428	psychiatric sequelae of COVID-19 infection	psychiatric sequela of INFunknownSUP infection	1	0	35429	39	35431	
13295	problem coping	problem coping	1	0	2895	4499	2895	
21595	vegetal models	vegetal model	1	0	3975	17849	3975	
4350	depression risk	depression risk	1	0	1542	1514	1542	
11562	perivascular spaces	perivascular space	1	0	11564	11563	11564	
30704	Twenty-five paediatric palliative care consultations	INFunknownSUP paediatric palliative care consultation	1	0	972	1575	978	
18472	markers of stress	marker of stress	1	0	5129	199	5129	
25805	median age of nonsurvivors	median age of nonsurvivor	1	0	25806	25809	906	
11822	new platforms	new platform	1	0	3919	69	3919	
7222	99th URL	INFunknownSUP URL	1	0	7224	7223	7224	
8253	CDR1 region of the heavy chain	INFunknownSUP region of the heavy chain	1	0	8254	8257	8256	
7309	week of December	week of December	1	0	7310	7311	7310	
27687	development of novel face masks	development of novel face mask	1	0	73	27689	73	
9022	RMS patients	RMS patient	1	0	60	9023	60	
10805	Africa accounts	Africa account	1	0	10807	668	10807	
20784	HCWs indicated discomfort	INFunknownSUP indicated discomfort	1	0	20786	20785	20788	
21491	effective interventions	effective intervention	1	0	757	2051	757	
17366	mixed logit model	mixed INFunknownSUP model	1	0	17368	9227	1078	
5168	kidney failure	kidney failure	1	0	1779	5169	1779	
5357	access to bariatric surgery	access to bariatric surgery	1	0	224	5359	224	
27810	disease treatment	disease treatment	1	0	97	209	97	
23169	severe disease:after	severe INFunknownSUP	1	0	23171	262	23171	
6138	Social Distance	Social Distance	1	0	6140	2019	6140	
36857	special-precautions area	special-precaution area	1	0	1089	36858	1089	
17971	-Albert Camus	-Albert Camus	1	0	4393	17972	4393	
34140	assessment grid	assessment grid	1	0	34142	238	34142	
36969	cross-sectional hospital-based survey	cross-sectional hospital-based survey	1	0	36971	2493	967	
9453	supplementary tool	supplementary tool	1	0	5487	550	5487	
17786	Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine	INFunknownSUP of INFunknownSUP mRNA-1273 vaccine	1	0	17787	17788	17787	
4479	great majority	great majority	1	0	4481	4480	4481	
24640	Candidate Antiviral Targets Intercellular communication	candidate antiviral target intercellular communication	1	0	24642	24253	11078	
6163	practical utility	practical utility	1	0	3934	6164	3934	
3890	COVID-19 patient cohorts	INFunknownSUP patient cohort	1	0	3892	40	3894	
33564	vaccination behavior	vaccination behavior	1	0	16069	437	16069	
8914	% of dental students	% of dental student	1	0	364	6860	364	
11907	important issue	important issue	1	0	2832	273	2832	
5359	bariatric surgery	bariatric surgery	1	0	1630	2394	1630	
22651	probability of mortality	probability of mortality	1	0	7627	1197	7627	
31349	corrected confidence-concern ratio	corrected confidence-concern ratio	1	0	31351	31350	2635	
9113	risk of aerosol exposure	risk of aerosol exposure	1	0	1542	9115	1542	
35785	different receptor molecules	different receptor molecule	1	0	35787	688	7076	
39217	receptor-binding domain of the glycoprotein S to 293T/ACE2 cells	receptor-binding domain of the glycoprotein S to INFunknownSUP cell	1	0	4749	39221	697	
21623	overview of the variation	overview of the variation	1	0	19301	9427	19301	
19458	cross-sectional cohort study	cross-sectional cohort study	1	0	2085	2493	2087	
16521	limbic/paralimbic regions	limbic/paralimbic region	1	0	5240	16522	5240	
28851	deployment of the HoloLens2	deployment of the INFunknownSUP	1	0	10837	3482	10837	
29394	undergraduate medical education	undergraduate medical education	1	0	3624	11601	361	
33916	social periphery	social periphery	1	0	33918	383	33918	
17413	sampling period	sampling period	1	0	5677	11863	5677	
38750	Care Personnel	Care Personnel	1	0	38752	5417	38752	
1907	y el numero de profesionales de medicina	y el numero de INFunknownSUP de INFunknownSUP	1	0	1909	1908	1919	
16638	mental health diagnoses	mental health diagnosis	1	0	13045	118	13045	
24211	biochemical assays SARS-CoV-2 outbreak	biochemical assay INFunknownSUP outbreak	1	0	24213	24212	310	
1872	skin-contacted products	INFunknownSUP product	1	0	1874	1873	1874	
22608	needs analysis	need analysis	1	0	486	3189	486	
17216	complex healthcare interventions	complex INFunknownSUP intervention	1	0	17218	13320	757	
39139	la epidemia	la INFunknownSUP	1	0	39141	14950	39141	
17860	different species	different specie	1	0	3957	688	3957	
2130	scholarly activities	scholarly activity	1	0	192	2131	192	
19518	population-level weekend alcohol consumption	population-level weekend alcohol consumption	1	0	1263	19519	1267	
27660	overall prevalence	overall prevalence	1	0	9272	2251	9272	
13289	cardiovascular signals	cardiovascular signal	1	0	4820	13290	4820	
18259	potential binding sites of these compounds	potential binding site of these compound	1	0	18261	1276	9165	
19755	types of analysis	type of analysis	1	0	1979	486	1979	
5542	social togetherness	social togetherness	1	0	5544	383	5544	
12180	MR-proADM values &gt	INFunknownSUP value &gt	1	0	2385	12181	2385	
4192	Investigacion cientifica	INFunknownSUP INFunknownSUP	1	0	4194	4193	4194	
9107	Nekemte town	INFunknownSUP town	1	0	9109	9108	9109	
32675	repeated diagnosis	repeated diagnosis	1	0	2168	22618	2168	
5572	Sample Survey	Sample Survey	1	0	5574	5573	5574	
29780	containment of this virus	containment of this virus	1	0	12039	778	12039	
3915	use of e-learning platforms	use of e-learning platform	1	0	292	3917	292	
9561	Multivariable analysis	Multivariable analysis	1	0	486	9562	486	
38888	case-fatality rate	case-fatality rate	1	0	1034	33846	1034	
33300	spinal surgery	spinal surgery	1	0	1630	14047	1630	
34279	serum concentration	serum concentration	1	0	11518	4556	11518	
2527	Northern Ireland and	Northern Ireland and	1	0	2529	2528	2531	
27746	effects model	effect model	1	0	1078	156	1078	
22866	results of one-way ANOVA	result of one-way INFunknownSUP	1	0	325	22868	325	
36132	Flesch Reading Ease scales	Flesch Reading ease scale	1	0	36134	25459	7864	
23070	offering evidence synthesis	offering evidence synthesis	1	0	23072	23071	14638	
12056	Isfahan COVID-19 registry	Isfahan INFunknownSUP registry	1	0	12058	12057	12060	
12530	active infection	active infection	1	0	41	3597	41	
16782	Culture Methods	Culture method	1	0	6982	16783	6982	
20459	substance abuse disorders	substance abuse disorder	1	0	20461	715	889	
13668	immune cells	immune cell	1	0	133	970	133	
39039	Association of androgenetic alopecia	association of androgenetic alopecia	1	0	16323	39041	16323	
35168	lung disease severity	lung disease severity	1	0	21919	772	5116	
24262	Valdecilla University Hospital	Valdecilla University Hospital	1	0	1877	14263	1879	
13307	Translational Myology	translational myology	1	0	13309	3019	13309	
784	reactive CD8 T cells	reactive INFunknownSUP T cell	1	0	786	785	133	
8847	Retrospective Study -	retrospective study INFunknownSUP	1	0	5345	8848	5345	
15434	Disease Prevention	Disease prevention	1	0	15436	5148	15436	
14458	Recognition efficiency of atypical cardiovascular readings	Recognition efficiency of atypical cardiovascular reading	1	0	14460	14459	14461	
7003	entire development	entire development	1	0	73	2269	73	
1860	National des Arts et Metiers	National des Arts et INFunknownSUP	1	0	1862	46	1868	
2203	likelihood of complication occurrence	likelihood of complication occurrence	1	0	2204	2205	2204	
35162	quantitative measure of radiographic lung disease severity	quantitative measure of radiographic lung disease severity	1	0	35164	1426	2466	
26610	medical mistrust	medical mistrust	1	0	7555	947	7555	
3759	ratio of observed SARS-CoV-2 infection clinical manifestations	ratio of observed INFunknownSUP infection clinical manifestation	1	0	2635	3761	2635	
12907	KDIGO criteria	INFunknownSUP criterion	1	0	3649	12908	3649	
22220	emergence of new viral strains	emergence of new viral strain	1	0	19875	22222	19875	
24452	oliguric AKI	INFunknownSUP Aki	1	0	13007	24453	13007	
18933	pandemic start	pandemic start	1	0	18935	113	18935	
12575	Pennsylvania State University	Pennsylvania State University	1	0	12577	12576	50	
37723	thousands of clinical trials	thousand of clinical trial	1	0	37724	21692	37724	
14207	average training precision	average training precision	1	0	14209	178	14211	
25094	urinary tract infection	urinary tract infection	1	0	41	19700	41	
5335	minimal clinical impact	minimal clinical impact	1	0	5337	5336	110	
4867	significant breakthrough	significant breakthrough	1	0	4869	908	4869	
25122	Cerebrovascular Diseases	cerebrovascular disease	1	0	6908	25123	6908	
30671	Social Vulnerability Index	Social vulnerability Index	1	0	30673	2019	7907	
33810	Support of the New Sexuality	support of the New sexuality	1	0	2021	33812	2021	
21069	trauma-informed principles of care	trauma-informed principle of care	1	0	21071	21070	17746	
20962	Central tendency	central tendency	1	0	15087	20963	15087	
8367	medication-assisted therapy	INFunknownSUP therapy	1	0	2273	8368	2273	
27657	information to the physicians	information to the physician	1	0	2591	21128	2591	
28878	in-person contact	in-person contact	1	0	1888	9275	1888	
30567	potential stressors	potential INFunknownSUP	1	0	14923	1276	14923	
24750	gender-matched control subjects	INFunknownSUP control subject	1	0	24752	11109	4893	
4337	rapid response systems	rapid response system	1	0	146	4338	146	
10442	ternary complex of S1	ternary complex of INFunknownSUP	1	0	10444	10443	10445	
5966	Formal evaluation of these changes	formal evaluation of these change	1	0	5968	5967	2399	
31356	architecture of receptor expression	architecture of receptor expression	1	0	13832	13833	13832	
26356	administration of a pilot mindfulness-based intervention	administration of a pilot INFunknownSUP intervention	1	0	631	26358	631	
2436	real-time reverse transcription polymerase chain reaction test	real-time reverse transcription polymerase chain reaction test	1	0	754	2437	754	
23962	ritos funebres	INFunknownSUP INFunknownSUP	1	0	23964	23963	23964	
14049	Weekly consumption	weekly consumption	1	0	1267	14050	1267	
23756	HRM procedure	HRM procedure	1	0	4693	15401	4693	
1716	new technology	new technology	1	0	1718	69	1718	
32622	personal digital device	personal digital device	1	0	32624	4961	3001	
3226	preservation of natural ecosystems	preservation of natural ecosystem	1	0	3227	3228	3227	
1880	voluntary Covid-19 testing programmes	voluntary INFunknownSUP testing programme	1	0	1882	1881	1886	
39207	realistic strategies	realistic strategy	1	0	300	39208	300	
6919	Scholar databases	scholar database	1	0	1755	6920	1755	
4906	search terms	search term	1	0	4908	344	4908	
9445	unselected cohort of service-users	unselected cohort of service-user	1	0	9447	9446	601	
1607	wall elastance	wall elastance	1	0	1609	1608	1609	
23672	western blot assay	western blot assay	1	0	23674	14915	3119	
6948	careful monitoring of renal complications	careful monitoring of renal complication	1	0	6950	6949	3271	
35173	IHT management times	IHT management time	1	0	21097	35174	12806	
31151	large database of compounds	large database of compound	1	0	31153	4250	879	
9673	awareness of the various psychiatric conditions	awareness of the various psychiatric condition	1	0	1612	9675	1612	
1565	current context	current context	1	0	1567	443	1567	
16485	Trauma center activity	trauma center activity	1	0	16487	16486	3990	
16147	mental health of the population	mental health of the population	1	0	118	1838	120	
12670	nursing problems of COVID-19 patients	nursing problem of INFunknownSUP patient	1	0	12671	911	6766	
33680	single dose vaccination	single dose vaccination	1	0	33682	1652	437	
17180	scientific world	scientific world	1	0	4336	2290	4336	
28373	IgG serological assays	IgG serological assay	1	0	2752	928	2754	
7040	Analysis of data	analysis of datum	1	0	204	22	204	
6466	preparedness of healthcare workers	preparedness of INFunknownSUP worker	1	0	6467	6468	6467	
25578	optimal use of NIRS modalities:alone	optimal use of INFunknownSUP INFunknownSUP	1	0	25580	7633	292	
31521	Acute respiratory distress syndrome	acute respiratory distress syndrome	1	0	24668	14013	1936	
23761	required admission to the intensive care unit	required admission to the intensive care unit	1	0	23763	20267	2865	
7603	cardiogenic shock	cardiogenic shock	1	0	6414	7604	6414	
20604	Personal Protection Measures	Personal Protection Measures	1	0	20606	20605	20608	
36981	rhesus macaque pneumonia models	rhesus macaque pneumonia model	1	0	22217	36982	3975	
36001	predictor of clinical outcomes	predictor of clinical outcome	1	0	1589	5448	1589	
11552	Genotype-Tissue Expression	Genotype-Tissue expression	1	0	3434	11553	3434	
24583	cancer cohort -	cancer cohort INFunknownSUP	1	0	5345	24584	5345	
3999	protective factors	protective factor	1	0	583	1455	583	
24119	tertiary hospitals	tertiary hospital	1	0	76	182	76	
22964	interview process	interview process	1	0	180	11572	180	
18261	binding sites of these compounds	binding site of these compound	1	0	17835	14102	9165	
26051	Spanish hospitals	Spanish hospital	1	0	76	26052	76	
32493	Clinical follow	clinical follow	1	0	32495	1501	32495	
7554	mistrust of governments	mistrust of government	1	0	7555	7556	7555	
14585	SARS-CoV-2 active adaptive immunity:post-vaccination	INFunknownSUP active adaptive immunity:post-vaccination	1	0	14587	28	14591	
15489	rigid management	rigid management	1	0	743	15490	743	
30791	Rothia mucilaginosa	INFunknownSUP INFunknownSUP	1	0	30793	30792	30793	
35152	essential membrane-bound bodies	essential membrane-bound body	1	0	35154	4197	8556	
10153	established clozapine monitoring system	established clozapine monitoring system	1	0	10155	10154	1327	
6514	recent treatment strategies	recent treatment strategy	1	0	6516	2128	300	
5485	decision tool	decision tool	1	0	5487	5486	5487	
14460	efficiency of atypical cardiovascular readings	efficiency of atypical cardiovascular reading	1	0	14461	14462	14461	
23824	triage patients	triage patient	1	0	60	6258	60	
34901	% of paediatric head injuries	% of paediatric head injury	1	0	364	34903	364	
5369	estimates of pooled odds ratio	estimate of pooled odd ratio	1	0	5370	5371	5370	
12731	positivity index	INFunknownSUP index	1	0	4017	1238	4017	
23158	major consequences	major consequence	1	0	4289	1318	4289	
6121	dynamic zero-inflated Poisson autoregressive model	dynamic zero-inflated Poisson INFunknownSUP model	1	0	2965	1540	1078	
388	higher magnitude of increase	high magnitude of increase	1	0	390	322	391	
10803	sub-Saharan Africa accounts	sub-Saharan Africa account	1	0	10805	10804	10807	
12346	demographic variables	demographic variable	1	0	817	1062	817	
7021	functional characterization	functional characterization	1	0	7023	4225	7023	
34451	treatment arms	treatment arm	1	0	34453	97	34453	
9287	potential inequities	potential inequity	1	0	9289	1276	9289	
31003	pathogen-derived proteins	INFunknownSUP protein	1	0	1126	31004	1126	
31482	Precautionary Principle	precautionary principle	1	0	31484	31483	31484	
3590	digital phenotyping	digital INFunknownSUP	1	0	3592	1094	3592	
1811	approved COVID-19 vaccines	approved INFunknownSUP vaccine	1	0	1813	1812	681	
38266	fewer specialty care	few specialty care	1	0	33993	1479	9	
12404	trajectory of dysphagia	trajectory of dysphagia	1	0	3985	12406	3985	
21042	ongoing high-quality education	ongoing high-quality education	1	0	21044	1059	361	
2937	high incidence of these diseases	high incidence of these disease	1	0	2939	13	2940	
16155	longer periods	long period	1	0	873	16156	873	
12360	encyclopedia of genes	encyclopedia of gene	1	0	12361	12362	12361	
1394	Deep Learning-Derived Chest Radiograph Scores COVID-19 patients	deep INFunknownSUP chest radiograph score INFunknownSUP patient	1	0	1396	1395	60	
2356	examination of the whole risk chain	examination of the whole risk chain	1	0	1800	2358	1800	
39244	mug of vaccine	mug of vaccine	1	0	39245	577	39245	
10321	multivariable analysis of each model	multivariable analysis of each model	1	0	10322	1078	486	
36400	removal of the nasogastric catheter	removal of the nasogastric catheter	1	0	8225	36402	8225	
13449	location of study	location of study	1	0	11895	2087	11895	
24701	psychological wellbeing of freelancers	psychological wellbeing of freelancer	1	0	24703	1380	23741	
17611	sufficient maturity	sufficient maturity	1	0	17613	4719	17613	
11239	arthroplasty procedure	INFunknownSUP procedure	1	0	4693	4243	4693	
22577	great increase	great increase	1	0	392	4480	392	
24735	Physical Activity	physical activity	1	0	24492	22012	24492	
32661	anti-SARS-CoV-2 IgG-infused group	INFunknownSUP INFunknownSUP group	1	0	18	32662	18	
6499	de datos MEDLINE	de dato INFunknownSUP	1	0	6501	1421	6503	
35075	supply chain failure	supply chain failure	1	0	35077	271	1779	
16936	lower mortality rates	low mortality rate	1	0	4976	594	83	
14066	quarantine regimes	quarantine regime	1	0	14068	2675	14068	
11693	mass vaccination campaigns	mass vaccination campaign	1	0	3886	11694	3886	
27437	performance indices	performance indices	1	0	7366	598	7366	
15619	rapid detection of infected people	rapid detection of infected people	1	0	15621	795	44	
30945	socio-economic factors	socio-economic factor	1	0	583	8670	583	
3901	research strategies	research strategy	1	0	300	36	300	
32063	total patients	total patient	1	0	60	1485	60	
5249	Health organizations	health organization	1	0	5251	5250	5251	
28683	ASAT &gt	ASAT INFunknownSUP	1	0	28685	28684	28685	
18815	estimated median incubation period	estimated median incubation period	1	0	18817	18816	5677	
23677	factors impact	factor impact	1	0	110	583	110	
19657	supplementation perceptions	supplementation perception	1	0	2955	19658	2955	
34675	ultrasound score involvement	ultrasound score involvement	1	0	3599	34676	3599	
5968	evaluation of these changes	evaluation of these change	1	0	2399	1336	2399	
2844	head injury presentations	head injury presentation	1	0	2846	2845	2848	
27143	early stages of the Coronavirus Disease	early stage of the INFunknownSUP Disease	1	0	764	11497	766	
428	microbiota composition	microbiota composition	1	0	430	429	430	
22283	centrifugal melt	centrifugal melt	1	0	253	251	253	
12550	Laparoendocsopic surgery	INFunknownSUP surgery	1	0	1630	12551	1630	
13049	high selectivity	high selectivity	1	0	13051	13	13051	
27159	high-risk comorbidities	high-risk comorbidity	1	0	676	1184	676	
15288	real-world instances of communication	real-world instance of communication	1	0	15290	15289	15291	
6950	monitoring of renal complications	monitoring of renal complication	1	0	3271	6952	3271	
36192	contactless community gardening program	contactless community gardening program	1	0	36194	36193	1790	
23436	majority of staff	majority of staff	1	0	4481	11	4481	
5810	definition of myocardial injury	definition of myocardial injury	1	0	5811	5812	5811	
7225	relevance of the evidence	relevance of the evidence	1	0	856	585	856	
2617	The War	The War	1	0	2619	2618	2619	
27246	part of the city	part of the city	1	0	734	9604	734	
25990	symptoms of SARS-CoV-2 infection	symptom of INFunknownSUP infection	1	0	86	1272	86	
18880	home ZIP codes	home zip code	1	0	4530	231	4532	
23059	Am J Epidemiol	Am J INFunknownSUP	1	0	23061	23060	23063	
7234	Plasma Tissue Inhibitor of MetalloProteinase	plasma tissue inhibitor of INFunknownSUP	1	0	7236	7235	7239	
36550	benchmark of the seroprevalence status	benchmark of the seroprevalence status	1	0	36551	36552	36551	
38807	units increment	unit increment	1	0	38809	6042	38809	
27981	Briggs Institute methodology	Briggs Institute methodology	1	0	27983	27982	11687	
26128	readability of the websites	readability of the website	1	0	996	15369	996	
22677	future lockdown periods	future INFunknownSUP period	1	0	22679	1367	873	
14472	small perivascular white matter lesions	small perivascular white matter lesion	1	0	14474	9600	162	
34334	operational ROC point	operational roc point	1	0	34336	16220	10333	
18545	results of the research	result of the research	1	0	325	36	325	
3248	descriptions of the neuropathological features of COVID-19 patients	description of the neuropathological feature of INFunknownSUP patient	1	0	3249	3250	3249	
22507	vulnerable population groups	vulnerable population group	1	0	22509	6402	2486	
6385	SARS-CoV-2 days	INFunknownSUP day	1	0	1645	28	1645	
8750	Epidemiologic studies	epidemiologic study	1	0	136	8751	136	
29230	Symptoms of nasal congestion	symptom of nasal congestion	1	0	14891	29232	14891	
18691	transmissibility of the Alpha variant	INFunknownSUP of the Alpha variant	1	0	3451	14079	3451	
11737	evidence of reinfection	evidence of reinfection	1	0	585	1451	585	
24062	La Peste	La INFunknownSUP	1	0	24064	21807	24064	
1531	patients Studies	patient study	1	0	1533	60	1533	
22201	complementary hypotheses	complementary hypothesis	1	0	22203	16434	22203	
22758	proactive response	proactive response	1	0	409	18311	409	
25604	socioeconomic disparities	socioeconomic disparity	1	0	10684	16	10684	
34176	high-risk adolescent	high-risk adolescent	1	0	11493	1184	11493	
1172	steroid treatment	steroid treatment	1	0	97	1173	97	
28003	COVID-positive pregnant females	COVID-positive pregnant female	1	0	13616	2737	11037	
6189	pathogenic mechanisms	pathogenic mechanism	1	0	1456	6190	1456	
28440	cardiovascular data	cardiovascular datum	1	0	22	13290	22	
30886	Kermany dataset	INFunknownSUP INFunknownSUP	1	0	17096	30887	17096	
25099	pregnancy test kits	pregnancy test kit	1	0	25101	1522	25103	
8833	renal tissue damage	renal tissue damage	1	0	7883	130	5946	
38130	Emergency Medicine Score	Emergency Medicine Score	1	0	38132	18540	38134	
10268	epicentre of the COVID-19	epicentre of the INFunknownSUP	1	0	10269	40	10269	
29635	Australian COVID-19 lockdown	Australian INFunknownSUP INFunknownSUP	1	0	15062	2506	1676	
20946	Administration of the HCQ+AZ combination	administration of the INFunknownSUP combination	1	0	20947	20948	20947	
26096	COVID-19 working environment	INFunknownSUP working environment	1	0	26098	40	3454	
26983	management command structure	management command structure	1	0	26985	743	2427	
37706	diagnostic kit	diagnostic kit	1	0	567	2219	567	
23783	remote delivery of care	remote delivery of care	1	0	23784	9	2840	
38799	occurrence of anxiety	occurrence of anxiety	1	0	2207	2772	2207	
17929	medical care	medical care	1	0	9	947	9	
29739	Outcome of Intestinal Ischemic Manifestations of COVID-19	outcome of intestinal ischemic manifestation of INFunknownSUP	1	0	10594	29741	10594	
18855	respiratory syndrome coronavirus:SARS-CoV	respiratory syndrome INFunknownSUP	1	0	18857	259	18859	
24971	significant predictors of mortality	significant predictor of mortality	1	0	24973	908	414	
35911	pre-tested structured questionnaire	INFunknownSUP structured questionnaire	1	0	29192	35912	9620	
23698	coronavirus-negative control sera	coronavirus-negative control sera	1	0	23700	1762	17161	
15080	prevalence of either IgM	prevalence of either Igm	1	0	9272	30	9272	
27594	substance use treatment facilities	substance use treatment facility	1	0	27598	714	2676	
34	proliferation of research	proliferation of research	1	0	35	36	35	
16687	cost-effectiveness of interventions to re-open universities	cost-effectiveness of intervention to INFunknownSUP university	1	0	16688	16691	16689	
1457	psychological illnesses	psychological illness	1	0	1459	1380	1459	
33608	viper Vipera nikolskii	viper INFunknownSUP INFunknownSUP	1	0	33610	33609	33612	
36041	cardiac symptoms	cardiac symptom	1	0	86	3858	86	
2570	younger age groups	young age group	1	0	2572	2571	2486	
24366	Characterization of myocardial injury	characterization of myocardial injury	1	0	24367	5812	24367	
21064	I2=67 %	INFunknownSUP %	1	0	364	21065	364	
4844	use of higher PEEP levels	use of high peep level	1	0	292	4846	292	
10259	Pearson coefficient	Pearson coefficient	1	0	4664	4230	4664	
2866	objectives of this study	objective of this study	1	0	2867	2087	2867	
19254	General Health Questionnaire	General Health questionnaire	1	0	19256	2695	19258	
16616	Organ Failure Assessment	Organ failure Assessment	1	0	16618	11176	2874	
35313	Neutrophil Counts	neutrophil Counts	1	0	35315	6360	35315	
6244	Refugee women	refugee woman	1	0	920	6245	920	
22165	Disease Coronavirus	disease INFunknownSUP	1	0	3206	10958	3206	
12063	claims data	claim datum	1	0	22	7052	22	
26101	impact of heavy personal protective equipment Surgeons	impact of heavy personal protective equipment surgeon	1	0	110	26103	110	
35006	World Health Organization website	World Health Organization website	1	0	545	12615	545	
13127	Front Line	Front Line	1	0	13129	13128	13129	
9895	period of the time	period of the time	1	0	5677	179	5677	
29860	condition of hepatic steatosis	condition of hepatic INFunknownSUP	1	0	8881	29862	8881	
882	clinical manifestations of SARS-CoV-2	clinical manifestation of INFunknownSUP	1	0	883	28	885	
26616	perspectives of COVID-19	perspective of INFunknownSUP	1	0	3304	40	3304	
17871	Thin-section CT	Thin-section CT	1	0	26	17872	26	
32375	presence of pericardial effusion	presence of pericardial effusion	1	0	675	241	675	
10700	weak/no evidence	INFunknownSUP evidence	1	0	585	10701	585	
28773	health guidelines	health guideline	1	0	91	120	91	
11608	mortalidad y letalidad como	INFunknownSUP y letalidad INFunknownSUP	1	0	11610	11609	4735	
3933	utility of this imaging technique	utility of this imaging technique	1	0	3934	3935	3934	
25571	complexity of patient health conditions	complexity of patient health condition	1	0	25572	25573	25572	
32293	Study ClinicalTrials.gov number	Study INFunknownSUP number	1	0	32295	2596	916	
30469	enhanced respiratory diseases	enhanced respiratory disease	1	0	30471	3888	315	
36722	second week of May	second week of May	1	0	36724	1279	7310	
23505	patient recall bias	patient recall bias	1	0	23507	2645	4930	
37363	peak of COVID-19 cases	peak of INFunknownSUP case	1	0	5928	7690	5928	
29076	recognition of olfactory dysfunction	recognition of olfactory dysfunction	1	0	13787	29078	13787	
7296	few effective treatments	few effective treatment	1	0	7298	6261	1295	
12381	world US $6	world US INFunknownSUP	1	0	12383	4336	12385	
5195	proportion of medical professionals	proportion of medical professional	1	0	910	5197	910	
23992	low level of misconceptions of prevention practices	low level of misconception of prevention practice	1	0	22598	16005	362	
38197	Tapanuli region of Indonesia	Tapanuli region of Indonesia	1	0	38199	38198	8256	
20880	local coordinators of IADS member organizations	local coordinator of INFunknownSUP member organization	1	0	20882	3173	20883	
29983	macular vessel densities	macular vessel density	1	0	29985	19275	22356	
1825	CEIm Cantabria	INFunknownSUP INFunknownSUP	1	0	1827	1826	1827	
23260	options of death rates evolution	option of death rate evolution	1	0	23261	23262	23261	
18557	COVID-19-recovered patients	COVID-19-recovered patient	1	0	60	18558	60	
18025	higher pre-booster titer of anti-S1 antibodies	high pre-booster titer of INFunknownSUP antibody	1	0	18027	322	18030	
16212	East Respiratory Syndrome virus	East respiratory syndrome virus	1	0	16214	16213	778	
31699	peptide-based therapies	INFunknownSUP therapy	1	0	5507	31700	5507	
33749	peer-reviewed journals	peer-reviewed journal	1	0	33751	32670	33751	
29838	negative participants	negative participant	1	0	4950	1338	4950	
37329	mechanisms of action	mechanism of action	1	0	1456	1223	1456	
30542	para el abordaje del duelo y la muerte	para el INFunknownSUP del INFunknownSUP y la INFunknownSUP	1	0	30544	30543	30556	
2674	quarantine facilities	quarantine facility	1	0	2676	2675	2676	
28568	health-related demands	health-related demand	1	0	10237	17027	10237	
22375	thrombocytopenic purpura	thrombocytopenic purpura	1	0	22377	22376	22377	
10921	ecuacion booleana	INFunknownSUP INFunknownSUP	1	0	10923	10922	10923	
26558	exhibit strong virucidal activity	exhibit strong INFunknownSUP activity	1	0	26560	26559	3990	
26689	types of alopecia	type of alopecia	1	0	1979	26691	1979	
37399	marine resources	marine resource	1	0	835	9837	835	
32732	steatosis condition	INFunknownSUP condition	1	0	8881	29864	8881	
32142	social targets	social target	1	0	4044	383	4044	
31875	binding mode of Arbidol to SARS-CoV-2 spike glycoprotein	binding mode of INFunknownSUP to INFunknownSUP spike glycoprotein	1	0	31876	7745	18075	
21012	cultural sector	cultural sector	1	0	11631	3638	11631	
9511	Twitter activity	twitter activity	1	0	3990	9512	3990	
27650	continued health risk	continued health risk	1	0	27652	27651	1542	
16324	earlier screening	early screening	1	0	7961	1520	7961	
39182	enough data	enough datum	1	0	22	39183	22	
10240	process conceptual framework	process conceptual framework	1	0	10242	180	4860	
18650	consistent information	consistent information	1	0	2591	10429	2591	
28508	multiple outlets	multiple outlet	1	0	25421	1776	25421	
37251	association of the Alpha variant	association of the Alpha variant	1	0	11619	14079	11619	
12691	end of symptoms	end of symptom	1	0	7132	86	7132	
30108	new variants of the virus	new variant of the virus	1	0	5466	778	1002	
27297	Tertiary Care Children	Tertiary Care Children	1	0	27299	14799	27301	
34584	response to COVID-19 impact	response to INFunknownSUP impact	1	0	409	34586	409	
20155	important new health policy voice	important new health policy voice	1	0	20157	273	12227	
37736	continual investments	continual investment	1	0	19705	37737	19705	
10557	occasion de	occasion de	1	0	1421	10558	1421	
37924	non-communicable disease	non-communicable disease	1	0	209	9627	209	
33334	chronic liver disease	chronic liver disease	1	0	8030	8230	209	
744	possible skin symptoms	possible skin symptom	1	0	746	745	86	
1786	inclusion of activities	inclusion of activity	1	0	1787	192	1787	
26744	contact-tracing apps	contact-tracing INFunknownSUP	1	0	17206	26745	17206	
7114	significant shifts	significant shift	1	0	4283	908	4283	
10172	concerted action	concerted action	1	0	1223	10173	1223	
10901	specialized resources	specialized resource	1	0	835	10902	835	
17639	Orthopaedic Surgery	orthopaedic surgery	1	0	2338	17640	2338	
10789	light-sheet microscopy imaging	light-sheet microscopy imaging	1	0	10791	10790	3936	
1899	El numero de pruebas y el numero de profesionales de medicina	El numero de INFunknownSUP y el numero de INFunknownSUP de INFunknownSUP	1	0	1901	1900	1919	
19552	content validity	content validity	1	0	13691	7469	13691	
26210	understanding of the extent of the impact	understanding of the extent of the impact	1	0	2715	26212	2715	
23483	animal origin	animal origin	1	0	10020	9009	10020	
10576	worse clinical presentation	bad clinical presentation	1	0	10578	10577	4163	
19794	toxicity of HCQ	toxicity of HCQ	1	0	19689	7775	19689	
22465	study of the evolution of the SARS-CoV-2 virus	study of the evolution of the INFunknownSUP virus	1	0	2087	22467	2087	
2339	data augmentation	datum augmentation	1	0	2341	22	2341	
19791	essential surgery	essential surgery	1	0	1630	4197	1630	
22273	Carceral facilities	INFunknownSUP facility	1	0	2676	22274	2676	
27406	Forty-eight cases	INFunknownSUP case	1	0	229	27407	229	
18287	prophylaxis measures	prophylaxis measure	1	0	317	4121	317	
16433	complementary serologic assay	complementary serologic assay	1	0	16435	16434	3119	
6945	Team interventions	team intervention	1	0	757	6946	757	
32672	critical patients	critical patient	1	0	60	223	60	
4761	RT- PCR	INFunknownSUP PCR	1	0	3981	4762	3981	
4500	COVID-19-associated liver injury	COVID-19-associated liver injury	1	0	4502	3357	713	
34839	exposure to nosocomial infection	exposure to INFunknownSUP infection	1	0	1054	34841	1054	
5113	CT severity score	CT severity score	1	0	1843	5114	1843	
18022	screening system	screening system	1	0	1327	7961	1327	
7720	jail health staff	jail health staff	1	0	7722	7721	11	
1955	ground-level NO2 concentrations	ground-level INFunknownSUP concentration	1	0	1957	1956	1959	
28285	mode of telehealth	mode of telehealth	1	0	18075	304	18075	
22485	recovery measure	recovery measure	1	0	2466	3007	2466	
34357	longitudinal data collection	longitudinal datum collection	1	0	19980	1106	16824	
30724	Dessie City Health	Dessie City Health	1	0	279	2812	279	
11188	BNT162b2 vaccine	INFunknownSUP vaccine	1	0	577	11189	577	
17904	Serum levels of IL-10	serum level of INFunknownSUP	1	0	9883	17905	169	
23607	disability of patients	disability of patient	1	0	23608	60	23608	
10679	SARS-CoV-2 S	INFunknownSUP S	1	0	6831	28	6831	
3433	Expression Assessments of ACE2	expression assessment of INFunknownSUP	1	0	3435	3434	3436	
6344	ongoing COVID19 pandemic	ongoing INFunknownSUP pandemic	1	0	6346	1059	113	
5259	negative group	negative group	1	0	18	1338	18	
23624	initial CT	initial CT	1	0	26	335	26	
5805	Health Organisation	Health Organisation	1	0	5807	279	5807	
29056	Older age	old age	1	0	906	22390	906	
1680	expert consensus statement	expert consensus statement	1	0	1682	1681	1684	
17939	real mobile phone data	real mobile phone datum	1	0	17941	17940	22	
25241	healthcare costs	INFunknownSUP cost	1	0	22726	494	22726	
9654	complete ophthalmological examination	complete ophthalmological examination	1	0	9656	4186	1800	
29882	third part of the survey	third part of the survey	1	0	7160	7099	734	
11766	University semester	University semester	1	0	1310	50	1310	
16397	Urinary albumin	urinary albumin	1	0	16399	2576	16399	
19732	Pancreatic Pseudocysts	pancreatic Pseudocyst	1	0	19734	19733	19734	
19384	Plastic Surgery Practices	Plastic surgery Practices	1	0	19386	19385	19388	
15829	clinical differences	clinical difference	1	0	5663	884	5663	
25351	symptom dimensionality	symptom dimensionality	1	0	25353	3814	25353	
20786	indicated discomfort	indicated discomfort	1	0	20788	20787	20788	
9284	community transmission	community transmission	1	0	876	3641	876	
5508	futures waves	future wave	1	0	1281	5509	1281	
13912	guide to public health strategies	guide to public health strategy	1	0	13913	13914	13913	
29995	Consortium members	Consortium member	1	0	16766	4989	16766	
21381	objective of this systematic review	objective of this systematic review	1	0	3611	21383	3611	
1557	Strategic positioning of pharmacists	strategic positioning of pharmacist	1	0	1559	1558	1560	
1763	control samples	control sample	1	0	1765	510	1765	
24525	dermatologic infections	INFunknownSUP infection	1	0	779	17491	779	
35013	post-COVID-19 infection	INFunknownSUP infection	1	0	41	35014	41	
8005	Turkish society	Turkish society	1	0	8007	8006	8007	
35154	membrane-bound bodies	membrane-bound body	1	0	8556	35155	8556	
30342	possible contact	possible contact	1	0	1888	745	1888	
8049	series data	series datum	1	0	22	8050	22	
925	positive IgG antibodies	positive IgG antibody	1	0	927	228	929	
32415	Reveal Extracellular Vesicles	Reveal extracellular vesicle	1	0	32417	32416	32419	
18241	immigrant areas	immigrant area	1	0	1579	18242	1579	
16684	COVID-19 pathogenesis	INFunknownSUP pathogenesis	1	0	14794	40	14794	
10771	support to nurse managers	support to nurse manager	1	0	260	9338	260	
10214	positive feedback	positive feedback	1	0	10216	228	10216	
18292	monitoring of transmission	monitoring of transmission	1	0	3271	876	3271	
23290	higher Hierarchical Condition Categories	high hierarchical condition category	1	0	23292	322	23296	
34910	community hospitals	community hospital	1	0	76	3641	76	
10360	confirmation of positive results	confirmation of positive result	1	0	10361	10362	10361	
34762	price to a larger percentage of the population	price to a large percentage of the population	1	0	9746	34764	9746	
281	junior HCPs	junior INFunknownSUP	1	0	283	282	283	
11245	psychological distress levels	psychological distress level	1	0	169	1973	169	
23900	Covid-19 patients Coronavirus Disease	INFunknownSUP patient INFunknownSUP Disease	1	0	5148	23901	5148	
7440	optical coherence tomography angiography	optical coherence tomography angiography	1	0	7442	7441	7446	
32945	prominent laboratory findings	prominent laboratory finding	1	0	15559	23139	3390	
20021	manejo competencial de los	INFunknownSUP INFunknownSUP de los	1	0	2632	20022	2632	
7433	functional effect of the COVID-19 pandemic	functional effect of the INFunknownSUP pandemic	1	0	7435	4225	1809	
7709	Current treatment	current treatment	1	0	97	7710	97	
15765	pathway of COVID-19 infection	pathway of INFunknownSUP infection	1	0	5003	39	5003	
26737	chronic kidney diseases	chronic kidney disease	1	0	26739	8230	315	
18224	Decompressive craniectomy	Decompressive INFunknownSUP	1	0	14454	18225	14454	
9680	nanomolar concentrations	nanomolar concentration	1	0	1959	9681	1959	
15641	stimulation of mononuclear cells	stimulation of mononuclear cell	1	0	15642	15643	15642	
22590	ACE2-specific signature	ACE2-specific signature	1	0	19531	22591	19531	
22918	virus isolation assays	virus isolation assay	1	0	22920	778	2754	
23507	recall bias	recall bias	1	0	4930	2319	4930	
15763	ocular-nasal-pulmonic pathway of COVID-19 infection	ocular-nasal-pulmonic pathway of INFunknownSUP infection	1	0	15765	15764	5003	
14805	risk of surgical site infection COVID-19	risk of surgical site infection INFunknownSUP	1	0	40	14806	40	
38583	impacts of the COVID-19 pandemic	impact of the INFunknownSUP pandemic	1	0	1385	111	1385	
37827	pathological region	pathological region	1	0	8256	37828	8256	
36220	terms of access to testing	term of access to testing	1	0	4908	36222	4908	
25263	mutation of SARS-CoV-2	mutation of INFunknownSUP	1	0	333	28	333	
37129	Modified Medical Research Council measure	modified Medical Research Council measure	1	0	37131	28518	2466	
34896	images Coronavirus-caused diseases	image INFunknownSUP disease	1	0	34898	4034	315	
36309	health support	health support	1	0	260	120	260	
36478	urgent cases	urgent case	1	0	229	8129	229	
11967	pulmonary aspergillosis	pulmonary aspergillosis	1	0	11969	590	11969	
31447	Spanish Agency	Spanish Agency	1	0	9435	31448	9435	
20430	higher population immunity	high population immunity	1	0	2459	322	257	
11341	infected contacts	infected contact	1	0	7082	1088	7082	
25824	contraindication to hydroxychloroquine	contraindication to hydroxychloroquine	1	0	25825	633	25825	
4399	mouth disease virus	mouth disease virus	1	0	4401	4400	778	
27378	higher initial WBC count	high initial WBC count	1	0	16658	322	1305	
34737	undesirable effects	undesirable effect	1	0	156	34738	156	
5138	prime reason	prime reason	1	0	5140	5139	5140	
14106	qualitative study	qualitative study	1	0	2087	8554	2087	
36787	Secondary outcome	secondary outcome	1	0	295	27758	295	
17941	mobile phone data	mobile phone datum	1	0	17943	3414	22	
7782	Significant kidney	significant kidney	1	0	5169	4575	5169	
6011	human resource	human resource	1	0	2703	2214	2703	
6286	positioning alternate	positioning alternate	1	0	6288	1560	6288	
15854	outbreak period	outbreak period	1	0	5677	310	5677	
2380	current debates	current debate	1	0	2382	443	2382	
21932	option of open book quizzes	option of open book quiz	1	0	5022	21934	5022	
36298	Quality Authority	Quality Authority	1	0	36300	14533	36300	
36824	% of the global disease burden	% of the global disease burden	1	0	364	36826	364	
25214	significant relationships	significant relationship	1	0	25216	908	25216	
14444	tissue rejection	tissue rejection	1	0	14446	4974	14446	
19373	membrane fusion	membrane fusion	1	0	13230	14632	13230	
5308	referral university hospital	referral university hospital	1	0	5310	2964	185	
37797	ROS production	Ros production	1	0	654	37798	654	
13988	Lasair II Particle Counter	INFunknownSUP II particle Counter	1	0	13994	13989	13994	
22207	rapid transition to telehealth	rapid transition to telehealth	1	0	8349	795	2091	
27910	preincubation time	preincubation time	1	0	179	27911	179	
1605	chest wall elastance	chest wall elastance	1	0	1607	25	1609	
24292	pandemic stay-at-home guidelines	pandemic stay-at-home guideline	1	0	24294	1354	91	
15758	feasibility of in-person visits	feasibility of in-person visit	1	0	4380	15760	4380	
13480	early NAC	early NAC	1	0	13482	55	13482	
29195	% of the world	% of the world	1	0	364	4336	364	
24114	wildlife protection regime	wildlife protection regime	1	0	24118	19022	24118	
15422	traditional modes of occupational therapy instruction	traditional mode of occupational therapy instruction	1	0	15424	1966	15425	
35040	large mortality	large mortality	1	0	1197	4250	1197	
2191	PPE survey	PPE survey	1	0	967	2192	967	
31606	bivariate analysis	INFunknownSUP analysis	1	0	486	31607	486	
21165	Emergency System	Emergency System	1	0	19651	18540	19651	
38217	health economic logic model	health economic logic model	1	0	38219	120	1078	
3884	social campaigns	social campaign	1	0	3886	383	3886	
25223	pre-clinical medical students	pre-clinical medical student	1	0	4129	25224	1177	
28241	category of patients	category of patient	1	0	17420	60	17420	
18155	Resident interviews	resident interview	1	0	10034	18156	10034	
12311	main clinical outcomes	main clinical outcome	1	0	5448	4679	263	
25930	RBC units	RBC unit	1	0	6042	6848	6042	
13791	physiology teaching	physiology teaching	1	0	2074	9131	2074	
15128	Center Zagreb	Center Zagreb	1	0	15130	2780	15130	
13310	shadow of COVID-19	shadow of INFunknownSUP	1	0	13311	40	13311	
3346	effective therapeutic strategy	effective therapeutic strategy	1	0	3348	2051	3350	
15245	difficult decision	difficult decision	1	0	5486	4690	5486	
32254	attention to social distancing	attention to social distancing	1	0	4885	382	4885	
1334	physiological changes	physiological change	1	0	1336	1335	1336	
9733	descriptive methods	descriptive method	1	0	205	9734	205	
32288	SARS-CoV-2 detection	INFunknownSUP detection	1	0	44	28	44	
12972	future epidemics	future epidemic	1	0	7930	1367	7930	
12220	accessory proteins	accessory protein	1	0	1126	12221	1126	
12027	hs-TnI assessment	INFunknownSUP assessment	1	0	238	10112	238	
19061	defence mechanisms	defence mechanism	1	0	1456	19062	1456	
4050	Novartis Safety Database	Novartis Safety Database	1	0	4052	4051	4054	
7905	Risk Index	Risk Index	1	0	7907	7906	7907	
10895	standard method	standard method	1	0	6587	2056	6587	
20288	rapid adaptation	rapid adaptation	1	0	20290	795	20290	
15342	antibiotic stewardship Public health responses	antibiotic stewardship public health response	1	0	15344	8615	200	
739	redemption process	redemption process	1	0	180	740	180	
8702	view of the strong family history of autoimmunity	view of the strong family history of autoimmunity	1	0	8703	8704	8703	
11913	tertiary care center	tertiary care center	1	0	11915	182	8718	
219	microglial proliferation	INFunknownSUP proliferation	1	0	35	220	35	
17547	multivariate Cox proportional hazard analyses	multivariate Cox proportional hazard analysis	1	0	17549	2408	4668	
13042	search of all diagnoses of foreign bodies	search of all diagnosis of foreign body	1	0	344	13044	344	
38274	JAK-STAT Pathway Inhibition	INFunknownSUP pathway inhibition	1	0	4076	38275	4076	
23307	individual responses	individual response	1	0	200	753	200	
398	Epidemiology of Pediatric Foreign Body Ingestions	epidemiology of pediatric foreign body ingestion	1	0	399	400	399	
17076	Relative Risk	relative risk	1	0	1450	17077	1450	
24530	The COVID-19 pandemic	The INFunknownSUP pandemic	1	0	111	2618	113	
1146	positive SARS-CoV-2 RNA test	positive INFunknownSUP RNA test	1	0	1148	228	754	
23294	Condition Categories	condition category	1	0	23296	23295	23296	
38969	rates of RTI	rate of RTI	1	0	83	38971	83	
22412	mean duration	mean duration	1	0	7404	194	7404	
6036	under-prepared intensive care units	under-prepared intensive care unit	1	0	6038	6037	6042	
21760	organism further studies	organism further study	1	0	21762	21761	136	
37888	effect of self-efficacy	effect of self-efficacy	1	0	1809	37890	1809	
8267	trial setting	trial setting	1	0	2854	965	2854	
33949	rapid heart transplantation Adequate immune response to vaccination	rapid heart transplantation adequate immune response to vaccination	1	0	33950	437	409	
5013	Universal SARS-CoV-2 testing	Universal INFunknownSUP testing	1	0	5015	5014	1885	
21469	importance of standardized early management of neurological patients	importance of standardized early management of neurological patient	1	0	2765	21471	2765	
21196	v-shaped trend	V-shaped trend	1	0	6677	21197	6677	
23034	insurance decision-making process	insurance decision-making process	1	0	23036	1711	180	
21243	pure water	pure water	1	0	21245	1749	21245	
32078	endometriosis surgery	endometriosis surgery	1	0	1630	9860	1630	
15248	Food Choice Determinants	food choice determinant	1	0	15252	15249	15252	
34011	implementation of quarantines	implementation of quarantine	1	0	396	34013	396	
25834	academic performance	academic performance	1	0	598	606	598	
30379	marked decrease	marked decrease	1	0	3084	22847	3084	
20869	sector of the new century	sector of the new century	1	0	11631	20871	11631	
24703	wellbeing of freelancers	wellbeing of freelancer	1	0	23741	24705	23741	
23763	admission to the intensive care unit	admission to the intensive care unit	1	0	2865	6	2865	
38147	Anxiety Scale	anxiety Scale	1	0	1203	15879	1203	
32773	immune-mediated presentation of SARS-CoV-2	INFunknownSUP presentation of INFunknownSUP	1	0	32775	32774	4163	
10651	decision makers	decision maker	1	0	793	5486	793	
21255	brain injury	brain injury	1	0	713	10043	713	
8909	organisation of pandemic prevention	organisation of pandemic prevention	1	0	8910	8911	8910	
35051	helper T cells	helper T cell	1	0	788	35052	133	
4420	Narrative review of viral dynamics	narrative review of viral dynamics	1	0	4421	4424	1723	
2268	entire country	entire country	1	0	2270	2269	2270	
21556	extensive fixation	extensive fixation	1	0	21558	15213	21558	
16118	vacant posts	vacant post	1	0	16120	16119	16120	
5029	response to this global outbreak	response to this global outbreak	1	0	409	5031	409	
6673	maculopapular-erythematous rash	maculopapular-erythematous rash	1	0	6675	6674	6675	
3446	dermatological lesions	dermatological lesion	1	0	162	3447	162	
26423	incidence of COVID-19 increases	incidence of INFunknownSUP increase	1	0	2940	26425	2940	
3787	higher percentage	high percentage	1	0	3789	322	3789	
17318	male gender	male gender	1	0	17286	709	17286	
18402	common radiologic pattern	common INFunknownSUP pattern	1	0	18404	699	4682	
22825	wastewater analysis	wastewater analysis	1	0	486	5093	486	
5426	abrupt transition	abrupt transition	1	0	2091	2089	2091	
23649	growth rate	growth rate	1	0	1034	1732	1034	
30119	impact of the severe acute respiratory syndrome-coronavirus-2	impact of the severe acute respiratory INFunknownSUP	1	0	110	30121	110	
19400	outcomes of nursing interventions	outcome of nursing intervention	1	0	263	19402	263	
10560	reformer la	reformer la	1	0	3572	10561	3572	
31975	work of universities	work of university	1	0	2162	10501	2162	
17818	disaster of COVID-19	disaster of INFunknownSUP	1	0	17819	40	17819	
2067	spread of the disease	spread of the disease	1	0	570	209	570	
28633	higher risk of blood transfusion	high risk of blood transfusion	1	0	18435	3128	1542	
19666	d. Patients	INFunknownSUP patient	1	0	10959	19667	10959	
11547	OTC products integration	OTC product integration	1	0	11549	7968	918	
18586	innovative data analysis	innovative datum analysis	1	0	17196	18587	486	
30998	computing resources	computing resource	1	0	835	30999	835	
4545	Automated Western immunoblotting detection	automated Western INFunknownSUP detection	1	0	44	4546	44	
20653	household contact	household contact	1	0	1888	18468	1888	
9402	successful remdesivir treatment	successful INFunknownSUP treatment	1	0	9404	9403	97	
34454	optical properties	optical property	1	0	1995	7441	1995	
9221	negative binomial mixed effects regressions	negative binomial mixed effect regression	1	0	9223	1338	9229	
37201	risk of transmission of SARS COV2	risk of transmission of INFunknownSUP INFunknownSUP	1	0	1542	37203	1542	
2276	hospital outbreak of SARS-CoV-2	hospital outbreak of INFunknownSUP	1	0	2278	185	310	
15983	miniaturization of traditional benchtop detection assays	miniaturization of traditional INFunknownSUP detection assay	1	0	15984	15985	15984	
38056	pathologic drivers of acute respiratory distress syndrome	pathologic driver of acute respiratory distress syndrome	1	0	38058	38057	33848	
24321	inexpensive source	inexpensive source	1	0	1971	24322	1971	
19463	exercise provision	exercise provision	1	0	6376	4799	6376	
2253	medical frontline workers	medical frontline worker	1	0	2255	947	1136	
6876	dissemination of this material	dissemination of this material	1	0	6877	551	6877	
18486	Frontline Workers	Frontline Workers	1	0	18488	18487	18488	
31107	protease utilization	protease utilization	1	0	4011	2918	4011	
3693	dynamics of COVID-19	dynamics of INFunknownSUP	1	0	3694	40	3694	
2898	patient population	patient population	1	0	1838	2645	1838	
8713	referral COVID-19 center COVID-19	referral INFunknownSUP center INFunknownSUP	1	0	8715	2964	40	
640	conditional indirect effects of stress	conditional indirect effect of stress	1	0	642	641	156	
26354	Online administration of a pilot mindfulness-based intervention	online administration of a pilot INFunknownSUP intervention	1	0	26356	217	631	
6458	infectious parameters	infectious parameter	1	0	6460	64	6460	
10621	Swedish pandemic policy	Swedish pandemic policy	1	0	10623	10622	293	
10195	visual assessment of lung CT	visual assessment of lung CT	1	0	10197	10196	238	
21894	standard scientific processes:was	standard scientific INFunknownSUP	1	0	21896	2056	21898	
12960	practical aspects of IoT MEMS	practical aspect of INFunknownSUP mem	1	0	12962	6164	2429	
1183	high-risk COVID-19 environments	high-risk INFunknownSUP environment	1	0	1185	1184	1187	
27945	Travel Restrictions	Travel restriction	1	0	27947	27946	27947	
16088	domains of respiratory failure	domain of respiratory failure	1	0	1180	3360	1180	
15948	record systems	record system	1	0	146	10572	146	
12601	H. Sarma	H. Sarma	1	0	12603	12602	12603	
30174	cases of the new coronavirus disease	case of the new coronavirus disease	1	0	229	30176	229	
1236	positivity rate of nAbs	INFunknownSUP rate of INFunknownSUP	1	0	1237	1240	1034	
1046	surgical cases	surgical case	1	0	229	663	229	
28021	COVID-19 onset	INFunknownSUP onset	1	0	1647	40	1647	
38346	unique population	unique population	1	0	1838	3547	1838	
38618	spread of a novel coronavirus	spread of a novel coronavirus	1	0	570	3644	570	
19208	direct effects of the pandemic	direct effect of the pandemic	1	0	7204	2012	156	
852	Additional biological relevance	additional biological relevance	1	0	854	853	856	
34973	high involvement	high involvement	1	0	3599	13	3599	
4427	industrial park	industrial park	1	0	4429	4428	4429	
17658	IL-1 beta	INFunknownSUP beta	1	0	17660	17659	17660	
23866	New Jersey	New Jersey	1	0	23868	1162	23868	
11368	molecular assay	molecular assay	1	0	3119	6935	3119	
7085	Convolutional Neural Network	convolutional neural Network	1	0	7087	3962	7089	
1199	Dysarthria Severity Scale	INFunknownSUP severity Scale	1	0	1203	1200	1203	
36693	COVID-19 CFR	INFunknownSUP CFR	1	0	23326	40	23326	
38660	blood centres	blood centre	1	0	2851	3129	2851	
1014	CD8 T cells of healthy unexposed donors	INFunknownSUP T cell of healthy unexposed donor	1	0	786	1020	133	
3461	unusual clinical manifestation of coronavirus disease	unusual clinical manifestation of coronavirus disease	1	0	3463	3462	3466	
18130	Possible applications	possible application	1	0	17602	18131	17602	
38048	popular data repositories	popular datum repository	1	0	38050	38049	38052	
38294	ischemic attack	ischemic attack	1	0	23017	5059	23017	
31658	recent pandemic of Coronavirus Disease 2019	recent pandemic of INFunknownSUP Disease 2019	1	0	31660	2128	113	
14376	post-pandemic periods	post-pandemic period	1	0	873	14377	873	
665	South Africa prompt healthcare providers	South Africa prompt INFunknownSUP provider	1	0	669	666	673	
24761	non-bizarre conspiracy	non-bizarre conspiracy	1	0	24763	24762	24763	
37894	future research	future research	1	0	36	1367	36	
37760	computer scientists	computer scientist	1	0	37762	37761	37762	
7805	possible candidates	possible candidate	1	0	4790	745	4790	
10403	initial SLT assessment	initial INFunknownSUP assessment	1	0	10405	335	238	
15810	intensive unit care	intensive unit care	1	0	15812	8	9	
14423	Pakistani adults	Pakistani adult	1	0	515	14424	515	
7386	selective inhibitor of JAK1/2	selective inhibitor of INFunknownSUP	1	0	7388	7387	4569	
35124	Vit C	INFunknownSUP C	1	0	2540	35125	2540	
20545	necessity of vaccination	necessity of vaccination	1	0	6535	437	6535	
14577	limited manpower	limited manpower	1	0	14579	5322	14579	
34364	multivariate research	multivariate research	1	0	36	2408	36	
31589	report of COVID-19	report of INFunknownSUP	1	0	378	40	378	
13591	tertiary referral COVID-19 center	tertiary referral INFunknownSUP center	1	0	13593	182	8718	
7351	FPL simulations	FPL simulation	1	0	7353	7352	7353	
12717	drug repurposing	drug INFunknownSUP	1	0	12719	352	12719	
12	high socioeconomic standard group	high socioeconomic standard group	1	0	14	13	18	
230	home residents	home resident	1	0	232	231	232	
12662	devastating outbreak	devastating outbreak	1	0	310	12663	310	
35941	Knowledge of the dermatologic manifestations	knowledge of the INFunknownSUP manifestation	1	0	885	35942	885	
34132	S1 protein surface	INFunknownSUP protein surface	1	0	7645	24070	7645	
37619	Complication of Post-COVID-19 Response	complication of INFunknownSUP Response	1	0	37620	37621	37620	
39297	% females	% female	1	0	11037	364	11037	
10610	beginning of COVID-19 vaccination	beginning of INFunknownSUP vaccination	1	0	10611	2836	10611	
9662	rich insights	rich insight	1	0	9664	9663	9664	
25754	geriatric assessment	geriatric assessment	1	0	238	2134	238	
20015	detection of pneumonia	detection of pneumonia	1	0	44	2369	44	
4944	SARS-CoV-2 IgG positive participants	INFunknownSUP IgG positive participant	1	0	4948	4627	4950	
8141	postoperative follow-up	postoperative follow-up	1	0	175	8142	175	
21261	severe COVID-19 infection Neurologic complications of COVID-19 infection	severe INFunknownSUP infection neurologic complication of INFunknownSUP infection	1	0	21263	262	705	
3691	transmission dynamics of COVID-19	transmission dynamics of INFunknownSUP	1	0	3693	876	3694	
14842	tailored approach of patients	tailored approach of patient	1	0	8742	60	1538	
31577	75th quartile	75th quartile	1	0	475	31578	475	
15678	use of COVID-19 vaccines	use of INFunknownSUP vaccine	1	0	292	1813	292	
38784	indice de letalidad relativa	INFunknownSUP de letalidad INFunknownSUP	1	0	38786	38785	38790	
37857	Cytokine Responses	INFunknownSUP response	1	0	29648	37858	29648	
38360	morbidity of foreign body ingestions	morbidity of foreign body ingestion	1	0	1216	38362	1216	
9236	average recall	average recall	1	0	2319	178	2319	
35135	peri-operative characteristics	peri-operative characteristic	1	0	1496	35136	1496	
11797	great pressure	great pressure	1	0	1027	4480	1027	
31047	safety of OTC supplements	safety of OTC supplement	1	0	6729	7967	6729	
17332	better prognosis	good prognosis	1	0	12920	1635	12920	
19611	country-level population-weighted NO2 concentrations	country-level population-weighted INFunknownSUP concentration	1	0	19613	19612	1959	
5114	CT severity	CT severity	1	0	5116	26	5116	
9947	Analysis Resource	Analysis Resource	1	0	9949	5482	9949	
6835	few hours	few hour	1	0	6837	6261	6837	
21155	risk of SARS-CoV-2 reinfection	risk of INFunknownSUP reinfection	1	0	1542	18079	1542	
31148	SARS-CoV-2 Pandemic	INFunknownSUP pandemic	1	0	6338	28	6338	
11386	3D coordinates of the pedestrian	3D coordinate of the pedestrian	1	0	11388	10448	11389	
28117	Epitope Database	Epitope Database	1	0	4054	28118	4054	
13192	closer monitoring	close monitoring	1	0	3271	13193	3271	
4381	referral rates	referral rate	1	0	83	2964	83	
34949	generation households	generation household	1	0	4614	3033	4614	
19314	ethical dilemmas	ethical dilemma	1	0	19316	19315	19316	
28357	pressure of communities	pressure of community	1	0	1027	948	1027	
12667	Prognostic Nomogram	prognostic nomogram	1	0	12669	3154	12669	
16327	structural inequities	structural inequity	1	0	9289	3549	9289	
13421	Adherence to recent operative guidelines	adherence to recent operative guideline	1	0	13422	13423	13422	
9425	percentage variation	percentage variation	1	0	9427	3789	9427	
20664	ambiguous role of children	ambiguous role of child	1	0	20666	20665	7288	
28222	cells model	cell model	1	0	1078	133	1078	
2744	proper vaccination	proper vaccination	1	0	437	449	437	
11621	particular severity of the disease	particular severity of the disease	1	0	11623	2853	5116	
4909	welfare of garment factory workers	welfare of garment factory worker	1	0	4910	4911	4910	
32608	Pakistani adult population	Pakistani adult population	1	0	1838	32609	1838	
34406	COVID-19 hospital environments	INFunknownSUP hospital environment	1	0	1187	1665	1187	
3907	memory/cognitive impairment	memory/cognitive impairment	1	0	3909	3908	3909	
38195	North Tapanuli region of Indonesia	North Tapanuli region of Indonesia	1	0	38197	37546	8256	
22333	quality-adjusted life months	quality-adjusted life month	1	0	22335	22334	761	
2240	resident financial well-being programs	resident financial well-being program	1	0	2242	2241	2246	
9583	Difference -	difference INFunknownSUP	1	0	5345	9584	5345	
26152	anonymous investigation	anonymous investigation	1	0	7714	26153	7714	
19083	hidden correlations	hidden correlation	1	0	4576	3176	4576	
11444	medical team	medical team	1	0	7208	947	7208	
24947	substantial agreement	substantial agreement	1	0	11664	3239	11664	
4948	positive participants	positive participant	1	0	4950	228	4950	
5848	Independent-samples Mann-Whitney U-test	Independent-samples Mann-Whitney INFunknownSUP	1	0	5850	5849	5852	
1143	vaccine prioritisation	vaccine INFunknownSUP	1	0	1145	577	1145	
54	early identification of older patients	early identification of old patient	1	0	56	55	57	
31231	Social position	social position	1	0	2825	24387	2825	
21906	pilot project	pilot project	1	0	11012	19913	11012	
8334	decrease of the infectious virus	decrease of the infectious virus	1	0	3084	8336	3084	
23447	inadequate isolation of infected people	inadequate isolation of infected people	1	0	23449	23448	6569	
19947	sensitivity performance of the sensor chips	sensitivity performance of the sensor chip	1	0	19949	2904	598	
3538	Pelviva group	INFunknownSUP group	1	0	18	3539	18	
5041	higher proportion	high proportion	1	0	910	322	910	
37701	scores &gt	score &gt	1	0	2385	3726	2385	
14357	greater predictive value	great predictive value	1	0	6369	302	1037	
18099	challenges of industrial-scale production of these devices	challenge of INFunknownSUP production of these device	1	0	2220	18101	2220	
28656	T2 mapping	INFunknownSUP mapping	1	0	28658	28657	28658	
34804	Impact of COVID-19 pandemic	impact of INFunknownSUP pandemic	1	0	802	111	802	
33404	COVID-19 Patients Limit Efficacy	INFunknownSUP Patients Limit efficacy	1	0	33408	16919	2112	
32886	reliability of SARS-CoV-2 IgG antibody testing	reliability of INFunknownSUP IgG antibody testing	1	0	6811	18827	6811	
10062	IPC training	IPC training	1	0	235	10063	235	
34645	virus-specific cytokine-producing polyfunctional T cells	virus-specific cytokine-producing polyfunctional T cell	1	0	34647	256	133	
13405	Reporting of Observational Studies	Reporting of observational study	1	0	13406	13407	13406	
10397	CDI risk	CDI risk	1	0	1542	72	1542	
38655	selective beta-blocking agents	selective INFunknownSUP agent	1	0	38657	7387	14767	
17717	introductions of SARS-CoV-2	introduction of INFunknownSUP	1	0	17718	28	17718	
9489	new fractional order mathematical model	new fractional order mathematical model	1	0	9491	69	1078	
1167	frequent comorbidities	frequent comorbidity	1	0	676	1168	676	
16968	SARS-CoV-2 binding affinity	INFunknownSUP binding affinity	1	0	2920	226	2922	
21645	emergency departments	emergency department	1	0	328	447	328	
14349	outbreaks of COVID-19	outbreak of INFunknownSUP	1	0	2892	40	2892	
13447	geographical location of study	geographical location of study	1	0	13449	13448	11895	
20079	determination of SARS-CoV-2	determination of INFunknownSUP	1	0	15931	28	15931	
13606	present pandemic	present pandemic	1	0	113	285	113	
4827	vaccine formulations	vaccine formulation	1	0	4829	577	4829	
30253	Antibody Levels	antibody Levels	1	0	30255	9862	30255	
26796	Los datos proceden de organismos internacionales	Los dato INFunknownSUP de INFunknownSUP INFunknownSUP	1	0	26806	26797	26806	
12799	spike protein of SARS-CoV-2	spike protein of INFunknownSUP	1	0	1795	28	1797	
29592	Observation Severe acute respiratory syndrome coronavirus	observation severe acute respiratory syndrome coronavirus	1	0	9923	29593	339	
214	Wiley Online Library	Wiley online Library	1	0	216	215	218	
16112	service shutdowns	service shutdown	1	0	16114	6375	16114	
21566	percentile score	percentile score	1	0	1843	21567	1843	
8617	situational analysis of the COVID-19 pandemic response	situational analysis of the INFunknownSUP pandemic response	1	0	8619	8618	486	
82	rates of PTSD symptoms	rate of INFunknownSUP symptom	1	0	83	84	83	
15688	feasibility study	feasibility study	1	0	2087	4380	2087	
19929	myth of Sisyphus	myth of Sisyphus	1	0	19930	19931	19930	
31130	utilitarianism-oriented human-wildlife relations	utilitarianism-oriented human-wildlife relation	1	0	31132	31131	31134	
21006	Institute of Allergy	Institute of allergy	1	0	20525	21008	20525	
32905	translational study	translational study	1	0	2087	32906	2087	
2801	distinct neutrophil states	distinct neutrophil state	1	0	2803	2802	2805	
32778	Viral dynamic data	viral dynamic datum	1	0	32780	8081	22	
34925	published reviews	published review	1	0	2554	2161	2554	
18051	trend of daily count of COVID-19 deaths	trend of daily count of INFunknownSUP death	1	0	6677	18053	6677	
23979	speech aerosol	speech aerosol	1	0	6808	23980	6808	
2452	Different Countries	Different Countries	1	0	2454	2453	2454	
38421	role of problem-focused coping	role of problem-focused coping	1	0	7288	2893	7288	
266	Architect i2000SR	architect INFunknownSUP	1	0	268	267	268	
16378	effectiveness of online learning	effectiveness of online learning	1	0	16379	2388	16379	
4325	associated strokes	associated stroke	1	0	3531	240	3531	
33444	Melbourne Hospital	Melbourne Hospital	1	0	1879	33445	1879	
7335	expression patterns	expression pattern	1	0	548	5729	548	
33479	times individual bubble members	time individual bubble member	1	0	33481	12806	16766	
17687	commercially-available cotton candy machines	commercially-available cotton candy machine	1	0	17689	17688	4511	
16041	new telemedicine technology	new telemedicine technology	1	0	16043	69	1718	
34887	quarantine history of a personal contact	quarantine history of a personal contact	1	0	34889	2675	5381	
39202	impact of the virus infection	impact of the virus infection	1	0	110	14073	110	
7202	secondary effects of the pandemic	secondary effect of the pandemic	1	0	7204	712	156	
10447	3D immunofluorescence of whole organs	3D immunofluorescence of whole organ	1	0	10449	10448	10450	
38503	consumption ratio	consumption ratio	1	0	2635	1267	2635	
17936	Trivial Lesions	trivial lesion	1	0	14026	17937	14026	
34764	larger percentage of the population	large percentage of the population	1	0	26711	9554	3789	
24747	utmost importance	utmost importance	1	0	2765	24748	2765	
38657	beta-blocking agents	INFunknownSUP agent	1	0	14767	38658	14767	
8244	quantitative policy	quantitative policy	1	0	293	1426	293	
32087	pairs of surgical gloves	pair of surgical glove	1	0	22238	32089	22238	
19555	healthcare facilities	INFunknownSUP facility	1	0	2676	494	2676	
13991	II Particle	II particle	1	0	13993	10856	13993	
30942	alopecia groups	alopecia group	1	0	2486	26691	2486	
24316	retrospective observational study	retrospective observational study	1	0	18803	10146	2087	
38486	dilatation technique	INFunknownSUP technique	1	0	562	38487	562	
28181	Food Choice Questionnaire	food choice questionnaire	1	0	19258	15249	19258	
25869	inference of B cell development processes	inference of B cell development process	1	0	579	25871	579	
31001	viral pathogen-derived proteins	viral INFunknownSUP protein	1	0	31003	1741	1126	
11349	primary prevention	primary prevention	1	0	1294	75	1294	
6813	existing epidemic curve	existing epidemic curve	1	0	6815	6308	6817	
1806	training effect of this model	training effect of this model	1	0	1808	235	1809	
17165	different intensities	different intensity	1	0	17167	688	17167	
32953	corona viruses	corona virus	1	0	2217	19344	2217	
17608	Replacement Registry	replacement registry	1	0	17610	17609	17610	
38827	confirmation of positive SARS-CoV-2	confirmation of positive INFunknownSUP	1	0	10361	38829	10361	
5713	genomic sequence of SARS-CoV-2	INFunknownSUP sequence of INFunknownSUP	1	0	5715	5714	5716	
23770	Patient-Centered Outcomes Research Institute	patient-centered outcome Research Institute	1	0	23772	23771	20525	
38886	COVID-19 case-fatality rate	INFunknownSUP case-fatality rate	1	0	38888	40	1034	
36240	negative impacts of proton pump inhibitor	negative impact of proton pump inhibitor	1	0	2972	36244	1385	
23318	clinical team	clinical team	1	0	7208	884	7208	
6624	Total GP consultation rates	total GP consultation rate	1	0	6626	6625	83	
4347	lipid accumulation	lipid accumulation	1	0	4349	4348	4349	
31143	New Ways of Teaching	New Ways of teaching	1	0	31145	1162	31146	
33705	Tomography Scans Background	tomography scan background	1	0	33707	33706	4013	
37101	less demyelination	less demyelination	1	0	37103	5525	37103	
2250	overall population	overall population	1	0	1838	2251	1838	
188	usual daily activities	usual daily activity	1	0	190	189	192	
7215	general public of Saudi Arabia	general public of Saudi Arabia	1	0	3696	7219	3698	
8200	protein features	protein feature	1	0	1469	1797	1469	
30397	new COVID-19 cases	new INFunknownSUP case	1	0	7690	69	229	
27939	MD -	Md INFunknownSUP	1	0	5345	27940	5345	
18146	effective recognition of trivial COVID-19 lesions	effective recognition of trivial INFunknownSUP lesion	1	0	18148	2051	13787	
19631	fear of the novel coronavirus disease	fear of the novel coronavirus disease	1	0	9468	19633	9468	
4756	inflammatory process	inflammatory process	1	0	180	3817	180	
15039	Combined Open Tracheostomy	Combined Open tracheostomy	1	0	15041	15040	15043	
10160	online interface	online interface	1	0	10162	541	10162	
1546	different healthcare strategies	different INFunknownSUP strategy	1	0	300	1547	300	
33465	big data analytics	big datum INFunknownSUP	1	0	14274	33466	14274	
15178	Further research	further research	1	0	36	15179	36	
35754	ceremonial behavior	ceremonial behavior	1	0	16069	35755	16069	
19896	risk of COVID-19 fatalities	risk of INFunknownSUP fatality	1	0	19900	19897	19900	
15105	Psoriatic Arthritis	psoriatic arthritis	1	0	15107	15106	15107	
30572	multidimensional analysis	multidimensional analysis	1	0	486	28437	486	
33076	current Chinese hospital reforms	current Chinese hospital reform	1	0	33078	443	22265	
28194	Consecutive patients	consecutive patient	1	0	60	28195	60	
20560	B virus	B virus	1	0	778	20561	778	
38647	drastic shift	drastic shift	1	0	37978	5869	37978	
2942	Kaiser Permanente Washington	Kaiser Permanente Washington	1	0	2944	2943	2946	
36430	occupational groups	occupational group	1	0	2486	2272	2486	
24863	teaching strategy	teaching strategy	1	0	3350	2074	3350	
26314	electrical double layer (EDL)-gated field-effect transistor-based biosensor	electrical double layer INFunknownSUP INFunknownSUP INFunknownSUP biosensor	1	0	26316	26315	26326	
29666	lack of data	lack of datum	1	0	11210	22	11210	
35419	psychometric properties	psychometric property	1	0	1995	35420	1995	
26976	severe CAP	severe cap	1	0	26978	262	26978	
31786	receptor blockers	receptor blocker	1	0	31788	3502	31788	
4410	viral disease progression	viral disease progression	1	0	4414	4411	4414	
30570	advanced multidimensional analysis	advanced multidimensional analysis	1	0	30572	5859	486	
11724	potential new therapeutic target	potential new therapeutic target	1	0	11726	1276	11730	
32967	care outcomes	care outcome	1	0	263	9	263	
13243	pharmacy services	pharmacy service	1	0	5980	5222	5980	
15801	quality of sleep	quality of sleep	1	0	3713	15803	3713	
33767	percent of respondents	percent of respondent	1	0	4123	861	4123	
19342	corona virus disease	corona virus disease	1	0	209	19343	209	
25320	surface types	surface type	1	0	1979	7645	1979	
21015	application of these techniques to clinical telemedicine	application of these technique to clinical telemedicine	1	0	21016	21019	125	
12740	contribution to virus spread	contribution to virus spread	1	0	6316	2884	6316	
9783	effect of Yinqiao powder	effect of INFunknownSUP powder	1	0	1809	9785	1809	
1624	restoration of elective spine surgery	restoration of elective spine surgery	1	0	1625	1626	1625	
39053	delivery model	delivery model	1	0	1078	2840	1078	
26619	digital devices	digital device	1	0	6162	1094	6162	
7422	Moderate Preterm Infant	moderate INFunknownSUP infant	1	0	7424	7423	7426	
24243	pathophysiology of either obesity	pathophysiology of either obesity	1	0	5651	24245	5651	
11589	long-term immunity	long-term immunity	1	0	257	4288	257	
36159	higher compliance	high compliance	1	0	2726	322	2726	
37151	% credible interval	% credible interval	1	0	37153	364	1794	
13109	spectral collocation method	spectral collocation method	1	0	13111	13110	6587	
11872	home isolation	home isolation	1	0	6569	231	6569	
35255	antimicrobial stewardship	antimicrobial stewardship	1	0	15345	35256	15345	
1909	el numero de profesionales de medicina	el numero de INFunknownSUP de INFunknownSUP	1	0	1911	1910	1919	
23863	clinical factors	clinical factor	1	0	583	884	583	
33175	unprecedented global disruption	unprecedented global disruption	1	0	33177	5915	12078	
36031	structured trust-wide technology-enhanced training	structured INFunknownSUP technology-enhanced training	1	0	36033	6409	235	
24287	motives:"healthy eaters	motives:"healthy eater	1	0	24289	24288	24289	
13493	Immunogenic T cell epitopes of SARS-CoV-2	immunogenic T cell epitope of INFunknownSUP	1	0	13495	13494	13500	
37808	human health systems	human health system	1	0	146	22330	146	
15944	electronic health record systems	electronic health record system	1	0	15946	10569	146	
3310	systems of policy advice	system of policy advice	1	0	146	3312	146	
22595	Wall Elastance	Wall elastance	1	0	22597	22596	22597	
23048	zero-inflated models	zero-inflated model	1	0	3975	2966	3975	
6206	injured foci	injured focus	1	0	6208	6207	6208	
15515	~80 %	~80 %	1	0	364	15516	364	
6708	Wuhan Tongji Hospital	Wuhan INFunknownSUP Hospital	1	0	6710	6709	1879	
23019	min of aerobic exercise	min of aerobic exercise	1	0	22686	23021	22686	
19086	significant independent factors	significant independent factor	1	0	581	908	583	
20020	manejo competencial de los profesionales sanitarios	INFunknownSUP INFunknownSUP de los INFunknownSUP INFunknownSUP	1	0	20028	20021	14626	
37065	SARS-CoV-2 body entrance	INFunknownSUP body entrance	1	0	37067	28	37069	
15529	monocular images	monocular image	1	0	4034	15530	4034	
22030	internal factors	internal factor	1	0	583	18382	583	
33030	immunogenic capacity of long peptides	immunogenic capacity of long peptide	1	0	33032	33031	3026	
586	vaccine-related pulmonary immunopathology enhancement	vaccine-related pulmonary Immunopathology enhancement	1	0	588	587	592	
18885	additional potent factor	additional potent factor	1	0	18887	7175	2183	
8119	multivariate model	multivariate model	1	0	1078	2408	1078	
31189	extended surgical mask use cohort	extended surgical mask use cohort	1	0	31191	288	601	
7615	comparable studies	comparable study	1	0	136	1493	136	
28082	Research Council	Research Council	1	0	6229	3674	6229	
37794	Results of this study	result of this study	1	0	10882	2087	10882	
28675	emergency flexible ureteroscopy	emergency flexible INFunknownSUP	1	0	23475	447	23477	
39084	non-operative management of appendicitis	non-operative management of appendicitis	1	0	39086	39085	743	
36503	KDIGO stage	INFunknownSUP stage	1	0	1521	12908	1521	
30825	fand sich	INFunknownSUP INFunknownSUP	1	0	30827	30826	30827	
27934	COVID-19-hospitalized patients Biomarkers	INFunknownSUP patient Biomarker	1	0	13339	9508	13339	
27333	natural history studies	natural history study	1	0	27335	3229	136	
31731	18F-FDG brain PET of long COVID patients	INFunknownSUP brain pet of long INFunknownSUP patient	1	0	31733	12201	12205	
11120	form of COVID-19 infection Individual susceptibility	form of INFunknownSUP infection individual susceptibility	1	0	11121	11122	11121	
38019	anti-S-2P geometric mean titer	INFunknownSUP geometric mean titer	1	0	38021	38020	18030	
23341	inhibition efficacy of heparin sodium	inhibition efficacy of heparin sodium	1	0	23343	9422	6704	
24642	Antiviral Targets Intercellular communication	antiviral target intercellular communication	1	0	24644	24643	11078	
22941	potential of Arbidol	potential of INFunknownSUP	1	0	6265	22943	6265	
2818	SARS-CoV-2-infected cases	SARS-CoV-2-infected case	1	0	229	2819	229	
38166	printing techniques	printing technique	1	0	691	38167	691	
34151	diagnostic tool	diagnostic tool	1	0	5487	2219	5487	
38899	ACE2 residues	INFunknownSUP residue	1	0	7744	4778	7744	
37843	reports of the overall clinical course	report of the overall clinical course	1	0	4651	37845	4651	
30666	HARMONICOV cohort	INFunknownSUP cohort	1	0	601	8934	601	
26185	psychosocial health of medical undergraduates	psychosocial health of medical undergraduate	1	0	26187	9177	120	
18948	neonatal SARS-coronavirus-2 infections	neonatal INFunknownSUP infection	1	0	18950	312	779	
14760	secure networks	secure network	1	0	4171	14761	4171	
11517	concentration of viral RNA	concentration of viral RNA	1	0	11518	11519	11518	
4953	diagnosis accuracy	diagnosis accuracy	1	0	4535	2168	4535	
31372	diagnostic values	diagnostic value	1	0	825	2219	825	
27480	understanding of the dynamics of COVID-19 transmission	understanding of the dynamics of INFunknownSUP transmission	1	0	2715	27482	2715	
15543	socioeconomic consequences of COVID-19	socioeconomic consequence of INFunknownSUP	1	0	15545	16	4289	
39142	subsequent step	subsequent step	1	0	23817	39143	23817	
7131	end of the semester	end of the semester	1	0	7132	1310	7132	
22066	ENT articles	Ent article	1	0	811	21127	811	
22777	value of the combined model	value of the combined model	1	0	1037	22779	1037	
18887	potent factor	potent factor	1	0	2183	1408	2183	
18653	elevated signals	elevated signal	1	0	4820	1705	4820	
4858	governance framework	governance framework	1	0	4860	2616	4860	
38626	conversion of a hospital	conversion of a hospital	1	0	12067	185	12067	
19963	complex change programmes	complex change programme	1	0	19965	13320	1886	
20915	Electronic Medical Records	Electronic Medical Records	1	0	20917	20916	20919	
14954	del duelo	del INFunknownSUP	1	0	14956	14955	14956	
7520	empirical analysis	empirical analysis	1	0	486	4924	486	
4505	social network questionnaires	social network questionnaire	1	0	4509	4506	4509	
38698	number of complications	number of complication	1	0	916	705	916	
36365	effects of dexamethasone	effect of INFunknownSUP	1	0	156	12123	156	
19644	Impact of Face-Recognition-Based	impact of INFunknownSUP	1	0	802	19646	802	
6639	robust exit strategies	robust exit strategy	1	0	647	6640	300	
17828	public cloud	public cloud	1	0	17830	1321	17830	
34596	Effective SARS-CoV-2 vaccines	effective INFunknownSUP vaccine	1	0	34598	12771	681	
26033	full protection	full protection	1	0	440	6703	440	
36346	orientation groups	orientation group	1	0	2486	28020	2486	
28803	ninth month post-infection	ninth month post-infection	1	0	28805	28804	25675	
19328	ongoing collection of key clinical trial endpoints	ongoing collection of key clinical trial endpoint	1	0	19330	1059	16824	
4138	social interaction	social interaction	1	0	2525	383	2525	
27803	research approaches	research approach	1	0	8111	36	8111	
9310	cross-sectional analysis of data	cross-sectional analysis of datum	1	0	9311	22	486	
27123	selected cases	selected case	1	0	229	1620	229	
0	fogged goggles	fogged goggle	1	0	2	1	2	
16905	MSD lung tumors	MSD lung tumor	1	0	16907	16906	16909	
10256	hand sanitizer	hand INFunknownSUP	1	0	10258	2503	10258	
17766	subgroup analysis	subgroup analysis	1	0	486	14031	486	
25107	Neuro-COVID Unit	INFunknownSUP Unit	1	0	16875	25108	16875	
36782	final version of record	final version of record	1	0	36784	4256	4435	
3243	nitric oxide treatment	nitric oxide treatment	1	0	3245	3244	97	
7375	negative proteinuria group	negative proteinuria group	1	0	7377	1338	18	
11346	Analysis Foundation	Analysis Foundation	1	0	11348	5482	11348	
33202	new asymptomatic patients	new asymptomatic patient	1	0	33204	69	60	
23205	number of COVID-19 cases	number of INFunknownSUP case	1	0	916	7690	916	
38701	collateral damage to patients	collateral damage to patient	1	0	38703	38702	5946	
20886	member organizations	member organization	1	0	5251	7209	5251	
24255	new wave	new wave	1	0	10210	69	10210	
7761	travel histories	travel history	1	0	7763	2879	7763	
11756	current pharmacological strategies	current pharmacological strategy	1	0	11758	443	300	
21176	environment support	environment support	1	0	260	3454	260	
1931	acute respiratory syndrome coronavirus	acute respiratory syndrome coronavirus	1	0	1933	1461	339	
30441	Delta variants	Delta variant	1	0	1002	19992	1002	
19168	current public health measures	current public health measure	1	0	16567	443	317	
33523	treatment success	treatment success	1	0	4063	97	4063	
11856	consensus guidelines	consensus guideline	1	0	91	1683	91	
16928	% bias	% bias	1	0	4930	364	4930	
11329	incident command response teams	incident command response team	1	0	11331	11330	5220	
26988	human body	human body	1	0	2710	2214	2710	
13263	Clinical Characteristics Form	clinical characteristic form	1	0	13267	2025	13267	
33663	COVID-19 contact-tracing mobile apps	INFunknownSUP contact-tracing mobile INFunknownSUP	1	0	33665	40	17206	
5758	por COVID-19	por INFunknownSUP	1	0	40	1418	40	
35066	matrix approach	matrix approach	1	0	1538	8449	1538	
12429	chronic low level of inflammation	chronic low level of inflammation	1	0	12431	8230	362	
7834	resultant stay-at-home orders	resultant stay-at-home order	1	0	7836	7835	7838	
20279	significant relationship	significant relationship	1	0	2722	908	2722	
35723	effective way	effective way	1	0	701	2051	701	
14747	veterinary RNA viruses	veterinary RNA virus	1	0	3742	14748	2217	
10458	SARS-CoV-2 susceptibility	INFunknownSUP susceptibility	1	0	10460	28	10460	
35962	Older adults	old adult	1	0	515	22390	515	
19117	Monitoring transmissibility	monitoring INFunknownSUP	1	0	3451	19118	3451	
1551	impact of these variants	impact of these variant	1	0	110	1002	110	
47	Taiwan University anatomy teachers	Taiwan University anatomy teacher	1	0	49	48	53	
35845	PTSD symptoms	INFunknownSUP symptom	1	0	86	35846	86	
4652	building resilience	building resilience	1	0	4654	4653	4654	
4461	discussion of examples	discussion of example	1	0	3060	4463	3060	
25938	16S rRNA V2	16S INFunknownSUP INFunknownSUP	1	0	25940	25939	25942	
38706	clinical investigation	clinical investigation	1	0	7714	884	7714	
12079	Access to health care	access to health care	1	0	12080	12081	12080	
23657	surgical adverse events	surgical adverse event	1	0	1081	663	1083	
27785	rheumatoid arthritis	rheumatoid arthritis	1	0	11903	27786	11903	
27580	rapid contract tracing	rapid contract tracing	1	0	27582	795	1889	
26304	focus of the humoral immune response	focus of the humoral immune response	1	0	8409	6113	8409	
35328	Zero-Inflated Time Series	Zero-Inflated Time Series	1	0	35330	35329	35332	
3506	Job type	Job type	1	0	775	3507	775	
10233	perception of imbalanced demands	perception of imbalanced demand	1	0	2387	10235	2387	
36169	range of mammalian RNA viruses	range of mammalian RNA virus	1	0	420	36171	420	
18036	global health crisis	global health crisis	1	0	408	18037	408	
9197	state-of-the-art methods	state-of-the-art method	1	0	205	533	205	
3873	threats technological vulnerabilities	threat technological vulnerability	1	0	3875	1370	3877	
8586	postoperative care	postoperative care	1	0	9	8142	9	
3938	global clinical characteristics of the COVID-19 patients	global clinical characteristic of the INFunknownSUP patient	1	0	3940	1954	1496	
39001	prevalence of SARS-CoV-2	prevalence of INFunknownSUP	1	0	9272	28	9272	
9921	SARS-CoV-2 Severe acute respiratory syndrome coronavirus	INFunknownSUP severe acute respiratory syndrome coronavirus	1	0	9923	28	339	
18191	public company	public company	1	0	9893	1321	9893	
9005	interaction assays	interaction assay	1	0	2754	2525	2754	
23051	public health purposes	public health purpose	1	0	23055	1320	23055	
5701	number of trade-offs	number of trade-off	1	0	916	4527	916	
37527	% hospitals	% hospital	1	0	76	364	76	
34959	optimal medical indications	optimal medical indication	1	0	34961	7633	34963	
7238	Inhibitor of MetalloProteinase	inhibitor of INFunknownSUP	1	0	7239	7240	7239	
35935	financial stressors	financial INFunknownSUP	1	0	14923	547	14923	
15553	percentage of Caucasians	percentage of Caucasians	1	0	3789	15555	3789	
23893	hospital stays	hospital stays	1	0	23895	185	23895	
30759	Medical undergraduate education	medical undergraduate education	1	0	30761	30760	361	
11612	letalidad como	letalidad INFunknownSUP	1	0	4735	11613	4735	
19901	commercially-available FFRs	commercially-available INFunknownSUP	1	0	19903	17688	19903	
10969	needed minimal oxygen support	needed minimal oxygen support	1	0	10971	10970	260	
18416	impact of this curricular transformation	impact of this curricular transformation	1	0	110	18418	110	
38014	health care industries	health care industry	1	0	38016	120	8158	
8580	Patent holders	patent holder	1	0	8582	8581	8582	
13098	occurrence rate	occurrence rate	1	0	1034	2207	1034	
18601	Scientific method	scientific method	1	0	6587	18602	6587	
6349	Active work	active work	1	0	2162	6350	2162	
24584	cancer cohort	cancer cohort	1	0	601	773	601	
20396	immune suppression therapy	immune suppression therapy	1	0	20398	970	2273	
32272	Spanish private hospitals	Spanish private hospital	1	0	32274	26052	76	
34815	ANS disorder	Ans disorder	1	0	7358	22303	7358	
28477	Severe Acute Respiratory Distress Syndrome	Severe acute respiratory distress syndrome	1	0	28479	5189	14017	
14467	long-distance communications	long-distance communication	1	0	14469	14468	14469	
9864	SARS-COV2 Infection	INFunknownSUP infection	1	0	9866	9865	9866	
17501	negative pressure environment	negative pressure environment	1	0	17503	1338	3454	
29071	baseline situation of the patients	baseline situation of the patient	1	0	29073	5344	3056	
20054	healthcare strategies	INFunknownSUP strategy	1	0	300	494	300	
25419	media outlets	medium outlet	1	0	25421	661	25421	
14763	efficacy of investigational agents	efficacy of investigational agent	1	0	6704	14765	6704	
27003	risk levels	risk level	1	0	169	1542	169	
11219	overhaul of the symptomatic breast services	overhaul of the symptomatic breast service	1	0	11220	11221	11220	
16269	heightened risk of exposure to severe acute respiratory syndrome coronavirus	heightened risk of exposure to severe acute respiratory syndrome coronavirus	1	0	16271	16270	1542	
37111	mix of private-public financing	mix of private-public financing	1	0	37112	37113	37112	
35362	work modifications	work modification	1	0	35364	2162	35364	
24106	cerebral hypometabolism	cerebral hypometabolism	1	0	1260	4322	1260	
15643	mononuclear cells	mononuclear cell	1	0	133	15644	133	
27915	hydrogel patches	INFunknownSUP patch	1	0	15413	27916	15413	
36517	data mining	datum mining	1	0	5834	22	5834	
28953	nonclinical healthcare workers	nonclinical INFunknownSUP worker	1	0	6468	28954	1136	
2677	new possibilities	new possibility	1	0	2679	69	2679	
9685	follow-up of the evolution of the number of infections	follow-up of the evolution of the number of infection	1	0	175	9687	175	
17888	expression pattern of ACE2	expression pattern of INFunknownSUP	1	0	17890	5729	4682	
4593	psychiatric sequalae of COVID-19	psychiatric INFunknownSUP of INFunknownSUP	1	0	4595	4594	4596	
7364	oxygenation indices	oxygenation indices	1	0	7366	7365	7366	
35592	liver transplantation	live transplantation	1	0	10540	23362	10540	
4181	activity design	activity design	1	0	4183	3990	4183	
21347	laboratory-confirmed COVID-19	laboratory-confirmed INFunknownSUP	1	0	3076	6439	3076	
20057	COVID-19 Behavior Tracker	INFunknownSUP behavior tracker	1	0	20059	40	20061	
33677	antigen test	antigen test	1	0	754	9207	754	
20864	digital training	digital training	1	0	235	1094	235	
29857	life tables	life table	1	0	29859	1434	29859	
34777	naive vaccinees	naive INFunknownSUP	1	0	34779	3656	34779	
8830	epidemiologic characteristics	epidemiologic characteristic	1	0	1496	8831	1496	
13860	predictors of prolonged sick leave	predictor of prolonged sick leave	1	0	414	6609	414	
37295	non-infected individuals	non-infected individual	1	0	1113	37296	1113	
1518	earlier stage of pregnancy	early stage of pregnancy	1	0	1519	1522	1521	
7332	cell-specific expression patterns of ACE2	cell-specific expression pattern of INFunknownSUP	1	0	7334	7333	548	
12454	COVID-19-related webpages	COVID-19-related webpage	1	0	12456	1384	12456	
14398	Disease progression	disease progression	1	0	4414	10958	4414	
23939	Different S1 Protein Sites	Different INFunknownSUP protein Sites	1	0	23941	2453	23945	
19606	nursing staff	nursing staff	1	0	11	1209	11	
6827	T403R RaTG13 S	INFunknownSUP INFunknownSUP S	1	0	6831	6828	6831	
20571	Study of Intestinal Diseases	study of intestinal disease	1	0	8850	20573	8850	
9176	psychosocial outcomes	psychosocial outcome	1	0	263	9177	263	
5454	high-risk settings	high-risk setting	1	0	2729	1184	2729	
29360	Currently Covid-19	Currently INFunknownSUP	1	0	1884	29361	1884	
5755	Mortalidad por COVID-19 y su relacion con las busquedas	INFunknownSUP por INFunknownSUP y Su INFunknownSUP con la INFunknownSUP	1	0	5761	5756	5771	
18096	position of comfort	position of comfort	1	0	2825	18098	2825	
36062	immunohistochemical analyses of brain tissue	immunohistochemical analysis of brain tissue	1	0	36064	36063	4668	
7512	vitro mRNA	INFunknownSUP INFunknownSUP	1	0	5727	248	5727	
5821	Cox regression analyses	Cox regression analysis	1	0	4668	5822	4668	
19839	dynamic negative binomial autoregressive model	dynamic negative binomial INFunknownSUP model	1	0	9829	1540	1078	
7791	social capacities	social capacity	1	0	7793	383	7793	
33718	transparent ratings of the body of evidence	transparent rating of the body of evidence	1	0	33720	33719	33489	
9030	vertical transmission of SARS-CoV-2	vertical transmission of INFunknownSUP	1	0	9032	875	876	
31071	modulation of NAD	modulation of NAD	1	0	19294	31073	19294	
34091	period of the pandemic	period of the pandemic	1	0	5677	113	5677	
1761	coronavirus-negative control samples	coronavirus-negative control sample	1	0	1763	1762	1765	
2831	issue p.	issue page	1	0	2833	2832	2833	
37219	rapid acceleration	rapid acceleration	1	0	37221	795	37221	
19228	adaptive immune response	adaptive immune response	1	0	6115	6264	409	
22423	study observation period	study observation period	1	0	7450	2087	5677	
13786	recognition of digital font	recognition of digital font	1	0	13787	13788	13787	
24348	well-being outcomes	well-being outcome	1	0	263	2245	263	
5051	UK Large-scale vaccination	UK large-scale vaccination	1	0	5053	5052	437	
20454	common understanding of the management	common understanding of the management	1	0	6942	743	2715	
7484	chart reviews	chart review	1	0	2554	7485	2554	
19440	Chi-square tests	Chi-square test	1	0	1365	19441	1365	
27103	repair factors BDNF	repair factor INFunknownSUP	1	0	27105	27104	27107	
3495	shared housing	shared housing	1	0	3497	3496	3497	
14884	simple parameters	simple parameter	1	0	6460	2770	6460	
29692	impact of lockdown policies	impact of INFunknownSUP policy	1	0	110	14694	110	
32721	routine practice	routine practice	1	0	3285	4898	3285	
37670	Statistical significance	statistical significance	1	0	458	37671	458	
9370	myriad of information	myriad of information	1	0	9371	2591	9371	
27249	numerous functional complaints	numerous functional complaint	1	0	4342	531	4344	
24183	overall conclusion	overall conclusion	1	0	24185	2251	24185	
21173	stage of COVID-19	stage of INFunknownSUP	1	0	1521	40	1521	
26895	individual samples	individual sample	1	0	1765	753	1765	
34740	personal well-being	personal well-being	1	0	2245	4961	2245	
34219	emotional support	emotional support	1	0	260	6765	260	
38118	dynamics of transmission	dynamics of transmission	1	0	3694	876	3694	
17272	management of diabetes	management of diabetes	1	0	743	17274	743	
18163	impact of vaccination activities	impact of vaccination activity	1	0	110	7954	110	
8453	lot of administrative duties	lot of administrative duty	1	0	4650	8455	4650	
4255	final follow-up	final follow-up	1	0	175	4256	175	
11706	utilization of human ACE2	utilization of human INFunknownSUP	1	0	4011	3458	4011	
18413	human cancer	human cancer	1	0	773	2214	773	
26436	regulatory guidelines	regulatory guideline	1	0	91	5686	91	
19577	Clinical trials	clinical trial	1	0	8639	1501	8639	
27009	patient data	patient datum	1	0	22	2645	22	
33665	contact-tracing mobile apps	contact-tracing mobile INFunknownSUP	1	0	33667	26745	17206	
23860	Special care	special care	1	0	9	13132	9	
14666	prevention of transmission of SARS-CoV-2	prevention of transmission of INFunknownSUP	1	0	1294	9032	1294	
32678	untargeted screening	untargeted screening	1	0	7961	32679	7961	
6494	gene ontology	gene ontology	1	0	6496	6495	6496	
32239	infectious disease outbreaks	infectious disease outbreak	1	0	2892	4216	2892	
9809	data usage	datum usage	1	0	2248	22	2248	
9824	experience of a condition	experience of a condition	1	0	2782	8881	2782	
33362	pharmacy profession	pharmacy profession	1	0	33364	5222	33364	
6551	Health Insurance Portability	Health Insurance portability	1	0	6553	279	6555	
3002	fundamental component of the recovery plan	fundamental component of the recovery plan	1	0	3004	3003	529	
14510	border restriction	border restriction	1	0	14512	14511	14512	
13002	water-soluble IgY	water-soluble IgY	1	0	13004	13003	13004	
5084	longitude ranges	longitude range	1	0	5086	5085	5086	
17032	French multicohort population-based serological survey	French multicohort INFunknownSUP serological survey	1	0	17034	17033	967	
19425	- classification	INFunknownSUP classification	1	0	1121	5345	1121	
19583	insurance type	insurance type	1	0	775	1711	775	
35459	epidemic phase	epidemic phase	1	0	1352	6542	1352	
10674	rare clinical entities	rare clinical entity	1	0	10676	10225	10678	
27092	objective indicator of exposure to the disease	objective indicator of exposure to the disease	1	0	27094	8297	20310	
25526	treatment of COVID-19-positive patients Tracheostomy	treatment of COVID-19-positive patient tracheostomy	1	0	97	25528	97	
30868	EuropePMC databases	INFunknownSUP database	1	0	1755	30869	1755	
26588	supply sufficiency	supply sufficiency	1	0	26590	271	26590	
16627	general responses	general response	1	0	200	1080	200	
37775	cellular interactions	cellular interaction	1	0	13158	4919	13158	
36995	diverse outpatient cohort of patients	diverse outpatient cohort of patient	1	0	36997	10278	601	
7419	different datasets	different INFunknownSUP	1	0	4432	688	4432	
9127	Typical immunopathology	typical Immunopathology	1	0	94	9128	94	
9136	infectious disease hospitalizations of neonates	infectious disease hospitalization of neonate	1	0	9140	4216	5091	
32280	7-item WHO-scale	INFunknownSUP WHO-scale	1	0	32282	32281	32282	
34055	undetectable adaptive immunity	undetectable adaptive immunity	1	0	34057	14704	257	
2149	upper respiratory tract infections	upper respiratory tract infection	1	0	2151	2150	779	
17191	third quarters	third quarter	1	0	8115	7099	8115	
20620	low resource settings	low resource setting	1	0	20622	457	2729	
28131	countries Electronic health	country electronic health	1	0	28133	1599	120	
10538	organ transplantation	organ transplantation	1	0	10540	1778	10540	
9259	proper diet	proper diet	1	0	9261	449	9261	
8672	antiviral medications	antiviral medication	1	0	4355	3989	4355	
24693	vast majority of organizers	vast majority of organizer	1	0	24695	19619	4481	
20681	Immune thrombocytopenia	Immune INFunknownSUP	1	0	20683	20682	20683	
24052	ACE2 entry receptor	INFunknownSUP entry receptor	1	0	5628	3437	3502	
33180	systemic inflammatory index	systemic inflammatory index	1	0	33182	1453	4017	
30350	grade levels	grade level	1	0	169	5049	169	
25521	balanced randomization scheme	balanced randomization scheme	1	0	25523	25522	25525	
15698	effective vaccines	effective vaccine	1	0	681	2051	681	
11643	departments of the Italian Universities	department of the Italian university	1	0	328	11645	328	
4566	TNF-alpha inhibitor etanercept	TNF-alpha inhibitor INFunknownSUP	1	0	4568	4567	4570	
35704	exact mechanism of JAK/STAT	exact mechanism of INFunknownSUP	1	0	35706	23838	10036	
19000	evidence of the importance of well-structured programs	evidence of the importance of well-structured program	1	0	585	19002	585	
20417	Corona Pandemic:(COVID-19):A Narrative Review Background Coronavirus disease	Corona INFunknownSUP narrative Review background INFunknownSUP disease	1	0	20419	10431	209	
30088	efficient manner	efficient manner	1	0	10535	4329	10535	
14401	Limpopo Province	Limpopo Province	1	0	3831	14402	3831	
38880	paramount example	paramount example	1	0	16680	2764	16680	
19618	vast majority of hip	vast majority of hip	1	0	19620	19619	4481	
25233	internet-based resources	INFunknownSUP resource	1	0	835	25234	835	
3332	QC-HC U-net	INFunknownSUP INFunknownSUP	1	0	3334	3333	3334	
39091	trocar incisions	trocar incision	1	0	39093	39092	39093	
33486	higher ratings of treatment perceptions	high rating of treatment perception	1	0	33488	322	33489	
31673	colossal impact	colossal impact	1	0	110	31674	110	
5845	scores of dentists	score of dentist	1	0	3726	5847	3726	
35611	contemporary pandemic stress levels	contemporary pandemic stress level	1	0	35613	16679	169	
33037	admission of these patients	admission of these patient	1	0	2865	60	2865	
30453	Lung lesions	lung lesion	1	0	162	8737	162	
38538	Further investigation	further investigation	1	0	7714	15179	7714	
36798	CLEAR project	clear project	1	0	11012	422	11012	
7587	panel discussion of the effects of the COVID-19 pandemic	panel discussion of the effect of the INFunknownSUP pandemic	1	0	7589	7588	3060	
25455	PS score	PS score	1	0	1843	18674	1843	
9282	intensity of community transmission	intensity of community transmission	1	0	2875	9284	2875	
28458	Healthcare professionals	Healthcare professional	1	0	121	1355	121	
37183	individual-based isolation measures	INFunknownSUP isolation measure	1	0	37185	37184	317	
1487	Korean IBD patients	Korean INFunknownSUP patient	1	0	1489	1488	60	
3569	orientar la prevencion	INFunknownSUP la INFunknownSUP	1	0	3571	3570	3573	
11560	enlarged perivascular spaces	enlarged perivascular space	1	0	11562	11561	11564	
10688	bias risk	bias risk	1	0	1542	4930	1542	
16216	Syndrome virus	syndrome virus	1	0	778	14017	778	
23662	negative individuals	negative individual	1	0	1113	1338	1113	
11091	risk of postoperative ICU admission	risk of postoperative ICU admission	1	0	1542	11093	1542	
26142	optimal cutoff of REMS	optimal cutoff of INFunknownSUP	1	0	26144	7633	26145	
33876	axial length	axial length	1	0	1347	33877	1347	
32588	response theory	response theory	1	0	21053	409	21053	
13572	Successful Lesson	successful lesson	1	0	13574	13573	13574	
3392	central locations	central location	1	0	3394	3393	3394	
2124	recommended precautions	recommended precaution	1	0	2126	2125	2126	
26519	surgery morbidity	surgery morbidity	1	0	1216	1630	1216	
18522	COVID-19 Pandemic Containment	INFunknownSUP pandemic containment	1	0	18526	6336	18526	
36088	July 4th -7th	July 4th INFunknownSUP	1	0	36090	36089	36092	
36153	standard-of-care remdesivir	INFunknownSUP INFunknownSUP	1	0	9405	36154	9405	
29358	Pandemic Currently Covid-19	pandemic Currently INFunknownSUP	1	0	29360	2450	1884	
22111	mg hydroxychloroquine sulfate coated tablet	mg hydroxychloroquine sulfate coated tablet	1	0	22113	22112	22119	
8800	unemployment rate	unemployment rate	1	0	1034	8801	1034	
1224	plan of the Iranian Blood Transfusion Organization	plan of the Iranian Blood transfusion Organization	1	0	1225	1226	1225	
1537	approach to dynamic risk modeling of mortality	approach to dynamic risk modeling of mortality	1	0	1538	1539	1538	
26046	initial chief complaint	initial chief complaint	1	0	26048	335	12929	
36139	viral load synthesis	viral load synthesis	1	0	14638	5917	14638	
7304	groups of oral species	group of oral specie	1	0	2486	7306	2486	
20350	UK Consortium	UK Consortium	1	0	4989	5052	4989	
26043	risk of hospitalization	risk of hospitalization	1	0	1542	11637	1542	
2592	treatment attendance	treatment attendance	1	0	2594	97	2594	
16273	exposure to severe acute respiratory syndrome coronavirus	exposure to severe acute respiratory syndrome coronavirus	1	0	1054	4709	1054	
17672	Odds Ratio	odd ratio	1	0	9907	17673	9907	
18122	private clinic	private clinic	1	0	7704	2401	7704	
18817	median incubation period	median incubation period	1	0	18819	2634	5677	
33475	mean number of times individual bubble members	mean number of time individual bubble member	1	0	914	33479	916	
23518	descriptive phenomenological research approach	descriptive phenomenological research approach	1	0	23520	9734	1538	
4870	Subsequent Cohorting	subsequent INFunknownSUP	1	0	4872	4871	4872	
38067	consideration of the resources	consideration of the resource	1	0	1097	835	1097	
31557	Simple Western system	simple Western system	1	0	31559	8289	1327	
17772	chronic comorbidities	chronic comorbidity	1	0	676	8230	676	
14583	Undetectable SARS-CoV-2 active adaptive immunity:post-vaccination	undetectable INFunknownSUP active adaptive immunity:post-vaccination	1	0	14585	14584	14591	
18076	better outcomes	good outcome	1	0	263	1635	263	
7774	HCQ metabolism	HCQ metabolism	1	0	7776	7775	7776	
1064	high clinical illness burden	high clinical illness burden	1	0	1066	13	1070	
3449	higher transmissibility	high INFunknownSUP	1	0	3451	322	3451	
22933	putative therapeutic product	putative therapeutic product	1	0	22935	22934	1735	
29332	prominent role of a CDR1 somatic hypermutation	prominent role of a INFunknownSUP somatic hypermutation	1	0	25433	29336	7288	
22755	video format	video format	1	0	22757	22756	22757	
27034	dental universities	dental university	1	0	10501	5656	10501	
28970	SARS-CoV-2 pneumonia	INFunknownSUP pneumonia	1	0	2369	28	2369	
21215	binary logistic regression models	binary logistic regression model	1	0	3975	5130	3975	
30507	biological diversity	biological diversity	1	0	8993	855	8993	
16059	multicentre British Association of Spine Surgeons	multicentre British Association of Spine surgeon	1	0	16061	16060	1952	
34326	life-threatening respiratory condition	life-threatening respiratory condition	1	0	34328	4753	8881	
6428	risk of Covid-19	risk of INFunknownSUP	1	0	1542	1884	1542	
2177	positive residents	positive resident	1	0	232	228	232	
1903	de pruebas y el numero de profesionales de medicina	de INFunknownSUP y el numero de INFunknownSUP de INFunknownSUP	1	0	1905	1421	1919	
6173	y el afrontamiento precoz que	y el INFunknownSUP INFunknownSUP que	1	0	6175	1908	6181	
21350	course of COVID-19	course of INFunknownSUP	1	0	5152	40	5152	
35871	all-cause mortality	INFunknownSUP mortality	1	0	1197	7017	1197	
31363	province of China	province of China	1	0	23950	4295	23950	
21185	hypoxic respiratory failure	hypoxic respiratory failure	1	0	3360	21186	1779	
29920	resident census	resident census	1	0	2123	1480	2123	
33350	evaluation of selected machine	evaluation of selected machine	1	0	2399	33352	2399	
25425	Ethical approval	ethical approval	1	0	13952	25426	13952	
20071	novel alternative	novel alternative	1	0	20073	810	20073	
31307	excellent performance of the algorithm	excellent performance of the algorithm	1	0	31308	1525	598	
14947	vez la prevencion del duelo complicado	vez la INFunknownSUP del INFunknownSUP INFunknownSUP	1	0	14949	14948	14957	
32	enormous proliferation of research	enormous proliferation of research	1	0	34	33	35	
12006	immune dynamics	immune dynamics	1	0	3694	970	3694	
3492	medication policy	medication policy	1	0	293	153	293	
21949	certain symptoms	certain symptom	1	0	86	8853	86	
11231	hours of public offices	hour of public office	1	0	6837	11233	6837	
22648	physical function	physical function	1	0	9243	1242	9243	
18515	lower respiratory tracts	low respiratory tract	1	0	18517	594	18519	
28503	various inflammatory markers	various inflammatory marker	1	0	6266	1099	5129	
28585	learning algorithm	learning algorithm	1	0	1525	2390	1525	
26651	production of goods	production of good	1	0	654	22478	654	
29762	39-year-old female	39-year-old female	1	0	29764	29763	29764	
6193	Significant associations	significant association	1	0	5750	4575	5750	
22404	impact of new variants	impact of new variant	1	0	110	5466	110	
18954	higher ACE2 inhibitory potency	high INFunknownSUP inhibitory potency	1	0	18958	18955	7480	
8114	quarters of the COVID-19 cohort	quarter of the INFunknownSUP cohort	1	0	8115	8116	8115	
27665	monitoring programs	monitoring program	1	0	2246	3271	2246	
12280	development of face masks	development of face mask	1	0	73	3034	73	
34649	polyfunctional T cells	polyfunctional T cell	1	0	788	34650	133	
6516	treatment strategies	treatment strategy	1	0	300	97	300	
30101	assessment of the possibility	assessment of the possibility	1	0	238	30103	238	
18444	use of the 100-mug dose	use of the INFunknownSUP dose	1	0	292	18446	292	
34627	full treatment escalation	full treatment escalation	1	0	34629	6703	34631	
37048	screening strategy of SARS-CoV-2 protective antibodies	screening strategy of INFunknownSUP protective antibody	1	0	18942	37052	3350	
1543	modeling of mortality	modeling of mortality	1	0	464	1197	464	
15574	PTSD related symptoms	INFunknownSUP related symptom	1	0	15576	85	86	
3983	disease trajectory	disease trajectory	1	0	3985	209	3985	
32055	olfactory epithelium	olfactory epithelium	1	0	32057	1702	32057	
34543	auspices of the federal government	auspice of the federal government	1	0	34544	34545	34544	
34236	activation of immune responses	activation of immune response	1	0	1013	969	1013	
23974	marine bioactive compounds	marine bioactive compound	1	0	23976	9837	14102	
27585	immune system of the elderly population	immune system of the elderly population	1	0	1325	27589	1327	
27541	CDC Evaluation of COVID-19	CDC evaluation of INFunknownSUP	1	0	27543	90	7849	
3917	e-learning platforms	e-learning platform	1	0	3919	3918	3919	
809	novel articles	novel article	1	0	811	810	811	
1690	Clinical Manifestations of COVID-19	clinical manifestation of INFunknownSUP	1	0	1691	40	1693	
22898	% of convalescents	% of convalescent	1	0	364	22900	364	
22843	Prevention Practices	prevention Practices	1	0	19388	15436	19388	
4226	SARS-CoV-2 mAbs	INFunknownSUP INFunknownSUP	1	0	4228	28	4228	
30953	impact of the variations	impact of the variation	1	0	110	30955	110	
16063	Association of Spine Surgeons	Association of Spine surgeon	1	0	1952	16065	1952	
657	polypropylene filtration media	polypropylene filtration medium	1	0	661	658	661	
2255	frontline workers	frontline worker	1	0	1136	2256	1136	
20464	various countries	various country	1	0	1599	1099	1599	
25326	Current literature	current literature	1	0	4698	7710	4698	
38499	Weekend to midweek consumption ratio	weekend to midweek consumption ratio	1	0	38500	38501	38500	
35800	attention to the conservation of personal protective equipment	attention to the conservation of personal protective equipment	1	0	4885	35802	4885	
20347	COVID-19 Genomics	INFunknownSUP INFunknownSUP	1	0	20349	40	20349	
32475	old patients	old patient	1	0	60	6693	60	
5229	Notes software	Notes software	1	0	5231	5230	5231	
23361	liver cirrhosis	live cirrhosis	1	0	23363	23362	23363	
31283	limited understanding of the impact of the COVID-19 pandemic	limited understanding of the impact of the INFunknownSUP pandemic	1	0	31285	5322	2715	
21367	acute stroke imaging	acute stroke imaging	1	0	3936	15656	3936	
31843	lower respiratory tract infections	low respiratory tract infection	1	0	2151	594	779	
7410	accuracy of detection	accuracy of detection	1	0	4535	44	4535	
19643	Impact of Face-Recognition-Based Access Control System	impact of INFunknownSUP Access Control System	1	0	19647	19644	19651	
11830	adequate space	adequate space	1	0	11832	270	11832	
30382	reactive arthritis	reactive arthritis	1	0	11903	785	11903	
33422	Caribbean nation	Caribbean nation	1	0	20531	33423	20531	
28053	likelihood of infectious disease morbidity	likelihood of infectious disease morbidity	1	0	2204	28055	2204	
31460	second wave of the pandemic	second wave of the pandemic	1	0	13103	113	10210	
11039	national criteria	national criterion	1	0	3649	517	3649	
28073	proposal of a convalescent plasma	proposal of a convalescent plasma	1	0	28074	28075	28074	
1636	management of COVID-19 patients	management of INFunknownSUP patient	1	0	743	911	743	
24389	Data of all countries	datum of all country	1	0	24390	1599	24390	
38952	worst-case scenario	worst-case scenario	1	0	5611	38953	5611	
31304	prothrombotic state	prothrombotic state	1	0	1961	31305	1961	
28159	surgical complications	surgical complication	1	0	705	663	705	
27307	detection of COVID-19-related findings	detection of COVID-19-related finding	1	0	44	27309	44	
38938	proportion of early infections	proportion of early infection	1	0	910	38940	910	
33322	health-care workers	health-care worker	1	0	1136	16517	1136	
35949	Education Department	Education Department	1	0	18541	3731	18541	
27790	acute diarrhea	acute diarrhea	1	0	27792	1461	27792	
38919	pharmacy leadership structure	pharmacy leadership structure	1	0	38921	5222	2427	
36642	RPTEC model	INFunknownSUP model	1	0	1078	32149	1078	
24568	vaccine failure	vaccine failure	1	0	1779	577	1779	
36481	severe pulmonary disease	severe pulmonary disease	1	0	36483	262	209	
25961	UC patients	UC patient	1	0	60	25962	60	
18953	higher ACE2 inhibitory potency of stem-derived	high INFunknownSUP inhibitory potency of INFunknownSUP	1	0	18954	18961	7480	
36625	remote web-based pulmonary rehabilitation programme models	remote INFunknownSUP pulmonary rehabilitation programme model	1	0	36627	2073	3975	
18520	Regular COVID-19 Pandemic Containment	regular INFunknownSUP pandemic containment	1	0	18522	18521	18526	
29663	asymptomatic populations	asymptomatic population	1	0	13188	1131	13188	
37610	Counter Supplements	Counter supplement	1	0	37612	13994	37612	
16853	various issues	various issue	1	0	3758	1099	3758	
33393	future mentoring	future mentoring	1	0	4041	1367	4041	
34616	American Pacific Islanders	American Pacific islander	1	0	34618	17605	34620	
21059	early stage of the disease	early stage of the disease	1	0	5998	209	1521	
6103	position statement AISF	position statement INFunknownSUP	1	0	6105	2825	6107	
16478	bilateral ground glass opacities	bilateral ground glass opacity	1	0	16480	10335	526	
31906	departments of the Italian University Hospitals	department of the Italian University hospital	1	0	328	31908	328	
725	sub-sternal chest pain	sub-sternal chest pain	1	0	727	726	729	
6633	parameters of the patients	parameter of the patient	1	0	6460	60	6460	
25075	effect of school FACS	effect of school INFunknownSUP	1	0	1809	25077	1809	
14554	resource setup	resource setup	1	0	14556	2703	14556	
35308	Digital Pathology	Digital pathology	1	0	35310	8676	35310	
759	sixth months	sixth month	1	0	761	760	761	
16180	screening visit	screening visit	1	0	16182	7961	16182	
34362	further multivariate research	further multivariate research	1	0	34364	7713	36	
23087	motor CD/FND	motor INFunknownSUP	1	0	1464	11523	1464	
15980	filtration rate	filtration rate	1	0	1034	145	1034	
11764	experience of a University semester	experience of a University semester	1	0	2782	11766	2782	
11367	molecular assay testing	molecular assay testing	1	0	1885	11368	1885	
11761	respect to this disease	respect to this disease	1	0	11762	209	11762	
21873	informational bariatric seminars	informational bariatric seminar	1	0	21875	21874	21877	
30368	full-time dental students	full-time dental student	1	0	6860	27902	1177	
36486	New Zealand convenience sample	New Zealand convenience sample	1	0	2755	1161	2757	
23780	SARS-CoV-2 waves	INFunknownSUP wave	1	0	1281	226	1281	
24447	upper respiratory infection	upper respiratory infection	1	0	24449	2150	41	
20467	genomic copies/swab	INFunknownSUP INFunknownSUP	1	0	20469	5714	20469	
456	low significance	low significance	1	0	458	457	458	
3892	patient cohorts	patient cohort	1	0	3894	710	3894	
26063	axon preservation	axon preservation	1	0	3227	26064	3227	
3	Covid-19 intensive care unit staff	INFunknownSUP intensive care unit staff	1	0	11	4	11	
35062	next generation matrix approach	next generation matrix approach	1	0	35064	2624	1538	
29743	Ischemic Manifestations of COVID-19	ischemic manifestation of INFunknownSUP	1	0	29745	29744	1693	
22186	simple point of care	simple point of care	1	0	22188	2770	10333	
17490	dermatologic lesions	INFunknownSUP lesion	1	0	162	17491	162	
17064	typical characteristic of the family	typical characteristic of the family	1	0	17066	17065	17067	
17097	Ayatollah Talleghani hospital	Ayatollah Talleghani hospital	1	0	17099	17098	185	
29258	upward trend	upward trend	1	0	6677	29259	6677	
8884	systemic disease	systemic disease	1	0	209	1453	209	
20599	bogy of the mind	bogy of the mind	1	0	20600	20601	20600	
25039	care framework to every patient encounter	care framework to every patient encounter	1	0	25041	9	4860	
11682	involvement index	involvement index	1	0	4017	3599	4017	
8190	written informed consent	written informed consent	1	0	8192	8191	8194	
10449	immunofluorescence of whole organs	immunofluorescence of whole organ	1	0	10450	10451	10450	
13958	patient survival	patient survival	1	0	1498	2645	1498	
20687	specific topic	specific topic	1	0	2553	2515	2553	
19893	pandemic spread	pandemic spread	1	0	570	1354	570	
33857	SARS-CoV-2 infected HCWs	INFunknownSUP infected INFunknownSUP	1	0	33859	28	33861	
15437	prevention of gatherings	prevention of gathering	1	0	1294	11144	1294	
3634	guideline adherence	guideline adherence	1	0	3636	3635	3636	
34882	full COVID-19 vaccination	full INFunknownSUP vaccination	1	0	2836	6703	437	
1789	program geography	program geography	1	0	1791	1790	1791	
5870	lifestyle changes	lifestyle change	1	0	1336	3399	1336	
23968	scale survey	scale survey	1	0	967	2422	967	
27302	Western literature	Western literature	1	0	4698	4549	4698	
6850	front lines of this epidemic	front line of this epidemic	1	0	6852	6851	6853	
6263	adaptive potential	adaptive potential	1	0	6265	6264	6265	
28432	potential dimensions of the multidimensional space of cardiovascular data	potential dimension of the multidimensional space of cardiovascular datum	1	0	28434	1276	15311	
25958	social identity	social identity	1	0	6760	383	6760	
13976	pandemic cases	pandemic case	1	0	229	1354	229	
11136	stability of anti-RBD	stability of INFunknownSUP	1	0	11137	11138	11137	
22005	epicenter of Canada	epicenter of Canada	1	0	22006	22007	22006	
11233	public offices	public office	1	0	10495	1321	10495	
38820	Presentation of Renal Papillary Necrosis	Presentation of renal papillary necrosis	1	0	4657	38822	4657	
17702	benchmarks results	benchmark result	1	0	325	17526	325	
30784	epidemiological modeling of SARS-CoV-2 behavior	epidemiological modeling of INFunknownSUP behavior	1	0	30786	18107	464	
34672	lung ultrasound score involvement index	lung ultrasound score involvement index	1	0	4017	34673	4017	
33217	model predictive control	model predictive control	1	0	33219	1078	510	
34014	control of COVID-19	control of INFunknownSUP	1	0	510	40	510	
955	Substantial undocumented infection	substantial undocumented infection	1	0	957	489	41	
19125	deamination-induced perpetual immunity to SAR-CoV-2 infection	INFunknownSUP perpetual immunity to INFunknownSUP infection	1	0	19126	19131	257	
4369	confirmed cases	confirmed case	1	0	229	4370	229	
1981	severe appendicitis	severe appendicitis	1	0	1983	262	1983	
12163	additional tools	additional tool	1	0	274	7175	274	
35659	Respiratory Tract Infections	respiratory tract infection	1	0	35661	3287	13088	
6628	consultation rates	consultation rate	1	0	83	6629	83	
1571	% cases	% case	1	0	229	364	229	
25157	laparoendocsopic procedures	INFunknownSUP procedure	1	0	4200	25158	4200	
16778	Variable Viral Culture Methods	variable viral Culture method	1	0	16780	16779	6982	
2789	Sewage Tests Sewage surveillance	sewage test sewage surveillance	1	0	2793	2790	2795	
5461	university tertiary referral	university tertiary referral	1	0	5463	1642	2964	
15896	results of these vaccines	result of these vaccine	1	0	325	681	325	
25725	global public health emergency	global public health emergency	1	0	25727	1954	447	
17525	benchmarks tool	benchmark tool	1	0	5487	17526	5487	
29367	mobility values	mobility value	1	0	825	2102	825	
17806	final laboratory examination score	final laboratory examination score	1	0	17808	4256	1843	
35258	potential predictors of sick leave	potential predictor of sick leave	1	0	413	1276	414	
1960	state of health	state of health	1	0	1961	120	1961	
37643	interview results	interview result	1	0	325	11572	325	
28958	possible impact of this type of variants	possible impact of this type of variant	1	0	28960	745	110	
31678	phase of the COVID-19 pandemic	phase of the INFunknownSUP pandemic	1	0	1352	111	1352	
5395	Tribute to All Covid-19 Fighters	tribute to all INFunknownSUP fighter	1	0	5396	5397	5396	
35968	COVID-19 Surveillance	INFunknownSUP surveillance	1	0	35970	40	35970	
25523	randomization scheme	randomization scheme	1	0	25525	25524	25525	
5477	RNA replication	RNA replication	1	0	2989	1151	2989	
1098	various factors	various factor	1	0	583	1099	583	
30266	analysis of data	analysis of datum	1	0	486	22	486	
24825	cytotoxic envelope protein	cytotoxic envelope protein	1	0	24827	24826	1797	
4649	lot of reports	lot of report	1	0	4650	4651	4650	
24915	approach to COVID-19 vaccine passport	approach to INFunknownSUP vaccine passport	1	0	1538	24917	1538	
12826	undergraduate exposure	undergraduate exposure	1	0	1054	12827	1054	
11277	in-hospital release of COVID-19 patients	in-hospital release of INFunknownSUP patient	1	0	5439	911	3720	
16673	impact of socioeconomic level	impact of socioeconomic level	1	0	110	7117	110	
34936	global problem	global problem	1	0	4499	1954	4499	
34769	IGHV3-53/3-66-encoded antibodies	INFunknownSUP antibody	1	0	929	34770	929	
2495	COVID-19 Response Separate Guidelines	INFunknownSUP Response separate guideline	1	0	2497	40	2501	
12035	delivery characteristics	delivery characteristic	1	0	1496	2840	1496	
20313	health assessment	health assessment	1	0	238	120	238	
21293	surges of COVID-19	surge of INFunknownSUP	1	0	21294	40	21294	
27287	agent of the pandemic coronavirus disease	agent of the pandemic coronavirus disease	1	0	12122	27289	12122	
20647	consultation outcomes	consultation outcome	1	0	263	6629	263	
34853	Stress Response Questionnaire	stress Response questionnaire	1	0	34855	9278	19258	
15136	additional reductions	additional reduction	1	0	15138	7175	15138	
6377	full-text screenings	INFunknownSUP screenings	1	0	6379	6378	6379	
31624	young children	young child	1	0	6153	2882	6153	
10778	abundance of Candidatus_Saccharibacteria	abundance of INFunknownSUP	1	0	10779	10780	10779	
24308	Bipolar disorder	bipolar disorder	1	0	7358	24309	7358	
24087	U test	U test	1	0	754	2300	754	
35860	urological intervention	urological intervention	1	0	5608	15037	5608	
28308	part of the questionnaire	part of the questionnaire	1	0	734	9620	734	
37210	catch-up program	catch-up program	1	0	1790	37211	1790	
6702	full efficacy	full efficacy	1	0	6704	6703	6704	
6810	reliability of data	reliability of datum	1	0	6811	22	6811	
10724	major reasons	major reason	1	0	10139	1318	10139	
19868	impact of healthcare	impact of INFunknownSUP	1	0	110	494	110	
5725	mRNA expression levels of pro-inflammatory cytokines tumor necrosis factor-alpha	INFunknownSUP expression level of pro-inflammatory cytokine tumor necrosis factor-alpha	1	0	5726	5731	169	
14381	socioeconomic standards	socioeconomic standard	1	0	14383	16	14383	
6565	year-to-year decreases	year-to-year decrease	1	0	165	6566	165	
28998	Chinese articles	Chinese article	1	0	811	1968	811	
33972	significant number of people	significant number of people	1	0	32026	908	916	
27601	modified oral intake	modified oral intake	1	0	22801	4210	22803	
27195	pattern of ischemic changes	pattern of ischemic change	1	0	4682	27197	4682	
27385	single-cell atlas	single-cell atlas	1	0	27387	11466	27387	
25760	facets of physical activity	facet of physical activity	1	0	18783	25762	18783	
37416	management of patients	management of patient	1	0	743	60	743	
26345	emergency fabrication of quick test kits	emergency fabrication of quick test kit	1	0	26347	447	17308	
6033	biomarker value	biomarker value	1	0	1037	6034	1037	
14937	potent SARS-CoV-2 inhibitors	potent INFunknownSUP inhibitor	1	0	14939	1408	8870	
30186	PPE items	PPE item	1	0	21024	2192	21024	
33062	compound libraries	compound library	1	0	26721	33063	26721	
10864	crucial factors	crucial factor	1	0	583	10865	583	
33296	safety of elective spinal surgery	safety of elective spinal surgery	1	0	6729	33298	6729	
19186	local clinical practice	local clinical practice	1	0	3283	3173	3285	
33219	predictive control	predictive control	1	0	510	4314	510	
37524	endoscopic images	endoscopic image	1	0	4034	8224	4034	
15916	potential source of phthalate exposure to humans	potential source of phthalate exposure to human	1	0	13414	13718	1971	
3793	COVID-19 pandemic Low-resource countries	INFunknownSUP pandemic Low-resource country	1	0	3797	111	1599	
18598	control precautions	control precaution	1	0	2126	510	2126	
23612	psychiatric presentations	psychiatric presentation	1	0	2848	4594	2848	
2449	Pandemic Management	pandemic management	1	0	2451	2450	2451	
9382	COVID-19 pandemic lockdown	INFunknownSUP pandemic INFunknownSUP	1	0	9384	40	1676	
26232	cost-effective complex healthcare innovation	cost-effective complex INFunknownSUP innovation	1	0	26234	19960	19710	
5939	decision tree of the value	decision tree of the value	1	0	5941	5486	5942	
11155	well-being of older people	well-being of old people	1	0	2245	11157	2245	
14779	mobile homes	mobile home	1	0	13529	3414	13529	
15649	urgent imaging protocol of acute stroke patients	urgent imaging protocol of acute stroke patient	1	0	15651	8129	7962	
36561	optimal lockdown	optimal INFunknownSUP	1	0	1676	7633	1676	
21445	associations of the vaccination rate	association of the vaccination rate	1	0	5750	4234	5750	
20502	United Arab Emirates	United Arab Emirates	1	0	20504	20503	20506	
25202	Wastewater catchment area representative	Wastewater catchment area representative	1	0	25204	25203	25208	
9970	nature of the antibody response	nature of the antibody response	1	0	1476	9972	1476	
33032	capacity of long peptides	capacity of long peptide	1	0	3026	33034	3026	
10405	SLT assessment	INFunknownSUP assessment	1	0	238	9368	238	
23000	High educational debt	High educational debt	1	0	12352	23001	3627	
35510	cerebral strokes	cerebral stroke	1	0	3531	4322	3531	
37	symptomatic COVID-19 infection	symptomatic INFunknownSUP infection	1	0	39	38	41	
30546	abordaje del duelo y la muerte	INFunknownSUP del INFunknownSUP y la INFunknownSUP	1	0	30548	30547	30556	
15075	laboratory examination scores	laboratory examination score	1	0	15077	1392	3726	
7125	high-school students	high-school student	1	0	1177	7126	1177	
30385	exchange of spike residue	exchange of spike residue	1	0	22025	30387	22025	
4334	parts of the world	part of the world	1	0	4335	4336	4335	
32464	3b ALITHIOS	INFunknownSUP INFunknownSUP	1	0	32466	32465	32466	
3053	current situation of COVID-19	current situation of INFunknownSUP	1	0	3054	40	3056	
14609	Big Pharma	Big Pharma	1	0	14611	14610	14611	
15975	Lead workforcE	Lead workforce	1	0	15977	15976	15977	
14192	original publications	original publication	1	0	14194	13288	14194	
29768	setting of COVID-19	setting of INFunknownSUP	1	0	2854	40	2854	
30001	Public health	Public health	1	0	120	840	120	
5765	relacion con las busquedas	INFunknownSUP con la INFunknownSUP	1	0	5767	5766	5771	
16203	39-bed intensive care unit	INFunknownSUP intensive care unit	1	0	6	16204	10	
33518	recent Ozone	recent ozone	1	0	33520	2128	33520	
10883	COVID-19 mental health	INFunknownSUP mental health	1	0	118	40	120	
12901	effective guidelines	effective guideline	1	0	91	2051	91	
7632	optimal memory consumption	optimal memory consumption	1	0	7634	7633	1267	
1003	Kindern die sportlichen Aktivitaten nicht	INFunknownSUP die sportlichen INFunknownSUP INFunknownSUP	1	0	1011	1004	1011	
15463	public services	public service	1	0	5980	1321	5980	
29966	health-system medication	health-system medication	1	0	153	29967	153	
26425	COVID-19 increases	INFunknownSUP increase	1	0	6329	40	6329	
36475	in-hospital deaths	in-hospital death	1	0	553	411	553	
29459	ablative body radiotherapy	ablative body radiotherapy	1	0	29461	11261	29463	
22298	mean differences	mean difference	1	0	5663	194	5663	
16888	reportable outcome	reportable outcome	1	0	295	16889	295	
16435	serologic assay	serologic assay	1	0	3119	16436	3119	
7066	single fraction	single fraction	1	0	7068	1652	7068	
10207	second wave of Coronavirus disease	second wave of INFunknownSUP disease	1	0	10209	1279	10210	
14908	global burden	global burden	1	0	1070	1954	1070	
11514	data-driven analysis	data-driven analysis	1	0	486	11515	486	
13625	home programs	home program	1	0	2246	231	2246	
18091	tertiary referral hospital	tertiary referral hospital	1	0	18093	182	185	
33433	medical disciplines	medical discipline	1	0	33435	947	33435	
10271	herbal constituents	herbal constituent	1	0	10273	10272	10273	
30965	post COVID-19 complications	post INFunknownSUP complication	1	0	27031	30966	705	
7871	COVID-19 Pfizer-BioNTech	INFunknownSUP INFunknownSUP	1	0	7873	40	7873	
31776	ROC-AUC analysis	INFunknownSUP analysis	1	0	486	31777	486	
13162	total number of outpatient encounters	total number of outpatient encounter	1	0	13163	13166	916	
2055	standard test	standard test	1	0	754	2056	754	
38857	bariatric population	bariatric population	1	0	1838	2394	1838	
33019	3-hour training module	INFunknownSUP training module	1	0	33021	33020	5565	
2101	mobility reduction strategies	mobility reduction strategy	1	0	2103	2102	300	
4245	ultrasound examinations	ultrasound examination	1	0	4247	4246	4247	
5324	infection status	infection status	1	0	2720	41	2720	
21233	low socioeconomic standard group	low socioeconomic standard group	1	0	14	457	18	
23633	influence of risk framing of COVID-19	influence of risk framing of INFunknownSUP	1	0	23634	23635	23634	
12877	season hospital admissions	season hospital admission	1	0	11670	12342	3085	
17281	certified beds	certified bed	1	0	17283	17282	17283	
33788	measurable antiviral activity	measurable antiviral activity	1	0	3988	33789	3990	
284	present meta-analysis	present meta-analysis	1	0	286	285	286	
29219	levels of positive-end	level of INFunknownSUP	1	0	169	29221	169	
37928	older Brazilians Brazil	old Brazilian Brazil	1	0	37930	59	37932	
15730	COVID-19 treatment	INFunknownSUP treatment	1	0	97	40	97	
1648	COVID symptoms	INFunknownSUP symptom	1	0	86	1649	86	
30660	important milestone	important milestone	1	0	30662	273	30662	
11786	validated-online survey	INFunknownSUP survey	1	0	967	11787	967	
3834	online methods	online method	1	0	205	541	205	
25391	PCT groups	PCT group	1	0	2486	16014	2486	
30820	Ubergangsbereich fand sich keine Verminderung der objektiven Leistungsparameter	Ubergangsbereich INFunknownSUP INFunknownSUP INFunknownSUP INFunknownSUP der INFunknownSUP Leistungsparameter	1	0	30822	30821	30834	
23335	B.1.1.7/Alpha lineage	B.1.1.7/Alpha lineage	1	0	485	23336	485	
12829	proper state	proper state	1	0	1961	449	1961	
21728	significant pericardial effusion	significant pericardial effusion	1	0	241	908	243	
29849	critical review	critical review	1	0	1723	223	1723	
5188	Severe acute respiratory syndrome	Severe acute respiratory syndrome	1	0	4712	5189	1936	
25796	amount of PPE	amount of PPE	1	0	8629	2192	8629	
15400	HRM measurements	HRM measurement	1	0	8077	15401	8077	
26079	different viral concentrations	different viral concentration	1	0	26081	688	1959	
6863	lakh deaths	lakh death	1	0	553	6864	553	
9225	mixed effects regressions	mixed effect regression	1	0	9229	9226	9229	
30731	importance of these molecular vehicles	importance of these molecular vehicle	1	0	2765	30733	2765	
36623	acceptance of remote web-based pulmonary rehabilitation programme models	acceptance of remote INFunknownSUP pulmonary rehabilitation programme model	1	0	1248	36625	1248	
12061	national claims data	national claim datum	1	0	12063	517	22	
10554	une occasion de reformer la	une occasion de reformer la	1	0	10560	10555	3572	
11291	level of androgens	level of androgen	1	0	362	11293	362	
19435	time series models	time series model	1	0	3975	15784	3975	
10533	safety-conscious manner	safety-conscious manner	1	0	10535	10534	10535	
36249	serum ferritin	serum ferritin	1	0	30359	4556	30359	
31068	fatty acids	fatty acid	1	0	31070	8029	31070	
6652	accumulation of genetic changes	accumulation of genetic change	1	0	4349	6654	4349	
5246	Journal of Stroke	Journal of stroke	1	0	5247	5248	5247	
30345	present time	present time	1	0	179	285	179	
27963	in-person encounters	in-person encounter	1	0	13168	9275	13168	
5830	extended lockdown	extended INFunknownSUP	1	0	1676	288	1676	
35746	8-session online MBI	INFunknownSUP online MBI	1	0	10383	35747	10385	
13652	current dreadful pandemic of coronavirus disease	current dreadful pandemic of coronavirus disease	1	0	13654	443	113	
28325	AKI stage	Aki stage	1	0	1521	13007	1521	
35181	two-factor structure	two-factor structure	1	0	2427	35182	2427	
16718	possible involvement	possible involvement	1	0	3599	745	3599	
5444	better disease-specific clinical outcomes	good disease-specific clinical outcome	1	0	5446	1635	263	
6076	older males	old male	1	0	5044	59	5044	
24506	kinetic analysis of S1-ACE2 complex dissociation	kinetic analysis of INFunknownSUP complex dissociation	1	0	24508	24507	486	
32172	- cRDT	INFunknownSUP INFunknownSUP	1	0	32174	5345	32174	
21710	sustained large volume of testing	sustained large volume of testing	1	0	21712	21711	3445	
4007	outpatient care utilization	outpatient care utilization	1	0	4011	3141	4011	
18680	resource conservation	resource conservation	1	0	10409	2703	10409	
36540	Inherent factors	inherent factor	1	0	583	36541	583	
31267	total disease burden	total disease burden	1	0	14223	1485	1070	
20149	general decline	general decline	1	0	16179	1080	16179	
32121	neural network	neural network	1	0	719	28114	719	
22736	residual abnormalities	residual abnormality	1	0	22738	4795	22738	
14143	identity checks	identity check	1	0	14145	6760	14145	
7818	peak of the COVID-19 outbreak	peak of the INFunknownSUP outbreak	1	0	5928	308	5928	
29439	clinical clusters	clinical cluster	1	0	860	884	860	
27699	advanced disease	advanced disease	1	0	209	5859	209	
6961	small-volume sewage	small-volume sewage	1	0	6963	6962	6963	
7272	operative field barrier system	operative field barrier system	1	0	7274	7273	1327	
9591	current review	current review	1	0	1723	443	1723	
18451	RBD-ACE2 binding assay	INFunknownSUP binding assay	1	0	18453	18452	3119	
4913	factory workers	factory worker	1	0	1136	4914	1136	
16739	redox imbalances	redox imbalance	1	0	16741	16740	16741	
37172	public life	public life	1	0	1434	1321	1434	
298	NIRS strategies	INFunknownSUP strategy	1	0	300	299	300	
14852	life-threatening viral pneumonia	life-threatening viral pneumonia	1	0	14854	4753	2369	
2610	drug use policy governance	drug use policy governance	1	0	2612	352	2616	
4934	international health policy	international health policy	1	0	4936	4086	293	
13925	effective infection control measures	effective infection control measure	1	0	13927	2051	317	
12244	damaging autoimmune mechanisms	damaging autoimmune mechanism	1	0	12246	12245	1456	
7903	Cardiac Risk Index	cardiac Risk Index	1	0	7905	7904	7907	
26973	recruitment of pneumocytes	recruitment of INFunknownSUP	1	0	3518	26975	3518	
28744	ground plane	ground plane	1	0	28746	16481	28746	
26316	double layer (EDL)-gated field-effect transistor-based biosensor	double layer INFunknownSUP INFunknownSUP INFunknownSUP biosensor	1	0	26318	1820	26326	
23411	Acute Crisis	acute crisis	1	0	23413	14013	23413	
7197	hand washing rate	hand washing rate	1	0	1034	2502	1034	
28840	antibody positivity rate	antibody INFunknownSUP rate	1	0	1034	28841	1034	
13951	approval of Chimeric Antigen Receptor	approval of chimeric antigen receptor	1	0	13952	13953	13952	
17150	ample repertoire of healthy unexposed subjects	ample repertoire of healthy unexposed subject	1	0	17152	17151	10422	
20043	certain therapeutic effect	certain therapeutic effect	1	0	20045	8853	1809	
34194	exact test	exact test	1	0	754	23838	754	
9450	Canadian children	Canadian child	1	0	6153	9451	6153	
6976	enhanced weighting	enhanced weighting	1	0	6978	3888	6978	
18779	General Surgery	General surgery	1	0	2338	2695	2338	
7321	Incremental prognostic value of biventricular longitudinal strain	incremental prognostic value of biventricular longitudinal strain	1	0	7323	7322	1037	
3631	relevant knowledge	relevant knowledge	1	0	213	346	213	
1371	poor clinical outcome	poor clinical outcome	1	0	1373	1372	295	
32542	COVID-19 pandemic -	INFunknownSUP pandemic INFunknownSUP	1	0	32544	40	5345	
36179	% decrease	% decrease	1	0	3084	364	3084	
20909	set initiative	set initiative	1	0	1986	651	1986	
23717	OCTA parameters	INFunknownSUP parameter	1	0	6460	23718	6460	
27765	Vitro Screening of Drug Libraries Severe acute respiratory syndrome coronavirus	Vitro screening of Drug library severe acute respiratory syndrome coronavirus	1	0	27767	27766	27768	
14484	external support mechanisms	external support mechanism	1	0	14486	14485	1456	
36424	detection limit	detection limit	1	0	1141	44	1141	
26060	favorable outcome	favorable outcome	1	0	295	12192	295	
11927	lower respiratory tract	low respiratory tract	1	0	11929	594	2154	
29669	specificity of the RDT	specificity of the INFunknownSUP	1	0	29670	4496	29670	
2138	formal benefit-risk analysis	formal INFunknownSUP analysis	1	0	2140	2139	486	
37244	normal controls	normal control	1	0	3772	2708	3772	
5761	y su relacion con las busquedas	y Su INFunknownSUP con la INFunknownSUP	1	0	5763	1908	5771	
22835	Male sex	male sex	1	0	5662	22836	5662	
13746	stronger association	strong association	1	0	11619	9719	11619	
11193	monitoring of the transmissibility	monitoring of the INFunknownSUP	1	0	3271	3451	3271	
26885	post care	post care	1	0	9	2282	9	
8293	potential risk-factors	potential risk-factor	1	0	8295	1276	8295	
7401	Median duration of nasopharyngeal positivity	Median duration of nasopharyngeal INFunknownSUP	1	0	7403	7402	7404	
4470	Unclear Implications	unclear implication	1	0	4472	4471	4472	
23874	key parameters of stroke care	key parameter of stroke care	1	0	23875	16772	6460	
28768	certolizumab pegol	INFunknownSUP INFunknownSUP	1	0	28770	28769	28770	
203	Analysis methods	analysis method	1	0	205	204	205	
25720	psychiatry Homeless experts	psychiatry homeless expert	1	0	25722	25721	6478	
7136	applicability to various clinical scenarios	applicability to various clinical scenario	1	0	7137	7138	7137	
25145	main aim	main aim	1	0	7070	4679	7070	
3610	objective of this research	objective of this research	1	0	3611	36	3611	
15639	response to stimulation of mononuclear cells	response to stimulation of mononuclear cell	1	0	409	15641	409	
32688	sequence diversity of SARS coronavirus	sequence diversity of INFunknownSUP coronavirus	1	0	32690	5716	8993	
450	threshold orderings	threshold ordering	1	0	452	451	452	
39294	COVID-19 characteristics	INFunknownSUP characteristic	1	0	1496	3706	1496	
8664	viral sequence data	viral sequence datum	1	0	8666	1741	22	
32349	Management of patients	management of patient	1	0	2451	60	2451	
10916	con su ecuacion booleana correspondiente	con su INFunknownSUP INFunknownSUP INFunknownSUP	1	0	10918	816	10924	
17296	London healthcare institution	London INFunknownSUP institution	1	0	17298	10393	17300	
28178	serum samples	serum sample	1	0	1765	4556	1765	
3185	clonal expansion	clonal expansion	1	0	781	3186	781	
9173	community risk	community risk	1	0	1542	3641	1542	
7063	Scientific Knowledge	Scientific Knowledge	1	0	7065	4332	7065	
65	SARS-CoV-2 Alpha	INFunknownSUP Alpha	1	0	67	28	67	
33970	mortality of a significant number of people	mortality of a significant number of people	1	0	1197	33972	1197	
12642	sample technique	sample technique	1	0	562	2757	562	
39225	293T/ACE2 cells	INFunknownSUP cell	1	0	133	39226	133	
35286	Emergency Response	Emergency Response	1	0	2498	18540	2498	
2834	COVID-19 vaccination programme delivery	INFunknownSUP vaccination programme delivery	1	0	2840	2835	2840	
31952	y social networking	y social networking	1	0	31954	1908	30744	
24234	effective adolescent treatment	effective adolescent treatment	1	0	24236	2051	97	
3734	identification of the virus	identification of the virus	1	0	57	778	57	
35674	Rapid Antigen Testing Method	Rapid antigen Testing Method	1	0	35676	9843	35680	
35229	Online Learning	online Learning	1	0	11396	217	11396	
28598	common facilitator	common facilitator	1	0	28600	699	28600	
18701	Transatlantic international discussion of the effects of the COVID-19 pandemic	transatlantic international discussion of the effect of the INFunknownSUP pandemic	1	0	18703	18702	3060	
8213	immunity arm	immunity arm	1	0	8215	257	8215	
11004	SARS-CoV-2-binding potency	INFunknownSUP potency	1	0	7480	11005	7480	
14275	patient populations	patient population	1	0	13188	2645	13188	
29618	few challenges	few challenge	1	0	2220	6261	2220	
4117	IgY-based antiviral prophylaxis	INFunknownSUP antiviral prophylaxis	1	0	4119	4118	4121	
22808	Inner retinal thickness overall	inner retinal thickness overall	1	0	22810	22809	22814	
6807	aerosol samples	aerosol sample	1	0	1765	6808	1765	
4622	health emergency	health emergency	1	0	447	120	447	
32568	ground-level concentrations	ground-level concentration	1	0	1959	1956	1959	
15031	university-affiliated hospital	university-affiliated hospital	1	0	185	15032	185	
9586	primary outcome of this study	primary outcome of this study	1	0	9587	2087	295	
6692	old days	old day	1	0	1645	6693	1645	
22335	life months	life month	1	0	761	1434	761	
11645	Italian Universities	Italian university	1	0	11647	115	11647	
19647	Access Control System	Access Control System	1	0	19649	19648	19651	
34998	NLR values	NLR value	1	0	825	2384	825	
33488	ratings of treatment perceptions	rating of treatment perception	1	0	33489	18483	33489	
29988	intervention utility	intervention utility	1	0	3934	5608	3934	
10643	presence of symptoms	presence of symptom	1	0	675	86	675	
14312	acid layer	acid layer	1	0	14314	14313	14314	
11323	care industry	care industry	1	0	2109	9	2109	
16609	low social position	low social position	1	0	16611	457	2825	
13464	African government	African government	1	0	99	5365	99	
16831	public hospitals	public hospital	1	0	76	1321	76	
38515	land-use changes	land-use change	1	0	1336	38516	1336	
1616	acute medicine	acute medicine	1	0	1110	1461	1110	
19428	hydroxychloroquine groups	hydroxychloroquine group	1	0	2486	633	2486	
8827	trainee wellness	trainee wellness	1	0	8829	8828	8829	
27885	NCD rates	INFunknownSUP rate	1	0	83	27886	83	
14318	conversion to open surgery	conversion to open surgery	1	0	12067	14320	12067	
9003	protein-protein interaction assays	protein-protein interaction assay	1	0	9005	9004	2754	
37315	virucidal activity of phospholipase A2s	INFunknownSUP activity of phospholipase A2s	1	0	37317	17002	3990	
29643	new norms	new norm	1	0	29645	69	29645	
11976	physical activities	physical activity	1	0	192	1242	192	
540	online education	online education	1	0	361	541	361	
21962	rare multisystemic disease	rare multisystemic disease	1	0	21964	10225	209	
25037	trauma-informed care framework to every patient encounter	trauma-informed care framework to every patient encounter	1	0	25039	21070	4860	
31223	reimagining of healthcare delivery	INFunknownSUP of INFunknownSUP delivery	1	0	2840	31224	2840	
35077	chain failure	chain failure	1	0	1779	2362	1779	
19286	clinical characteristics of COVID-19	clinical characteristic of INFunknownSUP	1	0	1494	40	1496	
15992	major indices	major indices	1	0	7366	1318	7366	
26560	strong virucidal activity	strong INFunknownSUP activity	1	0	26562	3987	3990	
2312	tertiary bronchi	tertiary bronchus	1	0	2314	182	2314	
16754	complementary therapeutic agent	complementary therapeutic agent	1	0	16756	16434	12122	
9219	zero-inflated negative binomial mixed effects regressions	zero-inflated negative binomial mixed effect regression	1	0	9221	2966	9229	
24847	moderate-severe ANC level	INFunknownSUP ANC level	1	0	24849	24848	362	
11250	routine activities	routine activity	1	0	192	4898	192	
38745	flu vaccination	flu vaccination	1	0	437	38746	437	
26442	poorer prognosis	poor prognosis	1	0	12920	10720	12920	
27358	optimal ventilator management	optimal ventilator management	1	0	27360	7633	743	
1745	pulse sensors	pulse sensor	1	0	1747	1746	1747	
6087	cohort study of rheumatic disease patients	cohort study of rheumatic disease patient	1	0	2085	6091	2087	
24601	rate of 30-day surgical site infection	rate of 30-day surgical site infection	1	0	1034	24603	1034	
2600	various institutions	various institution	1	0	2602	1099	2602	
30797	urine flow	urine flow	1	0	6423	30798	6423	
32936	catastrophic complication	catastrophic complication	1	0	2206	8422	2206	
34700	SARS-CoV-2 nAbs	INFunknownSUP INFunknownSUP	1	0	1240	28	1240	
8907	management organisation of pandemic prevention	management organisation of pandemic prevention	1	0	8909	743	8910	
33396	personal protective measures	personal protective measure	1	0	30477	4961	317	
33577	promising results	promising result	1	0	325	1856	325	
13248	Confidence Interval	confidence interval	1	0	13250	13249	13250	
29709	research programs	research program	1	0	2246	36	2246	
16528	Mund-Nase-Maske auf	Mund-Nase-Maske auf	1	0	16530	16529	16530	
4356	Clinical courses	clinical course	1	0	4358	1501	4358	
20892	Phage therapy	phage therapy	1	0	2273	20893	2273	
36579	complications of coronavirus disease	complication of coronavirus disease	1	0	705	338	705	
20268	tube feeding	tube feeding	1	0	20270	15498	20270	
33140	Biotechnology Information	Biotechnology Information	1	0	33142	33141	33142	
22538	survivors of Coronavirus	survivor of INFunknownSUP	1	0	2732	3206	2732	
27901	full-time workers	full-time worker	1	0	1136	27902	1136	
3778	common clinical symptoms	common clinical symptom	1	0	3780	699	86	
9293	current pandemic context	current pandemic context	1	0	9295	443	1567	
26888	targeted contact tracing	targeted contact tracing	1	0	1887	2239	1889	
15621	detection of infected people	detection of infected people	1	0	44	15623	44	
6309	configuration of the UK	configuration of the UK	1	0	6310	5052	6310	
34830	clinical research	clinical research	1	0	36	884	36	
25738	proteome of SARS-CoV-2	INFunknownSUP of INFunknownSUP	1	0	25739	28	25739	
21360	International Association of Dental Students	International Association of dental student	1	0	21362	13910	1952	
10555	une occasion de	une occasion de	1	0	10557	10556	1421	
22782	June 2021	June 2021	1	0	22784	22783	22784	
18591	COVID-19 positive/suspected patients	INFunknownSUP positive/suspected patient	1	0	18593	40	60	
23460	trimerization of SARS-CoV-2 spike glycoprotein	INFunknownSUP of INFunknownSUP spike glycoprotein	1	0	2147	7745	2147	
15812	unit care	unit care	1	0	9	10	9	
700	way of infection	way of infection	1	0	701	41	701	
33735	lives of the poor	life of the poor	1	0	33736	33737	33736	
23364	petechial/purpuric rashes	INFunknownSUP rash	1	0	23366	23365	23366	
22552	bottom-up direction	bottom-up direction	1	0	22318	22553	22318	
17974	Elderly individuals	elderly individual	1	0	1113	17975	1113	
13442	public health communication	public health communication	1	0	11078	1320	11078	
24161	preferences of service-users	preference of service-user	1	0	2599	8683	2599	
15602	acute COVID-19	acute INFunknownSUP	1	0	40	1461	40	
13202	high-risk group	high-risk group	1	0	18	1184	18	
7072	pivotal entry molecules	pivotal entry molecule	1	0	7074	7073	7076	
11507	adjunct risk stratification tool	adjunct risk stratification tool	1	0	5487	11508	5487	
11260	ablative body radiation therapy	ablative body radiation therapy	1	0	11262	11261	2273	
1644	days of the onset of COVID symptoms	day of the onset of INFunknownSUP symptom	1	0	1645	1646	1645	
6463	experienced fever	experienced fever	1	0	6465	6464	6465	
16028	particular interest	particular interest	1	0	7989	2853	7989	
34797	Recovery Supplemental Digital Content	Recovery Supplemental Digital content	1	0	12783	34798	7950	
28390	control eyes	control eye	1	0	18974	510	18974	
34760	low price to a larger percentage of the population	low price to a large percentage of the population	1	0	34762	457	9746	
15822	future of health care systems	future of health care system	1	0	15823	15824	15823	
9008	animal model	animal model	1	0	1078	9009	1078	
12593	child siblings	child sibling	1	0	12595	12594	12595	
22805	consuming zinc	consuming zinc	1	0	22807	22806	22807	
92	antibody-enhanced immunopathology	antibody-enhanced Immunopathology	1	0	94	93	94	
30739	variety of barriers	variety of barrier	1	0	881	10121	881	
16236	poorer clinical outcomes	poor clinical outcome	1	0	5448	10720	263	
3250	neuropathological features of COVID-19 patients	neuropathological feature of INFunknownSUP patient	1	0	3252	3251	1469	
28797	type antibodies	type antibody	1	0	929	775	929	
18434	higher risk of in-hospital mortality	high risk of in-hospital mortality	1	0	18435	1869	1542	
2000	abortion care	abortion care	1	0	9	2001	9	
29914	higher Hispanic non-white resident census	high Hispanic non-white resident census	1	0	29916	322	2123	
34847	community connections	community connection	1	0	12705	3641	12705	
18634	severe clinical course	severe clinical course	1	0	5150	262	5152	
31867	negative health consequences	negative health consequence	1	0	31869	1338	4289	
4067	regional sporadic outbreaks	regional sporadic outbreak	1	0	4069	4068	2892	
15375	Comparison of the Indicators of Psychological Stress	comparison of the indicator of psychological stress	1	0	15376	15377	15376	
27435	comparison of some performance indices	comparison of some performance indices	1	0	13707	27437	13707	
23102	narrowing of the topic agenda	narrowing of the topic agenda	1	0	23103	23104	23103	
29574	imposition of lockdown	imposition of INFunknownSUP	1	0	29575	1676	29575	
27510	specialty encounters	specialty encounter	1	0	13168	27511	13168	
8852	certain points	certain point	1	0	23	8853	23	
22654	229E seasonal coronaviruses	INFunknownSUP seasonal coronavirus	1	0	9478	22655	8796	
25946	specific preventative measures	specific preventative measure	1	0	25948	2515	317	
23167	post-COVID-19 severe disease:after	INFunknownSUP severe INFunknownSUP	1	0	23169	23168	23171	
20475	oral contraception	oral contraception	1	0	20477	427	20477	
27285	causative agent of the pandemic coronavirus disease	causative agent of the pandemic coronavirus disease	1	0	27287	27060	12122	
6568	isolation of the population	isolation of the population	1	0	6569	1838	6569	
4764	fewer students	few student	1	0	1177	1479	1177	
8434	early severity-of-illness assessment	early severity-of-illness assessment	1	0	8436	55	238	
8139	days of postoperative follow-up	day of postoperative follow-up	1	0	1645	8141	1645	
15930	determination of pedestrians	determination of pedestrian	1	0	15931	15932	15931	
33115	mechanism of the SARS-CoV2 virus	mechanism of the INFunknownSUP virus	1	0	10036	33117	10036	
12068	full COVID-19 setting	full INFunknownSUP setting	1	0	12070	6703	2854	
11610	y letalidad como	y letalidad INFunknownSUP	1	0	11612	1908	4735	
8421	catastrophic consequences	catastrophic consequence	1	0	4289	8422	4289	
10845	related acute lung injury	related acute lung injury	1	0	10847	2647	713	
30794	Cardiovascular Ultrasound	Cardiovascular ultrasound	1	0	30796	11775	30796	
8976	exponential growth rate	exponential growth rate	1	0	1034	8977	1034	
7868	COVID-19 Pfizer-BioNTech BNT16B2b2 mRNA vaccine	INFunknownSUP INFunknownSUP INFunknownSUP INFunknownSUP vaccine	1	0	577	7869	577	
31838	de la COVID-19	de la INFunknownSUP	1	0	31840	1914	40	
23393	everyday lifestyle	everyday lifestyle	1	0	3399	14753	3399	
10013	international guidelines	international guideline	1	0	91	4086	91	
32895	biochemical characteristics of patients	biochemical characteristic of patient	1	0	32897	24212	1496	
32385	pediatric general surgery cases	pediatric general surgery case	1	0	32387	3344	229	
28085	cell-to-cell contacts	cell-to-cell contact	1	0	7082	28086	7082	
20701	concerned bodies	concerned body	1	0	8556	20702	8556	
35631	unreactive mydriasis	unreactive mydriasis	1	0	35633	35632	35633	
28641	COVID-19 IgG1	INFunknownSUP INFunknownSUP	1	0	28643	40	28643	
30606	clinical risk factors	clinical risk factor	1	0	3561	884	583	
31812	Compromise Solution	compromise solution	1	0	31814	31813	31814	
2806	primed/boosted vaccine	INFunknownSUP vaccine	1	0	577	2807	577	
16587	recommendations matters	recommendation matter	1	0	16589	652	16589	
2787	COVID-19 Sewage Tests Sewage surveillance	INFunknownSUP sewage test sewage surveillance	1	0	2789	40	2795	
22504	Advanced School	Advanced School	1	0	3669	22505	3669	
543	Trials website	trial website	1	0	545	544	545	
23888	R01 AI112970	R01 AI112970	1	0	23890	23889	23890	
10859	Dermatology Education Covid-19	dermatology Education INFunknownSUP	1	0	10861	10860	1884	
27459	report anxiety	report anxiety	1	0	2772	378	2772	
2423	RNA secondary structure	RNA secondary structure	1	0	2425	1151	2427	
7050	health claims	health claim	1	0	7052	120	7052	
17001	virucidal effects	INFunknownSUP effect	1	0	156	17002	156	
26692	form of either person-bound expertise	form of either person-bound expertise	1	0	11121	26694	11121	
12910	user experience	user experience	1	0	2782	12911	2782	
37871	early phase of the outbreak	early phase of the outbreak	1	0	1350	310	1352	
17313	risk-stratified triage pathway	INFunknownSUP triage pathway	1	0	17315	17314	5003	
29923	utilizando terminos MeSH	INFunknownSUP INFunknownSUP mesh	1	0	29927	29924	29927	
19807	global vaccination coverage	global vaccination coverage	1	0	9873	1954	4933	
1929	anti-severe acute respiratory syndrome coronavirus	anti-severe acute respiratory syndrome coronavirus	1	0	1931	1930	339	
19545	response to novel health threats	response to novel health threat	1	0	409	19547	409	
12130	team interventions	team intervention	1	0	757	7208	757	
6747	field of education	field of education	1	0	6748	361	6748	
20563	available drugs	available drug	1	0	4584	832	4584	
15834	arthroplasty procedures	INFunknownSUP procedure	1	0	4200	15835	4200	
12442	health services delivery	health service delivery	1	0	12444	120	2840	
18992	initial screening	initial screening	1	0	7961	335	7961	
8720	risk of sick leave	risk of sick leave	1	0	1542	415	1542	
19246	hypometabolism of the frontal cluster	hypometabolism of the frontal cluster	1	0	1260	19248	1260	
17496	course of the epidemic of COVID-19	course of the epidemic of INFunknownSUP	1	0	5152	17498	5152	
5300	significant morbidity	significant morbidity	1	0	1216	908	1216	
32962	flat N-terminal domain	flat N-terminal domain	1	0	695	24687	697	
23966	Likert scale survey	Likert scale survey	1	0	23968	23967	967	
11973	pre-COVID-19 period	INFunknownSUP period	1	0	5677	600	5677	
23356	removal of the HRM catheter	removal of the HRM catheter	1	0	8225	23358	8225	
36008	novel predictors of COVID-19 mortality	novel predictor of INFunknownSUP mortality	1	0	36010	3645	414	
2714	understanding of mental health status	understanding of mental health status	1	0	2715	2716	2715	
17890	pattern of ACE2	pattern of INFunknownSUP	1	0	4682	3437	4682	
6739	main eligibility criteria	main eligibility criterion	1	0	6741	4679	3649	
3071	intra-hospital non COVID-19 mortality	INFunknownSUP non INFunknownSUP mortality	1	0	1197	3072	1197	
3598	involvement of patients	involvement of patient	1	0	3599	60	3599	
4791	self-reported dizziness/lightheadedness	self-reported dizziness/lightheadedness	1	0	4793	3911	4793	
11145	comprehensive support packages	comprehensive support package	1	0	11147	2902	11149	
1261	Estimated weekend alcohol consumption	estimated weekend alcohol consumption	1	0	1263	1262	1267	
2386	perception of online learning	perception of online learning	1	0	2387	2388	2387	
7892	assessment of vaccine impact	assessment of vaccine impact	1	0	238	7894	238	
38845	resident viewpoints	resident viewpoint	1	0	38847	2241	38847	
31702	infrastructure status of intensive care units	infrastructure status of intensive care unit	1	0	31704	21192	2720	
30536	permitieron identificar estrategias para el abordaje del duelo y la muerte	INFunknownSUP INFunknownSUP INFunknownSUP para el INFunknownSUP del INFunknownSUP y la INFunknownSUP	1	0	30542	30537	30556	
24714	Accreditation Council	accreditation council	1	0	24716	24715	24716	
35464	study case	study case	1	0	3368	2087	3368	
26591	protective efficacy	protective efficacy	1	0	6704	1455	6704	
15890	encouraging clinical trial results of these vaccines	encouraging clinical trial result of these vaccine	1	0	15892	15891	325	
6590	research of healthcare workers experiences	research of INFunknownSUP worker experience	1	0	36	6592	36	
23218	major global health problem	major global health problem	1	0	23220	1318	4499	
11577	General Medical Practitioner	General Medical practitioner	1	0	11579	2695	11581	
39006	disruption to planned operations	disruption to planned operation	1	0	12078	39008	12078	
11338	Colorectal Surgery	colorectal surgery	1	0	2338	11339	2338	
19802	impact of this policy change	impact of this policy change	1	0	110	9213	110	
26383	Compassionate use of camostat mesylate	compassionate use of INFunknownSUP INFunknownSUP	1	0	26385	26384	292	
5496	prolonged endotracheal intubation	prolonged endotracheal intubation	1	0	5498	5497	5500	
31984	impact of these changes	impact of these change	1	0	110	1336	110	
8270	Angiotensin-Converting Enzyme	INFunknownSUP enzyme	1	0	8272	8271	8272	
7842	vaccination process	vaccination process	1	0	180	437	180	
19126	deamination-induced perpetual immunity	INFunknownSUP perpetual immunity	1	0	19128	19127	257	
22530	level of exposure	level of exposure	1	0	362	1054	362	
16284	Close monitoring	close monitoring	1	0	3271	16285	3271	
8747	stem cells	stem cell	1	0	133	8748	133	
12136	rapid cellular entry	rapid cellular entry	1	0	12138	795	5629	
31297	random forest classification model	random forest classification model	1	0	31301	2345	1078	
28244	odds ratios	odd ratio	1	0	19889	5255	19889	
27966	period of the COVID-19 pandemic	period of the INFunknownSUP pandemic	1	0	5677	111	5677	
26005	anti-SARS-CoV-2 antibodies	INFunknownSUP antibody	1	0	929	4554	929	
22935	therapeutic product	therapeutic product	1	0	1735	3349	1735	
104	job satisfaction	job satisfaction	1	0	106	105	106	
21372	international literature	international literature	1	0	4698	4086	4698	
22349	VIMC-funded institutions	VIMC-funded institution	1	0	2602	22350	2602	
18185	pre-hospital emergency department of the public company	INFunknownSUP emergency department of the public company	1	0	18187	18186	13318	
2050	effective technique	effective technique	1	0	562	2051	562	
9978	inflation of zeros	inflation of zero	1	0	9979	9980	9979	
26682	SARS-CoV-2 RNA-positive cases	INFunknownSUP RNA-positive case	1	0	26684	226	229	
5270	Population of Hubei Province	population of Hubei Province	1	0	5271	3829	5271	
8221	urgent endoscopic removal	urgent endoscopic removal	1	0	8223	8129	8225	
25411	exposure of medical professionals	exposure of medical professional	1	0	1054	5197	1054	
38722	clinical characteristics of patients	clinical characteristic of patient	1	0	1494	60	1496	
28434	dimensions of the multidimensional space of cardiovascular data	dimension of the multidimensional space of cardiovascular datum	1	0	15311	28436	15311	
38403	new tools	new tool	1	0	274	69	274	
33352	selected machine	selected machine	1	0	934	1620	934	
35706	mechanism of JAK/STAT	mechanism of INFunknownSUP	1	0	10036	10986	10036	
17012	Chain Reaction	Chain reaction	1	0	17014	17013	17014	
10881	Results of the COVID-19 mental health	result of the INFunknownSUP mental health	1	0	10882	10883	10882	
26373	international graduate status	international graduate status	1	0	26375	4086	2720	
24228	optical coherence tomography	optical coherence tomography	1	0	24230	7441	7445	
27862	Korean Association	Korean association	1	0	16323	1488	16323	
12773	treatment of choice	treatment of choice	1	0	97	12775	97	
21475	management of neurological patients	management of neurological patient	1	0	743	16291	743	
24189	vedolizumab-treated patients	INFunknownSUP patient	1	0	60	24190	60	
9708	usefulness of the application of a prioritization score	usefulness of the application of a prioritization score	1	0	9709	9710	9709	
16197	manometry examination	manometry examination	1	0	1800	12287	1800	
33894	serious health challenge	serious health challenge	1	0	33896	3164	62	
7923	Exploratory factor analysis	exploratory factor analysis	1	0	2182	7924	486	
10950	Stress Scale	stress Scale	1	0	1203	9278	1203	
26147	in-hospital mortality of COVID-19	in-hospital mortality of INFunknownSUP	1	0	1869	40	1197	
4555	serum antibodies	serum antibody	1	0	929	4556	929	
37338	nasopharyngeal swaps	nasopharyngeal swap	1	0	37340	7406	37340	
5424	perception of this abrupt transition	perception of this abrupt transition	1	0	2387	5426	2387	
30456	short protein	short protein	1	0	1797	16760	1797	
5048	grade level	grade level	1	0	362	5049	362	
17833	complementary binding sites	complementary binding site	1	0	17835	16434	9165	
19128	perpetual immunity	perpetual immunity	1	0	257	19129	257	
33542	size of a self-isolating household unit	size of a self-isolating household unit	1	0	6366	33544	6366	
26084	screening test	screening test	1	0	754	7961	754	
222	critical access	critical access	1	0	224	223	224	
14148	evaluation of the HoloLens2	evaluation of the INFunknownSUP	1	0	2399	3482	2399	
10960	weekly PCR testing cost	weekly PCR testing cost	1	0	10966	5419	10966	
2229	use of continuous positive airway pressure	use of continuous positive airway pressure	1	0	292	2231	292	
13039	therapeutic strategies	therapeutic strategy	1	0	300	3349	300	
16965	high scores	high score	1	0	3726	13	3726	
1296	endovascular treatment	endovascular treatment	1	0	97	1297	97	
32496	emergency hospital	emergency hospital	1	0	185	447	185	
12628	consequential effects	consequential effect	1	0	156	12629	156	
11576	General Medical Practitioner treatment	General Medical practitioner treatment	1	0	97	11577	97	
26390	comparison to population-level measures of lockdowns	comparison to population-level measure of lockdown	1	0	13707	26392	13707	
17452	COVID-19 crisis to some extent	INFunknownSUP crisis to some extent	1	0	12688	17456	408	
19034	various findings	various finding	1	0	3390	1099	3390	
17321	effectiveness of REMS	effectiveness of INFunknownSUP	1	0	16379	17323	16379	
11147	support packages	support package	1	0	11149	260	11149	
2455	evaluations of the level of population immunity	evaluation of the level of population immunity	1	0	2456	2457	2456	
38389	Centralized manufacturing	centralized manufacturing	1	0	718	38390	718	
29478	transition to online learning	transition to online learning	1	0	2091	2388	2091	
38977	disease conditions	disease condition	1	0	2910	209	2910	
24258	Marques de Valdecilla University Hospital	Marques de Valdecilla University Hospital	1	0	24260	14260	1879	
22321	NLR value	NLR value	1	0	1037	2384	1037	
11541	neuropathological findings	neuropathological finding	1	0	3390	3251	3390	
13970	advisory bodies	advisory body	1	0	8556	6845	8556	
38314	military responses	military response	1	0	200	38315	200	
13942	probability of testing	probability of testing	1	0	7627	1885	7627	
17796	nutritional status	nutritional status	1	0	2720	17797	2720	
37998	non-survivors n=233	non-survivor INFunknownSUP	1	0	38000	37999	38000	
31198	real hope	real hope	1	0	30890	17940	30890	
30020	multilayer perceptron	multilayer INFunknownSUP	1	0	30022	30021	30022	
12233	Discrete Choice Experiment evidence	discrete choice experiment evidence	1	0	585	12234	585	
21473	early management of neurological patients	early management of neurological patient	1	0	21475	55	743	
26780	symptom onset to hospital discharge	symptom onset to hospital discharge	1	0	3813	26784	1647	
38023	mean titer	mean titer	1	0	18030	194	18030	
27808	way of the disease treatment	way of the disease treatment	1	0	701	27810	701	
20871	new century	new century	1	0	808	69	808	
3991	group A	group A	1	0	3475	18	3475	
29519	common dynamics	common dynamics	1	0	3694	699	3694	
32029	clinical predictive models	clinical predictive model	1	0	25179	884	3975	
20779	segments of the population	segment of the population	1	0	20780	1838	20780	
16681	unprecedented need	unprecedented need	1	0	9579	5915	9579	
19971	30th November	30th November	1	0	19973	19972	19973	
18101	industrial-scale production of these devices	INFunknownSUP production of these device	1	0	18102	6162	654	
12138	cellular entry	cellular entry	1	0	5629	4919	5629	
2826	emergency use authorization	emergency use authorization	1	0	2828	447	2830	
37900	activity levels	activity level	1	0	169	3990	169	
33068	low-acuity urologic issues	low-acuity urologic issue	1	0	33070	33069	3758	
8728	well-ventilated room	well-ventilated room	1	0	5742	8729	5742	
8893	Two-hundred forty-six patients	INFunknownSUP INFunknownSUP patient	1	0	60	8894	60	
28859	accessibility of a prophylactic	accessibility of a prophylactic	1	0	26678	28861	26678	
25665	institutional mistrust	institutional mistrust	1	0	7555	7909	7555	
13272	biomarkers of COVID-19	biomarker of INFunknownSUP	1	0	2577	40	2577	
17720	current ICUs	current INFunknownSUP	1	0	17722	443	17722	
20512	higher morbidity rates	high morbidity rate	1	0	20514	322	83	
21793	result of the use of face coverings	result of the use of face covering	1	0	2267	21795	2267	
5664	new vaccines	new vaccine	1	0	681	69	681	
15709	review of the available literature	review of the available literature	1	0	1723	15711	1723	
38226	Arthroplasty Surgical Volume	INFunknownSUP surgical volume	1	0	38228	38227	38230	
29991	subsistence costs of all Consortium members	subsistence cost of all Consortium member	1	0	29993	29992	22726	
27028	late December	late December	1	0	7311	26495	7311	
18607	access control	access control	1	0	510	224	510	
20819	review of the current global psychiatric literature	review of the current global psychiatric literature	1	0	1723	20821	1723	
8133	COVID-19 cases	INFunknownSUP case	1	0	229	3706	229	
28776	SARS-Cov-2 virus	INFunknownSUP virus	1	0	778	28777	778	
3205	Coronavirus Patients	INFunknownSUP Patients	1	0	3207	3206	3207	
38239	global supply chains	global supply chain	1	0	21980	1954	21982	
27702	Chinese Hospitals	Chinese hospital	1	0	27704	1968	27704	
2457	level of population immunity	level of population immunity	1	0	362	2459	362	
9710	application of a prioritization score	application of a prioritization score	1	0	125	6098	125	
854	biological relevance	biological relevance	1	0	856	855	856	
36371	national laboratory diagnostics strategy	national laboratory diagnostic strategy	1	0	36373	517	3350	
11073	deceased patients	deceased patient	1	0	60	11074	60	
9089	meta-analysis Post-Traumatic stress disorder	meta-analysis post-traumatic stress disorder	1	0	9091	286	7358	
28385	ACE receptors	ace receptor	1	0	8960	16789	8960	
30921	Susceptible-Exposed-Infected-Recovered-Deceased dynamics	INFunknownSUP dynamics	1	0	3694	30922	3694	
21698	Sewage matrix	sewage matrix	1	0	8449	2791	8449	
8047	time series data	time series datum	1	0	8049	179	22	
19765	neurosurgery match data	neurosurgery match datum	1	0	22	19766	22	
511	Underrepresentation of older adults	Underrepresentation of old adult	1	0	512	513	512	
27451	important result	important result	1	0	2267	273	2267	
16417	active pharmaceutical ingredients	active pharmaceutical ingredient	1	0	16419	3597	12263	
34303	number of studies	number of study	1	0	916	136	916	
3582	sudden smell loss	sudden smell loss	1	0	3584	3583	3586	
24535	management strategies	management strategy	1	0	300	743	300	
27134	rapid method of detection of viral diseases	rapid method of detection of viral disease	1	0	27136	795	6587	
21800	large clinical trials	large clinical trial	1	0	21692	4250	8639	
22105	high significance	high significance	1	0	458	13	458	
30041	financial losses	financial loss	1	0	4306	547	4306	
10411	less misconceptions	less misconception	1	0	1176	5525	1176	
20579	recent publications	recent publication	1	0	14194	2128	14194	
26527	waves of the outbreak	wave of the outbreak	1	0	1281	310	1281	
18769	monthly panel dataset of prefectures	monthly panel INFunknownSUP of prefecture	1	0	18771	18770	17096	
5884	major hepatectomies	major INFunknownSUP	1	0	5886	1318	5886	
24973	predictors of mortality	predictor of mortality	1	0	414	1197	414	
23746	18-week period of clozapine treatment	INFunknownSUP period of clozapine treatment	1	0	23747	23750	5677	
8894	Two-hundred forty-six	INFunknownSUP INFunknownSUP	1	0	8896	8895	8896	
27000	Neurological symptoms	neurological symptom	1	0	86	27001	86	
15309	crisis-related dimensions	crisis-related dimension	1	0	15311	15310	15311	
29245	cytokine inducible SH2	INFunknownSUP inducible INFunknownSUP	1	0	29247	8807	29249	
32191	long turnaround	long turnaround	1	0	10061	3921	10061	
33117	SARS-CoV2 virus	INFunknownSUP virus	1	0	778	30258	778	
35422	policymakers plan	policymaker plan	1	0	1225	35423	1225	
7507	CT scan of the chest	CT scan of the chest	1	0	7508	25	7510	
8324	diagnosis of bronchiolitis	diagnosis of INFunknownSUP	1	0	2168	5471	2168	
8052	median exposure	median exposure	1	0	1054	2634	1054	
14218	health data	health datum	1	0	22	120	22	
26226	devastating impact	devastating impact	1	0	110	12663	110	
21480	critical frontline	critical frontline	1	0	2256	223	2256	
36988	different possible future scenarios	different possible future scenario	1	0	36990	688	7142	
10277	diverse responses	diverse response	1	0	200	10278	200	
19786	clinical attention	clinical attention	1	0	4885	884	4885	
35278	metabolism of the frontal cluster	metabolism of the frontal cluster	1	0	7776	19248	7776	
15471	Eastern Uttar Pradesh	Eastern Uttar Pradesh	1	0	15473	15472	15475	
1244	greater vaccine acceptance	great vaccine acceptance	1	0	1246	302	1248	
35530	CLEAR associates	clear associate	1	0	35532	422	35532	
33261	short overview	short overview	1	0	19301	16760	19301	
28349	suggestive clinical presentation	suggestive clinical presentation	1	0	10578	24841	4163	
16419	pharmaceutical ingredients	pharmaceutical ingredient	1	0	12263	16420	12263	
29765	adult patients	adult patient	1	0	60	14179	60	
17120	Italian Society of Endoscopic Surgery	Italian Society of endoscopic surgery	1	0	17122	115	17123	
11859	random quota sampling	random quota sampling	1	0	11861	2346	11863	
5691	major psychological impact	major psychological impact	1	0	1379	1318	110	
39176	history of hypertension	history of hypertension	1	0	5381	39178	5381	
27851	convalescents Anti-viral immunity	convalescent anti-viral immunity	1	0	27853	22900	257	
33761	TLR agonists	TLR agonist	1	0	33763	33762	33763	
703	non-cardiac complications	non-cardiac complication	1	0	705	704	705	
28319	clear relation to final AKI stage	clear relation to final Aki stage	1	0	28321	9482	14883	
10007	X-Ray Severity	x-ray severity	1	0	1202	10008	1202	
10522	residential unit	residential unit	1	0	10	9936	10	
24124	public decisions	public decision	1	0	1942	1321	1942	
22721	potential drugs	potential drug	1	0	4584	1276	4584	
14315	bilateral hypometabolism	bilateral hypometabolism	1	0	1260	10335	1260	
5667	COVID-19 PI-SSI	INFunknownSUP INFunknownSUP	1	0	5669	40	5669	
29300	rapid detection tests	rapid detection test	1	0	29302	795	1365	
8819	distinct Species	distinct Species	1	0	8821	2802	8821	
38573	metabolism of this olfactory region	metabolism of this olfactory region	1	0	7776	38575	7776	
35037	Injury Molecule	Injury molecule	1	0	35039	2416	35039	
1306	activities of the spring semester	activity of the spring semester	1	0	192	1308	192	
18512	autoimmunity disorders	autoimmunity disorder	1	0	889	8710	889	
36776	endoscopic gastrostomy	endoscopic gastrostomy	1	0	36778	8224	36778	
34566	Vaccine hesitancy	vaccine hesitancy	1	0	1033	685	1033	
32669	peer-reviewed reports	peer-reviewed report	1	0	4651	32670	4651	
30959	mild COVID-19	mild INFunknownSUP	1	0	40	10809	40	
22988	higher expression of TMPRSS2	high expression of INFunknownSUP	1	0	22990	322	5729	
29697	Assessment of cytokines	Assessment of cytokine	1	0	2874	5734	2874	
30669	Prevention Social Vulnerability Index	prevention Social vulnerability Index	1	0	30671	15436	7907	
35648	absolute number of patients	absolute number of patient	1	0	19012	1302	916	
21500	typical COVID-19 symptoms	typical INFunknownSUP symptom	1	0	3912	17065	86	
1409	anti-viral effects	anti-viral effect	1	0	156	1410	156	
1204	tremendous help to nursing administrators	tremendous help to nursing administrator	1	0	1206	1205	1207	
19729	twenty-three patients	twenty-three patient	1	0	60	19730	60	
13794	mitochondrial function	mitochondrial function	1	0	9243	13795	9243	
29469	validation of tools	validation of tool	1	0	6319	274	6319	
7033	Paediatric palliative care consultations	paediatric palliative care consultation	1	0	978	7034	978	
14522	hospitalisation peak	hospitalisation peak	1	0	5928	14523	5928	
25248	analizado variables demograficas	INFunknownSUP variable INFunknownSUP	1	0	25250	25249	818	
12153	Mesenchymal Stem/Stromal Cells	mesenchymal INFunknownSUP cell	1	0	12155	141	12157	
30713	separate LV LS	separate INFunknownSUP LS	1	0	8964	30714	8966	
7276	barrier system	barrier system	1	0	1327	7277	1327	
31915	consistency measures of Cronbach	consistency measure of INFunknownSUP	1	0	31917	18383	317	
38575	olfactory region	olfactory region	1	0	8256	1702	8256	
4821	Oxidative stress	oxidative stress	1	0	199	4822	199	
10428	consistent Corona virus diagnosis	consistent Corona virus diagnosis	1	0	10430	10429	2168	
1634	better management of COVID-19 patients	good management of INFunknownSUP patient	1	0	1636	1635	743	
22255	% of all infections	% of all infection	1	0	364	779	364	
29389	social isolation policies	social isolation policy	1	0	1760	11420	1760	
9514	valuable information	valuable information	1	0	2591	9515	2591	
34472	non-pharmaceutic measures":the external technique of traditional Chinese medicine	non-pharmaceutic INFunknownSUP external technique of traditional Chinese medicine	1	0	34474	34473	562	
37319	phospholipase A2s	phospholipase A2s	1	0	26557	26555	26557	
26291	fiber production technique	fiber production technique	1	0	26293	26292	562	
13114	viral genome sequence data	viral genome sequence datum	1	0	13116	1741	22	
10129	Detection of Viruses	detection of virus	1	0	10130	10131	10130	
35981	group of patients	group of patient	1	0	18	60	18	
4928	sources of bias	source of bias	1	0	4158	4930	4158	
13809	IGHV3-53/3-66 germline genes	IGHV3-53/3-66 INFunknownSUP gene	1	0	13811	2261	12362	
27487	US dollars	US dollar	1	0	27489	3316	27489	
19199	Coagulation disorder	coagulation disorder	1	0	7358	19200	7358	
49	University anatomy teachers	University anatomy teacher	1	0	51	50	53	
33172	range 2.1x-7.5x	range INFunknownSUP	1	0	33174	420	33174	
22215	NHP pneumonia models	INFunknownSUP pneumonia model	1	0	22217	22216	3975	
12542	local hens	local hen	1	0	10439	3173	10439	
22102	Immanule Kant	INFunknownSUP Kant	1	0	22104	22103	22104	
1883	Covid-19 testing	INFunknownSUP testing	1	0	1885	1884	1885	
29373	instrumental variables	instrumental variable	1	0	817	6798	817	
11769	Entropy Analysis of COVID-19 Cardiovascular	entropy analysis of INFunknownSUP Cardiovascular	1	0	11771	11770	204	
19066	epidemiological characterization	epidemiological characterization	1	0	7023	18107	7023	
32021	Creatinine increase	creatinine increase	1	0	392	32022	392	
16051	variable overall effects	variable overall effect	1	0	16053	6800	156	
6890	adherence to preventive measures	adherence to preventive measure	1	0	3636	6892	3636	
32463	3b ALITHIOS study	INFunknownSUP INFunknownSUP study	1	0	2087	32464	2087	
38904	presentation of severe acute papillary necrosis	presentation of severe acute papillary necrosis	1	0	4163	38906	4163	
29522	Big data analytics	big datum INFunknownSUP	1	0	14274	29523	14274	
15476	Revision sessions	revision session	1	0	15478	15477	15478	
37548	communalistic resource-poor settings	communalistic INFunknownSUP setting	1	0	37550	37549	2729	
5056	severe ischemic injury	severe ischemic injury	1	0	5058	262	713	
17109	Telemedicine experience	INFunknownSUP experience	1	0	2782	17110	2782	
36075	enhanced sewage surveillance	enhanced sewage surveillance	1	0	32195	3888	2795	
38334	infectious agents	infectious agent	1	0	14767	64	14767	
35226	methodological innovation	methodological innovation	1	0	19710	1696	19710	
26830	COVID-19-related severe acute respiratory syndrome	COVID-19-related severe acute respiratory syndrome	1	0	4710	1384	1936	
9608	last years	last year	1	0	1313	3723	1313	
6396	genomic surveillance data	INFunknownSUP surveillance datum	1	0	6398	5714	22	
37054	protective antibodies	protective antibody	1	0	929	1455	929	
572	BNT162b2 mRNA COVID-19	INFunknownSUP INFunknownSUP INFunknownSUP	1	0	40	573	40	
20090	multisystem disease	multisystem disease	1	0	209	20091	209	
28393	Relevant trials	relevant trial	1	0	8639	28394	8639	
38863	high attendance	high attendance	1	0	2594	13	2594	
32783	qualified doctors	qualified doctor	1	0	2768	32784	2768	
26167	impacts of community gardening	impact of community gardening	1	0	1385	26169	1385	
1862	des Arts et Metiers	des Arts et INFunknownSUP	1	0	1864	1863	1868	
20199	chronic arthritis	chronic arthritis	1	0	11903	8230	11903	
12102	head injury concerns	head injury concern	1	0	12104	2845	12106	
963	vaccine trial	vaccine trial	1	0	965	577	965	
38689	hybrid politicized expert system	hybrid politicized expert system	1	0	38691	38690	1327	
6866	local capabilities	local capability	1	0	6868	3173	6868	
3374	elevated levels of CRP	elevated level of INFunknownSUP	1	0	3376	1705	169	
18566	promotion of vaccination	promotion of vaccination	1	0	18567	437	18567	
33624	safety of hydroxychloroquine	safety of INFunknownSUP	1	0	6729	33626	6729	
34609	observable epidemiological change	observable epidemiological change	1	0	34611	34610	9215	
25889	eligible websites	eligible website	1	0	15369	5236	15369	
37445	wide-ranging clinical spectrum	wide-ranging clinical spectrum	1	0	37447	37446	5866	
9423	formula of percentage variation	formula of percentage variation	1	0	9424	9425	9424	
25447	centre mutation	centre mutation	1	0	333	25448	333	
9765	COVID-19 lockdowns Nitrogen dioxide	INFunknownSUP lockdown nitrogen dioxide	1	0	9769	9766	9771	
3089	Serum Hydrogen Sulfide	Serum hydrogen sulfide	1	0	3091	3090	3093	
16815	paediatric ED attendances	paediatric editor attendance	1	0	16817	974	16819	
1594	episodes of pericarditis	episode of pericarditis	1	0	1595	1596	1595	
13875	community involvement	community involvement	1	0	3599	3641	3599	
21817	Hotel Augustus	Hotel Augustus	1	0	21819	21818	21819	
796	geographic spread of SARS-CoV-2	geographic spread of INFunknownSUP	1	0	798	797	570	
31153	database of compounds	database of compound	1	0	879	14102	879	
24574	10th-90th percentiles	INFunknownSUP percentile	1	0	24576	24575	24576	
26669	designing financial education sessions	designing financial education session	1	0	26671	26670	15478	
39249	rate of hospitalizations	rate of hospitalization	1	0	1034	5091	1034	
6456	model infectious parameters	model infectious parameter	1	0	6458	6457	6460	
31261	psychologic survey	INFunknownSUP survey	1	0	967	31262	967	
34503	levels of IL6	level of INFunknownSUP	1	0	169	34505	169	
13867	severe course of the disease	severe course of the disease	1	0	13869	262	5152	
4528	higher-risk ZIP codes	higher-risk zip code	1	0	4530	4529	4532	
21253	traumatic brain injury	traumatic brain injury	1	0	21255	14943	713	
20526	routinised periods	INFunknownSUP period	1	0	873	20527	873	
34836	individual unit	individual unit	1	0	10	753	10	
2294	heart rate maximum	heart rate maximum	1	0	2298	2295	2298	
31694	new assessment tool	new assessment tool	1	0	31696	69	5487	
5887	trade policy	trade policy	1	0	293	5888	293	
8776	Unwanted Proposal	unwanted Proposal	1	0	8778	8777	8778	
26103	heavy personal protective equipment Surgeons	heavy personal protective equipment surgeon	1	0	16067	15606	16067	
8659	persistent cellular immunity	persistent cellular immunity	1	0	4918	8660	257	
17218	healthcare interventions	INFunknownSUP intervention	1	0	757	494	757	
18846	development of COVID-19 vaccines	development of INFunknownSUP vaccine	1	0	73	1813	73	
20895	access to health services	access to health service	1	0	224	5978	224	
10830	Late Manifestation	late manifestation	1	0	10832	10831	10832	
24690	acid-binding domain	acid-binding domain	1	0	697	24691	697	
6269	resident day	resident day	1	0	6271	2241	6271	
13089	employment loss	employment loss	1	0	3586	13090	3586	
35025	COVID-19 patients Clostridioides	INFunknownSUP patient INFunknownSUP	1	0	35027	40	497	
15629	SARS Cov2 negative PCR	INFunknownSUP INFunknownSUP negative PCR	1	0	15633	15630	3981	
4258	median difference	median difference	1	0	4260	2634	4260	
13338	Biomarkers of tissue damage	Biomarker of tissue damage	1	0	13339	7883	13339	
30034	Effect of COVID-19 Pandemic	effect of INFunknownSUP pandemic	1	0	6097	6336	6097	
38320	viable cure	viable cure	1	0	36326	13764	36326	
17463	primary infection	primary infection	1	0	41	75	41	
8994	effects of NIRS modalities:high-flow nasal oxygen	effect of INFunknownSUP INFunknownSUP nasal oxygen	1	0	156	8996	156	
33613	lysosomal storage disorders	lysosomal storage disorder	1	0	33615	33614	889	
32519	past outbreaks	past outbreak	1	0	2892	1234	2892	
1127	surge response	surge response	1	0	409	1128	409	
38228	Surgical Volume	surgical volume	1	0	38230	28421	38230	
32211	specific preparation	specific preparation	1	0	32213	2515	32213	
4539	ligand-binding free energy	ligand-binding free energy	1	0	4541	4540	4543	
16001	knowledge of COVID-19 prevention practices	knowledge of INFunknownSUP prevention practice	1	0	213	16003	213	
30363	proportional hazard regression	proportional hazard regression	1	0	5036	17552	5036	
3406	online consensus workshops	online consensus workshop	1	0	3408	541	3410	
33192	myocardial T1 relaxation times	myocardial INFunknownSUP relaxation time	1	0	33194	5813	12806	
9736	common cutaneous manifestations	common cutaneous manifestation	1	0	9148	699	885	
26048	chief complaint	chief complaint	1	0	12929	26049	12929	
14546	full background	full background	1	0	14548	6703	14548	
24044	Whole-Genome Sequences of SARS-CoV-2	INFunknownSUP sequence of INFunknownSUP	1	0	24046	24045	24047	
18995	side of rare events	side of rare event	1	0	18996	18997	18996	
19413	long hours	long hour	1	0	6837	3921	6837	
3832	compatibility of online methods	compatibility of online method	1	0	3833	3834	3833	
519	research hospital	research hospital	1	0	185	36	185	
23247	few papers	few paper	1	0	21487	6261	21487	
5904	primary viral challenge	primary viral challenge	1	0	5906	75	62	
14744	Western Ethiopia	Western Ethiopia	1	0	11439	1848	11439	
31242	text message	text message	1	0	31244	31243	31244	
6320	available antibodies	available antibody	1	0	929	832	929	
38317	different options	different option	1	0	23261	688	23261	
1068	illness burden	illness burden	1	0	1070	1069	1070	
21044	high-quality education	high-quality education	1	0	361	21045	361	
21458	negative RT-PCR tests	negative INFunknownSUP test	1	0	21460	1338	1365	
3376	levels of CRP	level of INFunknownSUP	1	0	169	3378	169	
7771	sources of the information	source of the information	1	0	4158	2591	4158	
25052	antibody-dependent enhancement	antibody-dependent enhancement	1	0	592	25053	592	
24252	Candidate variables	candidate variable	1	0	817	24253	817	
9797	ICU admissions	ICU admission	1	0	3085	1658	3085	
12324	gene tissue analysis	gene tissue analysis	1	0	12326	6495	486	
2769	simple anxiety to probable depression	simple anxiety to probable depression	1	0	2771	2770	2772	
27427	rates of medical co-morbidities	rate of medical co-morbidity	1	0	83	11638	83	
1541	risk modeling of mortality	risk modeling of mortality	1	0	1543	1542	464	
24351	middle income countries	middle income country	1	0	24353	8655	1599	
14617	sanitario ni de los servicios	INFunknownSUP Ni de los INFunknownSUP	1	0	14619	14618	14625	
20480	African health care system	African health care system	1	0	20482	5365	1327	
5578	severity of the COVID-19 pandemic	severity of the INFunknownSUP pandemic	1	0	5116	111	5116	
14332	few days	few day	1	0	1645	6261	1645	
27277	fewer provider-related barriers	few provider-related barrier	1	0	27279	1479	10121	
11013	Logistic regression models	logistic regression model	1	0	3975	11014	3975	
14997	non-structural protein	non-structural protein	1	0	1797	14998	1797	
28922	resolution group	resolution group	1	0	18	1448	18	
35638	Department of Radiation Oncology	department of radiation oncology	1	0	35639	35640	35639	
34297	information support	information support	1	0	260	2591	260	
1515	Quality of life	quality of life	1	0	1516	1434	1516	
1508	higher rates of current depression	high rate of current depression	1	0	1509	1512	83	
21263	COVID-19 infection Neurologic complications of COVID-19 infection	INFunknownSUP infection neurologic complication of INFunknownSUP infection	1	0	21264	39	705	
5623	comparative studies	comparative study	1	0	136	5624	136	
38450	Creatinine ratio &gt	creatinine ratio &gt	1	0	38452	32022	2385	
36873	curve analyses	curve analysis	1	0	4668	6817	4668	
8273	SARS-CoV-2 particles	INFunknownSUP particle	1	0	8275	28	8275	
30982	Potential risks of vertical transmission of COVID-19	potential risk of vertical transmission of INFunknownSUP	1	0	30984	30596	8152	
8002	group n	group n	1	0	8004	18	8004	
14631	membrane materials	membrane material	1	0	2335	14632	2335	
14952	prevencion del duelo	INFunknownSUP del INFunknownSUP	1	0	14954	14953	14956	
2664	rapid prevention	rapid prevention	1	0	1294	795	1294	
18981	Dynamic pharmacy leadership	dynamic pharmacy leadership	1	0	18983	18982	18985	
36410	critical epidemiological characteristics	critical epidemiological characteristic	1	0	36412	223	1496	
26223	sample throughput	sample throughput	1	0	26225	2757	26225	
8558	IPS patients	IPS patient	1	0	60	8559	60	
27532	colorimetric methods	colorimetric method	1	0	205	27533	205	
6008	national guidelines	national guideline	1	0	91	517	91	
20103	Response Theory	Response theory	1	0	20105	2498	20105	
12919	prognosis of the disease	prognosis of the disease	1	0	12920	209	12920	
6909	children of White parents	child of White parent	1	0	6153	6911	6153	
7735	further education	further education	1	0	361	7713	361	
27065	related lung injury	related lung injury	1	0	2934	2647	713	
20948	HCQ+AZ combination	INFunknownSUP combination	1	0	367	20949	367	
18629	interaction network construction	interaction network construction	1	0	9749	2525	9751	
357	similar morphology	similar morphology	1	0	359	102	359	
38869	literary masterpieces	literary masterpiece	1	0	38871	38870	38871	
24613	suitable technique	suitable technique	1	0	562	24614	562	
14825	reproduction number of novel coronavirus	reproduction number of novel coronavirus	1	0	14827	4645	916	
32554	Reunion Island inpatients	Reunion Island inpatient	1	0	32556	32555	30487	
3157	South Kashmir	South Kashmir	1	0	3159	667	3159	
29150	ethnic women	ethnic woman	1	0	920	2122	920	
7408	terms of accuracy of detection	term of accuracy of detection	1	0	4908	7410	4908	
247	vitro data	INFunknownSUP datum	1	0	22	248	22	
3800	multivariate logistic analysis	multivariate logistic analysis	1	0	3802	2408	486	
18256	regression analysis	regression analysis	1	0	486	5036	486	
4577	high KA-to-kynurenine	high INFunknownSUP	1	0	4579	13	4579	
35121	class administrators	class administrator	1	0	1210	353	1210	
32301	HKU1 betacoronaviruses spike protein	INFunknownSUP betacoronavirus spike protein	1	0	32303	32302	1797	
20356	development of antiviral strategies	development of antiviral strategy	1	0	73	20358	73	
13636	agile approach	agile approach	1	0	1538	13637	1538	
21590	Estudio ecologico de	INFunknownSUP INFunknownSUP de	1	0	1421	21591	1421	
21751	Tube Placement	tube Placement	1	0	21753	21752	21753	
29106	large European cohort	large European cohort	1	0	29108	4250	601	
9256	combines opinions	combine opinion	1	0	9258	9257	9258	
28693	cord injury Excessive inflammation post-traumatic spinal cord injury	cord injury excessive inflammation post-traumatic spinal cord injury	1	0	28695	28694	713	
2320	own influenza infection	own influenza infection	1	0	2322	2321	41	
16302	access to expert clinical care	access to expert clinical care	1	0	224	16304	224	
32316	validation group	validation group	1	0	18	6319	18	
28045	faster time to results	fast time to result	1	0	28047	28046	179	
11753	selection of patients	selection of patient	1	0	5520	60	5520	
24679	multi-criteria performance evaluation methodology	INFunknownSUP performance evaluation methodology	1	0	24681	24680	11687	
15780	2019-nCoV cases time series	INFunknownSUP case time series	1	0	15784	15781	8050	
7654	Promotion of Vaccination	Promotion of vaccination	1	0	7655	3872	7655	
16785	better outcome	good outcome	1	0	295	1635	295	
34146	open-source Beiwe platform	open-source INFunknownSUP platform	1	0	34148	34147	1709	
33962	RT-PCR-negative cases	RT-PCR-negative case	1	0	229	33963	229	
25343	compatibility of e-Learning methods	compatibility of e-Learning method	1	0	3833	25345	3833	
2766	medical doctors	medical doctor	1	0	2768	947	2768	
22128	risk of incident AKI	risk of incident Aki	1	0	1542	22130	1542	
26787	isolating SARS-CoV-2	isolating INFunknownSUP	1	0	28	26788	28	
31910	University Hospitals	University hospital	1	0	31912	50	31912	
2926	well-recognized adverse events of transfusion-associated lung injury	well-recognized adverse event of transfusion-associated lung injury	1	0	2928	2927	1083	
20117	descriptive cross-sectional design	descriptive cross-sectional design	1	0	20119	9734	4183	
4433	Epidata version	INFunknownSUP version	1	0	4435	4434	4435	
774	type of cancer	type of cancer	1	0	775	773	775	
21773	SF-36 data	INFunknownSUP datum	1	0	22	9776	22	
15214	homoplasy of this transition	homoplasy of this transition	1	0	15215	2091	15215	
134	Thirty-two studies	INFunknownSUP study	1	0	136	135	136	
14519	maternity clinic	maternity clinic	1	0	7704	14520	7704	
24392	performance of a rapid chromatographic test	performance of a rapid chromatographic test	1	0	598	24394	598	
24663	Brazilian women	Brazilian woman	1	0	920	5567	920	
34181	demands of the local street population	demand of the local street population	1	0	10237	34183	10237	
22008	neuropsychiatric presentations	neuropsychiatric presentation	1	0	2848	22009	2848	
32642	delivery of pulmonary rehabilitation	delivery of pulmonary rehabilitation	1	0	2840	8680	2840	
899	green font colors	green font color	1	0	901	900	903	
35219	acute viral respiratory syndromes	acute viral respiratory syndrome	1	0	35221	1461	35225	
32727	one-stop breast clinic	one-stop breast clinic	1	0	32729	32728	7704	
34367	Determination of IgA	determination of IgA	1	0	34368	18813	34368	
33839	primary care delivery	primary care delivery	1	0	2840	6472	2840	
39098	low levels	low level	1	0	169	457	169	
32616	immunomodulatory therapy	immunomodulatory therapy	1	0	2273	25864	2273	
13257	de incidencia	de INFunknownSUP	1	0	13259	1421	13259	
30247	Low Immunoglobulin G Antibody Levels	Low immunoglobulin G antibody Levels	1	0	30249	20790	30255	
30471	respiratory diseases	respiratory disease	1	0	315	259	315	
15955	novel coronavirus	novel INFunknownSUP	1	0	15957	3645	15957	
15616	diabetic manifestations	diabetic manifestation	1	0	885	15617	885	
33615	storage disorders	storage disorder	1	0	889	33616	889	
500	Scottish app	Scottish App	1	0	502	501	502	
38578	linear regression analyses	linear regression analysis	1	0	4668	38579	4668	
18364	telemedicine usage	telemedicine usage	1	0	2248	16044	2248	
37199	high risk of transmission of SARS COV2	high risk of transmission of INFunknownSUP INFunknownSUP	1	0	37201	13	1542	
25656	positive sample	positive sample	1	0	2757	228	2757	
33504	clinician indebtedness	clinician indebtedness	1	0	33506	33505	33506	
32335	primary goals	primary goal	1	0	2542	75	2542	
21356	scientific committee of the International Association of Dental Students	scientific committee of the International Association of dental student	1	0	21358	2290	2265	
25220	animal susceptibility	animal susceptibility	1	0	10460	7340	10460	
4058	low-income workers	low-income worker	1	0	1136	953	1136	
26478	virtual healthcare	virtual INFunknownSUP	1	0	494	3148	494	
38840	low COVID-19 incidence	low INFunknownSUP incidence	1	0	38842	457	2940	
11875	human specimens	human specimen	1	0	7245	2214	7245	
24913	pragmatic approach to COVID-19 vaccine passport	pragmatic approach to INFunknownSUP vaccine passport	1	0	24915	5816	1538	
37156	COVID-19- related factors	INFunknownSUP related factor	1	0	37158	37157	583	
26472	possible causes	possible cause	1	0	19560	745	19560	
8153	vaccine implementations	vaccine implementation	1	0	8155	577	8155	
13508	negative effect	negative effect	1	0	1809	1338	1809	
29272	effective data-driven	effective INFunknownSUP	1	0	29274	2051	29274	
21418	years of the last decade	year of the last decade	1	0	1313	21420	1313	
14717	areas of the country	area of the country	1	0	1579	2270	1579	
9525	mean number of procedures	mean number of procedure	1	0	914	4200	916	
16915	Damaged Testis of COVID-19 Patients	damaged testis of INFunknownSUP Patients	1	0	16917	16916	16918	
38758	linear regression methods	linear regression method	1	0	205	38579	205	
29963	online-based survey	INFunknownSUP survey	1	0	967	29964	967	
9812	levels of platelets	level of platelet	1	0	169	9814	169	
15734	potential impacts of the changes	potential impact of the change	1	0	15736	1276	1385	
17129	moderation effect	moderation effect	1	0	1809	17130	1809	
33150	Science Direct	Science Direct	1	0	33152	33151	33152	
9025	CLEAR recommendations	clear recommendation	1	0	652	422	652	
21934	open book quizzes	open book quiz	1	0	21936	3995	21938	
32220	readers of any safety concern	reader of any safety concern	1	0	32221	32222	32221	
14033	characteristics age	characteristic age	1	0	906	1496	906	
12535	effective reproduction numbers (R(t))	effective reproduction number INFunknownSUP	1	0	12537	2051	12541	
25598	important determinant	important determinant	1	0	25600	273	25600	
1164	Adolescents today	adolescent today	1	0	1166	1165	1166	
34336	ROC point	roc point	1	0	10333	24405	10333	
31729	analysis of 18F-FDG brain PET of long COVID patients	analysis of INFunknownSUP brain pet of long INFunknownSUP patient	1	0	486	31731	486	
34862	cross-reactive memory CD8 T cells	cross-reactive memory INFunknownSUP T cell	1	0	34864	12516	133	
3214	asymptomatic carriers	asymptomatic carrier	1	0	3216	1131	3216	
19862	clinical manifestations of the virus	clinical manifestation of the virus	1	0	883	778	885	
7900	multivariant analysis	multivariant analysis	1	0	486	7901	486	
28200	useful support mechanisms	useful support mechanism	1	0	14486	10503	1456	
38602	younger participants	young participant	1	0	4950	2571	4950	
38733	CoV-2 IgG nucleocapsid antibodies	INFunknownSUP IgG nucleocapsid antibody	1	0	38735	29344	929	
32810	measures of entropy	measure of entropy	1	0	317	26166	317	
37629	virus detection techniques	virus detection technique	1	0	37631	778	691	
27834	main content of Guidance	main content of guidance	1	0	27836	4679	6700	
7256	COVID-19 Vaccine Hesitancy	INFunknownSUP vaccine hesitancy	1	0	7260	7257	7260	
20900	attention of the scientific community	attention of the scientific community	1	0	4885	20902	4885	
31954	social networking	social networking	1	0	30744	383	30744	
11395	Learning Environment Scale	Learning Environment Scale	1	0	11397	11396	1203	
35411	potential leads	potential lead	1	0	35413	1276	35413	
25091	pandemic wave	pandemic wave	1	0	10210	1354	10210	
6307	existing configuration of the UK	existing configuration of the UK	1	0	6309	6308	6310	
31531	health governance of all people	health governance of all people	1	0	31533	120	2616	
8789	ongoing school mentoring	ongoing school mentoring	1	0	8791	1059	4041	
24638	Intriguing Candidate Antiviral Targets Intercellular communication	intriguing candidate antiviral target intercellular communication	1	0	24640	24639	11078	
16177	significant decline	significant decline	1	0	16179	908	16179	
37583	experienced stigma	experienced stigma	1	0	37585	6464	37585	
4724	Eleven critical ill coronavirus disease	eleven critical ill coronavirus disease	1	0	4726	4725	209	
27674	select marine	select marine	1	0	27676	27675	27676	
36339	study of the liver position statement	study of the liver position statement	1	0	2087	36341	2087	
21651	different prioritization of expertise	different prioritization of expertise	1	0	21653	688	3209	
24324	different units of a selected district hospital	different unit of a selected district hospital	1	0	24326	688	6042	
35858	emergency urological intervention	emergency urological intervention	1	0	35860	447	5608	
3443	gas volume	gas volume	1	0	3445	3444	3445	
35398	deadly virus	deadly virus	1	0	778	35399	778	
26025	emergence of a new variant	emergence of a new variant	1	0	19875	937	19875	
11791	mutational activity	mutational activity	1	0	3990	4997	3990	
33896	health challenge	health challenge	1	0	62	120	62	
4665	Computational analyses of participant behaviour	computational analysis of participant behaviour	1	0	4666	4669	4668	
13979	distinct selectivity of SARS-CoV-2-induced humoral immunity	distinct selectivity of INFunknownSUP humoral immunity	1	0	13981	2802	13051	
14233	patient-related barriers	patient-related barrier	1	0	10121	14234	10121	
18745	environmental predictors of PS	environmental predictor of PS	1	0	18747	6806	414	
32148	RPTEC cells	INFunknownSUP cell	1	0	133	32149	133	
10365	rate of increase	rate of increase	1	0	1034	392	1034	
17769	IgY antibodies	IgY antibody	1	0	929	13004	929	
21883	DASS scales	Dass scale	1	0	7864	4659	7864	
34216	therapeutic guidelines	therapeutic guideline	1	0	91	3349	91	
37766	DELES subscales	dele subscale	1	0	9952	37767	9952	
22662	baseline seroprevalence	baseline seroprevalence	1	0	4090	22663	4090	
11419	social isolation regulations	social isolation regulation	1	0	11423	11420	11423	
4037	Outpatient Visits	outpatient visit	1	0	4039	4038	4039	
20707	network structures	network structure	1	0	3133	719	3133	
39071	management of hidradenitis suppurativa	management of hidradenitis INFunknownSUP	1	0	743	39073	743	
12943	survey link	survey link	1	0	3478	967	3478	
29264	procedure policies	procedure policy	1	0	1760	4693	1760	
8572	community surveillance	community surveillance	1	0	2795	3641	2795	
37704	absence of the diagnostic kit	absence of the diagnostic kit	1	0	4917	37706	4917	
6506	high-need Medicare patients	INFunknownSUP Medicare patient	1	0	2815	6507	60	
13298	group of women	group of woman	1	0	18	920	18	
5290	emergency housing	emergency housing	1	0	3497	447	3497	
615	book exams	book exam	1	0	617	616	617	
20414	treatment capacity	treatment capacity	1	0	3026	97	3026	
12447	positive bad obstetric history	positive bad obstetric history	1	0	5778	228	5381	
24508	analysis of S1-ACE2 complex dissociation	analysis of INFunknownSUP complex dissociation	1	0	486	24510	486	
35354	Likert scale	Likert scale	1	0	2422	23967	2422	
30039	major financial losses	major financial loss	1	0	30041	1318	4306	
31978	bat species	bat specie	1	0	3957	8902	3957	
26333	transversal y una guia clinica	transversal y una INFunknownSUP INFunknownSUP	1	0	26335	26334	26341	
10051	regional discrepancies	regional discrepancy	1	0	10053	4068	10053	
16354	survey experiments	survey experiment	1	0	16356	967	16356	
35059	AKI incidence	Aki incidence	1	0	2940	13007	2940	
31052	home program	home program	1	0	1790	231	1790	
3546	unique structural features	unique structural feature	1	0	3548	3547	1469	
23840	transfusion-associated circulatory overload	transfusion-associated circulatory overload	1	0	23842	2933	23844	
7377	proteinuria group	proteinuria group	1	0	18	7378	18	
5963	general increase	general increase	1	0	392	1080	392	
33436	treatment of the disease	treatment of the disease	1	0	97	209	97	
4689	difficult points of the procedure	difficult point of the procedure	1	0	4691	4690	23	
14688	new symptoms	new symptom	1	0	86	69	86	
1526	Utilization of the internet	utilization of the Internet	1	0	1527	1528	1527	
1193	Ambulatory Clinic	ambulatory Clinic	1	0	1195	1194	1195	
34137	Models I	Models I	1	0	15742	34138	15742	
8404	family needs	family need	1	0	3189	5380	3189	
17697	novel approaches	novel approach	1	0	8111	810	8111	
37480	focal center	focal center	1	0	8718	37481	8718	
20846	CT Findings of Coronavirus Disease 2019	CT finding of INFunknownSUP Disease 2019	1	0	20848	26	20849	
38566	lecture examination scores	lecture examination score	1	0	15077	6699	3726	
35322	investigation project	investigation project	1	0	11012	7714	11012	
11844	virus propagation	virus propagation	1	0	11846	778	11846	
12925	clot evacuation	clot evacuation	1	0	12927	12926	12927	
25919	free wall longitudinal strain	free wall longitudinal strain	1	0	1105	25920	1107	
23715	macular OCTA parameters	macular INFunknownSUP parameter	1	0	23717	19275	6460	
33024	strict criteria	strict criterion	1	0	3649	8859	3649	
20068	lack of efficacy	lack of efficacy	1	0	11210	6704	11210	
2730	MEWS of survivors	mew of survivor	1	0	2731	2732	2731	
32605	societal changes	societal change	1	0	1336	26058	1336	
10421	repertoire risk off-target effects	repertoire risk off-target effect	1	0	10423	10422	156	
28779	laparoscopic scissors	INFunknownSUP scissors	1	0	28781	127	28781	
17966	Clinical characteristics of patients	clinical characteristic of patient	1	0	1500	60	1496	
25080	samples of respondents	sample of respondent	1	0	1765	861	1765	
10280	SARS-CoV-2 Infection	INFunknownSUP infection	1	0	9866	226	9866	
33021	training module	training module	1	0	5565	235	5565	
1386	Jail residents	jail resident	1	0	232	1387	232	
2208	policy decisions	policy decision	1	0	1942	293	1942	
35085	multiple relevant covariates	multiple relevant covariate	1	0	35087	1776	35089	
36593	impact of UpToDate	impact of INFunknownSUP	1	0	110	28911	110	
33699	Fourteen studies	fourteen study	1	0	136	33700	136	
17147	science Inequalities	science inequality	1	0	17149	1115	17149	
7836	stay-at-home orders	stay-at-home order	1	0	7838	1759	7838	
14929	event outcomes	event outcome	1	0	263	14930	263	
14429	hospital visitors	hospital visitor	1	0	14431	185	14431	
38877	prevention awareness	prevention awareness	1	0	1612	1294	1612	
33164	influence of the environmental temperature	influence of the environmental temperature	1	0	23634	33166	23634	
15036	urological practice	urological practice	1	0	3285	15037	3285	
39122	diferencias sugieren una subestimacion generalizada	INFunknownSUP INFunknownSUP Una INFunknownSUP INFunknownSUP	1	0	39130	39123	39130	
19623	increase vaccination uptake	increase vaccination uptake	1	0	19625	392	19195	
28469	adverse impact of the COVID-19	adverse impact of the INFunknownSUP	1	0	3535	1082	110	
27082	virus spike protein	virus spike protein	1	0	1795	778	1797	
27844	altered IB	altered Ib	1	0	27846	4150	27846	
29290	New Labour program	New Labour program	1	0	29292	1162	1790	
3211	Weight gain	Weight gain	1	0	3213	3212	3213	
37497	- dRDT	INFunknownSUP INFunknownSUP	1	0	37499	5345	37499	
15103	Refractory Psoriatic Arthritis	refractory psoriatic arthritis	1	0	15105	15104	15107	
33934	digital pathology solutions	digital pathology solution	1	0	9378	2092	9378	
6388	prediction models	prediction model	1	0	3975	3336	3975	
39148	single testing step	single testing step	1	0	39150	1652	23817	
28335	audience of adult horse show participants	audience of adult horse show participant	1	0	23080	28337	23080	
28288	Rh phenotype	Rh phenotype	1	0	28290	28289	28290	
34789	Social distancing protocols	social distancing protocol	1	0	18004	34790	18004	
24359	causes of long-lasting immune responses	cause of long-lasting immune response	1	0	19560	24361	19560	
7862	IER-S scales	INFunknownSUP scale	1	0	7864	7863	7864	
3967	Memory (ConvLSTM)-based deep learning models	Memory INFunknownSUP deep learning model	1	0	3969	3968	3975	
32125	county-level variables	county-level variable	1	0	817	32126	817	
30026	Paediatric ED attendances	paediatric editor attendance	1	0	16817	6254	16819	
19566	survival of coronavirus disease	survival of coronavirus disease	1	0	1498	338	1498	
16876	risk mechanisms	risk mechanism	1	0	1456	1542	1456	
19175	IDT probes	Idt probe	1	0	19177	19176	19177	
35437	participant sociodemographic	participant INFunknownSUP	1	0	35439	4670	35439	
1641	university students	university student	1	0	1177	1642	1177	
36312	intramuscular-alum-only vaccine	INFunknownSUP vaccine	1	0	577	36313	577	
8808	receptor activation	receptor activation	1	0	1013	3502	1013	
36854	subfertile patients	subfertile patient	1	0	60	36855	60	
2020	Support Rate Scale	support Rate Scale	1	0	2022	2021	1203	
37696	main mechanisms	main mechanism	1	0	1456	4679	1456	
18860	legitimate strategy	legitimate strategy	1	0	3350	18861	3350	
8983	global trade	global trade	1	0	5888	1954	5888	
22222	new viral strains	new viral strain	1	0	22224	69	22226	
9070	combined set	combined set	1	0	651	9071	651	
31945	viral spike glycoprotein interaction	viral spike glycoprotein interaction	1	0	31949	13180	2525	
31220	age populations	age population	1	0	13188	906	13188	
37658	early therapeutic intervention Viral infections	early therapeutic intervention viral infection	1	0	37660	55	779	
18492	major challenge	major challenge	1	0	62	1318	62	
38818	Rare Presentation of Renal Papillary Necrosis	rare Presentation of renal papillary necrosis	1	0	38820	38819	4657	
13189	stress-related SLI	stress-related SLI	1	0	13191	13190	13191	
12577	State University	State University	1	0	50	4877	50	
5675	payback period	payback period	1	0	5677	5676	5677	
34403	viral carriage	viral carriage	1	0	34405	1741	34405	
11214	high fidelity	high fidelity	1	0	11216	13	11216	
14221	lower disease burden	low disease burden	1	0	14223	594	1070	
26580	surgical protocols	surgical protocol	1	0	18004	663	18004	
11995	biosecurity programs	biosecurity program	1	0	2246	11996	2246	
22370	HCC scores	HCC score	1	0	3726	22371	3726	
6728	safety limits	safety limit	1	0	43	6729	43	
4384	% of all patients	% of all patient	1	0	364	60	364	
34606	Ashwagandha leaves	INFunknownSUP leaf	1	0	34608	7482	34608	
20478	South African health care system	South African health care system	1	0	20480	5363	1327	
35848	ACE2 Peptide Fragment Interaction	INFunknownSUP peptide fragment Interaction	1	0	35850	3437	35854	
29126	ML algorithms	ML algorithm	1	0	10650	690	10650	
37382	antibody memory boost to human coronaviruses	antibody memory boost to human coronavirus	1	0	37384	5924	37387	
31580	eligibility criteria of the current stroke guidelines	eligibility criterion of the current stroke guideline	1	0	6741	29240	3649	
18453	binding assay	binding assay	1	0	3119	2921	3119	
33256	shedding of viral RNA	shedding of viral RNA	1	0	5158	11519	5158	
727	chest pain	chest pain	1	0	729	25	729	
1721	retrospective review	retrospective review	1	0	1723	1722	1723	
37144	Efficient Data-Augmented Detection of COVID-19	efficient INFunknownSUP detection of INFunknownSUP	1	0	37146	37145	10130	
22293	spectrum of symptoms	spectrum of symptom	1	0	5866	86	5866	
37113	private-public financing	private-public financing	1	0	37115	37114	37115	
38193	remote North Tapanuli region of Indonesia	remote North Tapanuli region of Indonesia	1	0	38195	2073	8256	
7453	risk of respiratory infections	risk of respiratory infection	1	0	1542	7455	1542	
11409	mixed-methods formative evaluation	mixed-method formative evaluation	1	0	11411	11410	2399	
8890	cut-off score	cut-off score	1	0	1843	5277	1843	
18872	COVID19-inhibitory activity of withanolides	INFunknownSUP activity of INFunknownSUP	1	0	18874	18873	3990	
6485	pulmonary lobes	pulmonary lobe	1	0	2673	590	2673	
1547	different healthcare	different INFunknownSUP	1	0	494	688	494	
33384	emergent appendectomies	emergent appendectomy	1	0	3513	1832	3513	
35462	example of study case	example of study case	1	0	16680	35464	16680	
17579	Disease-2019 Patients	Disease-2019 Patients	1	0	3207	17580	3207	
15159	pandemic outbreak	pandemic outbreak	1	0	310	113	310	
30474	emergency mode	emergency mode	1	0	18075	447	18075	
26087	large healthcare provider	large INFunknownSUP provider	1	0	26089	4250	9087	
14917	stage of the pandemic	stage of the pandemic	1	0	1521	113	1521	
13301	Issue of the European Journal of Translational Myology	issue of the European journal of translational myology	1	0	13302	13303	13302	
7424	Preterm Infant	INFunknownSUP infant	1	0	7426	7425	7426	
36663	production process	production process	1	0	180	654	180	
20028	profesionales sanitarios	INFunknownSUP INFunknownSUP	1	0	14626	20029	14626	
15392	further transmission	further transmission	1	0	876	7713	876	
33628	rural/suburban areas	rural/suburban area	1	0	1579	33629	1579	
35483	Equipment Management Systems	Equipment Management Systems	1	0	35485	35484	20278	
13228	cell-cell fusion	INFunknownSUP fusion	1	0	13230	13229	13230	
31112	equation modeling	equation modeling	1	0	464	31113	464	
23297	prothrombin activity percentage	prothrombin activity percentage	1	0	23299	16373	3789	
25649	critical medication shortages	critical medication shortage	1	0	13850	223	13852	
32119	convolutional neural network	convolutional neural network	1	0	32121	32120	719	
19716	detrimental effect of PLA2s	detrimental effect of INFunknownSUP	1	0	19718	15335	1809	
32380	assessment quizzes	assessment quiz	1	0	21938	238	21938	
24801	transmission of COVID-19 infection	transmission of INFunknownSUP infection	1	0	876	39	876	
6217	therapy services	therapy service	1	0	5980	2273	5980	
9216	education credits	education credit	1	0	9218	361	9218	
31245	College Students	College student	1	0	4368	31246	4368	
14798	Tertiary Health Care Center	Tertiary Health Care Center	1	0	9354	14799	2780	
33325	median income	median income	1	0	5356	2634	5356	
12097	Diagnostic performance evaluation	diagnostic performance evaluation	1	0	2399	12098	2399	
34032	infected subjects	infected subject	1	0	4893	1088	4893	
10312	digital barriers	digital barrier	1	0	10121	1094	10121	
1580	Singapore Experience	Singapore experience	1	0	1582	1581	1582	
24698	common complication	common complication	1	0	2206	699	2206	
35618	public gathering	public gathering	1	0	35620	1321	35620	
33640	inflammatory storms	inflammatory storm	1	0	33642	3817	33642	
13197	design of medical equipment	design of medical equipment	1	0	4183	13199	4183	
31390	surface concentration	surface concentration	1	0	11518	7645	11518	
17808	laboratory examination score	laboratory examination score	1	0	17810	1392	1843	
11718	Intake Scale	intake Scale	1	0	1203	11719	1203	
11527	hour composite influent wastewater samples	hour composite influent wastewater sample	1	0	11529	11528	1765	
33985	experience of any condition	experience of any condition	1	0	2782	8881	2782	
30575	longitudinal studies	longitudinal study	1	0	136	1106	136	
36255	decline of the disease	decline of the disease	1	0	16179	209	16179	
3032	generation of face masks	generation of face mask	1	0	3033	3034	3033	
21201	coronavirus diseases	coronavirus disease	1	0	315	339	315	
17204	popularity of the apps	popularity of the INFunknownSUP	1	0	17205	17206	17205	
4590	unexpected findings	unexpected finding	1	0	3390	4591	3390	
15020	blood types	blood type	1	0	1979	3129	1979	
29285	time of the COVID-19 pandemic	time of the INFunknownSUP pandemic	1	0	179	111	179	
19453	Sociological Society	sociological Society	1	0	17123	19454	17123	
19508	unmistakable approaches	unmistakable approach	1	0	8111	19509	8111	
28834	hygiene regulations	hygiene regulation	1	0	11423	8770	11423	
8450	retention rates	retention rate	1	0	83	8451	83	
11362	advisory systems	advisory system	1	0	146	11363	146	
771	lung cancer	lung cancer	1	0	773	772	773	
26337	una guia clinica	una INFunknownSUP INFunknownSUP	1	0	26339	15009	26341	
5681	COVID-19 vaccine regulatory misalignment	INFunknownSUP vaccine regulatory misalignment	1	0	5685	3688	5687	
4602	novel zoonotic diseases	novel INFunknownSUP disease	1	0	4604	810	315	
12843	viral dissemination	viral dissemination	1	0	6877	1741	6877	
34434	significant improvements	significant improvement	1	0	11849	908	11849	
1211	Phylogenetic analysis	phylogenetic analysis	1	0	486	1212	486	
8546	Estimates of Vaccine Effectiveness of BNT162b2	estimate of vaccine effectiveness of INFunknownSUP	1	0	8547	8548	8547	
698	common way of infection	common way of infection	1	0	700	699	701	
14776	abundant microhemorrhages	abundant microhemorrhage	1	0	14778	14777	14778	
16048	rate reduction	rate reduction	1	0	490	1034	490	
28370	3-drug regimen	INFunknownSUP regimen	1	0	15845	28371	15845	
6030	line test	line test	1	0	754	6031	754	
39073	hidradenitis suppurativa	hidradenitis INFunknownSUP	1	0	39075	39074	39075	
154	action/side effects	INFunknownSUP effect	1	0	156	155	156	
14635	cell-free protein	INFunknownSUP protein	1	0	1797	7824	1797	
17920	suppressors of cytokine	suppressor of INFunknownSUP	1	0	17921	3718	17921	
29928	higher rate of office visits	high rate of office visit	1	0	1725	29932	1034	
12141	COVID-19 situation	INFunknownSUP situation	1	0	3056	40	3056	
27264	tyrosine phosphatases	tyrosine phosphatase	1	0	27266	27265	27266	
4229	Pearson correlation test	Pearson correlation test	1	0	4231	4230	754	
22459	social interactions	social interaction	1	0	13158	383	13158	
8855	Mental Hygiene	mental hygiene	1	0	8857	8856	8857	
31603	payer discussions	payer discussion	1	0	28764	31604	28764	
22502	XVII Advanced School	XVII Advanced School	1	0	22504	22503	3669	
2175	SARS-CoV-2 positive residents	INFunknownSUP positive resident	1	0	2177	28	232	
5403	residents of Northern California	resident of Northern California	1	0	232	5405	232	
5238	well-aerated regions	INFunknownSUP region	1	0	5240	5239	5240	
32089	surgical gloves	surgical glove	1	0	1821	663	1821	
17346	nosocomial outbreak of severe acute respiratory syndrome coronavirus	INFunknownSUP outbreak of severe acute respiratory syndrome coronavirus	1	0	7750	4709	310	
34352	activation of the NLRP3 inflammasome	activation of the INFunknownSUP INFunknownSUP	1	0	1013	18299	1013	
11475	social networks of older adults	social network of old adult	1	0	11476	513	4171	
30098	state of emergency	state of emergency	1	0	1961	447	1961	
28595	Ethnic Women	ethnic woman	1	0	28597	28596	28597	
30155	enhanced cell stress responses	enhanced cell stress response	1	0	196	3888	200	
20594	neurological dysfunction	neurological dysfunction	1	0	3856	2728	3856	
36291	disease outcome	disease outcome	1	0	295	209	295	
22360	autoimmune HLH	autoimmune HLH	1	0	22362	12247	22362	
28991	gold standard of viral detection	gold standard of viral detection	1	0	28993	2054	17	
393	wide-scale implementation of telehealth	wide-scale implementation of telehealth	1	0	395	394	396	
26360	mindfulness-based intervention	INFunknownSUP intervention	1	0	5608	1039	5608	
25850	cytotoxicity of HCQ	cytotoxicity of HCQ	1	0	25851	7775	25851	
38077	sewage data	sewage datum	1	0	22	6963	22	
32838	impact of asynchronous online anatomy teaching	impact of asynchronous online anatomy teaching	1	0	110	32840	110	
4389	philosopher Albert Camus	philosopher Albert Camus	1	0	4391	4390	4393	
10505	summary of the key elements of the full protocol	summary of the key element of the full protocol	1	0	10506	10507	10506	
28648	student loans	student loan	1	0	28650	23848	28650	
35767	additional obstacles	additional obstacle	1	0	35769	7175	35769	
10169	third trimester	third trimester	1	0	10171	7099	10171	
34275	low HCQ serum concentration	low HCQ serum concentration	1	0	34277	457	11518	
37960	ventilator settings	ventilator setting	1	0	2729	27361	2729	
32919	long-term consequences of the COVID-19 pandemic	long-term consequence of the INFunknownSUP pandemic	1	0	32921	4288	4289	
11680	severity involvement index	severity involvement index	1	0	11682	5116	4017	
31543	performance of insurance companies	performance of insurance company	1	0	598	2404	598	
35695	PISQ-IR score	INFunknownSUP score	1	0	1843	35696	1843	
18125	rapid response mechanism	rapid response mechanism	1	0	10036	4338	10036	
24960	language therapy	language therapy	1	0	2273	10391	2273	
36514	car industry	car industry	1	0	2109	36515	2109	
3303	perspectives of the health system	perspective of the health system	1	0	3304	3305	3304	
2040	primer ano de pandemia	primer Ano de INFunknownSUP	1	0	2042	2041	2046	
37109	impact of the mix of private-public financing	impact of the mix of private-public financing	1	0	110	37111	110	
2044	de pandemia	de INFunknownSUP	1	0	2046	1421	2046	
10493	government offices	government office	1	0	10495	99	10495	
21375	trivial lesions	trivial lesion	1	0	162	18151	162	
33965	Long-Term Care Program	Long-Term Care Program	1	0	33967	33966	25193	
27478	thorough understanding of the dynamics of COVID-19 transmission	thorough understanding of the dynamics of INFunknownSUP transmission	1	0	27480	27479	2715	
1317	major public health scourge	major public health scourge	1	0	1319	1318	1323	
29350	secondary metabolites etc.	secondary metabolite etc.	1	0	29352	712	29354	
34827	care targets	care target	1	0	4044	9	4044	
12723	speed of disease diagnosis	speed of disease diagnosis	1	0	4300	12725	4300	
11294	partial lockdown of areas	partial INFunknownSUP of area	1	0	11296	961	1676	
31324	PET abnormalities	pet abnormality	1	0	22738	26077	22738	
37662	intervention Viral infections	intervention viral infection	1	0	37664	5608	779	
21004	National Institute of Allergy	National Institute of allergy	1	0	21006	46	20525	
36214	blood cells	blood cell	1	0	133	3129	133	
35661	Tract Infections	tract infection	1	0	13088	35662	13088	
2180	exploratory factor analysis	exploratory factor analysis	1	0	2182	2181	486	
735	CME credit redemption process	CME credit redemption process	1	0	737	736	180	
18577	bacterial species	bacterial specie	1	0	3957	2517	3957	
38380	Health Economics	Health Economics	1	0	38382	279	38382	
363	% CIs	% CI	1	0	365	364	365	
16983	stay-at-home order	stay-at-home order	1	0	9494	1759	9494	
37835	Vaccine Alliance	vaccine Alliance	1	0	37837	685	37837	
34086	Sexual Health	sexual health	1	0	5250	34087	5250	
36059	public healthcare	public INFunknownSUP	1	0	494	1321	494	
37279	feature importance	feature importance	1	0	2765	29494	2765	
6028	second line test	second line test	1	0	6030	1279	754	
29554	physical activity venues	physical activity venue	1	0	29558	25762	29558	
27482	dynamics of COVID-19 transmission	dynamics of INFunknownSUP transmission	1	0	3694	24109	3694	
34509	real time	real time	1	0	179	17940	179	
4615	IgG subclasses	IgG subclass	1	0	4617	928	4617	
7785	exposure reduction	exposure reduction	1	0	490	1054	490	
10727	degrees of efficacy	degree of efficacy	1	0	10728	6704	10728	
1258	clusters of hypometabolism	cluster of hypometabolism	1	0	860	1260	860	
26261	frequency of proteinuria	frequency of proteinuria	1	0	19362	7378	19362	
15334	detrimental consequences	detrimental consequence	1	0	4289	15335	4289	
7359	literature search of PubMed	literature search of INFunknownSUP	1	0	7360	7363	344	
35445	AKI severity	Aki severity	1	0	5116	13007	5116	
831	available educational resources	available educational resource	1	0	833	832	835	
35525	negative impacts of COVID-19	negative impact of INFunknownSUP	1	0	2972	40	1385	
27054	esophageal high-resolution manometry	esophageal high-resolution manometry	1	0	27056	27055	12287	
33110	Enterobacter complex	INFunknownSUP complex	1	0	10445	33111	10445	
32360	practical measures	practical measure	1	0	317	6164	317	
31285	understanding of the impact of the COVID-19 pandemic	understanding of the impact of the INFunknownSUP pandemic	1	0	2715	109	2715	
36683	individuals of general population	individual of general population	1	0	1113	1836	1113	
27464	Surgery Practice	surgery practice	1	0	17535	2338	17535	
19721	SARS-CoV-2 structural proteins	INFunknownSUP structural protein	1	0	10375	28	1126	
37830	attitudes of dental students	attitude of dental student	1	0	30964	6860	30964	
28088	monthly average	monthly average	1	0	12012	18770	12012	
6198	lightweight network	lightweight network	1	0	719	6199	719	
14071	phase of virus infection	phase of virus infection	1	0	1352	14073	1352	
35792	renal injury	renal injury	1	0	713	130	713	
10109	higher hs-TnI concentrations	high INFunknownSUP concentration	1	0	1959	10110	1959	
20617	Adult patients	adult patient	1	0	60	20618	60	
37576	domain-adaptive CAD framework	domain-adaptive cad framework	1	0	37578	37577	4860	
23014	secondary attack rate	secondary attack rate	1	0	23016	712	1034	
37161	health-care settings	health-care setting	1	0	2729	16517	2729	
27926	less systemic reactions	less systemic reaction	1	0	27928	5525	19148	
10827	eligible candidates	eligible candidate	1	0	4790	5236	4790	
8973	economic appraisal	economic appraisal	1	0	8975	108	8975	
38986	later time	late time	1	0	179	30881	179	
36919	relevant predictors	relevant predictor	1	0	414	346	414	
13233	work schedules	work schedule	1	0	13235	2162	13235	
12046	Maximum PXS scores	maximum PXS score	1	0	4888	12047	3726	
25735	protective eyewear	protective eyewear	1	0	25737	1455	25737	
4162	presentation of pericarditis	presentation of pericarditis	1	0	4163	1596	4163	
6215	physical therapy services	physical therapy service	1	0	6217	1242	5980	
4803	psychiatric vulnerability	psychiatric vulnerability	1	0	4805	4594	4805	
930	support vector machine	support vector machine	1	0	932	260	934	
5436	management plans	management plan	1	0	5320	743	5320	
25280	general population comparators	general population comparator	1	0	25284	1836	25284	
29741	Intestinal Ischemic Manifestations of COVID-19	intestinal ischemic manifestation of INFunknownSUP	1	0	29743	20574	1693	
30480	Civil war	civil war	1	0	10783	30481	10783	
27312	caesarean section delivery	Caesarean section delivery	1	0	22058	27313	2840	
5306	tertiary referral university hospital	tertiary referral university hospital	1	0	5308	182	185	
21685	Quebec prioritized in-person	Quebec INFunknownSUP in-person	1	0	21687	21686	9275	
19361	frequency of clozapine monitoring	frequency of clozapine monitoring	1	0	19362	19363	19362	
16171	new parameter	new parameter	1	0	16173	69	16173	
17826	combination of public cloud	combination of public cloud	1	0	367	17828	367	
25871	B cell development processes	B cell development process	1	0	25875	6431	3381	
23772	Outcomes Research Institute	outcome Research Institute	1	0	23774	9631	20525	
7908	institutional practices	institutional practice	1	0	5378	7909	5378	
6230	Bivariate analysis	INFunknownSUP analysis	1	0	486	6231	486	
8675	Digital habits of pulmonary rehabilitation service-users	Digital habit of pulmonary rehabilitation service-user	1	0	8677	8676	8678	
37092	social mentality	social mentality	1	0	37094	383	37094	
18221	percentage of people	percentage of people	1	0	3789	694	3789	
7569	affects employees	affect employee	1	0	7097	7570	7097	
33085	immune regulation	immune regulation	1	0	9043	970	9043	
3178	N1 set	INFunknownSUP set	1	0	651	3179	651	
6721	peer discussion	peer discussion	1	0	3060	6722	3060	
30310	year of research	year of research	1	0	3822	36	3822	
14809	surgical site	surgical site	1	0	11198	663	11198	
8394	disposable mask	disposable mask	1	0	290	2996	290	
1423	Semi quantitative real-time RT-PCR results	semi quantitative real-time INFunknownSUP result	1	0	1425	1424	325	
17436	total immunoglobulins	total immunoglobulin	1	0	17438	1485	17438	
15545	consequences of COVID-19	consequence of INFunknownSUP	1	0	4289	40	4289	
10386	4-person room	INFunknownSUP room	1	0	5742	10387	5742	
11393	Education Learning Environment Scale	Education Learning Environment Scale	1	0	11395	3731	1203	
28686	viral spill-over	viral INFunknownSUP	1	0	28688	1741	28688	
4157	sources of information	source of information	1	0	4158	2591	4158	
22120	tropical infectious diseases	tropical infectious disease	1	0	313	22121	315	
11632	UK adults	UK adult	1	0	515	5052	515	
23470	indicators of the critical outcome	indicator of the critical outcome	1	0	23471	608	23471	
8520	direct observations	direct observation	1	0	8522	2012	8522	
11377	baseline characteristics	baseline characteristic	1	0	1496	5344	1496	
12599	Ramaswamy H. Sarma	Ramaswamy H. Sarma	1	0	12601	12600	12603	
21828	case series of SARS-CoV-2 rT-PCR testing	case series of INFunknownSUP INFunknownSUP testing	1	0	20220	21832	8050	
35564	dental care	dental care	1	0	9	5656	9	
24466	repeated offers	repeated offer	1	0	24468	22618	24468	
4209	modified oral diets	modified oral diet	1	0	4211	4210	4213	
37450	SARS-CoV-2 lineage 20a strain	INFunknownSUP lineage INFunknownSUP strain	1	0	37452	226	1107	
31055	neurologic manifestations	neurologic manifestation	1	0	885	31056	885	
36552	seroprevalence status	seroprevalence status	1	0	2720	4090	2720	
6884	next steps	next step	1	0	2077	2624	2077	
20833	CT scan results	CT scan result	1	0	325	7508	325	
28782	mentor training	mentor training	1	0	235	28783	235	
31105	furin protease utilization	INFunknownSUP protease utilization	1	0	31107	31106	4011	
34469	antigen-based tests	INFunknownSUP test	1	0	1365	12859	1365	
20422	Narrative Review Background Coronavirus	narrative Review background INFunknownSUP	1	0	3206	20423	3206	
24500	establishment of the diagnosis	establishment of the diagnosis	1	0	24501	2168	24501	
3844	neuropathological features	neuropathological feature	1	0	1469	3251	1469	
17066	characteristic of the family	characteristic of the family	1	0	17067	5380	17067	
5295	spread of the new coronavirus	spread of the new coronavirus	1	0	570	5297	570	
15455	nonpolar interactions	nonpolar interaction	1	0	13158	15456	13158	
13654	dreadful pandemic of coronavirus disease	dreadful pandemic of coronavirus disease	1	0	13655	338	113	
5612	average length of ICU stay	average length of ICU stay	1	0	5614	178	1347	
24221	% response rate	% response rate	1	0	24223	364	1034	
37949	Global Access Facility	Global Access Facility	1	0	37951	14037	37953	
23292	Hierarchical Condition Categories	hierarchical condition category	1	0	23294	23293	23296	
10248	general management	general management	1	0	743	1080	743	
23433	natural infection	natural infection	1	0	41	3229	41	
30844	R01 GM124280	R01 GM124280	1	0	30846	23889	30846	
34592	rhesus macaques Effective SARS-CoV-2 vaccines	rhesus macaque effective INFunknownSUP vaccine	1	0	34596	25364	681	
37104	main risk factors	main risk factor	1	0	3561	4679	583	
10085	psychosocial support	psychosocial support	1	0	260	9177	260	
34634	alpha1 domain	INFunknownSUP domain	1	0	697	34635	697	
27974	vertical transmission of COVID-19	vertical transmission of INFunknownSUP	1	0	874	40	876	
39061	successful COVID-19 vaccine	successful INFunknownSUP vaccine	1	0	3688	9403	577	
16127	Multiorgan Failure	Multiorgan failure	1	0	11178	16128	11178	
3773	Fatal COVID-19 infections	fatal INFunknownSUP infection	1	0	3775	3774	779	
28729	Louis-Bar syndrome	INFunknownSUP syndrome	1	0	1936	28730	1936	
20119	cross-sectional design	cross-sectional design	1	0	4183	2493	4183	
22517	needs of care	need of care	1	0	3189	9	3189	
16241	efficiency of this vaccine	efficiency of this vaccine	1	0	14461	577	14461	
36950	Abdulaziz University	Abdulaziz University	1	0	50	36951	50	
9121	San Diego	San Diego	1	0	9123	9122	9123	
7970	days post-inoculation of Vero E6 cells	day post-inoculation of Vero INFunknownSUP cell	1	0	7972	1645	7973	
5603	anxiety symptomology	anxiety symptomology	1	0	5605	2772	5605	
36189	RT-PCR testing	INFunknownSUP testing	1	0	1885	7046	1885	
31201	Zusammenfassend beeinflusst	INFunknownSUP INFunknownSUP	1	0	31203	31202	31203	
29218	levels of positive-end expiratory pressure	level of INFunknownSUP expiratory pressure	1	0	29222	29219	1027	
80	Prevalence rates of PTSD symptoms	prevalence rate of INFunknownSUP symptom	1	0	82	81	83	
9659	detectable anti-SARS-CoV-2	detectable INFunknownSUP	1	0	9661	9660	9661	
16372	prothrombin time	prothrombin time	1	0	179	16373	179	
15362	function of medical staff	function of medical staff	1	0	9243	15364	9243	
22301	status of ANS	status of Ans	1	0	2720	22303	2720	
2266	result to the entire country	result to the entire country	1	0	2267	2268	2267	
28808	outcome prediction	outcome prediction	1	0	3336	295	3336	
11648	% acute	% acute	1	0	11650	364	11650	
25443	evidence of germinal centre mutation	evidence of germinal centre mutation	1	0	585	25445	585	
37915	concordance index	concordance index	1	0	4017	37916	4017	
16907	lung tumors	lung tumor	1	0	16909	772	16909	
33137	multiple sources	multiple source	1	0	4158	1776	4158	
28175	human papillomavirus	human papillomavirus	1	0	28177	2214	28177	
3797	Low-resource countries	Low-resource country	1	0	1599	3798	1599	
2555	high global human mobility	high global human mobility	1	0	2557	13	2102	
1284	integrative uncertainty tolerance model	integrative uncertainty tolerance model	1	0	1286	1285	1078	
24938	practical guidance	practical guidance	1	0	18482	6164	18482	
25787	satisfactory manner	satisfactory manner	1	0	10535	17494	10535	
38591	COVID-19 policy	INFunknownSUP policy	1	0	293	40	293	
8946	observational cross-sectional study	observational cross-sectional study	1	0	2492	3552	2087	
21394	knee arthroplasty volume	knee INFunknownSUP volume	1	0	21396	4241	3445	
6004	diligent adherence to national guidelines	diligent adherence to national guideline	1	0	6006	6005	3636	
9683	rigorous follow-up of the evolution of the number of infections	rigorous follow-up of the evolution of the number of infection	1	0	9685	9684	175	
39022	adult family members	adult family member	1	0	29329	32611	16766	
37167	pharmaceutical industry	pharmaceutical industry	1	0	2109	16420	2109	
35027	patients Clostridioides	patient INFunknownSUP	1	0	497	60	497	
4680	transmission pattern	transmission pattern	1	0	4682	876	4682	
7566	unprecedented circumstances	unprecedented circumstance	1	0	7568	5915	7568	
7671	data-augmentation models	data-augmentation model	1	0	3975	7672	3975	
14725	extraction tool	extraction tool	1	0	5487	14726	5487	
3004	component of the recovery plan	component of the recovery plan	1	0	529	3006	529	
32128	Epidemiological data	epidemiological datum	1	0	22	30431	22	
13208	interstitial lung disease	interstitial lung disease	1	0	13210	13209	209	
27070	outcomes of coronavirus disease	outcome of coronavirus disease	1	0	263	338	263	
28742	coordinates of the ground plane	coordinate of the ground plane	1	0	11389	28744	11389	
28805	month post-infection	month post-infection	1	0	25675	2167	25675	
22352	NO2 column densities	INFunknownSUP column density	1	0	22354	164	22356	
30522	somatic hypermutations	somatic hypermutation	1	0	30524	23926	30524	
34579	mortality rates of COVID-19	mortality rate of INFunknownSUP	1	0	4976	40	83	
23794	cross sectional study	cross sectional study	1	0	10496	23795	2087	
5349	effect of the COVID-19 outbreak	effect of the INFunknownSUP outbreak	1	0	1809	308	1809	
15325	mild disease	mild disease	1	0	209	10809	209	
18683	New results	new result	1	0	325	15446	325	
14720	xsGastrointestinal symptoms	xsGastrointestinal symptom	1	0	86	14721	86	
38940	early infections	early infection	1	0	779	55	779	
3675	medical fraternity	medical fraternity	1	0	3677	947	3677	
3106	I2=28 %	INFunknownSUP %	1	0	364	3107	364	
28530	teaching activities	teaching activity	1	0	192	2074	192	
17810	examination score	examination score	1	0	1843	1800	1843	
13255	tasas de incidencia	INFunknownSUP de INFunknownSUP	1	0	13257	13256	13259	
31334	thrombophilia markers	INFunknownSUP marker	1	0	5129	31335	5129	
18320	una lectura	una INFunknownSUP	1	0	18322	15009	18322	
36321	number of students	number of student	1	0	916	1177	916	
4378	acceptable feasibility	acceptable feasibility	1	0	4380	4379	4380	
19312	maelstrom of ethical dilemmas	maelstrom of ethical dilemma	1	0	19313	19314	19313	
19109	adjuvanted subunit vaccines	INFunknownSUP subunit vaccine	1	0	19111	19110	681	
22580	actual protein validation	actual protein validation	1	0	22582	22581	6319	
9903	Incidence Rate Ratio	incidence rate ratio	1	0	9907	9904	9907	
31957	transmembrane protease	transmembrane protease	1	0	2918	31958	2918	
39168	regulator of metaflammation	regulator of INFunknownSUP	1	0	39169	39170	39169	
6284	lateral positioning alternate	lateral positioning alternate	1	0	6286	6285	6288	
6970	history of COVID-19	history of INFunknownSUP	1	0	5381	40	5381	
35115	anti-SARS-CoV-2 prophylaxis	INFunknownSUP prophylaxis	1	0	4121	4554	4121	
11825	hospitalization time period	hospitalization time period	1	0	11827	11637	5677	
14236	meaningfulness dimension	meaningfulness dimension	1	0	10927	14237	10927	
15497	tube placement	tube placement	1	0	15499	15498	15499	
22439	natural content	natural content	1	0	6700	3229	6700	
14112	urgent conditions	urgent condition	1	0	2910	8129	2910	
6597	Dermatologic treatments	INFunknownSUP treatment	1	0	1295	6598	1295	
26538	multivariate logistic regression	multivariate logistic regression	1	0	5132	2408	5036	
18623	Seasonal Influenza	seasonal influenza	1	0	18625	18624	18625	
7629	biological parameters	biological parameter	1	0	6460	855	6460	
9501	greater positive health outcomes	great positive health outcome	1	0	9503	302	263	
35729	specific context of home confinement	specific context of home confinement	1	0	35731	2515	1567	
36212	red blood cells	red blood cell	1	0	36214	36213	133	
16898	engineered synthetic phages	engineered synthetic phage	1	0	16900	16899	16902	
18441	vedolizumab to placebo	INFunknownSUP to placebo	1	0	18442	18443	18442	
35731	context of home confinement	context of home confinement	1	0	1567	12580	1567	
27419	National Centre	National Centre	1	0	27421	46	27421	
34474	measures":the external technique of traditional Chinese medicine	INFunknownSUP external technique of traditional Chinese medicine	1	0	34476	34475	562	
22555	current findings	current finding	1	0	3390	443	3390	
2365	SARS-CoV-2 infected pneumonia	INFunknownSUP infected pneumonia	1	0	2367	28	2369	
9404	remdesivir treatment	INFunknownSUP treatment	1	0	97	9405	97	
34946	Descriptive statistics	descriptive statistic	1	0	34948	13705	34948	
20296	divergent seasonal coronaviruses	divergent seasonal coronavirus	1	0	9478	20297	8796	
25682	generations of coronavirus	generation of coronavirus	1	0	25683	339	25683	
3147	virtual application process	virtual application process	1	0	3149	3148	180	
22830	Nephrology Training Curriculum	INFunknownSUP Training curriculum	1	0	22832	22831	22834	
18776	especial attention	especial attention	1	0	4885	18777	4885	
19354	Novel Coronavirus Disease Rapid	Novel INFunknownSUP Disease Rapid	1	0	19356	19355	9843	
37819	skin conditions	skin condition	1	0	2910	161	2910	
17007	cost saving of $1.90	cost saving of INFunknownSUP	1	0	17009	10966	17010	
4100	mental illness	mental illness	1	0	1069	119	1069	
6764	emotional problems	emotional problem	1	0	6766	6765	6766	
31351	confidence-concern ratio	confidence-concern ratio	1	0	2635	31352	2635	
10137	various reasons	various reason	1	0	10139	1099	10139	
4219	accurate height values	accurate height value	1	0	4221	324	825	
10178	Australian context	Australian context	1	0	1567	2506	1567	
11494	widely-used additives	INFunknownSUP additive	1	0	8863	11495	8863	
24797	likelihood of a vertical transmission of COVID-19 infection	likelihood of a vertical transmission of INFunknownSUP infection	1	0	2204	24799	2204	
18464	cytokine production	INFunknownSUP production	1	0	654	3718	654	
3208	prioritization level	prioritization level	1	0	362	3209	362	
4296	fast execution speed	fast execution speed	1	0	4298	4297	4300	
12155	Stem/Stromal Cells	INFunknownSUP cell	1	0	12157	12156	12157	
27326	golden year of Otolaryngology research	golden year of otolaryngology research	1	0	27327	27330	3822	
17734	severity of shortness of breath	severity of shortness of breath	1	0	5116	6272	5116	
17140	lower odds of hospitalization	low odd of hospitalization	1	0	15296	594	5255	
527	critical component	critical component	1	0	529	223	529	
38908	acute papillary necrosis	acute papillary necrosis	1	0	21868	1461	5738	
7236	Tissue Inhibitor of MetalloProteinase	tissue inhibitor of INFunknownSUP	1	0	7238	7237	7239	
17304	Various subthemes	various subtheme	1	0	17306	7431	17306	
11058	non-hospitalized Covid-19	INFunknownSUP INFunknownSUP	1	0	1884	11059	1884	
14814	laboratory markers concentrations	laboratory marker concentration	1	0	14816	1392	1959	
34411	patient-month records	patient-month record	1	0	10747	34412	10747	
13887	abnormal electrocardiograph	abnormal electrocardiograph	1	0	13889	13888	13889	
8989	high viral diversity	high viral diversity	1	0	8991	13	8993	
250	centrifugal melt spinning	centrifugal melt spinning	1	0	252	251	254	
10819	therapeutic efficacy	therapeutic efficacy	1	0	6704	3349	6704	
33286	binding of the SARS-CoV-2 receptor	binding of the INFunknownSUP receptor	1	0	986	33288	986	
37824	binding inhibitors	binding inhibitor	1	0	8870	2921	8870	
22156	response funds	response fund	1	0	22158	409	22158	
21720	game theory perspective	game theory perspective	1	0	21722	21721	21724	
9085	care provider	care provider	1	0	9087	9	9087	
11110	healthy individuals	healthy individual	1	0	1113	1021	1113	
20803	one-time entry	one-time entry	1	0	5629	20804	5629	
33910	APOBEC-like RNA	INFunknownSUP RNA	1	0	1151	33911	1151	
19363	clozapine monitoring	clozapine monitoring	1	0	3271	10156	3271	
22832	Training Curriculum	Training curriculum	1	0	22834	22833	22834	
31088	cerebral vein thrombosis	cerebral vein thrombosis	1	0	31090	4322	31092	
36066	brain tissue	brain tissue	1	0	4974	10043	4974	
1353	pandemic Healthcare	pandemic Healthcare	1	0	1355	1354	1355	
24039	Formation of the S1-ACE2 complex	formation of the INFunknownSUP complex	1	0	24040	24041	24040	
752	individual test	individual test	1	0	754	753	754	
4045	renal proximal tubules	renal proximal tubule	1	0	4047	130	4049	
16464	successful partnerships	successful partnership	1	0	16466	9403	16466	
7931	resource management time	resource management time	1	0	7933	2703	179	
31550	American Medical Association	American Medical Association	1	0	31552	17605	1952	
8822	rural Medicare beneficiaries	rural Medicare beneficiary	1	0	8824	8823	8826	
28018	type of orientation	type of orientation	1	0	775	28020	775	
10654	main entry pathway of severe acute respiratory syndrome coronavirus	main entry pathway of severe acute respiratory syndrome coronavirus	1	0	10656	4679	5003	
30430	Epidemiological links	epidemiological link	1	0	30432	30431	30432	
2188	cases of myocarditis	case of myocarditis	1	0	229	2190	229	
22791	indicator of health care service use	indicator of health care service use	1	0	20310	22793	20310	
23928	recall period	recall period	1	0	5677	2319	5677	
19763	analysis of neurosurgery match data	analysis of neurosurgery match datum	1	0	486	19765	486	
12895	SARS-CoV-2 antibody	INFunknownSUP antibody	1	0	5924	226	5924	
18782	facets of the program	facet of the program	1	0	18783	1790	18783	
29121	level of seasonal influenza	level of seasonal influenza	1	0	362	2377	362	
34331	economic development	economic development	1	0	73	108	73	
21163	Medical Emergency System	Medical Emergency System	1	0	21165	2779	19651	
31248	2D image points	INFunknownSUP image point	1	0	31250	31249	23	
39124	diferencias sugieren	INFunknownSUP INFunknownSUP	1	0	39126	39125	39126	
360	education level	education level	1	0	362	361	362	
26192	telephonic unstructured individual interviews	telephonic unstructured individual interview	1	0	26194	26193	10034	
560	MARCOS technique	Marcos technique	1	0	562	561	562	
20537	narrative information	narrative information	1	0	2591	17749	2591	
27320	epidemiology character	epidemiology character	1	0	27322	16585	27322	
10648	treatment algorithms	treatment algorithm	1	0	10650	97	10650	
15189	interface of an ECG machine	interface of an ECG machine	1	0	10162	15191	10162	
264	Abbott Architect i2000SR	Abbott architect INFunknownSUP	1	0	266	265	268	
10117	respondents report barriers	respondent report barrier	1	0	10119	861	10121	
32746	empirical results	empirical result	1	0	325	4924	325	
5893	Rennes University Hospital	Rennes University Hospital	1	0	1877	5894	1879	
18093	referral hospital	referral hospital	1	0	185	2964	185	
2042	ano de pandemia	Ano de INFunknownSUP	1	0	2044	2043	2046	
7681	total DALYs	total INFunknownSUP	1	0	7683	1485	7683	
3048	care of COVID-19 patients	care of INFunknownSUP patient	1	0	9	911	9	
8099	Higher rates	high rate	1	0	83	4887	83	
2821	combination supine position	combination supine position	1	0	2823	367	2825	
11459	Jordan Objective	Jordan objective	1	0	11461	11460	11461	
28008	powerful means	powerful mean	1	0	28010	28009	28010	
4497	cognitive problem	cognitive problem	1	0	4499	4498	4499	
31224	reimagining of healthcare	INFunknownSUP of INFunknownSUP	1	0	31225	494	31225	
13611	Non-pharmaceutical interventions	non-pharmaceutical intervention	1	0	757	12707	757	
841	Health England	Health England	1	0	843	279	843	
4152	rapid wide application	rapid wide application	1	0	4154	795	125	
18307	downward trend	downward trend	1	0	6677	18308	6677	
24328	selected district hospital	selected district hospital	1	0	24330	1620	185	
21318	temporary prophylaxis	temporary prophylaxis	1	0	4121	21319	4121	
12882	development of novel antiviral therapies	development of novel antiviral therapy	1	0	73	12884	73	
23267	Levels of food insecurity	level of food insecurity	1	0	9819	170	9819	
27859	Emory University	Emory University	1	0	50	27860	50	
32491	m. Clinical follow	INFunknownSUP clinical follow	1	0	32493	32492	32495	
29833	voluntary basis	voluntary basis	1	0	15433	1881	15433	
24781	percentage of Black	percentage of Black	1	0	3789	24783	3789	
8904	living arrangement	living arrangement	1	0	8906	8905	8906	
6792	difficile infection rates	INFunknownSUP infection rate	1	0	6794	6793	83	
957	undocumented infection	undocumented infection	1	0	41	958	41	
19160	Swedish non-hospitalized healthcare	Swedish INFunknownSUP INFunknownSUP	1	0	19162	10622	494	
14264	expression of pro-inflammatory cytokines	expression of pro-inflammatory cytokine	1	0	5729	5732	5729	
34752	quantitative manner	quantitative manner	1	0	10535	1426	10535	
25062	The COVID-19 Global Pandemic	The INFunknownSUP Global pandemic	1	0	25064	2618	6338	
39210	National Health Insurance-contracted hospitals	National Health INFunknownSUP hospital	1	0	39212	46	76	
12967	Architect IgG test	architect IgG test	1	0	12969	267	754	
11538	main characteristics	main characteristic	1	0	1496	4679	1496	
37146	Data-Augmented Detection of COVID-19	INFunknownSUP detection of INFunknownSUP	1	0	37148	37147	10130	
37036	organ dysfunction syndrome	organ dysfunction syndrome	1	0	37038	1778	1936	
27200	mRNA-1273 vaccine	mRNA-1273 vaccine	1	0	577	17791	577	
15818	complex post-COVID future of health care systems	complex INFunknownSUP future of health care system	1	0	15820	13320	15823	
30236	vitro efficacy of hydroxychloroquine	INFunknownSUP efficacy of hydroxychloroquine	1	0	30238	248	6704	
23588	Paroxysmal nocturnal haemoglobinuria	paroxysmal nocturnal haemoglobinuria	1	0	23590	23589	23592	
37379	antibody-enhanced infection	antibody-enhanced infection	1	0	41	93	41	
14728	income of the affected strata	income of the affected stratum	1	0	5356	14730	5356	
16715	Bayesian Computation	INFunknownSUP computation	1	0	16717	3700	16717	
35382	Acute Stress Reaction	acute stress reaction	1	0	35384	14013	17014	
36057	armamentarium of public healthcare	armamentarium of public INFunknownSUP	1	0	36058	36059	36058	
21123	care children	care child	1	0	6153	9	6153	
13731	rebreather mask	rebreather mask	1	0	290	13732	290	
26921	Long Covid	Long INFunknownSUP	1	0	26923	3964	26923	
31766	network pharmacology Coronavirus disease	network pharmacology INFunknownSUP disease	1	0	31768	719	209	
30948	analysis of radiographic images	analysis of radiographic image	1	0	486	30950	486	
18426	fatal cases	fatal case	1	0	229	18427	229	
35869	28-day all-cause mortality	INFunknownSUP INFunknownSUP mortality	1	0	35871	35870	1197	
31340	delayed peak	delayed peak	1	0	5928	4161	5928	
34077	influence well-being	influence well-being	1	0	2245	23634	2245	
32749	cost-saving-$77.36 million)/QALY	cost-saving-$77.36 INFunknownSUP	1	0	32751	32750	32751	
38357	diagnosis of diseases	diagnosis of disease	1	0	2168	315	2168	
21299	uncontrollable situation	uncontrollable situation	1	0	3056	21300	3056	
26363	differential diagnosis of complex cases	differential diagnosis of complex case	1	0	26365	3104	2168	
689	ML techniques	ML technique	1	0	691	690	691	
20134	particular hold great promise	particular hold great promise	1	0	20136	2853	20140	
38233	knowledge acquisition	knowledge acquisition	1	0	3710	213	3710	
7609	vitro study	INFunknownSUP study	1	0	2087	248	2087	
2564	continuous assessment	continuous assessment	1	0	238	2232	238	
31218	diverse age populations	diverse age population	1	0	31220	10278	13188	
36440	Human semen quality	Human semen quality	1	0	24443	36441	3713	
29737	Poor Outcome of Intestinal Ischemic Manifestations of COVID-19	Poor outcome of intestinal ischemic manifestation of INFunknownSUP	1	0	29739	29738	10594	
13641	life events	life event	1	0	1083	1434	1083	
12788	relationship of satellite-derived atmospheric column NO2 data	relationship of INFunknownSUP atmospheric column INFunknownSUP datum	1	0	2722	12790	2722	
25083	critical assessment of the evidence	critical assessment of the evidence	1	0	25085	223	238	
18785	stress process model	stress process model	1	0	18787	199	1078	
32573	management of the patients	management of the patient	1	0	743	60	743	
7048	ridiculous health claims	ridiculous health claim	1	0	7050	7049	7052	
17760	% male	% male	1	0	17762	364	17762	
6203	drug-binding analysis	drug-binding analysis	1	0	486	6204	486	
39036	Urinary Tract	urinary tract	1	0	35662	2576	35662	
14628	electrospun nanofiber-based	INFunknownSUP INFunknownSUP	1	0	14630	14629	14630	
25272	observational data	observational datum	1	0	22	3552	22	
35194	Therapeutic Goods Administration	therapeutic Goods Administration	1	0	35196	35195	7614	
20215	greater risk of death	great risk of death	1	0	20216	4722	1542	
35802	conservation of personal protective equipment	conservation of personal protective equipment	1	0	10409	4960	10409	
22619	low doses of lipopolysaccharides	low dose of lipopolysaccharide	1	0	22621	457	678	
24577	Clinical HCWs	clinical INFunknownSUP	1	0	24579	1501	24579	
12073	protective factor	protective factor	1	0	2183	1455	2183	
17960	infection precautions	infection precaution	1	0	2126	41	2126	
27825	food processor	food processor	1	0	27827	171	27827	
37081	medical advice	medical advice	1	0	3314	947	3314	
33390	complete recovery	complete recovery	1	0	3007	4186	3007	
9082	health care provider safety	health care provider safety	1	0	6729	9083	6729	
2557	global human mobility	global human mobility	1	0	2559	1954	2102	
14839	journal articles	journal article	1	0	811	14840	811	
7574	duty of patient care	duty of patient care	1	0	7575	4004	7575	
24695	majority of organizers	majority of organizer	1	0	4481	24145	4481	
14516	SRS-22 score	INFunknownSUP score	1	0	1843	14517	1843	
26820	inputs chest X-ray images	input chest X-ray image	1	0	10095	26821	4034	
61	challenge of infectious SARS-CoV-2 Alpha	challenge of infectious INFunknownSUP Alpha	1	0	62	63	62	
13333	version of the Hamilton-Norwood scale	version of the Hamilton-Norwood scale	1	0	4435	13335	4435	
2281	post processing strategies	post processing strategy	1	0	2283	2282	300	
28247	difference-in-difference design	difference-in-difference design	1	0	4183	28248	4183	
30361	Cox proportional hazard regression	Cox proportional hazard regression	1	0	30363	5823	5036	
5235	eligible studies	eligible study	1	0	136	5236	136	
13343	primary endpoints	primary endpoint	1	0	13345	75	13345	
34783	steps method	step method	1	0	6587	2077	6587	
35043	use of steroid	use of steroid	1	0	292	1173	292	
9800	wide range of psychopathological presentations	wide range of psychopathological presentation	1	0	9802	4155	420	
3294	Systemic Inflammatory Predictors of In-Hospital Mortality	systemic inflammatory predictor of in-hospital mortality	1	0	3296	3113	3299	
37208	sustained catch-up program	sustained catch-up program	1	0	37210	21711	1790	
31132	human-wildlife relations	human-wildlife relation	1	0	31134	31133	31134	
4110	Hospital of GMC Anantnag	hospital of GMC INFunknownSUP	1	0	4111	4112	4111	
38629	severe cases of COVID	severe case of INFunknownSUP	1	0	5526	1649	229	
16083	concentrations of the peptide	concentration of the peptide	1	0	1959	7496	1959	
33481	individual bubble members	individual bubble member	1	0	33483	753	16766	
6911	White parents	White parent	1	0	6913	6912	6913	
2127	recent advances	recent advance	1	0	2129	2128	2129	
14342	autopsied COVID-19 patients	INFunknownSUP INFunknownSUP patient	1	0	60	14343	60	
20770	important information	important information	1	0	2591	273	2591	
28917	respiratory support needs	respiratory support need	1	0	3189	258	3189	
38842	COVID-19 incidence	INFunknownSUP incidence	1	0	2940	40	2940	
28451	in-hospital mortality predictive model	in-hospital mortality predictive model	1	0	28455	1869	1078	
21204	COVID-19 outbreak COVID-19	INFunknownSUP outbreak INFunknownSUP	1	0	21206	40	40	
19351	3D Localization	3D localization	1	0	19353	10448	19353	
14980	considerations Obsessive-compulsive disorder	consideration obsessive-compulsive disorder	1	0	14982	14981	7358	
33646	lesser degree	lesser degree	1	0	12635	6648	12635	
32277	respondent ethnicity	respondent ethnicity	1	0	32279	32278	32279	
23421	specific tetramer	specific INFunknownSUP	1	0	23423	2515	23423	
37391	CME activity evaluations	CME activity evaluation	1	0	37393	736	2456	
21560	Spearman Correlation	Spearman correlation	1	0	21562	13756	21562	
30589	genomic studies	INFunknownSUP study	1	0	136	5714	136	
15167	mutation of R403T	mutation of INFunknownSUP	1	0	333	15169	333	
16704	ground-based monitoring	ground-based monitoring	1	0	3271	16705	3271	
30264	hoc analysis of data	hoc analysis of datum	1	0	30266	30265	486	
33243	popularity of virtual horse showing	popularity of virtual horse showing	1	0	17205	33245	17205	
35946	online seminar	online seminar	1	0	12716	541	12716	
27893	HCPs perceptions	INFunknownSUP perception	1	0	2955	283	2955	
8344	future zoonotic diseases	future INFunknownSUP disease	1	0	4604	1367	315	
35192	Australian Therapeutic Goods Administration	Australian therapeutic Goods Administration	1	0	35194	2506	7614	
25817	recital of selected ML models	recital of selected ML model	1	0	25818	25819	25818	
31646	aeroben Intensitatsbereich durchgefuhrt werden	INFunknownSUP Intensitatsbereich INFunknownSUP INFunknownSUP	1	0	31648	30816	31652	
17616	telehealth services	telehealth service	1	0	5980	304	5980	
18194	potential etiologies of cerebral microbleeds	potential etiology of cerebral INFunknownSUP	1	0	12386	18198	12388	
16554	anatomical positioning	anatomical positioning	1	0	1560	16555	1560	
13598	English local authorities	English local authority	1	0	13600	13599	9210	
15060	recency of the COVID-19 lockdown	recency of the INFunknownSUP INFunknownSUP	1	0	15061	15062	15061	
4767	SARS virus	INFunknownSUP virus	1	0	778	2224	778	
22296	standardized mean differences	standardized mean difference	1	0	22298	10795	5663	
32420	snake PLA2s	snake INFunknownSUP	1	0	32422	32421	32422	
7957	Employment status	employment status	1	0	2720	7958	2720	
9967	antibody concentrations	antibody concentration	1	0	1959	5924	1959	
30259	prospective monitoring	prospective monitoring	1	0	3271	2084	3271	
33637	world regions	world region	1	0	5240	4336	5240	
37038	dysfunction syndrome	dysfunction syndrome	1	0	1936	3856	1936	
2881	young adults	young adult	1	0	515	2882	515	
32900	delivery of remote care	delivery of remote care	1	0	2840	32902	2840	
29877	public health planners	public health planner	1	0	29881	1320	29881	
17541	groups Patients	group patient	1	0	10959	2486	10959	
8696	sustainable way	sustainable way	1	0	701	8697	701	
37530	Health Professions	Health profession	1	0	37532	279	37532	
1268	controlled trial SARS-CoV-2 infection	controlled trial INFunknownSUP infection	1	0	1272	1269	41	
17225	ethyl sulfate	ethyl sulfate	1	0	17227	17226	17227	
3408	consensus workshops	consensus workshop	1	0	3410	1683	3410	
21601	Twenty-six studies	twenty-six study	1	0	136	21602	136	
24424	face-to-face intervention	face-to-face intervention	1	0	5608	4673	5608	
5108	metal nanoparticles	metal nanoparticle	1	0	5110	5109	5110	
33558	high acceptability	high acceptability	1	0	23407	13	23407	
19586	RT-PCR-positive cases	INFunknownSUP case	1	0	229	19587	229	
5519	selection of moxibustion device	selection of INFunknownSUP device	1	0	5520	5521	5520	
22617	repeated low doses of lipopolysaccharides	repeated low dose of lipopolysaccharide	1	0	22619	22618	678	
35450	conspiracy theory	conspiracy theory	1	0	21053	24763	21053	
32803	influenza virus haemagglutinin	influenza virus haemagglutinin	1	0	32807	20746	32807	
2428	aspects of VIMC	aspect of INFunknownSUP	1	0	2429	2430	2429	
244	macroscopic hematuria	macroscopic hematuria	1	0	246	245	246	
32511	World Health Organizations	World Health Organizations	1	0	32513	5804	32515	
24709	available high-sensitive troponin	available high-sensitive INFunknownSUP	1	0	24711	832	4478	
25680	future generations of coronavirus	future generation of coronavirus	1	0	25682	1367	25683	
5221	pharmacy State	pharmacy state	1	0	5223	5222	5223	
14505	% LatinX	% INFunknownSUP	1	0	14507	364	14507	
16502	management of the COVID-19 outbreak	management of the INFunknownSUP outbreak	1	0	743	308	743	
27212	childhood adverse experiences	childhood adverse experience	1	0	27214	27213	1339	
6209	general access to expert physical therapy services	general access to expert physical therapy service	1	0	6211	1080	224	
28481	Respiratory Distress Syndrome	respiratory distress syndrome	1	0	28483	3287	14017	
14939	SARS-CoV-2 inhibitors	INFunknownSUP inhibitor	1	0	8870	28	8870	
2307	alloreactivity of allogeneic cells	alloreactivity of INFunknownSUP cell	1	0	2308	2309	2308	
13454	natural peptide drugs	natural peptide drug	1	0	13456	3229	4584	
38835	threat to patient care	threat to patient care	1	0	38836	4004	38836	
36102	high prevalence of infection	high prevalence of infection	1	0	30629	13	9272	
16651	regions of mainland China	region of mainland China	1	0	5240	10467	5240	
8329	healthcare delivery	INFunknownSUP delivery	1	0	2840	494	2840	
27131	AAST score	INFunknownSUP score	1	0	1843	27132	1843	
33605	Gel electrophoresis	gel INFunknownSUP	1	0	5163	33606	5163	
36511	Pandemic-Focused Time	INFunknownSUP Time	1	0	35331	36512	35331	
33129	Li et al. used multiple sources	Li et al. used multiple source	1	0	33131	33130	4158	
1175	misconceptions of students	misconception of student	1	0	1176	1177	1176	
23021	aerobic exercise	aerobic exercise	1	0	4799	23022	4799	
27767	Screening of Drug Libraries Severe acute respiratory syndrome coronavirus	screening of Drug library severe acute respiratory syndrome coronavirus	1	0	27768	27769	27768	
21591	Estudio ecologico	INFunknownSUP INFunknownSUP	1	0	21593	21592	21593	
7504	% plan	% plan	1	0	1225	364	1225	
13698	Effect of COVID-19	effect of INFunknownSUP	1	0	6097	40	6097	
26215	Symptoms of vomiting	symptom of vomiting	1	0	14891	26217	14891	
16065	Spine Surgeons	Spine surgeon	1	0	16067	16066	16067	
32283	evidence of immunological imprinting	evidence of immunological imprinting	1	0	585	32285	585	
21551	Health professionals	Health professional	1	0	121	279	121	
2333	teaching materials	teaching material	1	0	2335	2074	2335	
37196	Autoimmune Disease	autoimmune disease	1	0	10958	37197	10958	
34476	external technique of traditional Chinese medicine	external technique of traditional Chinese medicine	1	0	34478	14485	562	
27343	cardiovascular magnetic resonance imaging	cardiovascular magnetic resonance imaging	1	0	27345	13290	3936	
16668	Segmentation of infected region	segmentation of infected region	1	0	16669	16670	16669	
12337	None of the patients	none of the patient	1	0	12338	60	12338	
21790	twelve phthalates	twelve INFunknownSUP	1	0	21792	21791	21792	
30598	Antibiotic Use	antibiotic use	1	0	3481	30599	3481	
144	filtration systems	filtration system	1	0	146	145	146	
35586	cell-killing mechanisms	cell-killing mechanism	1	0	1456	35587	1456	
26327	estudio piloto prospectivo transversal y una guia clinica	INFunknownSUP INFunknownSUP INFunknownSUP transversal y una INFunknownSUP INFunknownSUP	1	0	26333	26328	26341	
9570	US counties	US county	1	0	9572	3316	9572	
30162	academic research	academic research	1	0	36	606	36	
32019	plasma Creatinine increase	plasma creatinine increase	1	0	32021	28077	392	
12839	high risk of viral dissemination	high risk of viral dissemination	1	0	4980	12843	1542	
16316	certain laboratory findings	certain laboratory finding	1	0	15559	8853	3390	
18249	battery drainage	battery drainage	1	0	18251	18250	18251	
25460	Kincaid Grade Level	Kincaid Grade Level	1	0	25462	25461	8466	
38906	severe acute papillary necrosis	severe acute papillary necrosis	1	0	38908	262	5738	
29416	Arabic speakers	Arabic speaker	1	0	29418	2589	29418	
7808	effect of ABO blood groups	effect of ABO blood group	1	0	1809	7810	1809	
4699	arrival of COVID-19 vaccines	arrival of INFunknownSUP vaccine	1	0	4700	1813	4700	
22566	IL-2-producing T cells	IL-2-producing T cell	1	0	788	22567	133	
16391	viral pathogenicity	viral INFunknownSUP	1	0	16393	1741	16393	
26274	injection of P36-5D2	injection of INFunknownSUP	1	0	26275	26276	26275	
36386	dental practice	dental practice	1	0	3285	5656	3285	
32151	30-day mortality rate	30-day mortality rate	1	0	1034	4516	1034	
18065	clinical engagement	clinical engagement	1	0	3684	884	3684	
13303	European Journal of Translational Myology	European journal of translational myology	1	0	13305	1622	13306	
20114	few comorbidities	few comorbidity	1	0	676	6261	676	
23409	Times of Acute Crisis	Times of acute crisis	1	0	23410	23411	23410	
22692	wearable devices	wearable device	1	0	6162	22693	6162	
37881	broad range of viral pathogens	broad range of viral pathogen	1	0	37883	7135	420	
27206	training programs	training program	1	0	2246	235	2246	
3821	year of the COVID-19 pandemic	year of the INFunknownSUP pandemic	1	0	3822	111	3822	
26250	Papers Index	Papers Index	1	0	7907	26251	7907	
23610	new psychiatric presentations	new psychiatric presentation	1	0	23612	69	2848	
17051	Public Space	Public Space	1	0	17053	840	17053	
14146	cohort evaluation of the HoloLens2	cohort evaluation of the INFunknownSUP	1	0	14148	601	2399	
25881	context of coronavirus pandemic	context of coronavirus pandemic	1	0	1567	25883	1567	
11850	IRT findings	IRT finding	1	0	3390	11851	3390	
20007	molecular diversity	molecular diversity	1	0	8993	6935	8993	
35890	cell types	cell type	1	0	1979	197	1979	
5640	significant interruption	significant interruption	1	0	5642	908	5642	
23242	human cell lines	human cell line	1	0	23244	2214	6853	
13407	Observational Studies	observational study	1	0	1533	13408	1533	
35056	Surgery of Trauma	surgery of trauma	1	0	2338	16486	2338	
30172	clinical cases of the new coronavirus disease	clinical case of the new coronavirus disease	1	0	30174	884	229	
1497	survival curves	survival curve	1	0	1499	1498	1499	
28903	incidences of illness	incidence of illness	1	0	28904	1069	28904	
20931	dense connection	dense connection	1	0	8937	6395	8937	
3193	T2DM patients	INFunknownSUP patient	1	0	60	3194	60	
21936	book quizzes	book quiz	1	0	21938	616	21938	
27089	localization error	localization error	1	0	373	16351	373	
19040	2(1 %	INFunknownSUP %	1	0	364	19041	364	
37282	normal TnI	normal Tni	1	0	37284	2708	37284	
5619	long-term post-recovery comparative studies	long-term INFunknownSUP comparative study	1	0	5621	4288	136	
9908	positive coronavirus PCR	positive coronavirus PCR	1	0	9910	228	3981	
21837	Virus-induced cytopathic effects	INFunknownSUP INFunknownSUP effect	1	0	5539	21838	156	
22170	spread of the epidemic	spread of the epidemic	1	0	570	6542	570	
22357	Shortness of Breath	shortness of breath	1	0	22358	22359	22358	
24164	potential diagnostic devices	potential diagnostic device	1	0	24166	1276	6162	
27598	treatment facilities	treatment facility	1	0	2676	97	2676	
36966	sentiment analysis	sentiment analysis	1	0	486	36967	486	
18863	majority of the severe acute respiratory syndrome-coronavirus	majority of the severe acute respiratory syndrome-coronavirus	1	0	4481	18865	4481	
4897	routine paediatric palliative care consultations	routine paediatric palliative care consultation	1	0	972	4898	978	
2975	context of new COVID-19 variants of concern	context of new INFunknownSUP variant of concern	1	0	1567	2977	1567	
17715	multiple introductions of SARS-CoV-2	multiple introduction of INFunknownSUP	1	0	17717	1776	17718	
26684	RNA-positive cases	RNA-positive case	1	0	229	26685	229	
334	initial outbreak of coronavirus disease	initial outbreak of coronavirus disease	1	0	336	335	310	
8603	study cut-off	study cut-off	1	0	5277	2087	5277	
5562	COVID-19 module of the Brazilian National Household Sample Survey	INFunknownSUP module of the Brazilian National household Sample Survey	1	0	5564	40	5565	
15739	MHC I allele	MHC I allele	1	0	15741	15740	15743	
37377	low-level antibody-enhanced infection	low-level antibody-enhanced infection	1	0	37379	37378	41	
10183	III vaccine trials	III vaccine trial	1	0	10185	10184	8639	
907	significant proportion of COVID-19 patients	significant proportion of INFunknownSUP patient	1	0	909	908	910	
35812	number of aerosol particles	number of aerosol particle	1	0	916	28571	916	
29342	SARS- CoV-2	INFunknownSUP INFunknownSUP	1	0	29344	29343	29344	
26402	Mainland China	Mainland China	1	0	4295	26403	4295	
21386	eran revisiones sistematicas	INFunknownSUP INFunknownSUP INFunknownSUP	1	0	21390	21387	21390	
12086	fine-scale changes	fine-scale change	1	0	1336	12087	1336	
1831	emergent appendectomy	emergent appendectomy	1	0	1833	1832	1833	
13964	usability issues	usability issue	1	0	3758	8888	3758	
31931	independent published studies	independent published study	1	0	31933	582	136	
8626	significant amount of time	significant amount of time	1	0	8628	908	8629	
19513	prolonged task times	prolonged task time	1	0	19515	5497	12806	
4364	Drivers of Dental Students	Drivers of dental student	1	0	4365	4366	4365	
24213	assays SARS-CoV-2 outbreak	assay INFunknownSUP outbreak	1	0	24215	2754	310	
18141	degree of financial literacy	degree of financial literacy	1	0	12635	10286	12635	
38552	better performance	good performance	1	0	598	1635	598	
36296	Information Quality Authority	Information Quality Authority	1	0	36298	33142	36300	
20789	Low seropositivity	Low INFunknownSUP	1	0	20791	20790	20791	
35833	new reality	new reality	1	0	35835	69	35835	
27689	novel face masks	novel face mask	1	0	3034	810	3036	
21909	current global SARS-CoV-2 pandemic	current global INFunknownSUP pandemic	1	0	21911	443	113	
14660	Optimal lockdown	optimal INFunknownSUP	1	0	1676	13534	1676	
5488	acyclic graph	acyclic graph	1	0	5490	5489	5490	
24622	World Health Organization Clinical Progression Scale	World Health Organization clinical progression Scale	1	0	24628	12615	1203	
33803	assault of the novel Corona virus	assault of the novel Corona virus	1	0	11449	33805	11449	
4878	con mas de	con ma de	1	0	4880	816	1421	
28294	higher IES-R	high INFunknownSUP	1	0	28296	322	28296	
27513	UK teaching hospital	UK teaching hospital	1	0	16724	5052	185	
35265	primary care consultations	primary care consultation	1	0	978	6472	978	
18787	process model	process model	1	0	1078	180	1078	
25775	snapshot of the workings of symptomatic breast services	snapshot of the working of symptomatic breast service	1	0	12647	25777	12647	
34231	urgent suspected cancer	urgent suspected cancer	1	0	34233	8129	773	
12185	pulmonary involvement	pulmonary involvement	1	0	3599	590	3599	
15646	discussion of the pandemic	discussion of the pandemic	1	0	3060	113	3060	
22863	specific therapy	specific therapy	1	0	2273	2515	2273	
18027	pre-booster titer of anti-S1 antibodies	pre-booster titer of INFunknownSUP antibody	1	0	18029	18028	18030	
37907	Cerebral Artery Infarction	cerebral artery infarction	1	0	37909	37908	37911	
25536	part of the healthcare sector	part of the INFunknownSUP sector	1	0	11631	25537	11631	
27904	health officials	health official	1	0	25622	120	25622	
14864	multidisciplinary management	multidisciplinary management	1	0	743	5219	743	
3786	higher percentage of uninsured people	high percentage of uninsured people	1	0	3787	3790	3789	
27951	COVID-19 pandemic Recent research	INFunknownSUP pandemic Recent research	1	0	26882	111	36	
15095	second semester	second semester	1	0	1310	1279	1310	
19483	significant predictors of lockdown coping	significant predictor of INFunknownSUP coping	1	0	19485	908	414	
1319	public health scourge	public health scourge	1	0	1323	1320	1323	
1275	potential second waves of COVID-19 spread	potential second wave of INFunknownSUP spread	1	0	1277	1276	570	
8257	heavy chain	heavy chain	1	0	2362	8258	2362	
36064	analyses of brain tissue	analysis of brain tissue	1	0	4668	36066	4668	
32457	long-term extension phase 3b ALITHIOS study	long-term extension phase INFunknownSUP INFunknownSUP study	1	0	32459	4288	2087	
34075	experiences influence well-being	experience influence well-being	1	0	34077	1339	2245	
7794	Air of a Clinic	Air of a Clinic	1	0	7795	1195	7795	
11406	Anti-S Abs	INFunknownSUP Abs	1	0	2660	11407	2660	
11918	percentage of these cases	percentage of these case	1	0	3789	229	3789	
33045	discussion of a number of practical implications	discussion of a number of practical implication	1	0	3060	33047	3060	
13064	AIDS Relief	AIDS Relief	1	0	13066	13065	13066	
39163	vaccine injection	vaccine injection	1	0	26275	577	26275	
20609	fifty-one COVID-19 patients	INFunknownSUP INFunknownSUP patient	1	0	60	20610	60	
4752	life-threatening gastrointestinal inflammatory process	life-threatening gastrointestinal inflammatory process	1	0	4754	4753	180	
8377	outbreak of severe acute respiratory syndrome coronavirus	outbreak of severe acute respiratory syndrome coronavirus	1	0	310	4709	310	
28146	hematologic malignancy	hematologic malignancy	1	0	28148	28147	28148	
25812	Work Engagement Scale	Work engagement Scale	1	0	25814	25813	1203	
27655	useful information to the physicians	useful information to the physician	1	0	27657	10503	2591	
4248	large number of COVID-19 patients	large number of INFunknownSUP patient	1	0	4249	911	916	
32627	index patient	index patient	1	0	710	4017	710	
31993	use of non-invasive ventilation	use of non-invasive ventilation	1	0	292	22488	292	
2022	Rate Scale	Rate Scale	1	0	1203	2023	1203	
35352	5-point Likert scale	INFunknownSUP Likert scale	1	0	35354	35353	2422	
23976	bioactive compounds	bioactive compound	1	0	14102	23977	14102	
8020	possible reactivity	possible reactivity	1	0	8022	745	8022	
1191	Community Ambulatory Clinic	Community ambulatory Clinic	1	0	1193	1192	1195	
34389	Clinical Interventional Trials	clinical interventional trial	1	0	34391	1501	544	
2467	refugee women	refugee woman	1	0	920	2468	920	
17601	applications of bacteriophages	application of bacteriophage	1	0	17602	17603	17602	
33847	drivers of COVID-19 vaccine-related attitude	driver of INFunknownSUP vaccine-related attitude	1	0	33848	33849	33848	
19485	predictors of lockdown coping	predictor of INFunknownSUP coping	1	0	414	19487	414	
18844	global development of COVID-19 vaccines	global development of INFunknownSUP vaccine	1	0	18846	1954	73	
23099	fine resolution	fine resolution	1	0	1448	23100	1448	
13726	living arrangements	living arrangement	1	0	13728	8905	13728	
5015	SARS-CoV-2 testing	INFunknownSUP testing	1	0	1885	28	1885	
18922	ECMO-related complications	ECMO-related complication	1	0	705	18923	705	
30387	spike residue	spike residue	1	0	8124	31	8124	
37891	Covid-19-facing status	Covid-19-facing status	1	0	2720	1578	2720	
1028	higher vaccine hesitancy rate	high vaccine hesitancy rate	1	0	1030	322	1034	
30106	appearance of new variants of the virus	appearance of new variant of the virus	1	0	30107	30108	30107	
10142	Outcomes UpToDate	outcome INFunknownSUP	1	0	10144	9631	10144	
35699	confirmed SARS-CoV-2	confirmed INFunknownSUP	1	0	28	4370	28	
33702	Positive Engagement	positive engagement	1	0	25815	6974	25815	
16165	reproductive number	reproductive number	1	0	916	16166	916	
14587	active adaptive immunity:post-vaccination	active adaptive immunity:post-vaccination	1	0	14589	3597	14591	
19812	effective minimization of the spread	effective minimization of the spread	1	0	19814	2051	19815	
9747	drug-ingredient-gene network construction	INFunknownSUP network construction	1	0	9749	9748	9751	
30956	live video	live video	1	0	22756	7346	22756	
21806	La mortalidad	La INFunknownSUP	1	0	11609	21807	11609	
19103	HLA molecules	HLA molecule	1	0	7076	19104	7076	
35405	US cohort	US cohort	1	0	601	3316	601	
31387	satellite-derived surface concentration estimates	INFunknownSUP surface concentration estimate	1	0	5370	31388	5370	
22871	dynamic priority	dynamic priority	1	0	19575	1540	19575	
431	Psychosocial Experiences	psychosocial experience	1	0	433	432	433	
10147	review of children	review of child	1	0	1723	6153	1723	
28302	financial crisis	financial crisis	1	0	408	547	408	
16494	Labordiagnostika AG	Labordiagnostika AG	1	0	16496	16495	16496	
21116	development of effective treatments	development of effective treatment	1	0	73	7298	73	
39326	air exchange	air exchange	1	0	22025	868	22025	
1454	protective mechanisms	protective mechanism	1	0	1456	1455	1456	
34952	brief overview of the history of the concept	brief overview of the history of the concept	1	0	34954	34953	19301	
33235	speckle-tracking echocardiography	speckle-tracking echocardiography	1	0	33237	33236	33237	
17243	dendritic cells	dendritic cell	1	0	133	17244	133	
14305	couple of Chinese tourists	couple of Chinese tourist	1	0	14306	14307	14306	
15748	high resolution mass spectrometry	high resolution mass spectrometry	1	0	15750	13	15754	
36545	difficile toxins A	INFunknownSUP toxin A	1	0	36547	498	3475	
19007	anti-S Abs positive	INFunknownSUP Abs positive	1	0	3365	2658	3365	
2433	academic hospital	academic hospital	1	0	185	606	185	
27136	method of detection of viral diseases	method of detection of viral disease	1	0	6587	27138	6587	
35676	Antigen Testing Method	antigen Testing Method	1	0	35678	13956	35680	
2680	relevant scientific discoveries	relevant scientific discovery	1	0	2682	346	2684	
2304	potential benefits	potential benefit	1	0	2306	1276	2306	
3593	IC50 values	INFunknownSUP value	1	0	825	3594	825	
7306	oral species	oral specie	1	0	3957	427	3957	
35395	Management of COVID-19	management of INFunknownSUP	1	0	2451	40	2451	
8168	introduction to the window of tolerance	introduction to the window of tolerance	1	0	381	8170	381	
23010	wide range of secondary attack rate	wide range of secondary attack rate	1	0	23012	4155	420	
33466	big data	big datum	1	0	29525	9540	29525	
2521	gray matter	gray matter	1	0	2523	2522	2523	
13890	comprehensive nursing care management plan	comprehensive nursing care management plan	1	0	13892	2902	1225	
9757	Individual-level testing	Individual-level testing	1	0	1885	9758	1885	
21899	sequence variability of these RNA viruses	sequence variability of these RNA virus	1	0	21901	5716	6407	
39255	curricular adaptations	curricular adaptation	1	0	32868	18419	32868	
10591	Core Outcome Measures	Core outcome measure	1	0	10593	10592	10595	
36630	pulmonary rehabilitation programme	pulmonary rehabilitation programme	1	0	36632	590	2839	
32076	elective endometriosis surgery	elective endometriosis surgery	1	0	32078	1627	1630	
25886	psychological stress	psychological stress	1	0	199	1380	199	
36196	gardening program	gardening program	1	0	1790	26171	1790	
1004	Kindern die sportlichen Aktivitaten	INFunknownSUP die sportlichen INFunknownSUP	1	0	1006	1005	1010	
13439	Familial cluster	familial cluster	1	0	13441	13440	13441	
23845	university student health care center	university student health care center	1	0	23849	23846	8718	
3980	PCR tests	PCR test	1	0	1365	3981	1365	
19917	air sampling	air sampling	1	0	11863	868	11863	
34618	Pacific Islanders	Pacific islander	1	0	34620	34619	34620	
30550	duelo y la muerte	INFunknownSUP y la INFunknownSUP	1	0	30552	14956	30556	
6488	frequencies of deviations	frequency of deviation	1	0	374	6490	374	
29783	specific online learning behavior promotion	specific online learning behavior promotion	1	0	18567	23830	18567	
33275	chronic health problem	chronic health problem	1	0	23222	8230	4499	
17614	use of telehealth services	use of telehealth service	1	0	292	17616	292	
17383	stabilization assay	stabilization assay	1	0	3119	17384	3119	
22389	Older patients	old patient	1	0	60	22390	60	
4353	prescribed medications	prescribed medication	1	0	4355	4354	4355	
37533	Blood donations	blood donation	1	0	5205	2850	5205	
16068	behavior of people	behavior of people	1	0	16069	694	16069	
5070	number of daily COVID-19 patients	number of daily INFunknownSUP patient	1	0	916	5072	916	
3144	use of factor	use of factor	1	0	292	2183	292	
33764	telehealth visits	telehealth visit	1	0	13123	304	13123	
19	corresponding data points	corresponding datum point	1	0	21	20	23	
12728	symptoms of stress	symptom of stress	1	0	86	199	86	
37293	numbers of non-infected individuals	number of non-infected individual	1	0	12095	37295	12095	
18297	role of NLRP3 inflammasome	role of INFunknownSUP INFunknownSUP	1	0	7288	18299	7288	
4467	293T-ACE2 cells	INFunknownSUP cell	1	0	133	4468	133	
11635	day hospitalization	day hospitalization	1	0	11637	6271	11637	
557	outbreak data	outbreak datum	1	0	22	310	22	
25293	inductive approaches	inductive approach	1	0	8111	25294	8111	
2497	Response Separate Guidelines	Response separate guideline	1	0	2499	2498	2501	
13729	non rebreather mask	non rebreather mask	1	0	13731	3075	290	
7043	standard RT-PCR studies	standard INFunknownSUP study	1	0	7045	2056	136	
35863	final model	final model	1	0	1078	4256	1078	
4055	comparator groups	comparator group	1	0	2486	4056	2486	
5242	Systematic search	systematic search	1	0	344	5243	344	
34200	reproductive numbers	reproductive number	1	0	12095	16166	12095	
19213	vulnerable persons	vulnerable person	1	0	19215	6402	19215	
21313	descriptive statistical tests	descriptive statistical test	1	0	21315	9734	1365	
9543	pandemic of COVID-19	pandemic of INFunknownSUP	1	0	113	40	113	
34990	eye disease	eye disease	1	0	209	4106	209	
22931	benefit-risk of this putative therapeutic product	INFunknownSUP of this putative therapeutic product	1	0	2141	22933	2141	
29935	local inflammation	local inflammation	1	0	3116	3173	3116	
4642	basic reproduction number of 2019-nCoV	basic reproduction number of INFunknownSUP	1	0	4644	4643	916	
21227	COVID-19 illness	INFunknownSUP illness	1	0	1069	40	1069	
3761	observed SARS-CoV-2 infection clinical manifestations	observed INFunknownSUP infection clinical manifestation	1	0	3763	3762	885	
36044	costly external consultancy	costly external consultancy	1	0	36046	36045	36048	
20191	residential workers	residential worker	1	0	1136	9936	1136	
9041	emotion regulation	emotion regulation	1	0	9043	9042	9043	
1074	implementation of RF model	implementation of RF model	1	0	396	1076	396	
15701	mailing list	mailing list	1	0	15703	15702	15703	
11607	mortalidad y letalidad como variables respuesta	INFunknownSUP y letalidad INFunknownSUP variable INFunknownSUP	1	0	11615	11608	11617	
30832	objektiven Leistungsparameter	INFunknownSUP Leistungsparameter	1	0	30834	30833	30834	
620	levels of angiotensin-converting enzyme	level of INFunknownSUP enzyme	1	0	169	622	169	
9099	authorized users	authorized user	1	0	1818	9100	1818	
35713	overflow of admissions	overflow of admission	1	0	35714	3085	35714	
6394	dense genomic surveillance data	dense INFunknownSUP surveillance datum	1	0	6396	6395	22	
3358	acute respiratory failure	acute respiratory failure	1	0	3360	1461	1779	
16823	collection media	collection medium	1	0	661	16824	661	
14911	significant diminution	significant diminution	1	0	14913	908	14913	
3541	Google mobility data	INFunknownSUP mobility datum	1	0	3543	3542	22	
33835	prominent mode of primary care delivery	prominent mode of primary care delivery	1	0	33837	23139	18075	
32632	enzyme-linked immunosorbent assay	enzyme-linked immunosorbent assay	1	0	32634	32633	3119	
17183	economic reserves	economic reserve	1	0	17185	108	17185	
20811	complement inhibition	complement inhibition	1	0	9422	10075	9422	
20093	essential procedures	essential procedure	1	0	4200	4197	4200	
28740	vertical coordinates of the ground plane	vertical coordinate of the ground plane	1	0	28742	875	11389	
3257	outbreak-affected patients	outbreak-affected patient	1	0	60	3258	60	
37553	Ethics approval	Ethics approval	1	0	13952	11029	13952	
7192	dispensings of antibiotics	dispensing of antibiotic	1	0	7193	7194	7193	
38743	recent flu vaccination	recent flu vaccination	1	0	38745	2128	437	
28381	possible role of ACE receptors	possible role of ace receptor	1	0	28382	28385	7288	
35273	Multivariable logistic regression	Multivariable logistic regression	1	0	5132	9562	5036	
33442	Royal Melbourne Hospital	Royal Melbourne Hospital	1	0	33444	33443	1879	
33233	2D speckle-tracking echocardiography	INFunknownSUP speckle-tracking echocardiography	1	0	33235	31249	33237	
34372	sample of non-hospitalized patients	sample of INFunknownSUP patient	1	0	2757	34374	2757	
780	expansion of SARS-CoV-2 reactive CD8 T cells	expansion of INFunknownSUP reactive INFunknownSUP T cell	1	0	781	782	781	
25607	excess lung weight	excess lung weight	1	0	7984	25608	2711	
21626	higher dimeric IgA	high INFunknownSUP IgA	1	0	18813	21627	18813	
14059	average age of patients	average age of patient	1	0	1534	60	906	
38773	booster effects	booster effect	1	0	156	804	156	
30425	Serum IgG levels	Serum IgG level	1	0	23689	3090	169	
31618	pseudotyped viruses	INFunknownSUP virus	1	0	2217	31619	2217	
35347	prevalence of PTSD symptoms	prevalence of INFunknownSUP symptom	1	0	9272	84	9272	
17585	skipped-generation households	skipped-generation household	1	0	4614	17586	4614	
2292	% heart rate maximum	% heart rate maximum	1	0	2294	364	2298	
25832	low academic performance	low academic performance	1	0	25834	457	598	
11304	CD4 cytokine response	INFunknownSUP INFunknownSUP response	1	0	409	11305	409	
6141	important contributor	important contributor	1	0	6143	273	6143	
38599	therapeutic intervention	therapeutic intervention	1	0	5608	3349	5608	
6571	use of hand sanitizers	use of hand INFunknownSUP	1	0	292	6573	292	
34903	paediatric head injuries	paediatric head injury	1	0	34905	974	31866	
25662	Maximal oxygenation	maximal oxygenation	1	0	7365	25663	7365	
34457	level of protection	level of protection	1	0	362	440	362	
3166	whole-brain voxel-based analysis to a local database	whole-brain INFunknownSUP analysis to a local database	1	0	3168	3167	486	
18469	size &gt	size &gt	1	0	2385	6366	2385	
15655	acute stroke patients	acute stroke patient	1	0	60	15656	60	
15387	Measurement of Alternatives	measurement of alternative	1	0	15388	15389	15388	
32343	implementation of epidemiology	implementation of epidemiology	1	0	396	16585	396	
3509	emergent surgical appendectomies	emergent surgical appendectomy	1	0	3511	1832	3513	
3168	voxel-based analysis to a local database	INFunknownSUP analysis to a local database	1	0	3169	3172	486	
26221	higher sample throughput	high sample throughput	1	0	26223	322	26225	
9910	coronavirus PCR	coronavirus PCR	1	0	3981	339	3981	
17678	SPP-inductive events	INFunknownSUP event	1	0	1083	17679	1083	
25597	important determinant of food choices	important determinant of food choice	1	0	25598	25601	25600	
1970	source of heterogeneity	source of heterogeneity	1	0	1971	1972	1971	
23542	Head Injury Discharge	Head Injury discharge	1	0	23544	23543	23546	
12092	low numbers of samples	low number of sample	1	0	12094	457	12095	
30701	nerve fiber	nerve fiber	1	0	26292	30702	26292	
31782	angiotensin II receptor blockers	angiotensin II receptor blocker	1	0	31784	29876	31788	
8062	profile to SARS-CoV-2 infection	profile to INFunknownSUP infection	1	0	3088	1272	3088	
9530	effect of risk framing	effect of risk framing	1	0	1809	9532	1809	
2113	Telehealth Medication Abortions	Telehealth medication abortion	1	0	2115	2114	2117	
25515	viral surfing	viral surfing	1	0	25517	1741	25517	
24522	transmissibility measures	INFunknownSUP measure	1	0	317	3451	317	
10456	likelihood of SARS-CoV-2 susceptibility	likelihood of INFunknownSUP susceptibility	1	0	2204	10458	2204	
7660	mistrust of medical personnel	mistrust of medical personnel	1	0	7555	7662	7555	
14700	economical systems	economical system	1	0	146	14701	146	
8753	anti-spike IgG titers	anti-spike IgG titer	1	0	8755	8754	8757	
20407	negative pressure air flow	negative pressure air flow	1	0	20409	1338	6423	
5752	Breakthrough infection	breakthrough infection	1	0	41	1894	41	
35703	exact mechanism of JAK/STAT inhibition	exact mechanism of INFunknownSUP inhibition	1	0	9422	35704	9422	
35533	microscale non-woven fibers	INFunknownSUP non-woven fiber	1	0	35535	35534	35537	
32112	transfer learning-based multi-class convolutional neural network model	transfer INFunknownSUP INFunknownSUP convolutional neural network model	1	0	32114	10218	1078	
1084	drug procurement	drug procurement	1	0	1086	352	1086	
20496	space infections	space infection	1	0	779	11832	779	
20045	therapeutic effect	therapeutic effect	1	0	1809	3349	1809	
37845	overall clinical course	overall clinical course	1	0	5150	2251	5152	
31423	plaque reduction assay	plaque reduction assay	1	0	31425	31424	3119	
1301	absolute neutrophil count	absolute neutrophil count	1	0	1303	1302	1305	
32445	ambispective study	INFunknownSUP study	1	0	2087	32446	2087	
22812	thickness overall	thickness overall	1	0	22814	22813	22814	
23901	Covid-19 patients Coronavirus	INFunknownSUP patient INFunknownSUP	1	0	23903	1884	3206	
28094	ODI total score	ODI total score	1	0	28096	28095	1843	
24186	clinical end-users	clinical end-user	1	0	24188	884	24188	
13456	peptide drugs	peptide drug	1	0	4584	7496	4584	
19814	minimization of the spread	minimization of the spread	1	0	19815	570	19815	
33610	Vipera nikolskii	INFunknownSUP INFunknownSUP	1	0	33612	33611	33612	
18271	severe albuminuria	severe albuminuria	1	0	18273	262	18273	
2166	month of diagnosis	month of diagnosis	1	0	2167	2168	2167	
31816	Sense of Coherence	sense of coherence	1	0	7550	31818	7550	
36678	days of follow-up of women	day of follow-up of woman	1	0	1645	36680	1645	
21554	consequent extensive fixation	consequent extensive fixation	1	0	21556	21555	21558	
126	laparoscopic surgeons	INFunknownSUP surgeon	1	0	128	127	128	
36204	South African experience	South African experience	1	0	36206	5363	2782	
17645	better results	good result	1	0	325	1635	325	
749	treat policy	treat policy	1	0	293	750	293	
4112	GMC Anantnag	GMC INFunknownSUP	1	0	4114	4113	4114	
946	medical communities	medical community	1	0	948	947	948	
11416	aerosol production	aerosol production	1	0	654	6808	654	
15998	different groups	different group	1	0	2486	688	2486	
28716	aspects of COVID-19 diagnosis	aspect of INFunknownSUP diagnosis	1	0	2429	21536	2429	
37347	African Americans	African Americans	1	0	37349	5365	37349	
34879	face-to-face contact	face-to-face contact	1	0	1888	4673	1888	
8996	NIRS modalities:high-flow nasal oxygen	INFunknownSUP INFunknownSUP nasal oxygen	1	0	9000	8997	3956	
31753	half of participants	half of participant	1	0	6059	4950	6059	
31061	Primary Care Access	primary Care Access	1	0	19648	7917	19648	
36093	Univariate logistic regression analysis	INFunknownSUP logistic regression analysis	1	0	36095	36094	486	
15579	possible ways of treatments	possible way of treatment	1	0	15581	745	15582	
7947	Web Content Accessibility Guidelines	Web content accessibility guideline	1	0	7949	7948	2501	
12776	% sensitivity	% sensitivity	1	0	2904	364	2904	
9276	Development of the Stress	Development of the stress	1	0	9277	9278	9277	
8247	status scores	status score	1	0	3726	2720	3726	
38512	office visit	office visit	1	0	16182	29933	16182	
35093	research team	research team	1	0	7208	36	7208	
13111	collocation method	collocation method	1	0	6587	13112	6587	
426	oral microbiota composition	oral microbiota composition	1	0	428	427	430	
12231	body of Discrete Choice Experiment evidence	body of discrete choice experiment evidence	1	0	2710	12233	2710	
30822	fand sich keine Verminderung der objektiven Leistungsparameter	INFunknownSUP INFunknownSUP INFunknownSUP INFunknownSUP der INFunknownSUP Leistungsparameter	1	0	30830	30823	30834	
35494	function of contact-rate reduction	function of INFunknownSUP reduction	1	0	9243	35496	9243	
4372	2-Dose Vaccination	INFunknownSUP vaccination	1	0	3872	4373	3872	
24809	postoperative period	postoperative period	1	0	5677	8142	5677	
16249	Peggy Notebaert Premier Fellowship	Peggy INFunknownSUP Premier fellowship	1	0	16251	16250	16255	
31164	website design tool	website design tool	1	0	31166	545	5487	
31519	meta-analysis Acute respiratory distress syndrome	meta-analysis acute respiratory distress syndrome	1	0	31521	286	1936	
4072	Effects of Renin-Angiotensin Inhibition	effect of INFunknownSUP inhibition	1	0	4076	4073	4076	
31908	Italian University Hospitals	Italian University hospital	1	0	31910	115	31912	
19339	immune memory	immune memory	1	0	7635	970	7635	
24900	eleven marine fungi compounds	eleven marine fungus compound	1	0	24902	8242	14102	
17359	Specific Concerns Cancer patients	specific concern Cancer patient	1	0	17361	17360	60	
16742	urgent surgery	urgent surgery	1	0	1630	8129	1630	
16912	human antibody	human antibody	1	0	5924	2214	5924	
21428	olfactory gateway	olfactory gateway	1	0	17337	1702	17337	
21291	unstopped surges of COVID-19	unstopped surge of INFunknownSUP	1	0	21293	21292	21294	
9166	less oxygen support	less oxygen support	1	0	8285	5525	260	
2470	impact of FACS	impact of INFunknownSUP	1	0	110	2472	110	
5483	comprehensive decision tool	comprehensive decision tool	1	0	5485	2902	5487	
18053	daily count of COVID-19 deaths	daily count of INFunknownSUP death	1	0	18055	191	1305	
32225	real-world uncertainty	real-world uncertainty	1	0	1287	15289	1287	
14580	socio-communal systems	socio-communal system	1	0	146	14581	146	
1758	stay-at-home policies	stay-at-home policy	1	0	1760	1759	1760	
26981	incident management command structure	incident management command structure	1	0	26983	11330	2427	
32686	investigations of sequence diversity of SARS coronavirus	investigation of sequence diversity of INFunknownSUP coronavirus	1	0	12639	32688	12639	
36657	Facebook advertising	INFunknownSUP advertising	1	0	36659	36658	36659	
24442	semen quality parameters	semen quality parameter	1	0	6460	24443	6460	
26296	primary care patients	primary care patient	1	0	60	6472	60	
26919	experience of Long Covid	experience of Long INFunknownSUP	1	0	2782	26921	2782	
16994	detectable subgenomic RNA	detectable INFunknownSUP RNA	1	0	16996	9660	1151	
10996	vital data transfer	vital datum transfer	1	0	10998	3010	10218	
14494	study cohort	study cohort	1	0	601	2087	601	
10813	marker of severity	marker of severity	1	0	10814	5116	10814	
38479	data enhancement methods	data enhancement method	1	0	38481	14273	205	
22482	American Association	American Association	1	0	1952	17605	1952	
15003	case series report	case series report	1	0	15005	3368	378	
13477	light weight	light weight	1	0	2711	13478	2711	
7936	outbreak of the severe acute respiratory syndrome coronavirus	outbreak of the severe acute respiratory syndrome coronavirus	1	0	310	4709	310	
5172	objektive korperliche Leistungsfahigkeit sowie	INFunknownSUP INFunknownSUP INFunknownSUP INFunknownSUP	1	0	5178	5173	5178	
26339	guia clinica	INFunknownSUP INFunknownSUP	1	0	26341	26340	26341	
12821	philosophical scripture	philosophical scripture	1	0	12823	12822	12823	
27446	coronavirus disease patients	coronavirus disease patient	1	0	60	338	60	
9950	anxiety subscales	anxiety subscale	1	0	9952	2772	9952	
1440	ulcerative colitis	ulcerative colitis	1	0	1442	1441	1442	
8699	treatment-resistant schizophrenia	treatment-resistant schizophrenia	1	0	8701	8700	8701	
17029	Loss of taste	loss of taste	1	0	17030	17031	17030	
31592	dermatological life quality of the health care workers	dermatological life quality of the health care worker	1	0	31594	3447	3713	
11267	consequences of COVID-19 pandemic	consequence of INFunknownSUP pandemic	1	0	4289	111	4289	
11299	full days	full day	1	0	1645	6703	1645	
31432	Student loan	student loan	1	0	31434	31433	31434	
18893	Elevated PCT levels	elevated PCT level	1	0	18895	15360	169	
29013	new disease wave	new disease wave	1	0	29015	69	10210	
13023	Major surgical societies	major surgical society	1	0	13025	13024	350	
29862	hepatic steatosis	hepatic INFunknownSUP	1	0	29864	9015	29864	
13391	postponement of consultations	postponement of consultation	1	0	13392	978	13392	
5241	Systematic search of literature	systematic search of literature	1	0	5242	4698	344	
1383	COVID-19-related impacts	COVID-19-related impact	1	0	1385	1384	1385	
12537	reproduction numbers (R(t))	reproduction number INFunknownSUP	1	0	12541	12538	12541	
4736	immunosuppressive immature neutrophils	immunosuppressive immature neutrophil	1	0	4738	4737	4740	
16891	zero-inflated negative binomial regression	zero-inflated negative binomial regression	1	0	16893	2966	5036	
13467	mean R0 ranges	mean INFunknownSUP range	1	0	13469	194	5086	
5321	limited resources	limited resource	1	0	835	5322	835	
22115	sulfate coated tablet	sulfate coated tablet	1	0	22117	17227	22119	
11470	risk factors of CDI	risk factor of CDI	1	0	3561	72	583	
19111	subunit vaccines	subunit vaccine	1	0	681	8764	681	
826	positive test results	positive test result	1	0	828	228	325	
23489	immunoglobulin M	immunoglobulin M	1	0	23491	23490	23491	
25269	transplant procedures	transplant procedure	1	0	4200	21249	4200	
32230	insufficient data	insufficient datum	1	0	22	3024	22	
37660	therapeutic intervention Viral infections	therapeutic intervention viral infection	1	0	37662	3349	779	
30617	Estimation of the prevalence	estimation of the prevalence	1	0	30618	9272	30618	
3315	US Marine recruit training base	US Marine recruit training base	1	0	3317	3316	3323	
37396	public areas	public area	1	0	1579	1321	1579	
13031	inflammatory mediators	inflammatory mediator	1	0	13033	3817	13033	
22448	Detection Methods of COVID-19	detection method of INFunknownSUP	1	0	22450	10130	6982	
20034	Molecular Networking	molecular networking	1	0	20036	19781	20036	
28027	useful routine blood parameters	useful routine blood parameter	1	0	20715	10503	6460	
16646	private clinics	private clinic	1	0	3424	2401	3424	
5118	severe radiographic lung involvement	severe radiographic lung involvement	1	0	5120	262	3599	
33720	ratings of the body of evidence	rating of the body of evidence	1	0	33489	33722	33489	
24592	treatment perception	treatment perception	1	0	2387	97	2387	
25244	Se han analizado variables demograficas	Se han INFunknownSUP variable INFunknownSUP	1	0	25246	18963	818	
16343	unprecedented way	unprecedented way	1	0	701	5915	701	
39274	house quarantine	house quarantine	1	0	2675	39275	2675	
11789	wider mutational activity	wide mutational activity	1	0	11791	11790	3990	
1484	total lockdowns	total lockdown	1	0	1486	1485	1486	
29	IgM spike	Igm spike	1	0	31	30	31	
3548	structural features	structural feature	1	0	1469	3549	1469	
27913	Efficacy of hydrogel patches	efficacy of INFunknownSUP patch	1	0	2112	27915	2112	
21859	multiple methods	multiple method	1	0	205	1776	205	
3650	dispersal of SARS-CoV-2	dispersal of INFunknownSUP	1	0	3651	28	3651	
13671	routine clinical data	routine clinical datum	1	0	6185	4898	22	
3665	Recent studies	Recent study	1	0	136	2477	136	
33166	environmental temperature	environmental temperature	1	0	195	6806	195	
13282	IgG ELISA kit	IgG Elisa kit	1	0	1219	928	567	
29021	particular power	particular power	1	0	7608	2853	7608	
24076	kinetics of the SARS-CoV-2 spike protein S1	kinetics of the INFunknownSUP spike protein INFunknownSUP	1	0	24077	24078	24077	
35003	Chemical Society	Chemical Society	1	0	17123	35004	17123	
16867	Oxford University Clinical Research Unit	Oxford University clinical Research Unit	1	0	16869	16868	16875	
839	Public Health England	Public Health England	1	0	841	840	843	
13166	outpatient encounters	outpatient encounter	1	0	13168	327	13168	
33047	number of practical implications	number of practical implication	1	0	916	33049	916	
20261	haemovigilance system	haemovigilance system	1	0	1327	20262	1327	
24681	performance evaluation methodology	performance evaluation methodology	1	0	24683	598	11687	
18133	staff members	staff member	1	0	16766	11	16766	
9384	pandemic lockdown	pandemic INFunknownSUP	1	0	1676	1354	1676	
2238	targeted resident financial well-being programs	targeted resident financial well-being program	1	0	2240	2239	2246	
8208	life of residents	life of resident	1	0	1434	232	1434	
24356	camera calibration	camera calibration	1	0	24358	24357	24358	
2923	fourteen studies	fourteen study	1	0	136	2924	136	
18569	prevention strategies	prevention strategy	1	0	300	1294	300	
31773	IL-6 production	INFunknownSUP production	1	0	654	31774	654	
2484	race/ethnic groups	race/ethnic group	1	0	2486	2485	2486	
28983	correlation analyses	correlation analysis	1	0	4668	2889	4668	
22188	point of care	point of care	1	0	10333	9	10333	
34123	physical activity behaviours	physical activity behaviour	1	0	19221	25762	19221	
35448	QAnon conspiracy theory	INFunknownSUP conspiracy theory	1	0	35450	35449	21053	
1858	Conservatoire National des Arts et Metiers	conservatoire National des Arts et INFunknownSUP	1	0	1860	1859	1868	
25504	laboratory equipment	laboratory equipment	1	0	3038	1392	3038	
25029	regulatory data	regulatory datum	1	0	22	5686	22	
2650	maximum impact	maximum impact	1	0	110	2651	110	
3356	COVID-19-associated acute respiratory failure	COVID-19-associated acute respiratory failure	1	0	3358	3357	1779	
13469	R0 ranges	INFunknownSUP range	1	0	5086	5384	5086	
9629	COVID-19 Outcomes	INFunknownSUP outcome	1	0	9631	40	9631	
4625	Abbott SARS-CoV-2 IgG	Abbott INFunknownSUP IgG	1	0	4627	265	928	
35499	emergence of new pandemic threats	emergence of new pandemic threat	1	0	19875	35501	19875	
20274	Eukaryotic Cell-Free Systems	INFunknownSUP INFunknownSUP Systems	1	0	20278	20275	20278	
9247	infection prevention	infection prevention	1	0	1294	41	1294	
655	non-woven polypropylene filtration media	non-woven polypropylene filtration medium	1	0	657	656	661	
4451	Event Scale-Revised	Event INFunknownSUP	1	0	4453	4452	4453	
12988	clinical evidence	clinical evidence	1	0	585	884	585	
21665	filter effect	filter effect	1	0	1809	21666	1809	
12725	disease diagnosis	disease diagnosis	1	0	2168	209	2168	
24673	treatment administration	treatment administration	1	0	631	97	631	
32313	panel of controls	panel of control	1	0	7588	3772	7588	
24776	mutation signature	mutation signature	1	0	19531	333	19531	
4552	anti-SARS-CoV-2 serum antibodies ELISA	INFunknownSUP serum antibody Elisa	1	0	1220	4553	1220	
8550	Effectiveness of BNT162b2	effectiveness of INFunknownSUP	1	0	8551	574	8551	
26938	acute ischemic stroke	acute ischemic stroke	1	0	26940	1461	15219	
23225	top medical schools	top medical school	1	0	23227	78	6421	
14739	SARS-CoV-2 test result	INFunknownSUP test result	1	0	2267	14740	2267	
13253	las tasas de incidencia	la INFunknownSUP de INFunknownSUP	1	0	13255	5770	13259	
28455	predictive model	predictive model	1	0	1078	4314	1078	
26766	Patient demographics	patient demographic	1	0	26768	26767	26768	
12410	SARS-CoV-2 prevalence	INFunknownSUP prevalence	1	0	9272	28	9272	
25860	AutoDock Vina	INFunknownSUP Vina	1	0	4538	25861	4538	
21812	New York University	New York University	1	0	50	4874	50	
39234	functional outcome scores	functional outcome score	1	0	39236	4225	3726	
8654	middle cerebral artery	middle cerebral artery	1	0	8656	8655	8658	
23036	decision-making process	decision-making process	1	0	180	22388	180	
28152	Australian Government	Australian government	1	0	9523	2506	9523	
4814	systolic blood pressure signals	systolic blood pressure signal	1	0	4820	4815	4820	
22923	bundle of PPE-related measures	bundle of PPE-related measure	1	0	22924	22925	22924	
37285	independent review	independent review	1	0	1723	582	1723	
11360	policy advisory systems	policy advisory system	1	0	11362	293	146	
22154	last-minute response funds	last-minute response fund	1	0	22156	22155	22158	
32695	phone survey of female workers	phone survey of female worker	1	0	32697	17944	967	
12444	services delivery	service delivery	1	0	2840	5980	2840	
19270	2-x-2 between-subjects	INFunknownSUP INFunknownSUP	1	0	19272	19271	19272	
27472	manufacturing facilities	manufacturing facility	1	0	2676	718	2676	
15938	BMI &gt	BMI &gt	1	0	2385	15939	2385	
28867	retrospective review of the patients	retrospective review of the patient	1	0	28869	10146	1723	
36237	mortality of COVID-19	mortality of INFunknownSUP	1	0	1197	40	1197	
37967	infection transmissibility of children	infection INFunknownSUP of child	1	0	37969	41	3451	
15589	prevalence of chronic lung sequela of COVID-19	prevalence of chronic lung sequela of INFunknownSUP	1	0	9272	15591	9272	
12858	antigen-based rapid diagnostic testing	INFunknownSUP rapid diagnostic testing	1	0	12860	12859	1885	
6437	laboratory-confirmed SARS-CoV-2 cases	laboratory-confirmed INFunknownSUP case	1	0	229	6438	229	
34730	SARS-CoV-2 antiviral assays	INFunknownSUP antiviral assay	1	0	34732	28	2754	
35209	hospital arrival to brain imaging	hospital arrival to brain imaging	1	0	35211	185	4700	
18563	neuroimaging finding	neuroimaging finding	1	0	18565	18564	18565	
17213	substantial literature	substantial literature	1	0	4698	3239	4698	
9596	cell therapies	cell therapy	1	0	5507	197	5507	
8986	viral culture	viral culture	1	0	8988	1741	8988	
34060	degree of psychological impact	degree of psychological impact	1	0	12635	1379	12635	
23942	S1 Protein	INFunknownSUP protein	1	0	5697	23943	5697	
571	BNT162b2 mRNA COVID-19 vaccine	INFunknownSUP INFunknownSUP INFunknownSUP vaccine	1	0	577	572	577	
2490	school-based cross-sectional study	school-based cross-sectional study	1	0	2492	2491	2087	
5174	objektive korperliche	INFunknownSUP INFunknownSUP	1	0	5176	5175	5176	
12815	particular risk	particular risk	1	0	1542	2853	1542	
37133	Research Council measure	Research Council measure	1	0	37135	3674	2466	
15572	prevalence of PTSD related symptoms	prevalence of INFunknownSUP related symptom	1	0	9272	15574	9272	
30308	golden year of research	golden year of research	1	0	30310	27328	3822	
31761	future viral disasters	future viral disaster	1	0	31763	1367	31765	
13844	Pharmacy Partnership	Pharmacy Partnership	1	0	13846	13845	13846	
19909	effects of trauma	effect of trauma	1	0	156	2783	156	
32358	adaptation of practical measures	adaptation of practical measure	1	0	20290	32360	20290	
35456	place of work	place of work	1	0	27255	2162	27255	
37002	UK Biobank	UK INFunknownSUP	1	0	37004	5052	37004	
19589	interpersonal transmission	interpersonal transmission	1	0	876	19590	876	
13909	International Development	International Development	1	0	9277	13910	9277	
24603	30-day surgical site infection	30-day surgical site infection	1	0	24605	4517	41	
15377	Indicators of Psychological Stress	indicator of psychological stress	1	0	15378	15379	15378	
19558	similar causes	similar cause	1	0	19560	102	19560	
38113	characteristics of COVID-19 cases	characteristic of INFunknownSUP case	1	0	1496	7690	1496	
30620	signs of encephalitis	sign of encephalitis	1	0	3011	18658	3011	
7254	Control of COVID-19 Vaccine Hesitancy	Control of INFunknownSUP vaccine hesitancy	1	0	7255	7256	7255	
13919	hematological system	hematological system	1	0	1327	8601	1327	
7515	Nursing care management	Nursing care management	1	0	7517	7516	743	
10355	camostat mesylate treatment	INFunknownSUP INFunknownSUP treatment	1	0	97	10356	97	
418	inter-quartile range	inter-quartile range	1	0	420	419	420	
13505	sense of agency	sense of agency	1	0	1672	13507	1672	
34168	preventive measure	preventive measure	1	0	2466	6893	2466	
871	control periods	control period	1	0	873	510	873	
15206	model method	model method	1	0	6587	1078	6587	
22953	promising treatment	promising treatment	1	0	97	1856	97	
31555	JessTM Simple Western system	INFunknownSUP simple Western system	1	0	31557	31556	1327	
6220	Seroprevalence of SARS-CoV-2 Antibodies	Seroprevalence of INFunknownSUP antibody	1	0	6221	6222	6221	
19625	vaccination uptake	vaccination uptake	1	0	19195	437	19195	
33781	Infectious disease	infectious disease	1	0	209	6907	209	
27839	longer duration of hospitalization	long duration of hospitalization	1	0	24830	16156	7404	
2360	risk chain	risk chain	1	0	2362	1542	2362	
35304	genetic counseling	genetic counseling	1	0	35306	6655	35306	
12872	Brain Damage	Brain damage	1	0	12874	2951	12874	
16161	estimates of the basic reproductive number	estimate of the basic reproductive number	1	0	5370	16163	5370	
14347	significant outbreaks of COVID-19	significant outbreak of INFunknownSUP	1	0	14349	908	2892	
36368	mental state	mental state	1	0	1961	119	1961	
7859	safety glasses	safety glass	1	0	7861	6729	7861	
22204	unique scenario	unique scenario	1	0	5611	3547	5611	
36922	Median presymptomatic infectious period	Median presymptomatic infectious period	1	0	36924	7402	5677	
8458	field of pathology	field of pathology	1	0	6748	2094	6748	
26793	moderate degree	moderate degree	1	0	12635	4684	12635	
24907	computational analyses	computational analysis	1	0	4668	13184	4668	
17569	Trial registration number	trial registration number	1	0	17571	17570	916	
6778	vaccine transmission	vaccine transmission	1	0	876	577	876	
12889	initial guidelines	initial guideline	1	0	91	335	91	
684	Vaccine Efficiency	vaccine efficiency	1	0	686	685	686	
14755	active COVID-19 disease	active INFunknownSUP disease	1	0	14757	3597	209	
21952	work-based learning programme	INFunknownSUP learning programme	1	0	2839	21953	2839	
17574	Data analysis	Data analysis	1	0	486	5098	486	
33818	ASA score &gt	ASA score &gt	1	0	23956	1842	2385	
35643	comparison to healthy subjects	comparison to healthy subject	1	0	13707	30062	13707	
9904	Incidence Rate	incidence rate	1	0	9906	9905	9906	
25187	Substance Use Treatment Program	substance Use Treatment Program	1	0	25189	25188	25193	
10217	transfer to intensive care unit	transfer to intensive care unit	1	0	10218	6	10218	
11336	Safe Colorectal Surgery	Safe colorectal surgery	1	0	11338	11337	2338	
17444	epidemic period of bronchiolitis	epidemic period of INFunknownSUP	1	0	12266	5471	5677	
31861	assessments of acceptability	assessment of acceptability	1	0	1393	23407	1393	
33267	human corona	human corona	1	0	19344	2214	19344	
9481	clear differences	clear difference	1	0	5663	9482	5663	
26858	cell count	cell count	1	0	1305	197	1305	
31428	AUCs of COVID-19	INFunknownSUP of INFunknownSUP	1	0	31429	40	31429	
7471	Korea Centers	Korea Centers	1	0	7473	3871	7473	
6111	early humoral immune response	early humoral immune response	1	0	6113	55	409	
10145	retrospective review of children	retrospective review of child	1	0	10147	10146	1723	
35300	significant percentage	significant percentage	1	0	3789	908	3789	
25372	sharp drop	sharp drop	1	0	25374	25373	25374	
13595	COVID-19 center	INFunknownSUP center	1	0	8718	40	8718	
28973	home healthcare workers	home INFunknownSUP worker	1	0	6468	231	1136	
15397	period of schooling	period of schooling	1	0	5677	15399	5677	
34277	HCQ serum concentration	HCQ serum concentration	1	0	34279	7775	11518	
34529	risk-factor group	risk-factor group	1	0	18	34530	18	
8370	functional dysbiosis	functional dysbiosis	1	0	8372	4225	8372	
24767	residential care service workers	residential care service worker	1	0	24769	9936	1136	
38730	Coronavirus infections	Coronavirus infection	1	0	779	38731	779	
29452	high stress level	high stress level	1	0	29454	13	362	
23351	early outbreak of COVID-19	early outbreak of INFunknownSUP	1	0	23353	55	310	
38030	Mental Health Care	mental Health Care	1	0	38032	8856	5417	
2106	garment industry jobs	garment industry job	1	0	2110	2107	2110	
12013	laboratory tests results	laboratory test result	1	0	325	4639	325	
22002	Letter to the Editor	letter to the editor	1	0	22003	22004	22003	
6339	Influenced Public Discourse	Influenced Public Discourse	1	0	6341	6340	6343	
11673	online version of this article	online version of this article	1	0	11674	3869	4435	
20386	respiratory SARS-CoV-2	respiratory INFunknownSUP	1	0	28	259	28	
8472	relevant subjective factors	relevant subjective factor	1	0	8474	346	583	
27871	wider applications	wide application	1	0	17602	11790	17602	
24290	Coronavirus pandemic stay-at-home guidelines	INFunknownSUP pandemic stay-at-home guideline	1	0	24292	3206	91	
14455	Psychiatric Sequelae	psychiatric sequela	1	0	14457	14456	14457	
33773	evaluation of the QoL of ASD patients	evaluation of the QoL of INFunknownSUP patient	1	0	2399	33775	2399	
14415	profound impact COVID-19	profound impact INFunknownSUP	1	0	40	12609	40	
22915	cardiovascular mortality	cardiovascular mortality	1	0	1197	13290	1197	
33851	vaccine-related attitude	vaccine-related attitude	1	0	12193	587	12193	
25008	health facility	health facility	1	0	25010	120	25010	
26866	503B outsourcing facilities	INFunknownSUP outsourcing facility	1	0	26868	26867	2676	
35678	Testing Method	Testing Method	1	0	35680	25495	35680	
2278	outbreak of SARS-CoV-2	outbreak of INFunknownSUP	1	0	310	28	310	
37905	Malignant Cerebral Artery Infarction	malignant cerebral artery infarction	1	0	37907	37906	37911	
8991	viral diversity	viral diversity	1	0	8993	1741	8993	
27865	comorbid diseases	comorbid disease	1	0	315	11911	315	
12271	Face masks	Face mask	1	0	3036	12272	3036	
35886	different immune cell types	different immune cell type	1	0	35888	688	1979	
18619	new arena	new arena	1	0	18621	69	18621	
15186	widespread implications	widespread implication	1	0	9549	10627	9549	
18106	epidemiological changes	epidemiological change	1	0	1336	18107	1336	
11592	amount of alveolar recruitment	amount of alveolar recruitment	1	0	8629	11594	8629	
37452	lineage 20a strain	lineage INFunknownSUP strain	1	0	37454	485	1107	
11901	cases of arthritis	case of arthritis	1	0	229	11903	229	
25428	severity of SARS-CoV-2 infection	severity of INFunknownSUP infection	1	0	5116	1272	5116	
14671	important changes	important change	1	0	1336	273	1336	
26098	working environment	working environment	1	0	3454	26099	3454	
19075	terms of local control	term of local control	1	0	4908	19077	4908	
6786	Healthcare facility-onset Clostridioides difficile infection rates	Healthcare facility-onset INFunknownSUP INFunknownSUP infection rate	1	0	6788	1355	83	
10808	mild adverse events	mild adverse event	1	0	1081	10809	1083	
4880	mas de	ma de	1	0	1421	4881	1421	
14127	pandemic year	pandemic year	1	0	3822	1354	3822	
22745	Pharmacists Matter	pharmacist Matter	1	0	22747	22746	22747	
22642	29(14 %	INFunknownSUP %	1	0	364	22643	364	
29461	body radiotherapy	body radiotherapy	1	0	29463	2710	29463	
16480	ground glass opacities	ground glass opacity	1	0	16482	16481	526	
6871	maximal infectious period	maximal infectious period	1	0	6873	6872	5677	
34347	anatomy laboratory groups	anatomy laboratory group	1	0	2486	26964	2486	
15840	I2=71 %	INFunknownSUP %	1	0	364	15841	364	
22281	cost centrifugal melt	cost centrifugal melt	1	0	22283	10966	253	
38992	multivariable logistic regression analysis	multivariable logistic regression analysis	1	0	36095	10323	486	
2398	evaluation of private health insurance companies	evaluation of private health insurance company	1	0	2399	2400	2399	
23692	ill-defined margins	ill-defined margin	1	0	23694	23693	23694	
37684	Information Support	information support	1	0	2021	37685	2021	
39123	diferencias sugieren una subestimacion	INFunknownSUP INFunknownSUP Una INFunknownSUP	1	0	39127	39124	39129	
6761	digital slides	digital slide	1	0	6763	1094	6763	
25422	secondary outcome	secondary outcome	1	0	295	712	295	
22558	higher levels of depression	high level of depression	1	0	12250	1514	169	
24004	additional binding sites	additional binding site	1	0	17835	7175	9165	
3009	vital signs	vital sign	1	0	3011	3010	3011	
29700	sporting events	sporting event	1	0	1083	29701	1083	
11864	spread of this disease	spread of this disease	1	0	570	209	570	
25317	signs of COVID-19	sign of INFunknownSUP	1	0	3011	40	3011	
17752	budgetary shortfalls	budgetary shortfall	1	0	17754	17753	17754	
5786	transcriptional mutations	transcriptional mutation	1	0	3785	5787	3785	
21039	arrangements of ACE2	arrangement of INFunknownSUP	1	0	13728	3437	13728	
8898	- March	INFunknownSUP March	1	0	8900	5345	8900	
35127	nucleocapsid specific immunity	INFunknownSUP specific immunity	1	0	35129	35128	257	
32735	Impact of Intolerance of Uncertainty	impact of intolerance of uncertainty	1	0	802	32737	802	
23138	prominent care delivery mode	prominent care delivery mode	1	0	23140	23139	18075	
21089	proportions of international graduates	proportion of international graduate	1	0	15614	21091	15614	
17117	conventional criteria	conventional criterion	1	0	3649	8443	3649	
36584	Wastewater analysis	wastewater analysis	1	0	486	36585	486	
12538	reproduction numbers	reproduction number	1	0	12095	4645	12095	
4571	thromboembolic events	thromboembolic event	1	0	1083	4572	1083	
18160	teaching methods	teaching method	1	0	205	2074	205	
8083	Data interrogation-	Data INFunknownSUP	1	0	8085	5098	8085	
31097	video teaching	video teaching	1	0	2074	22756	2074	
35069	untrained ones	untrained one	1	0	35071	35070	35071	
8336	infectious virus	infectious virus	1	0	778	64	778	
25561	postoperative intensive care unit	postoperative intensive care unit	1	0	6	8142	10	
21440	observational case series	observational case series	1	0	20220	3552	8050	
11667	detection approaches	detection approach	1	0	8111	44	8111	
37581	COVID-19 experienced stigma	INFunknownSUP experienced stigma	1	0	37583	40	37585	
14898	high-flow nasal oxygen	INFunknownSUP nasal oxygen	1	0	9000	14899	3956	
11929	respiratory tract	respiratory tract	1	0	2154	259	2154	
33355	employee outcomes	employee outcome	1	0	263	33356	263	
39320	beneficial work	beneficial work	1	0	2162	36364	2162	
3587	agranulocytosis case	agranulocytosis case	1	0	3368	3588	3368	
8306	messenger RNA vaccine	messenger RNA vaccine	1	0	8308	8307	577	
2733	strategies of nurses	strategy of nurse	1	0	300	2735	300	
29822	IgG serology	IgG serology	1	0	5992	928	5992	
35809	questionnaire data	questionnaire datum	1	0	22	9620	22	
5858	advanced technological tools	advanced technological tool	1	0	5860	5859	274	
5262	statistical evidence of a difference	statistical evidence of a difference	1	0	5264	5263	585	
32442	short-term follow-up	short-term follow-up	1	0	175	32443	175	
18604	face-recognition-based access control system	INFunknownSUP access control system	1	0	18606	18605	1327	
15564	past year	past year	1	0	3822	1234	3822	
18418	curricular transformation	curricular transformation	1	0	1708	18419	1708	
26481	face-to-face outpatient	face-to-face outpatient	1	0	327	4673	327	
36709	tissue optical clearing	tissue optical clearing	1	0	36711	4974	36713	
6934	molecular weight	molecular weight	1	0	2711	6935	2711	
33537	Parents/guardians of children	Parents/guardian of child	1	0	33538	6153	33538	
21438	Retrospective observational case series	retrospective observational case series	1	0	21440	8849	8050	
10502	useful tool	useful tool	1	0	5487	10503	5487	
28747	high-risk populations	high-risk population	1	0	13188	1184	13188	
18622	Seasonal Influenza Vaccine	seasonal influenza vaccine	1	0	685	18623	685	
17169	Electrospun nanofiber-based	INFunknownSUP INFunknownSUP	1	0	14630	17170	14630	
11326	infected cells	infected cell	1	0	133	1088	133	
27572	presence of skin problems	presence of skin problem	1	0	675	21707	675	
11896	small autopsy series	small autopsy series	1	0	11898	9600	8050	
30220	random testing campaigns/surveys	random testing campaigns/survey	1	0	30222	2346	30224	
9520	Autonomous Government of Catalonia	autonomous government of Catalonia	1	0	9522	9521	9523	
2197	Multiple Sclerosis	multiple sclerosis	1	0	2199	2198	2199	
22671	interpersonal trauma	interpersonal trauma	1	0	2783	19590	2783	
12431	low level of inflammation	low level of inflammation	1	0	12432	3116	362	
18839	reflexive thematic analysis	reflexive thematic analysis	1	0	7563	18840	486	
8922	uninterrupted care	uninterrupted care	1	0	9	8923	9	
36654	critical illness	critical illness	1	0	1069	223	1069	
4188	pulmonary findings	pulmonary finding	1	0	3390	590	3390	
9769	Nitrogen dioxide	nitrogen dioxide	1	0	9771	9770	9771	
19833	Cybersecurity threats	Cybersecurity threat	1	0	1370	19834	1370	
3950	online facilities	online facility	1	0	2676	541	2676	
21341	medical oxygen	medical oxygen	1	0	3956	947	3956	
36924	presymptomatic infectious period	presymptomatic infectious period	1	0	6873	36925	5677	
30800	various products	various product	1	0	1874	1099	1874	
10547	la pandemie COVID-19 une occasion de reformer la sante	la INFunknownSUP INFunknownSUP une occasion de reformer la INFunknownSUP	1	0	10549	3572	10563	
13948	intense distress	intense distress	1	0	1975	12704	1975	
25907	Younger age groups	young age group	1	0	2572	25908	2486	
4846	higher PEEP levels	high peep level	1	0	4848	322	169	
8156	television industries	television industry	1	0	8158	8157	8158	
12545	risk of viral contamination	risk of viral contamination	1	0	1542	12547	1542	
37185	isolation measures	isolation measure	1	0	317	6569	317	
814	con variables demograficas	con variable INFunknownSUP	1	0	818	815	818	
6967	AJHP style	INFunknownSUP style	1	0	2049	6968	2049	
25819	selected ML models	selected ML model	1	0	25821	1620	3975	
28436	multidimensional space of cardiovascular data	multidimensional space of cardiovascular datum	1	0	28438	28437	11832	
30096	nationwide state of emergency	nationwide state of emergency	1	0	30098	21400	1961	
6533	unequivocal necessity	unequivocal necessity	1	0	6535	6534	6535	
24894	undetectable sources	undetectable source	1	0	4158	14704	4158	
27197	ischemic changes	ischemic change	1	0	1336	5059	1336	
26797	Los datos proceden de organismos	Los dato INFunknownSUP de INFunknownSUP	1	0	26799	10415	26805	
36992	future scenarios	future scenario	1	0	7142	1367	7142	
4718	sufficient resources	sufficient resource	1	0	835	4719	835	
21722	theory perspective	theory perspective	1	0	21724	21053	21724	
18285	primary prophylaxis measures	primary prophylaxis measure	1	0	18287	75	317	
12372	initiator of toxic innate immune responses	initiator of toxic innate immune response	1	0	12373	12374	12373	
13014	N95 masks	N95 mask	1	0	3036	13015	3036	
6519	scale of the COVID-19 pandemic	scale of the INFunknownSUP pandemic	1	0	2422	111	2422	
1181	exposure to high-risk COVID-19 environments	exposure to high-risk INFunknownSUP environment	1	0	1054	1183	1054	
4415	Attitude of health professionals	attitude of health professional	1	0	4416	4417	4416	
375	Recommendations- report writing	INFunknownSUP report writing	1	0	377	376	379	
19528	metabolic signature of HCQ	metabolic signature of HCQ	1	0	19530	6357	19531	
18216	transmission risk	transmission risk	1	0	1542	876	1542	
10893	gold standard method	gold standard method	1	0	10895	2054	6587	
3403	anti-viral properties	anti-viral property	1	0	1995	1410	1995	
32929	target cell surface receptor	target cell surface receptor	1	0	32931	11730	3502	
37791	unique characteristics	unique characteristic	1	0	1496	3547	1496	
20720	hospital room	hospital room	1	0	5742	185	5742	
8715	COVID-19 center COVID-19	INFunknownSUP center INFunknownSUP	1	0	8717	40	40	
10691	time musings	time musing	1	0	10693	179	10693	
22183	% of deaths	% of death	1	0	364	553	364	
22961	multiple viruses	multiple virus	1	0	2217	1776	2217	
25920	free wall	free wall	1	0	1608	4542	1608	
27096	exposure to the disease	exposure to the disease	1	0	1054	209	1054	
26625	older population	old population	1	0	1838	59	1838	
10238	stress process conceptual framework	stress process conceptual framework	1	0	10240	199	4860	
24414	inflammatory syndrome	inflammatory syndrome	1	0	1936	3817	1936	
36483	pulmonary disease	pulmonary disease	1	0	209	590	209	
37491	conventional microscopy	conventional microscopy	1	0	10792	8443	10792	
23695	P-values &lt	INFunknownSUP &lt	1	0	22514	23696	22514	
19349	Pedestrian 3D Localization	pedestrian 3D localization	1	0	19351	19350	19353	
25585	bacterial network	bacterial network	1	0	719	2517	719	
8314	copeptin values &gt	INFunknownSUP value &gt	1	0	2385	8315	2385	
8235	genomic similarities	INFunknownSUP similarity	1	0	2582	5714	2582	
11411	formative evaluation	formative evaluation	1	0	2399	11412	2399	
27627	outbreak of the Corona Virus Disease	outbreak of the Corona virus Disease	1	0	310	27629	310	
31115	pathophysiological features of obese patient metabolism	pathophysiological feature of obese patient metabolism	1	0	31117	8219	1469	
13566	neutrophil changes	neutrophil change	1	0	1336	1304	1336	
6108	intranasal steroid	intranasal steroid	1	0	1173	6109	1173	
17061	defense response	defense response	1	0	409	13742	409	
13057	positive airway pressure:on patients	positive airway INFunknownSUP patient	1	0	13059	228	60	
13914	public health strategies	public health strategy	1	0	300	1320	300	
5061	risk exposure	risk exposure	1	0	1054	1542	1054	
5224	different assays	different assay	1	0	2754	688	2754	
12274	impact of methylprednisolone	impact of INFunknownSUP	1	0	110	2513	110	
15857	clinical studies	clinical study	1	0	136	884	136	
30147	health security	health security	1	0	12279	120	12279	
24517	proliferation marker Ki67	proliferation marker INFunknownSUP	1	0	24519	35	24521	
29953	clinical researchers	clinical researcher	1	0	29955	884	29955	
9185	Operative Field Barrier	operative Field Barrier	1	0	9187	9186	9189	
10242	conceptual framework	conceptual framework	1	0	4860	10243	4860	
20809	Terminal complement inhibition	terminal complement inhibition	1	0	20811	20810	9422	
26020	blood cell counts	blood cell count	1	0	26022	3129	5090	
30520	rare somatic hypermutations	rare somatic hypermutation	1	0	30522	10225	30524	
22056	cesarean section delivery	Cesarean section delivery	1	0	22058	22057	2840	
36821	medical specialists	medical specialist	1	0	36823	947	36823	
11453	children under-5	child INFunknownSUP	1	0	11455	6153	11455	
38597	effective therapeutic intervention	effective therapeutic intervention	1	0	38599	2051	5608	
5058	ischemic injury	ischemic injury	1	0	713	5059	713	
32914	clinical impact of this benefit	clinical impact of this benefit	1	0	32916	884	110	
7315	exploratory phase	exploratory phase	1	0	1352	2181	1352	
10672	Diagnosis of rare clinical entities	diagnosis of rare clinical entity	1	0	10673	10674	10673	
22563	U.S. President	U.S. President	1	0	22565	21303	22565	
23031	binomial regressions	binomial regression	1	0	9229	9224	9229	
13363	overall SARS-CoV-2 positivity	overall INFunknownSUP INFunknownSUP	1	0	13365	2251	1238	
27403	70th-90th percentiles	INFunknownSUP percentile	1	0	24576	27404	24576	
985	binding to HLA-A*02:01 monomers	binding to HLA-A*02:01 monomer	1	0	986	987	986	
14302	new increase	new increase	1	0	392	69	392	
15170	Prolonged viral shedding	prolonged viral shedding	1	0	5156	12299	5158	
10861	Education Covid-19	Education INFunknownSUP	1	0	1884	3731	1884	
27372	IgM prevalence	Igm prevalence	1	0	9272	30	9272	
17152	repertoire of healthy unexposed subjects	repertoire of healthy unexposed subject	1	0	10422	17154	10422	
1926	instructor support	instructor support	1	0	260	1927	260	
25970	individual sample	individual sample	1	0	2757	753	2757	
27749	composite endpoint death	composite endpoint death	1	0	4722	10301	4722	
1449	Risk of reinfection	risk of reinfection	1	0	1450	1451	1450	
163	NO2 decreases	INFunknownSUP decrease	1	0	165	164	165	
17235	part of the COVID-19 response	part of the INFunknownSUP response	1	0	734	8919	734	
11623	severity of the disease	severity of the disease	1	0	5116	209	5116	
12750	ilio-psoas hematoma	INFunknownSUP hematoma	1	0	12752	12751	12752	
28864	hemispheric syndrome	hemispheric syndrome	1	0	1936	28865	1936	
22144	Credible Interval	credible interval	1	0	13250	22145	13250	
5457	heart failure university tertiary referral	heart failure university tertiary referral	1	0	5461	5458	2964	
13614	resilience of pregnant females	resilience of pregnant female	1	0	4654	13616	4654	
10593	Outcome Measures	outcome measure	1	0	10595	10594	10595	
26322	(EDL)-gated field-effect	INFunknownSUP INFunknownSUP	1	0	26324	26323	26324	
36892	marked worsening	marked worsening	1	0	30073	22847	30073	
22713	assay formulation	assay formulation	1	0	22493	3119	22493	
23941	S1 Protein Sites	INFunknownSUP protein Sites	1	0	23945	23942	23945	
6667	Th2-associated IgG2	Th2-associated INFunknownSUP	1	0	6669	6668	6669	
37855	Differential Cytokine Responses	differential INFunknownSUP response	1	0	37857	37856	29648	
1512	current depression	current depression	1	0	1514	443	1514	
37138	detailed guidance	detailed guidance	1	0	18482	21498	18482	
32068	national publics	national public	1	0	32070	517	32070	
38650	early elevation	early elevation	1	0	33005	55	33005	
1012	activation of CD8 T cells of healthy unexposed donors	activation of INFunknownSUP T cell of healthy unexposed donor	1	0	1013	1014	1013	
30581	little systematic study	little systematic study	1	0	30583	7173	2087	
27099	upregulation of tissue repair factors BDNF	upregulation of tissue repair factor INFunknownSUP	1	0	27100	27101	27100	
18152	COVID-19 lesions	INFunknownSUP lesion	1	0	162	40	162	
1896	spike antibodies	spike antibody	1	0	929	31	929	
20259	haphazard haemovigilance system	haphazard haemovigilance system	1	0	20261	20260	1327	
7831	research question	research question	1	0	7833	36	7833	
3711	product quality	product quality	1	0	3713	1735	3713	
24457	access cohort	access cohort	1	0	601	224	601	
33780	Infectious disease outbreaks	infectious disease outbreak	1	0	2892	33781	2892	
36636	Central obesity	central obesity	1	0	24245	20963	24245	
8444	systemic vaccines	systemic vaccine	1	0	681	1453	681	
36278	typical symptoms of fever	typical symptom of fever	1	0	36280	17065	86	
36648	contextual conditions	contextual condition	1	0	2910	12505	2910	
39228	Male patients	male patient	1	0	60	22836	60	
25671	wave of the pandemic	wave of the pandemic	1	0	10210	113	10210	
25255	aetiological investigations	aetiological investigation	1	0	12639	25256	12639	
33902	interferon-gamma-induced phosphorylation of JAK	INFunknownSUP INFunknownSUP of Jak	1	0	33903	944	945	
38259	meta-analysis Acute kidney injury	meta-analysis acute kidney injury	1	0	30197	286	713	
25644	differential gene	differential gene	1	0	6495	3104	6495	
36363	beneficial effects of dexamethasone	beneficial effect of INFunknownSUP	1	0	36365	36364	156	
17563	CT scans	CT scan	1	0	15094	26	15094	
16287	Clinical outcome of neurological patients	clinical outcome of neurological patient	1	0	16288	16291	295	
37024	SARS-CoV-2 antibody results	INFunknownSUP antibody result	1	0	325	12892	325	
35019	exclusive treatment of COVID-19 patients Clostridioides difficile infection	exclusive treatment of INFunknownSUP patient INFunknownSUP INFunknownSUP infection	1	0	35021	17540	97	
9182	Negative Pressure	negative pressure	1	0	9184	7170	9184	
18407	Author Correction	author correction	1	0	18409	18408	18409	
1140	limit of detection	limit of detection	1	0	1141	44	1141	
8442	conventional systemic vaccines	conventional systemic vaccine	1	0	8444	8443	681	
38983	duration of transition	duration of transition	1	0	7404	2091	7404	
15660	personal losses	personal loss	1	0	4306	4961	4306	
17475	COVID-19-enriched neutrophil states	INFunknownSUP neutrophil state	1	0	2803	17476	2805	
19914	SARS-CoV-2 air sampling study	INFunknownSUP air sampling study	1	0	19916	28	2087	
34632	ACE2 alpha1 domain	INFunknownSUP INFunknownSUP domain	1	0	34634	4778	697	
36727	diagnosis of AL amyloidosis	diagnosis of al INFunknownSUP	1	0	2168	28601	2168	
13983	SARS-CoV-2-induced humoral immunity	INFunknownSUP humoral immunity	1	0	13985	13984	257	
2529	Ireland and	Ireland and	1	0	2531	2530	2531	
12212	modern democracies	modern democracy	1	0	12214	12213	12214	
15473	Uttar Pradesh	Uttar Pradesh	1	0	15475	15474	15475	
5524	less severe cases	less severe case	1	0	5526	5525	229	
2953	positive perceptions	positive perception	1	0	2955	228	2955	
24313	clinical features	clinical feature	1	0	1469	884	1469	
26784	hospital discharge	hospital discharge	1	0	26786	185	26786	
21266	infection Neurologic complications	infection neurologic complication	1	0	21268	41	705	
35971	new metabolite	new metabolite	1	0	17224	69	17224	
24812	TCR repertoire of COVID	TCR repertoire of INFunknownSUP	1	0	24814	24813	10422	
18315	BNT 162b2 vaccination	BNT INFunknownSUP vaccination	1	0	18317	18316	437	
25125	substantial morbidity	substantial morbidity	1	0	1216	3239	1216	
7241	reinfection viral specimens	reinfection viral specimen	1	0	7243	1451	7245	
32094	vaccination centre	vaccination centre	1	0	25448	437	25448	
26732	font of the cardiovascular readings	font of the cardiovascular reading	1	0	902	14464	902	
8128	urgent referrals	urgent referral	1	0	4124	8129	4124	
39280	health disparities	health disparity	1	0	10684	120	10684	
33131	et al. used multiple sources	et al. used multiple source	1	0	33133	1867	4158	
14227	renal replacement therapy	renal replacement therapy	1	0	14229	130	2273	
14272	data analytics	data INFunknownSUP	1	0	14274	14273	14274	
29177	chronic health problems	chronic health problem	1	0	29179	8230	6766	
7045	RT-PCR studies	INFunknownSUP study	1	0	136	7046	136	
20358	antiviral strategies	antiviral strategy	1	0	300	3989	300	
8981	collapse of global trade	collapse of global trade	1	0	8982	8983	8982	
4454	Cell Repertoire Analysis	cell repertoire analysis	1	0	4456	4455	204	
6171	espiritual y el afrontamiento precoz que	espiritual y el INFunknownSUP INFunknownSUP que	1	0	6173	6172	6181	
21193	Eleven surgeons-in-training	eleven surgeons-in-training	1	0	21195	4725	21195	
38875	high prevention awareness	high prevention awareness	1	0	38877	13	1612	
27992	M15 (3-O-(6-O-alpha-l-arabinopyranosyl)-beta-d-glucopyranosyl-1,4-dimethoxyxanthone)	M15 INFunknownSUP	1	0	27994	27993	27994	
4568	inhibitor etanercept	inhibitor INFunknownSUP	1	0	4570	4569	4570	
30748	deep learning-based models	deep INFunknownSUP model	1	0	30750	2520	3975	
17824	careful combination of public cloud	careful combination of public cloud	1	0	17826	6949	367	
37923	non-communicable disease care	non-communicable disease care	1	0	9	37924	9	
39221	glycoprotein S to 293T/ACE2 cells	glycoprotein S to INFunknownSUP cell	1	0	39223	7749	39224	
29841	Operationalizing Cooperative Research	INFunknownSUP cooperative research	1	0	29843	29842	29845	
20696	recovery phase of the pandemic	recovery phase of the pandemic	1	0	20698	3007	1352	
7279	needs of research study operations	need of research study operation	1	0	3189	7281	3189	
33967	Care Program	Care Program	1	0	25193	5417	25193	
24546	prolonged QTc	prolonged QTc	1	0	24548	5497	24548	
27454	teaching sessions	teaching session	1	0	15478	2074	15478	
2283	processing strategies	processing strategy	1	0	300	2284	300	
6788	facility-onset Clostridioides difficile infection rates	facility-onset INFunknownSUP INFunknownSUP infection rate	1	0	6790	496	83	
38506	types of barriers	type of barrier	1	0	1979	10121	1979	
25951	cost estimate of the kit	cost estimate of the kit	1	0	25953	10966	19137	
25312	Social-distancing Policies	Social-distancing policy	1	0	25314	25313	25314	
11778	chart review	chart review	1	0	1723	7485	1723	
27126	high 18F-FDG uptake	high INFunknownSUP uptake	1	0	27128	13	19195	
3006	recovery plan	recovery plan	1	0	1225	3007	1225	
20740	diagnostic tools	diagnostic tool	1	0	274	2219	274	
5685	regulatory misalignment	regulatory misalignment	1	0	5687	5686	5687	
6501	datos MEDLINE	dato INFunknownSUP	1	0	6503	6502	6503	
11579	Medical Practitioner	Medical practitioner	1	0	11581	2779	11581	
23005	different communicative dynamics	different communicative dynamics	1	0	23007	688	3694	
9223	binomial mixed effects regressions	binomial mixed effect regression	1	0	9225	9224	9229	
16598	metabolic clusters	metabolic cluster	1	0	860	6357	860	
32959	multiple vulnerabilities	multiple vulnerability	1	0	3877	1776	3877	
6169	atencion espiritual y el afrontamiento precoz que	INFunknownSUP espiritual y el INFunknownSUP INFunknownSUP que	1	0	6171	6170	6181	
4319	malignant cerebral SARS-CoV2 associated strokes	malignant cerebral INFunknownSUP associated stroke	1	0	4321	3530	3531	
15966	better protection	good protection	1	0	440	1635	440	
28659	public adoption of these apps	public adoption of these INFunknownSUP	1	0	28661	1321	88	
7684	immune systems	immune system	1	0	146	970	146	
31925	correlation coefficient	correlation coefficient	1	0	4664	2889	4664	
1446	one-kilometre resolution	INFunknownSUP resolution	1	0	1448	1447	1448	
19293	modulation of inflammatory cytokines	modulation of inflammatory cytokine	1	0	19294	19295	19294	
21251	important traumatic brain injury	important traumatic brain injury	1	0	21253	273	713	
26979	system incident management command structure	system incident management command structure	1	0	26981	1327	2427	
25964	STATA version	Stata version	1	0	4435	25965	4435	
17519	effect of some exposure	effect of some exposure	1	0	1809	1054	1809	
35569	Scoring Systems	Scoring Systems	1	0	20278	35570	20278	
1214	COVID-19 morbidity	INFunknownSUP morbidity	1	0	1216	40	1216	
29033	zero-inflated negative binomial autoregressive model to the data	zero-inflated negative binomial INFunknownSUP model to the datum	1	0	9827	22	1078	
39288	anonymous questionnaires	anonymous questionnaire	1	0	4509	26153	4509	
14069	acute phase of virus infection	acute phase of virus infection	1	0	14071	1461	1352	
13183	computational framework	computational framework	1	0	4860	13184	4860	
24399	preparatory school students	preparatory school student	1	0	1177	16472	1177	
31474	development of effective tests	development of effective test	1	0	73	31476	73	
12043	nurse staffing	nurse staffing	1	0	12045	9339	12045	
20377	Rapid scoping review	rapid scoping review	1	0	20379	20378	1723	
23016	attack rate	attack rate	1	0	1034	23017	1034	
36876	main issues	main issue	1	0	3758	4679	3758	
20138	great promise	great promise	1	0	20140	4480	20140	
35223	respiratory syndromes	respiratory syndrome	1	0	35225	259	35225	
19766	neurosurgery match	neurosurgery match	1	0	16974	6083	16974	
20445	non-COVID-19 patients	INFunknownSUP patient	1	0	60	8107	60	
29754	surgical services	surgical service	1	0	5980	663	5980	
28448	novel insights	novel insight	1	0	9664	3645	9664	
16446	preoperative SARS-CoV-2 infection rates	preoperative INFunknownSUP infection rate	1	0	16448	16447	83	
37170	lockdown of public life	INFunknownSUP of public life	1	0	1676	37172	1676	
6561	Instrument (OMI)-derived year-to-year decreases	Instrument INFunknownSUP year-to-year decrease	1	0	6563	6562	165	
26644	community-based outpatient clinic	community-based outpatient clinic	1	0	26646	26645	7704	
1361	regular penetration tests	regular penetration test	1	0	1363	870	1365	
31135	possible events	possible event	1	0	1083	745	1083	
2978	new COVID-19 variants	new INFunknownSUP variant	1	0	2980	69	1002	
6391	intrinsic capacity	intrinsic capacity	1	0	3026	6392	3026	
7095	hospital employees	hospital employee	1	0	7097	185	7097	
21627	higher dimeric	high INFunknownSUP	1	0	21629	322	21629	
8216	various pathophysiological pathways	various pathophysiological pathway	1	0	8218	1099	8220	
29187	effects logit model	effect INFunknownSUP model	1	0	17368	156	1078	
31156	logical next step	logical next step	1	0	31158	31157	23817	
11028	Ethics Committee	Ethics Committee	1	0	11030	11029	11030	
5699	untold number of trade-offs	untold number of trade-off	1	0	5701	5700	916	
37816	virtue ethics	virtue ethic	1	0	37818	7461	37818	
22053	final sample	final sample	1	0	2757	4256	2757	
38674	common strategies	common strategy	1	0	300	699	300	
20738	accurate diagnostic tools	accurate diagnostic tool	1	0	20740	324	274	
27	SARS-CoV-2 IgM spike	INFunknownSUP Igm spike	1	0	29	28	31	
4759	positive RT- PCR	positive INFunknownSUP PCR	1	0	4761	228	3981	
28328	effect of an air purifier	effect of an air purifier	1	0	1809	21032	1809	
12952	coronavirus virus	coronavirus virus	1	0	778	339	778	
34416	GRADE assessment	grade assessment	1	0	238	6119	238	
21983	members of communities	member of community	1	0	16766	948	16766	
29030	artificial saliva	artificial saliva	1	0	29032	29031	29032	
2597	Food preferences	Food preference	1	0	2599	2598	2599	
5564	module of the Brazilian National Household Sample Survey	module of the Brazilian National household Sample Survey	1	0	5565	5566	5565	
27341	multiparametric cardiovascular magnetic resonance imaging	multiparametric cardiovascular magnetic resonance imaging	1	0	27343	27342	3936	
10202	possible transmission of the virus	possible transmission of the virus	1	0	10204	745	876	
30395	lower new COVID-19 cases	low new INFunknownSUP case	1	0	30397	594	229	
8911	pandemic prevention	pandemic prevention	1	0	1294	1354	1294	
763	early stages of non-small cell lung cancer	early stage of non-small cell lung cancer	1	0	764	767	766	
35283	Reinfection risk	Reinfection risk	1	0	1542	35284	1542	
21947	occurrence of certain symptoms	occurrence of certain symptom	1	0	2207	21949	2207	
24598	local laboratory	local laboratory	1	0	1392	3173	1392	
33922	49-year-old south-Asian	49-year-old south-Asian	1	0	33924	33923	33924	
26567	Measure Older Adults	measure old adult	1	0	25491	1655	25493	
10378	isolation policies	isolation policy	1	0	1760	6569	1760	
18877	medical review	medical review	1	0	1723	947	1723	
22956	COVID-19 CT image	INFunknownSUP CT image	1	0	22958	40	22960	
4841	sample PCR	sample PCR	1	0	3981	2757	3981	
5008	thirty-one COVID-19 patients	Thirty-one INFunknownSUP patient	1	0	911	5009	60	
27241	sequence alignment of ACE2	sequence alignment of INFunknownSUP	1	0	27243	5716	3505	
21542	repertoire characteristics	repertoire characteristic	1	0	1496	10422	1496	
6592	healthcare workers experiences	INFunknownSUP worker experience	1	0	6594	494	1339	
3940	clinical characteristics of the COVID-19 patients	clinical characteristic of the INFunknownSUP patient	1	0	3942	884	1496	
20523	National Institute	National Institute	1	0	20525	46	20525	
16850	technical act	technical act	1	0	16852	4083	16852	
6626	GP consultation rates	GP consultation rate	1	0	6628	2328	83	
18627	protein-protein interaction network construction	protein-protein interaction network construction	1	0	18629	9004	9751	
8634	shorter time	short time	1	0	179	8635	179	
38693	expert system	expert system	1	0	1327	1681	1327	
25696	number of visitors	number of visitor	1	0	916	14431	916	
15711	available literature	available literature	1	0	4698	832	4698	
18068	residents of the treatment program	resident of the treatment program	1	0	232	18070	232	
28255	better teamwork	good teamwork	1	0	3839	1635	3839	
5094	treatment plants	treatment plant	1	0	5096	97	5096	
9327	development of effective strategies	development of effective strategy	1	0	73	9329	73	
24849	ANC level	ANC level	1	0	362	24850	362	
31949	glycoprotein interaction	glycoprotein interaction	1	0	2525	7749	2525	
3623	medical education debt	medical education debt	1	0	3627	3624	3627	
5932	addiction treatment programming	addiction treatment programming	1	0	5936	5933	5936	
13961	electrochemical analyses	electrochemical analysis	1	0	4668	13962	4668	
31562	implementation challenges	implementation challenge	1	0	2220	396	2220	
26335	y una guia clinica	y una INFunknownSUP INFunknownSUP	1	0	26337	1908	26341	
16491	EUROIMMUN Medizinische	INFunknownSUP INFunknownSUP	1	0	16493	13279	16493	
22136	risk to women	risk to woman	1	0	1542	920	1542	
10140	Performance Outcomes UpToDate	performance outcome INFunknownSUP	1	0	10142	10141	10144	
21286	odds ratio of patients	odd ratio of patient	1	0	5254	60	2635	
2653	substance use disorders	substance use disorder	1	0	889	714	889	
31913	internal consistency measures of Cronbach	internal consistency measure of INFunknownSUP	1	0	31915	18382	317	
30899	screening process	screening process	1	0	180	7961	180	
6981	Methods Appraisal Tool	method appraisal Tool	1	0	6983	6982	6985	
530	numerous state-of-the-art technologies	numerous state-of-the-art technology	1	0	532	531	70	
5529	initial levels of biomarkers	initial level of biomarker	1	0	5531	335	169	
15227	Proton pump inhibitor	proton pump inhibitor	1	0	15229	15228	4569	
30373	toxicities of drugs	toxicity of drug	1	0	30374	4584	30374	
18642	Neutrophil to lymphocyte ratio	neutrophil to lymphocyte ratio	1	0	18643	18644	18643	
4926	plausible sources of bias	plausible source of bias	1	0	4928	4927	4158	
8861	levels of additives	level of additive	1	0	169	8863	169	
39133	la magnitud de la epidemia	la INFunknownSUP de la INFunknownSUP	1	0	39135	14950	39141	
38175	microfluidics devices	microfluidics device	1	0	6162	38176	6162	
33634	match results	match result	1	0	325	16974	325	
12714	introductory seminar	introductory seminar	1	0	12716	12715	12716	
5097	Data availability	Data availability	1	0	5099	5098	5099	
13351	routine healthcare	routine INFunknownSUP	1	0	494	4898	494	
1798	ophthalmologic examination	INFunknownSUP examination	1	0	1800	1799	1800	
966	survey data	survey datum	1	0	22	967	22	
4391	Albert Camus	Albert Camus	1	0	4393	4392	4393	
25638	pipeline to SARS-CoV-2 differential gene expression signatures	pipeline to INFunknownSUP differential gene expression signature	1	0	25639	25640	25639	
29099	B cells memory activation	B cell memory activation	1	0	29103	29100	1013	
6685	Experimental Biology Host Societies	experimental biology Host society	1	0	6689	6686	6691	
36266	external factors	external factor	1	0	583	14485	583	
9390	neuroprotective effects	neuroprotective effect	1	0	156	9391	156	
28625	economic resumption	economic resumption	1	0	187	108	187	
14390	cascades of the JAK/STAT pathway	cascade of the INFunknownSUP pathway	1	0	14391	10985	14391	
10769	continuous support to nurse managers	continuous support to nurse manager	1	0	10771	2232	260	
18639	post-intervention period	post-intervention period	1	0	5677	212	5677	
15685	clinical feasibility study Conversion disorder/functional neurological disorder	clinical feasibility study conversion disorder/functional neurological disorder	1	0	15691	15686	7358	
3855	dysfunction of the cardiac autonomic nervous system	dysfunction of the cardiac autonomic nervous system	1	0	3856	3857	3856	
30353	metal nose bridge	metal nose bridge	1	0	30355	5109	30357	
14412	lasting transformation	lasting transformation	1	0	1708	14413	1708	
6650	rapid accumulation of genetic changes	rapid accumulation of genetic change	1	0	6652	795	4349	
8136	last FU	last fu	1	0	8138	3723	8138	
4635	results of early laboratory tests	result of early laboratory test	1	0	325	4637	325	
17023	lung cells	lung cell	1	0	133	772	133	
18874	activity of withanolides	activity of INFunknownSUP	1	0	3990	7483	3990	
5557	social media platforms	social media platform	1	0	3919	5558	3919	
19256	Health Questionnaire	Health questionnaire	1	0	19258	279	19258	
10124	ongoing coronavirus disease-2019	ongoing coronavirus INFunknownSUP	1	0	10126	1059	10128	
36035	technology-enhanced training	technology-enhanced training	1	0	235	36036	235	
26628	insurance assessment problem	insurance assessment problem	1	0	26630	1711	4499	
15085	central tendency	central tendency	1	0	15087	3393	15087	
32719	everyday routine practice	everyday routine practice	1	0	32721	14753	3285	
19259	treatment of SARS-CoV-2	treatment of INFunknownSUP	1	0	97	28	97	
17980	viral replication data	viral replication datum	1	0	22	2987	22	
12209	procedural simulator	procedural simulator	1	0	12211	12210	12211	
23039	prior research	prior research	1	0	36	5165	36	
25345	e-Learning methods	e-Learning method	1	0	205	25346	205	
6771	multiplex immunoassays	multiplex immunoassay	1	0	6773	3118	6773	
26081	viral concentrations	viral concentration	1	0	1959	1741	1959	
1170	early steroid treatment	early steroid treatment	1	0	1172	55	97	
15005	series report	series report	1	0	378	8050	378	
7698	average temperature	average temperature	1	0	195	178	195	
16579	MIRA database	Mira database	1	0	879	16580	879	
35389	containment measures	containment measure	1	0	317	12039	317	
5087	weekly counts of hospitalizations	weekly count of hospitalization	1	0	5089	5088	5090	
24122	stringent public decisions	stringent public decision	1	0	24124	24123	1942	
33376	simulation scenarios	simulation scenario	1	0	7142	9152	7142	
38964	recent rapid increase	recent rapid increase	1	0	6453	2128	392	
3233	public health data	public health datum	1	0	22	1320	22	
32564	health-relevant ambient ground-level concentrations	health-relevant ambient ground-level concentration	1	0	32566	32565	1959	
2682	scientific discoveries	scientific discovery	1	0	2684	2290	2684	
20371	Individual cases	individual case	1	0	229	11127	229	
38339	widespread use of face coverings	widespread use of face covering	1	0	21795	10627	292	
26445	feasibility of a larger project	feasibility of a large project	1	0	4380	18431	4380	
4806	time of reinfection	time of reinfection	1	0	179	1451	179	
28757	personalized care plan	personalized care plan	1	0	28759	28758	1225	
18975	COVID-19 eyes	INFunknownSUP eye	1	0	18974	3706	18974	
34931	alternative manufacturing strategy	alternative manufacturing strategy	1	0	34933	10647	3350	
36445	groups of occupational therapy students	group of occupational therapy student	1	0	2486	11602	2486	
27338	touching sensation	touching sensation	1	0	27340	27339	27340	
10947	input virus	input virus	1	0	778	10948	778	
8075	generation measurements	generation measurement	1	0	8077	3033	8077	
25641	SARS-CoV-2 differential gene expression	INFunknownSUP differential gene expression	1	0	25643	28	5729	
22173	digital gap	digital gap	1	0	2397	1094	2397	
30326	membrane oxygenation	membrane oxygenation	1	0	7365	14632	7365	
10103	temperature &gt	temperature &gt	1	0	2385	195	2385	
23740	wellbeing of the population	wellbeing of the population	1	0	23741	1838	23741	
21875	bariatric seminars	bariatric seminar	1	0	21877	2394	21877	
9011	Pandemic Scenario	pandemic Scenario	1	0	9013	2450	9013	
30554	la muerte	la INFunknownSUP	1	0	30556	3572	30556	
36764	User Behaviour	User behaviour	1	0	36766	36765	36766	
33133	al. used multiple sources	al. used multiple source	1	0	33135	33134	4158	
20271	PCR-positive patient	PCR-positive patient	1	0	710	13160	710	
22243	Cross-sectional observational study	cross-sectional observational study	1	0	18803	5854	2087	
2928	adverse events of transfusion-associated lung injury	adverse event of transfusion-associated lung injury	1	0	1081	2932	1083	
2562	summative continuous assessment	INFunknownSUP continuous assessment	1	0	2564	2563	238	
5800	serious risk	serious risk	1	0	1542	3164	1542	
36895	abnormal abdominal radiographs	abnormal abdominal radiograph	1	0	36897	13888	36899	
29386	world perspectives	world perspective	1	0	3304	4336	3304	
19850	cancer mortality	cancer mortality	1	0	1197	773	1197	
27567	current status of neurointervention	current status of neurointervention	1	0	27569	443	2720	
28111	NetCTLPan neural network of the Epitope Database	INFunknownSUP neural network of the Epitope Database	1	0	28113	28112	719	
31431	Student loan debt	student loan debt	1	0	3627	31432	3627	
24396	chromatographic test	chromatographic test	1	0	754	24397	754	
15972	non-respiratory infections	non-respiratory infection	1	0	779	15973	779	
24483	FDA approval	FDA approval	1	0	13952	24484	13952	
6144	second waves of the COVID-19 pandemic	second wave of the INFunknownSUP pandemic	1	0	6145	111	1281	
24280	stable pain	stable pain	1	0	729	18660	729	
33209	prospective cohort	prospective cohort	1	0	601	2084	601	
22775	predictive value of the combined model	predictive value of the combined model	1	0	22777	4314	1037	
26679	in-person exposure	in-person exposure	1	0	1054	9275	1054	
4733	asi como	asi INFunknownSUP	1	0	4735	4734	4735	
7342	agranulocytosis incidence	agranulocytosis incidence	1	0	2940	3588	2940	
37447	clinical spectrum	clinical spectrum	1	0	5866	884	5866	
32897	characteristics of patients	characteristic of patient	1	0	1496	60	1496	
30322	veno-venous extracorporeal membrane oxygenation	veno-venous extracorporeal membrane oxygenation	1	0	30324	30323	7365	
23396	Inorganic polyphosphates	inorganic polyphosphate	1	0	23398	23397	23398	
1111	suspected individuals	suspected individual	1	0	1113	1112	1113	
25829	understanding of the impact	understanding of the impact	1	0	2715	110	2715	
28344	dynamical model adjustment	dynamical model adjustment	1	0	28346	28345	28348	
11811	higher depression levels	high depression level	1	0	11813	322	169	
7543	standard equipment	standard equipment	1	0	3038	2056	3038	
34871	potential role of the pharmacist	potential role of the pharmacist	1	0	34873	1276	7288	
23903	patients Coronavirus	patient INFunknownSUP	1	0	3206	60	3206	
3529	malignant strokes	malignant stroke	1	0	3531	3530	3531	
35693	Overall PISQ-IR score	overall INFunknownSUP score	1	0	35695	29400	1843	
2348	responsible decisions	responsible decision	1	0	1942	2349	1942	
11568	observed data	observed datum	1	0	22	3762	22	
6401	vulnerable person	vulnerable person	1	0	6403	6402	6403	
13522	higher levels of motivation	high level of motivation	1	0	12250	13526	169	
33561	upper-middle-income economies	upper-middle-income economy	1	0	8542	33562	8542	
24549	SARS-CoV-2 infection Participants	INFunknownSUP infection participant	1	0	24553	1272	24553	
3887	enhanced well-being	enhanced well-being	1	0	2245	3888	2245	
5382	estimates of R0	estimate of INFunknownSUP	1	0	5370	5384	5370	
18672	factors of PS	factor of PS	1	0	583	18674	583	
26761	similar death rates	similar death rate	1	0	23263	102	83	
26489	novel triage pathway	novel triage pathway	1	0	17315	810	5003	
4135	safe social interaction alternatives	safe social interaction alternative	1	0	4137	4136	4141	
26234	complex healthcare innovation	complex INFunknownSUP innovation	1	0	26236	13320	19710	
1311	clinical years	clinical year	1	0	1313	884	1313	
34498	divergence filter	divergence filter	1	0	21666	34499	21666	
35506	COVID-19-related malignant cerebral strokes	COVID-19-related malignant cerebral stroke	1	0	35508	1384	3531	
5826	economic impact of an extended lockdown	economic impact of an extended INFunknownSUP	1	0	5828	108	110	
27828	neutralizing-antibody titers	neutralizing-antibody titer	1	0	8757	26723	8757	
3498	relevant protein receptor	relevant protein receptor	1	0	3500	346	3502	
26722	neutralizing-antibody responses	neutralizing-antibody response	1	0	200	26723	200	
12264	bronchiolitis epidemic period	INFunknownSUP epidemic period	1	0	12266	5471	5677	
2583	accessible web-based Arabic health information	accessible INFunknownSUP Arabic health information	1	0	2587	2584	2591	
16383	sampling periods	sampling period	1	0	873	11863	873	
35535	non-woven fibers	non-woven fiber	1	0	35537	656	35537	
1731	growth national product	growth national product	1	0	1733	1732	1735	
20031	sociodemographic questions	sociodemographic question	1	0	4066	20032	4066	
37454	20a strain	INFunknownSUP strain	1	0	1107	37455	1107	
31011	purposes of this study	purpose of this study	1	0	23055	2087	23055	
12556	trained mentors	trained mentor	1	0	8788	12557	8788	
29419	right decision	right decision	1	0	5486	15176	5486	
4119	antiviral prophylaxis	antiviral prophylaxis	1	0	4121	3989	4121	
26613	number of households	number of household	1	0	916	4614	916	
18150	trivial COVID-19 lesions	trivial INFunknownSUP lesion	1	0	18152	18151	162	
14736	care procedure	care procedure	1	0	4693	9	4693	
38279	short-term safety profile	short-term safety profile	1	0	38281	32443	3088	
63	infectious SARS-CoV-2 Alpha	infectious INFunknownSUP Alpha	1	0	65	64	67	
34939	higher respiratory system compliance	high respiratory system compliance	1	0	24338	322	2726	
9267	set metrics	set metric	1	0	9269	651	9269	
11626	active identification	active identification	1	0	57	3597	57	
17934	Diagnosis of Trivial Lesions	diagnosis of trivial lesion	1	0	10673	17936	10673	
30121	severe acute respiratory syndrome-coronavirus-2	severe acute respiratory INFunknownSUP	1	0	30123	262	30127	
4861	ps &lt	INFunknownSUP &lt	1	0	4863	4862	4863	
31476	effective tests	effective test	1	0	1365	2051	1365	
26194	unstructured individual interviews	unstructured individual interview	1	0	26196	26195	10034	
5125	potential metagenomic markers	potential INFunknownSUP marker	1	0	5127	1276	5129	
6151	infected children	infected child	1	0	6153	1088	6153	
10854	War II	War II	1	0	10856	2619	10856	
5451	final article	final article	1	0	3869	4256	3869	
21148	zoonotic beta coronavirus	INFunknownSUP beta coronavirus	1	0	21150	4605	339	
605	academic hospitals	academic hospital	1	0	76	606	76	
30817	und aerob-anaeroben	und INFunknownSUP	1	0	30819	30818	30819	
24246	resident deaths	resident death	1	0	553	2241	553	
16950	recurrencies tumors	recurrency tumor	1	0	16909	16951	16909	
23987	number of secondary cases	number of secondary case	1	0	916	21280	916	
18341	severe coronavirus disease	severe coronavirus disease	1	0	338	262	209	
38083	predilection of lower lobe	predilection of low lobe	1	0	38084	38085	38084	
38866	high-tech mannequin	high-tech mannequin	1	0	38868	10619	38868	
6278	effect of the pandemic	effect of the pandemic	1	0	1809	113	1809	
32550	Exhaustive assessment of Reunion Island inpatients	exhaustive assessment of Reunion Island inpatient	1	0	32552	32551	238	
7618	sensitivity of NO2 to lockdowns	sensitivity of INFunknownSUP to lockdown	1	0	7619	1486	2904	
34889	history of a personal contact	history of a personal contact	1	0	5381	34891	5381	
29096	screening station	screening station	1	0	29098	7961	29098	
3859	autonomic nervous system	autonomic nervous system	1	0	3861	3860	1327	
31548	Journal of the American Medical Association	Journal of the American Medical Association	1	0	5247	31550	5247	
18489	oral antibiotics	oral antibiotic	1	0	7194	427	7194	
13172	Binding-antibody responses	INFunknownSUP response	1	0	200	13173	200	
532	state-of-the-art technologies	state-of-the-art technology	1	0	70	533	70	
176	average time of the process	average time of the process	1	0	177	180	179	
8413	Anticipated Regulatory Network	anticipated Regulatory Network	1	0	8415	8414	7089	
28402	nonrespiratory clinical manifestations	nonrespiratory clinical manifestation	1	0	883	28403	885	
30939	healthy eaters	healthy eater	1	0	24289	1021	24289	
1901	numero de pruebas y el numero de profesionales de medicina	numero de INFunknownSUP y el numero de INFunknownSUP de INFunknownSUP	1	0	1903	1902	1919	
15985	traditional benchtop detection assays	traditional INFunknownSUP detection assay	1	0	15987	1966	2754	
5955	COVID-19:A Multicentric	INFunknownSUP INFunknownSUP	1	0	5957	5956	5957	
12794	column NO2 data	column INFunknownSUP datum	1	0	12796	12795	22	
8321	active metabolites	active metabolite	1	0	8323	3597	8323	
38106	interrupted time series analysis	interrupted time series analysis	1	0	38108	38107	486	
33238	consistent guidelines	consistent guideline	1	0	91	10429	91	
21396	arthroplasty volume	INFunknownSUP volume	1	0	3445	4243	3445	
29066	effect of renin-angiotensin-aldosterone system	effect of renin-angiotensin-aldosterone system	1	0	1809	29068	1809	
23140	care delivery mode	care delivery mode	1	0	18073	9	18075	
26545	public COVID-19 data	public INFunknownSUP datum	1	0	12497	1321	22	
15722	invasive surgical treatment of endometriosis	invasive surgical treatment of endometriosis	1	0	15724	6302	97	
34755	Pregnancy Current evidence	pregnancy current evidence	1	0	34757	34756	585	
23075	visual arts	visual art	1	0	23077	10196	23077	
24976	transpulmonary pressures	transpulmonary pressure	1	0	17663	24977	17663	
25148	external mandates	external mandate	1	0	25150	14485	25150	
17514	Perspective Clinical characteristics	Perspective clinical characteristic	1	0	1500	10704	1496	
32591	hypoxia-associated changes	hypoxia-associated change	1	0	1336	3843	1336	
1137	liver diseases	liver disease	1	0	315	1138	315	
12935	lack of economic security	lack of economic security	1	0	11210	12937	11210	
9575	prognostic stratification	prognostic stratification	1	0	3809	158	3809	
11990	spectrum of disease	spectrum of disease	1	0	5866	209	5866	
37951	Access Facility	Access Facility	1	0	37953	19648	37953	
38822	Renal Papillary Necrosis	renal papillary necrosis	1	0	38824	20184	38826	
2612	use policy governance	use policy governance	1	0	2614	292	2616	
38796	testing of the patient	testing of the patient	1	0	1885	710	1885	
31239	engineering teams	engineering team	1	0	5220	31240	5220	
27330	Otolaryngology research	otolaryngology research	1	0	36	27331	36	
33458	use of evidence	use of evidence	1	0	292	585	292	
33873	ulcerative keratitis	ulcerative keratitis	1	0	33875	1441	33875	
35336	Sars-CoV-2 infected patients	INFunknownSUP infected patient	1	0	8103	35337	60	
14028	additional subgroup analyses	additional subgroup analysis	1	0	14030	7175	4668	
23792	present cross sectional study	present cross sectional study	1	0	23794	285	2087	
19446	Polymerase chain reaction	polymerase chain reaction	1	0	2445	19447	2447	
8717	center COVID-19	center INFunknownSUP	1	0	40	8718	40	
15613	proportions of hospitalizations	proportion of hospitalization	1	0	15614	5091	15614	
26283	degree of agreement	degree of agreement	1	0	12635	11664	12635	
18254	logistic regression analysis	logistic regression analysis	1	0	18256	3803	486	
31676	second phase of the COVID-19 pandemic	second phase of the INFunknownSUP pandemic	1	0	31678	1279	1352	
29292	Labour program	Labour program	1	0	1790	29293	1790	
38780	creado un indice de letalidad relativa	creado un INFunknownSUP de letalidad INFunknownSUP	1	0	38782	38781	38790	
32131	pandemic era of COVID-19	pandemic era of INFunknownSUP	1	0	9794	1354	9542	
33931	daily environments	daily environment	1	0	1187	191	1187	
21094	administration of PPI	administration of PPI	1	0	631	8185	631	
28474	Oral Microbiota	Oral INFunknownSUP	1	0	28476	11717	28476	
13788	digital font	digital font	1	0	902	1094	902	
5053	Large-scale vaccination	large-scale vaccination	1	0	437	5054	437	
239	associated pericardial effusion	associated pericardial effusion	1	0	241	240	243	
6160	ECG devices	ECG device	1	0	6162	6161	6162	
19882	follow-up profiles	follow-up profile	1	0	6820	175	6820	
9651	Aerosol spread	aerosol spread	1	0	570	9652	570	
33574	protein P53	protein p53	1	0	33576	1797	33576	
31696	assessment tool	assessment tool	1	0	5487	238	5487	
30152	SARS-CoV-2 Receptor	INFunknownSUP receptor	1	0	13957	28	13957	
17821	protective goggles	protective goggle	1	0	2	1455	2	
32324	virus infectivity	virus infectivity	1	0	26717	778	26717	
12665	Validation of a Prognostic Nomogram	validation of a prognostic nomogram	1	0	12666	12667	12666	
31250	image points	image point	1	0	23	22960	23	
26397	attractive therapeutic target	attractive therapeutic target	1	0	11728	26398	11730	
36228	much uptake of health economics methods	much uptake of health economics method	1	0	36230	36229	19195	
33014	mental health outcomes	mental health outcome	1	0	263	118	263	
555	early outbreak data	early outbreak datum	1	0	557	55	22	
30125	respiratory syndrome-coronavirus-2	respiratory INFunknownSUP	1	0	30127	259	30127	
236	impact assessment	impact assessment	1	0	238	110	238	
24646	Intercellular communication	intercellular communication	1	0	11078	24647	11078	
8956	T cell receptors	T cell receptor	1	0	8960	8957	8960	
23647	intrinsic growth rate	intrinsic growth rate	1	0	23649	6392	1034	
19773	rapid adaption of the existing framework	rapid adaption of the existing framework	1	0	19775	795	2609	
9942	reinfection incidence rate	reinfection incidence rate	1	0	9944	1451	1034	
29348	biosynthesis of secondary metabolites etc.	biosynthesis of secondary metabolite etc.	1	0	29349	29350	29349	
7764	essential health care resources	essential health care resource	1	0	7766	4197	835	
2221	recent SARS coronavirus	recent INFunknownSUP coronavirus	1	0	2223	2128	339	
34970	collinear equations	collinear equation	1	0	3105	34971	3105	
21168	preparedness scores	preparedness score	1	0	3726	6467	3726	
7101	scalable monitoring tools	scalable monitoring tool	1	0	7103	7102	274	
21387	eran revisiones	INFunknownSUP INFunknownSUP	1	0	21389	21388	21389	
1241	physical health	physical health	1	0	120	1242	120	
11819	available divisions	available division	1	0	11821	832	11821	
32252	lack of attention to social distancing	lack of attention to social distancing	1	0	11210	32254	11210	
15933	citation trends of the articles	citation trend of the article	1	0	15935	15934	11700	
16168	next day	next day	1	0	6271	2624	6271	
15340	post-pandemic antibiotic stewardship Public health responses	post-pandemic antibiotic stewardship public health response	1	0	15342	14377	200	
39155	staff confidence	staff confidence	1	0	1793	11	1793	
20332	Significant differences	significant difference	1	0	5663	4575	5663	
8206	daily life of residents	daily life of resident	1	0	8208	191	1434	
5303	17 AS	17 AS	1	0	5305	5304	5305	
9146	number of cutaneous manifestations	number of cutaneous manifestation	1	0	916	9148	916	
2778	Medical Center	Medical Center	1	0	2780	2779	2780	
5749	associations of time	association of time	1	0	5750	179	5750	
31080	HBM factors	HBM factor	1	0	583	31081	583	
31716	Nephrology Training Program	Nephrology Training Program	1	0	31718	31717	25193	
7138	various clinical scenarios	various clinical scenario	1	0	7140	1099	7142	
19890	double-edged sword	double-edged sword	1	0	19892	19891	19892	
20230	type b	type b	1	0	20232	775	20232	
36225	Grey literature	Grey literature	1	0	4698	36226	4698	
37205	SARS COV2	INFunknownSUP INFunknownSUP	1	0	37207	2224	37207	
11309	register changes	register change	1	0	1336	11310	1336	
8872	medium length of stay	medium length of stay	1	0	1346	8873	1347	
8592	metabolomics analysis of serum	INFunknownSUP analysis of serum	1	0	8593	4556	486	
28765	detailed guidelines	detailed guideline	1	0	91	21498	91	
13046	foreign bodies	foreign body	1	0	8556	13047	8556	
6154	common trait	common trait	1	0	6156	699	6156	
25533	infected adults	infected adult	1	0	515	1088	515	
5501	Allogeneic donor-derived MSC therapies	INFunknownSUP INFunknownSUP MSC therapy	1	0	5505	5502	5507	
1093	digital revolution	digital revolution	1	0	1095	1094	1095	
17278	lack of sleep	lack of sleep	1	0	11210	15803	11210	
10925	social dimension	social dimension	1	0	10927	383	10927	
35129	specific immunity	specific immunity	1	0	257	2515	257	
16713	Approximate Bayesian Computation	approximate INFunknownSUP computation	1	0	16715	16714	16717	
36006	significant novel predictors of COVID-19 mortality	significant novel predictor of INFunknownSUP mortality	1	0	36008	908	414	
33228	direct patient care	direct patient care	1	0	4004	2012	9	
18760	- range	INFunknownSUP range	1	0	420	5345	420	
22874	high-flow oxygen	INFunknownSUP oxygen	1	0	3956	14899	3956	
32338	second reader	second reader	1	0	32340	1279	32340	
28539	Intensive Care Unit -ICUs-	intensive Care Unit INFunknownSUP	1	0	28545	28540	28545	
9203	dengue virus antigen	dengue virus antigen	1	0	9205	2344	9207	
30699	retinal nerve fiber	retinal nerve fiber	1	0	30701	22811	26292	
10618	high-tech laboratories	high-tech laboratory	1	0	9126	10619	9126	
14294	unilateral lung involvement	unilateral lung involvement	1	0	5122	14295	3599	
15175	right diagnosis	right diagnosis	1	0	2168	15176	2168	
38541	higher stress levels	high stress level	1	0	5949	322	169	
24236	adolescent treatment	adolescent treatment	1	0	97	24237	97	
17664	mechanisms of coronavirus	mechanism of INFunknownSUP	1	0	1456	17666	1456	
29356	COVID-19 Pandemic Currently Covid-19	INFunknownSUP pandemic Currently INFunknownSUP	1	0	29358	40	1884	
24472	emotional role	emotional role	1	0	7288	6765	7288	
17228	Prospective observational cohort study	prospective observational cohort study	1	0	17230	17229	2087	
10265	COVID-19 survivors	INFunknownSUP survivor	1	0	2732	40	2732	
21676	medical community	medical community	1	0	3641	947	3641	
26842	relation to the theory	relation to the theory	1	0	14883	21053	14883	
18211	pillar of medical systems	pillar of medical system	1	0	18212	18213	18212	
24218	Necrotizing enterocolitis	INFunknownSUP INFunknownSUP	1	0	24220	24219	24220	
706	61-year-old male patient	61-year-old male patient	1	0	708	707	710	
993	online readability calculator	online readability calculator	1	0	995	541	997	
24789	southern hemisphere countries	southern hemisphere country	1	0	24791	24790	1599	
14893	Adolescents Exposure to trauma	adolescent exposure to trauma	1	0	14895	1165	14896	
1855	promising outcomes	promising outcome	1	0	263	1856	263	
1736	general new viral pathogens	general new viral pathogen	1	0	1738	1080	1057	
6425	airway opening	airway opening	1	0	6427	2236	6427	
4012	Background immunity	background immunity	1	0	257	4013	257	
24589	national responses	national response	1	0	200	517	200	
35235	ocular disorders	ocular disorder	1	0	889	35236	889	
29050	SARS-CoV-2-positive patients	SARS-CoV-2-positive patient	1	0	60	14388	60	
21989	medical care workers	medical care worker	1	0	1134	947	1136	
35952	trained healthcare professionals	trained INFunknownSUP professional	1	0	634	12557	121	
30742	molecular networking	molecular networking	1	0	30744	6935	30744	
4824	1x PBS	1x PBS	1	0	4826	4825	4826	
5803	World Health Organisation	World Health Organisation	1	0	5805	5804	5807	
12922	databases of PubMed	database of INFunknownSUP	1	0	1755	7363	1755	
11965	COVID-19-associated pulmonary aspergillosis	COVID-19-associated pulmonary aspergillosis	1	0	11967	3357	11969	
24628	Clinical Progression Scale	clinical progression Scale	1	0	24630	1501	1203	
35626	different withanolides/ligands	different withanolides/ligand	1	0	35628	688	35628	
32649	progression to severe acute respiratory syndrome	progression to severe acute respiratory syndrome	1	0	4414	4710	4414	
7413	physical contact	physical contact	1	0	1888	1242	1888	
12962	aspects of IoT MEMS	aspect of INFunknownSUP mem	1	0	2429	1188	2429	
27080	part of the virus spike protein	part of the virus spike protein	1	0	734	27082	734	
27818	median infectious period	median infectious period	1	0	6873	2634	5677	
24412	Multisystem inflammatory syndrome	Multisystem inflammatory syndrome	1	0	24414	24413	1936	
38183	pandemic coronavirus disease	pandemic coronavirus disease	1	0	338	113	209	
37276	numerous compounds	numerous compound	1	0	14102	531	14102	
3066	endemic viral infections	endemic viral infection	1	0	3068	3067	779	
11751	Careful selection of patients	careful selection of patient	1	0	11753	11752	5520	
38571	better metabolism of this olfactory region	good metabolism of this olfactory region	1	0	38573	1635	7776	
15053	evidence of lymph node involvement	evidence of lymph node involvement	1	0	585	15055	585	
19469	log-rank test	INFunknownSUP test	1	0	754	19470	754	
1685	expert consensus statement	expert consensus statement	1	0	1682	1686	1684	
13116	genome sequence data	genome sequence datum	1	0	8666	2173	22	
6983	Appraisal Tool	appraisal Tool	1	0	6985	6984	6985	
31166	design tool	design tool	1	0	5487	4183	5487	
28862	left hemispheric syndrome	left hemispheric syndrome	1	0	28864	28863	1936	
6130	virus challenge	virus challenge	1	0	62	778	62	
38555	medical records	medical record	1	0	10747	947	10747	
12207	low-tech procedural simulator	low-tech procedural simulator	1	0	12209	12208	12211	
17732	extreme severity of shortness of breath	extreme severity of shortness of breath	1	0	17734	17733	5116	
16869	University Clinical Research Unit	University clinical Research Unit	1	0	16871	50	16875	
348	professional societies	professional society	1	0	350	234	350	
29111	progression to respiratory failure	progression to respiratory failure	1	0	4414	3360	4414	
19165	cohort analysis	cohort analysis	1	0	486	601	486	
27017	recovery of the olfactory function	recovery of the olfactory function	1	0	3007	20164	3007	
28415	serious adverse event	serious adverse event	1	0	28417	3164	14930	
8760	domain of the S1 subunit	domain of the INFunknownSUP subunit	1	0	697	8762	697	
15824	health care systems	health care system	1	0	15826	120	146	
27239	Multiple sequence alignment of ACE2	multiple sequence alignment of INFunknownSUP	1	0	27241	2198	3505	
31452	decrease of bronchiolitis cases	decrease of INFunknownSUP case	1	0	3084	31454	3084	
21901	variability of these RNA viruses	variability of these RNA virus	1	0	6407	3742	6407	
8736	Lung tissue	lung tissue	1	0	4974	8737	4974	
25275	numerous negative consequences	numerous negative consequence	1	0	25277	531	4289	
2358	whole risk chain	whole risk chain	1	0	2360	2359	2362	
20610	fifty-one COVID-19	INFunknownSUP INFunknownSUP	1	0	40	20611	40	
10444	complex of S1	complex of INFunknownSUP	1	0	10445	8763	10445	
2873	Assessment of the intensity	Assessment of the intensity	1	0	2874	2875	2874	
34993	combination of ventricular strain	combination of ventricular strain	1	0	367	34995	367	
13609	Spain Non-pharmaceutical interventions	Spain non-pharmaceutical intervention	1	0	13611	13610	757	
7103	monitoring tools	monitoring tool	1	0	274	3271	274	
19994	31-year-old male patient	31-year-old male patient	1	0	708	19995	710	
1200	Dysarthria Severity	INFunknownSUP severity	1	0	1202	1201	1202	
35538	% false negatives	% false negative	1	0	35540	364	35542	
7797	severe respiratory complications	severe respiratory complication	1	0	7799	262	705	
35698	confirmed SARS-CoV-2 infection	confirmed INFunknownSUP infection	1	0	41	35699	41	
35744	satisfaction of an 8-session online MBI	satisfaction of an INFunknownSUP online MBI	1	0	106	35746	106	
1559	positioning of pharmacists	positioning of pharmacist	1	0	1560	1561	1560	
28014	significant impact of type of orientation	significant impact of type of orientation	1	0	28015	28018	110	
11321	health care industry	health care industry	1	0	11323	120	2109	
2396	gap of evaluation of private health insurance companies	gap of evaluation of private health insurance company	1	0	2397	2398	2397	
14175	intervention period	intervention period	1	0	5677	5608	5677	
11571	interview scale	interview scale	1	0	2422	11572	2422	
11391	Distance Education Learning Environment Scale	Distance Education Learning Environment Scale	1	0	11393	6140	1203	
12765	tracheostomy simulation training	tracheostomy simulation training	1	0	12767	12766	235	
21420	last decade	last decade	1	0	21422	3723	21422	
26848	absolute value	absolute value	1	0	1037	1302	1037	
35294	awareness of COVID-19	awareness of INFunknownSUP	1	0	1612	40	1612	
28225	mean age of participants	mean age of participant	1	0	19216	4950	906	
14406	genetic evidence	genetic evidence	1	0	585	6655	585	
932	vector machine	vector machine	1	0	934	933	934	
10334	bilateral lungs	bilateral lung	1	0	10336	10335	10336	
34103	Patient Health Questionnaire-9	Patient Health INFunknownSUP	1	0	34105	34104	34107	
8436	severity-of-illness assessment	severity-of-illness assessment	1	0	238	8437	238	
27847	vaccination of SARS-CoV-2 convalescents Anti-viral immunity	vaccination of INFunknownSUP convalescent anti-viral immunity	1	0	437	27849	437	
15849	paediatric urological productivity	paediatric urological productivity	1	0	15851	974	7145	
26930	preliminary evidence base	preliminary evidence base	1	0	17783	11891	3323	
1529	COVID-19 patients Studies	INFunknownSUP patient study	1	0	1531	40	1533	
8038	therapeutic procedures	therapeutic procedure	1	0	4200	3349	4200	
6079	high proportion	high proportion	1	0	910	13	910	
36465	metabolite kynurenic acid	metabolite INFunknownSUP acid	1	0	36129	17224	7492	
6718	boosts antibody	boost antibody	1	0	5924	6719	5924	
18346	healthy hospital workers	healthy hospital worker	1	0	18348	1021	1136	
33713	quality of healthcare services	quality of INFunknownSUP service	1	0	3713	6491	3713	
2135	population impacts	population impact	1	0	1385	1838	1385	
21785	situation of global fight	situation of global fight	1	0	3056	21787	3056	
5185	bei gut-trainierten	bei INFunknownSUP	1	0	5187	5186	5187	
8036	elective therapeutic procedures	elective therapeutic procedure	1	0	8038	1627	4200	
4015	ultra-violet index	ultra-violet index	1	0	4017	4016	4017	
23200	periods of population quarantine	period of population quarantine	1	0	873	23202	873	
29715	SARS-CoV1 outbreak	INFunknownSUP outbreak	1	0	310	29716	310	
2342	diagnosis of dengue	diagnosis of dengue	1	0	2168	2344	2168	
28965	safety of anakinra	safety of INFunknownSUP	1	0	6729	10687	6729	
18972	COVID-19 eyes	INFunknownSUP eye	1	0	18974	40	18974	
2064	nimble implementation	nimble implementation	1	0	396	2065	396	
11163	Infection Severe acute respiratory syndrome	infection severe acute respiratory syndrome	1	0	9924	9866	1936	
21953	work-based learning	INFunknownSUP learning	1	0	2390	21954	2390	
37728	treatment outcomes of patients	treatment outcome of patient	1	0	29649	97	263	
14870	primary treatment	primary treatment	1	0	97	75	97	
24966	residents of nursing homes	resident of nursing home	1	0	232	13527	232	
4833	Vo Euganeo	Vo INFunknownSUP	1	0	4835	4834	4835	
37472	antibiotic treatment	antibiotic treatment	1	0	97	8615	97	
20353	critical role	critical role	1	0	7288	223	7288	
32603	impact of societal changes	impact of societal change	1	0	110	32605	110	
13433	form antibody	form antibody	1	0	5924	11121	5924	
19131	SAR-CoV-2 infection	INFunknownSUP infection	1	0	41	19132	41	
16595	use case	use case	1	0	3368	292	3368	
34029	B.1 variant	B.1 variant	1	0	939	34030	939	
4178	socioeconomic status	socioeconomic status	1	0	2720	16	2720	
3737	universal testing	universal testing	1	0	1885	3738	1885	
31869	health consequences	health consequence	1	0	4289	120	4289	
2841	major challenges	major challenge	1	0	2220	1318	2220	
17838	variant 501.V2	variant INFunknownSUP	1	0	17840	17839	17840	
34272	epidemiological model	epidemiological model	1	0	1078	18107	1078	
25496	vaccine candidates	vaccine candidate	1	0	4790	577	4790	
24240	research teamwork	research teamwork	1	0	3839	36	3839	
38406	genetic content	genetic content	1	0	6700	6655	6700	
8686	integration of OTC supplements	integration of OTC supplement	1	0	918	7967	918	
6621	COVID-19 immunotherapy	INFunknownSUP immunotherapy	1	0	6623	40	6623	
27353	stated ceiling of treatment	stated ceiling of treatment	1	0	27355	27354	27356	
2421	scale RNA secondary structure	scale RNA secondary structure	1	0	2423	2422	2427	
8299	financial planning	financial planning	1	0	5774	547	5774	
7951	Accessibility Guidelines	accessibility guideline	1	0	2501	7952	2501	
24563	Oxford University Hospitals	Oxford University Hospitals	1	0	12485	16868	12487	
949	access to hospital	access to hospital	1	0	224	185	224	
32383	series of pediatric general surgery cases	series of pediatric general surgery case	1	0	8050	32385	8050	
27234	chest CT examination	chest CT examination	1	0	1800	24	1800	
19916	air sampling study	air sampling study	1	0	2087	19917	2087	
31213	ambient NO2 levels	ambient INFunknownSUP level	1	0	31215	11598	169	
6600	neurological complaints	neurological complaint	1	0	4344	2728	4344	
29103	memory activation	memory activation	1	0	1013	7635	1013	
6705	world economy	world economy	1	0	6605	4336	6605	
29412	general population of Arabic speakers	general population of Arabic speaker	1	0	1836	29416	1838	
32261	evolution to a serious disease	evolution to a serious disease	1	0	3741	17469	3741	
31119	obese patient metabolism	obese patient metabolism	1	0	7776	31120	7776	
21569	potent inhibitors	potent inhibitor	1	0	8870	1408	8870	
22527	Rapid reviews	rapid review	1	0	2554	20378	2554	
10890	outcome of patients	outcome of patient	1	0	295	60	295	
6781	Twenty-one mathematical models	twenty-one mathematical model	1	0	5597	6782	3975	
23081	COVID-19-positive patient	COVID-19-positive patient	1	0	710	3218	710	
31100	extreme stress levels	extreme stress level	1	0	5949	17733	169	
1452	systemic protective mechanisms	systemic protective mechanism	1	0	1454	1453	1456	
32840	asynchronous online anatomy teaching	asynchronous online anatomy teaching	1	0	32842	1997	2074	
24774	novel mutation signature	novel mutation signature	1	0	24776	810	19531	
3931	clinical utility of this imaging technique	clinical utility of this imaging technique	1	0	3933	884	3934	
27643	delayed emergency department access	delayed emergency department access	1	0	13855	4161	224	
4278	gut microbiota shifts of COVID-19 patients	gut microbiota shift of INFunknownSUP patient	1	0	4282	1041	4283	
17571	registration number	registration number	1	0	916	17572	916	
9017	purpose of this scoping review	purpose of this INFunknownSUP review	1	0	4098	9019	4098	
27012	higher mortality rates	high mortality rate	1	0	4976	322	83	
13825	Immunological analyses	immunological analysis	1	0	4668	13826	4668	
10907	psychiatric illness	psychiatric illness	1	0	1069	4594	1069	
34743	COVID-19 restrictions	INFunknownSUP restriction	1	0	2880	3706	2880	
29587	impact of SARS-CoV-2 infection	impact of INFunknownSUP infection	1	0	110	1272	110	
7487	understanding of the disease	understanding of the disease	1	0	2715	209	2715	
1597	federal countries	federal country	1	0	1599	1598	1599	
36232	health economics methods	health economics method	1	0	205	7753	205	
30065	Pediatric radiology	pediatric radiology	1	0	30067	401	30067	
28156	Clavien-Dindo classification	INFunknownSUP classification	1	0	1121	28157	1121	
26467	digital content	digital content	1	0	6700	1094	6700	
33156	safety profile of vedolizumab	safety profile of INFunknownSUP	1	0	33158	6729	3088	
30231	Taiwan Coronavirus disease	Taiwan INFunknownSUP disease	1	0	6281	48	209	
32931	cell surface receptor	cell surface receptor	1	0	32933	197	3502	
22133	% decreases	% decrease	1	0	165	364	165	
29001	traditional regulatory philosophy	traditional regulatory philosophy	1	0	29003	1966	19989	
21246	solid-organ transplant recipients	solid-organ transplant recipient	1	0	21248	21247	11385	
30176	new coronavirus disease	new coronavirus disease	1	0	209	5297	209	
21736	selected schools	selected school	1	0	6421	1620	6421	
866	L-1 air	L-1 air	1	0	868	867	868	
11122	COVID-19 infection Individual susceptibility	INFunknownSUP infection individual susceptibility	1	0	11124	40	10460	
2567	multiple doses	multiple dose	1	0	678	1776	678	
13319	complex associations	complex association	1	0	5750	13320	5750	
31120	obese patient	obese patient	1	0	2645	2170	2645	
7266	chi-square method	chi-square method	1	0	6587	7267	6587	
32690	diversity of SARS coronavirus	diversity of INFunknownSUP coronavirus	1	0	8993	2223	8993	
1523	XGBoost algorithm	INFunknownSUP algorithm	1	0	1525	1524	1525	
33212	% males	% male	1	0	5044	364	5044	
5031	global outbreak	global outbreak	1	0	310	1954	310	
19533	COVID-19 at-scale	INFunknownSUP at-scale	1	0	19535	40	19535	
33328	negative results	negative result	1	0	325	1338	325	
8265	clinical trial setting	clinical trial setting	1	0	8267	884	2854	
2078	asymptomatic HCW	asymptomatic INFunknownSUP	1	0	2080	1131	2080	
5997	early stage of the COVID-19 outbreak	early stage of the INFunknownSUP outbreak	1	0	5998	308	1521	
39044	important weapon	important weapon	1	0	39046	273	39046	
5609	current scenario	current scenario	1	0	5611	443	5611	
17661	substantial pressures	substantial pressure	1	0	17663	3239	17663	
25329	parts of the World	part of the World	1	0	4335	5804	4335	
24486	vaccine-induced population immunity	INFunknownSUP population immunity	1	0	2459	12390	257	
32762	preterm infant	INFunknownSUP infant	1	0	32764	32763	32764	
22450	Methods of COVID-19	method of INFunknownSUP	1	0	6982	40	6982	
13365	SARS-CoV-2 positivity	INFunknownSUP INFunknownSUP	1	0	1238	28	1238	
33247	horse showing	horse showing	1	0	33249	13037	33249	
25197	ethnic minority group	ethnic minority group	1	0	18	14549	18	
31648	Intensitatsbereich durchgefuhrt werden	Intensitatsbereich INFunknownSUP INFunknownSUP	1	0	31650	31649	31652	
38394	risk of AKI	risk of Aki	1	0	1542	13007	1542	
11101	strong heterogeneity of the antibody response	strong heterogeneity of the antibody response	1	0	11103	3987	1972	
12659	intrathoracic pressure	intrathoracic pressure	1	0	1027	12660	1027	
13410	Face mask:A potential source of phthalate exposure	Face INFunknownSUP potential source of phthalate exposure	1	0	13412	12272	1971	
39097	low levels of digital literacy	low level of digital literacy	1	0	39098	31742	169	
30256	presence of SARS-CoV2	presence of INFunknownSUP	1	0	675	30258	675	
6070	psychological assessment	psychological assessment	1	0	238	1380	238	
32009	Detection of SARS-CoV-2 B.1.617.2	detection of INFunknownSUP B.1.617.2	1	0	32013	17386	32013	
26131	Search strategies	search strategy	1	0	300	26132	300	
7458	companion virtue to compassion	companion virtue to compassion	1	0	7459	7462	7461	
33667	mobile apps	mobile INFunknownSUP	1	0	17206	3414	17206	
27813	economic growth	economic growth	1	0	1732	108	1732	
37876	response to the COVID-19 pandemic	response to the INFunknownSUP pandemic	1	0	409	111	409	
9656	ophthalmological examination	ophthalmological examination	1	0	1800	9657	1800	
13377	differential stability	differential stability	1	0	11137	3104	11137	
30657	crop production	crop production	1	0	654	30658	654	
28519	Early Warning Score	Early Warning score	1	0	28521	28520	28523	
24343	bone marrow	bone marrow	1	0	24345	24344	24345	
16710	structural network	structural network	1	0	719	3549	719	
4147	effects of altered home-lives	effect of altered home-life	1	0	156	4149	156	
18662	VIDAS SARS-COV-2 IgG	Vidas INFunknownSUP IgG	1	0	18664	7112	928	
341	systematic search of relevant studies	systematic search of relevant study	1	0	342	345	344	
10791	microscopy imaging	microscopy imaging	1	0	3936	10792	3936	
2790	Sewage Tests	sewage test	1	0	2792	2791	2792	
25299	ongoing outbreak of a novel coronavirus	ongoing outbreak of a novel coronavirus	1	0	25301	1059	310	
4122	percent of referrals	percent of referral	1	0	4123	4124	4123	
23255	times of global emergency	time of global emergency	1	0	12806	3078	12806	
869	regular control periods	regular control period	1	0	871	870	873	
10979	sequenced isolates	INFunknownSUP isolate	1	0	10981	10980	10981	
26657	family dynamics	family dynamics	1	0	3694	5380	3694	
18334	bilateral rectal/orbital gyrus	bilateral rectal/orbital gyrus	1	0	18336	10335	18043	
33865	measurable benefit	measurable benefit	1	0	297	33789	297	
5166	acute kidney failure	acute kidney failure	1	0	5168	1461	1779	
15359	Elevated hs-TnI	elevated INFunknownSUP	1	0	10112	15360	10112	
4620	global health emergency	global health emergency	1	0	4622	1954	447	
18703	international discussion of the effects of the COVID-19 pandemic	international discussion of the effect of the INFunknownSUP pandemic	1	0	7589	4086	3060	
22250	risk of SARS-CoV-2 transmission	risk of INFunknownSUP transmission	1	0	1542	15860	1542	
39049	integrated service delivery model	integrated service delivery model	1	0	39051	507	1078	
4459	iterative discussion of examples	iterative discussion of example	1	0	4461	4460	3060	
26405	clinical study of COVID-19	clinical study of INFunknownSUP	1	0	16630	40	2087	
25985	objective measure of efficacy	objective measure of efficacy	1	0	25987	8297	2466	
17122	Society of Endoscopic Surgery	Society of endoscopic surgery	1	0	17123	17124	17123	
36747	US health care delivery system	US health care delivery system	1	0	36749	3316	1327	
3473	Group A	Group A	1	0	3475	1845	3475	
24649	approach matters	approach matter	1	0	16589	1538	16589	
17985	convenient tool	convenient tool	1	0	5487	17986	5487	
23439	sustained introductions	sustained introduction	1	0	17718	21711	17718	
36749	health care delivery system	health care delivery system	1	0	36751	120	1327	
22849	molecular levels	molecular level	1	0	169	6935	169	
36961	Antimicrobial Resistance Patterns	Antimicrobial resistance pattern	1	0	36963	36962	24738	
29457	Stereotactic ablative body radiotherapy	stereotactic ablative body radiotherapy	1	0	29459	29458	29463	
18790	case report	case report	1	0	378	3368	378	
13896	management plan	management plan	1	0	1225	743	1225	
38855	regard to the bariatric population	regard to the bariatric population	1	0	38856	38857	38856	
38219	economic logic model	economic logic model	1	0	38221	108	1078	
32775	presentation of SARS-CoV-2	presentation of INFunknownSUP	1	0	4163	28	4163	
3926	transition experience	transition experience	1	0	2782	2091	2782	
10106	release of patients	release of patient	1	0	3720	60	3720	
5411	software quality	software quality	1	0	3713	5231	3713	
12119	anti-inflammatory agent dexamethasone	anti-inflammatory agent INFunknownSUP	1	0	12121	9193	12123	
1828	Kaplan-Meier analysis	Kaplan-Meier analysis	1	0	486	1829	486	
13278	EUROIMMUN SARS-CoV-2 IgG ELISA kit	INFunknownSUP INFunknownSUP IgG Elisa kit	1	0	13280	13279	567	
34380	prescriber specialty	prescriber specialty	1	0	27511	34381	27511	
35435	aspects of participant sociodemographic	aspect of participant INFunknownSUP	1	0	2429	35437	2429	
35881	treatment rooms	treatment room	1	0	35883	97	35883	
38349	individual-level risk	individual-level risk	1	0	1542	38350	1542	
29225	preoperative systemic therapy	preoperative systemic therapy	1	0	29227	16447	2273	
26861	% of power	% of power	1	0	364	7608	364	
15328	drug development	drug development	1	0	73	352	73	
21425	Health Interventions	Health intervention	1	0	12708	279	12708	
1340	intensive care unit length of stay	intensive care unit length of stay	1	0	1346	6	1347	
13989	Lasair II Particle	INFunknownSUP II particle	1	0	13991	13990	13993	
8600	hematological cancers	hematological cancer	1	0	8602	8601	8602	
5120	radiographic lung involvement	radiographic lung involvement	1	0	5122	5121	3599	
24494	average ratio	average ratio	1	0	2635	178	2635	
4553	anti-SARS-CoV-2 serum antibodies	INFunknownSUP serum antibody	1	0	4555	4554	929	
26066	impacts of direct COVID-19 infection	impact of direct INFunknownSUP infection	1	0	1385	26068	1385	
8281	type of necessary oxygen support	type of necessary oxygen support	1	0	775	8283	775	
37022	positive SARS-CoV-2 antibody results	positive INFunknownSUP antibody result	1	0	37024	228	325	
26385	use of camostat mesylate	use of INFunknownSUP INFunknownSUP	1	0	292	10356	292	
15055	lymph node involvement	lymph node involvement	1	0	15057	13682	3599	
479	COVID-19 pandemic declaration	INFunknownSUP pandemic declaration	1	0	483	111	483	
20326	careful investigation	careful investigation	1	0	7714	6949	7714	
2476	Recent data	Recent datum	1	0	22	2477	22	
922	cerebrovascular disease	cerebrovascular disease	1	0	209	923	209	
7777	regression of life expectancy	regression of life expectancy	1	0	5036	4404	5036	
20644	regions of OC43	region of INFunknownSUP	1	0	5240	20646	5240	
13092	% of the females	% of the female	1	0	364	11037	364	
27725	production issues	production issue	1	0	3758	654	3758	
18919	safe levels	safe level	1	0	169	4136	169	
26565	Technology to Measure Older Adults	technology to measure old adult	1	0	26566	26567	26566	
29873	SC2 receptor	INFunknownSUP receptor	1	0	3502	4801	3502	
7730	Artificial Intelligence-Based Model	artificial INFunknownSUP Model	1	0	7732	7731	7734	
30991	precarious respiratory status	precarious respiratory status	1	0	30993	30992	2720	
28893	data-augmented deep learning models	data-augmented deep learning model	1	0	3971	28894	3975	
14130	HRB open databases	HRB open database	1	0	14132	14131	1755	
29732	immunologic manifestations of the disease	immunologic manifestation of the disease	1	0	29734	29733	885	
28826	immune hemolysis	immune hemolysi	1	0	28828	970	28828	
5442	variety of better disease-specific clinical outcomes	variety of good disease-specific clinical outcome	1	0	881	5444	881	
31928	preventive behavior	preventive behavior	1	0	16069	6893	16069	
36378	P value &lt	P value &lt	1	0	36380	13223	4863	
5833	mining of huge raw datasets	mining of huge raw INFunknownSUP	1	0	5834	5835	5834	
18329	Higher in-hospital mortality	high in-hospital mortality	1	0	1869	4887	1197	
18809	user feedback	user feedback	1	0	10216	12911	10216	
36621	greater acceptance of remote web-based pulmonary rehabilitation programme models	great acceptance of remote INFunknownSUP pulmonary rehabilitation programme model	1	0	36623	302	1248	
37475	mixed ground-glass	mixed ground-glass	1	0	525	9227	525	
29250	injection site	injection site	1	0	11198	26275	11198	
30830	der objektiven Leistungsparameter	der INFunknownSUP Leistungsparameter	1	0	30832	30831	30834	
35606	levels of anti-S Abs	level of INFunknownSUP Abs	1	0	169	2658	169	
29621	burden of disease	burden of disease	1	0	1070	209	1070	
19836	Nucleocapsid reactivity	INFunknownSUP reactivity	1	0	8022	19837	8022	
30803	different changes	different change	1	0	1336	688	1336	
14036	Global News	Global News	1	0	14038	14037	14038	
26036	systematic literature search	systematic literature search	1	0	7360	343	344	
18593	positive/suspected patients	positive/suspected patient	1	0	60	18594	60	
28277	public media	public medium	1	0	661	1321	661	
15958	online sample	online sample	1	0	2757	541	2757	
35290	human angiotensin-converting	human INFunknownSUP	1	0	11587	2214	11587	
9880	scientific fields	scientific field	1	0	9882	2290	9882	
30189	oliguric acute kidney injury Acute kidney injury	INFunknownSUP acute kidney injury acute kidney injury	1	0	30191	24453	713	
15567	characterization of monoclonal antibodies	characterization of monoclonal antibody	1	0	7023	15569	7023	
1124	spike proteins	spike protein	1	0	1126	31	1126	
39212	Health Insurance-contracted hospitals	Health INFunknownSUP hospital	1	0	39214	279	76	
29447	effective screening method	effective screening method	1	0	29449	2051	6587	
36714	significant contribution to improvements	significant contribution to improvement	1	0	36716	908	6316	
33682	dose vaccination	dose vaccination	1	0	437	2537	437	
24270	dropout rate	dropout rate	1	0	1034	24271	1034	
38103	strong preference	strong preference	1	0	4438	3987	4438	
15724	surgical treatment of endometriosis	surgical treatment of endometriosis	1	0	662	9860	97	
24989	significant improvement	significant improvement	1	0	10698	908	10698	
6697	lecture content delivery	lecture content delivery	1	0	2840	6698	2840	
563	portable detection kit	portable detection kit	1	0	565	564	567	
31536	specific characteristics	specific characteristic	1	0	1496	2515	1496	
4610	mean number of households	mean number of household	1	0	914	4614	916	
12955	mean time interval	mean time interval	1	0	1794	12956	1794	
3423	clinics of medical centers	clinic of medical center	1	0	3424	3425	3424	
13973	risk of infection	risk of infection	1	0	1542	41	1542	
12436	response prevention	response prevention	1	0	1294	409	1294	
11482	Protection challenges of pregnant women	Protection challenge of pregnant woman	1	0	11484	11483	2220	
36420	satisfied low detection limit	satisfied low detection limit	1	0	36422	36421	1141	
13679	enlargement of lymph node	enlargement of lymph node	1	0	13680	13681	13680	
25356	SARS-CoV-2 nucleocapsid	INFunknownSUP INFunknownSUP	1	0	25358	28	25358	
14335	various food choice determinants	various food choice determinant	1	0	14337	1099	14341	
15878	Anxiety Disorder-7 scale	anxiety INFunknownSUP scale	1	0	15880	15879	2422	
9195	various state-of-the-art methods	various state-of-the-art method	1	0	9197	1099	205	
26328	estudio piloto prospectivo	INFunknownSUP INFunknownSUP INFunknownSUP	1	0	26332	26329	26332	
1631	crazy paving	crazy paving	1	0	1633	1632	1633	
38364	body ingestions	body ingestion	1	0	38366	2710	38366	
22161	Acute Respiratory Disease Coronavirus	acute respiratory disease INFunknownSUP	1	0	22163	14013	3206	
28055	infectious disease morbidity	infectious disease morbidity	1	0	1216	4216	1216	
9493	order mathematical model	order mathematical model	1	0	9495	9494	1078	
20666	role of children	role of child	1	0	7288	6153	7288	
30083	employment of female workers	employment of female worker	1	0	13090	22442	13090	
37483	Kynurenic acid	INFunknownSUP acid	1	0	7492	37484	7492	
17009	saving of $1.90	saving of INFunknownSUP	1	0	17010	17011	17010	
4154	wide application	wide application	1	0	125	4155	125	
34647	cytokine-producing polyfunctional T cells	cytokine-producing polyfunctional T cell	1	0	34649	34648	133	
11007	Harvard University	Harvard University	1	0	50	11008	50	
32478	m distance	m distance	1	0	32480	32479	32480	
4522	high morbidity	high morbidity	1	0	1216	13	1216	
13044	diagnoses of foreign bodies	diagnosis of foreign body	1	0	13045	13046	13045	
15232	wave of the coronavirus disease	wave of the coronavirus disease	1	0	10210	338	10210	
35513	structure analyses	structure analysis	1	0	4668	2427	4668	
14808	surgical site infection	surgical site infection	1	0	41	14809	41	
990	sixty-six patients	INFunknownSUP patient	1	0	60	991	60	
17439	% of malarial patients	% of malarial patient	1	0	364	17441	364	
37121	invitation sources	invitation source	1	0	4158	37122	4158	
13634	part of an agile approach	part of an agile approach	1	0	734	13636	734	
12098	Diagnostic performance	diagnostic performance	1	0	598	12099	598	
10710	whole Syrian hamster lung lobes	whole Syrian hamster lung lobe	1	0	2667	2359	2673	
22928	entire cohort	entire cohort	1	0	601	2269	601	
28988	factorial design	factorial design	1	0	4183	28989	4183	
36577	major complications of coronavirus disease	major complication of coronavirus disease	1	0	36579	1318	705	
31191	surgical mask use cohort	surgical mask use cohort	1	0	601	24717	601	
2962	university-based referral	university-based referral	1	0	2964	2963	2964	
2625	stages of the pandemic response	stage of the pandemic response	1	0	766	2627	766	
25770	minimum of social distancing	minimum of social distancing	1	0	25771	382	25771	
26935	medical discharge	medical discharge	1	0	26786	947	26786	
22248	lower risk of SARS-CoV-2 transmission	low risk of INFunknownSUP transmission	1	0	22250	594	1542	
19157	step-by-step protocol	step-by-step protocol	1	0	7962	7211	7962	
12991	study participants	study participant	1	0	4950	2087	4950	
19219	protective behaviours	protective behaviour	1	0	19221	1455	19221	
25547	Heart failure management	Heart failure management	1	0	25549	25548	743	
13784	target recognition of digital font	target recognition of digital font	1	0	13786	11730	13787	
18617	valuable new arena	valuable new arena	1	0	18619	9515	18621	
9180	Continuous Negative Pressure	continuous negative pressure	1	0	9182	9181	9184	
29678	passive transfer of diluted postvaccination polyclonal antibodies	passive transfer of diluted postvaccination polyclonal antibody	1	0	29680	29679	10218	
5837	raw datasets	raw INFunknownSUP	1	0	4432	5838	4432	
8373	context of the worldwide outbreak of severe acute respiratory syndrome coronavirus	context of the worldwide outbreak of severe acute respiratory syndrome coronavirus	1	0	1567	8375	1567	
16734	quality of COVID-19-related information	quality of COVID-19-related information	1	0	3713	16056	3713	
2038	el primer ano de pandemia	el primer Ano de INFunknownSUP	1	0	2040	1910	2046	
37909	Artery Infarction	artery infarction	1	0	37911	37910	37911	
9578	need of respiratory support	need of respiratory support	1	0	9579	258	9579	
12020	instrument TROPOMI	instrument INFunknownSUP	1	0	7262	7265	7262	
2121	ethnic census	ethnic census	1	0	2123	2122	2123	
13743	current interest	current interest	1	0	7989	443	7989	
13260	IL-1R2+ neutrophils	INFunknownSUP neutrophil	1	0	4740	13261	4740	
20987	in-patient beds	in-patient bed	1	0	17283	20988	17283	
20085	development of significant capabilities	development of significant capability	1	0	73	20087	73	
17081	inpatient stay	inpatient stay	1	0	1348	3339	1348	
7210	step-by-step schedule	step-by-step schedule	1	0	7212	7211	7212	
4775	human ACE2 receptor	human INFunknownSUP receptor	1	0	4777	2214	3502	
23272	simple interventions	simple intervention	1	0	757	2770	757	
35603	in-hospital isolation	in-hospital isolation	1	0	6569	411	6569	
34225	Disability weights	disability weight	1	0	34227	12473	34227	
6504	high-cost high-need Medicare patients	high-cost INFunknownSUP Medicare patient	1	0	6506	6505	60	
38484	percutaneous dilatation technique	percutaneous INFunknownSUP technique	1	0	38486	36775	562	
11026	Research Ethics Committee	Research Ethics Committee	1	0	11028	3674	11030	
859	clusters of respondents	cluster of respondent	1	0	860	861	860	
33707	Scans Background	scan background	1	0	4013	33708	4013	
20275	Eukaryotic Cell-Free	INFunknownSUP INFunknownSUP	1	0	20277	20276	20277	
37067	body entrance	body entrance	1	0	37069	2710	37069	
22194	minor scalp wound infections	minor scalp wound infection	1	0	22196	22195	779	
20782	half of the HCWs indicated discomfort	half of the INFunknownSUP indicated discomfort	1	0	6059	20784	6059	
38524	chest X-ray	chest X-ray	1	0	10098	25	10098	
27631	Virus Disease	virus Disease	1	0	5148	12462	5148	
22180	Certolizumab Pegol	INFunknownSUP INFunknownSUP	1	0	22182	22181	22182	
19652	source of antigen	source of antigen	1	0	1971	9207	1971	
4439	high-efficiency particle air filters	high-efficiency particle air filter	1	0	4441	4440	4445	
13061	pressure:on patients	INFunknownSUP patient	1	0	60	13062	60	
24306	history of Bipolar disorder	history of bipolar disorder	1	0	5381	24308	5381	
20519	bulletins of the Italian National Institute	bulletin of the Italian National Institute	1	0	20520	20521	20520	
17177	higher grades	high grade	1	0	13725	322	13725	
21483	Hundreds of research papers	hundred of research paper	1	0	21484	21485	21484	
5511	clinical routine	clinical routine	1	0	5513	884	5513	
26311	insurance agencies	insurance agency	1	0	26313	1711	26313	
36121	suitable combination of antibody	suitable combination of antibody	1	0	36123	24614	367	
24739	timing of intervention	timing of intervention	1	0	9056	5608	9056	
11061	bubble size	bubble size	1	0	6366	11062	6366	
23590	nocturnal haemoglobinuria	nocturnal haemoglobinuria	1	0	23592	23591	23592	
21105	dimension of integration	dimension of integration	1	0	10927	918	10927	
13807	usage of IGHV3-53/3-66 germline genes	usage of IGHV3-53/3-66 INFunknownSUP gene	1	0	2248	13809	2248	
23759	% required admission to the intensive care unit	% required admission to the intensive care unit	1	0	23761	364	2865	
4956	low number of personal protective equipment	low number of personal protective equipment	1	0	4958	457	916	
7403	duration of nasopharyngeal positivity	duration of nasopharyngeal INFunknownSUP	1	0	7404	7405	7404	
8122	Spike residue	Spike residue	1	0	8124	8123	8124	
14352	socioeconomic characteristics of the communities	socioeconomic characteristic of the community	1	0	14354	16	1496	
29682	diluted postvaccination polyclonal antibodies	diluted postvaccination polyclonal antibody	1	0	29684	29683	929	
15047	Lung ultrasound	Lung ultrasound	1	0	4246	2415	4246	
12818	symptomatic people	symptomatic people	1	0	694	38	694	
25995	acute clinical manifestations	acute clinical manifestation	1	0	883	1461	885	
21968	outpatient department	outpatient department	1	0	13318	327	13318	
33696	intestinal infections	intestinal infection	1	0	779	15756	779	
33040	microm-sized particles	microm-sized particle	1	0	8275	33041	8275	
10400	positive findings	positive finding	1	0	3390	228	3390	
27742	Select random effects model	select random effect model	1	0	27744	27743	1078	
37850	dietary nutrient intake	dietary nutrient intake	1	0	37852	3126	22803	
11771	Analysis of COVID-19 Cardiovascular	analysis of INFunknownSUP Cardiovascular	1	0	204	11773	204	
7823	cell-free systems	INFunknownSUP system	1	0	146	7824	146	
38400	presence of diarrhea	presence of diarrhea	1	0	675	27792	675	
37778	emotional reactions	emotional reaction	1	0	19148	6765	19148	
19397	multi-system complications	multi-system complication	1	0	705	19398	705	
39089	small trocar incisions	small trocar incision	1	0	39091	9600	39093	
34598	SARS-CoV-2 vaccines	INFunknownSUP vaccine	1	0	681	28	681	
30583	systematic study	systematic study	1	0	2087	343	2087	
26550	Snake venom phospholipase A2s exhibit strong virucidal activity	snake venom phospholipase A2s exhibit strong INFunknownSUP activity	1	0	26552	26551	3990	
20760	levels of tumor necrosis factor-alpha	level of tumor necrosis factor-alpha	1	0	169	5735	169	
23684	multicellular organisms	multicellular organism	1	0	13697	23685	13697	
26057	societal conditions	societal condition	1	0	2910	26058	2910	
38669	skin manifestation	skin manifestation	1	0	3466	161	3466	
27823	home food processor	home food processor	1	0	27825	231	27827	
30313	overall cohort	overall cohort	1	0	601	2251	601	
16829	rural public hospitals	rural public hospital	1	0	16831	8823	76	
22549	reason of these differences	reason of these difference	1	0	5140	5663	5140	
35634	large German Department of Radiation Oncology	large German department of radiation oncology	1	0	35636	4250	35639	
37638	3D localization method	3D localization method	1	0	37640	10448	6587	
25537	part of the healthcare	part of the INFunknownSUP	1	0	734	494	734	
31660	pandemic of Coronavirus Disease 2019	pandemic of INFunknownSUP Disease 2019	1	0	113	20850	113	
19120	major impact	major impact	1	0	110	1318	110	
2482	non-white race/ethnic groups	non-white race/ethnic group	1	0	2484	2483	2486	
12483	Italian University Hospitals	Italian University Hospitals	1	0	12485	115	12487	
25751	telehealth geriatric assessment model	INFunknownSUP geriatric assessment model	1	0	25753	2326	1078	
26578	laparoendoscopic surgical protocols	laparoendoscopic surgical protocol	1	0	26580	26579	18004	
14995	effect of the non-structural protein	effect of the non-structural protein	1	0	1809	14997	1809	
10370	authority figures	authority figure	1	0	10372	10371	10372	
26076	PET scans	pet scan	1	0	15094	26077	15094	
28252	CT findings	CT finding	1	0	3390	26	3390	
5863	wide spectrum of severity	wide spectrum of severity	1	0	5865	4155	5866	
19965	change programmes	change programme	1	0	1886	9215	1886	
35866	Global Prevalence	global prevalence	1	0	81	12085	81	
4510	machines learning	machine learning	1	0	2390	4511	2390	
28346	model adjustment	model adjustment	1	0	28348	1078	28348	
7027	peak of the pandemic	peak of the pandemic	1	0	5928	113	5928	
22234	Median time	Median time	1	0	179	7402	179	
7080	close contacts	close contact	1	0	7082	614	7082	
30528	phospholipolytic activity	phospholipolytic activity	1	0	3990	30529	3990	
535	harmful effects of COVID-19	harmful effect of INFunknownSUP	1	0	537	536	156	
16158	CD patients	CD patient	1	0	60	16159	60	
28258	nationwide website survey	nationwide website survey	1	0	28260	21400	967	
11001	information flow	information flow	1	0	6423	2591	6423	
28096	total score	total score	1	0	1843	1485	1843	
21679	therapeutic candidates	therapeutic candidate	1	0	4790	3349	4790	
30835	control group n	control group n	1	0	8004	8561	8004	
34711	search engines	search engine	1	0	34713	344	34713	
9352	Student Health Care Center	Student Health Care Center	1	0	9354	9353	2780	
29899	T cell responses	T cell response	1	0	200	8957	200	
23723	composite endpoints	composite endpoint	1	0	13345	10302	13345	
6101	present position statement AISF	present position statement INFunknownSUP	1	0	6103	285	6107	
21074	right to private ownership	right to private ownership	1	0	9429	21076	9429	
14538	health care services	health care service	1	0	7828	120	5980	
22660	mean baseline seroprevalence	mean baseline seroprevalence	1	0	22662	194	4090	
677	doses of Oxford-AstraZeneca vaccines	dose of INFunknownSUP vaccine	1	0	678	679	678	
38709	contact cases	contact case	1	0	229	1888	229	
22163	Respiratory Disease Coronavirus	respiratory disease INFunknownSUP	1	0	22165	3287	3206	
1006	die sportlichen Aktivitaten	die sportlichen INFunknownSUP	1	0	1010	1007	1010	
38091	potent stimulator of ACE2	potent stimulator of INFunknownSUP	1	0	38093	1408	29871	
33264	European population	European population	1	0	1838	1622	1838	
14627	electrospun nanofiber-based membrane materials	INFunknownSUP INFunknownSUP membrane material	1	0	14631	14628	2335	
37371	Eleven cases	eleven case	1	0	229	4725	229	
6411	septic shock n=	septic shock INFunknownSUP	1	0	6306	6412	6306	
11890	preliminary analysis	preliminary analysis	1	0	486	11891	486	
5408	medical supply	medical supply	1	0	271	947	271	
17556	safety management	safety management	1	0	743	6729	743	
10414	Los articulos seleccionados	Los INFunknownSUP INFunknownSUP	1	0	10416	10415	10418	
3965	Short-Term Memory (ConvLSTM)-based deep learning models	short-term Memory INFunknownSUP deep learning model	1	0	3967	3966	3975	
32115	learning-based multi-class	INFunknownSUP INFunknownSUP	1	0	32117	30751	32117	
13550	Public awareness	public awareness	1	0	1612	4302	1612	
33510	response to a trial of NIRS	response to a trial of INFunknownSUP	1	0	409	33512	409	
15925	prognostic performance	prognostic performance	1	0	598	158	598	
22473	universal destination of earth	universal destination of earth	1	0	22474	7253	7252	
2383	NLR &gt	NLR &gt	1	0	2385	2384	2385	
29924	utilizando terminos	INFunknownSUP INFunknownSUP	1	0	29926	29925	29926	
33215	nonlinear model predictive control	nonlinear model predictive control	1	0	33217	3100	510	
31414	clinical evaluators	clinical evaluator	1	0	31416	884	31416	
6695	online lecture content delivery	online lecture content delivery	1	0	6697	541	2840	
3363	false positive	false positive	1	0	3365	3364	3365	
31804	COVID-19 lockdown resilience	INFunknownSUP INFunknownSUP resilience	1	0	4654	15062	4654	
13894	care management plan	care management plan	1	0	13896	9	1225	
8677	habits of pulmonary rehabilitation service-users	habit of pulmonary rehabilitation service-user	1	0	8678	8679	8678	
31936	range of effects	range of effect	1	0	420	156	420	
35751	Government messages	government message	1	0	35753	9523	35753	
17343	data breaches	data breach	1	0	17345	14273	17345	
16288	Clinical outcome	clinical outcome	1	0	295	1501	295	
13880	US metropolitan area Sex	US metropolitan area sex	1	0	13882	3316	10683	
30184	fewer PPE items	few PPE item	1	0	30186	1479	21024	
34440	benchmark 3D U-Net	benchmark 3D INFunknownSUP	1	0	34442	34441	34444	
39110	probability signals	probability signal	1	0	4820	7627	4820	
26464	story Supplemental	story Supplemental	1	0	26466	26465	26466	
10204	transmission of the virus	transmission of the virus	1	0	876	778	876	
5591	training false-positive	training false-positive	1	0	5593	235	5593	
1839	low ASA score	low ASA score	1	0	1841	457	1843	
9564	precautionary methods	precautionary method	1	0	205	9437	205	
37933	latter value	latter value	1	0	1037	37934	1037	
31179	analysis of the public health	analysis of the public health	1	0	486	1320	486	
38712	novel method of detection of COVID-19	novel method of detection of INFunknownSUP	1	0	38714	810	6587	
37963	conservative level of infection transmissibility of children	conservative level of infection INFunknownSUP of child	1	0	37965	37964	362	
10432	virus diagnosis	virus diagnosis	1	0	2168	778	2168	
1913	de profesionales de medicina	de INFunknownSUP de INFunknownSUP	1	0	1915	1914	1919	
11776	retrospective chart review	retrospective chart review	1	0	11778	10146	1723	
14914	western China	western China	1	0	4295	14915	4295	
7083	learnability of the Convolutional Neural Network	learnability of the convolutional neural Network	1	0	7084	7085	7084	
23442	Italian National Government	Italian National Government	1	0	23444	115	23446	
17480	low COVID-19 infection rate	low INFunknownSUP infection rate	1	0	11885	457	1034	
14404	available genetic evidence	available genetic evidence	1	0	14406	832	585	
22841	COVID-19 Prevention Practices	INFunknownSUP prevention Practices	1	0	22843	40	19388	
6043	COVID-19-related pro-inflammatory cytokines	COVID-19-related pro-inflammatory cytokine	1	0	5732	1384	5734	
26649	large-scale production of goods	large-scale production of good	1	0	26651	8638	654	
1356	1-h pad test	1-h pad test	1	0	1358	1357	754	
27709	PEEP-induced alveolar recruitment	INFunknownSUP alveolar recruitment	1	0	11594	27710	3518	
29376	form of mental health support	form of mental health support	1	0	11121	29378	11121	
21896	scientific processes:was	scientific INFunknownSUP	1	0	21898	2290	21898	
25476	24th December	24th December	1	0	7311	25477	7311	
31998	initial phase of the pandemic	initial phase of the pandemic	1	0	20698	335	1352	
16121	otolaryngologic symptoms	otolaryngologic symptom	1	0	86	16122	86	
23178	downregulate human ACE-2	INFunknownSUP human INFunknownSUP	1	0	23180	23179	23182	
11565	high infection	high infection	1	0	41	13	41	
33688	self-directed learning	self-directed learning	1	0	2390	33689	2390	
758	sixth months of constraints	sixth month of constraint	1	0	759	762	761	
38924	investigational evidence of SARS-CoV-2	investigational evidence of INFunknownSUP	1	0	38926	14766	585	
4544	Automated Western immunoblotting detection of anti-SARS-CoV-2 serum antibodies ELISA	automated Western INFunknownSUP detection of INFunknownSUP serum antibody Elisa	1	0	4545	4552	44	
20423	Narrative Review Background	narrative Review background	1	0	12606	4422	4013	
5906	viral challenge	viral challenge	1	0	62	1741	62	
21399	nationwide survey	nationwide survey	1	0	967	21400	967	
38160	Microfluidic devices	Microfluidic device	1	0	6162	38161	6162	
5257	HIDAT negative group	INFunknownSUP negative group	1	0	5259	5258	18	
29174	simulation CT	simulation CT	1	0	26	9152	26	
16101	psychological assistance	psychological assistance	1	0	16103	1380	16103	
4449	Impact of Event Scale-Revised	impact of Event INFunknownSUP	1	0	802	4451	802	
193	mean temperature	mean temperature	1	0	195	194	195	
5789	analysis of available evidence	analysis of available evidence	1	0	486	5791	486	
36318	Vulnerable patients	vulnerable patient	1	0	60	36319	60	
15736	impacts of the changes	impact of the change	1	0	1385	1336	1385	
13052	contagious variant	contagious variant	1	0	939	13053	939	
24230	coherence tomography	coherence tomography	1	0	7445	1673	7445	
16507	portable system	portable system	1	0	1327	564	1327	
30919	age-structured Susceptible-Exposed-Infected-Recovered-Deceased dynamics	age-structured INFunknownSUP dynamics	1	0	30921	30920	3694	
326	outpatient departments	outpatient department	1	0	328	327	328	
22261	Chinese health reforms	Chinese health reform	1	0	22263	1968	22265	
30413	Short term safety of booster immunization	short term safety of booster immunization	1	0	30415	30414	6729	
26144	cutoff of REMS	cutoff of INFunknownSUP	1	0	26145	17323	26145	
7987	significant interest	significant interest	1	0	7989	908	7989	
6927	quality of surgical care	quality of surgical care	1	0	3713	6929	3713	
37739	substrates of interest	substrate of interest	1	0	37740	7989	37740	
31633	subject groups	subject group	1	0	2486	31634	2486	
2702	resource related challenges	resource related challenge	1	0	2704	2703	2220	
23576	positive swab	positive swab	1	0	3979	228	3979	
1600	government restrictive policy	government restrictive policy	1	0	1602	99	293	
28220	HepaRG cells model	INFunknownSUP cell model	1	0	28222	23231	1078	
23191	Inter-hospital transfer	INFunknownSUP transfer	1	0	10218	23192	10218	
2462	Primary outcome measure	primary outcome measure	1	0	2466	2463	2466	
5974	important public health services	important public health service	1	0	5976	273	5980	
23152	ICU beds	ICU bed	1	0	17283	1658	17283	
27490	successful research	successful research	1	0	36	9403	36	
32006	Rapid Diagnosis	Rapid diagnosis	1	0	10673	9843	10673	
17917	life-saving procedure	life-saving procedure	1	0	4693	13070	4693	
24779	higher percentage of Black	high percentage of Black	1	0	24781	322	3789	
3653	naive CD8 T cells of unexposed individuals Recent studies	naive INFunknownSUP T cell of unexposed individual Recent study	1	0	3654	3661	133	
38805	5-logarithmic units increment	5-logarithmic unit increment	1	0	38807	38806	38809	
38292	transient ischemic attack	transient ischemic attack	1	0	38294	9471	23017	
1443	STAMINA trial	stamina trial	1	0	965	1444	965	
32194	sewage surveillance program	sewage surveillance program	1	0	1790	32195	1790	
18351	significant progression	significant progression	1	0	4414	908	4414	
13452	drawback of natural peptide drugs	drawback of natural peptide drug	1	0	13453	13454	13453	
30339	epidemic periods	epidemic period	1	0	873	12267	873	
27668	human activities	human activity	1	0	192	2214	192	
17793	questionnaire-based survey	INFunknownSUP survey	1	0	967	17794	967	
3961	Convolutional Long Short-Term Memory (ConvLSTM)-based deep learning models	convolutional Long short-term Memory INFunknownSUP deep learning model	1	0	3963	3962	3975	
26112	high-cost high-need patients	high-cost INFunknownSUP patient	1	0	24067	6505	60	
15379	Psychological Stress	psychological stress	1	0	9278	15380	9278	
9344	Cancer Patients	Cancer Patients	1	0	3207	9345	3207	
16678	contemporary example	contemporary example	1	0	16680	16679	16680	
3596	active involvement of patients	active involvement of patient	1	0	3598	3597	3599	
38714	method of detection of COVID-19	method of detection of INFunknownSUP	1	0	6587	30023	6587	
16487	center activity	center activity	1	0	3990	8718	3990	
17403	high-risk aerosol-generating procedures	high-risk aerosol-generating procedure	1	0	4675	1184	4200	
14920	distribution of stressors of medical students	distribution of INFunknownSUP of medical student	1	0	2621	14922	2621	
13689	convergent validity	convergent validity	1	0	13691	2259	13691	
26639	rapid screening tool	rapid screening tool	1	0	26641	795	5487	
29449	screening method	screening method	1	0	6587	7961	6587	
6530	support initiatives	support initiative	1	0	6532	260	6532	
1993	anionic properties	anionic property	1	0	1995	1994	1995	
17757	data pipelines	datum pipeline	1	0	17759	22	17759	
27856	possible gatherings	possible gathering	1	0	11144	745	11144	
17186	poor in-hospital outcomes	poor in-hospital outcome	1	0	410	1372	263	
6312	steps of the procedure	step of the procedure	1	0	2077	4693	2077	
8211	adaptive immunity arm	adaptive immunity arm	1	0	8213	6264	8215	
27569	status of neurointervention	status of neurointervention	1	0	2720	27571	2720	
37621	Post-COVID-19 Response	INFunknownSUP Response	1	0	2498	37622	2498	
26457	COVID-19 pandemic:the Philadelphia story Supplemental digital content	INFunknownSUP INFunknownSUP Philadelphia story Supplemental digital content	1	0	26461	26458	6700	
24571	waves of the survey	wave of the survey	1	0	1281	967	1281	
18336	rectal/orbital gyrus	rectal/orbital gyrus	1	0	18043	18337	18043	
26236	healthcare innovation	INFunknownSUP innovation	1	0	19710	494	19710	
7087	Neural Network	neural Network	1	0	7089	7088	7089	
15010	mayor incidencia	mayor INFunknownSUP	1	0	15012	15011	15012	
10816	mobile health	mobile health	1	0	120	3414	120	
565	detection kit	detection kit	1	0	567	44	567	
18326	Healthcare systems	Healthcare system	1	0	146	1355	146	
25490	Older Adults Testing of vaccine candidates	old adult Testing of vaccine candidate	1	0	25494	25491	25495	
22880	use of eukaryotic cell-free systems	use of INFunknownSUP INFunknownSUP system	1	0	292	22882	292	
28399	Caputo sense	Caputo sense	1	0	1672	28400	1672	
34535	child patients	child patient	1	0	60	12594	60	
11333	response teams	response team	1	0	5220	409	5220	
6769	bead-based multiplex immunoassays	INFunknownSUP multiplex immunoassay	1	0	6771	6770	6773	
893	use of nanomaterials	use of nanomaterial	1	0	292	895	292	
34228	time of presentation	time of presentation	1	0	179	4163	179	
6067	next pandemic	next pandemic	1	0	113	2624	113	
18348	hospital workers	hospital worker	1	0	1136	185	1136	
9613	heart rate signals	heart rate signal	1	0	4820	2295	4820	
23571	average area	average area	1	0	1089	178	1089	
30916	breakthrough infection	breakthrough infection	1	0	41	4869	41	
38521	Mexican hospital	Mexican hospital	1	0	185	38522	185	
18548	new methods	new method	1	0	205	69	205	
9721	management characteristics	management characteristic	1	0	1496	743	1496	
21687	prioritized in-person	INFunknownSUP in-person	1	0	9275	21688	9275	
33952	heart transplantation Adequate immune response	heart transplantation adequate immune response	1	0	29483	20244	409	
34112	magnetic resonance	magnetic resonance	1	0	9917	6768	9917	
29148	minority ethnic women	minority ethnic woman	1	0	29150	14551	920	
11191	real-time monitoring of the transmissibility	real-time monitoring of the INFunknownSUP	1	0	11193	1429	3271	
37936	higher education	high education	1	0	361	322	361	
6681	decision of the leaders of the Experimental Biology Host Societies	decision of the leader of the experimental biology Host society	1	0	5486	6683	5486	
14002	testing capacities	testing capacity	1	0	7793	1885	7793	
11380	chi2 tests	INFunknownSUP test	1	0	1365	11381	1365	
6996	early predictors of in-hospital mortality	early predictor of in-hospital mortality	1	0	6998	55	414	
26671	financial education sessions	financial education session	1	0	15478	26672	15478	
18148	recognition of trivial COVID-19 lesions	recognition of trivial INFunknownSUP lesion	1	0	13787	18150	13787	
5616	ICU stay	ICU stay	1	0	1348	1658	1348	
37194	New-Onset Autoimmune Disease	INFunknownSUP autoimmune disease	1	0	37196	37195	10958	
3169	voxel-based analysis	INFunknownSUP analysis	1	0	486	3170	486	
27345	magnetic resonance imaging	magnetic resonance imaging	1	0	27347	6768	3936	
22428	surgical specialties	surgical specialty	1	0	22430	663	22430	
11157	older people	old people	1	0	694	59	694	
32571	better management of the patients	good management of the patient	1	0	32573	1635	743	
33837	mode of primary care delivery	mode of primary care delivery	1	0	18075	33839	18075	
29222	expiratory pressure	expiratory pressure	1	0	1027	29223	1027	
7289	% of primary care providers	% of primary care provider	1	0	364	7291	364	
21642	use of phytochemicals	use of phytochemical	1	0	292	21644	292	
20188	Fecal transmission	fecal transmission	1	0	876	20189	876	
24095	new-onset autoimmune disease	new-onset autoimmune disease	1	0	24097	24096	209	
16688	cost-effectiveness of interventions	cost-effectiveness of intervention	1	0	16689	757	16689	
10110	higher hs-TnI	high INFunknownSUP	1	0	10112	322	10112	
9171	possible community risk	possible community risk	1	0	9173	745	1542	
7011	community genomic surveillance	community INFunknownSUP surveillance	1	0	7013	3641	2795	
22767	clinical information of COVID-19	clinical information of INFunknownSUP	1	0	22769	884	2591	
27475	development of leukocytosis	development of INFunknownSUP	1	0	73	13101	73	
8159	COVID-19 death	INFunknownSUP death	1	0	4722	40	4722	
31745	somatic symptoms	somatic symptom	1	0	86	23926	86	
17335	possible gateway	possible gateway	1	0	17337	745	17337	
7281	research study operations	research study operation	1	0	7285	2796	7285	
15008	una mayor incidencia	una mayor INFunknownSUP	1	0	15010	15009	15012	
34053	cases of undetectable adaptive immunity	case of undetectable adaptive immunity	1	0	229	34055	229	
33034	long peptides	long peptide	1	0	26504	3921	26504	
19536	unexpected changes	unexpected change	1	0	1336	4591	1336	
3395	life to a sedentary lifestyle	life to a sedentary lifestyle	1	0	1434	3397	1434	
38249	random-effects model	INFunknownSUP model	1	0	1078	38250	1078	
13569	Limited data	limited datum	1	0	22	13570	22	
8311	high impact	high impact	1	0	110	13	110	
3810	signs of infection	sign of infection	1	0	3011	41	3011	
16443	patient traffic	patient traffic	1	0	16445	710	16445	
8176	glial scar	INFunknownSUP scar	1	0	8178	8177	8178	
4175	current landscape	current landscape	1	0	4177	443	4177	
33891	Era of ART	era of art	1	0	12986	33893	12986	
25912	cmH2O PEEP	INFunknownSUP peep	1	0	3521	25913	3521	
22117	coated tablet	coated tablet	1	0	22119	22118	22119	
15913	immunological mechanisms	immunological mechanism	1	0	1456	148	1456	
26239	positive effects	positive effect	1	0	156	228	156	
33401	common findings	common finding	1	0	3390	699	3390	
22944	key species	key specie	1	0	3957	850	3957	
28762	multifaceted discussions	multifaceted discussion	1	0	28764	28763	28764	
18063	levels of clinical engagement	level of clinical engagement	1	0	169	18065	169	
3289	multiple organ systems	multiple organ system	1	0	3291	1776	146	
7802	Camostat mesylate	INFunknownSUP INFunknownSUP	1	0	7804	7803	7804	
29887	different number of positive samples	different number of positive sample	1	0	29889	688	916	
21505	nosocomial transmission	INFunknownSUP transmission	1	0	876	6858	876	
2776	Kinshasa Medical Center	Kinshasa Medical Center	1	0	2778	2777	2780	
10209	wave of Coronavirus disease	wave of INFunknownSUP disease	1	0	10210	6281	10210	
7756	12-zone lung ultrasound	INFunknownSUP lung ultrasound	1	0	7758	7757	4246	
24836	rare phenomenon suggestive of protective immunity	rare phenomenon suggestive of protective immunity	1	0	24838	10225	24839	
8779	myeloproliferative neoplasms	myeloproliferative neoplasm	1	0	8781	8780	8781	
16519	connected limbic/paralimbic regions	connected limbic/paralimbic region	1	0	16521	16520	5240	
7339	animal health	animal health	1	0	120	7340	120	
23680	biological functions of multicellular organisms	biological function of multicellular organism	1	0	23682	855	23683	
14642	uninfected adults	uninfected adult	1	0	515	14643	515	
1280	waves of COVID-19	wave of INFunknownSUP	1	0	1281	40	1281	
1051	constant exposure to aerosolized pathogens	constant exposure to INFunknownSUP pathogen	1	0	1053	1052	1054	
2158	up-to-date published work	up-to-date published work	1	0	2160	1781	2162	
34191	web-based resources	INFunknownSUP resource	1	0	835	2586	835	
4029	patient-treatment years	patient-treatment year	1	0	1313	4030	1313	
19300	overview of the unpreparedness of Libyan hospitals	overview of the unpreparedness of Libyan hospital	1	0	19301	19302	19301	
27335	history studies	history study	1	0	136	5381	136	
14867	anxiety disorders	anxiety disorder	1	0	889	2772	889	
17301	findings of the study	finding of the study	1	0	3390	2087	3390	
37592	high viral load	high viral load	1	0	5917	13	5919	
38271	% +-	% INFunknownSUP	1	0	38273	364	38273	
29140	China Coronavirus disease	China INFunknownSUP disease	1	0	6281	4295	209	
22793	health care service use	health care service use	1	0	292	22794	292	
27816	approximate median infectious period	approximate median infectious period	1	0	27818	27817	5677	
14634	cell-free protein synthesis	INFunknownSUP protein synthesis	1	0	14638	14635	14638	
24950	Architect SARS-CoV-2 IgG	architect INFunknownSUP IgG	1	0	4627	267	928	
14674	estudios cualitativos	estudio INFunknownSUP	1	0	14676	14675	14676	
21745	Percutaneous Endoscopic Gastrostomy Tube Placement	percutaneous endoscopic gastrostomy tube Placement	1	0	21751	21746	21753	
32501	planar lipid bilayer measurements	planar lipid bilayer measurement	1	0	32503	32502	8077	
34377	number of LRTI	number of INFunknownSUP	1	0	916	34379	916	
21054	height of the COVID-19 pandemic	height of the INFunknownSUP pandemic	1	0	4222	111	4222	
20374	preferred meat/fish	preferred INFunknownSUP	1	0	20376	13604	20376	
31888	perinatal mental health services	perinatal mental health service	1	0	7526	8419	5980	
5480	Enrichment Analysis	enrichment Analysis	1	0	5482	5481	5482	
7061	Use of Scientific Knowledge	use of Scientific Knowledge	1	0	3481	7063	3481	
21497	detailed anthropometrics	detailed anthropometric	1	0	21499	21498	21499	
10509	elements of the full protocol	element of the full protocol	1	0	10510	10511	10510	
21353	hot-spot areas	INFunknownSUP area	1	0	1579	21354	1579	
22100	philosopher Immanule Kant	philosopher INFunknownSUP Kant	1	0	22102	4390	22104	
34083	livelihood assistance	livelihood assistance	1	0	16103	34084	16103	
29500	heterogenicity of troponin	INFunknownSUP of INFunknownSUP	1	0	29501	4478	29501	
10078	medical school	medical school	1	0	355	947	355	
18213	medical systems	medical system	1	0	146	947	146	
37090	positive social mentality	positive social mentality	1	0	37092	228	37094	
23729	metropolitan hospitals	metropolitan hospital	1	0	76	13883	76	
1038	mindfulness-based interventions	INFunknownSUP intervention	1	0	757	1039	757	
25742	Liver Transplantation	live transplantation	1	0	25744	25743	25744	
669	prompt healthcare providers	prompt INFunknownSUP provider	1	0	671	670	673	
35118	monthly antibiotic	monthly antibiotic	1	0	35120	18770	35120	
23173	rapid diagnostic tests	rapid diagnostic test	1	0	3947	795	1365	
28311	Atangana-Baleanu fractional derivative	INFunknownSUP fractional derivative	1	0	28313	28312	28315	
29975	38-year-old subject	38-year-old subject	1	0	16027	29976	16027	
29562	unprecedented high levels of class	unprecedented high level of class	1	0	29564	5915	169	
12389	vaccine-induced immunity	INFunknownSUP immunity	1	0	257	12390	257	
24059	Cancer Network	Cancer Network	1	0	7089	9345	7089	
13655	dreadful pandemic	dreadful pandemic	1	0	113	13656	113	
1748	pure parenchymal bands	pure INFunknownSUP band	1	0	1750	1749	1752	
8523	inflammatory response	inflammatory response	1	0	409	3817	409	
12975	Croatian university hospital	Croatian university hospital	1	0	5310	12976	185	
17854	number of Sponsors	number of sponsor	1	0	916	17856	916	
3131	managerial structures	managerial structure	1	0	3133	3132	3133	
15299	Retinal findings of COVID-19 patients	retinal finding of INFunknownSUP patient	1	0	15301	15300	3390	
20040	case-control study	case-control study	1	0	2087	20041	2087	
4196	essential surgical procedures	essential surgical procedure	1	0	4198	4197	4200	
33882	groups of undergraduate occupational therapy students	group of undergraduate occupational therapy student	1	0	2486	33884	2486	
38307	duration of the infectious period of COVID-19	duration of the infectious period of INFunknownSUP	1	0	7404	38309	7404	
37988	cytokine abundance	INFunknownSUP abundance	1	0	10779	3718	10779	
18367	acceptance levels	acceptance level	1	0	169	1248	169	
13034	in-person horse shows	in-person horse show	1	0	13036	9275	13038	
8536	Viral genome sequencing	viral genome sequencing	1	0	8097	8537	8097	
32647	rapid progression to severe acute respiratory syndrome	rapid progression to severe acute respiratory syndrome	1	0	32649	795	4414	
18950	SARS-coronavirus-2 infections	INFunknownSUP infection	1	0	779	18951	779	
3802	logistic analysis	logistic analysis	1	0	486	3803	486	
37636	pedestrian 3D localization method	pedestrian 3D localization method	1	0	37638	27088	6587	
32472	serogroup A	serogroup A	1	0	3475	32473	3475	
19149	control animals	control animal	1	0	19151	510	19151	
11289	elevated level of androgens	elevated level of androgen	1	0	11291	1705	362	
14922	stressors of medical students	INFunknownSUP of medical student	1	0	14923	4129	14923	
8517	present review	present review	1	0	1723	285	1723	
2070	emergency remote teaching	emergency remote teaching	1	0	2072	447	2074	
2058	medical research	medical research	1	0	36	947	36	
6994	identification of early predictors of in-hospital mortality	identification of early predictor of in-hospital mortality	1	0	57	6996	57	
21782	Covid-19 Pandemic	INFunknownSUP pandemic	1	0	6338	1884	6338	
32417	Extracellular Vesicles	extracellular vesicle	1	0	32419	32418	32419	
19936	Skill Programme	Skill programme	1	0	19938	19937	19938	
34714	effective management	effective management	1	0	743	2051	743	
33555	targeted immunotherapies	targeted immunotherapy	1	0	33557	2239	33557	
22020	available gas exchange data	available gas exchange datum	1	0	22022	832	22	
21690	numerous clinical trials	numerous clinical trial	1	0	21692	531	8639	
38999	point prevalence of SARS-CoV-2	point prevalence of INFunknownSUP	1	0	39001	10333	9272	
30673	Vulnerability Index	vulnerability Index	1	0	7907	30674	7907	
36222	access to testing	access to testing	1	0	224	1885	224	
37203	transmission of SARS COV2	transmission of INFunknownSUP INFunknownSUP	1	0	876	37205	876	
38152	anti-inflammatory drug use	anti-inflammatory drug use	1	0	38154	9193	292	
34979	GI symptoms	GI symptom	1	0	86	34980	86	
25892	Severe COVID-19	severe INFunknownSUP	1	0	3076	22446	3076	
22739	alcohol concentration	alcohol concentration	1	0	11518	1266	11518	
29724	consequences of this pandemic	consequence of this pandemic	1	0	4289	113	4289	
4023	number of marriages	number of marriage	1	0	916	4025	916	
22311	presentation of COVID-19	presentation of INFunknownSUP	1	0	4163	40	4163	
19749	function characteristics	function characteristic	1	0	1496	9243	1496	
13195	interface design of medical equipment	interface design of medical equipment	1	0	13197	10162	4183	
26991	well-established online learning environment support	well-established online learning environment support	1	0	26993	26992	260	
21071	principles of care	principle of care	1	0	17746	9	17746	
10748	mid-regional proadrenomedullin	mid-regional INFunknownSUP	1	0	10750	10749	10750	
9975	understanding of teamwork	understanding of teamwork	1	0	2715	3839	2715	
34841	nosocomial infection	INFunknownSUP infection	1	0	41	6858	41	
806	20th century	20th century	1	0	808	807	808	
15593	lung sequela of COVID-19	lung sequela of INFunknownSUP	1	0	15595	772	15596	
7894	vaccine impact	vaccine impact	1	0	110	577	110	
11403	housing dissatisfaction	housing dissatisfaction	1	0	11405	3497	11405	
29774	estimation of R	estimation of R	1	0	10490	1036	10490	
2081	multicentre prospective cohort study	INFunknownSUP prospective cohort study	1	0	2083	2082	2087	
18277	weeks post-outbreak	week post-outbreak	1	0	18279	18278	18279	
7517	care management	care management	1	0	743	9	743	
15290	instances of communication	instance of communication	1	0	15291	11078	15291	
20304	long periods of time	long period of time	1	0	20305	179	873	
10430	Corona virus diagnosis	Corona virus diagnosis	1	0	10432	10431	2168	
272	important tools	important tool	1	0	274	273	274	
1783	extraordinary sophistication	extraordinary sophistication	1	0	1785	1784	1785	
880	variety of clinical manifestations of SARS-CoV-2	variety of clinical manifestation of INFunknownSUP	1	0	881	882	881	
35718	cross-sectional observational study	cross-sectional observational study	1	0	18803	2493	2087	
2286	RNA virus	RNA virus	1	0	778	1151	778	
12515	cross-reactive CD4 memory T cells	cross-reactive INFunknownSUP memory T cell	1	0	12517	12516	133	
12009	weighted average of the laboratory tests results	weighted average of the laboratory test result	1	0	12011	12010	12012	
17528	notion of integration	notion of integration	1	0	17529	918	17529	
19687	cardiac toxicity	cardiac toxicity	1	0	19689	3858	19689	
27267	course of COVID-19 infection	course of INFunknownSUP infection	1	0	5152	39	5152	
14620	ni de los	Ni de los	1	0	2630	14621	2632	
38008	demographic questionnaire	demographic questionnaire	1	0	9620	1062	9620	
26777	natural experiment	natural experiment	1	0	14142	3229	14142	
10604	Additional questions	additional question	1	0	4066	853	4066	
1108	academic medicine	academic medicine	1	0	1110	606	1110	
21656	young man	young man	1	0	21658	2882	21658	
37616	booster dose	booster dose	1	0	2537	804	2537	
13603	preferred method	preferred method	1	0	6587	13604	6587	
22846	marked difference	marked difference	1	0	4260	22847	4260	
5994	Ophthalmic examination	ophthalmic examination	1	0	1800	5995	1800	
27707	assessment of PEEP-induced alveolar recruitment	assessment of INFunknownSUP alveolar recruitment	1	0	238	27709	238	
14703	undetectable concentrations of viral RNA	undetectable concentration of viral RNA	1	0	14705	14704	1959	
38975	specific disease conditions	specific disease condition	1	0	38977	2515	2910	
30009	printed adapter	printed adapter	1	0	30011	30010	30011	
36392	single primer-probe set	single primer-probe set	1	0	36394	1652	651	
29627	various conditions	various condition	1	0	2910	1099	2910	
7916	Primary Care post-market evaluation	primary Care post-market evaluation	1	0	7920	7917	2399	
38256	animal coronaviruses	animal coronavirus	1	0	8796	7340	8796	
33088	sustainable interventions	sustainable intervention	1	0	757	8697	757	
18180	infectious diseases prevalence	infectious disease prevalence	1	0	9272	313	9272	
12631	financial insecurity	financial insecurity	1	0	172	547	172	
27948	monocular cameras	monocular camera	1	0	2063	15530	2063	
11031	% of healthcare workers	% of INFunknownSUP worker	1	0	364	6468	364	
16837	COVID-19 pandemic impact	INFunknownSUP pandemic impact	1	0	110	111	110	
11312	logarithmic loss	logarithmic loss	1	0	3586	11313	3586	
27393	suitable options	suitable option	1	0	23261	24614	23261	
26903	SARS-CoV-2 quantitative reverse transcription polymerase chain reaction	INFunknownSUP quantitative reverse transcription polymerase chain reaction	1	0	16332	28	2447	
4655	Case Presentation	Case Presentation	1	0	4657	4656	4657	
17374	elevated systemic metabolic inflammation	elevated systemic metabolic inflammation	1	0	17376	1705	3116	
18370	serious problems	serious problem	1	0	6766	3164	6766	
15410	Small patches of ground-glass opacity	small patch of ground-glass opacity	1	0	15412	15411	15413	
2977	new COVID-19 variants of concern	new INFunknownSUP variant of concern	1	0	2978	79	1002	
17207	global assessment	global assessment	1	0	238	1954	238	
36470	immune system win	immune system win	1	0	36474	1325	36474	
32291	mRNA-1273 Study ClinicalTrials.gov number	mRNA-1273 Study INFunknownSUP number	1	0	32293	32292	916	
34982	presence of GI symptoms	presence of GI symptom	1	0	675	34976	675	
275	non-aerated compartment	INFunknownSUP compartment	1	0	277	276	277	
18252	multivariate logistic regression analysis	multivariate logistic regression analysis	1	0	18254	2408	486	
19503	oral microbiota structure	oral microbiota structure	1	0	19505	427	2427	
11064	fecal aerosols	fecal aerosol	1	0	10600	11065	10600	
5566	Brazilian National Household Sample Survey	Brazilian National household Sample Survey	1	0	5568	5567	5574	
28822	COVID-19 related immune hemolysis	INFunknownSUP related immune hemolysi	1	0	28824	40	28828	
35491	series of variants	series of variant	1	0	8050	1002	8050	
38972	marine bacteria	marine bacterium	1	0	38974	9837	38974	
37918	key protective measures	key protective measure	1	0	30477	850	317	
14927	time to event outcomes	time to event outcome	1	0	179	14929	179	
27714	systemic therapies	systemic therapy	1	0	5507	1453	5507	
15337	ACE2 expression	INFunknownSUP expression	1	0	5729	4778	5729	
27162	initial results	initial result	1	0	325	335	325	
24771	service workers	service worker	1	0	1136	6375	1136	
3514	upper quartile of recruitment	upper quartile of recruitment	1	0	3516	2150	475	
1766	Accepted manuscripts	accepted manuscript	1	0	1768	1767	1768	
22967	selected governments	selected government	1	0	7556	1620	7556	
9239	Medicare Beneficiaries	Medicare beneficiary	1	0	9241	2816	9241	
31650	durchgefuhrt werden	INFunknownSUP INFunknownSUP	1	0	31652	31651	31652	
27366	higher-touch intervention	higher-touch intervention	1	0	5608	27367	5608	
10549	pandemie COVID-19 une occasion de reformer la sante	INFunknownSUP INFunknownSUP une occasion de reformer la INFunknownSUP	1	0	10551	10550	10563	
3385	18F-FDG PET/CT findings of patients	INFunknownSUP INFunknownSUP finding of patient	1	0	3389	1157	3390	
28667	commercial centrifuges	commercial centrifuge	1	0	15716	1770	15716	
13995	acquired hematopoietic stem cell	acquired hematopoietic stem cell	1	0	13997	13996	197	
4266	program research ranking	program research ranking	1	0	4268	1790	4270	
23096	Multidisciplinary collaborations	multidisciplinary collaboration	1	0	23098	23097	23098	
20461	abuse disorders	abuse disorder	1	0	889	20462	889	
23735	infected surfaces	infected surface	1	0	8528	1088	8528	
15157	COVID-19 pandemic outbreak	INFunknownSUP pandemic outbreak	1	0	15159	40	310	
18819	incubation period	incubation period	1	0	5677	18820	5677	
36774	percutaneous endoscopic gastrostomy	percutaneous endoscopic gastrostomy	1	0	36776	36775	36778	
11910	comorbid IBD	comorbid IBD	1	0	11912	11911	11912	
34818	Yale New Haven Health	Yale New Haven Health	1	0	34820	34819	279	
35475	blood products	blood product	1	0	1874	3129	1874	
32175	computational drug	computational drug	1	0	352	13184	352	
17294	multisite London healthcare institution	multisite London INFunknownSUP institution	1	0	17296	17295	17300	
5881	General Population	General Population	1	0	5883	2695	5883	
18763	effective responses	effective response	1	0	200	2051	200	
20628	SARS-CoV-2 infection Myocardial injury	INFunknownSUP infection myocardial injury	1	0	20632	1272	713	
1233	past studies	past study	1	0	136	1234	136	
20848	Findings of Coronavirus Disease 2019	finding of INFunknownSUP Disease 2019	1	0	20849	20850	20849	
8229	chronic therapy	chronic therapy	1	0	2273	8230	2273	
26556	A2s exhibit strong virucidal activity	A2s exhibit strong INFunknownSUP activity	1	0	26558	26557	3990	
7312	different genders	different gender	1	0	7314	688	7314	
4040	mentoring program targets	mentoring program target	1	0	4042	4041	4044	
3724	pre-confinement scores	pre-confinement score	1	0	3726	3725	3726	
2784	risk of fomite	risk of INFunknownSUP	1	0	1542	2786	1542	
37565	major stress factor	major stress factor	1	0	37567	1318	2183	
34611	epidemiological change	epidemiological change	1	0	9215	18107	9215	
14592	mitogen-activated protein kinase	INFunknownSUP protein kinase	1	0	14596	14593	14596	
1226	Iranian Blood Transfusion Organization	Iranian Blood transfusion Organization	1	0	1228	1227	1232	
20532	high rates of morbidity	high rate of morbidity	1	0	12621	1216	83	
29798	anti-NP titers	INFunknownSUP titer	1	0	8757	29799	8757	
22309	common presentation of COVID-19	common presentation of INFunknownSUP	1	0	22311	699	4163	
3942	characteristics of the COVID-19 patients	characteristic of the INFunknownSUP patient	1	0	1496	911	1496	
20048	city desire	city desire	1	0	20050	9604	20050	
23580	COVID-19 Immunity	INFunknownSUP immunity	1	0	23582	40	23582	
27398	case fatality rate	case fatality rate	1	0	1034	3367	1034	
25204	catchment area representative	catchment area representative	1	0	25206	25205	25208	
11502	strength index	strength index	1	0	4017	11503	4017	
5206	ABO blood group type	ABO blood group type	1	0	775	5207	775	
3296	Inflammatory Predictors of In-Hospital Mortality	inflammatory predictor of in-hospital mortality	1	0	3298	3297	3299	
18517	respiratory tracts	respiratory tract	1	0	18519	259	18519	
36397	clinic visit	clinic visit	1	0	16182	7704	16182	
36209	COVID-19 Deaths	INFunknownSUP death	1	0	36211	40	36211	
3175	hidden correlation	hidden correlation	1	0	2889	3176	2889	
14259	Marques de Valdecilla	Marques de Valdecilla	1	0	14261	14260	14263	
9599	small study	small study	1	0	2087	9600	2087	
15601	acute COVID-19 infection	acute INFunknownSUP infection	1	0	41	15602	41	
22472	universal destination of earth goods	universal destination of earth good	1	0	22478	22473	22478	
14614	gasto sanitario ni de los servicios sanitarios	INFunknownSUP INFunknownSUP Ni de los INFunknownSUP INFunknownSUP	1	0	14616	14615	14626	
31278	mean recovery time	mean recovery time	1	0	12810	194	179	
10181	Phase III vaccine trials	phase III vaccine trial	1	0	10183	10182	8639	
31960	younger family members	young family member	1	0	29329	2571	16766	
20635	associated public health measures	associated public health measure	1	0	16567	240	317	
30877	spread of the infection	spread of the infection	1	0	570	41	570	
27849	SARS-CoV-2 convalescents Anti-viral immunity	INFunknownSUP convalescent anti-viral immunity	1	0	27851	28	257	
30718	early autumn	early autumn	1	0	30720	55	30720	
27150	principal diagnosis of an infectious disease	principal diagnosis of an infectious disease	1	0	27152	19054	2168	
20990	prognostic factor	prognostic factor	1	0	2183	158	2183	
19225	specific rotations	specific rotation	1	0	9364	2515	9364	
4707	evolution of the severe acute respiratory syndrome coronavirus	evolution of the severe acute respiratory syndrome coronavirus	1	0	3741	4709	3741	
21455	global impact	global impact	1	0	110	1954	110	
5200	disease patterns	disease pattern	1	0	548	209	548	
16430	serology assay	serology assay	1	0	3119	5992	3119	
5914	unprecedented pressure	unprecedented pressure	1	0	1027	5915	1027	
21615	inexact Newton	inexact Newton	1	0	21617	21616	21617	
29868	potent stimulator of the SC2 receptor angiotensin	potent stimulator of the INFunknownSUP receptor angiotensin	1	0	29870	1408	29871	
19366	high mutation frequencies	high mutation frequency	1	0	19368	13	374	
23375	significant market	significant market	1	0	23377	908	23377	
4328	efficient calculations	efficient calculation	1	0	4330	4329	4330	
9535	Demographic data	demographic datum	1	0	22	9536	22	
34003	herd immunity threshold	herd immunity threshold	1	0	451	503	451	
1756	effects of stay-at-home policies	effect of stay-at-home policy	1	0	156	1758	156	
9913	surface plasmon resonance	surface plasmon resonance	1	0	9915	7645	9917	
20712	moral dilemmas	moral dilemma	1	0	19316	1315	19316	
22069	people of the world	people of the world	1	0	694	4336	694	
20338	financial well-being initiatives	financial well-being initiative	1	0	6532	2243	6532	
10310	provider-related digital barriers	provider-related digital barrier	1	0	10312	10311	10121	
33126	large variance	large variance	1	0	33128	4250	33128	
33823	national COVID-19 lockdown	national INFunknownSUP INFunknownSUP	1	0	15062	517	1676	
15581	ways of treatments	way of treatment	1	0	15582	1295	15582	
12745	Ventilator-associated pneumonia	Ventilator-associated pneumonia	1	0	2369	12746	2369	
22445	Severe oliguria	severe oliguria	1	0	22447	22446	22447	
6840	characteristics of the policy advisory systems	characteristic of the policy advisory system	1	0	1496	6842	1496	
12875	Pandemic season hospital admissions	pandemic season hospital admission	1	0	12877	2450	3085	
24997	enzyme replacement therapy	enzyme replacement therapy	1	0	14229	624	2273	
15707	comprehensive review of the available literature	comprehensive review of the available literature	1	0	15709	2902	1723	
20301	bacterial consortia	bacterial consortia	1	0	20303	2517	20303	
19907	harmful effects of trauma	harmful effect of trauma	1	0	19909	536	156	
22679	lockdown periods	INFunknownSUP period	1	0	873	1676	873	
20632	Myocardial injury	myocardial injury	1	0	713	20633	713	
8332	substantial decrease of the infectious virus	substantial decrease of the infectious virus	1	0	8334	3239	3084	
29712	role of hepatologists	role of hepatologist	1	0	7288	29714	7288	
9242	function of gut microbiota	function of gut microbiota	1	0	9243	1041	9243	
5740	3-person room	INFunknownSUP room	1	0	5742	5741	5742	
1396	Learning-Derived Chest Radiograph Scores COVID-19 patients	INFunknownSUP chest radiograph score INFunknownSUP patient	1	0	60	1397	60	
402	Foreign Body Ingestions	foreign body ingestion	1	0	404	403	406	
9995	continuing battle	continuing battle	1	0	9997	9996	9997	
34720	patient register	patient register	1	0	11310	2645	11310	
8375	worldwide outbreak of severe acute respiratory syndrome coronavirus	worldwide outbreak of severe acute respiratory syndrome coronavirus	1	0	8377	8376	310	
19243	livestock grazing	livestock grazing	1	0	19245	18502	19245	
34345	size of anatomy laboratory groups	size of anatomy laboratory group	1	0	6366	34347	6366	
10226	cardiac complication of COVID-19 infection	cardiac complication of INFunknownSUP infection	1	0	10228	3858	2206	
2712	timely understanding of mental health status	timely understanding of mental health status	1	0	2714	2713	2715	
7345	live medicine	live medicine	1	0	1110	7346	1110	
35470	excessive number of zeros	excessive number of zero	1	0	35472	35471	916	
34681	Multivariate analysis	multivariate analysis	1	0	486	34682	486	
7468	content analysis	content analysis	1	0	486	7469	486	
37262	initial nasopharyngeal polymerase chain reaction test	initial nasopharyngeal polymerase chain reaction test	1	0	23115	335	754	
24652	transmission rates	transmission rate	1	0	83	876	83	
18501	livestock health	livestock health	1	0	120	18502	120	
13412	mask:A potential source of phthalate exposure	INFunknownSUP potential source of phthalate exposure	1	0	13414	13413	1971	
24933	specific Arabic terms	specific Arabic term	1	0	24935	2515	4908	
12121	agent dexamethasone	agent INFunknownSUP	1	0	12123	12122	12123	
37687	isolation hospitals	isolation hospital	1	0	76	6569	76	
23544	Injury Discharge	Injury discharge	1	0	23546	2416	23546	
37148	Detection of COVID-19	detection of INFunknownSUP	1	0	10130	40	10130	
24963	eighty-eight cases	eighty-eight case	1	0	229	24964	229	
13236	pandemic potential of this disease	pandemic potential of this disease	1	0	13237	209	6265	
10283	low financial literacy levels	low financial literacy level	1	0	10285	457	169	
35555	fewer primary care encounters	few primary care encounter	1	0	35557	1479	13168	
10479	alimentary tract	alimentary tract	1	0	2154	10480	2154	
20023	manejo competencial	INFunknownSUP INFunknownSUP	1	0	20025	20024	20025	
35957	unique CLEAR methodology	unique clear methodology	1	0	23593	3547	11687	
21037	spatial arrangements of ACE2	spatial arrangement of INFunknownSUP	1	0	21039	21038	13728	
29777	surgical activity	surgical activity	1	0	3990	663	3990	
8296	objective evidence	objective evidence	1	0	585	8297	585	
26709	higher percentage of the population	high percentage of the population	1	0	26711	322	3789	
36758	Health Policies	Health policy	1	0	25314	279	25314	
38771	potential booster effects	potential booster effect	1	0	38773	1276	156	
20573	Intestinal Diseases	intestinal disease	1	0	6908	20574	6908	
31574	behavior of participants	behavior of participant	1	0	16069	4950	16069	
173	1-month follow-up	INFunknownSUP follow-up	1	0	175	174	175	
5534	Cellular homeostasis	cellular homeostasis	1	0	5536	5535	5536	
34891	personal contact	personal contact	1	0	1888	4961	1888	
25549	failure management	failure management	1	0	743	1779	743	
29399	Overall crude mortality rate	overall crude mortality rate	1	0	29401	29400	1034	
13186	US populations	US population	1	0	13188	3316	13188	
5594	COVID-19 Treatment	INFunknownSUP Treatment	1	0	5596	40	5596	
10056	life cycle	life cycle	1	0	6481	1434	6481	
22593	Chest Wall Elastance	chest Wall elastance	1	0	22595	1401	22597	
12197	Weifen syndrome	INFunknownSUP syndrome	1	0	1936	12198	1936	
10032	patient interviews	patient interview	1	0	10034	2645	10034	
9436	precautionary principle	precautionary principle	1	0	9438	9437	9438	
20239	Outcome measures	outcome measure	1	0	317	10594	317	
16761	generation times	generation time	1	0	12806	3033	12806	
23743	clinical courses	clinical course	1	0	4358	884	4358	
14286	routine work	routine work	1	0	2162	4898	2162	
8628	amount of time	amount of time	1	0	8629	179	8629	
19072	risk of URTIs	risk of INFunknownSUP	1	0	1542	19074	1542	
30017	radiological model	radiological model	1	0	1078	1592	1078	
8640	spontaneous results	spontaneous result	1	0	325	8641	325	
7231	SMS invitations	INFunknownSUP invitation	1	0	1570	7232	1570	
8250	positive test	positive test	1	0	754	228	754	
36110	rate ratio	rate ratio	1	0	2635	1034	2635	
35110	length of sick leave	length of sick leave	1	0	1347	415	1347	
26801	proceden de organismos	INFunknownSUP de INFunknownSUP	1	0	26803	26802	26805	
20470	small number of teachers	small number of teacher	1	0	20472	9600	916	
24840	suggestive of protective immunity	suggestive of protective immunity	1	0	24841	24842	24841	
424	distinctive oral microbiota composition	distinctive oral microbiota composition	1	0	426	425	430	
22176	Successful Use of Certolizumab Pegol	successful use of INFunknownSUP INFunknownSUP	1	0	22178	13573	3481	
19095	lung tumor data	lung tumor datum	1	0	19097	772	22	
26874	shortage of material resources	shortage of material resource	1	0	8840	26876	8840	
3371	large-sized newspapers	large-sized newspaper	1	0	3373	3372	3373	
14663	income instability	income instability	1	0	1073	5356	1073	
25635	Clinical data	clinical datum	1	0	22	1501	22	
19043	convalescent serum samples	convalescent serum sample	1	0	1765	19044	1765	
32183	NHS evidence	NHS evidence	1	0	585	20147	585	
8429	presence of liveoid lesions	presence of INFunknownSUP lesion	1	0	675	8431	675	
5164	prior acute kidney failure	prior acute kidney failure	1	0	5166	5165	1779	
20582	assessment of individual cities	assessment of individual city	1	0	238	20584	238	
21001	neighborhood prevalence	neighborhood prevalence	1	0	9272	21002	9272	
27422	feasible option	feasible option	1	0	5022	27423	5022	
37350	African Americans	African Americans	1	0	37349	37351	37349	
31504	potential SARS-CoV-2 variants	potential INFunknownSUP variant	1	0	1002	31505	1002	
1646	onset of COVID symptoms	onset of INFunknownSUP symptom	1	0	1647	1648	1647	
33595	Role of procalcitonin	role of procalcitonin	1	0	33596	33597	33596	
19752	British Columbia	British Columbia	1	0	19754	16062	19754	
8589	NGM5 policy	INFunknownSUP policy	1	0	293	8590	293	
16375	target genes	target gene	1	0	12362	11730	12362	
8935	social connection	social connection	1	0	8937	383	8937	
35384	Stress Reaction	stress reaction	1	0	17014	9278	17014	
9396	microbiome composition	microbiome composition	1	0	430	9397	430	
29341	SARS- CoV-2 virus infection	INFunknownSUP INFunknownSUP virus infection	1	0	14073	29342	41	
25840	large reductions	large reduction	1	0	15138	4250	15138	
33057	initial onset of symptoms	initial onset of symptom	1	0	9702	335	1647	
1049	near constant exposure to aerosolized pathogens	near constant exposure to INFunknownSUP pathogen	1	0	1051	1050	1054	
33512	trial of NIRS	trial of INFunknownSUP	1	0	965	299	965	
8055	Post-recovery period COVID-19	Post-recovery period INFunknownSUP	1	0	8057	8056	40	
22346	COVID-19 vulnerability	INFunknownSUP vulnerability	1	0	4805	40	4805	
8488	level of transparency	level of transparency	1	0	362	2291	362	
6716	infection boosts antibody	infection boost antibody	1	0	6718	41	5924	
21137	history of mental disorders	history of mental disorder	1	0	5381	21139	5381	
20250	clinical staff	clinical staff	1	0	11	884	11	
9788	results of the measures	result of the measure	1	0	325	317	325	
33871	peripheral ulcerative keratitis	peripheral ulcerative keratitis	1	0	33873	523	33875	
32740	number of countries	number of country	1	0	916	1599	916	
20587	blood groups A	blood group A	1	0	3475	7812	3475	
19942	experimental COVID-19 treatments	experimental INFunknownSUP treatment	1	0	19944	12146	1295	
20937	elective pediatric general surgery cases	elective pediatric general surgery case	1	0	229	20938	229	
8045	count time series data	count time series datum	1	0	8047	1305	22	
27722	secondary endpoints	secondary endpoint	1	0	13345	712	13345	
2143	immunosuppression modification	immunosuppression modification	1	0	2145	2144	2145	
26583	Stringency of the measures	stringency of the measure	1	0	26584	317	26584	
30517	face-to-face on-campus	face-to-face on-campus	1	0	30519	4673	30519	
36547	toxins A	toxin A	1	0	3475	36548	3475	
18718	% of target dose	% of target dose	1	0	364	18720	364	
18997	rare events	rare event	1	0	1083	10225	1083	
14535	random-effect meta-analysis	INFunknownSUP meta-analysis	1	0	286	14536	286	
18857	syndrome coronavirus:SARS-CoV	syndrome INFunknownSUP	1	0	18859	1936	18859	
13380	online curricula	online curriculum	1	0	13382	541	13382	
8864	30-day mortality risk	30-day mortality risk	1	0	1542	4516	1542	
34185	street population	street population	1	0	1838	34186	1838	
25236	Chinese databases	Chinese database	1	0	1755	1968	1755	
10318	disease course	disease course	1	0	5152	209	5152	
8954	virus-specific T cell receptors	virus-specific T cell receptor	1	0	8956	256	8960	
23147	manufacture of face masks	manufacture of face mask	1	0	23148	3034	23148	
2372	risk mitigation strategies	risk mitigation strategy	1	0	2374	1542	300	
12898	mean score	mean score	1	0	1843	194	1843	
6157	Dental Community	dental Community	1	0	1192	4367	1192	
8109	education approaches	education approach	1	0	8111	361	8111	
2095	conference proceedings	conference proceeding	1	0	2097	2096	2097	
3335	prediction model	prediction model	1	0	1078	3336	1078	
23042	personal stress	personal stress	1	0	199	4961	199	
17338	COVID-19 pandemic restrictions	INFunknownSUP pandemic restriction	1	0	17340	3706	2880	
13955	Antigen Receptor	antigen receptor	1	0	13957	13956	13957	
24630	Progression Scale	progression Scale	1	0	1203	24631	1203	
11984	technology use	technology use	1	0	292	1718	292	
4856	risk governance framework	risk governance framework	1	0	4858	1542	4860	
17694	novel approaches	novel approach	1	0	8111	3645	8111	
6178	afrontamiento precoz	INFunknownSUP INFunknownSUP	1	0	6180	6179	6180	
2939	incidence of these diseases	incidence of these disease	1	0	2940	315	2940	
17016	VSV pseudoparticle infection	INFunknownSUP pseudoparticle infection	1	0	9279	17017	41	
24820	genomic copies/m3 air	INFunknownSUP INFunknownSUP air	1	0	868	24821	868	
10035	mechanism of disease	mechanism of disease	1	0	10036	209	10036	
4047	proximal tubules	proximal tubule	1	0	4049	4048	4049	
19817	network design	network design	1	0	4183	719	4183	
11318	thrombotic complications	thrombotic complication	1	0	705	11319	705	
14849	nonessential cases	nonessential case	1	0	229	5899	229	
7195	proper hand washing rate	proper hand washing rate	1	0	7197	449	1034	
27108	cadaver dissection	cadaver dissection	1	0	27110	27109	27110	
32092	local vaccination centre	local vaccination centre	1	0	32094	3173	25448	
14887	reliable methods	reliable method	1	0	205	12654	205	
10740	function of SCI mice	function of SCI mouse	1	0	9243	10742	9243	
12604	Systematic Review Background	systematic Review background	1	0	12606	5243	4013	
19511	gloves prolonged task times	glove prolonged task time	1	0	19513	1821	12806	
13585	association of depression	association of depression	1	0	11619	1514	11619	
11600	undergraduate occupational therapy students	undergraduate occupational therapy student	1	0	11602	11601	1177	
6988	PPE training	PPE training	1	0	235	6989	235	
7187	COVID-19 content	INFunknownSUP content	1	0	6700	40	6700	
28527	on-demand solutions	on-demand solution	1	0	9378	28528	9378	
26676	multiple accessibility	multiple accessibility	1	0	26678	1776	26678	
29916	Hispanic non-white resident census	Hispanic non-white resident census	1	0	29918	29917	2123	
35325	Managing COVID-19	Managing INFunknownSUP	1	0	40	35326	40	
24515	cell proliferation marker Ki67	cell proliferation marker INFunknownSUP	1	0	24517	197	24521	
25502	specialized laboratory equipment	specialized laboratory equipment	1	0	25504	10902	3038	
37470	Empiric antibiotic treatment	empiric antibiotic treatment	1	0	37472	37471	97	
27051	Respiratory Diseases	respiratory disease	1	0	6908	3287	6908	
6408	structured viruses	structured virus	1	0	2217	6409	2217	
34043	negative effects of COVID-19	negative effect of INFunknownSUP	1	0	537	1338	156	
31850	COVID-19-secure pathways	INFunknownSUP pathway	1	0	8220	31851	8220	
5971	seroprevalence ratio	seroprevalence ratio	1	0	2635	4090	2635	
26458	COVID-19 pandemic:the	INFunknownSUP INFunknownSUP	1	0	26460	40	26460	
34374	non-hospitalized patients	INFunknownSUP patient	1	0	60	11059	60	
15217	hemorrhagic stroke	hemorrhagic stroke	1	0	15219	12525	15219	
38961	Twenty-one patients	twenty-one patient	1	0	60	6782	60	
5865	spectrum of severity	spectrum of severity	1	0	5866	5116	5866	
20540	absence of similar research	absence of similar research	1	0	4917	20542	4917	
25643	differential gene expression	differential gene expression	1	0	5729	25644	5729	
8541	economies of Turkey	economy of Turkey	1	0	8542	8543	8542	
7427	multirisk models	INFunknownSUP model	1	0	3975	7428	3975	
32097	diagnosis of OCD	diagnosis of INFunknownSUP	1	0	2168	32099	2168	
23503	potential patient recall bias	potential patient recall bias	1	0	23505	1276	4930	
11740	personal relevance	personal relevance	1	0	856	4961	856	
8467	seasonal bronchiolitis peaks	seasonal INFunknownSUP peak	1	0	8471	8468	8471	
31933	published studies	published study	1	0	136	2161	136	
29819	pronounced themes	pronounced theme	1	0	12658	29820	12658	
33004	elevation of particles	elevation of particle	1	0	33005	8275	33005	
18504	Levene T-test	Levene INFunknownSUP	1	0	18506	18505	18506	
4293	provinces/regions of China	provinces/region of China	1	0	4294	4295	4294	
2274	heart of a hospital outbreak of SARS-CoV-2	heart of a hospital outbreak of INFunknownSUP	1	0	2275	2276	2275	
10877	health reform	health reform	1	0	10879	120	10879	
17926	lung consolidations	lung consolidation	1	0	17928	772	17928	
10044	implementation of modified teaching strategies	implementation of modified teaching strategy	1	0	396	10046	396	
11500	signal strength index	signal strength index	1	0	11502	11501	4017	
25793	alveolar hemorrhage	alveolar hemorrhage	1	0	25795	11595	25795	
2550	COVID-19-related topic reviews	COVID-19-related topic review	1	0	2552	1384	2554	
3463	clinical manifestation of coronavirus disease	clinical manifestation of coronavirus disease	1	0	3464	338	3466	
4407	future nephrologists	future nephrologist	1	0	4409	1367	4409	
13428	(SARS-CoV-2)-infected patients	(SARS-CoV-2)-infected patient	1	0	60	13429	60	
18274	Collection of Abstracts	collection of abstract	1	0	15383	18276	15383	
14730	affected strata	affected stratum	1	0	14732	9606	14732	
7479	potency of Ashwagandha withanolides	potency of INFunknownSUP INFunknownSUP	1	0	7480	7481	7480	
28670	era of COVID-19 pandemic:Data	era of INFunknownSUP INFunknownSUP	1	0	9542	28672	9542	
19490	relevant details	relevant detail	1	0	19492	346	19492	
14788	general population of Saudi	general population of Saudi	1	0	1836	7220	1838	
21823	context-specific information security	context-specific information security	1	0	21825	21824	12279	
8197	delivery strategy	delivery strategy	1	0	3350	2840	3350	
11108	gender-matched healthy individuals	INFunknownSUP healthy individual	1	0	11110	11109	1113	
33207	ongoing prospective cohort	ongoing prospective cohort	1	0	33209	1059	601	
17162	repercussion of these restrictions	repercussion of these restriction	1	0	17163	2880	17163	
18958	inhibitory potency	inhibitory potency	1	0	7480	2227	7480	
29364	% elsewhere	% elsewhere	1	0	29366	364	29366	
22085	serial intervals	serial interval	1	0	22087	12026	22087	
7850	RT-qPCR Primer-Probe	INFunknownSUP INFunknownSUP	1	0	7852	7851	7852	
19954	SARS-CoV-2 pandemic Bronchiolitis	INFunknownSUP pandemic INFunknownSUP	1	0	19956	28	19958	
30684	S proteins of bat coronaviruses	S protein of bat coronavirus	1	0	30685	30688	1126	
17395	second national lockdown	second national INFunknownSUP	1	0	1674	1279	1676	
35311	Absolute Neutrophil Counts	absolute neutrophil Counts	1	0	35313	35312	35315	
26607	final analysis	final analysis	1	0	486	4256	486	
1668	part of ECEALHBA	part of INFunknownSUP	1	0	734	1670	734	
6869	potential maximal infectious period	potential maximal infectious period	1	0	6871	1276	5677	
22909	pulmonary metastases	pulmonary metastasis	1	0	22911	590	22911	
27165	timing of corticosteroid treatment	timing of corticosteroid treatment	1	0	9056	27167	9056	
13985	humoral immunity	humoral immunity	1	0	257	6114	257	
12969	IgG test	IgG test	1	0	754	928	754	
21121	tertiary care children	tertiary care child	1	0	21123	182	6153	
22196	scalp wound infections	scalp wound infection	1	0	22198	22197	779	
37977	shift to telehealth	shift to telehealth	1	0	37978	304	37978	
30733	molecular vehicles	molecular vehicle	1	0	30735	6935	30735	
15787	Johns Hopkins University	Johns Hopkins University	1	0	15789	15788	50	
18574	rates of hospitalizations	rate of hospitalization	1	0	83	5091	83	
29496	elder men	elder man	1	0	29498	29497	29498	
20382	CHI3L1 axis	INFunknownSUP axis	1	0	20384	20383	20384	
19144	frequent local reactions	frequent local reaction	1	0	19146	1168	19148	
23936	suspected cancers	suspected cancer	1	0	8602	1112	8602	
3152	Prognostic value of copeptin	prognostic value of INFunknownSUP	1	0	3153	3156	1037	
22520	residential treatment program setting	residential treatment program setting	1	0	22522	9936	2854	
27087	pedestrian localization error	pedestrian localization error	1	0	27089	27088	373	
1119	correct classification	correct classification	1	0	1121	1120	1121	
19999	novel modes of presentation	novel mode of presentation	1	0	20001	810	15425	
3020	Mobility Medicine	mobility medicine	1	0	3022	1949	3022	
4441	particle air filters	particle air filter	1	0	4443	4442	4445	
27836	content of Guidance	content of guidance	1	0	6700	27838	6700	
9057	individual characteristics	individual characteristic	1	0	1496	753	1496	
28511	Additional research	additional research	1	0	36	853	36	
24982	Southern California health system	Southern California health system	1	0	24984	24983	1327	
15832	number of arthroplasty procedures	number of INFunknownSUP procedure	1	0	916	15834	916	
29843	Cooperative Research	cooperative research	1	0	29845	29704	29845	
17284	characteristics of gender	characteristic of gender	1	0	1496	17286	1496	
38431	novel drug discovery	novel drug discovery	1	0	38433	810	38435	
4780	non-human primate studies of SARS-CoV-2 vaccine candidates	non-human primate study of INFunknownSUP vaccine candidate	1	0	4782	4781	136	
29550	extended closures of physical activity venues	extended closure of physical activity venue	1	0	29552	288	23196	
11783	specific antibodies	specific antibody	1	0	929	2515	929	
2727	neurological settings	neurological setting	1	0	2729	2728	2729	
26347	fabrication of quick test kits	fabrication of quick test kit	1	0	17308	26349	17308	
13997	hematopoietic stem cell	hematopoietic stem cell	1	0	13999	13998	197	
12865	different levels of infection	different level of infection	1	0	12867	688	169	
8943	School Students	School student	1	0	4368	3669	4368	
26868	outsourcing facilities	outsourcing facility	1	0	2676	26869	2676	
8576	vivo/in vitro	INFunknownSUP INFunknownSUP	1	0	248	8577	248	
6211	access to expert physical therapy services	access to expert physical therapy service	1	0	224	6213	224	
28734	negative pressure	negative pressure	1	0	1027	1338	1027	
26525	third waves of the outbreak	third wave of the outbreak	1	0	26527	7099	1281	
30329	independent predictors of higher mortality	independent predictor of high mortality	1	0	3261	4513	414	
36971	hospital-based survey	hospital-based survey	1	0	967	21210	967	
10423	risk off-target effects	risk off-target effect	1	0	10425	1542	156	
28701	post-traumatic spinal cord injury	post-traumatic spinal cord injury	1	0	28703	23278	713	
421	CLEAR projects	clear project	1	0	423	422	423	
10132	host immune system	host immune system	1	0	1325	10133	1327	
20489	immigrant detention centers	immigrant detention center	1	0	20491	18242	3427	
30433	Retraction notice	retraction notice	1	0	30435	30434	30435	
12149	Alloreactivity of Allogeneic Mesenchymal Stem/Stromal Cells	Alloreactivity of INFunknownSUP mesenchymal INFunknownSUP cell	1	0	12150	12151	12150	
5853	Cross-sectional analysis	cross-sectional analysis	1	0	486	5854	486	
38897	occupancy of ACE2 residues	occupancy of INFunknownSUP residue	1	0	38898	38899	38898	
11691	absence of mass vaccination campaigns	absence of mass vaccination campaign	1	0	4917	11693	4917	
4424	viral dynamics	viral dynamics	1	0	3694	1741	3694	
794	rapid geographic spread of SARS-CoV-2	rapid geographic spread of INFunknownSUP	1	0	796	795	570	
33567	innate immune response	innate immune response	1	0	6115	12377	409	
32872	epidemiological studies	epidemiological study	1	0	136	18107	136	
18647	complex process	complex process	1	0	180	13320	180	
25688	significant potential	significant potential	1	0	6265	908	6265	
22033	Routine blood tests	routine blood test	1	0	12566	22034	1365	
4541	free energy	free energy	1	0	4543	4542	4543	
4561	level of vaccine hesitancy	level of vaccine hesitancy	1	0	362	1031	362	
25021	download volume	INFunknownSUP volume	1	0	3445	25022	3445	
14593	mitogen-activated protein	INFunknownSUP protein	1	0	1797	14594	1797	
39041	androgenetic alopecia	androgenetic alopecia	1	0	26691	39042	26691	
35072	comparative vertebrates	comparative vertebrate	1	0	35074	5624	35074	
24661	consecutive Brazilian women	consecutive Brazilian woman	1	0	24663	6607	920	
29803	associated consultations	associated consultation	1	0	978	240	978	
38491	multistep project	multistep project	1	0	11012	38492	11012	
36171	mammalian RNA viruses	mammalian RNA virus	1	0	3742	36172	2217	
36015	mouse model of spinal cord injury	mouse model of spinal cord injury	1	0	36017	36016	1078	
35770	combination hydroxychloroquine	combination hydroxychloroquine	1	0	633	367	633	
6416	April 2016-April	April 2016-April	1	0	6418	6417	6418	
27663	continuous monitoring programs	continuous monitoring program	1	0	27665	2232	2246	
24267	complement protein	complement protein	1	0	1797	10075	1797	
21268	Neurologic complications	neurologic complication	1	0	705	21269	705	
37664	Viral infections	viral infection	1	0	779	8081	779	
24917	COVID-19 vaccine passport	INFunknownSUP vaccine passport	1	0	24921	3688	24921	
28047	time to results	time to result	1	0	179	325	179	
35666	stimulus policy	stimulus policy	1	0	293	35667	293	
11024	Regional Research Ethics Committee	Regional Research Ethics Committee	1	0	11026	11025	11030	
13811	germline genes	INFunknownSUP gene	1	0	12362	13812	12362	
1948	Mobility Medicine Association	mobility Medicine Association	1	0	1950	1949	1952	
35417	strong psychometric properties	strong psychometric property	1	0	35419	3987	1995	
6354	relevance of this metabolic profile	relevance of this metabolic profile	1	0	856	6356	856	
4172	possible resurgence	possible resurgence	1	0	4174	745	4174	
26817	PCR prevalence	PCR prevalence	1	0	9272	3981	9272	
14723	priori extraction tool	priori extraction tool	1	0	14725	14724	5487	
28191	Dimeric PLA2	INFunknownSUP INFunknownSUP	1	0	28193	28192	28193	
32613	therapeutic benefit	therapeutic benefit	1	0	297	3349	297	
18793	prevalence of non-communicable diseases	prevalence of non-communicable disease	1	0	9272	9626	9272	
21639	warming planet	warming planet	1	0	21641	21640	21641	
13215	measurement methods	measurement method	1	0	205	6671	205	
19320	SARS-CoV-2 laboratory-confirmed cases	INFunknownSUP laboratory-confirmed case	1	0	19322	28	229	
36520	Longitudinal ventilatory ratio monitoring	longitudinal ventilatory ratio monitoring	1	0	36522	8478	3271	
21886	expression of androgen receptors	expression of androgen receptor	1	0	5729	21888	5729	
306	Management of COVID-19 outbreak	Management of INFunknownSUP outbreak	1	0	307	308	307	
36280	symptoms of fever	symptom of fever	1	0	86	6465	86	
22877	residual groups	residual group	1	0	2486	4795	2486	
10175	viral envelope	viral envelope	1	0	10177	1741	10177	
9998	use of mechanical ventilation	use of mechanical ventilation	1	0	292	6303	292	
201	Conversation Analysis methods	conversation analysis method	1	0	203	202	205	
9935	residential substance use programs	residential substance use program	1	0	9937	9936	2246	
17977	anxiety responses	anxiety response	1	0	200	2772	200	
20018	el manejo competencial de los profesionales sanitarios	el INFunknownSUP INFunknownSUP de los INFunknownSUP INFunknownSUP	1	0	20020	1910	14626	
9467	fear of interaction	fear of interaction	1	0	9468	2525	9468	
25926	adequate supply of RBC units	adequate supply of RBC unit	1	0	269	25930	271	
30355	nose bridge	nose bridge	1	0	30357	30356	30357	
14212	explanatory power	explanatory power	1	0	7608	14213	7608	
6952	renal complications	renal complication	1	0	705	130	705	
12463	Immunoglobulin gene heterogeneity	immunoglobulin gene heterogeneity	1	0	12465	12464	1972	
37153	credible interval	credible interval	1	0	1794	37154	1794	
3228	natural ecosystems	natural ecosystem	1	0	3230	3229	3230	
36217	preference scores	preference score	1	0	3726	4438	3726	
3040	female individuals	female individual	1	0	1113	3041	1113	
15717	Mor et al	Mor et al	1	0	15719	15718	15721	
26552	venom phospholipase A2s exhibit strong virucidal activity	venom phospholipase A2s exhibit strong INFunknownSUP activity	1	0	26554	26553	3990	
37769	average precision	average precision	1	0	14211	178	14211	
12846	less research	less research	1	0	36	5525	36	
16775	odds of mortality	odd of mortality	1	0	5255	1197	5255	
11344	Disease Analysis Foundation	Disease Analysis Foundation	1	0	11346	5148	11348	
13549	Public awareness campaigns	public awareness campaign	1	0	3886	13550	3886	
25261	continuous mutation of SARS-CoV-2	continuous mutation of INFunknownSUP	1	0	25263	2232	333	
15846	C-159T rs2569190	INFunknownSUP INFunknownSUP	1	0	15848	15847	15848	
28155	Clavien-Dindo classification of surgical complications	INFunknownSUP classification of surgical complication	1	0	28156	28159	1121	
6733	MR device	Mr device	1	0	3001	6734	3001	
7536	receptor-binding domain of the spike protein	receptor-binding domain of the spike protein	1	0	4749	1795	697	
28942	priming proteases	priming protease	1	0	28944	28943	28944	
21283	Ethiopia Knowledge	Ethiopia Knowledge	1	0	7065	11439	7065	
19932	Critical Apraisal Skill Programme	critical INFunknownSUP Skill programme	1	0	19934	19263	19938	
13000	separation of water-soluble IgY	separation of water-soluble IgY	1	0	13001	13002	13001	
33177	global disruption	global disruption	1	0	12078	1954	12078	
24386	Social Support	social support	1	0	2021	24387	2021	
14962	TMPRSS2 SARS-CoV-2	INFunknownSUP INFunknownSUP	1	0	28	6251	28	
25117	pandemic of 21st century	pandemic of 21st century	1	0	113	25119	113	
2687	East respiratory syndrome coronavirus	East respiratory syndrome coronavirus	1	0	1933	2688	339	
38362	foreign body ingestions	foreign body ingestion	1	0	38364	13047	38366	
8302	open-label trial of a messenger RNA vaccine	open-label trial of a messenger RNA vaccine	1	0	8304	8303	965	
17879	medical sciences	medical science	1	0	17881	947	17881	
17045	healthcare model	INFunknownSUP model	1	0	1078	494	1078	
21362	Association of Dental Students	Association of dental student	1	0	1952	4366	1952	
30515	combined face-to-face on-campus	combined face-to-face on-campus	1	0	30517	9071	30519	
22072	valid participants	valid participant	1	0	4950	5019	4950	
19505	microbiota structure	microbiota structure	1	0	2427	429	2427	
22401	genus level	genus level	1	0	362	22402	362	
2547	% of the people	% of the people	1	0	364	694	364	
25239	future healthcare costs	future INFunknownSUP cost	1	0	25241	1367	22726	
33710	low cross-reactivity	low cross-reactivity	1	0	27783	457	27783	
14474	perivascular white matter lesions	perivascular white matter lesion	1	0	162	14475	162	
24838	phenomenon suggestive of protective immunity	phenomenon suggestive of protective immunity	1	0	24839	24840	24839	
15090	chest CT scans	chest CT scan	1	0	15094	24	15094	
37852	nutrient intake	nutrient intake	1	0	22803	37853	22803	
32771	postinflammatory immune-mediated presentation of SARS-CoV-2	postinflammatory INFunknownSUP presentation of INFunknownSUP	1	0	32773	32772	4163	
28316	COVID-19 Screening	INFunknownSUP screening	1	0	27768	40	27768	
32037	phage interaction	phage interaction	1	0	2525	22951	2525	
12596	early spread	early spread	1	0	570	55	570	
17577	Coronavirus Disease-2019 Patients	INFunknownSUP Disease-2019 Patients	1	0	17579	3206	3207	
12174	y CUIDEN	y INFunknownSUP	1	0	12176	1908	12176	
23799	proteinuria status	proteinuria status	1	0	2720	7378	2720	
11665	different detection approaches	different detection approach	1	0	11667	688	8111	
12418	initial exam	initial exam	1	0	3998	335	3998	
1953	global ground-level NO2 concentrations	global ground-level INFunknownSUP concentration	1	0	1955	1954	1959	
36286	Concomitant bacterial counts	concomitant bacterial count	1	0	36288	36287	5090	
18310	proactive lockdown	proactive INFunknownSUP	1	0	1676	18311	1676	
6805	environmental aerosol samples	environmental aerosol sample	1	0	6807	6806	1765	
13740	host defense	host defense	1	0	13742	10133	13742	
26375	graduate status	graduate status	1	0	2720	26376	2720	
2636	recommended core outcome measures	recommended core outcome measure	1	0	1850	2125	317	
6442	sides of the Atlantic	side of the Atlantic	1	0	6443	6444	6443	
34270	predictive epidemiological model	predictive epidemiological model	1	0	34272	4314	1078	
22710	initial defects	initial defect	1	0	22712	335	22712	
22730	Molecular assays	molecular assay	1	0	2754	19781	2754	
30976	technical constraints	technical constraint	1	0	762	4083	762	
17376	systemic metabolic inflammation	systemic metabolic inflammation	1	0	17378	1453	3116	
18928	recovery stages of infection	recovery stage of infection	1	0	18930	3007	766	
35787	receptor molecules	receptor molecule	1	0	7076	3502	7076	
16448	SARS-CoV-2 infection rates	INFunknownSUP infection rate	1	0	6794	226	83	
15989	detection assays	detection assay	1	0	2754	44	2754	
32780	dynamic data	dynamic datum	1	0	22	1540	22	
9187	Field Barrier	Field Barrier	1	0	9189	9188	9189	
13706	comparison of admission characteristics	comparison of admission characteristic	1	0	13707	13708	13707	
26755	intravascular haemolysis	intravascular haemolysis	1	0	26757	26756	26757	
13758	electrocautery energy devices	electrocautery energy device	1	0	13760	13759	6162	
12813	patients of particular risk	patient of particular risk	1	0	60	12815	60	
24821	genomic copies/m3	INFunknownSUP INFunknownSUP	1	0	24823	5714	24823	
19991	Delta variant	Delta variant	1	0	939	19992	939	
4886	Higher PXS scores	high PXS score	1	0	4888	4887	3726	
5531	levels of biomarkers	level of biomarker	1	0	169	2577	169	
7030	Preliminary analysis	preliminary analysis	1	0	486	7031	486	
11484	challenges of pregnant women	challenge of pregnant woman	1	0	2220	3137	2220	
25552	risk of COVID-19 infection	risk of INFunknownSUP infection	1	0	1542	39	1542	
28042	Trauma-informed care	Trauma-informed care	1	0	9	28043	9	
29795	single intraperitoneal	single INFunknownSUP	1	0	29797	1652	29797	
9517	vitamin D	vitamin D	1	0	9519	2539	9519	
11209	lack of vaccine hesitancy	lack of vaccine hesitancy	1	0	11210	1031	11210	
8468	seasonal bronchiolitis	seasonal INFunknownSUP	1	0	5471	2378	5471	
22098	writings of the philosopher Immanule Kant	writing of the philosopher INFunknownSUP Kant	1	0	22099	22100	22099	
16584	epidemiology of the COVID-19	epidemiology of the INFunknownSUP	1	0	16585	40	16585	
22304	protected didactic time	protected didactic time	1	0	22306	22305	179	
8806	cytokine receptor activation	INFunknownSUP receptor activation	1	0	8808	8807	1013	
8073	aerosol generation measurements	aerosol generation measurement	1	0	8075	6808	8077	
36719	positive serology	positive serology	1	0	5992	228	5992	
29211	true unknown SI	true unknown SI	1	0	29213	29212	29215	
17604	American Joint Replacement Registry	American Joint replacement registry	1	0	17606	17605	17610	
28814	cluster of differentiation	cluster of differentiation	1	0	13441	28816	13441	
28188	prediction of the disease	prediction of the disease	1	0	3336	209	3336	
15951	rapid dissemination of novel coronavirus	rapid dissemination of novel INFunknownSUP	1	0	15953	795	6877	
36963	Resistance Patterns	resistance pattern	1	0	24738	36964	24738	
36660	active substance	active substance	1	0	715	3597	715	
8028	fatty liver disease	fatty liver disease	1	0	8030	8029	209	
4201	skin diseases	skin disease	1	0	315	161	315	
39214	Insurance-contracted hospitals	INFunknownSUP hospital	1	0	76	39215	76	
29454	stress level	stress level	1	0	362	199	362	
15883	light of the ongoing nature of pandemics	light of the ongoing nature of pandemic	1	0	8068	15885	8068	
30059	wealthy nations	wealthy nation	1	0	30061	30060	30061	
6382	tract infection	tract infection	1	0	41	2154	41	
34057	adaptive immunity	adaptive immunity	1	0	257	6264	257	
24353	income countries	income country	1	0	1599	5356	1599	
8479	quantitative analysis of influent wastewater data	quantitative analysis of influent wastewater datum	1	0	8481	1426	486	
16230	Chronic Disease	chronic disease	1	0	10958	16231	10958	
30531	urgent healthcare	urgent INFunknownSUP	1	0	494	8129	494	
26092	harsh conditions of the COVID-19 working environment	harsh condition of the INFunknownSUP working environment	1	0	26093	26096	2910	
34905	head injuries	head injury	1	0	31866	2845	31866	
31169	atypical clinical course	atypical clinical course	1	0	5150	4932	5152	
19405	use of protective equipment	use of protective equipment	1	0	292	4962	292	
11365	implementation of molecular assay testing	implementation of molecular assay testing	1	0	396	11367	396	
31789	socioeconomic adversity	socioeconomic adversity	1	0	31791	16	31791	
34860	evidence of cross-reactive memory CD8 T cells	evidence of cross-reactive memory INFunknownSUP T cell	1	0	585	34862	585	
12038	containment of COVID-19	containment of INFunknownSUP	1	0	12039	40	12039	
1255	appropriate interventions	appropriate intervention	1	0	757	1256	757	
10638	Additional socio-economic complications	additional socio-economic complication	1	0	10640	853	705	
17813	spread of this contagious disease	spread of this contagious disease	1	0	570	17815	570	
38748	Health Care Personnel	Health Care Personnel	1	0	38750	279	38752	
38016	care industries	care industry	1	0	8158	9	8158	
20131	Feasibility study	feasibility study	1	0	2087	20132	2087	
28651	original articles	original article	1	0	811	13288	811	
39086	management of appendicitis	management of appendicitis	1	0	743	1983	743	
38042	lung complications	lung complication	1	0	705	772	705	
31856	Large vessel occlusion	large vessel occlusion	1	0	31858	31857	31860	
24711	high-sensitive troponin	high-sensitive INFunknownSUP	1	0	4478	24712	4478	
3267	high score	high score	1	0	1843	13	1843	
33805	novel Corona virus	novel Corona virus	1	0	33807	810	778	
25315	early signs of COVID-19	early sign of INFunknownSUP	1	0	25317	55	3011	
4633	erroneous results of early laboratory tests	erroneous result of early laboratory test	1	0	4635	4634	325	
12343	day of birth	day of birth	1	0	6271	12345	6271	
33756	support to healthcare workers	support to INFunknownSUP worker	1	0	260	6468	260	
6556	high levels of migration	high level of migration	1	0	167	6560	169	
21248	transplant recipients	transplant recipient	1	0	11385	21249	11385	
17619	need of urgent treatment	need of urgent treatment	1	0	9579	17621	9579	
10347	new death	new death	1	0	4722	69	4722	
27222	sensor collection	sensor collection	1	0	16824	19952	16824	
35726	rapid-response surveys	rapid-response survey	1	0	35728	35727	35728	
9645	clinical motility testing Aerosol spread	clinical motility testing aerosol spread	1	0	9647	884	570	
15405	decision to post-pone 2020PMD	decision to INFunknownSUP INFunknownSUP	1	0	5486	15407	5486	
18175	chronic genetic disorders	chronic genetic disorder	1	0	18177	8230	889	
26597	aim of this case series	aim of this case series	1	0	7070	20220	7070	
10368	important authority figures	important authority figure	1	0	10370	273	10372	
35998	accurate location	accurate location	1	0	11895	324	11895	
404	Body Ingestions	body ingestion	1	0	406	405	406	
29721	detection primer-probe	detection primer-probe	1	0	29723	44	29723	
38383	manufacturing of non-woven media Centralized manufacturing	manufacturing of non-woven medium centralized manufacturing	1	0	718	38385	718	
11150	Work-related Stress	work-related stress	1	0	9278	11151	9278	
26856	blood cell count	blood cell count	1	0	26858	3129	1305	
18986	IgG4 responses	INFunknownSUP response	1	0	200	18987	200	
11508	adjunct risk stratification	adjunct risk stratification	1	0	3807	11509	3809	
17866	well-being of older adults	well-being of old adult	1	0	2245	513	2245	
21929	trainee feedback	trainee feedback	1	0	10216	8828	10216	
6201	structure-guided drug-binding analysis	INFunknownSUP drug-binding analysis	1	0	6203	6202	486	
3081	progressive decrease of admissions	progressive decrease of admission	1	0	3083	3082	3084	
16590	SARS-CoV-2 vRNA	INFunknownSUP INFunknownSUP	1	0	16592	226	16592	
25573	patient health conditions	patient health condition	1	0	2908	2645	2910	
29006	importance of blood glucose control	importance of blood glucose control	1	0	2765	29008	2765	
4052	Safety Database	Safety Database	1	0	4054	4053	4054	
36100	current high prevalence of infection	current high prevalence of infection	1	0	36102	443	9272	
15995	PCT measurements	PCT measurement	1	0	8077	15996	8077	
26916	frequency of FBIs	frequency of INFunknownSUP	1	0	19362	8366	19362	
19500	knowledge base	knowledge base	1	0	3323	213	3323	
30578	type of alopecia	type of alopecia	1	0	775	26691	775	
38501	midweek consumption ratio	midweek consumption ratio	1	0	38503	38502	2635	
34248	Moral distress	moral distress	1	0	1975	34249	1975	
5568	National Household Sample Survey	National household Sample Survey	1	0	5570	46	5574	
31093	asynchronous online video teaching	asynchronous online video teaching	1	0	31095	1997	2074	
21466	work dissonance	work dissonance	1	0	21468	2162	21468	
17230	observational cohort study	observational cohort study	1	0	2085	3552	2087	
35664	Economic stimulus policy	economic stimulus policy	1	0	35666	35665	293	
39277	Integrated care	integrated care	1	0	9	39278	9	
5414	HIV Care Infrastructures	HIV Care infrastructure	1	0	5416	5415	5418	
23310	comprehensive studies	comprehensive study	1	0	136	2902	136	
20487	federal immigrant detention centers	federal immigrant detention center	1	0	20489	1598	3427	
20925	length of hospitalisation	length of hospitalisation	1	0	1347	14523	1347	
29894	Evaluation of Skin Problems	evaluation of skin Problems	1	0	7849	29896	7849	
7128	COVID-19-related symptoms	COVID-19-related symptom	1	0	86	1384	86	
29541	defense mechanisms	defense mechanism	1	0	1456	13742	1456	
21082	Health Belief Model Perspective	Health belief Model Perspective	1	0	21084	279	10704	
35359	cardiac biomarkers	cardiac biomarker	1	0	2577	3858	2577	
8195	teaching delivery strategy	teaching delivery strategy	1	0	8197	2074	3350	
9503	positive health outcomes	positive health outcome	1	0	9505	228	263	
10293	children of parents	child of parent	1	0	6153	6913	6153	
16388	Action Research	Action Research	1	0	3674	16389	3674	
24049	peak month	peak month	1	0	2167	24050	2167	
30544	el abordaje del duelo y la muerte	el INFunknownSUP del INFunknownSUP y la INFunknownSUP	1	0	30546	1910	30556	
2011	direct effects of the COVID-19 pandemic	direct effect of the INFunknownSUP pandemic	1	0	2013	2012	156	
23166	post-COVID-19 severe disease:after immunosuppressants	INFunknownSUP severe INFunknownSUP immunosuppressant	1	0	23172	23167	23172	
6361	Gelatinase-Associated Lipocalin	Gelatinase-Associated Lipocalin	1	0	6363	6362	6363	
1277	second waves of COVID-19 spread	second wave of INFunknownSUP spread	1	0	570	1278	570	
15023	methods of vaccine delivery	method of vaccine delivery	1	0	205	15025	205	
9124	various laboratories	various laboratory	1	0	9126	1099	9126	
10730	SARS-CoV-2 school outbreaks	INFunknownSUP school outbreak	1	0	10732	226	2892	
3584	smell loss	smell loss	1	0	3586	3585	3586	
12677	pre-COVID-19 world Vaccination	INFunknownSUP world vaccination	1	0	12679	600	3872	
39030	higher PEEP	high peep	1	0	3521	322	3521	
2887	significant correlation	significant correlation	1	0	2889	908	2889	
34285	high capacity adsorption filtration membranes	high capacity adsorption filtration membrane	1	0	34287	13	34293	
2524	interaction of viruses	interaction of virus	1	0	2525	2217	2525	
13830	organ-level architecture	organ-level architecture	1	0	13832	13831	13832	
35557	primary care encounters	primary care encounter	1	0	13168	6472	13168	
13902	rise to adequate immune response	rise to adequate immune response	1	0	13903	13904	13903	
2354	systematic examination of the whole risk chain	systematic examination of the whole risk chain	1	0	2356	343	1800	
9028	Intrauterine vertical transmission of SARS-CoV-2	intrauterine vertical transmission of INFunknownSUP	1	0	9030	9029	876	
8000	corticosteroid group n	corticosteroid group n	1	0	8002	8001	8004	
37478	COVID-19 focal center	INFunknownSUP focal center	1	0	37480	40	8718	
38980	challenging period	challenging period	1	0	5677	37058	5677	
34657	workflow integration	INFunknownSUP integration	1	0	918	34658	918	
4506	social network	social network	1	0	719	383	719	
21958	inter-hospital transfer	INFunknownSUP transfer	1	0	10218	7898	10218	
27274	social teaching	social teaching	1	0	2074	383	2074	
39058	complement system	complement system	1	0	1327	10075	1327	
10566	review of electronic health record	review of electronic health record	1	0	1723	10568	1723	
18668	Coronavirus COVID-19	INFunknownSUP INFunknownSUP	1	0	40	3206	40	
6296	potential COVID-19	potential INFunknownSUP	1	0	40	1276	40	
19708	telemedicine innovation	telemedicine innovation	1	0	19710	16044	19710	
31371	diagnostic values of the suggested model	diagnostic value of the suggested model	1	0	31372	31375	825	
26646	outpatient clinic	outpatient clinic	1	0	7704	327	7704	
13287	original cardiovascular signals	original cardiovascular signal	1	0	13289	13288	4820	
4574	Significant correlations	significant correlation	1	0	4576	4575	4576	
38409	association of LUSI	association of INFunknownSUP	1	0	11619	38411	11619	
35357	abnormal cardiac biomarkers	abnormal cardiac biomarker	1	0	35359	13888	2577	
17648	certainty of the available evidence	certainty of the available evidence	1	0	17649	5791	17649	
17846	production of vegetal cultures	production of vegetal culture	1	0	654	17848	654	
13020	consultation parameters	consultation parameter	1	0	6460	6629	6460	
19961	delivery of complex change programmes	delivery of complex change programme	1	0	2840	19963	2840	
34708	Systematic review	systematic review	1	0	1723	5243	1723	
14612	de gasto sanitario ni de los servicios sanitarios	de INFunknownSUP INFunknownSUP Ni de los INFunknownSUP INFunknownSUP	1	0	14614	1421	14626	
2828	use authorization	use authorization	1	0	2830	292	2830	
31361	Hubei province of China	Hubei province of China	1	0	31363	3830	23950	
2736	COVID-positive pregnant ladies	COVID-positive pregnant lady	1	0	2738	2737	2740	
19235	Sciences Pearson	Sciences Pearson	1	0	4230	5785	4230	
29355	COVID-19 Pandemic Currently Covid-19 pandemic	INFunknownSUP pandemic Currently INFunknownSUP pandemic	1	0	113	29356	113	
22996	resident well-being High educational debt	resident well-being High educational debt	1	0	22998	2241	3627	
20146	NHS COVID-19	NHS INFunknownSUP	1	0	3076	20147	3076	
390	magnitude of increase	magnitude of increase	1	0	391	392	391	
3842	hypoxia-associated neuropathological features	hypoxia-associated neuropathological feature	1	0	3844	3843	1469	
20291	healthcare system capacity	INFunknownSUP system capacity	1	0	3026	20292	3026	
32204	closures of physical activity-supporting facilities	closure of physical INFunknownSUP facility	1	0	23196	2858	23196	
7134	broad applicability to various clinical scenarios	broad applicability to various clinical scenario	1	0	7136	7135	7137	
36836	hepatitis C infections	hepatitis C infection	1	0	36838	36837	779	
36049	long period of time	long period of time	1	0	36050	179	5677	
7845	AL patients	al patient	1	0	60	7846	60	
36126	vulnerable groups	vulnerable group	1	0	2486	6402	2486	
35138	Hidden Correlations	Hidden correlation	1	0	35140	35139	35140	
38791	single vaccination	single vaccination	1	0	437	1652	437	
29047	regions of the world	region of the world	1	0	5240	4336	5240	
6236	hospital resources	hospital resource	1	0	835	185	835	
29771	different outcomes	different outcome	1	0	263	688	263	
32789	DIF contrast	DIF contrast	1	0	32791	32790	32791	
26365	diagnosis of complex cases	diagnosis of complex case	1	0	2168	15872	2168	
32859	perspectives of the impact of the COVID-19 pandemic	perspective of the impact of the INFunknownSUP pandemic	1	0	3304	109	3304	
17851	conventional methods	conventional method	1	0	205	8443	205	
33572	tumor protein P53	tumor protein p53	1	0	33574	5736	33576	
12399	emergency surgical care	emergency surgical care	1	0	6929	447	9	
32705	official public sites	official public site	1	0	32707	20518	9165	
20484	care system	care system	1	0	1327	9	1327	
35371	substantial variation	substantial variation	1	0	9427	3239	9427	
3012	medical providers	medical provider	1	0	673	947	673	
28039	detailed reporting	detailed reporting	1	0	28041	21498	28041	
21820	nasal cavity	nasal cavity	1	0	21822	1472	21822	
33314	accuracy of COVID-19 detection	accuracy of INFunknownSUP detection	1	0	4535	29430	4535	
34080	increase of a unit	increase of a unit	1	0	392	10	392	
38686	Italian cases	Italian case	1	0	229	115	229	
29336	CDR1 somatic hypermutation	INFunknownSUP somatic hypermutation	1	0	29338	8255	29340	
31735	PET of long COVID patients	pet of long INFunknownSUP patient	1	0	12205	25367	12205	
18686	dual Medicaid coverage	dual Medicaid coverage	1	0	18688	18687	4933	
2111	Efficacy of Telehealth Medication Abortions	efficacy of Telehealth medication abortion	1	0	2112	2113	2112	
29630	nanomaterials-based detection technology	INFunknownSUP detection technology	1	0	29632	29631	1718	
1122	SARS-CoV-2 spike proteins	INFunknownSUP spike protein	1	0	1124	28	1126	
10573	greater focus	great focus	1	0	8409	302	8409	
33496	strict safety measures	strict safety measure	1	0	31528	8859	317	
20212	JAMA criteria	JAMA criterion	1	0	3649	17701	3649	
35516	multivariable binary logistic regression model	multivariable binary logistic regression model	1	0	21922	10323	1078	
233	professional training	professional training	1	0	235	234	235	
27769	Drug Libraries Severe acute respiratory syndrome coronavirus	Drug library severe acute respiratory syndrome coronavirus	1	0	27771	4969	339	
12319	dynamics of anti-viral immunity	dynamics of anti-viral immunity	1	0	3694	12321	3694	
3978	swab PCR tests	swab PCR test	1	0	3980	3979	1365	
21620	stroke management	stroke management	1	0	743	15219	743	
23390	n =251	n INFunknownSUP	1	0	23392	8004	23392	
24283	food choice motives:"healthy eaters	food choice motives:"healthy eater	1	0	24287	14338	24289	
21412	severe/life-threatening COVID-19	severe/life-threatening INFunknownSUP	1	0	40	21413	40	
17433	percentage of patients	percentage of patient	1	0	3789	60	3789	
29547	different lineages	different lineage	1	0	29549	688	29549	
15928	height determination of pedestrians	height determination of pedestrian	1	0	15930	4222	15931	
14082	trend of COVID-19 deaths	trend of INFunknownSUP death	1	0	6677	14084	6677	
18964	realizo busqueda bibliografica	INFunknownSUP INFunknownSUP INFunknownSUP	1	0	18968	18965	18968	
32950	SARS-CoV-2-associated disease	SARS-CoV-2-associated disease	1	0	209	32951	209	
20867	healthcare sector of the new century	INFunknownSUP sector of the new century	1	0	20869	494	11631	
10581	Sense of coherence	sense of coherence	1	0	7550	1673	7550	
19737	dimensions of integration	dimension of integration	1	0	15311	918	15311	
32105	non-adaptive pooled-sample screening protocol	non-adaptive pooled-sample screening protocol	1	0	32107	32106	7962	
6767	magnetic bead-based multiplex immunoassays	magnetic INFunknownSUP multiplex immunoassay	1	0	6769	6768	6773	
38004	online self-report demographic questionnaire	online self-report demographic questionnaire	1	0	38006	541	9620	
36900	COVID-19 Emerging evidence	INFunknownSUP Emerging evidence	1	0	36902	40	585	
37505	post-COVID era	INFunknownSUP era	1	0	9542	15821	9542	
35270	Non-Endemic Provinces	INFunknownSUP Provinces	1	0	35272	35271	35272	
11618	association of groups	association of group	1	0	11619	2486	11619	
35672	Comparison of the Rapid Antigen Testing Method	comparison of the Rapid antigen Testing Method	1	0	15376	35674	15376	
12480	males n	male n	1	0	8004	5044	8004	
31384	Cases of endometriosis	case of endometriosis	1	0	31385	9860	31385	
28697	Excessive inflammation post-traumatic spinal cord injury	excessive inflammation post-traumatic spinal cord injury	1	0	28701	28698	713	
26602	dynamic pharmacy leadership	dynamic pharmacy leadership	1	0	18983	1540	18985	
37805	phage display	phage display	1	0	37807	22951	37807	
36826	global disease burden	global disease burden	1	0	14223	1954	1070	
4304	individual losses	individual loss	1	0	4306	753	4306	
15523	recent examples	recent example	1	0	4463	2128	4463	
34197	real-time reproductive numbers (R(t))	real-time reproductive number INFunknownSUP	1	0	34199	1429	12541	
1399	Chest Radiograph Scores COVID-19	chest radiograph score INFunknownSUP	1	0	40	1400	40	
34414	routine GRADE assessment	routine grade assessment	1	0	34416	4898	238	
30907	erratic behaviour	erratic behaviour	1	0	469	466	469	
5376	food practices	food practice	1	0	5378	171	5378	
25209	mRNA-1273 COVID-19 Vaccines	mRNA-1273 INFunknownSUP vaccine	1	0	7090	17791	7092	
5111	higher CT severity score	high CT severity score	1	0	5113	322	1843	
3655	naive CD8	naive INFunknownSUP	1	0	787	3656	787	
7368	Cycle threshold	cycle threshold	1	0	451	7369	451	
27243	alignment of ACE2	alignment of INFunknownSUP	1	0	3505	3437	3505	
26342	entire population	entire population	1	0	1838	2269	1838	
22125	construct validity	construct validity	1	0	13691	22126	13691	
11954	inconclusive results	inconclusive result	1	0	325	11955	325	
31499	frequent finding	frequent finding	1	0	18565	1168	18565	
27363	recent study	recent study	1	0	2087	2128	2087	
13805	preferential usage of IGHV3-53/3-66 germline genes	preferential usage of IGHV3-53/3-66 INFunknownSUP gene	1	0	13807	13806	2248	
25691	front-line health workers	front-line health worker	1	0	21240	25692	1136	
3717	cytokine release syndrome	INFunknownSUP release syndrome	1	0	3719	3718	1936	
4991	Analyses of genome annotations	analysis of genome annotation	1	0	4992	4993	4992	
19718	effect of PLA2s	effect of INFunknownSUP	1	0	1809	19720	1809	
29950	COVID-19-related aspects	COVID-19-related aspect	1	0	2429	1384	2429	
9076	large-volume sewage	large-volume sewage	1	0	6963	9077	6963	
23304	cavity mucosa	cavity mucosa	1	0	23306	21822	23306	
3566	para orientar la prevencion y el	para INFunknownSUP la INFunknownSUP y el	1	0	3568	3567	1910	
20661	non-serious talk	non-serious talk	1	0	20663	20662	20663	
20013	automatic detection of pneumonia	automatic detection of pneumonia	1	0	20015	20014	44	
14821	estimation of the basic reproduction number of novel coronavirus	estimation of the basic reproduction number of novel coronavirus	1	0	10490	14823	10490	
35248	asymptomatic cancer patients	asymptomatic cancer patient	1	0	35250	1131	60	
15237	Povidone-iodine preprocedural rinse:An	INFunknownSUP preprocedural INFunknownSUP	1	0	15239	15238	15241	
36953	Available evidence	available evidence	1	0	585	36954	585	
14042	resources of the individual spinal units	resource of the individual spinal unit	1	0	835	14044	835	
21510	virus particles	virus particle	1	0	8275	778	8275	
16873	Research Unit	Research Unit	1	0	16875	3674	16875	
2896	cancer patient population	cancer patient population	1	0	2898	773	1838	
211	post-intervention knowledge	post-intervention knowledge	1	0	213	212	213	
21695	intense re-exposure	intense re-exposure	1	0	21697	12704	21697	
22038	related articles	related article	1	0	811	2647	811	
32040	conversion disorder/functional neurological disorder	conversion disorder/functional neurological disorder	1	0	15693	12067	7358	
18890	flu-like symptoms	flu-like symptom	1	0	86	18891	86	
30419	booster immunization	booster immunization	1	0	19253	804	19253	
19269	2-x-2 between-subjects design	INFunknownSUP INFunknownSUP design	1	0	4183	19270	4183	
8173	hs-TNI testing	INFunknownSUP testing	1	0	1885	8174	1885	
28848	perifoveal regions	perifoveal region	1	0	5240	28849	5240	
33903	interferon-gamma-induced phosphorylation	INFunknownSUP INFunknownSUP	1	0	945	33904	945	
19330	collection of key clinical trial endpoints	collection of key clinical trial endpoint	1	0	16824	19332	16824	
3435	Assessments of ACE2	assessment of INFunknownSUP	1	0	3436	3437	3436	
28708	Understanding of guidance	understanding of guidance	1	0	28709	18482	28709	
3153	Prognostic value	prognostic value	1	0	1037	3154	1037	
15484	severity of COVID-19 disease	severity of INFunknownSUP disease	1	0	5116	14757	5116	
36263	medical workers	medical worker	1	0	1136	947	1136	
12395	patient access to emergency surgical care	patient access to emergency surgical care	1	0	12397	2645	224	
10425	off-target effects	off-target effect	1	0	156	10426	156	
16357	state-of-the-art models	state-of-the-art model	1	0	3975	533	3975	
34775	% of naive vaccinees	% of naive INFunknownSUP	1	0	364	34777	364	
21787	global fight	global fight	1	0	21789	1954	21789	
3847	health statuses	health status	1	0	3849	120	3849	
9096	cerebral hemodynamics	cerebral hemodynamics	1	0	9098	4322	9098	
13649	transfusion-transmissible infections	transfusion-transmissible infection	1	0	779	13650	779	
27105	factors BDNF	factor INFunknownSUP	1	0	27107	583	27107	
23132	cardiovascular diseases	cardiovascular disease	1	0	315	13290	315	
13175	program target	program target	1	0	11730	1790	11730	
38691	politicized expert system	politicized expert system	1	0	38693	38692	1327	
23061	J Epidemiol	J INFunknownSUP	1	0	23063	23062	23063	
29165	Day Care	Day Care	1	0	5417	29166	5417	
19692	midterm score	midterm score	1	0	1843	19693	1843	
7077	skilled workforce	skilled workforce	1	0	3750	7078	3750	
5159	standard gel electrophoresis	standard gel INFunknownSUP	1	0	5161	2056	5163	
6438	laboratory-confirmed SARS-CoV-2	laboratory-confirmed INFunknownSUP	1	0	28	6439	28	
20521	Italian National Institute	Italian National Institute	1	0	20523	115	20525	
3416	major SARS-CoV-2 variants of concern	major INFunknownSUP variant of concern	1	0	3417	79	1002	
27138	detection of viral diseases	detection of viral disease	1	0	44	14657	44	
17896	sick leave &gt	sick leave &gt	1	0	2385	415	2385	
21994	hospital course	hospital course	1	0	5152	185	5152	
5493	microparticle immunoassay	microparticle immunoassay	1	0	5495	5494	5495	
33049	practical implications	practical implication	1	0	9549	6164	9549	
14005	serological responses	serological response	1	0	200	2753	200	
15468	coronavirus infection	coronavirus infection	1	0	41	339	41	
7679	% of the total DALYs	% of the total INFunknownSUP	1	0	364	7681	364	
28724	Communalistic Resource-Limited Africa	communalistic Resource-Limited Africa	1	0	28726	28725	668	
37177	types of training	type of training	1	0	1979	235	1979	
34118	Unilateral lung involvement	unilateral lung involvement	1	0	5122	34119	3599	
2487	moral obligation	moral obligation	1	0	2489	1315	2489	
37883	range of viral pathogens	range of viral pathogen	1	0	420	1740	420	
34563	essential research	essential research	1	0	36	4197	36	
32222	safety concern	safety concern	1	0	79	6729	79	
19515	task times	task time	1	0	12806	468	12806	
12215	issue of great concern	issue of great concern	1	0	2832	12217	2832	
27496	in-person seminars	in-person seminar	1	0	21877	9275	21877	
18462	inflammatory cytokine production	inflammatory INFunknownSUP production	1	0	18464	3817	654	
36080	global virus spread	global virus spread	1	0	2884	1954	570	
17700	JAMA benchmarks results	JAMA benchmark result	1	0	17702	17701	325	
6821	efficient strategy	efficient strategy	1	0	3350	4329	3350	
11586	angiotensin-converting enzyme	INFunknownSUP enzyme	1	0	624	11587	624	
3556	killer cells	killer cell	1	0	133	3557	133	
7477	inhibitory potency of Ashwagandha withanolides	inhibitory potency of INFunknownSUP INFunknownSUP	1	0	7479	2227	7480	
18930	stages of infection	stage of infection	1	0	766	41	766	
20141	SARS-CoV-2 surrogate virus	INFunknownSUP surrogate virus	1	0	20143	28	778	
38299	reproductive medical experience	reproductive medical experience	1	0	38301	16166	2782	
32217	key task	key task	1	0	468	850	468	
20253	higher knowledge	high knowledge	1	0	213	322	213	
28645	beginning of the pandemic	beginning of the pandemic	1	0	10611	113	10611	
38824	Papillary Necrosis	papillary necrosis	1	0	38826	38825	38826	
8704	strong family history of autoimmunity	strong family history of autoimmunity	1	0	8706	3987	5381	
26494	late detection	late detection	1	0	44	26495	44	
32274	private hospitals	private hospital	1	0	76	2401	76	
30761	undergraduate education	undergraduate education	1	0	361	11601	361	
38028	Perinatal Mental Health Care	perinatal mental Health Care	1	0	38030	38029	5417	
2327	GP consultations	GP consultation	1	0	978	2328	978	
24752	control subjects	control subject	1	0	4893	510	4893	
27186	transcriptomic data	INFunknownSUP datum	1	0	22	27187	22	
17493	satisfactory outlet	satisfactory outlet	1	0	17495	17494	17495	
26041	lower risk of hospitalization	low risk of hospitalization	1	0	26043	594	1542	
8765	basal cell	basal cell	1	0	197	8766	197	
17210	fourth quarter	fourth quarter	1	0	7100	17211	7100	
19334	clinical trial endpoints	clinical trial endpoint	1	0	13345	15893	13345	
26730	color of the font of the cardiovascular readings	color of the font of the cardiovascular reading	1	0	13030	26732	13030	
37052	SARS-CoV-2 protective antibodies	INFunknownSUP protective antibody	1	0	37054	28	929	
22168	rapid spread of the epidemic	rapid spread of the epidemic	1	0	22170	795	570	
22494	multi-centric cross-sectional study	multi-centric cross-sectional study	1	0	2492	22495	2087	
20324	warrants careful investigation	warrant careful investigation	1	0	20326	20325	7714	
19064	timely epidemiological characterization	timely epidemiological characterization	1	0	19066	2713	7023	
27739	dermatology teaching	dermatology teaching	1	0	2074	27740	2074	
22224	viral strains	viral strain	1	0	22226	1741	22226	
24024	IHHN ED	INFunknownSUP editor	1	0	6256	24025	6256	
34855	Response Questionnaire	Response questionnaire	1	0	19258	2498	19258	
4169	area networks	area network	1	0	4171	1089	4171	
23457	higher satisfaction	high satisfaction	1	0	106	322	106	
35828	regulatory authorities USA	regulatory authority USA	1	0	35832	16944	35832	
26815	observed PCR prevalence	observed PCR prevalence	1	0	26817	3762	9272	
13639	current life events	current life event	1	0	13641	443	1083	
6922	access to healthcare services	access to INFunknownSUP service	1	0	224	6491	224	
36330	el acompanamiento	el INFunknownSUP	1	0	36332	1910	36332	
18295	hidden role of NLRP3 inflammasome	hidden role of INFunknownSUP INFunknownSUP	1	0	18297	3176	7288	
36272	ACE2-RBD interaction	INFunknownSUP interaction	1	0	2525	36273	2525	
9555	particle sizes	particle size	1	0	9557	4442	9557	
7612	Drugs Administration	Drugs Administration	1	0	7614	7613	7614	
5621	post-recovery comparative studies	INFunknownSUP comparative study	1	0	5623	5622	136	
28654	quantitative T2 mapping	quantitative INFunknownSUP mapping	1	0	28656	1426	28658	
3101	system of differential equations	system of differential equation	1	0	1327	3103	1327	
30641	keywords COVID-19	keyword INFunknownSUP	1	0	40	30642	40	
1407	potent anti-viral effects	potent anti-viral effect	1	0	1409	1408	156	
23579	COVID-19 Immunity Passport	INFunknownSUP immunity passport	1	0	23583	23580	23583	
28265	protection equipment	protection equipment	1	0	3038	440	3038	
10628	implementation of infectious disease surveillance	implementation of infectious disease surveillance	1	0	396	10630	396	
28588	positive SARS-CoV-2 PCR	positive INFunknownSUP PCR	1	0	5548	228	3981	
32269	Preventive strategies	preventive strategy	1	0	300	32270	300	
31023	knowledge of the predictors of in-hospital mortality	knowledge of the predictor of in-hospital mortality	1	0	213	6998	213	
34496	% divergence filter	% divergence filter	1	0	34498	364	21666	
11264	radiation therapy	radiation therapy	1	0	2273	11265	2273	
5920	urinary bladder	urinary bladder	1	0	5922	2662	5922	
23343	efficacy of heparin sodium	efficacy of heparin sodium	1	0	6704	5631	6704	
4979	high risk of transmission of SARS-COV-2	high risk of transmission of INFunknownSUP	1	0	4980	4983	1542	
3732	accurate identification of the virus	accurate identification of the virus	1	0	3734	324	57	
27175	significant proportion of the reactive CD8 T clones	significant proportion of the reactive INFunknownSUP T clone	1	0	27177	908	910	
36639	overall patients	overall patient	1	0	60	2251	60	
5392	survey respondents	survey respondent	1	0	861	967	861	
27754	secondary infections	secondary infection	1	0	779	712	779	
29523	Big data	big datum	1	0	29525	29524	29525	
37124	immature humoral response	immature humoral response	1	0	16313	4739	409	
9250	Subgroup analysis	subgroup analysis	1	0	486	9251	486	
14365	number of post-operative complications	number of post-operative complication	1	0	916	14367	916	
22341	essential health services	essential health service	1	0	5978	4197	5980	
13328	comparable humoral responses	comparable humoral response	1	0	13330	1493	200	
10623	pandemic policy	pandemic policy	1	0	293	1354	293	
38433	drug discovery	drug discovery	1	0	38435	352	38435	
4747	main receptor-binding domain	main receptor-binding domain	1	0	4749	4679	697	
16133	General Practitioners	general practitioner	1	0	16135	16134	16135	
2370	COVID-19 risk mitigation strategies	INFunknownSUP risk mitigation strategy	1	0	2372	40	300	
20420	Pandemic:(COVID-19):A Narrative Review Background Coronavirus	INFunknownSUP narrative Review background INFunknownSUP	1	0	20422	20421	3206	
5947	self-reported stress levels	self-reported stress level	1	0	5949	3911	169	
7722	health staff	health staff	1	0	11	120	11	
23155	diagnosis process	diagnosis process	1	0	180	2168	180	
38096	outbreaks Extensive testing of populations	outbreak extensive testing of population	1	0	38098	2892	1885	
11698	long-term trends	long-term trend	1	0	11700	4288	11700	
30889	hope of vaccine development	hope of vaccine development	1	0	30890	14645	30890	
31689	Combination antiviral therapies	combination antiviral therapy	1	0	12886	31690	5507	
6644	commercial activities	commercial activity	1	0	192	1770	192	
32468	Neisseria meningitidis serogroup A	INFunknownSUP INFunknownSUP serogroup A	1	0	32472	32469	3475	
19912	pilot SARS-CoV-2 air sampling study	pilot INFunknownSUP air sampling study	1	0	19914	19913	2087	
8483	influent wastewater data	influent wastewater datum	1	0	22	8484	22	
7269	viral transmission	viral transmission	1	0	876	1741	876	
29956	novel coronavirus disease pandemic	novel coronavirus disease pandemic	1	0	113	19633	113	
12066	conversion to a full COVID-19 setting	conversion to a full INFunknownSUP setting	1	0	12067	12068	12067	
6233	cases of seroconversion	case of seroconversion	1	0	229	6235	229	
31872	moderate level	moderate level	1	0	362	4684	362	
9347	quarantine of people	quarantine of people	1	0	2675	694	2675	
22499	fast review	fast review	1	0	1723	4297	1723	
2944	Permanente Washington	Permanente Washington	1	0	2946	2945	2946	
16809	independent factor	independent factor	1	0	2183	582	2183	
32397	medical complications	medical complication	1	0	705	947	705	
18244	approval process	approval process	1	0	180	13952	180	
8491	younger adults	young adult	1	0	515	2571	515	
30165	provision of integrated exercise pathways	provision of integrated exercise pathway	1	0	6376	30167	6376	
28517	Modified Early Warning Score	modified Early Warning score	1	0	28519	28518	28523	
33280	Superficial thrombophlebitis	superficial thrombophlebitis	1	0	33282	33281	33282	
27652	health risk	health risk	1	0	1542	120	1542	
24017	potential of eukaryotic cell-free systems	potential of INFunknownSUP INFunknownSUP system	1	0	6265	22882	6265	
5575	confirmed COVID-19	confirmed INFunknownSUP	1	0	40	4370	40	
5045	admission rates	admission rate	1	0	83	2865	83	
31401	trauma-informed approach	trauma-informed approach	1	0	1538	21070	1538	
23808	resource utilisation	resource utilisation	1	0	23810	2703	23810	
32544	pandemic -	pandemic INFunknownSUP	1	0	5345	1354	5345	
24884	public health protection measure	public health protection measure	1	0	24888	1320	2466	
8932	trial HARMONICOV	trial INFunknownSUP	1	0	8934	965	8934	
32630	research-based enzyme-linked immunosorbent assay	research-based enzyme-linked immunosorbent assay	1	0	32632	32631	3119	
36194	community gardening program	community gardening program	1	0	36196	3641	1790	
23414	current fourth wave of COVID-19	current fourth wave of INFunknownSUP	1	0	23416	443	10210	
14245	types of FBs	type of FB	1	0	1979	14247	1979	
34300	evolution of these changes	evolution of these change	1	0	3741	1336	3741	
12502	learning of contextual practices	learning of contextual practice	1	0	2390	12504	2390	
3826	Thanksgiving holiday	Thanksgiving holiday	1	0	3828	3827	3828	
17763	laboratory performance	laboratory performance	1	0	598	1392	598	
9211	significant policy change	significant policy change	1	0	9213	908	9215	
7493	effect of the peptide QAKTFLDKFNHEAEDLFYQ	effect of the peptide INFunknownSUP	1	0	1809	7495	1809	
7598	set of clinical presentations	set of clinical presentation	1	0	651	7600	651	
36341	liver position statement	liver position statement	1	0	36343	1138	1684	
16098	lockdown context	INFunknownSUP context	1	0	1567	16099	1567	
28910	UpToDate learning	INFunknownSUP learning	1	0	2390	28911	2390	
19951	sensor chips	sensor chip	1	0	19953	19952	19953	
9362	clinical rotations	clinical rotation	1	0	9364	884	9364	
23215	IgY precipitation	IgY precipitation	1	0	23217	13004	23217	
33493	English articles	English article	1	0	811	13599	811	
4916	absence of cellular immunity	absence of cellular immunity	1	0	4917	4918	4917	
6096	Effect of a prioritization score	effect of a prioritization score	1	0	6097	6098	6097	
11126	Individual susceptibility	individual susceptibility	1	0	10460	11127	10460	
23674	blot assay	blot assay	1	0	3119	13647	3119	
37180	link to the survey	link to the survey	1	0	3478	967	3478	
18911	progression of the COVID-19 pandemic	progression of the INFunknownSUP pandemic	1	0	4414	111	4414	
2336	Laparoscopic Surgery	INFunknownSUP surgery	1	0	2338	2337	2338	
10435	egg yolks of hens	egg yolk of hen	1	0	10437	10436	10438	
2511	mg/kg of methylprednisolone	INFunknownSUP of INFunknownSUP	1	0	2512	2513	2512	
15595	sequela of COVID-19	sequela of INFunknownSUP	1	0	15596	40	15596	
39311	emergent pandemic	emergent pandemic	1	0	113	1832	113	
38098	Extensive testing of populations	extensive testing of population	1	0	38100	9050	1885	
17059	well-appropriate defense response	well-appropriate defense response	1	0	17061	17060	409	
8362	higher rate of FBIs	high rate of INFunknownSUP	1	0	1725	8366	1034	
23585	CoV-mediated disease.1	INFunknownSUP INFunknownSUP	1	0	23587	23586	23587	
31509	particular challenge to diabetic patients	particular challenge to diabetic patient	1	0	31511	2853	62	
3025	capacity of diagnostic testing	capacity of diagnostic testing	1	0	3026	3027	3026	
18204	naso-/oro-pharyngeal PCR testing	naso-/oro-pharyngeal PCR testing	1	0	5421	18205	1885	
26927	stress conditions	stress condition	1	0	2910	199	2910	
782	SARS-CoV-2 reactive CD8 T cells	INFunknownSUP reactive INFunknownSUP T cell	1	0	784	28	133	
39179	large crowds	large crowd	1	0	39181	4250	39181	
23252	cancer surgeries	cancer surgery	1	0	13315	773	13315	
473	25th quartile	25th quartile	1	0	475	474	475	
16296	asthma prevalence	asthma prevalence	1	0	9272	16297	9272	
19620	majority of hip	majority of hip	1	0	4481	4093	4481	
27309	COVID-19-related findings	COVID-19-related finding	1	0	3390	1384	3390	
39223	S to 293T/ACE2 cells	S to INFunknownSUP cell	1	0	39224	39225	39224	
2163	healthy people	healthy people	1	0	694	1021	694	
19789	definition of essential surgery	definition of essential surgery	1	0	5811	19791	5811	
32400	host factors	host factor	1	0	583	10133	583	
15322	serum cytokines	serum cytokine	1	0	5734	4556	5734	
36771	Covid-19 transmission	INFunknownSUP transmission	1	0	876	1884	876	
13017	vaccination appointment	vaccination appointment	1	0	1569	437	1569	
37317	activity of phospholipase A2s	activity of phospholipase A2s	1	0	3990	37319	3990	
22524	program setting	program setting	1	0	2854	1790	2854	
11962	beginning of COVID-19	beginning of INFunknownSUP	1	0	10611	40	10611	
4345	neutral lipid accumulation	neutral lipid accumulation	1	0	4347	4346	4349	
7474	nephrotic syndrome	nephrotic syndrome	1	0	1936	7475	1936	
36724	week of May	week of May	1	0	7310	32456	7310	
27555	extended surgical mask use policy	extended surgical mask use policy	1	0	27557	288	293	
11979	marker of cardiac involvement	marker of cardiac involvement	1	0	10814	11981	10814	
1071	financial instability	financial instability	1	0	1073	547	1073	
9858	excision of endometriosis	excision of endometriosis	1	0	9859	9860	9859	
38719	molecular processes	molecular process	1	0	3381	6935	3381	
23618	dysarthria severity	INFunknownSUP severity	1	0	5116	14492	5116	
3763	SARS-CoV-2 infection clinical manifestations	INFunknownSUP infection clinical manifestation	1	0	883	1272	885	
27388	COVID-19 Associated Stress	INFunknownSUP Associated stress	1	0	27390	40	9278	
35562	elective dental care	elective dental care	1	0	35564	1627	9	
17923	intracranial bleeding	intracranial bleeding	1	0	17925	17924	17925	
10598	infected aerosols	infected aerosol	1	0	10600	1088	10600	
25471	hydroxychloroquine placebo tablet	hydroxychloroquine placebo tablet	1	0	25473	633	22119	
17154	healthy unexposed subjects	healthy unexposed subject	1	0	17156	1021	4893	
12870	Severe Brain Damage	Severe Brain damage	1	0	12872	5189	12874	
19004	well-structured programs	well-structured program	1	0	2246	19005	2246	
29904	outcomes of neurological COVID-19 patients	outcome of neurological INFunknownSUP patient	1	0	263	29906	263	
16219	operational guide	operational guide	1	0	13913	16220	13913	
5696	Protein inhibitor	protein inhibitor	1	0	4569	5697	4569	
22373	Immune thrombocytopenic purpura	Immune thrombocytopenic purpura	1	0	22375	20682	22377	
18750	Lifestyle interventions	Lifestyle intervention	1	0	757	18751	757	
39239	mechanical circulatory support	mechanical circulatory support	1	0	39241	6304	260	
21274	inflammatory profile	inflammatory profile	1	0	3088	3817	3088	
13488	effects-factors of risk severity	effects-factor of risk severity	1	0	13489	13490	13489	
2414	Lung Injury	Lung Injury	1	0	2416	2415	2416	
3878	care intensification	care intensification	1	0	3880	9	3880	
30993	respiratory status	respiratory status	1	0	2720	259	2720	
10703	Perspective piece	Perspective piece	1	0	10705	10704	10705	
7741	key residues of SARS-CoV-2 spike glycoprotein	key residue of INFunknownSUP spike glycoprotein	1	0	7743	850	7744	
9992	extra measures	extra measure	1	0	317	9993	317	
30271	software upgrade procedures	software upgrade procedure	1	0	30273	5231	4200	
30293	intense program	intense program	1	0	1790	12704	1790	
31636	solange die Belastungen primar im aeroben Intensitatsbereich durchgefuhrt werden	INFunknownSUP die INFunknownSUP primar im INFunknownSUP Intensitatsbereich INFunknownSUP INFunknownSUP	1	0	31642	31637	31652	
22794	health care service	health care service	1	0	22796	120	6375	
21404	range of data collection	range of data collection	1	0	420	21406	420	
29978	summary of actions	summary of action	1	0	10506	29980	10506	
29943	convenience sample of paediatric urologists	convenience sample of paediatric urologist	1	0	2755	17901	2757	
11949	3D world points	3D world point	1	0	11951	10448	23	
37982	assessment of hazards	assessment of hazard	1	0	238	37984	238	
6241	stress rate	stress rate	1	0	1034	199	1034	
1769	commercial antibodies	commercial antibody	1	0	929	1770	929	
36929	Bhagwad Gita	INFunknownSUP Gita	1	0	36931	36930	36931	
296	benefit of NIRS strategies	benefit of INFunknownSUP strategy	1	0	297	298	297	
30788	SARS-CoV-2 behavior	INFunknownSUP behavior	1	0	16069	28	16069	
459	SARS-CoV-2 RBD	INFunknownSUP RBD	1	0	461	28	461	
10024	use of e-learning methods	use of e-learning method	1	0	292	10026	292	
14426	non-exposed individuals	non-exposed individual	1	0	1113	14427	1113	
13154	current understanding of the interactions	current understanding of the interaction	1	0	13156	443	2715	
5105	awareness of symptoms	awareness of symptom	1	0	1612	86	1612	
3522	positive COVID-19 test result	positive INFunknownSUP test result	1	0	3524	228	2267	
7372	three-fifths of the hospitals	three-fifth of the hospital	1	0	7373	76	7373	
5984	related health systems	related health system	1	0	5986	2647	146	
15729	COVID-19 treatment of patients	INFunknownSUP treatment of patient	1	0	15730	60	97	
4	Covid-19 intensive care unit	INFunknownSUP intensive care unit	1	0	6	5	10	
21618	parameters of stroke management	parameter of stroke management	1	0	6460	21620	6460	
21911	global SARS-CoV-2 pandemic	global INFunknownSUP pandemic	1	0	9304	1954	113	
10018	human origin	human origin	1	0	10020	2214	10020	
13763	viable filtration media	viable filtration medium	1	0	13765	13764	661	
15312	deep throat swabs	deep throat swab	1	0	15314	2520	15316	
17168	Electrospun nanofiber-based respiratory face masks:a	INFunknownSUP INFunknownSUP respiratory face INFunknownSUP	1	0	17172	17169	17176	
20758	expression levels of tumor necrosis factor-alpha	expression level of tumor necrosis factor-alpha	1	0	20760	5729	169	
2575	Urinary biomarkers	urinary biomarker	1	0	2577	2576	2577	
31973	joint work of universities	joint work of university	1	0	31975	31974	2162	
14958	antibody screening	antibody screening	1	0	7961	5924	7961	
13107	Jacobi spectral collocation method	Jacobi spectral collocation method	1	0	13109	13108	6587	
10934	related infection patterns	related infection pattern	1	0	10516	2647	548	
34041	Mitigation of the negative effects of COVID-19	mitigation of the negative effect of INFunknownSUP	1	0	34042	34043	34042	
24992	public health academic	public health academic	1	0	24996	1320	24996	
3654	naive CD8 T cells	naive INFunknownSUP T cell	1	0	788	3655	133	
26871	respiratory epithelia	respiratory INFunknownSUP	1	0	26873	259	26873	
1875	Okayama University Hospital	Okayama University Hospital	1	0	1877	1876	1879	
26499	immune changes	immune change	1	0	1336	970	1336	
24581	asymptomatic cancer cohort -	asymptomatic cancer cohort INFunknownSUP	1	0	24583	1131	5345	
29889	number of positive samples	number of positive sample	1	0	916	29891	916	
37247	multivariable analysis of the association of the Alpha variant	multivariable analysis of the association of the Alpha variant	1	0	10322	37251	486	
33464	big data analytics of response of medical personnel	big datum INFunknownSUP of response of medical personnel	1	0	33465	33470	14274	
17114	promoters of genes	promoter of gene	1	0	17115	12362	17115	
32100	Aim of the present study	aim of the present study	1	0	32101	15548	32101	
14906	enormous global burden	enormous global burden	1	0	14908	33	1070	
32624	digital device	digital device	1	0	3001	1094	3001	
10122	recent ongoing coronavirus disease-2019	recent ongoing coronavirus INFunknownSUP	1	0	10124	2128	10128	
33654	thromboembolic risk	thromboembolic risk	1	0	1542	4572	1542	
23145	time of manufacture of face masks	time of manufacture of face mask	1	0	179	23147	179	
4809	impact of psychological distress	impact of psychological distress	1	0	110	1973	110	
960	partial vaccination	partial vaccination	1	0	437	961	437	
7463	occurrence of HAI	occurrence of hai	1	0	2207	6959	2207	
14470	few small perivascular white matter lesions	few small perivascular white matter lesion	1	0	14472	6261	162	
14447	study sample	study sample	1	0	2757	2087	2757	
32866	minor adaptations	minor adaptation	1	0	32868	22195	32868	
26946	General Practitioner	General practitioner	1	0	11581	2695	11581	
10682	Sex disparities	sex disparity	1	0	10684	10683	10684	
7106	main objective of this study	main objective of this study	1	0	7108	4679	3611	
3551	observational information	observational information	1	0	2591	3552	2591	
38794	routine testing of the patient	routine testing of the patient	1	0	38796	4898	1885	
5769	las busquedas	la INFunknownSUP	1	0	5771	5770	5771	
36543	Clostridium difficile toxins A	clostridium INFunknownSUP toxin A	1	0	36545	17875	3475	
14197	cause of VAP	cause of VAP	1	0	14198	14199	14198	
13684	location of the infected patients	location of the infected patient	1	0	11895	8103	11895	
15445	New technologies	new technology	1	0	70	15446	70	
3699	Bayesian Net	INFunknownSUP Net	1	0	3701	3700	3701	
31825	principle of immune response	principle of immune response	1	0	9438	6115	9438	
27114	index test	index test	1	0	754	4017	754	
31768	pharmacology Coronavirus disease	pharmacology INFunknownSUP disease	1	0	6281	31769	209	
15576	related symptoms	related symptom	1	0	86	2647	86	
8131	symptomatic COVID-19 cases	symptomatic INFunknownSUP case	1	0	8133	38	229	
12500	cross-country learning of contextual practices	cross-country learning of contextual practice	1	0	12502	12501	2390	
21471	standardized early management of neurological patients	standardized early management of neurological patient	1	0	21473	10795	743	
33849	COVID-19 vaccine-related attitude	INFunknownSUP vaccine-related attitude	1	0	33851	40	12193	
36199	automated capillary-based assay	automated INFunknownSUP assay	1	0	36201	33978	3119	
2559	human mobility	human mobility	1	0	2102	2214	2102	
23239	Ninety-eight webpages	Ninety-eight webpage	1	0	12456	23240	12456	
27214	adverse experiences	adverse experience	1	0	1339	1082	1339	
21129	confirmatory research	confirmatory research	1	0	36	21130	36	
15820	post-COVID future of health care systems	INFunknownSUP future of health care system	1	0	15822	15821	15823	
9476	exposure to seasonal coronaviruses	exposure to seasonal coronavirus	1	0	1054	9478	1054	
36534	medium age	medium age	1	0	906	5430	906	
13882	metropolitan area Sex	metropolitan area sex	1	0	13884	13883	10683	
27831	ability of ACE2	ability of INFunknownSUP	1	0	27832	3437	27832	
35374	bariatric orientation	bariatric orientation	1	0	28020	2394	28020	
36732	Factorial Analysis of Variance	factorial analysis of variance	1	0	36734	36733	204	
36090	4th -7th	4th INFunknownSUP	1	0	36092	36091	36092	
14307	Chinese tourists	Chinese tourist	1	0	14309	1968	14309	
34024	home neurosurgery program	home neurosurgery program	1	0	34026	231	1790	
36796	cost of a CLEAR project	cost of a clear project	1	0	10966	36798	10966	
26630	assessment problem	assessment problem	1	0	4499	238	4499	
755	tailored interventions	tailored intervention	1	0	757	756	757	
19679	middle-income countries	middle-income country	1	0	1599	19680	1599	
19376	epidemic situation of the school	epidemic situation of the school	1	0	19378	12267	3056	
33104	work balances	work balance	1	0	33106	2162	33106	
19274	macular vessel density	macular vessel density	1	0	19276	19275	19278	
13069	life-saving treatment	life-saving treatment	1	0	97	13070	97	
12980	partial return to workplaces	partial return to workplace	1	0	12982	961	10040	
995	readability calculator	readability calculator	1	0	997	996	997	
24658	healthcare practitioners	INFunknownSUP practitioner	1	0	13543	494	13543	
33250	Carbohydrate Chemistry	carbohydrate chemistry	1	0	33252	33251	33252	
15344	stewardship Public health responses	stewardship public health response	1	0	15346	15345	200	
32556	Island inpatients	Island inpatient	1	0	30487	32557	30487	
17240	crazy-paving sign	crazy-paving sign	1	0	15839	17241	15839	
16953	series of subepidemics	series of subepidemic	1	0	8050	16955	8050	
857	homogenous clusters of respondents	homogenous cluster of respondent	1	0	859	858	860	
14961	TMPRSS2 SARS-CoV-2 Entry Molecules	INFunknownSUP INFunknownSUP entry molecule	1	0	14965	14962	14967	
19472	multivariate analysis method	multivariate analysis method	1	0	6587	2407	6587	
17400	degree holders	degree holder	1	0	8582	12635	8582	
19307	additional test cases	additional test case	1	0	19309	7175	229	
28365	global human health	global human health	1	0	22330	1954	120	
11089	low risk of postoperative ICU admission	low risk of postoperative ICU admission	1	0	11091	457	1542	
19706	iteration of telemedicine innovation	iteration of telemedicine innovation	1	0	19707	19708	19707	
30191	acute kidney injury Acute kidney injury	acute kidney injury acute kidney injury	1	0	30197	6659	713	
4359	Fear of COVID-19 Scale	fear of INFunknownSUP Scale	1	0	3222	4361	3222	
30204	literature databases	literature database	1	0	1755	4698	1755	
25943	bacterial ARDS	bacterial INFunknownSUP	1	0	25945	2517	25945	
31942	EndNote software	INFunknownSUP software	1	0	5231	31943	5231	
34654	free-text feedback	INFunknownSUP feedback	1	0	10216	34655	10216	
23842	circulatory overload	circulatory overload	1	0	23844	23843	23844	
3685	serious conditions	serious condition	1	0	2910	3164	2910	
25332	end of December	end of December	1	0	7132	7311	7132	
31014	3-week period	INFunknownSUP period	1	0	5677	31015	5677	
14793	pathogenesis of the novel coronavirus	pathogenesis of the novel coronavirus	1	0	14794	3644	14794	
20940	pediatric general surgery	pediatric general surgery	1	0	20942	3344	1630	
15181	Principal Component Analysis	principal component analysis	1	0	15183	15182	204	
37717	level of support	level of support	1	0	362	260	362	
28714	various aspects of COVID-19 diagnosis	various aspect of INFunknownSUP diagnosis	1	0	28716	1099	2429	
20517	official bulletins of the Italian National Institute	official bulletin of the Italian National Institute	1	0	20519	20518	20520	
10931	quality of air	quality of air	1	0	3713	868	3713	
38297	Italian reproductive medical experience	Italian reproductive medical experience	1	0	38299	115	2782	
27049	Chronic Respiratory Diseases	chronic respiratory disease	1	0	27051	16231	6908	
38053	Non-invasive ventilation	non-invasive ventilation	1	0	6305	18357	6305	
28616	high frequency	high frequency	1	0	19362	13	19362	
16400	Australian healthcare workforce capability	Australian INFunknownSUP workforce capability	1	0	16406	16401	16406	
3559	awareness of risk factors	awareness of risk factor	1	0	1612	3561	1612	
12259	verification of active ingredients	verification of active ingredient	1	0	12260	12261	12260	
11036	females n	female n	1	0	8004	11037	8004	
32908	Ontario parents	Ontario parent	1	0	6913	32909	6913	
30031	bloodstream infections	bloodstream infection	1	0	779	30032	779	
5672	parenteral nutrition	parenteral nutrition	1	0	5674	5673	5674	
9668	inflammatory variables	inflammatory variable	1	0	817	3817	817	
9915	plasmon resonance	plasmon resonance	1	0	9917	9916	9917	
18507	Prevalence of Covid-19 infection	prevalence of INFunknownSUP infection	1	0	81	18509	81	
19934	Apraisal Skill Programme	INFunknownSUP Skill programme	1	0	19936	19935	19938	
19487	lockdown coping	INFunknownSUP coping	1	0	2895	16099	2895	
20795	IgM positive	Igm positive	1	0	3365	30	3365	
34130	mapping of the S1 protein surface	mapping of the INFunknownSUP protein surface	1	0	28658	34132	28658	
9038	year of vaccination	year of vaccination	1	0	3822	437	3822	
37995	PXS score	PXS score	1	0	1843	4889	1843	
28488	household reagents	household reagent	1	0	28490	18468	28490	
833	educational resources	educational resource	1	0	835	834	835	
1044	non-urgent surgical cases	non-urgent surgical case	1	0	1046	1045	229	
10676	clinical entities	clinical entity	1	0	10678	884	10678	
31820	undetected COVID-19 infection	undetected INFunknownSUP infection	1	0	39	31821	41	
16856	Few patients	few patient	1	0	60	16857	60	
15964	overall better protection	overall good protection	1	0	15966	2251	440	
22828	Adapting Nephrology Training Curriculum	adapting INFunknownSUP Training curriculum	1	0	22830	22829	22834	
17430	emissions sector	emission sector	1	0	11631	17431	11631	
29437	distinct clinical clusters	distinct clinical cluster	1	0	29439	2802	860	
16115	immunisation data	immunisation datum	1	0	22	16116	22	
8967	week period	week period	1	0	5677	7310	5677	
14054	D - Dimer	D INFunknownSUP dimer	1	0	14056	14055	14058	
3483	Mixed Reality Headset	mixed reality headset	1	0	3485	3484	3487	
22392	timely intervention	timely intervention	1	0	5608	2713	5608	
45	National Taiwan University anatomy teachers	National Taiwan University anatomy teacher	1	0	47	46	53	
20504	Arab Emirates	Arab Emirates	1	0	20506	20505	20506	
34894	X-ray images Coronavirus-caused diseases	X-ray image INFunknownSUP disease	1	0	34896	10098	315	
8260	logistic regression analyses	logistic regression analysis	1	0	4668	5132	4668	
32244	region sequences	region sequence	1	0	19827	8256	19827	
15672	Data Collection	Data Collection	1	0	15674	5098	15674	
14597	estimates of the basic reproduction number	estimate of the basic reproduction number	1	0	5370	14599	5370	
26641	screening tool	screening tool	1	0	5487	7961	5487	
23007	communicative dynamics	communicative dynamics	1	0	3694	23008	3694	
37046	rapid screening strategy of SARS-CoV-2 protective antibodies	rapid screening strategy of INFunknownSUP protective antibody	1	0	37048	795	3350	
15041	Open Tracheostomy	Open tracheostomy	1	0	15043	15042	15043	
13899	high inflation	high inflation	1	0	9979	13	9979	
32975	own social media platforms	own social medium platform	1	0	5552	2321	3919	
38509	extraordinary circumstances	extraordinary circumstance	1	0	7568	1784	7568	
26747	effects of job	effect of job	1	0	156	105	156	
35927	mild COVID-19 symptoms	mild INFunknownSUP symptom	1	0	3912	10809	86	
10344	point of SAVE-9	point of INFunknownSUP	1	0	10333	9619	10333	
8162	Priority-setting guidelines	Priority-setting guideline	1	0	91	8163	91	
4268	research ranking	research ranking	1	0	4270	36	4270	
23370	lower complication rates	low complication rate	1	0	22707	594	83	
34110	cardiac magnetic resonance	cardiac magnetic resonance	1	0	34112	3858	9917	
14985	few studies	few study	1	0	136	6261	136	
15331	Working schedule	Working schedule	1	0	7212	15332	7212	
29507	Effective cleaning	effective cleaning	1	0	29509	12771	29509	
16104	COVID-19 care	INFunknownSUP care	1	0	9	40	9	
30781	patient outreach	patient outreach	1	0	30783	2645	30783	
13280	SARS-CoV-2 IgG ELISA kit	INFunknownSUP IgG Elisa kit	1	0	13282	28	567	
24635	clinical resource	clinical resource	1	0	2703	884	2703	
32179	higher level	high level	1	0	362	322	362	
33143	perpetual immunity to the SARS-CoV-2 virus	perpetual immunity to the INFunknownSUP virus	1	0	33145	19129	257	
10005	Pulmonary X-Ray Severity	pulmonary x-ray severity	1	0	10007	10006	1202	
26161	Joint Mission	Joint Mission	1	0	26163	17607	26163	
29675	resource allocation	resource allocation	1	0	29677	2703	29677	
30093	interferon-stimulated genes	interferon-stimulated gene	1	0	12362	30094	12362	
1376	severe psychological impact of the outbreak	severe psychological impact of the outbreak	1	0	1377	310	110	
30973	close proximity	close proximity	1	0	30975	614	30975	
12547	viral contamination	viral contamination	1	0	12549	1741	12549	
10988	Primary Care Patients	primary Care Patients	1	0	3207	7917	3207	
36558	design of optimal lockdown strategies	design of optimal INFunknownSUP strategy	1	0	4183	36560	4183	
20710	COVID-19 moral dilemmas	INFunknownSUP moral dilemma	1	0	20712	40	19316	
35414	Priority-setting dilemmas	Priority-setting dilemma	1	0	19316	8163	19316	
9963	Time course of antibody concentrations	time course of antibody concentration	1	0	9965	9964	5152	
38623	Mild Infection	mild infection	1	0	9866	38624	9866	
23821	parameter space	parameter space	1	0	11832	16173	11832	
5397	Covid-19 Fighters	INFunknownSUP fighter	1	0	5399	1884	5399	
33623	safety of hydroxychloroquine chemoprophylaxis	safety of INFunknownSUP chemoprophylaxis	1	0	8584	33624	8584	
22574	psychological hotline	psychological INFunknownSUP	1	0	22576	1380	22576	
37213	plasma proteomics	plasma INFunknownSUP	1	0	37215	28077	37215	
26562	virucidal activity	INFunknownSUP activity	1	0	3990	17002	3990	
21488	Hashimoto thyroiditis	Hashimoto thyroiditis	1	0	21490	21489	21490	
15683	CANDO clinical feasibility study Conversion disorder/functional neurological disorder	Cando clinical feasibility study conversion disorder/functional neurological disorder	1	0	15685	15684	7358	
7481	Ashwagandha withanolides	INFunknownSUP INFunknownSUP	1	0	7483	7482	7483	
10545	de la pandemie COVID-19 une occasion de reformer la sante	de la INFunknownSUP INFunknownSUP une occasion de reformer la INFunknownSUP	1	0	10547	1421	10563	
8733	general interest	general interest	1	0	7989	1080	7989	
28500	Infectious virus	infectious virus	1	0	778	6907	778	
12041	high nurse staffing	high nurse staffing	1	0	12043	13	12045	
8011	enhanced understanding of the effects of the COVID-19 pandemic	enhanced understanding of the effect of the INFunknownSUP pandemic	1	0	8013	3888	2715	
26799	datos proceden de organismos	dato INFunknownSUP de INFunknownSUP	1	0	26801	6502	26805	
2425	secondary structure	secondary structure	1	0	2427	712	2427	
15746	chromatography high resolution mass spectrometry	chromatography high resolution mass spectrometry	1	0	15748	15747	15754	
27682	elderly COVID-19 patients	elderly INFunknownSUP patient	1	0	911	1329	60	
26769	Procedure type	procedure type	1	0	775	26770	775	
19592	potential exposure	potential exposure	1	0	1054	1276	1054	
38653	use of selective beta-blocking agents	use of selective INFunknownSUP agent	1	0	292	38655	292	
15407	post-pone 2020PMD	INFunknownSUP INFunknownSUP	1	0	15409	15408	15409	
25987	measure of efficacy	measure of efficacy	1	0	2466	6704	2466	
4797	importance of exercise	importance of exercise	1	0	2765	4799	2765	
29208	back-boosting effect	back-boosting effect	1	0	1809	29209	1809	
15492	key risk factors	key risk factor	1	0	3561	850	583	
9602	major city	major city	1	0	9604	1318	9604	
24935	Arabic terms	Arabic term	1	0	4908	2589	4908	
24984	California health system	California health system	1	0	3305	5407	1327	
29632	detection technology	detection technology	1	0	1718	44	1718	
25827	better understanding of the impact	good understanding of the impact	1	0	25829	1635	2715	
7093	% of all hospital employees	% of all hospital employee	1	0	364	7095	364	
8315	copeptin values	INFunknownSUP value	1	0	825	3156	825	
9365	initial SLT evaluation	initial INFunknownSUP evaluation	1	0	9367	335	2399	
1704	elevated MCP-1	elevated INFunknownSUP	1	0	1706	1705	1706	
3291	organ systems	organ system	1	0	146	1778	146	
8941	Preparatory School Students	preparatory School student	1	0	8943	8942	4368	
16895	binomial regression	binomial regression	1	0	5036	9224	5036	
38026	Experiences of Perinatal Mental Health Care	experience of perinatal mental Health Care	1	0	433	38028	433	
33373	international bodies	international body	1	0	8556	4086	8556	
34772	mass production	mass production	1	0	654	11695	654	
16200	CRP levels	INFunknownSUP level	1	0	169	3378	169	
21975	Twenty-seven percent	INFunknownSUP percent	1	0	4123	21976	4123	
19443	normal patients	normal patient	1	0	60	2708	60	
15778	curve of 2019-nCoV cases time series	curve of INFunknownSUP case time series	1	0	6817	15780	6817	
16311	SARS-CoV-2 humoral response	INFunknownSUP humoral response	1	0	16313	28	409	
8232	COVID-19 repertoires	INFunknownSUP repertoire	1	0	8234	40	8234	
23599	pace of research	pace of research	1	0	23600	36	23600	
38254	potential of animal coronaviruses	potential of animal coronavirus	1	0	6265	38256	6265	
8041	Ghana Discrete count time series data	Ghana discrete count time series datum	1	0	8043	100	22	
7651	patient sample	patient sample	1	0	2757	2645	2757	
15789	Hopkins University	Hopkins University	1	0	50	15790	50	
19433	zero-inflated time series models	zero-inflated time series model	1	0	19435	2966	3975	
14857	colloidal gold immunochromatographic assay	colloidal gold immunochromatographic assay	1	0	14859	14858	3119	
546	financial patterns	financial pattern	1	0	548	547	548	
8656	cerebral artery	cerebral artery	1	0	8658	4322	8658	
2006	12-Hour Staff Shifts	INFunknownSUP staff shift	1	0	2008	2007	2010	
19059	antiretroviral defence mechanisms	antiretroviral defence mechanism	1	0	19061	19060	1456	
37840	outbreak/pandemic situation	outbreak/pandemic situation	1	0	3056	37841	3056	
7701	vaccine clinic locations	vaccine clinic location	1	0	3394	7702	3394	
3273	High levels of mortality	high level of mortality	1	0	3274	1197	169	
17893	therapeutic approach	therapeutic approach	1	0	1538	3349	1538	
16367	mitigation global priorities	mitigation global priority	1	0	16369	2375	16371	
37969	transmissibility of children	INFunknownSUP of child	1	0	3451	6153	3451	
37016	cardiovascular disease	cardiovascular disease	1	0	209	13290	209	
25043	patient encounter	patient encounter	1	0	4838	2645	4838	
14557	COVID-19-positive male patient	COVID-19-positive male patient	1	0	708	3218	710	
12358	kyoto encyclopedia of genes	INFunknownSUP encyclopedia of gene	1	0	12360	12359	12361	
12058	COVID-19 registry	INFunknownSUP registry	1	0	12060	40	12060	
35481	Medical Equipment Management Systems	Medical Equipment Management Systems	1	0	35483	2779	20278	
29295	systemic low-grade inflammation	systemic low-grade inflammation	1	0	3114	1453	3116	
4618	current global health emergency	current global health emergency	1	0	4620	443	447	
16500	better management of the COVID-19 outbreak	good management of the INFunknownSUP outbreak	1	0	16502	1635	743	
24449	respiratory infection	respiratory infection	1	0	41	259	41	
15969	use of IGHV4-39	use of INFunknownSUP	1	0	292	15971	292	
12094	numbers of samples	number of sample	1	0	12095	1765	12095	
4073	Effects of Renin-Angiotensin	effect of INFunknownSUP	1	0	2994	4075	2994	
733	part of the CME credit redemption process	part of the CME credit redemption process	1	0	734	735	734	
3672	Programs Research	Programs Research	1	0	3674	3673	3674	
30283	possible approaches	possible approach	1	0	8111	745	8111	
10464	chemiluminescence method	chemiluminescence method	1	0	6587	10465	6587	
16222	tens of meters	ten of meter	1	0	16223	16224	16223	
14951	prevencion del duelo complicado	INFunknownSUP del INFunknownSUP INFunknownSUP	1	0	14957	14952	14957	
27390	Associated Stress	Associated stress	1	0	9278	27391	9278	
11491	male adolescent	male adolescent	1	0	11493	709	11493	
7009	regular community genomic surveillance	regular community INFunknownSUP surveillance	1	0	7011	870	2795	
17102	youth horse show participants	youth horse show participant	1	0	17104	17103	4950	
5181	subjektive Belastungsempfinden bei gut-trainierten	INFunknownSUP INFunknownSUP bei INFunknownSUP	1	0	5185	5182	5187	
13075	mini-Delphi method	INFunknownSUP method	1	0	6587	13076	6587	
11993	global biosecurity programs	global biosecurity program	1	0	11995	1954	2246	
7291	primary care providers	primary care provider	1	0	673	6472	673	
4493	positivity rates	INFunknownSUP rate	1	0	83	1238	83	
30934	accomplishments Coronavirus disease	accomplishment INFunknownSUP disease	1	0	6281	30935	209	
3783	high-frequency mutations	high-frequency mutation	1	0	3785	3784	3785	
31228	late November	late November	1	0	19973	26495	19973	
6175	el afrontamiento precoz que	el INFunknownSUP INFunknownSUP que	1	0	6181	6176	6181	
15760	in-person visits	in-person visit	1	0	13123	9275	13123	
30894	crucial limitation	crucial limitation	1	0	30896	10865	30896	
31858	vessel occlusion	vessel occlusion	1	0	31860	19277	31860	
11372	infectious disease outbreak	infectious disease outbreak	1	0	310	4216	310	
28937	viral spike protein	viral spike protein	1	0	1797	13180	1797	
877	online database	online database	1	0	879	541	879	
15792	higher proportions of academic medical centers	high proportion of academic medical center	1	0	15793	15796	15614	
20912	diagnostic features	diagnostic feature	1	0	1469	2219	1469	
4224	functional SARS-CoV-2 mAbs	functional INFunknownSUP INFunknownSUP	1	0	4226	4225	4228	
19828	Vitamin C	vitamin C	1	0	2540	19829	2540	
35035	Kidney Injury Molecule	Kidney Injury molecule	1	0	35037	35036	35039	
39252	Western countries	Western country	1	0	1599	4549	1599	
19451	American Sociological Society	American sociological Society	1	0	19453	19452	17123	
22861	proven specific therapy	proven specific therapy	1	0	22863	20097	2273	
12457	Respiratory Syncytial Virus Immunoglobulin gene heterogeneity	respiratory syncytial virus immunoglobulin gene heterogeneity	1	0	12463	12458	1972	
18675	social distancing rules	social distancing rule	1	0	18679	382	18679	
15259	pulmonary immunology	pulmonary immunology	1	0	15261	590	15261	
5020	treatment option	treatment option	1	0	5022	97	5022	
26169	community gardening	community gardening	1	0	26171	3641	26171	
17363	Cancer patients	Cancer patient	1	0	60	9345	60	
3231	incomplete public health data	incomplete public health datum	1	0	3233	3232	22	
6061	different communities	different community	1	0	948	688	948	
6914	valid tool	valid tool	1	0	5487	5019	5487	
30169	exercise pathways	exercise pathway	1	0	8220	4799	8220	
37567	stress factor	stress factor	1	0	2183	199	2183	
32869	virus vRNA	virus INFunknownSUP	1	0	16592	778	16592	
9420	binding inhibition	binding inhibition	1	0	9422	2921	9422	
2053	gold standard test	gold standard test	1	0	2055	2054	754	
22383	Ab responses	Ab response	1	0	200	22384	200	
8241	eleven countries	eleven country	1	0	1599	8242	1599	
18323	Person-to-person transmission	person-to-person transmission	1	0	876	18324	876	
26530	re-design models	re-design model	1	0	3975	26531	3975	
3564	Latinoamerica para orientar la prevencion y el	Latinoamerica para INFunknownSUP la INFunknownSUP y el	1	0	3566	3565	1910	
38452	ratio &gt	ratio &gt	1	0	2385	2635	2385	
30652	wide geographical distribution	wide geographical distribution	1	0	30654	4155	2621	
15686	clinical feasibility study	clinical feasibility study	1	0	15688	884	2087	
13081	survey participants	survey participant	1	0	4950	967	4950	
38563	% specificity	% specificity	1	0	29670	364	29670	
34431	certain threshold	certain threshold	1	0	451	8853	451	
4873	New York State	New York State	1	0	4877	4874	4877	
26633	gustatory dysfunctions	gustatory dysfunction	1	0	26477	26634	26477	
38776	Se ha creado un indice de letalidad relativa	Se ha creado un INFunknownSUP de letalidad INFunknownSUP	1	0	38778	18963	38790	
2696	Self-Efficacy Scale	INFunknownSUP Scale	1	0	1203	2697	1203	
29081	structural differences	structural difference	1	0	5663	3549	5663	
4032	radiological images	radiological image	1	0	4034	1592	4034	
38532	Transplant patients	transplant patient	1	0	60	12780	60	
9307	higher anxiety	high anxiety	1	0	2772	322	2772	
24580	asymptomatic cancer cohort - results	asymptomatic cancer cohort INFunknownSUP result	1	0	325	24581	325	
38860	secondary outcomes	secondary outcome	1	0	263	712	263	
36324	virological cure	virological cure	1	0	36326	31086	36326	
12326	tissue analysis	tissue analysis	1	0	486	4974	486	
19477	second quarter	second quarter	1	0	7100	1279	7100	
13600	local authorities	local authority	1	0	9210	3173	9210	
17799	Implementation of the core outcome measures	implementation of the core outcome measure	1	0	17800	1850	17800	
35064	generation matrix approach	generation matrix approach	1	0	35066	3033	1538	
37640	localization method	localization method	1	0	6587	16351	6587	
34614	Asian American Pacific Islanders	Asian American Pacific islander	1	0	34616	34615	34620	
22634	Logistic regression analysis	logistic regression analysis	1	0	486	11014	486	
33643	Global features	global feature	1	0	1469	12085	1469	
10553	une occasion de reformer la sante	une occasion de reformer la INFunknownSUP	1	0	10563	10554	10563	
18421	nasopharyngeal swab specimens	nasopharyngeal swab specimen	1	0	7245	15807	7245	
10967	type of needed minimal oxygen support	type of needed minimal oxygen support	1	0	775	10969	775	
5173	objektive korperliche Leistungsfahigkeit	INFunknownSUP INFunknownSUP INFunknownSUP	1	0	5177	5174	5177	
21079	laparoscopic surgery	INFunknownSUP surgery	1	0	1630	127	1630	
8125	importance of nutrition	importance of nutrition	1	0	2765	5674	2765	
2499	Separate Guidelines	separate guideline	1	0	2501	2500	2501	
35316	human movement	human movement	1	0	8571	2214	8571	
10296	Practical Challenges	practical challenge	1	0	10298	10297	10298	
31505	potential SARS-CoV-2	potential INFunknownSUP	1	0	226	1276	226	
22147	endemic Clostridium difficile infection	endemic clostridium INFunknownSUP infection	1	0	17874	3067	41	
21746	Percutaneous Endoscopic Gastrostomy	percutaneous endoscopic gastrostomy	1	0	21748	12764	21750	
10971	minimal oxygen support	minimal oxygen support	1	0	8285	5336	260	
19222	mid-term follow-up	mid-term follow-up	1	0	175	19223	175	
11970	Omaha system	Omaha system	1	0	1327	11971	1327	
29155	cytotoxicity to Vero E6 cells	cytotoxicity to Vero INFunknownSUP cell	1	0	25851	7974	25851	
2932	transfusion-associated lung injury	transfusion-associated lung injury	1	0	2934	2933	713	
1753	Electronic databases	electronic database	1	0	1755	1754	1755	
13940	higher probability of testing	high probability of testing	1	0	13942	322	7627	
34294	ecological study	ecological study	1	0	2087	34295	2087	
27152	diagnosis of an infectious disease	diagnosis of an infectious disease	1	0	2168	4216	2168	
35216	Zaire Ebolavirus	Zaire INFunknownSUP	1	0	35218	35217	35218	
17559	Food Preferences	Food preference	1	0	17561	2598	17561	
21770	cytidine deaminase	cytidine INFunknownSUP	1	0	21772	21771	21772	
9505	health outcomes	health outcome	1	0	263	120	263	
21460	RT-PCR tests	INFunknownSUP test	1	0	1365	7046	1365	
32505	bilayer measurements	bilayer measurement	1	0	8077	32506	8077	
10082	respirator disinfection	respirator disinfection	1	0	10084	10083	10084	
7354	Obsessive compulsive disorder	obsessive compulsive disorder	1	0	7356	7355	7358	
10954	Inflammatory Bowel Disease	inflammatory bowel disease	1	0	10956	3297	10958	
4744	stress symptoms	stress symptom	1	0	86	199	86	
7466	Thematic content analysis	thematic content analysis	1	0	7468	7467	486	
26054	continuous variables	continuous variable	1	0	817	2232	817	
2603	telehealth access	INFunknownSUP access	1	0	224	2326	224	
31253	name coronavirus	name coronavirus	1	0	339	31254	339	
8278	surgery outcomes	surgery outcome	1	0	263	1630	263	
12188	Next steps	next step	1	0	2077	12189	2077	
2205	complication occurrence	complication occurrence	1	0	2207	2206	2207	
33727	digital transition	digital transition	1	0	2091	1094	2091	
11721	Mexico City	Mexico City	1	0	2814	11722	2814	
13695	marine organisms	marine organism	1	0	13697	9837	13697	
38100	testing of populations	testing of population	1	0	1885	13188	1885	
25136	patient history	patient history	1	0	5381	2645	5381	
10685	effect of anakinra	effect of INFunknownSUP	1	0	1809	10687	1809	
28107	future study	future study	1	0	2087	1367	2087	
26790	video clips	video clip	1	0	26792	1891	26792	
5794	existential threats	existential threat	1	0	1370	4388	1370	
20385	respiratory SARS-CoV-2 exposure	respiratory INFunknownSUP exposure	1	0	1054	20386	1054	
30688	bat coronaviruses	bat coronavirus	1	0	8796	8902	8796	
316	measures of COVID-19 IU	measure of INFunknownSUP IU	1	0	317	318	317	
30296	major issues	major issue	1	0	3758	1318	3758	
27535	disease symptoms	disease symptom	1	0	86	209	86	
2367	infected pneumonia	infected pneumonia	1	0	2369	1088	2369	
30853	government decisions	government decision	1	0	1942	99	1942	
12706	Non-pharmaceutical Interventions	non-pharmaceutical intervention	1	0	12708	12707	12708	
3618	toxic levels of stress	toxic level of stress	1	0	3620	3619	169	
24427	key issues	key issue	1	0	3758	850	3758	
14056	- Dimer	INFunknownSUP dimer	1	0	14058	5345	14058	
31066	exogenous fatty acids	exogenous fatty acid	1	0	31068	31067	31070	
23854	apparent recovery	apparent recovery	1	0	3007	23855	3007	
7155	Naive Bayesian	naive INFunknownSUP	1	0	3700	7156	3700	
23299	activity percentage	activity percentage	1	0	3789	3990	3789	
36201	capillary-based assay	INFunknownSUP assay	1	0	3119	36202	3119	
20934	different infections	different infection	1	0	779	688	779	
30979	negative aspects	negative aspect	1	0	2429	1338	2429	
28962	type of variants	type of variant	1	0	775	1002	775	
11935	absence of data	absence of datum	1	0	4917	22	4917	
20727	high rate	high rate	1	0	1034	13	1034	
17199	Mental Health of Nurses	mental health of nurse	1	0	17200	17203	5250	
37029	purpose novel research	purpose novel research	1	0	37031	4098	36	
24538	possible mitigation steps	possible mitigation step	1	0	2077	6824	2077	
10472	elective spine surgery services	elective spine surgery service	1	0	5980	1626	5980	
27294	priority-setting dilemmas	priority-setting dilemma	1	0	19316	27295	19316	
35221	viral respiratory syndromes	viral respiratory syndrome	1	0	35223	1741	35225	
34601	better physical fitness	good physical fitness	1	0	34603	1635	34605	
19660	new virus	new virus	1	0	778	69	778	
18410	32268212/ Corona	32268212/ Corona	1	0	10431	18411	10431	
10185	vaccine trials	vaccine trial	1	0	8639	577	8639	
25458	Flesch Kincaid Grade Level	Flesch Kincaid Grade Level	1	0	25460	25459	8466	
22925	PPE-related measures	PPE-related measure	1	0	317	22926	317	
19332	key clinical trial endpoints	key clinical trial endpoint	1	0	19334	850	13345	
23550	high sensitivity	high sensitivity	1	0	2904	13	2904	
13622	system of production	system of production	1	0	1327	654	1327	
18031	anti-S1 antibodies	INFunknownSUP antibody	1	0	929	18032	929	
12720	Awareness programs	awareness program	1	0	2246	12721	2246	
9208	European authorities	European authority	1	0	9210	9209	9210	
12191	favorable attitude	favorable attitude	1	0	12193	12192	12193	
29383	Dental professionals	dental professional	1	0	121	4367	121	
1185	COVID-19 environments	INFunknownSUP environment	1	0	1187	40	1187	
22290	comparative study	comparative study	1	0	2087	5624	2087	
1208	nursing administrators	nursing administrator	1	0	1210	1209	1210	
1743	resistive pulse sensors	resistive pulse sensor	1	0	1745	1744	1747	
6774	dynamics of Covid-19 vaccine transmission	dynamics of INFunknownSUP vaccine transmission	1	0	3694	6776	3694	
28313	fractional derivative	fractional derivative	1	0	28315	9492	28315	
16013	PCT &gt	PCT &gt	1	0	2385	16014	2385	
9772	US hip	US hip	1	0	4093	3316	4093	
8997	NIRS modalities:high-flow	INFunknownSUP INFunknownSUP	1	0	8999	299	8999	
23982	available ground monitoring	available ground monitoring	1	0	23984	832	3271	
1577	Covid-19-facing areas	Covid-19-facing area	1	0	1579	1578	1579	
35472	number of zeros	number of zero	1	0	916	9980	916	
10059	on-site turnaround	on-site turnaround	1	0	10061	10060	10061	
19983	infection risk	infection risk	1	0	1542	41	1542	
25982	mild course	mild course	1	0	5152	10809	5152	
15946	health record systems	health record system	1	0	15948	120	146	
8494	rate of respiratory tract infections	rate of respiratory tract infection	1	0	1034	2151	1034	
1412	Pesquisa Nacional por Amostra de Domicilios	INFunknownSUP Nacional por INFunknownSUP de INFunknownSUP	1	0	1420	1413	1422	
30128	presence of SARS-CoV-2	presence of INFunknownSUP	1	0	675	28	675	
20993	terrestrial point clouds	terrestrial point cloud	1	0	13397	20994	13399	
30663	population resilience	population resilience	1	0	4654	1838	4654	
32713	regional differences	regional difference	1	0	5663	4068	5663	
32409	Host Non-Coding RNAs Reveal Extracellular Vesicles	Host INFunknownSUP INFunknownSUP Reveal extracellular vesicle	1	0	32411	32410	32419	
18044	nonhuman primate literature	nonhuman primate literature	1	0	4698	5586	4698	
36461	amount of the tryptophan metabolite kynurenic acid	amount of the tryptophan metabolite INFunknownSUP acid	1	0	8629	36463	8629	
6799	variable Dimitris	variable INFunknownSUP	1	0	6801	6800	6801	
9376	plausible solutions	plausible solution	1	0	9378	4927	9378	
29660	Conference abstracts	conference abstract	1	0	29662	29661	29662	
487	Substantial reduction of healthcare facility-onset Clostridioides difficile infection	substantial reduction of INFunknownSUP facility-onset INFunknownSUP INFunknownSUP infection	1	0	488	491	490	
15183	Component Analysis	component analysis	1	0	204	15184	204	
30950	radiographic images	radiographic image	1	0	4034	5121	4034	
17298	healthcare institution	INFunknownSUP institution	1	0	17300	494	17300	
9546	future implications COVID-19 infection	future implication INFunknownSUP infection	1	0	9548	1367	41	
8426	metabolic derangements	metabolic derangement	1	0	8428	6357	8428	
33158	profile of vedolizumab	profile of INFunknownSUP	1	0	3088	18442	3088	
6838	main characteristics of the policy advisory systems	main characteristic of the policy advisory system	1	0	6840	4679	1496	
8901	bat virus	bat virus	1	0	778	8902	778	
31354	organ-level architecture of receptor expression	organ-level architecture of receptor expression	1	0	31356	13831	13832	
25266	lipid rafts	lipid raft	1	0	25268	4348	25268	
14562	alert-assignment time	alert-assignment time	1	0	179	14563	179	
27616	acute non-ischemic	acute INFunknownSUP	1	0	27618	1461	27618	
31381	Preventative measures	preventative measure	1	0	317	31382	317	
6255	ED triage staff	editor triage staff	1	0	6257	6256	11	
15987	benchtop detection assays	INFunknownSUP detection assay	1	0	15989	15988	2754	
39291	practical dissection	practical dissection	1	0	27110	6164	27110	
4951	higher diagnosis accuracy	high diagnosis accuracy	1	0	4953	322	4535	
26212	extent of the impact	extent of the impact	1	0	17456	110	17456	
19002	importance of well-structured programs	importance of well-structured program	1	0	2765	19004	2765	
9205	virus antigen	virus antigen	1	0	9207	778	9207	
33079	Chinese hospital	Chinese hospital	1	0	185	1968	185	
23919	Pooled rates	pooled rate	1	0	83	23920	83	
35850	Peptide Fragment Interaction	peptide fragment Interaction	1	0	35852	35851	35854	
20379	scoping review	scoping review	1	0	1723	20380	1723	
11794	peptide concentration	peptide concentration	1	0	11518	7496	11518	
8086	collective response to public health emergencies	collective response to public health emergency	1	0	8088	8087	409	
19053	principal components of vertebrate antiretroviral defence mechanisms	principal component of vertebrate antiretroviral defence mechanism	1	0	19055	19054	19056	
34690	electronic surveillance	electronic surveillance	1	0	2795	10569	2795	
19603	vaccine clinics	vaccine clinic	1	0	3424	577	3424	
5161	gel electrophoresis	gel INFunknownSUP	1	0	5163	5162	5163	
8023	significant influencer	significant influencer	1	0	8025	908	8025	
29168	satisfaction Adolescents	satisfaction adolescent	1	0	1165	106	1165	
3805	early risk stratification	early risk stratification	1	0	3807	55	3809	
506	integrated pest control	integrated pest control	1	0	508	507	510	
33830	estimates of nonessential hip	estimate of nonessential hip	1	0	5370	33832	5370	
16732	analysis of the quality of COVID-19-related information	analysis of the quality of COVID-19-related information	1	0	486	16734	486	
31917	measures of Cronbach	measure of INFunknownSUP	1	0	317	31919	317	
12849	important implications	important implication	1	0	9549	273	9549	
36848	age-associated diseases	age-associated disease	1	0	315	36849	315	
1738	new viral pathogens	new viral pathogen	1	0	1740	69	1057	
31457	host cells	host cell	1	0	133	10133	133	
26714	significant infectivity of the virus	significant infectivity of the virus	1	0	26716	908	26717	
18806	serological evaluation	serological evaluation	1	0	2399	2753	2399	
7163	sensitivity analyses	sensitivity analysis	1	0	4668	2904	4668	
16261	shortage of healthcare workforce	shortage of INFunknownSUP workforce	1	0	8840	3748	8840	
18551	systemic changes	systemic change	1	0	1336	1453	1336	
12755	link to immune responses	link to immune response	1	0	3478	969	3478	
15714	expensive centrifuges	expensive centrifuge	1	0	15716	15715	15716	
27928	systemic reactions	systemic reaction	1	0	19148	1453	19148	
24827	envelope protein	envelope protein	1	0	1797	10177	1797	
10719	poorer immune response	poor immune response	1	0	6115	10720	409	
4240	knee arthroplasty surgery	knee INFunknownSUP surgery	1	0	4242	4241	1630	
30004	suboptimal efficacy	suboptimal efficacy	1	0	6704	21573	6704	
34864	memory CD8 T cells	memory INFunknownSUP T cell	1	0	786	7635	133	
17172	respiratory face masks:a	respiratory face INFunknownSUP	1	0	17174	259	17176	
25625	non-emergency dental care services	non-emergency dental care service	1	0	25627	25626	5980	
4237	protein interaction	protein interaction	1	0	2525	1797	2525	
33691	place April	place April	1	0	6417	27255	6417	
14785	presence of overcrowding	presence of overcrowding	1	0	675	14787	675	
33120	Intergenerational coresidence	intergenerational coresidence	1	0	33122	33121	33122	
4094	therapeutic pericardiocentesis	therapeutic INFunknownSUP	1	0	4096	3349	4096	
30134	poor prognosis of the disease	poor prognosis of the disease	1	0	21212	209	12920	
5023	recycling strategies	recycling strategy	1	0	300	5024	300	
6053	new teaching strategies	new teaching strategy	1	0	6055	69	300	
30587	further genomic studies	further INFunknownSUP study	1	0	30589	7713	136	
12950	respiratory coronavirus virus	respiratory coronavirus virus	1	0	12952	259	778	
611	on-campus close book exams	on-campus close book exam	1	0	613	612	617	
8771	important core outcomes	important core outcome	1	0	8773	273	263	
6958	HAI episode	hai episode	1	0	6960	6959	6960	
14189	limited knowledge	limited knowledge	1	0	213	5322	213	
18467	household size &gt	household size &gt	1	0	18469	18468	2385	
35213	brain imaging	brain imaging	1	0	3936	10043	3936	
27806	accurate way of the disease treatment	accurate way of the disease treatment	1	0	27808	324	701	
37600	Israeli National Stroke Registry	Israeli National stroke registry	1	0	37602	37601	17610	
4077	irreversible regional injury	irreversible regional injury	1	0	4079	4078	713	
35080	concurrent clinical trial	concurrent clinical trial	1	0	15893	35081	965	
36508	endemic betacoronaviruses	endemic betacoronavirus	1	0	32304	3067	32304	
2849	Blood centres	blood centre	1	0	2851	2850	2851	
19682	% of medical professionals	% of medical professional	1	0	364	5197	364	
18480	development of guidance	development of guidance	1	0	73	18482	73	
37563	considerable major stress factor	considerable major stress factor	1	0	37565	37564	2183	
5976	public health services	public health service	1	0	5978	1321	5980	
11861	quota sampling	quota sampling	1	0	11863	11862	11863	
36373	laboratory diagnostics strategy	laboratory diagnostic strategy	1	0	36375	1392	3350	
17056	District Hospital	District Hospital	1	0	1879	17057	1879	
9872	vaccination coverage of children	vaccination coverage of child	1	0	9873	6153	4933	
2913	transmembrane serine protease type	INFunknownSUP serine protease type	1	0	775	2914	775	
13755	Spearman Coefficients	Spearman coefficient	1	0	13757	13756	13757	
2980	COVID-19 variants	INFunknownSUP variant	1	0	1002	40	1002	
10626	widespread implementation of infectious disease surveillance	widespread implementation of infectious disease surveillance	1	0	10628	10627	396	
8503	rate of COVID-19	rate of INFunknownSUP	1	0	1034	40	1034	
30202	various literature databases	various literature database	1	0	30204	1099	1755	
5275	predefined cut-off	predefined cut-off	1	0	5277	5276	5277	
14752	everyday conditions	everyday condition	1	0	2910	14753	2910	
10519	economic precarity	economic INFunknownSUP	1	0	10521	108	10521	
18898	implementation of MDTs	implementation of INFunknownSUP	1	0	396	18900	396	
11714	Functional Oral Intake Scale	functional Oral intake Scale	1	0	11716	11715	1203	
38045	linear opacities	linear opacity	1	0	526	8845	526	
22687	travel time	travel time	1	0	179	2879	179	
36343	position statement	position statement	1	0	1684	2825	1684	
36574	COVID-19-affected patients	COVID-19-affected patient	1	0	60	36575	60	
28890	unique issues	unique issue	1	0	3758	3547	3758	
1420	de Domicilios	de INFunknownSUP	1	0	1422	1421	1422	
8407	policy focus	policy focus	1	0	8409	293	8409	
4662	B coefficient	B coefficient	1	0	4664	1846	4664	
25512	serological testing	serological testing	1	0	1885	2753	1885	
37034	multiple organ dysfunction syndrome	multiple organ dysfunction syndrome	1	0	37036	1776	1936	
34097	management methods	management method	1	0	205	743	205	
28063	mild SARS-CoV-2 infection	mild INFunknownSUP infection	1	0	28065	10809	41	
14064	strict quarantine regimes	strict quarantine regime	1	0	14066	8859	14068	
23961	ritos funebres alternativos	INFunknownSUP INFunknownSUP INFunknownSUP	1	0	23965	23962	23965	
27063	COVID-19 related lung injury	INFunknownSUP related lung injury	1	0	27065	40	713	
25623	suspension of non-emergency dental care services	suspension of non-emergency dental care service	1	0	13503	25625	13503	
25069	COVID areas	INFunknownSUP area	1	0	1579	1649	1579	
24941	frequent communication	frequent communication	1	0	11078	1168	11078	
24655	manufacturing practice	manufacturing practice	1	0	3285	718	3285	
19777	existing framework	existing framework	1	0	4860	6308	4860	
21450	high-risk surgical procedures	high-risk surgical procedure	1	0	4198	1184	4200	
5232	number of attacks	number of attack	1	0	916	5234	916	
6275	release criteria	release criterion	1	0	3649	3720	3649	
24595	placebo-treated patients	placebo-treated patient	1	0	60	24596	60	
29401	crude mortality rate	crude mortality rate	1	0	1196	5253	1034	
18394	definite treatment	definite treatment	1	0	97	16709	97	
20821	current global psychiatric literature	current global psychiatric literature	1	0	20823	443	4698	
19494	Occupational therapy	occupational therapy	1	0	2273	19495	2273	
12572	time-consuming process	time-consuming process	1	0	180	12573	180	
4361	COVID-19 Scale	INFunknownSUP Scale	1	0	1203	40	1203	
21572	suboptimal neutralisation rates	suboptimal neutralisation rate	1	0	21574	21573	83	
9956	field-effect transistor-based biosensing system	INFunknownSUP INFunknownSUP INFunknownSUP system	1	0	1327	9957	1327	
12807	degree students	degree student	1	0	1177	12635	1177	
35087	relevant covariates	relevant covariate	1	0	35089	346	35089	
20669	periods of pandemic restrictions	period of pandemic restriction	1	0	873	17340	873	
18088	implementation of the criteria	implementation of the criterion	1	0	396	3649	396	
37393	activity evaluations	activity evaluation	1	0	2456	3990	2456	
15285	kidney transplantations	kidney transplantation	1	0	15287	5169	15287	
18475	stronger positive effect	strong positive effect	1	0	18477	9719	1809	
13322	substantial reduction	substantial reduction	1	0	490	3239	490	
8621	COVID-19 pandemic response	INFunknownSUP pandemic response	1	0	2627	40	409	
573	BNT162b2 mRNA	INFunknownSUP INFunknownSUP	1	0	575	574	575	
35621	short time period	short time period	1	0	11827	16760	5677	
13884	area Sex	area sex	1	0	10683	1089	10683	
33989	Food Preference	food preference	1	0	33991	15250	33991	
23427	Comprehensive Knowledge	comprehensive knowledge	1	0	23429	23428	23429	
35107	languages English	language English	1	0	35109	35108	35109	
19018	EG method	EG method	1	0	6587	19019	6587	
29179	health problems	health problem	1	0	6766	120	6766	
24734	Physical Activity Patterns	physical activity pattern	1	0	24738	24735	24738	
34442	3D U-Net	3D INFunknownSUP	1	0	34444	10448	34444	
34560	wealth of guidance	wealth of guidance	1	0	34561	18482	34561	
29422	% lower NO2 concentrations	% low INFunknownSUP concentration	1	0	29424	364	1959	
27192	postrecovery period	postrecovery period	1	0	5677	27193	5677	
12053	training accuracy	training accuracy	1	0	4535	235	4535	
34128	computational mapping of the S1 protein surface	computational mapping of the INFunknownSUP protein surface	1	0	34130	13184	28658	
13354	psychological factors	psychological factor	1	0	583	1380	583	
8927	benefit-risk assessment	INFunknownSUP assessment	1	0	238	2141	238	
39171	neutrophil to lymphocyte ratio	neutrophil to lymphocyte ratio	1	0	39172	18644	39172	
331	E484K mutation	INFunknownSUP mutation	1	0	333	332	333	
5354	high income	high income	1	0	5356	13	5356	
38032	Health Care	Health Care	1	0	5417	279	5417	
7626	probability of patients	probability of patient	1	0	7627	60	7627	
32459	extension phase 3b ALITHIOS study	extension phase INFunknownSUP INFunknownSUP study	1	0	32461	32460	2087	
16174	Elecsys assay	INFunknownSUP assay	1	0	3119	15283	3119	
2028	internet sobre salud mental durante el primer ano de pandemia	Internet INFunknownSUP INFunknownSUP mental INFunknownSUP el primer Ano de INFunknownSUP	1	0	2030	1528	2046	
17642	lower anxiety	low anxiety	1	0	2772	594	2772	
36863	standard life expectancy	standard life expectancy	1	0	4404	2056	4406	
32081	Admission MR-proADM	admission INFunknownSUP	1	0	32083	32082	32083	
33884	undergraduate occupational therapy students	undergraduate occupational therapy student	1	0	1177	33885	1177	
13927	infection control measures	infection control measure	1	0	13929	41	317	
13159	PCR-positive samples	PCR-positive sample	1	0	1765	13160	1765	
11284	position change of patients	position change of patient	1	0	11285	60	9215	
9491	fractional order mathematical model	fractional order mathematical model	1	0	9493	9492	1078	
22270	pool data	pool datum	1	0	22	22271	22	
5067	higher KA:K	high INFunknownSUP	1	0	5069	322	5069	
24112	legitimacy of wildlife protection regime	legitimacy of wildlife protection regime	1	0	24113	24114	24113	
22091	electronic health record software	electronic health record software	1	0	5231	10568	5231	
371	copying error	copying error	1	0	373	372	373	
20529	demand of the nation	demand of the nation	1	0	20530	20531	20530	
4970	Toxicities Studies	toxicity study	1	0	1533	4971	1533	
34204	severe renal papillary necrosis	severe renal papillary necrosis	1	0	21866	262	5738	
15804	decision-analytic model	decision-analytic model	1	0	1078	15805	1078	
630	administration of hydroxychloroquine to healthcare professionals	administration of hydroxychloroquine to INFunknownSUP professional	1	0	631	632	631	
11531	influent wastewater samples	influent wastewater sample	1	0	11533	8485	1765	
32522	perception of health care professionals	perception of health care professional	1	0	2387	23124	2387	
15239	preprocedural rinse:An	preprocedural INFunknownSUP	1	0	15241	15240	15241	
28323	final AKI stage	final Aki stage	1	0	28325	4256	1521	
38352	cell attachment	cell attachment	1	0	38354	197	38354	
6247	self-controlled study	self-controlled study	1	0	2087	6248	2087	
28968	moderate-intensity SARS-CoV-2 pneumonia	moderate-intensity INFunknownSUP pneumonia	1	0	28970	28969	2369	
33589	RF algorithm	RF algorithm	1	0	1525	1077	1525	
34512	satisfaction of online MBIs	satisfaction of online INFunknownSUP	1	0	106	625	106	
26329	estudio piloto	INFunknownSUP INFunknownSUP	1	0	26331	26330	26331	
6166	blood spots	blood spot	1	0	6168	3129	6168	
18955	higher ACE2	high INFunknownSUP	1	0	3437	322	3437	
8848	Retrospective Study	retrospective study	1	0	8850	8849	8850	
34786	Curriculum adaptation	curriculum adaptation	1	0	20290	22834	20290	
19547	novel health threats	novel health threat	1	0	19549	810	1370	
36304	working of the breast clinic	working of the breast clinic	1	0	26099	32729	26099	
37233	right lateral	right lateral	1	0	29642	15176	29642	
16490	EUROIMMUN Medizinische Labordiagnostika AG	INFunknownSUP INFunknownSUP Labordiagnostika AG	1	0	16494	16491	16496	
5367	Summary estimates of pooled odds ratio	summary estimate of pooled odd ratio	1	0	5369	5368	5370	
5626	primary entry receptor	primary entry receptor	1	0	5628	75	3502	
19097	tumor data	tumor datum	1	0	22	5736	22	
10738	neuromotor function of SCI mice	neuromotor function of SCI mouse	1	0	10740	10739	9243	
25863	immunomodulatory intervention	immunomodulatory intervention	1	0	5608	25864	5608	
12517	CD4 memory T cells	INFunknownSUP memory T cell	1	0	12519	11306	133	
18530	precision medicine	precision medicine	1	0	1110	14211	1110	
10290	bio-layer interferometry	bio-layer interferometry	1	0	10292	10291	10292	
15083	models of central tendency	model of central tendency	1	0	3975	15085	3975	
26122	P/F ratio	P/F ratio	1	0	2635	26123	2635	
18773	dataset of prefectures	INFunknownSUP of prefecture	1	0	17096	18775	17096	
28141	acute respiratory disease	acute respiratory disease	1	0	17132	1461	209	
31763	viral disasters	viral disaster	1	0	31765	1741	31765	
6750	diagnostic value	diagnostic value	1	0	1037	2219	1037	
6176	el afrontamiento precoz	el INFunknownSUP INFunknownSUP	1	0	6178	1910	6180	
20158	new health policy	new health policy	1	0	4936	69	293	
29086	connection method	connection method	1	0	6587	8937	6587	
27347	resonance imaging	resonance imaging	1	0	3936	9917	3936	
17038	serological survey	serological survey	1	0	967	2753	967	
5521	moxibustion device	INFunknownSUP device	1	0	3001	1964	3001	
17036	population-based serological survey	INFunknownSUP serological survey	1	0	17038	3439	967	
29352	metabolites etc.	metabolite etc.	1	0	29354	8323	29354	
39247	overall rate of hospitalizations	overall rate of hospitalization	1	0	39249	2251	1034	
14988	systemic light chain	systemic light chain	1	0	14990	1453	2362	
37991	association of severe PXS score	association of severe PXS score	1	0	11619	37993	11619	
11923	viral infection of the lower respiratory tract	viral infection of the low respiratory tract	1	0	11924	11927	41	
24979	cottoquinazolines B	cottoquinazoline B	1	0	20561	24980	20561	
24103	population mobility	population mobility	1	0	2102	1838	2102	
36427	valuable knowledge	valuable knowledge	1	0	213	9515	213	
7391	total sample size	total sample size	1	0	7393	1485	6366	
36706	eosinophil count	eosinophil count	1	0	1305	36707	1305	
3986	strong antiviral activity	strong antiviral activity	1	0	3988	3987	3990	
2393	bariatric patients	bariatric patient	1	0	60	2394	60	
13853	Delayed emergency department access	delayed emergency department access	1	0	13855	13854	224	
737	credit redemption process	credit redemption process	1	0	739	738	180	
14024	Skin Lesions	skin lesion	1	0	14026	14025	14026	
19714	demonstration of a detrimental effect of PLA2s	demonstration of a detrimental effect of INFunknownSUP	1	0	19715	19716	19715	
38426	psychological halo effect	psychological halo effect	1	0	21050	1380	1809	
1087	infected area	infected area	1	0	1089	1088	1089	
7972	post-inoculation of Vero E6 cells	post-inoculation of Vero INFunknownSUP cell	1	0	7973	7974	7973	
8887	usability heuristics	usability heuristics	1	0	8889	8888	8889	
26739	kidney diseases	kidney disease	1	0	315	5169	315	
11331	command response teams	command response team	1	0	11333	11332	5220	
2608	adaption of drug use policy governance	adaption of drug use policy governance	1	0	2609	2610	2609	
17427	COVID-19-related experience	COVID-19-related experience	1	0	2782	1384	2782	
13967	subset of residents	subset of resident	1	0	13968	232	13968	
32488	appropriate precautions	appropriate precaution	1	0	2126	1256	2126	
29941	trans-Atlantic convenience sample of paediatric urologists	trans-Atlantic convenience sample of paediatric urologist	1	0	29943	29942	2757	
16349	three-dimensional localization	three-dimensional localization	1	0	16351	16350	16351	
18158	remote teaching methods	remote teaching method	1	0	18160	2073	205	
38252	zoonotic potential of animal coronaviruses	INFunknownSUP potential of animal coronavirus	1	0	38254	4605	6265	
10998	data transfer	datum transfer	1	0	10218	22	10218	
34964	neonatal inpatients	neonatal inpatient	1	0	30487	312	30487	
6239	baseline stress rate	baseline stress rate	1	0	6241	5344	1034	
9332	technical sheet	technical sheet	1	0	9334	4083	9334	
28106	future study phases	future study phase	1	0	28110	28107	28110	
5505	MSC therapies	MSC therapy	1	0	5507	5506	5507	
15382	Collection of SARS-CoV-2 Virus	collection of INFunknownSUP virus	1	0	15383	15384	15383	
6327	mutation increases	mutation increase	1	0	6329	333	6329	
19848	Predictions of cancer mortality	prediction of cancer mortality	1	0	19849	19850	19849	
11256	Single-fraction stereotactic ablative body radiation therapy	Single-fraction stereotactic ablative body radiation therapy	1	0	11258	11257	2273	
39188	career levels	career level	1	0	169	39189	169	
1425	quantitative real-time RT-PCR results	quantitative real-time INFunknownSUP result	1	0	1427	1426	325	
16016	non-COVID-19 health services	INFunknownSUP health service	1	0	5978	8107	5980	
18596	Infection control precautions	infection control precaution	1	0	18598	9866	2126	
25753	geriatric assessment model	geriatric assessment model	1	0	1078	25754	1078	
32619	Hospital Conversion	Hospital conversion	1	0	15692	1879	15692	
16093	host angiotensin-converting enzyme-2	host INFunknownSUP INFunknownSUP	1	0	16095	10133	16097	
16947	primary analysis	primary analysis	1	0	486	75	486	
15773	interface of electrocardiogram	interface of electrocardiogram	1	0	10162	15775	10162	
18611	acute disease	acute disease	1	0	209	1461	209	
19613	population-weighted NO2 concentrations	population-weighted INFunknownSUP concentration	1	0	1957	19614	1959	
26410	medical equipment of ICUs	medical equipment of INFunknownSUP	1	0	13199	17722	3038	
17710	fear of COVID-19 infection	fear of INFunknownSUP infection	1	0	9468	39	9468	
35549	further evaluation	further evaluation	1	0	2399	7713	2399	
7228	Heparin treatment	heparin treatment	1	0	97	7229	97	
16542	network structure	network structure	1	0	2427	719	2427	
21739	ongoing challenge	ongoing challenge	1	0	62	1059	62	
23513	incremental prognostic value	incremental prognostic value	1	0	7324	23514	1037	
34540	hospitalization risk	hospitalization risk	1	0	1542	11637	1542	
37511	sterile products	sterile product	1	0	1874	37512	1874	
15866	preservice teachers	preservice teacher	1	0	53	15867	53	
11878	chi-squared test	INFunknownSUP test	1	0	754	11879	754	
18376	reliable instrument	reliable instrument	1	0	7265	12654	7265	
19986	Western philosophy COVID-19	Western philosophy INFunknownSUP	1	0	19988	1848	40	
36522	ventilatory ratio monitoring	ventilatory ratio monitoring	1	0	3271	32816	3271	
22288	retrospective comparative study	retrospective comparative study	1	0	22290	10146	2087	
30809	performance of the RDT	performance of the INFunknownSUP	1	0	598	4496	598	
27679	Pandemic Surge	pandemic surge	1	0	9069	2450	9069	
12779	Transplant Recipients Supplemental Digital Content	transplant recipient Supplemental Digital content	1	0	12781	12780	7950	
5835	huge raw datasets	huge raw INFunknownSUP	1	0	5837	5836	4432	
16422	initial diagnosis	initial diagnosis	1	0	2168	335	2168	
19655	OTC supplementation perceptions	OTC supplementation perception	1	0	19657	7968	2955	
22629	nature of COVID-19 disease	nature of INFunknownSUP disease	1	0	1476	14757	1476	
5034	quantile regression	INFunknownSUP regression	1	0	5036	5035	5036	
14816	markers concentrations	marker concentration	1	0	1959	5129	1959	
35822	COVID-19 diagnoses	INFunknownSUP diagnosis	1	0	13045	40	13045	
8597	mild/moderate severity	mild/moderate severity	1	0	5116	8598	5116	
35572	cerebellar clusters	cerebellar cluster	1	0	860	35573	860	
30144	HC group	HC group	1	0	18	30145	18	
35429	psychiatric sequelae	psychiatric sequela	1	0	35431	4594	35431	
13078	recurrent thoughts	recurrent thought	1	0	13080	13079	13080	
14713	main industrial areas of the country	main industrial area of the country	1	0	14715	4679	1579	
5650	pathophysiology of this novel coronavirus	pathophysiology of this novel coronavirus	1	0	5651	3644	5651	
15070	susceptibility to SARS-CoV-2 infection	susceptibility to INFunknownSUP infection	1	0	10460	1272	10460	
33544	self-isolating household unit	self-isolating household unit	1	0	33546	33545	10	
15262	Transmembrane Protease Serine	INFunknownSUP protease serine	1	0	15264	15263	15266	
33078	Chinese hospital reforms	Chinese hospital reform	1	0	22265	33079	22265	
10381	satisfaction of an online MBI	satisfaction of an online MBI	1	0	106	10383	106	
31718	Training Program	Training Program	1	0	25193	22833	25193	
4430	accessible datasets	accessible INFunknownSUP	1	0	4432	2585	4432	
25582	NIRS modalities:alone	INFunknownSUP INFunknownSUP	1	0	25584	299	25584	
2211	fast-growing human respiratory viruses	fast-growing human respiratory virus	1	0	2213	2212	2217	
21957	inter-hospital transfer of patients	INFunknownSUP transfer of patient	1	0	21958	60	10218	
10235	imbalanced demands	imbalanced demand	1	0	10237	10236	10237	
3840	various hypoxia-associated neuropathological features	various hypoxia-associated neuropathological feature	1	0	3842	1099	1469	
20183	Renal replacement therapy	renal replacement therapy	1	0	14229	20184	2273	
15815	marginalised populations	INFunknownSUP population	1	0	13188	15816	13188	
4132	vaccine dose	vaccine dose	1	0	2537	577	2537	
17048	Veillonella infantium	Veillonella INFunknownSUP	1	0	17050	17049	17050	
25453	mean PS score	mean PS score	1	0	25455	194	1843	
24558	Motor Function Assessment	Motor function Assessment	1	0	24560	24559	2874	
15426	occupational therapy instruction	occupational therapy instruction	1	0	15430	2271	15430	
20157	new health policy voice	new health policy voice	1	0	12227	20158	12227	
12679	world Vaccination	world vaccination	1	0	3872	4336	3872	
5026	laboratory diagnosis	laboratory diagnosis	1	0	2168	1392	2168	
10054	viral life cycle	viral life cycle	1	0	10056	1741	6481	
36879	potential drivers	potential driver	1	0	33848	1276	33848	
6932	high molecular weight	high molecular weight	1	0	6934	13	2711	
488	Substantial reduction	substantial reduction	1	0	490	489	490	
35884	numbers of different immune cell types	number of different immune cell type	1	0	12095	35886	12095	
13436	meeting capacities	meeting capacity	1	0	7793	2543	7793	
9159	RNA structure dependence of sites	RNA structure dependence of site	1	0	9161	1151	9164	
17457	mainland Europe	mainland Europe	1	0	17459	10468	17459	
15108	common signs	common sign	1	0	3011	699	3011	
22666	SARS-CoV-2-infected samples	SARS-CoV-2-infected sample	1	0	1765	2819	1765	
16545	Respiratory Failure	respiratory failure	1	0	11178	3287	11178	
33746	long-term investigation	long-term investigation	1	0	7714	4288	7714	
20440	metal organic framework	metal organic framework	1	0	20442	5109	4860	
27589	elderly population	elderly population	1	0	1838	1329	1838	
36244	proton pump inhibitor	proton pump inhibitor	1	0	15229	36245	4569	
30167	integrated exercise pathways	integrated exercise pathway	1	0	30169	507	8220	
34676	ultrasound score	ultrasound score	1	0	1843	4246	1843	
33828	weekly estimates of nonessential hip	weekly estimate of nonessential hip	1	0	33830	5088	5370	
15651	imaging protocol of acute stroke patients	imaging protocol of acute stroke patient	1	0	15653	3936	7962	
31758	hospital areas	hospital area	1	0	1579	185	1579	
28321	relation to final AKI stage	relation to final Aki stage	1	0	14883	28323	14883	
742	management of possible skin symptoms	management of possible skin symptom	1	0	743	744	743	
14132	open databases	open database	1	0	1755	3995	1755	
13828	organ-level architecture of receptor expression profiles	organ-level architecture of receptor expression profile	1	0	6820	13829	6820	
31318	medical decisions	medical decision	1	0	1942	947	1942	
38883	treatment interruption	treatment interruption	1	0	5642	97	5642	
7856	cellular infection	cellular infection	1	0	41	4919	41	
27462	Plastic Surgery Practice	Plastic surgery practice	1	0	27464	19385	17535	
20923	respect to the length of hospitalisation	respect to the length of hospitalisation	1	0	11762	20925	11762	
26663	heavy gloves	heavy glove	1	0	1821	8258	1821	
10920	ecuacion booleana correspondiente	INFunknownSUP INFunknownSUP INFunknownSUP	1	0	10924	10921	10924	
20228	influenzae type b	influenzae type b	1	0	20230	20229	20232	
11465	single-cell RNAseq levels	single-cell INFunknownSUP level	1	0	11467	11466	169	
12562	initial routine blood tests	initial routine blood test	1	0	12564	335	1365	
23333	transmissibility of the B.1.1.7/Alpha lineage	INFunknownSUP of the B.1.1.7/Alpha lineage	1	0	3451	23335	3451	
18238	original data	original datum	1	0	22	13288	22	
29801	COVID-19 associated consultations	INFunknownSUP associated consultation	1	0	29803	3706	978	
14140	binding experiment	binding experiment	1	0	14142	2921	14142	
8057	period COVID-19	period INFunknownSUP	1	0	40	5677	40	
4231	correlation test	correlation test	1	0	754	2889	754	
29100	B cells	B cell	1	0	133	1846	133	
7261	TROPOMI satellite instrument	INFunknownSUP satellite instrument	1	0	7263	7262	7265	
1917	de medicina	de INFunknownSUP	1	0	1919	1914	1919	
3867	Comment article	Comment article	1	0	3869	3868	3869	
1915	profesionales de medicina	INFunknownSUP de INFunknownSUP	1	0	1917	1916	1919	
24683	evaluation methodology	evaluation methodology	1	0	11687	2399	11687	
38921	leadership structure	leadership structure	1	0	2427	18985	2427	
29137	mean seroprevalence	mean seroprevalence	1	0	4090	194	4090	
16246	mental disorder	mental disorder	1	0	7358	119	7358	
32034	peak force	peak force	1	0	28362	5928	28362	
5606	package intervention	package intervention	1	0	5608	5607	5608	
22614	QC-HC U-Net	INFunknownSUP INFunknownSUP	1	0	22616	3333	22616	
10499	Australian universities	Australian university	1	0	10501	2506	10501	
16976	lack of personal protective equipment	lack of personal protective equipment	1	0	11210	4960	11210	
27543	Evaluation of COVID-19	evaluation of INFunknownSUP	1	0	7849	40	7849	
23811	risk of SARS-CoV-2 infection	risk of INFunknownSUP infection	1	0	1542	1272	1542	
19356	Coronavirus Disease Rapid	INFunknownSUP Disease Rapid	1	0	9843	11497	9843	
31312	special emphasis	special emphasis	1	0	31314	4884	31314	
29059	COVID-19 mortality risk	INFunknownSUP mortality risk	1	0	1542	29060	1542	
24644	Targets Intercellular communication	target intercellular communication	1	0	24646	24645	11078	
37912	vaccine-preventable diseases	vaccine-preventable disease	1	0	315	37913	315	
31596	quality of the health care workers	quality of the health care worker	1	0	3713	1132	3713	
9179	Continuous Negative Pressure Operative Field Barrier	continuous negative pressure operative Field Barrier	1	0	9185	9180	9189	
29319	status of personal protective equipment	status of personal protective equipment	1	0	2720	4960	2720	
18177	genetic disorders	genetic disorder	1	0	889	6655	889	
19867	impact of healthcare organization	impact of INFunknownSUP organization	1	0	19871	19868	19871	
17841	possible hospital	possible hospital	1	0	185	745	185	
16708	definite structural network	definite structural network	1	0	16710	16709	719	
8095	Sanger sequencing	Sanger sequencing	1	0	8097	8096	8097	
30316	C-reactive protein	C-reactive protein	1	0	1797	30317	1797	
9464	laboratory z-scores	laboratory z-score	1	0	9466	1392	9466	
23738	mental wellbeing of the population	mental wellbeing of the population	1	0	23740	119	23741	
34394	potential factors of lockdown resilience	potential factor of INFunknownSUP resilience	1	0	34396	1276	583	
18102	industrial-scale production	INFunknownSUP production	1	0	654	18103	654	
23481	probable animal origin	probable animal origin	1	0	23483	2774	10020	
37041	harmonization of modified curriculum	harmonization of modified curriculum	1	0	37042	37043	37042	
9781	therapeutic effect of Yinqiao powder	therapeutic effect of INFunknownSUP powder	1	0	9783	3349	1809	
14847	% of nonessential cases	% of nonessential case	1	0	364	14849	364	
36206	African experience	African experience	1	0	2782	5365	2782	
27880	food safety management	food safety management	1	0	743	11816	743	
34873	role of the pharmacist	role of the pharmacist	1	0	7288	34875	7288	
27457	COVID-19 report anxiety	INFunknownSUP report anxiety	1	0	27459	40	2772	
35656	occupational category	occupational category	1	0	17420	2272	17420	
2185	SARS-CoV-2 Mpro	INFunknownSUP INFunknownSUP	1	0	2187	28	2187	
13749	Accountability Act	accountability act	1	0	13751	13750	13751	
27111	negative result	negative result	1	0	2267	1338	2267	
321	higher accurate results	high accurate result	1	0	323	322	325	
29129	economic recovery	economic recovery	1	0	3007	108	3007	
9762	precautionary measures	precautionary measure	1	0	317	9437	317	
26349	quick test kits	quick test kit	1	0	25101	22387	25103	
37930	Brazilians Brazil	Brazilian Brazil	1	0	37932	30409	37932	
4782	primate studies of SARS-CoV-2 vaccine candidates	primate study of INFunknownSUP vaccine candidate	1	0	4784	4783	136	
26267	critical illness-associated cerebral microbleeds	critical illness-associated cerebral INFunknownSUP	1	0	19264	223	18200	
36688	observed mortality rates	observed mortality rate	1	0	4976	3762	83	
36333	major organs	major organ	1	0	10453	1318	10453	
37980	imprecise assessment of hazards	imprecise assessment of hazard	1	0	37982	37981	238	
2514	specific bacterial consortium	specific bacterial consortium	1	0	2516	2515	2518	
35629	unilateral unreactive mydriasis	unilateral unreactive mydriasis	1	0	35631	14295	35633	
3091	Hydrogen Sulfide	hydrogen sulfide	1	0	3093	3092	3093	
38926	evidence of SARS-CoV-2	evidence of INFunknownSUP	1	0	585	28	585	
25904	time of Coronavirus	time of INFunknownSUP	1	0	179	3206	179	
4085	international circulation	international circulation	1	0	4087	4086	4087	
3568	orientar la prevencion y el	INFunknownSUP la INFunknownSUP y el	1	0	3574	3569	1910	
38275	JAK-STAT Pathway	INFunknownSUP pathway	1	0	38277	38276	38277	
31923	rank correlation coefficient	rank correlation coefficient	1	0	31925	31924	4664	
19021	wildlife protection policy	wildlife protection policy	1	0	293	19022	293	
27217	clinical samples	clinical sample	1	0	1765	884	1765	
16253	Premier Fellowship	Premier fellowship	1	0	16255	16254	16255	
8548	Vaccine Effectiveness of BNT162b2	vaccine effectiveness of INFunknownSUP	1	0	8550	685	8551	
16034	altered drug metabolism	altered drug metabolism	1	0	11098	4150	7776	
3083	decrease of admissions	decrease of admission	1	0	3084	3085	3084	
32911	coronavirus spikes	coronavirus spike	1	0	32913	339	32913	
15892	clinical trial results of these vaccines	clinical trial result of these vaccine	1	0	15896	15893	325	
14949	la prevencion del duelo complicado	la INFunknownSUP del INFunknownSUP INFunknownSUP	1	0	14951	14950	14957	
13425	operative guidelines	operative guideline	1	0	91	7273	91	
34233	suspected cancer	suspected cancer	1	0	773	1112	773	
27317	current treatment	current treatment	1	0	97	443	97	
33439	contextual differences	contextual difference	1	0	5663	12505	5663	
18119	cancer therapy	cancer therapy	1	0	2273	773	2273	
38558	effects of social distancing	effect of social distancing	1	0	156	382	156	
3163	serious cases	serious case	1	0	229	3164	229	
13765	filtration media	filtration medium	1	0	661	145	661	
24888	protection measure	protection measure	1	0	2466	440	2466	
33919	decision to patient	decision to patient	1	0	5486	710	5486	
37291	significant numbers of non-infected individuals	significant number of non-infected individual	1	0	37293	908	12095	
13708	admission characteristics	admission characteristic	1	0	1496	2865	1496	
